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Abstract 
Abnormal Sonic Hedgehog (SHH) signalling leads to increased transcriptional 
activation of its downstream effector, GLI2, which is implicated in the pathogenesis of a 
variety of human tumours, including human basal cell carcinoma (BCC). However, little 
is known about the molecular mechanisms underlying the tumourigenic role of GLI2 in 
human skin keratinocytes. This study examines the effects of inducible and stable 
expression of constitutively active GLI2 (GLI2∆N) oncogenic transcription factor, on 
immortalised human epidermal keratinocytes. It is shown here that GLI2∆N 
overexpressing N/TERT keratinocytes display gene expression patterns and phenotypic 
characteristics reminiscent of those observed in human BCC in vivo. It is also shown for 
first time, that expression of GLI2∆N in N/TERT keratinocytes is sufficient to induce 
accumulation of binucleated/tetraploid cells as evidenced by an increase in G2/M phase 
of the cell cycle and binucleate cell counting, and to promote polyploidy and 
aneuploidy, in the absence of increased cell death or apoptosis. This cell cycle 
deregulation is accompanied by strong activation of anti-apoptotic protein BCL-2 and 
simultaneous suppression of important cell-cycle regulators such as 14-3-3σ and CDK 
inhibitor p21
WAF1/CIP1
, with no change in p53 protein levels, indicating uncontrolled 
proliferation of cells with ploidy abnormalities and/or DNA damage. Consistently, it is 
shown that p21
WAF1/CIP1
 protein is also absent in human BCC tumours and that forced 
overexpression of GLI2∆N renders human keratinocytes resistant to apoptosis mediated 
by ultraviolet B (UVB, 290-320 nm), one of the most important etiological factors in 
BCC formation. Karyotype analysis of GLI2∆N N/TERT keratinocytes further 
demonstrates that overexpression of GLI2∆N induces numerical (tetraploidy, 
polyploidy, aneuploidy) and structural instability in N/TERT keratinocytes including 
chromosomal translocations and double minute chromosomes. Furthermore, β-catenin 
activation is the most common alteration observed during aberrant WNT signalling, and 
is often implicated in the development of human carcinogenesis and metastasis. In this 
study it is shown that GLI2∆N induction induces nuclear accumulation of β-catenin in 
keratinocyte cell culture and in the basal layer of organotypic skin rafts, similar to 
human BCCs. In addition, several WNT genes were found to be upregulated upon 
GLI2∆N induction, while β-catenin transcriptional activity is increased upon stable and 
conditional expression of GLI2∆N. Overall these data give new insights for the possible 
mechanisms that mediate the tumourigenic potential of GLI2.  
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CHAPTER ONE 
 
 
 
1   INTRODUCTION 
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1.1 Human skin  
The skin is a vital organ that covers the entire outside of the body and guards the 
underlying muscles, bones, ligaments and internal organs, forming a protective barrier 
against pathogens and injuries from the environment. The skin is the largest organ of the 
body in surface area and weight and it consists of two main layers, the epidermis and 
dermis, which are the superficial thinner portion, and the deeper connective tissue 
respectively (anatomical representation of skin is given in Figure 1.1). During 
embryogenesis epidermis is derived from the ectoderm and the dermis from the 
mesoderm. Below the dermis, but not strictly part of the skin is the subcutaneous layer 
(hypodermis). The skin and its appendages including hair follicles, sebaceous and sweat 
glands and nails, ensure a number of critical functions necessary for animal survival. 
Skin, apart from protecting mammals from pathogen and injuries, also protects from 
water loss and temperature change. Other functions include sensory roles, vitamin D 
synthesis, immune surveillance, excretion of wastes through sweat glands, sociosexual 
communication and reproduction by virtue of its appearance and smell (i.e. hormones 
and pherormones) (Freinkel & Woodley, 2001; Tortora & Grabowski, 2003; Goldsmith, 
2005a; Blanpain & Fuchs, 2006). 
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Figure 1.1: Skin structure. 
Diagram showing the multi layered structure of human skin. 
http://www.essentialdayspa.com/Skin_Anathomy_and_Physiology.htm 
 
 
1.1.1 Epidermis 
Human epithelia are tissues composed of cells lining the cavities and surfaces of the 
body. They are classified into different groups, according to their structure and the 
amount of layers of which they are composed. Mature epidermis is a stratified 
squamous epithelium whose outermost layer is the skin surface. The outer covering of 
the skin, is comprised of a stratified multilayered squamous epithelium - known as the 
interfollicular epidermis (IFE) - and associated hair follicles, sebaceous glands and 
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sweat glands which are mainly parts of the dermis. Its main function is to act as a 
waterproof protective barrier and it contains four main types of cells: keratinocytes, 
about 90% of epidermal cells, melanocytes, Langerhans cells, and Merkel cells 
(Freinkel & Woodley, 2001; Tortora & Grabowski, 2003; Goldsmith, 2005a).  
 
Keratinocytes, the most abundant cell type in the epidermis are epithelial cells and 
produce hair follicles, sweat and sebaceous glands, and the outer covering of the skin. 
Keratinocytes are named after the filamentous keratin family of proteins that make up a 
major part of its distinctive cytoskeleton (network of keratin intermediate filaments - 
IFs). Along with microtubules and microfilaments, keratins giving rise to the 
keratinized layer of the epidermis can be used as markers for the epidermis layers, since 
the proportion of different keratins changes as the keratinocytes differentiate. The basal 
layer of the stratified epithelium is typified by the expression of keratins K5 and K14 as 
well as keratin K15 (in the embryo), whereas the intermediate suprabasal layers express 
K1 and K10 (Fuchs, 1993; Freinkel & Woodley, 2001; Tortora & Grabowski, 2003; 
Goldsmith, 2005a; Blanpain & Fuchs, 2006). 
 
The epidermis is divided into many layers where cells are formed through mitosis at the 
innermost layers. They move up the strata changing shape and composition as they 
differentiate and become filled with keratin. They eventually reach the top layer and 
become sloughed off or desquamated, being replaced by inner cells moving outward. 
This process is called keratinization  and takes place within weeks (~ 14 days for mice 
and 28-30 days for human) (Potten & Morris, 1988; Potten & Booth, 2002). The 
outermost layer of epidermis consists of 25 to 30 layers of dead cells. 
 
The five layers of the epidermis are the stratum basale or stratum germinativum (basal 
layer), and the suprabasal layers including stratum spinosum (spinal layer), stratum 
granulosum (granular layer), stratum lucidum (clear layer), and the outermost layer 
stratum corneum (cornified layer), which represent the progressing stages of 
keratinocytes differentiation (maturation of keratinocytes) (Figure 1.2). All the four 
layers (basal layer, spinal layer, granular layer and cornified layer) are found both in 
thick and thin skin, which is defined according to the thickness of the epidermis, while 
the clear layer is only found in thick skin which lacks hair follicles, and as such is only 
observed in the palms of the hands and the soles of the feet. Thin skin covers most of 
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the body and contains hair follicles as well (Freinkel & Woodley, 2001; Tortora & 
Grabowski, 2003; Goldsmith, 2005a). 
 
Differentiation of human epidermis is associated with a series of morphological and 
biochemical changes as cells migrate from the proliferative and mitotic basal cell layer 
through the non proliferative, post mitotic but metabolically active  suprabasal layers 
where the terminal phase of maturation is completed (Fuchs, 1990). Keratinocytes in 
each of these layers are expressing different molecular markers such as keratins, 
involucrin, filaggrin, and loricrin (Fuchs, 1990; Fuchs, 1993; Candi et al., 2005; Fuchs, 
2008).  
 
 
Figure 1.2: Layers of the epidermis. 
The epidermis consists of five different layers of keratinocytes: the stratum basale, the stratum 
spinosum, the stratum granulosum, the stratum lucidum and the stratum corneum 
(http://dermatology.about.com/od/anatomy/ss/epidermis.htm). 
 
 
The stratum germinativum (stratum basale or basal cell layer) is the layer of 
keratinocytes that lies at the base of the epidermis immediately above the dermis and is 
responsible for constantly renewing epidermal cells. It consists of a single layer of tall, 
simple columnar epithelial cells lying on a basement membrane. These undifferentiated, 
proliferative cells are mitotically active and differentiate outward to form the distinctive 
suprabasal layers of the differentiated tissue. About 25% of the basal cells are also 
melanocytes, which produce melanin that provides pigmentation for skin and hair. 
Keratinocytes of the basal layer synthesize K5 and K14 forming cytoskeletal filaments 
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(keratin intermediated filaments) that aggregate into thin bundles (tonofilaments) 
(Fuchs, 1990; Fuchs, 1993; Freinkel & Woodley, 2001; Tortora & Grabowski, 2003; 
Goldsmith, 2005a).  
 
The basement membrane zone (BMZ) which provides the support of basal keratinocytes 
is an extracellular network, rich in extracellular matrix (ECM) and growth factors that 
are produced and deposited at the interface of the epidermis and separate the epidermis 
from the dermis (Figure 1.3A). The ECM, also known as connective tissue (fibrous 
tissue) or mesenchyme, which includes the interstitial matrix (present between various 
animal cells - dermal fibroblasts - (i.e. in the intercellular spaces)) and the basement 
membrane is composed of a mixture of proteins and polysaccharides, including laminin, 
fibronectin, and collagen and elastin which give structural support to the resident cells 
and elasticity to tissues respectively (Figure 1.3A) (Stanley et al., 1982; Alonso & 
Fuchs, 2003b; Blanpain & Fuchs, 2006; Blanpain et al., 2007; Fuchs, 2008). In culture, 
keratinocytes synthesize and deposit the major basement membrane components (i.e. 
fibronectin, laminin, collagen IV), even though the proteins are not organized into a 
recognizable basement membrane (Alitalo et al., 1982; Brown & Parkinson, 1983; Kubo 
et al., 1984; O'Keefe et al., 1984; Oguchi et al., 1985; Bohnert et al., 1986), supporting 
the idea that epidermal keratinocytes are responsible for the synthesis of at least some of 
the components of the basement membrane in human skin (Brown & Parkinson, 1983). 
Fibroblasts (dermal cells) are also capable of synthesising many of the components of 
the basement membrane (Bohnert et al., 1986; Okamoto & Kitano, 1993). Different 
layers have been identified within the basement membrane zone including (i) the plasma 
membrane of the basal keratinocytes, (ii) the lamina lucida that contains mainly laminin, 
integrins and anchoring filaments, (iii) the lamina densa that contains mainly type IV 
collagen, and which fuses with lamina lucida and forms the basal lamina, and (iv) the 
lamina reticularis that contains mainly type VII collagen and is attached to the basal 
lamina with type VII anchoring fibrils and microfibrils (Figure 1.3B) (Stanley et al., 
1982). Anchoring of keratinocytes to the basement membrane is mediated through  
hemidesmosomes, which are protein complexes in the inner basal surface of 
keratinocytes in the epidermis (integrin β4 participates in the formation of 
hemidesmosomes (Dowling et al., 1996)), and are anchoring the cell to the underlying 
basement membrane, by connecting the intermediate keratin filaments with the 
extracellular matrix (Borradori & Sonnenberg, 1999; Nievers et al., 1999; van der Flier 
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& Sonnenberg, 2001), as well as through focal adhesions which are formed  by 
clustering of integrins interspersed on the basal surface of the basal keratinocytes in the 
epidermis and connects the actin cytoskeleton with the extracellular matrix (see 
Chapter 3, Section 3.3.5) (De Strooper et al., 1989; Peltonen et al., 1989; Hynes, 1992; 
Jensen et al., 1999; van der Flier & Sonnenberg, 2001; Blanpain & Fuchs, 2006; 
Blanpain et al., 2007; Fuchs, 2008). The cells of the basal (expressing keratin filaments 
K5 and K14) and spinous layers (expressing keratin filaments K1 and K10) are attached 
to each other by means of cadherin (calcium dependent adhesion molecules)-based 
adherens junctions (see Section 1.4.1) and desmosomes using cadherin proteins, 
respectively, whereas cells in the granular layer are attached to each other by means of 
tight junctions (Fuchs, 1990; Fuchs, 1993; Garrod, 1993; Nievers et al., 1999; Cereijido 
& Anderson, 2001; van der Flier & Sonnenberg, 2001; Blanpain & Fuchs, 2006; 
Blanpain et al., 2007; Fuchs, 2008). Desmosomes are membrane junctions that 
interconnect cells into three-dimensional lattices by connecting the keratin filament 
cytoskeletons of adjacent cells using different cadherin proteins (i.e. desmoglein), 
whereas adherens junctions are membrane junctions that connect the actin filament 
cytoskeletons of adjacent cells, using different cadherin proteins (i.e. E-cadherin) (see 
Section 1.4.1). Tight junctions are membrane junctions that join the actin cytoskeletons 
of adjacent cells using claudin and occludin proteins which establish a paracellular 
barrier that controls the flow of molecules and water in the intercellular space between 
the cells (sealing of the intercellular space). 
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Figure 1.3: Basement membrane zone.  
(A) The basement membrane supports the basal keratinocytes and separates the epidermis from 
the dermis (Alonso & Fuchs, 2003b). (B) The different layers of the basement membrane zone 
at dermal-epidermal junction (IBC Ltd, USA ‘Bioengineering of Skin Substitutes’ handbook 
September 1997).  
B 
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Keratinocytes originate in the basal layer from the division of keratinocyte stem cells 
known as epidermal stem cells which are undifferentiated and have an unlimited self-
renewal capacity. Epidermal basal stem cells strongly adhere to their underlying 
basement membrane and maintain the homeostasis of the interfollicular epidermis by 
replenishing the suprabasal terminally differentiated cells (Blanpain & Fuchs, 2006). 
Undifferentiated basal keratinocyte stem cells, compared to differentiated keratinocytes, 
have greater life span, are slow cycling and divide to rise to a cell that will remain in the 
basal layer as a stem cell and to a daughter cell, known as transit-amplifying cell (TA). 
Transit-amplifying cells, initially will undergo a few rounds of division and then 
following an irreversible withdrawal from the cell cycle (Potten & Morris, 1988), along 
with loss of integrins expression from the cell surface (De Strooper et al., 1989; 
Peltonen et al., 1989) and loss of adhesiveness to a range of extracellular matrix 
proteins, they will be pushed up through the layers of the epidermis, undergoing gradual 
differentiation until they will reach the stratum corneum where they form a layer of 
enucleated, flattened, highly keratinized cells called squamous (Figure 1.4) (Adams & 
Watt, 1990; Lavker & Sun, 2000; Watt et al., 2006; Fuchs, 2008). This layer forms an 
effective barrier to the entry of foreign matter and infectious agents into the body and 
minimises moisture loss. 
 
Figure 1.4: Stages of keratinocyte differentiation in the epidermis. 
Homeostasis of the epidermis is maintained by a subpopulation of basal stem cells (stem cell 
keratinocytes) which adhere to their underlying membrane and are mitotically active cells. Their 
daughter cells known as transit-amplifying cells have a limited proliferative potential, withdraw 
irreversibly from the cell cycle and are destined to undergo terminal differentiation as they 
move upward to the suprabasal layers of the epidermis. Stem cells (purple), Transit-amplifying 
cells (green), Terminally differentiated cells (pink) (Owens & Watt, 2003). 
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The stratum spinosum or spinal layer is a multi-layered (4-8 layers) arrangement of 
cuboidal cells and is the first layer of the differentiation compartment formed by the 
migration of  cells from the basal layer (Fuchs, 1990; Freinkel & Woodley, 2001; 
Tortora & Grabowski, 2003; Goldsmith, 2005a). Although, cells of the stratum 
spinosum are normally post-mitotic, they are still metabolically active and synthesize 
K1 and K10 forming cytoskeletal filaments that aggregate to form tonofibrillar bundles 
which are thicker than tonofilament bundles in basal cells (Fuchs, 1993). These keratin 
intermediate filaments are anchored to the desmosomes, which are more abundant in 
spinous cells than in basal cells, joining adjacent cells to provide extra structural 
support, helping the skin resist abrasion (Fuchs, 1993; Blanpain & Fuchs, 2006; Fuchs, 
2008). As cells move upwards within the spinal layer they synthesize lamellar granules 
which contain lipids that are going to be released into the intercellular spaces of 
granular and stratum corneum cells, and they are responsible for the barrier properties of 
these cells (avoidance of transepidermal water loss) (Fuchs, 1990; Fuchs, 1993). In 
addition, spinous cells at this time also make glutamine and lysine-rich envelope 
proteins, such as involucrin, which is the major soluble cytoplasmic protein precursor of 
the cornified envelope (stratum corneum) in human stratified squamous epithelia, and 
provides a scaffold to which other proteins subsequently become cross-linked and form 
the cornified envelop (Rice & Green, 1977; Murphy et al., 1984; Fuchs, 1990; Fuchs, 
1993; Candi et al., 2005; Fuchs, 2008). 
 
The stratum granulosum or granular layer typically contains 3 to 5 of layers of 
squamous cells with many small basophilic granules (keratohyalin granules - made from 
free ribosomes) in their cytoplasm. Keratohyalin protein forms dense cytoplasmic 
granules that contain profilaggrin - the precursor of the interfilamentous protein 
filaggrin. Additional structural proteins of the cornified envelope including loricrin and 
involucrin are further synthesised by granular cells to reinforce the cornified envelope 
just beneath the plasma membrane. The cells in the stratum granulosum have lost their 
nuclei and are characterised by dark clumps of cytoplasmic material (lamellar granules - 
produced by Golgi apparatus). Lamellar granules that have been made earlier in the 
upper spinous layers, fuse with the plasma membrane and release lipids in into 
intercellular spaces of granular and stratum corneum cells, whereas some of the lipids 
become covalently attached to proteins of the cornified envelope. The envelope proteins 
are vital for the formation of the cornified envelope, which is an insoluble protein 
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structure that is assembled by the cross-linking of the envelope proteins through the 
activation of several enzymes known as transglutaminases (TGs). Transglutaminases are 
calcium dependent enzymes which mediate the formation of a covalently linked 
network of proteins, to finally replace the plasma membrane of terminally differentiated 
keratinocytes in the stratum corneum, and to also act as a scaffold for lipid attachment 
(Fuchs, 1990; Fuchs, 1993; Steven & Steinert, 1994; Candi et al., 2005; Fuchs, 2008). 
Granular layer is the highest layer in the epidermis where living cells are found 
(Freinkel & Woodley, 2001; Tortora & Grabowski, 2003; Goldsmith, 2005a). 
 
The stratum lucidum or clear layer is a thin, clear layer of dead skin cells in the 
epidermis and it helps reduce friction and shear forces between the stratum corneum and 
stratum granulosum. It is named for its translucent appearance under a microscope and 
its keratinocytes are flattened and contain a clear substance called eleidin (intermediate 
form of keratin), which eventually is transformed to keratin that gives the stratum 
lucidum its waterproof properties. This layer is found beneath the stratum corneum of 
thick skin, and as such is only found on the palms of the hands and the soles of the feet 
(Freinkel & Woodley, 2001; Tortora & Grabowski, 2003; Goldsmith, 2005a). 
 
The stratum corneum or cornified layer is the outermost layer of the epidermis (the 
outermost layer of the skin) that constitutes a barrier for the organism against the 
external environment, keeping microorganisms out and essential body fluids in (Fuchs, 
1990; Fuchs, 1993; Freinkel & Woodley, 2001; Tortora & Grabowski, 2003; Goldsmith, 
2005a; Fuchs, 2008). It is composed mainly of dead, terminally differentiated, cornified, 
flattened cells that lack nuclei and are known as corneocytes (cornified keratinocytes). 
As these dead cells slough off, they are continuously replaced by new cells from the 
stratum germinativum (basale). During the transition of granular cells to cornified 
keratinocytes profilaggrin is converted to filaggrin which aggregates the keratin 
filaments into tight bundles (conversion of bundling tonofibrils into macrofirillar 
cables). This promotes the collapse of the cell into a flattened shape which is 
characteristic of the corneocytes of the cornified layer (Fuchs, 1990; Fuchs, 1993; 
Steven & Steinert, 1994; Candi et al., 2005; Fuchs, 2008). Therefore, corneocytes 
mostly consist of keratin intermediate filaments embedded in a filaggrin matrix and 
surrounded by insoluble lipids (Steven & Steinert, 1994; Candi et al., 2005; Fuchs, 
2008). Corneocytes are tightly attached to each other by corneodesmosomes (modified 
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desmosomal structures), which are proteolytically degraded in the uppermost layers of 
the cornified layer to allow desquamation (Serre et al., 1991; Candi et al., 2005).  
 
1.1.2 Dermis 
The dermis is the thickest of the three layers of the skin. It is a layer of skin beneath the 
epidermis that consists of connective tissue (see Section 1.1.1), and cushions the body 
from stress and strain. The main function of the dermis is to regulate the temperature, to 
supply the epidermis with nutrient-saturated blood and to store much of the body’s 
water supply. The dermis is tightly connected to the epidermis by a basement membrane 
(see Section 1.1.1), and harbours many nerve endings that provide the sense of touch 
and heat. It provides skin’s pliability, elasticity, and tensile strength, and thus protecting 
the body from mechanical injury.  
 
The dermis is composed of two layers the papillary layer, a superficial area adjacent to 
the epidermis and a deep thicker one, known as the reticular layer (Figure 1.1). The 
papillary region is composed of loose areolar connective tissue with elastic fibres and it 
contains dermal papillae that house capillaries and free nerve endings. The papillae 
provide the dermis with a "bumpy" surface that interdigitates with the epidermis, 
strengthening the connection between the two layers of skin. The reticular region lies 
deep to the papillary region and is usually much thicker. It is composed of dense 
irregular connective tissue with bundles of collagen, some elastic fibers and adipose 
tissue may be present, and receives its name from the dense concentration of 
collagenous, elastic, and reticular fibers that weave throughout it. These protein fibers 
give the dermis its properties of strength, extensibility, and elasticity. Type I collagen -
the main component of the dermis - is the major dermal collagen with 15% of type III 
and lesser amounts of type IV and V. Dermis contains most of the skin’s specialized 
cells such as adipose cells, mast cells, schwan cells, neurons, with fibroblasts being its 
principal cells. Located in the dermis are also the hair follicles, sebaceous glands, lymph 
vessels, blood vessels, sweat glands and nerve endings (Figure 1.1) (Freinkel & 
Woodley, 2001; Tortora & Grabowski, 2003; Goldsmith, 2005a). 
 
Chapter 1: Introduction 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 38 
1.1.3 Hair follicle 
Hair follicle is a complex ‘mini-organ’. A hair follicle is part of the skin that grows hair 
by packing cells together (Schmidt-Ullrich & Paus, 2005). Hair like sebaceous glands, 
have evolved in skin to form a thermoregulatory system common in mammals. 
 
1.1.3.1 Hair follicle morphogenesis 
Hair follicle is formed during embryogenesis as an appendage of the epidermis and 
involves a temporal series of epithelial-mesenchymal interactions (Figure 1.5) (Millar, 
2002; Schmidt-Ullrich & Paus, 2005; Alonso & Fuchs, 2006; Blanpain & Fuchs, 2006). 
In the embryo, the skin begins as a single layer of epidermal stem cells. Soon after, as 
mesenchymal cells populate the skin to form the underlying collagenous dermis, 
morphogenesis of the hair follicle begins (Schmidt-Ullrich & Paus, 2005; Alonso & 
Fuchs, 2006). Initially, some of the undifferentiated basal cells receive a signal from the 
overlaying epidermis to make an appendage and to adopt a hair follicular fate. In 
response, the epidermis transmits a signal to the underlying dermal cells, in order to 
condense and form the dermal papilla cells (DP). The condensation of these specialized 
cells (DP) in the dermis, stimulates the epithelial stem cells within the overlying 
epidermal basal layer and these start to respond to this DP signal by changing their 
shape (elongate) to develop a bud or “placode”, of hair progenitor cells that 
subsequently proliferate and grow downward, elaborating differentiation required to 
form the epidermal appendage (discrete lineages of the hair follicle and its hair). As the 
developing follicle extends downward and enwraps the DP, the cells at the base 
maintain a highly proliferative state. During follicle maturation, these rapidly 
proliferating cells, called matrix cells, after several rounds of cell division, differentiate 
upward to form the hair shaft (the structure composed of terminally differentiated 
keratinocytes that emerges from the skin surface as hair), its channel the inner root 
sheath (IRS) and the companion layer. Enclosed by the basement membrane, the basal 
layer of the follicle is referred to as the outer root sheath (ORS) and similar to the 
interfollicular epidermis it also expresses K5 and K14 keratins. Hair follicles also 
contain sebaceous glands to ensure the water impermeability of the hair. Also attached 
to the follicle is a tiny bundle of muscle fiber called the arrector pili, that is responsible 
for causing the follicle lissis to become more perpendicular to the surface of the skin, 
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and causing the follicle to protrude slightly above the surrounding skin (Blanpain & 
Fuchs, 2006).                    
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Figure 1.5: Hair follicle formation. 
Hair follicle development during embryogenesis involves a series of epithelial-mesenchymal 
interactions. Mesenchymal cells (dermal papilla) initially stimulate the single layer of epidermal 
stem cells to adopt a hair follicular fate, which in turn stimulates the dermal papilla (DP) cells to 
condense. Then, the dermis by the condensation of DP sends a signal to the epidermis, 
stimulating the overlying epithelial stem cells to grow downward and produce a hair follicle. 
The hair follicle consists of the outer root sheath (ORS), the inner root sheath (IRS), the 
companion layer, the hair shaft, the arrector pili muscle and the sebaceous gland (Blanpain & 
Fuchs, 2006). 
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1.1.3.2 Hair follicle cycle 
The hair coat requires a constant supply of new hairs throughout the lifetime. To 
produce new hairs, existing follicles undergo cycles of growth (anagen), regression 
(catagen) and rest (telogen) (Figure 1.6). During each anagen phase, follicles produce 
an entire hair shaft, while, during catagen and telogen, follicles reset and prepare their 
stem cells so that they can receive the signal to start the next growth phase and make the 
new hair shaft (Alonso & Fuchs, 2006). 
 
After hair follicle formation, and when matrix cells exhaust their proliferative capacity 
or the stimulus required for it, hair growth stops and the follicle regresses and draws the 
dermal papilla upward. At this time, the follicle enters a destructive phase - catagen- in 
which the lower two-thirds of the hair follicle rapidly degenerates by a process 
involving apoptosis. The upper third of the follicle remains intact as a pocket of cells 
surrounding the old hair shaft. The base of this pocket of cells is known as the “bulge”, 
which is the natural reservoir of hair follicle stem cells necessary to form a new hair 
follicle. After catagen, the bulge stem cells enter a resting stage, known as telogen, in 
which the DP cells are in close contact with the bulge stem cells. At the start of the next 
hair cycle, quiescent stem cells residing at the base of the bulge are stimulated to 
migrate and proliferate to supply the cells needed for hair-follicle regeneration and hair 
growth (anagen), in a process that significantly resembles to that of embryonic 
folliculogenesis (Blanpain & Fuchs, 2006; Blanpain et al., 2007). 
 
The three main signalling pathways which are involved in hair follicle morphogenesis 
and adult hair cycle are the Wnt/β-catenin (WNT), the sonic hedgehog (SHH) and the 
bone morphogenetic protein (BMP) (Millar, 2002; Schmidt-Ullrich & Paus, 2005; 
Blanpain & Fuchs, 2006). Bone morphogenetic proteins are secreted proteins that 
activate signal transduction by binding to a transmembrane receptor complex composed 
of Bmpr1 (Bone morphogenetic protein receptor 1) and Bmpr2 (Bone morphogenetic 
protein receptor 2) receptors (Blanpain & Fuchs, 2006). The role of BMPs in skin 
development begins in the neuroectothelium, when BMP signalling specifies 
uncommitted ectodermal cells to become epidermis (Nikaido et al., 1999; Blanpain & 
Fuchs, 2006). Later, during early hair follicle morphogenesis, BMP signalling is 
inhibited by a soluble inhibitor named Noggin, which is expressed by the dermal 
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condensates in order for the placode formation and hair follicle induction to occur (by 
promoting expression of LEF-1) (Botchkarev et al., 1999; Jamora et al., 2003; Blanpain 
& Fuchs, 2006). After placode formation through WNT signalling activation and as 
follicle maturation has progressed through SHH signalling activation, the activation of 
BMP signalling  is essential for the matrix cell to differentiate to form the hair shaft and 
the inner root sheath (IRS) (Blanpain & Fuchs, 2006). Noggin is not only necessary in 
early stages of hair follicle morphogenesis, but it has also been reported to be required 
in the hair growth propagation (telogen to anagen transition) in the postnatal skin, via 
inhibition of BMP4 (Bone Morphogenetic Protein 4) and activation of SHH signalling 
(Botchkarev et al., 2001). The other two signalling pathways and their role to hair 
follicle morphogenesis and adult hair cycle are described in the following sections 
(Section 1.3.1 and Section 1.3.3, and Section 1.4.2 and Section 1.5.1). 
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Figure 1.6: Hair follicle cycle. 
Existing follicles undergo cycles of growth (anagen), regression (catagen), and rest (telogen) 
(Blanpain & Fuchs, 2006). 
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1.1.4 Hypodermis 
The hypodermis or subcutaneous skin, consists of areolar and adipose tissue that 
insulates the body, and serves as a reserve energy supply (Figure 1.1) (Freinkel & 
Woodley, 2001; Tortora & Grabowski, 2003; Goldsmith, 2005a).   
 
1.1.5 Epidermal stem cells 
Stem cells are cell types capable of extensive self-renewal and unlimited replicative 
potential throughout adult life, which also have the ability to produce daughters that 
undergo terminal differentiation and thus differentiate into a diverse range of 
specialized cell types (Lajtha, 1979). Most epithelial tissues, including skin, self-renew 
throughout adult life due to the presence of multipotent stem cells and/or unipotent 
progenitor cells. This renewal capacity of the skin is dependent on proliferation of a 
subpopulation of keratinocytes, known as epidermal stem cells (Lavker & Sun, 2000; 
Blanpain & Fuchs, 2006; Watt et al., 2006; Blanpain et al., 2007). Thus, epidermal stem 
cells (SC) are responsible for renewing the epidermis throughout adult life giving rise to 
the differentiating cells of the interfollicular epidermis (IFE), hair follicles (HF) and 
sebaceous glands (SG) (Watt, 2001; Watt, 2002; Blanpain et al., 2007). Therefore, it 
appears to be at least three distinct niches of skin epidermal stem cells, the follicle 
bulge, the base of the sebaceous glands and the basal layer of the epidermis (Figure 1.7) 
and it also seems that these three progenitor populations share a few common 
expression markers such as K5, K14, p63, E-cadherin, α3β1 and α6β4 integrins as well as 
reduced levels of desmosomes and increased levels of adherens junctions (Fuchs, 2008).  
 
 
 
 
 
 
 
 
 
 
 
Chapter 1: Introduction 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Location of epidermal stem cells. 
Epidermal stem cells is believed to reside in three locations: in the hair follicle bulge, in the 
basal layer of the interfollicular epidermis (IFE) either as clusters (left of the IFE) or singly 
distributed (right of the IFE) (it is still unclear), and in the sebaceous gland (SG) (Watt et al., 
2006). 
 
 
The best characterised of these three reservoirs of stem cells, is the bulge of the hair 
follicle which consists of  multipotent stem cells that can give rise to all lineages of skin 
epithelia including interfollicular epidermis (Figure 1.8), when the skin is wounded in 
order to help the repair of the epidermis leading to the complete regeneration of the 
damaged epidermis (Cotsarelis et al., 1990; Taylor et al., 2000; Oshima et al., 2001; 
Blanpain & Fuchs, 2006; Levy et al., 2007). However, unless the skin is wounded, 
bulge cells only function in hair follicle homeostasis and are not essential for 
maintenance of the interfollicular epidermis, which instead depends on its own resident 
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stem cell population (Claudinot et al., 2005; Ito et al., 2005; Levy et al., 2005; Watt et 
al., 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: Bulge stem cells. 
The bulge dominance model. Epidermal stem cells of the bulge are multipotent stem cells which 
are thought to contribute to the lineages of the hair follicle, the sebaceous gland and the 
epidermis and are the only reservoir of stem cells in the skin. Transit-amplifying cells from 
bulge stem cells differentiate in order to form the respective tissues (Alonso & Fuchs, 2003b). 
 
However, more recently it was shown by Jaks et al. (Jaks et al., 2008) that there is 
another ‘primitive’ stem cell population which is able to give rise to all cell types in the 
mouse hair follicle including the bulge cells and is marked by high expression of Lgr5. 
These Lgr5-expressing cells are located in the lower bulge and secondary germ area of 
mouse telogen hair follicles and in the lower outer root sheath of anagen hair follicles 
(Jaks et al., 2008). Surprisingly, in contrast with the notion thet hair follicle stem cells 
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are relatively quiescent and located in the bulge of telogen hair follicles, the Lgr5-
expressing cells are actively-cycling and showed potent self-renewal and hair follicle 
reconstitution ability (Jaks et al., 2008). In addition,  Lgr6, a close relative of Lgr5 stem 
cell gene, marks a distinct population of stem cells giving rise to all lineages of the skin 
(Snippert et al., 2010). Lgr6 is expressed in the earliest embryonic hair placodes and 
resides in a previously uncharacterised region directly above the mouse follicle bulge. 
Therefore, Lgr6 marks the most primitive epidermal stem cells which are located 
directly above the CD34 and keratin 15-positive bulge and replace the whole epidermis 
and its appendages under normal conditions and upon wounding  (Snippert et al., 2010). 
 
Even though it is known for many years that stem cells exist within the basal layer, it is 
not yet resolved whether all cells of the basal compartment are stem cells, and thus a 
single progenitor population through asymmetric division can give rise to committed 
cells by differentially partitioning proteins to the daughters (asymmetric division model) 
as very recently proposed by Clayton et al. (Clayton et al., 2007; Jones et al., 2007; 
Fuchs, 2008), or only a small number of stem cells exist within the basal layer as 
originally proposed by Potten et al. (Epidermal Proliferative Unit - EPU model) (Potten, 
1974; Fuchs, 2008).  
 
According to the EPU model (Figure 1.9), the mouse epidermis is divided into a 
number of units each of which is known as epidermal proliferative unit that consists of 
~ 10 tightly packed basal cells, which yield a stack of increasingly larger and flatter 
intermediate keratinized cells (‘columnar unit’), finally giving rise to a single hexagonal 
surface cell (Mackenzie, 1970; Potten, 1974; Mackenzie, 1997). Although, this model is 
extensively studied in mice, a similar columnar (stacking) organization is also present in 
the human epidermis and in that of other mammalians, suggesting some 
compartmentalization comparable to the EPU of the mouse (Mackenzie, 1969; 
Mackenzie et al., 1981). This notion was further supported by experiments where either 
mice or human keratinocytes were retrovirally transduced with the Lac-Z gene, which 
coded for the β-gal, and grafted into athymic mice (Mackenzie, 1997; Kolodka et al., 
1998). β-gal expression in the reconstituted epidermis occurred in columnar clusters, 
consistent with the concept of the EPU model. In addition, due to the columnar 
organization, and the highly mitotic activity of the basal cells in the periphery of the 
units compared to the mitotically quiescent cells beneath the central regions of the units, 
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it is suggested that each EPU contains a single slow-cycling, self-renewing stem cell. 
The remaining basal cells of the unit, are stem cell daughters that have left the stem cell 
compartment, are able to divide a small number of times prior to terminal 
differentiation, and are known as transit-amplifying cells or committed progenitors for 
the hemopoietic system (Mackenzie, 1970; Potten, 1974; Mackenzie, 1997; Kolodka et 
al., 1998; Watt, 2002).  
 
 
 
 
 
 
Figure 1.9: Epidermal Proliferative Unit (EPU) model. 
Potten's model of the epidermal proliferation unit for mice. Each approximately hexagonal unit 
of surface skin renews from a basal layer comprising about ten cells, of which only one basal 
stem cell (S) renews the unit (Steven, 2007). 
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1.1.5.1 Heterogeneity in the epidermal basal layer  
1.1.5.1.1 Heterogeneity in vitro and in vivo  
The existence of a progenitor cell compartment (hemopoietic system) equivalent to 
transit-amplifying cells in the basal membrane that are still cycling (Potten & Morris, 
1988), amplifies the effect of each stem cell division so that a relatively small number of 
slow rounds of stem cell division-probably a requirement for stem cell ‘safety’ (‘error 
free’ stem cell genome) and conservation of cell’s proliferative potential -  results in the 
production of a large number of terminally differentiated cells (Lajtha, 1979; Jones & 
Watt, 1993; Lavker & Sun, 2000; Potten & Booth, 2002). Thus, under steady-state 
conditions in vivo, epidermal stem cells in mouse epidermis are believed to divide 
infrequently, and to have a long cell cycle time, estimated to be about twice (200 hr or 8 
days) that of the transit-amplifying cells, unless there is need for regeneration of the 
tissue due to tissue damage or due to in vitro culture conditions, in which cases they are 
capable of sustained self-renewal (more frequent divisions) (Potten, 1974; Potten et al., 
1982; Clausen et al., 1986; Loeffler et al., 1987; Potten & Morris, 1988; Kirkhus & 
Clausen, 1990; Potten & Booth, 2002). Information for the human epidermis is largely 
lacking, but the stem cell cycle time is likely to be greater than 500 hr (about 21 days) 
(Potten & Booth, 2002). In vivo, the mouse stem cell cycle times are capable of 
reductions from 200 hr to significantly less than 12 hr under wounding conditions 
(Potten & Booth, 2002). In vitro, although epidermal stem cells are capable of sustained 
self-renewal (frequent divisions - clonal growth), transit-amplifying cells will undergo 
differentiation within a few rounds of division (no clonal growth) (Watt et al., 2006). 
On the other hand, adult tissue stem cells have a long cell cycle time in vivo, or may 
spend much of their time out of cycling in G0 or quiescence (rarely cycling), one of the 
most universally accepted criterion of stem cells (Lajtha, 1963; Lajtha, 1979; Potten et 
al., 1982; Clausen et al., 1986; Potten & Morris, 1988; Clausen & Potten, 1990; Potten 
& Booth, 2002). 
 
During in vitro culture conditions, even if stem cells have sustained self-renewal and 
their overall cell cycle length might be shorter from their in vivo one, still there is 
heterogeneity in the cell cycle times between human cells in culture (Potten & Morris, 
1988; Clausen & Potten, 1990). Cell kinetic analysis in human keratinocytes in vitro, 
revealed two discrete subpopulations, one fast and one more slowly cycling population 
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(Dover & Potten, 1983). Results based on multiparameter RNA/DNA analysis of cells 
stained with the metachromatic dye acridine orange, also revealed two distinct 
subpopulations of human epidermal cells, markedly differing in RNA content, growing 
in vitro (Eisinger et al., 1979). Usage of the acridine orange dye allows differential 
staining of DNA and RNA due to the fact that when the dye binds the double-stranded 
DNA fluoresces green, while when it binds the single-stranded RNA fluoresces red. 
Thus, flow cytometry analysis showed that the majority of the epidermal cells had high-
RNA content and were rapidly cycling, while a minority population had lower RNA 
values and were cycling much slower (Eisinger et al., 1979). Given that in other cell 
systems the non-cycling quiescent cells are characterised by a low RNA content 
compared to their cycling counterparts (Darzynkiewicz et al., 1977; Darzynkiewicz et 
al., 1979), a proportion of  these low RNA content epidermal cells might represent a 
non-cycling quiescent subpopulation. 
 
It has also further been shown that in human epidermal cultures grown in vitro, the low- 
RNA content and long cell-cycle time epidermal cells were small, while the high-RNA 
content and short cell-cycle time epidermal cells were significantly larger (two to three 
times) (Staiano-Coico et al., 1986). Both of these subpopulations were proliferating, 
albeit at different rates, but there was also a third subpopulation of cells consisting of 
large, non-dividing cells with the highest RNA content. Therefore, it is suggested that 
the small basal cells (low RNA, long cell cycle time) have stem cell properties,  while 
the larger cells (high RNA, short cell cycle time) resemble the transit-amplifying cells 
and terminally differentiating keratinocytes (Barrandon & Green, 1985; Staiano-Coico 
et al., 1986). 
 
The evidence of this heterogeneity within the proliferative compartment in the 
epidermis (Clausen & Potten, 1990) is supported not only from in vitro studies of 
cultured human keratinocytes (holoclones, paraclones, meroclones) (see Chapter 3, 
Section 3.3.4) (Barrandon & Green, 1987), but also by  further in vivo functional studies 
which show that even though a 60% of basal cells are known to be cycling, only 10% of 
the basal keratinocytes are able to form new epidermis when mouse skin is damaged by 
radiation (Withers, 1967; Potten & Hendry, 1973; Potten & Morris, 1988). Thus, this 
10% of dividing cells with a high proliferative capacity are believed to correspond to 
stem cells, while the rest 50% of dividing cells are the transit-amplifying cells which are 
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able to divide for a small number of times, before they will give rise to the remaining 
40% of the basal layer cells. This 40% seems to be the cells that have withdraw 
irreversibly from the cell cycle (post-mitotic) and are committed to terminal 
differentiation (Potten et al., 1982; Potten & Morris, 1988).  
 
1.1.5.1.2 Heterogeneity of basal keratinocytes on their ability to respond to 
tumour promoter treatment 
The functional heterogeneity of basal keratinocytes can also be reflected in their 
differential ability to respond to tumour promoter treatment in vitro. Phorbol esters such 
as TPA (12-0-tetradecanoyl phorbol-13-acetate), also known as PMA (phorbol 12-
myristate 13 acetate), are strong tumour promoters for carcinogen-initiated mouse skin, 
due to their ability to modulate the balance between keratinocyte proliferation and 
differentiation (Boutwell, 1974; Yuspa et al., 1976; Scribner & Suss, 1978). Single 
application of TPA in mouse skin causes differentiation/cell death and regenerative 
epidermal hyperplasia which is thought to be essential for tumour promotion (Argyris, 
1980a; Argyris, 1980b). Induction of sustained hyperplasia by TPA treatment has also 
been reported in human foreskin epidermis maintained as a xenograft in nude mice 
(Yuspa et al., 1979). In vitro, TPA induces terminal differentiation in cultures of normal 
(Hawley-Nelson et al., 1982; Parkinson & Emmerson, 1982) and SV-40-transformed 
(Mufson et al., 1982) human epidermal keratinocytes, while keratinocytes derived from 
human squamous cell carcinoma oppose suspension induced differentiation in vitro 
(Rheinwald & Beckett, 1980) suggesting that transformed cells might be less sensitive 
to TPA-induced terminal differentiation compared to their normal counterparts 
(Parkinson et al., 1983).   
 
Treatment of mouse basal keratinocytes cultured in low calcium, with TPA, can induce 
both terminal differentiation by induction of the enzyme epidermal transglutaminase in 
a subpopulation of cells, and cell growth and proliferation in another (resistant to 
differentiation), a response that depends upon the nature of the target cell (Yuspa et al., 
1980; Yuspa et al., 1982). The resistant in TPA-induced differentiation basal cells kept 
also their resistance to subsequent extracellular calcium-induced differentiation, while 
upon a second exposure to TPA (applied in a short term after the first one - 4 days), 
instead of these cells to differentiate like the control cells did, they were stimulated to 
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proliferate (Yuspa et al., 1982). Further work has shown that a similar functional 
heterogeneity is also present in normal human epidermal keratinocytes in vitro with 
transformed human keratinocyte lines containing far more TPA-differentiation resistant 
cells than their normal counterparts (Parkinson et al., 1983). It was estimated that a sub-
population comprising approximately 10% of cultured normal human epidermal 
keratinocytes, is refractory to TPA-induced differentiation, and does not loose its 
cloning efficiency (colony formation capacity) upon exposure to TPA (Parkinson et al., 
1983). Interestingly, the estimate of TPA resistant keratinocytes was roughly equivalent 
to the estimated proportion of stem cells occupying the mouse basal layer of the 
epidermis in vivo (Parkinson et al., 1983; Parkinson et al., 1987; Potten & Morris, 1988; 
Clausen & Potten, 1990). It was thus postulated that TPA resistant cells may represent a 
population of immature keratinocytes that are defective in their commitment to terminal 
differentiation, and are thus likely to be stem cells.  
 
It was later established that the growth inhibitory effect of TPA was indeed targeted to 
keratinocytes that were more committed to terminal differentiation rather than immature 
basal cells (Parkinson et al., 1987). TPA treatment was able to induce a strong 
proliferative effect in human keratinocytes derived from the more immature foetal skin, 
but had the opposite effect when it was used to treat juvenile human keratinocytes 
(Parkinson et al., 1987). Furthermore, the proportion of TPA resistant keratinocytes was 
shown to be inversely correlated with donor age of either human or mouse skin, and can 
reach up to 30% in newborn mice (Parkinson et al., 1987). This further supported the 
evidence of a functional heterogeneity among basal epidermal keratinocytes in vitro and 
further suggested that the more immature basal epidermal keratinocytes comprise the 
proliferating keratinocyte population in response to phorbol ester treatment.  
 
1.1.5.1.3 Heterogeneity of basal keratinocytes revealed from studies of label-
retaining cells (LRC) 
More evidence for the cellular heterogeneity in the basal layer is also provided by 
studies of label-retaining cells (LRC). Due to the infrequent and slow-cycling nature of 
stem cell, a single pulse with tritiated thymidine (
3
H-TdR), a DNA precursor typically 
used to label cells in S phase, will not be enough to label all stem cells. Therefore, 
continuous administration of 
3
H-TdR for a prolonged period to neonatal or young adult 
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mice will be required, in order for the majority of stem cells to be labelled. Hence, once 
epidermal stem cells are labelled, due to their slow cycling status they will retain the 
isotope for an extended period of time in contrast to rapidly dividing cells (transit-
amplifying cells) and thus can be identified as “label-retaining cells” (Bickenbach, 
1981; Potten & Morris, 1988; Clausen & Potten, 1990). Studies on these cells show that 
label-retaining cells have a non-random distribution in the epidermis, found scattered 
and located towards the centre of columns of keratinocytes in the interfollicular 
epidermis (~ 1 - 4% - 30 d chase period) (EPU-epidermal proliferation unit), the site 
suggested for basal stem cells (Potten, 1974; Bickenbach, 1981; Potten & Morris, 1988; 
Mackenzie, 1997; Potten & Booth, 2002), or being concentrated in a region of the hair 
follicle known as the ‘bulge’ (~ 60% LRCs - 20 d chase period), the site suggested for 
the hair follicle stem cells (Cotsarelis et al., 1990; Morris & Potten, 1994; Morris & 
Potten, 1999).  
 
Even though, label-retaining cells are slow cycling, they can be stimulated to proliferate 
by mitotic activation accompanied by an undifferentiated phenotype, following 
application of the tumour promoter TPA, known to stimulate DNA synthesis in both the 
epidermis and hair follicle (Bickenbach, 1981; Morris et al., 1986; Cotsarelis et al., 
1990). In contrast, most of the mature pulse-labelled cells were rarely found in mitosis 
in response to TPA treatment but were instead displaced from the basal layer and 
ultimately lost from the epidermis (Morris et al., 1986). Thus, label-retaining cells 
proliferate, whereas most pulse-labelled cells differentiate in early response to TPA, in 
agreement with the in vitro study (Parkinson et al., 1983) that reported the existence of a 
subpopulation of normal cultured human keratinocytes which are resistant to TPA 
induced differentiation, and thus may represent stem cells which have been selected by 
TPA, due to their defective commitment to terminal differentiation. 
 
Although, at least some of the labelled cells might be arrested in S phase as a 
consequence of radiation-induced DNA damage, Morris and Potten (Morris & Potten, 
1994) ruled out this possibility by correlating label retention with proliferative potential 
in vitro. They showed that label retaining basal cells cultured from mouse epidermis, 
divide to form colonies (more clonogenic) and appear to possess greater proliferative 
potential than do pulse-labelled cells (mature basal cells), which form colonies only 
rarely (Morris & Potten, 1994). Another study by Bickenbach et al. (Bickenbach & 
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Chism, 1998) further supported the clonogenic capacity and extended growth of mice 
3
H-TdR and bromodeoxyuridine - BrdU (thymidine analog incorporated into 
proliferating cells - S phase) LRCs, consisting of clones of small and slow growing 
cells, which are also accompanied by another keratinocyte stem cell characteristic (Li et 
al., 1998), the rapid attachment to different extracellular matrix proteins of the basal 
membrane. This in vitro clonogenic capacity of the 
3
H-TdR LRC and BrdU LRC along 
with their capability of rapid attachment to different substrates, further support the view 
that LRC may be representative of slow cycling epidermal stem cells. In addition, this 
further supports previous studies that have demonstrated that the clonogenic 
keratinocytes in vitro of the rat and human hair follicles reside primarily in the bulge 
region of the hair follicle, where LRC have been found to be  located (Cotsarelis et al., 
1990), with the only difference that in human, the zone of clonogenic cells was broader 
extending from the bulge to the lower outer-root-sheath (ORS) (Kobayashi et al., 1993; 
Rochat et al., 1994).  
 
More recent studies have also demonstrated that LRC, apart from being clonogenic in 
vitro, have also the capacity of self-renewal, another stem cell characteristic. Both 
Taylor et al. (Taylor et al., 2000) and Tumbar et al. (Tumbar et al., 2004) showed that 
bulge LRC have the capacity to regenerate epidermis in response to injury. Tumbar et 
al. (Tumbar et al., 2004) also showed that bulge LRC are able to regenerate hair follicle 
during the normal hair cycle, which supports the studies of Oshima et al. (Oshima et al., 
2001) demonstrating the ability of bulge cells to contribute to all the differentiation 
lineages involved in the formation of hair follicle as well as in the differentiation into 
sebocytes and interfollicular epidermis.  
 
Label-retaining basal cells also resemble morphological stem cell characteristics. In 
vitro density gradient sedimentation methods, which allow the separation of  cells on the 
basis of size and density, were used in order to separate epidermal cells harvested from 
mice adult skin (Morris et al., 1990). It is well established that decreasing density and 
increasing size are correlated with maturity (differentiation) of keratinocytes and 
therefore differences in density might permit enrichment for a subpopulation of basal 
cells having in vivo and in vitro properties of immature undifferentiated epidermal cells 
(Morris et al., 1990). Thus, suprabasal keratinocytes remained primarily at the top of the 
gradient (less dense, large size), while basal keratinocytes sedimented throughout, but 
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were enriched at the lower part of the gradient (more dense, small size), following 
further continuous sedimentation in order for the basal cells to become separated 
according to different density. Interestingly, sedimentation of subpopulations of 
epidermal basal cells from adult mice labelled in vivo with 
3
H-TdR or with a 
carcinogen, showed that the densest fraction which is morphologically characterised by 
small cells with high nuclear to cytoplasmic ratio is enriched for LRCs, or carcinogen 
retaining cells, while maturing pulse labelled cells were enriched in lighter fractions  
(larger cells) (Morris et al., 1990). Moreover, dense basal cells from normal epidermal 
cells were enriched about two fold for cells that can form colonies in vitro (Morris et al., 
1990). Therefore, overall LRC are small, dense cells with high ratio of nuclear to 
cytoplasmic volume, with self-renewal capacity and high clonogenic in vitro potential, 
all of which are known epidermal stem cell characteristics (Barrandon & Green, 1987; 
Morris et al., 1990; Jensen et al., 1999; Morris, 2000; Tani et al., 2000; Zhou et al., 
2004). 
 
1.1.5.1.4 Functional validity of LRCs 
The functional validity of LRCs was further supported by the first study that linked 
specific cell surface markers (potentially epidermal stem cell markers) with both in vitro 
growth potential and in vivo cell kinetic analysis (Li et al., 1998; Tani et al., 2000). Tani 
et al. (Tani et al., 2000) isolated mice keratinocytes through FACS and demonstrated 
that the subpopulation of mice keratinocytes characterised by high levels of integrin α6 
(adhesion molecule) and low levels of trasferrin-receptor CD71 (proliferation associated 
surface marker), termed α6
bri
 CD71
dim
 cells, are enriched for epithelial stem cells due to 
their small, blast like with high nuclear to cytoplasmic ratio morphology and due to the 
fact that are comprising only a minor population (~ 8%) of quiescent cells at the time of 
the isolation from the epidermis, exhibiting a great long-term proliferative capacity in 
vitro, as it has been previously shown for α6
bri
 CD71
dim
 human keratinocytes (Li et al., 
1998). Interestingly, this cell fraction (α6
bri
 CD71
dim
) was enriched in label-retaining 
cells (~ 70%), rendering slow-cycling 
3
H-TdR LRCs, a valid term for murine 
keratinocyte stem cells. Conversely, the other subpopulation of murine keratinocytes 
expressing both high levels of α6 and CD71 markers, termed as α6
bri
 CD71
bri 
cells, 
represent the majority of keratinocytes (~ 60%), which are larger and exhibit only  
short-term proliferative potential in vitro, as it has also been shown for α6
bri
 CD71
bri
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human keratinocytes (Li et al., 1998), and thus thought to represent the transit-
amplifying cells (Tani et al., 2000). Importantly, this fraction is enriched (~ 70%) in 
3
H-
TdR pulse-labelled cells (PLCs) labelled after a single injection of 
3
H-TdR. In addition, 
immunostaining of skin mouse revealed the presence of CD71
dim
 cells in the bulge of 
the hair follicle, a well documented location of keratinocyte stem cells (Cotsarelis et al., 
1990).  
 
1.1.5.1.5  LRCs in human 
The evidence for the presence of LRCs in vivo is restricted to mice, due to the 
unfeasible application of labelling protocols to humans. However, LRCs have been 
observed in human embryonic and fetal epidermis growing in vitro (organ cultures) 
(Bickenbach & Holbrook, 1987). Approximately 4% and 2% of the embryonic and the 
fetal epidermal cells respectively, retained 
3
H-TdR label after a chase period of 21 days 
in organ culture. In addition, a recent study demonstrated the presence of human LRCs 
in reconstructed human epidermis. Human epidermal keratinocytes were grown on top 
of either collagen matrix (maximum 4 weeks - one complete epidermal regeneration 
cycle), or on modified dermal equivalents (human fibroblasts scaffolds), the latter of 
which are able to support tissue regeneration for a minimum period of 12 weeks 
(Muffler et al., 2008). Keratinocytes were repeatedly pulsed with iododeoxyuridine - 
IdU (thymidine analog incorporated into proliferating cells - S phase) for either 2 days 
or for 2 weeks for collagen (col-OTC) and scaffold (sca-OTC) organotypic cultures 
respectively, and basal LRCs unevenly and randomly dispersed throughout the basal 
layer, were identified in both types of reconstructed epidermis after a chase period of 2 
weeks for collagen and 2-10 weeks for scaffold supported reconstructs, but only the 
scaffold organotypic cultures supported the maintenance of human epidermal stem cells 
and long-term epidermal regeneration. Even though, initially all cells were labelled 
(100%) in sca-OTS, LRC percentages decreased down to  ~ 1% of basal cells, and 
remained constant for the 8 and 10 week chase period, suggesting reestablishment of the 
homeostasis of the epidermis. Interestingly, longer chase periods of 10 weeks in 
scaffold supported epithelium, revealed the presence of quiescent basal LRCs, which 
were frequently close to mitotically active non-labelled basal keratinocytes. However, 
some Ki-67 positive LRCs were seen at all time points (including 10 week chase period) 
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indicating that while in long term OTCs and presumably in homeostatic conditions, 
LRCs are largely quiescent, they are still capable of proliferation. Although organotypic 
reconstruction of human epithelium is not an exact representation of the in vivo 
situation, this study, based on the demonstration of LRCs in an optimised tissue 
organization, and the finding that LRCs appear at a frequency (<1%) (after a 6 week 
chase period in the interfollicular epidermis), similar to the percentage estimated of cells 
which are able to reconstitute the mouse epidermis (stem cells) observed in another in 
vivo study in mice (Schneider et al., 2003), and very close to the number of  LRCs 
found in mouse epidermis (2% 30 d after labelling - 0.2% 8 mo after labelling) 
(Bickenbach, 1981), suggests that a similar LRC-based stem cell hierarchy may exist in 
human epithelium.  
 
However, previous studies in mice had shown that the percentage of cells which are 
able to reconstitute the mouse epidermis after irradiation, are ~ 10% as I have 
previously mentioned (Withers, 1967; Potten & Hendry, 1973). The discrepancies 
regarding the estimated percentages (0.01-10%) of stem cells occupying the basal layer 
of the epidermis could potentially be attributed to the differences in the techniques that 
were employed to detect such populations (Potten & Morris, 1988; Clausen & Potten, 
1990; Bickenbach & Chism, 1998; Schneider et al., 2003). Notably, the percentage of 
cells that could reconstitute mouse epidermis after transplantation in the fascia (soft 
tissue component of the connective tissue system) of immune deficient mice was only 
0.01%, which is 1000 times smaller than the estimated percentage of cells that 
reconstituted mouse epidermis following irradiation (~ 10%). One limitation of the 
former observation could be the possibly reduced transplantation efficiency of mouse 
keratinocytes, taking into account that fascia might be a suboptimal environment for 
epidermal stem cell growth compared to the observations made in intact mouse 
epidermis during irradiation experiments. On the other hand, the estimate of 0.2 - 2% of 
LRCs in mouse epidermis, reported by Bickenbach et al. (Bickenbach, 1981) and other 
label retaining studies (Clausen & Potten, 1990; Bickenbach & Chism, 1998) is in good 
approximation to the percentage of LRCs found in human embryonic and fetal 
epidermis in vitro (Bickenbach & Holbrook, 1987) and in human sca-OCTs (Muffler et 
al., 2008), if one takes into account the intrinsic differences between mouse and human 
keratinocytes, and the differences between an in vivo situation and an in vitro 
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reconstituted epidermis or in vitro culture. Thus the exact number of epidermal stem 
cells still remains elusive. 
 
1.1.5.1.6 LRCs and immortal strand hypothesis 
Even if the slow cell cycle of stem cells seems to be the reason for the presence of 
LRCs, it is unlikely to be the sole explanation. The retention of label in bulge stem cells 
is not surprising, taking into account that these cells rarely undergo cell cycle 
progression and division once the follicle is formed. On the other hand, it is surprising 
that label retention persists in the interfollicular epidermis for many weeks and over a 
time course when stem cells would have been expected to have divided many times, 
according to cell kinetic analysis, and hence to have diluted their incorporated label 
(Potten & Morris, 1988; Potten & Booth, 2002; Potten et al., 2002). Thus, either stem 
cells divide even less frequent and much slower than the initial kinetic studies have 
predicted, or other explanations for the label retention must apply. One such 
explanation could be the selective DNA strand segregation in which case stem cells do 
not randomly segregate their DNA but selectively retain some radiolabelled DNA 
strands. This hypothesis (immortal DNA strand hypothesis) was first proposed for stem 
cells self-renewal by John Cairns in 1975 (Figure 1.10) (Cairns, 1975). During 
replication, the double helix of each chromosome is pulled apart and each strand serves 
as the template for creating the new opposite strand. After replication, due to fact that 
DNA is duplicated semi-conservatively, the two copies called sister chromatids are each 
half old and half brand new. During mitosis, the chromatid pairs are separated from 
each other and are randomly segregated into the daughter cells (one pair per daughter 
cell). According to Cairns’ hypothesis, adult stem cells during mitosis, sort the old 
(templates) from the new DNA strands (non-random template segregation) and divide 
their DNA asymmetrically in a way that one daughter cell will always contain the older 
(‘grandparent’) template strands (stem cell), while the other daughter cell will contain 
the newly (‘parent’) synthesised strands (transit-amplifying cells) (Figure 1.10) (Cairns, 
1975; Rando, 2007). According to Cairns (Cairns, 1975) this is a protective mechanism, 
by which adult stem cells avoid acquiring mutations arising from errors in DNA 
replication that could lead to cancer. Thus, stem cell would retain, throughout the life of 
the organism, its original (‘immortal’) error-free DNA strands, that were generated 
when the cell population first arose during development, and these immortal strands 
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would continue to serve as error-free templates indefinitely. At the same time the newly 
synthesised strands (with any replication-associated errors) would pass to the daughters 
destined for terminally differentiation and subsequent loss (transit-amplifying cells) 
(Cairns, 1975; Rando, 2007). This phenomenon would suggest that label given at a  
time when new stem cells are being made either during development or tissue 
regeneration after injury (label-retention assay), would be incorporated into the 
permanent (immortal) template DNA strands in the stem cells and thus become 
permanently labelled - become LRCs of which label retention will not be necessarily 
related to the length of the cell cycle (Cairns, 1975; Potten & Booth, 2002; Rando, 
2007). On the other hand, if the label is given under homeostatic conditions, where only 
the newly synthesised strands will be labelled, and if the segregation is not random and 
the stem cell retains the older unlabelled template strands, it will lose all label by the 
second division after administration of the label (label-release assay) (Rando, 2007). 
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Figure 1.10: Immortal strand hypothesis. 
Retention of an immortal strand during self-renewal (Top panel). Adult stem cell, containing a 
single chromosome consisting of an older (‘grandparent’) template (blue) and a younger 
(‘parent’) template (red). Following DNA replication and due to an asymmetric division it gives 
rise to a new stem cell (SC) through self-renewal and to the transit-amplifying cell (TA) which 
will give rise to the differentiated mature cells. According to the immortal strand hypothesis the 
sister chromatid containing the older ‘immortal’ strand (blue) remains with the continually 
renewing stem cell through repeated asymmetric divisions for the life of the organism. Random 
and non-random template strand segregation (Bottom panel). Differences in distribution of 
multiple chromatids (in this example, in a theoretical cell with 4 pairs of chromosomes giving 
rise to 16 sister chromatids following DNA replication) if the segregation is either random or 
non-random. According to Cairns (Cairns, 1975), following DNA replication adults stem cells 
sort the old (templates) from the new DNA strands (non-random template segregation) and 
divide their DNA asymmetrically in a way that one daughter cell will always contain the older 
(‘grandparent’) template strands, while the other daughter cell will contain the newly (‘parent’) 
synthesised strand (Rando, 2007). 
TA TA 
TA 
Replication 
SC SC SC 
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The immortal strand hypothesis proposed by Cairns was not purely theoretical. Studies 
since 1960 had shown that there was non-random template strand segregation based in 
DNA template age in bacteria (Cuzin & Jacob, 1965), in mouse embryonic fibroblasts 
(Lark et al., 1966) and in the growing root tips of plants (Lark, 1967). Further, in vitro 
and in vivo studies using either label-retention or label-release assays in stem cells of the 
mouse small intestine (Potten et al., 1978; Potten et al., 2002), breast (Smith, 2005), 
brain (Karpowicz et al., 2005) and muscle (Shinin et al., 2006) have shown that stem 
cells segregate their chromosomes non randomly and asymmetrically, and tend to keep 
the same old template DNA strand through successive divisions, highly supporting the 
immortal strand hypothesis. In another noteworthy study by Merok et al. (Merok et al., 
2002), in vitro cultured cells (immortal non-tumourigenic mouse mammary epithelial 
cells), that model the in vivo asymmetric cell kinetics of adult stem cells (renewal 
growth) upon p53 inducible activation, were used (Sherley et al., 1995). They used this 
in vitro model in order to show that when p53 is continuously overexpressed in non-
stem cells, the cells are induced to divide asymmetrically like adult stem cells (one 
dividing self-renew stem cell and one daughter cell destined for differentiation), and 
they also keep their old template strands together (non-random co-segregation of 
chromosomes containing immortal DNA strands) compared to the non-continuously 
overexpressing p53 cells (Merok et al., 2002). 
 
One of the main restrictions in order for the immortal strand hypothesis to become 
broadly accepted is the fact that all in vivo stem cell examples of non random strand 
segregation have been limited to, at most, a few percent of the cells. However, recently 
Conboy et al. (Conboy et al., 2007) showed that in muscle stem cells (satellite cells), 
during tissue regeneration, the frequency of asymmetric divisions associated with 
template strand segregation is not as rare as in the other stem cell self-renewal in vivo 
studies, but it is approaching the 50% of the proliferating (dividing) stem cells labelled 
in vivo. This difference in frequency, is probably due to the fact that previous in vivo 
studies have sought evidence of the non-random segregation during normal homeostatic 
turnover, while in Conboy et al. (Conboy et al., 2007) study, the experiments were 
carried out during tissue repair, where there is tremendous cell division and thus high 
rate of stem cell expansion. Interestingly, satellite cells not only segregate their DNA 
non-randomly by separating all the chromatids with the older templates from those 
containing the newer templates during multiple and subsequent divisions, but also the 
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daughter cells adopt different fates according to the age of the DNA that they inherited 
(Conboy et al., 2007). The daughter cells that inherit the older strands retain the more 
undifferentiated phenotype while the daughter cells that inherit the new strands are more 
prone to differentiation as revealed by Desmin expression, a marker for muscle 
differentiation (Conboy et al., 2007). 
 
While it is obvious from all these studies that chromosomes are segregated 
asymmetrically in certain cells, it is not yet clear what is the mechanism behind this 
segregation process, whether the fate of the daughter cells is determined by 
chromosome segregation or vice versa, and if the only reason of this non-random 
segregation is the protection of the genome from acquiring mutations. Thus, one other 
possibility for the latter, which is proposed by Lansdorp (Lansdorp, 2007) is that 
asymmetric cell division and cell fate are co directed by epigenetic differences between 
sister chromatids (‘silent sister hypothesis’). According to this hypothesis, epigenetic 
signatures that are present in centromeric DNA regions as well as in certain stem cell-
associated gene regions in the chromatids, can direct chromatid specific non-random 
segregation during mitosis. Non-random segregation of sister chromatids will therefore 
result in one daughter cell retaining the sister chromatid with an ‘active’ stem cell gene 
pattern (stem cell), and another daughter where stem cells related genes are ‘silenced’ 
(transit-amplifying cell). This supports a mechanism whereby the fate of each cell is 
decided, based upon the epigenetic signatures present on the inherited chromatid, and 
proposes that non-random chromatid segregation serves not to avoid DNA replication 
errors, but instead to regulate cell fate (Lansdorp, 2007). 
 
1.1.5.2 Epidermal stem cells and cancer 
The latent period between exposure to known carcinogens and the development of 
tumours is long, generally months in mice or decades in humans, and involves several 
steps the first of which is tumour initiation. Thus, initiated cells or their progeny must 
persist in epithelial tissues at least for these lengths of time (Potten & Morris, 1988).  
According to this, in two-stage carcinogenesis (benign and malignant cutaneous 
neoplasma) in mice the tumour responses are evoked whether promotion (exposure to a 
non carcinogenic promoter - i.e. TPA) is begun one week or one year after the exposure 
to the carcinogen (tumour initiation i.e. DMBA - 7,12-dimenthylbenz(a)anthracene 
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mutagen) (Potten & Morris, 1988). The initiation event is commonly through a 
mutational event presumably one associated with genes controlling cell proliferation 
and/or self-maintenance, and which is able to make an epidermal cell a neoplastic cell, 
while promotion is the expression of the neoplastic cells (Scribner & Suss, 1978). 
Although such initiation mutational events could in principle occur in any cell within 
the tissue, the high and rapid cell migration, would mean that most of these cells that 
have acquired the mutations, are lost through the normal process of terminal 
differentiation within a few days of being mutated (Potten & Morris, 1988) (unless of 
course the mutation’s effect is expressed very quickly and serves to prevent cell from 
being discarded (Cairns, 1975)). Moreover, most tumours are clonal in origin and it has 
been estimated that five events in humans, and two or three in mice are required to 
transform a normal cell into a cancer cell (Hahn et al., 1999; Hahn & Weinberg, 2002).  
 
The process of skin carcinogenesis in mice, also involves a series of biological 
transitions through different stages including hyperplasia, dysplasia, benign papilloma, 
keratoacanthoma, squamous invasive carcinoma, which are induced by or associated 
with the accumulation of multiple genetic alterations in the target-cell population 
(Perez-Losada & Balmain, 2003). Therefore, immortalization of the cancer cells is a 
necessary prerequisite to allow the accumulation of these genetic alterations. According 
to all these notions, only long-term residents of the epidermis, and presumably stem 
cells, have the ability to accumulate the multiple additional mutations that can lead to 
aberrant activation of signalling pathways that normally control proliferation, 
differentiation, and eventually resulting in tumour formation (Owens & Watt, 2003).  
 
In agreement with this and similar to LRC studies, radioactively labelled carcinogens 
are also retained in a few cells in the basal layer predominantly located towards the 
centre of the EPU, as well as in hair follicles (Morris et al., 1986). These carcinogen 
label retaining cells resembled the slow cycling 
3
H-TdR LRC characteristics including 
mitotic activation by TPA, rather than the rapid dividing basal cells ones (mature basal 
cells). Double labelling experiments with 
3
H-TdR and carbon-14-labelled 
benzo(a)pyrene (BP) carcinogen, showed that both molecules are detecting the same 
slow cycling sub-population of epidermal basal cells suggesting that LRCs, and 
presumably epidermal stem cells, are the cells that retain carcinogens for long periods of 
time (Morris et al., 1986; Potten & Morris, 1988). 
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This suggestion was further supported by the later finding, that cells within the basal 
layer of mouse epidermis that are predominantly responsible for tumour formation, in a 
modified application of the classic two-stage carcinogenesis model, are not only 
persistent but are also quiescent, another known stem cell characteristic (Morris et al., 
1997). By the use of fluorouracil 5-fluoro-dUMP (5-FU) which blocks DNA synthesis, 
Morris et al. (Morris et al., 1997) were able to selectively kill all rapidly dividing cells, 
sparing all quiescent populations of the mouse epidermis. Despite the extensive damage 
to the epidermis and hair follicles (reduction in the number of basal cells in the 
interfollicular epidermis, reduction and completely slough off of the epidermis, death of 
the cells of anagen hair germ and thus blockade of the hair growth) inflicted by 5-FU 
treatments, complete hair follicle and epidermal regeneration was achieved after 30 days 
and 6 weeks respectively, suggesting the persistence of quiescent stem cell populations 
in mouse epidermis responsible for the regeneration (Morris et al., 1997). 5-FU drug is 
neither an initiator (5-FU + TPA), nor a promoter (DMBA + 5-FU) of carcinogenesis, 
since its application does not cause any tumour formation. Surprisingly, 5-FU treatment 
before (5-FU + DMBA + TPA) or after (DMBA + 5-FU + TPA) initiation of mouse 
skin with DMBA, did not affect the rate of neither papilloma nor carcinoma formation, 
following tumour promotion with TPA (Morris et al., 1997). This suggests that initiated 
cells by DMBA are resistant to 5-FU and thus are not actively cycling, but quiescent 
cells, residing mainly in the bulge of the hair follicle. Therefore, the fact that mice 
developed epidermal tumours after selective killing of rapidly dividing cells, further 
strengthened the idea that the targets of tumour initiation are indeed quiescent, and 
probably stem cells, which after application of a tumour promoter undergo multiple 
rounds of division, fix the damage within the genome and thus express the transforming 
mutation, caused by initiation (Morris, 2000). 
 
Finally, due to all these studies, it is not surprising that these quiescent target cells of 
carcinogenic action are residing in places where stem cells are thought to be located. 
Initiated mouse skin (DMBA-initiated) can also be promoted to form tumours, by 
repeated induction of full thickness epidermal wounding (repeated abrasion), possibly 
as a consequence of the regenerative hyper-proliferative response of the epidermis 
(Argyris, 1980b). Importantly, the technique used to cause such epidermal abrasions 
allows complete removal of the interfollicular epidermis, while preserving hair follicles 
intact. Therefore, tumours that formed after this continuous epidermal abrasion, have 
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arised from hair follicles suggesting that follicular stem cells are strong candidates for 
tumour initiation (Argyris, 1980b). Following up on this possibility, and using the same 
skin abrasion technique, Morris et al. (Morris et al., 2000) aimed to define the location 
of epidermal tumour initiating cells, again by making use of the two-stage 
carcinogenesis model on either abraded or unabraded skin. Although removal of 
interfollicular epidermis by single abrasion in DMBA initiated mice following by TPA 
treatment, resulted in reduced incidence of papillomas, the number of carcinomas was 
essentially the same for either abraded or unabraded mouse skin (Morris et al., 2000). 
This also supports the previous observations, and suggests that targets of tumour 
initiation in two-stage carcinogenesis models, are stem cells found in the hair follicles 
and to a lesser degree in the interfollicular epidermis (Morris et al., 2000). 
 
The principal that epidermal stem cells already possess the features (self renewal and 
unlimited replicative potential), which are required for cell transformation, and thus are 
strong candidates for the origin of epidermal tumours, is well illustrated in the case of 
p53 mutations with the typical UVB-signature, that have been found in clones of 
phenotypically normal, human sun-exposed skin (Brash & Haseltine, 1982; Jonason et 
al., 1996; Brash & Ponten, 1998; Jensen et al., 1999; Owens & Watt, 2003). Although 
single mutated cells were predominantly suprabasal, terminally differentiated cells, 
patches of p53 mutant cells possess characteristics such as size, distribution, and 
location that are indicative of stem and transit-amplifying cells (Jensen et al., 1999; 
Owens & Watt, 2003). This sets an example for the clonal expansion of mutant stem 
cells that are increasingly susceptible to the acquisition of further genetic hits and thus 
oncogenic transformation. 
 
On the other hand, the possibility that tumours arise from de-differentiated transit-
amplifying cells cannot be excluded but in that case, immortalization does not exist like 
in the primitive target stem-cell population. Thus, more genetic events are required to 
these committed, with limited self-renewal capacity cells, in order first to acquire self-
renewal and unlimited replicative capacity, followed by further mutations that will be 
necessary to result in tumour formation. According to this notion, both in vitro and in 
vivo studies have shown that committed to differentiation (transit-amplifying cells) or 
even post-mitotic terminally differentiated epidermal cells, can re-acquire the ability of 
sustained proliferation in response to retroviral (in vitro) or to forced targeted (under the 
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control of keratin or involucrin promoter) expression (in vivo) of several oncogenes 
such as Ras and c-myc (Barrandon et al., 1989; Bailleul et al., 1990; Greenhalgh et al., 
1993; Brown et al., 1998; Pelengaris et al., 1999). However, in all these cases either the 
lesions that formed did not progress to malignancy, or the only tumours that formed 
were benign papillomas that tend to regress (Bailleul et al., 1990; Greenhalgh et al., 
1993; Brown et al., 1998; Pelengaris et al., 1999), compared to the non-regressed 
malignant carcinomas that mice developed upon targeted Ras expression in the putative 
epidermal stem cells of the hair follicles (Brown et al., 1998). Thus, even though some 
aspects of transformation might be reactivated in the differentiated cells (i.e. 
hyperplasia), and can contribute to skin cancer development, fully malignant cells, 
maintenance of benign tumours or progression of benign tumours to carcinomas, might 
require many more genetic events (Owens & Watt, 2003; Perez-Losada & Balmain, 
2003). 
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1.2 Skin cancer 
Skin cancer is the most common human malignancy partly due to the fact that the skin 
is vulnerable to the effects of carcinogens such as UV radiation. Skin cancer can be 
subdivided generally into melanoma skin cancers which consist of malignant melanoma 
derived from melanocytes, and non-melanoma skin cancers (NMSCs) which consist of 
Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), derived from 
keratinocytes of the skin (Brash & Ponten, 1998). Other types of epidermal tumours 
mainly arising from the hair follicle include the trichofolliculoma, cylindroma, 
pilomatrichoma and sebaceous adenoma (Toftgard, 2000; Owens & Watt, 2003). 
 
1.2.1 Basal Cell Carcinoma (BCC) 
Basal cell carcinoma (BCC), first described by Jacob in 1827 (Jacob, 1827), is the most 
common malignant neoplasm of humans (Miller, 1991a; Miller, 1991b; Miller & 
Weinstock, 1994; Dicker et al., 2002; Lacour, 2002; Wong et al., 2003; Rubin et al., 
2005; Crowson, 2006; Epstein, 2008). Accounting for about half of all cancers in the 
United States and approximately for 80% of all non-melanoma skin cancers (NMSCs), 
with almost 1,000,000 new occurrences per year in the United States (US) alone, BCC 
is the most common cancer in the Western world (Miller, 1991a; Miller & Weinstock, 
1994; Wong et al., 2003; Rubin et al., 2005; Crowson, 2006; Rubin & de Sauvage, 
2006; Epstein, 2008; Ramsey, 2009). BCC is generally a disorder of white individuals 
(especially those with fair skin) and more commonly of those of European ancestry, 
which occurs more frequently in men than in women, mainly on the sun-exposed skin, 
and that tends to occur after the age of 50 (Wong et al., 2003; Crowson, 2006; Epstein, 
2008; Jiang & Szyfelbein, 2009; Ramsey, 2009). However, recent literature reports an 
increase in the incidence of BCC in the 30-39 age group, perhaps correlated with the use 
of ultraviolet (UV) light sunbeds for cosmetic tanning purposes, especially among 
younger women (Karagas et al., 2002; de Vries et al., 2004; Christenson et al., 2005; 
Rubin et al., 2005; Delfino et al., 2006; Bath-Hextall et al., 2007; Epstein, 2008; Jiang 
& Szyfelbein, 2009). In addition, the incidence of BCC also varies geographically and 
globally. States that are close to the equator, such as Hawaii, have an incidence of 
almost 3 times that of states in the Midwest, such as Minnesota, while Australia has the 
highest rate of basal cell carcinoma in the world, with certain regions reporting an 
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incidence of up to 2% per year (Marks et al., 1993; Diepgen & Mahler, 2002; Daya-
Grosjean & Couve-Privat, 2005; Rubin et al., 2005; Epstein, 2008; Jiang & Szyfelbein, 
2009).  
Basal cell carcinomas (BCCs) are keratinocyte tumours that are so named because of 
their histological resemblance to the cells along the basement membrane - the ‘basal’ 
layer of the epidermis of the skin (Epstein, 2008). The majority of BCCs are slow 
growing, locally invading, rarely metastasizing, with no precursor lesions and are 
negative for markers of differentiation (undifferentiated tumours) (see Section 1.3.6), in 
contrast to squamous cell carcinomas (SCCs), which are positive for differentiation 
markers (differentiated tumours), and which unlike BCCs, have detectable precursor 
lesions and are more aggressive (Miller, 1991a; Miller, 1991b; Brash & Ponten, 1998; 
Lacour, 2002; Owens & Watt, 2003; Wong et al., 2003; Daya-Grosjean & Couve-
Privat, 2005; Rubin et al., 2005; Crowson, 2006; Epstein, 2008; Telfer et al., 2008; 
Ramsey, 2009).  
 
Despite the high frequency of BCCs, the death rate is extraordinarily low, reflecting the 
effective treatment of BCCs, including surgical and non-surgical (i.e. radiotherapy, 
topical therapy, photodynamic therapy) methods, and the fact the these tumours rarely 
metastasize (metastatic rates ranging from 0.0028 - 0.55% and BCC most often 
metastasize to the regional lymph nodes, followed by bone, lung and liver) (Miller, 
1991a; Miller, 1991b; Wong et al., 2003; Walling et al., 2004; Rubin et al., 2005; 
Epstein, 2008; Telfer et al., 2008; Jiang & Szyfelbein, 2009; Ramsey, 2009). It is not 
entirely clear why BCC usually does not metastasize, but a possibility might be that 
specialised abnormal stroma is required for its growth, which might be absent or of 
different composition at the new site that BCC cells translocate to, and thus does not 
favour their growth (Blewitt, 1980; Miller, 1991b; Epstein, 2008). This could also 
explain why attempts to transplant (Van Scott & Reinertson, 1961; Cooper & Pinkus, 
1977) or culture (Flaxman & Van Scott, 1968; Flaxman, 1972) BCC cells often result in 
limited growth with frequent terminal differentiation (Miller, 1991b). Indeed there is 
some evidence that BCCs are especially dependent on stroma (stroma-dependent 
tumours), at least for their experimental transplantation to other sites in humans (Van 
Scott & Reinertson, 1961; Epstein, 2008). However, BCC can cause significant tissue 
destruction by local invasion and because BCC most commonly affects the head and 
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neck, surgery is often complicated with unsightly scarring and cosmetic disfigurement is 
frequent (Epstein, 2008; Ramsey, 2009). In addition, recurrence of BCC after local 
excision is common because of non-contiguous growth and difficulty in defining 
surgical margins (Miller, 1991a; Gailani & Bale, 1997). Furthermore, loss of vision or 
the eye may occur with orbital involvement, while perineural invasion and spread of 
BCC can result in loss of nerve function (Ramsey, 2009). Moreover, because BCCs are 
prone to ulceration, they provide a focus of infection (Ramsey, 2009). Therefore, 
enlightening and understanding the molecular pathogenesis and the events contributing 
to BCC development, might be translated into more effective prevention and treatment 
(Dicker et al., 2002; Rubin et al., 2005; Epstein, 2008). 
 
1.2.2 Clinical and Histological features of Basal Cell Carcinoma 
Basal cell carcinoma (BCC) characteristically arises in body areas exposed to the sun 
and is most common on the head (face, ears, scalp) and neck, followed by the trunk and 
arms and legs (Miller, 1991a; Rubin et al., 2005; Jiang & Szyfelbein, 2009; Ramsey, 
2009). They have also been reported in unusual sites such as breasts, perianal area, 
genitalia, palms and soles, whereas the natural history of basal cell carcinoma is that of 
a slowly growing lesion, increasing in size and depth over months and years (Rubin et 
al., 2005; Nahabedian, 2008). Several clinical and histologic subtypes of basal cell 
carcinoma have been described, exhibiting different patterns of behaviour (Ramsey, 
2009). Clinically and histologically, basal cell carcinomas (BCCs) are divided into five 
major types including nodular (solid), superficial, micronodular, infiltrating and 
morpheaform (sclerosing), which are all undifferentiated tumours and from which the 
aggressive growth tumours are the micronodular (intermediate between least and most 
aggressive), infiltrating (most aggressive) and morpheaform (most aggressive) (Sexton 
et al., 1990; Brown & Perry, 2000; Wong et al., 2003; Walling et al., 2004; Rubin et al., 
2005; Crowson, 2006; Nahabedian, 2008; Jiang & Szyfelbein, 2009; Ramsey, 2009). 
Tumours with mixed patterns can be common, and other rare morphologic subtypes 
have also been described (Sexton et al., 1990; Wong et al., 2003; Walling et al., 2004; 
Rubin et al., 2005; Jiang & Szyfelbein, 2009).  
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Nodular BCC (Figure 1.11) represents the most common variant of this neoplasm and 
frequently occurs on the head, neck and upper back (Ramsey, 2009). This is the type of 
BCC that shows a translucent pearly papule with a rolled (raised) border and 
telangiectasia, whereas the lesions may be crusted or ulcerated and they may be 
associated with intermittent bleeding (Figure 1.11A, B) (Wong et al., 2003; Rubin et 
al., 2005; Crowson, 2006; Jiang & Szyfelbein, 2009; Ramsey, 2009). The nodular form 
of BCC is characterised by discrete large or small nests of basaloid cells in either the 
papillary or reticular dermis, accompanied by slit-like retractions from the stroma 
(Figure 1.11C, D) (Crowson, 2006). Regardless of  the overall size of these nodular 
nests, tumour cells tend to align more densely in a palisade pattern in the periphery of 
these nests and typically have large, hyperchromatic, oval nuclei and little cytoplasm 
(Figure 1.11D ii) (Ramsey, 2009). Mitoses are infrequent and apoptotic cells are rare 
(Crowson, 2006). 
 
Superficial BCC (Figure 1.12A, B) is characterised by scaly patches that are pink to 
red-brown, often with central clearing and with slightly raised border (Wong et al., 
2003; Rubin et al., 2005; Jiang & Szyfelbein, 2009; Ramsey, 2009). A threadlike border 
is frequent and superficial BCC is commonly observed on the trunk and has little 
tendency to become invasive (Ramsey, 2009). Superficial BCC (Figure 1.12C) appears 
as buds of basaloid cells attached to the undersurface of the epidermis. Nests of various 
sizes are often seen in the upper dermis and tumour cell aggregates typically show 
peripheral palisading (Ramsey, 2009). Commonly, superficial BCC is characterised by a 
proliferation of basaloid cells that form an axis parallel to the epidermal surface and 
demonstrate slit-like retraction of the palisaded basal cells from the subjacent stroma 
(Figure 1.12D) (Crowson, 2006). Mitoses and individual cell necrosis are uncommon 
(Crowson, 2006). 
 
Micronodular BCC (Figure 1.13) manifests a plaque-like indurated lesion with a poorly 
marked contour (Crowson, 2006). It is not prone to ulceration while it may appear 
yellow-white when stretched and it is firm to the touch (Ramsey, 2009). Histologically, 
the micronodular type (Figure 1.13 i) is similar to nodular, manifesting tumour nests of 
basaloid cells with roughly the same round shape and contour as nodular BCC, but are 
smaller and widely dispersed in an often asymmetric distribution extending deeper into 
the dermis and/or subcutis (Crowson, 2006; Jiang & Szyfelbein, 2009; Ramsey, 2009). 
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The retraction spaces are less pronounced than in the nodular form of BCC, and the 
surrounding stroma shows a collagenised morphology (Figure 1.13 ii), suggesting that 
micronodular lesions may be an intermediate step between nodular and aggressive 
growth subtypes, such as infiltrating and morpheaform (Crowson, 2006; Nahabedian, 
2008; Ramsey, 2009). Micronodular BCC has been also reported to have a higher 
incidence of local recurrence that nodular BCC (Crowson, 2006; Jiang & Szyfelbein, 
2009). 
 
Infiltrating BCC (Figure 1.14A) and morpheaform (sclerosing) BCC (Figure 1.15A) 
clinically both  appear as an indurated white-to-waxy sclerotin (scarlike) plaque with ill-
defined margins (indistinct borders which are often extend well beyond clinical 
margins), resembling a scar and is most commonly observed in the head and neck area. 
Ulceration, bleeding and crusting are uncommon in infiltrating BCC, as well as in 
morpheaform BCC (Wong et al., 2003; Rubin et al., 2005; Crowson, 2006; Nahabedian, 
2008; Jiang & Szyfelbein, 2009; Ramsey, 2009). Histologically, both infiltrating 
(Figure 1.14B) and morpheaform (Figure 1.15B) BCCs have growth patterns resulting 
in elongated strands of basaloid cells that are extending into the tissue, rather than round 
nests (Walling et al., 2004; Crowson, 2006; Ramsey, 2009). Infiltrating BCC (Figure 
1.14B) arises as strands of basaloid tumour cells, 4-8 cells thick, with spiky, irregular 
appearance, embedded in a dense fibrous stroma (the stroma is frequently fibrotic with 
proplastic stromal fibroblasts), whereas an admixed nodular component is often 
observed in this BCC subtype (Crowson, 2006; Jiang & Szyfelbein, 2009; Ramsey, 
2009). Similarly, morpheaform BCC (Figure 1.15B) arises as thinner, narrow strands of 
basaloid tumour cells, 1-2 cells thick and cords up to five cells may be present (tumour 
tongues), with no basal lamina and embedded in a densely collagenised stroma 
containing proplastic fibroblasts (Crowson, 2006; Jiang & Szyfelbein, 2009; Ramsey, 
2009). Slit-like retraction from the stroma is less pronounced in infiltrating and 
morpheaform BCC, compared to nodular and superficial ones, but is still often 
demonstratable (Crowson, 2006; Ramsey, 2009). In addition, both infiltrating and 
morpheaform BCC show individual cell necrosis and mitotic activity of the neoplastic 
cells (Crowson, 2006). Infiltrating and morpheaform subtypes which are classified as 
aggressive BCCs, in contrast to non-aggressive nodular and superficial BCCs, apart 
from showing deep invasion of the dermis and at some times invasion of the subcutis, 
they may exhibit perineural invasion as well, making difficult their removal and 
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increasing the incidence of recurrence (Brown & Perry, 2000; Walling et al., 2004; 
Crowson, 2006; Nahabedian, 2008).  
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Figure 1.11: Nodular BCC. 
Clinical morphology: (A) This translucent pink papule has telangiectases and a crusted erosion, 
characteristic of nodular basal cell carcinoma. (B) Nodular basal cell carcinoma appearing as a 
waxy, translucent papule with central depression and a few small erosions. Histomorphology: 
(C), (D), (i) Rounded nodular aggregates of basalioma cells and of variable size are present in 
the dermis and exhibit peripheral palisading (PP) and retraction artefact (RA) (cleft formation). 
(D), (ii) The nodules of tumour show a peripheral palisade of basaloid cells, and at the interface 
with the stroma, slit-like retraction is seen (arrow) whereas stromas so no significant 
fibroplasias. Modified from (Crowson, 2006; Ramsey, 2009). 
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Figure 1.12: Superficial BCC. 
Clinical morphology: (A) Scale, erythema (redness of the skin caused by hyperemia of the 
capillaries in the lower layers of the skin), and a threadlike raised border are present in this 
superficial basal cell carcinoma on the trunk. (B) Larger, superficial basal cell carcinoma. 
Histomorphology: (C) Nests of basaloid cells are seen budding from the undersurface of the 
epidermis. (D) A proliferation of basaloid cells parallel to the long axis of the epidermis. Serial 
sectioning showed the small nest at left to connect to the remainder of the tumour, which is in 
continuity with the undersurface of the epidermis. Modified from (Crowson, 2006; Ramsey, 
2009).  
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Figure 1.13: Micronodular BCC. 
Histomorphology: (i), (ii) Micronodular BCC manifests uniformly small nests of neoplastic 
basal cells with rounded peripheral contours extending widely throughout the sampled dermis. 
(ii) The adjacent stroma shows fibroplasia, indicating a transition step in evolution from nodular 
to aggressive growth BCC. Modified from (Crowson, 2006). 
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Figure 1.14: Infiltrating BCC. 
Clinical morphology: (A) This infiltrating basal cell cancer has ill-defined borders and 
telangiectases. Histomorphology: (B) In a densely proplastic and heavily collagenised stroma, 
small irregular tongues of neoplastic basaloid cells often 5-8 cells thick are embedded in the 
collagen table. However the tumour tongues manifest an admixture of rounded nodules, large 
nodules with irregular contours and small irregular tongues of tumour cells embedded in the 
fibrous stroma. These lesions almost invariably arise in sun-damaged skin, the morphologic 
evidence of which is solar elastosis (arrow). Modified from (Crowson, 2006; Ramsey, 2009).  
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Figure 1.15: Morpheaform BCC. 
Clinical morphology: (A) Large, scarlike morpheaform basal cell cancer. Histomorphology: (B) 
Like infiltrating BCC, the morpheaform BCC shows heavy stromal collagenisation and 
proplasia of stromal fibroblasts. Small irregular (sharply angulated) tongues of neoplastic 
basaloid cells, often 1-4 cells thick are embedded in this fibrous stroma. Modified from 
(Crowson, 2006; Ramsey, 2009).  
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1.2.3 Risk factors and Molecular genetics of Basal Cell Carcinoma 
Ultraviolet (UV) radiation which is the carcinogenic factor in sunlight (Soehnge et al., 
1997) is known to be one of the main risk and etiological factors in human skin BCC 
formation (Miller, 1991b; Gailani & Bale, 1997; Lacour, 2002; Wong et al., 2003; 
Daya-Grosjean & Couve-Privat, 2005; Rubin et al., 2005; Crowson, 2006; Epstein, 
2008; Jiang & Szyfelbein, 2009; Ramsey, 2009), since the most frequent mutations 
found in particular genes (tumour suppressor genes) in human BCCs, have the ‘UV 
signature’ of UV-light mediated mutations (Grossman & Leffell, 1997; Soehnge et al., 
1997; Brash & Ponten, 1998; Armstrong & Kricker, 2001; de Gruijl et al., 2001; 
Ehrhart et al., 2003; Epstein, 2008). These specific mutations in DNA, are consistently 
associated with UV radiation, and are characterised by C (cytidine) to T (thymidine) or 
CC to TT transitions at dipyrimidine sites, induced by UVB (solar ultraviolet B, 280-
320 nm) radiation (see Chapter 4, Section 4.2.5) (Brash & Haseltine, 1982; Grossman 
& Leffell, 1997).  
 
In addition, physical factors such as skin type, hair and eye colour are also an important 
consideration for BCC tumour formation, since very fair skinned individuals (skin type 
1) with red or blonde hair and light coloured eyes are at high risk of developing BCCs, a 
risk which increases with childhood freckling and severe sunburn (Wong et al., 2003; 
Daya-Grosjean & Couve-Privat, 2005; Rubin et al., 2005; Crowson, 2006; Ramsey, 
2009). Other risk factors that have been linked to the development of BCC are 
environmental insults such as ionizing radiation and arsenic exposure, family history of 
BCC, low intake of vitamins and high intake of fats (Miller, 1991b; Wong et al., 2003; 
Daya-Grosjean & Couve-Privat, 2005; Rubin et al., 2005; Crowson, 2006; Epstein, 
2008; Ramsey, 2009). Moreover, patients on immunosuppressive treatment (organ-
transplant recipients) such as renal and heart transplant recipients, also have an 
increased risk of basal cell carcinoma (Miller, 1991b; Wong et al., 2003; Daya-Grosjean 
& Couve-Privat, 2005; Rubin et al., 2005; Crowson, 2006; Jiang & Szyfelbein, 2009; 
Ramsey, 2009).  
 
Interestingly, several genetic conditions are associated with the predisposition to basal 
cell carcinoma, including albinism (defect of melanin production), Bazex’s syndrome 
(X-linked dominant condition with features of follicular atrophoderma, hypotrichosis, 
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hypophidrosis and multiple BCCs), xeroderma pigmentosum and nevoid basal cell 
carcinoma syndrome (Gorlin syndrome) (Miller, 1991b; Wong et al., 2003; Daya-
Grosjean & Couve-Privat, 2005; Crowson, 2006; Jiang & Szyfelbein, 2009; Ramsey, 
2009). Xeroderma pigmentosum (XP) is an autosomal recessive genetic disorder of 
DNA repair in which the ability to repair damage caused by ultraviolet (UV) light is 
deficient and is associated with an acute photosensitivity manifested by sunlight 
induced abnormal pigmentation, a dry prematurely aged skin and a predisposition to 
develop multiple skin cancers at a very early age, including BCCs (Stary & Sarasin, 
2002; Lehmann, 2003; Daya-Grosjean & Couve-Privat, 2005; Crowson, 2006; Ramsey, 
2009). Gorlin or nevoid basal cell carcinoma (NBCC) syndrome is an autosomal 
dominant hereditary disease which predisposes patients to the early development of 
multiple BCCs, medulloblastomas and ovarian fibromas and is characterised by a range 
of developmental anomalies, including skeletal abnormalities, dental malformations, 
facial dysmorphism, hyperkeratosis of the palms and soles and basal cell nevi (Gorlin, 
1987; Gorlin, 1995; Chiang et al., 1996; Gailani & Bale, 1997; Kimonis et al., 1997; 
Ming et al., 1998; Booth, 1999; Wicking et al., 1999; Villavicencio et al., 2000; Bale & 
Yu, 2001; Mullor et al., 2002; Wong et al., 2003; Daya-Grosjean & Couve-Privat, 2005; 
Athar et al., 2006; Crowson, 2006; Ramsey, 2009). 
The genetic analysis of Gorlin or nevoid basal cell carcinoma (NBCC) syndrome has 
been shown to be caused by patched (PTCH) gene germline inactivation mutations, a 
tumour suppressor gene which is located to chromosome 9q22.3, while frequent loss of 
heterozygosity at 9q22.3 (loss of the remaining wild-type allele at 9q22.3) is observed 
in BCCs and other tumours from these patients (Gailani et al., 1992; Hahn et al., 1996b; 
Johnson et al., 1996; Unden et al., 1996; Gailani & Bale, 1997; Unden et al., 1997; 
Brash & Ponten, 1998; Happle, 1999; Ling et al., 2001; Dicker et al., 2002; Daya-
Grosjean & Couve-Privat, 2005). Loss of heterozygosity is a genetic mechanism by 
which a cell heterozygous for a gene – i.e. tumour suppressor gene – (due to mutation of 
the gene in one allele) becomes either homozygous or hemizygous for the mutant allele, 
because the corresponding wild-type allele is lost due to a somatic mutational event 
(Happle, 1999). Mutation of the inherited wild-type copy in Gorlin patients has been 
shown to occur by both loss of heterozygosity (germline mutation of one PTCH allele 
and loss of the normal copy of PTCH) and point mutation (germline mutation of one 
PTCH allele and point mutation in the remaining non-deleted wild-type PTCH allele) 
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(Unden et al., 1996; Gailani & Bale, 1997; Booth, 1999). Similarly, PTCH inactivated 
mutations occur frequently in sporadic BCCs (60-70%) and in BCCs associated with 
xeroderma pigmentosum (80-90%), as well as allelic loss of the remaining wild-type 
patched gene (53%) (loss of heterozygosity of PTCH) (Gailani et al., 1996; Gailani & 
Bale, 1997; Soehnge et al., 1997; Unden et al., 1997; Brash & Ponten, 1998; Bodak et 
al., 1999; Booth, 1999; D'Errico et al., 2000; Ling et al., 2001; Dicker et al., 2002; 
Lacour, 2002; Daya-Grosjean & Couve-Privat, 2005; Reifenberger et al., 2005; Teh et 
al., 2005). UVB irradiation has been shown to be responsible for a 40-50% of PTCH 
mutations in sporadic human BCCs and for an 80% of PTCH mutations in BCCs 
associated with xeroderma pigmentosum (Bodak et al., 1999; D'Errico et al., 2000; 
Lacour, 2002; Daya-Grosjean & Couve-Privat, 2005; Reifenberger et al., 2005). 
Interestingly, a study by Teh et al. (Teh et al., 2005) using genomewide single 
nucleotide polymorphism microarray in sporadic human basal cell carcinoma, followed 
by DNA sequencing, showed that 93% of BCCs had loss of heterozygosity (LOH) at 
9q, of which 69% had mutations in the Patched gene, while 62% of the 9q LOH were a 
result of allelic loss and 38% of the 9q LOH, with no change in copy number, were a 
result of uniparental disomy. Uniparental disomy during meiosis (division of sperm and 
egg cells) is when a person receives two copies of a chromosome or part of a 
chromosome from one parent and no copies from the other parent. Uniparental disomy 
occurs also as a somatic event either due to chromosome non-disjunction, where one 
daughter cell acquires three copies of a chromosome and the other daughter cell one 
copy of the chromosome (one daughter cell acquires both copies of the wild-type gene 
and one copy of the mutant gene whereas the other daughter cell acquires one copy of 
the mutant gene and no copy of the wild-type gene followed by subsequent 
chromosomal duplication) or due to mitotic recombination (mitotic cross-over) where 
there is exchange of segments between chromatids of homologous chromosomes 
(Happle, 1999). 
Importantly, the protein encoded by PTCH gene, the gene affected in Gorlin patients 
and in sporadic BCCs, is the Hedgehog (HH) ligand receptor and the HH signalling 
pathway repressor, a pathway which is critical in embryonic development (see Section 
1.3) (Chen & Struhl, 1996; Marigo & Tabin, 1996; Stone et al., 1996; Brash & Ponten, 
1998; Athar et al., 2006; Kasper et al., 2006a; Epstein, 2008). Thus patched inactivation 
(i.e. by mutations) is linked to constitutive activation of the HH pathway and gives the 
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first evidence for an involvement of HH signalling pathway in tumourigenesis (see 
Section 1.3) (Brash & Ponten, 1998; Booth, 1999; Bale & Yu, 2001; Daya-Grosjean & 
Couve-Privat, 2005; Kasper et al., 2006a; Epstein, 2008). 
Another gene which is frequently mutated (40-60%) in sporadic human BCCs and in 
BCCs associated with xeroderma pigmentosum is the p53 tumour suppressor gene, 
which encodes for a protein that regulates the cell cycle and induces apoptosis in the 
cells (Barbareschi et al., 1992; Shea et al., 1992; Grossman & Leffell, 1997; Ponten et 
al., 1997; Soehnge et al., 1997; Bodak et al., 1999; D'Errico et al., 2000; de Gruijl et al., 
2001; Ling et al., 2001; Dicker et al., 2002; Lacour, 2002; Daya-Grosjean & Couve-
Privat, 2005; Reifenberger et al., 2005; Epstein, 2008). UVB irradiation is known to be 
responsible for a high number (65-75%) of p53 mutations in human sporadic and XP-
related BCCs (Bodak et al., 1999; D'Errico et al., 2000; Demirkan et al., 2000; Dicker et 
al., 2002; Lacour, 2002; Bolshakov et al., 2003; Daya-Grosjean & Couve-Privat, 2005; 
Reifenberger et al., 2005).  
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1.3 Hedgehog (HH) signalling pathway 
1.3.1 HH signalling network 
The hedgehog (HH) signal transduction pathway was originally discovered by genetic 
analysis in Drosophila melanogaster embryos (Nusslein-Volhard & Wieschaus, 1980), 
containing a single hedgehog gene (hh), but subsequent studies showed that it is more 
complex in vertebrates, and three hedgehog homologue proteins have been identified in 
mammals (Echelard et al., 1993; Goodrich et al., 1996; Wicking et al., 1999; Bale & 
Yu, 2001; Ingham & McMahon, 2001; Hooper & Scott, 2005). These include the Sonic 
hedgehog (Shh (mouse) /SHH (human)), Indian hedgehog (Ihh (mouse) /IHH (human)) 
and the Desert hedgehog (Dhh (mouse) / DHH (human)) (Echelard et al., 1993), of 
which the Shh/SHH is the best-characterised since it is the most potent and most 
broadly expressed in embryonic and adult tissues (Chiang et al., 1996; Ming et al., 
1998; Wicking et al., 1999; Bale & Yu, 2001; Pathi et al., 2001; Ruiz i Altaba et al., 
2002b; Daya-Grosjean & Couve-Privat, 2005; Athar et al., 2006).  
 
Although some crucial differences exist, the HH signalling mechanisms are generally 
conserved between Drosophila and higher organisms (Goodrich et al., 1996; Hahn et 
al., 1996a; Booth, 1999; Ingham & McMahon, 2001; Ruiz i Altaba et al., 2002a; Cohen, 
2003; Pasca di Magliano & Hebrok, 2003; Wetmore, 2003; Beachy et al., 2004; Lum & 
Beachy, 2004; Daya-Grosjean & Couve-Privat, 2005; Hooper & Scott, 2005; Rubin & 
de Sauvage, 2006; Rohatgi & Scott, 2007; Varjosalo & Taipale, 2007). In the absence of 
hh/HH signal (i.e. SHH) (Figure 1.16a), a 12-transmembrane receptor protein Patched 
(Ptc in Drosophila  and PTCH or PTCH1 in humans, Ptch or Ptch1 in mouse, since a 
second patched gene PTCH2/Ptch2 was identified in vertebrates (Carpenter et al., 1998; 
Motoyama et al., 1998a; Booth, 1999; Smyth et al., 1999; Wicking et al., 1999; 
Zaphiropoulos et al., 1999; Toftgard, 2000; Pasca di Magliano & Hebrok, 2003)) 
(Hooper & Scott, 1989; Nakano et al., 1989; Goodrich et al., 1996; Hahn et al., 1996a), 
inhibits the activity of a 7-transmembrane protein Smoothened (SMO in humans, Smo 
in mouse and Drosophila) (Alcedo et al., 1996; van den Heuvel & Ingham, 1996; Xie et 
al., 1998; Ingham & McMahon, 2001; Cohen, 2003; Ruiz-Gomez et al., 2007), possibly 
catalytically and not through protein-protein interaction (Stone et al., 1996; Denef et al., 
2000; Kalderon, 2000; Taipale et al., 2002; Rohatgi & Scott, 2007; Varjosalo & Taipale, 
Chapter 1: Introduction 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 83 
2007), thereby inhibiting the downstream transduction cascade. In Drosophila the 
cytoplasmic tail of Smo interacts with a multimolecular complex in the cytoplasm, 
consisting of (i) microtubule-associated kinesin-like protein Costal2 (Cos2) - a key 
negative regulator of the Hh pathway downstream of Smo that promotes 
phosphorylation of Ci transcription factor, (ii) serine-threonine protein kinase 
Suppressor of Fused (Sufu) - a negative regulator (minor role) of the Hh pathway 
downstream of Smo, (iii) serine-threonine protein kinase Fused (Fu) - a protein that acts 
positively on the Hh pathway downstream of Smo by inducing the nuclear accumulation 
of Ci and enhancing its transcriptional activity, and (iv) the zinc-finger transcription 
factor cubitus interruptus (Ci) (see Section 1.3.2) (Preat et al., 1990; Limbourg-
Bouchon et al., 1991; Preat, 1992; Chen & Struhl, 1996; Robbins et al., 1997; Sisson et 
al., 1997; Monnier et al., 1998; Chuang & McMahon, 1999; Methot & Basler, 2000; 
Fukumoto et al., 2001; Methot & Basler, 2001; Cohen, 2003; Jia et al., 2003; Lum et al., 
2003; Lum & Beachy, 2004; Hooper & Scott, 2005; Rubin & de Sauvage, 2006; 
Varjosalo & Taipale, 2007); whereas in vertebrates the cytoplasmic tail of smoothened 
containing the domain that binds to Cos2 and Cos2 are not involved (Varjosalo et al., 
2006) and the multimolecular complex consists of (i) SUFU/Sufu - a key negative 
regulator (major role) of the Hh pathway downstream of Smo, with an important role 
also in the shuttling of the GLI proteins between the cytoplasm and the nucleus, (ii) 
FU/Fu (?) - a protein that acts positively on the Hh pathway downstream of Smo and 
(iii) GLI1/Gli1, GLI2/Gli2, GLI3/Gli3 (Ci homologues in Drosophila (see Section 
1.3.2)), which in both cases (Drosophila and vertebrates) the protein complexes are 
bound to microtubules/cytoskeleton and serve to retain the Ci/Gli transcription factors 
in the cytoplasm without activating transcription (Ding et al., 1999; Kogerman et al., 
1999; Pearse et al., 1999; Stone et al., 1999; Murone et al., 2000; Ruiz i Altaba et al., 
2002a; Pasca di Magliano & Hebrok, 2003; Wetmore, 2003; Beachy et al., 2004; Lum 
& Beachy, 2004; Merchant et al., 2004; Barnfield et al., 2005; Chen et al., 2005; Daya-
Grosjean & Couve-Privat, 2005; Merchant et al., 2005; Rubin & de Sauvage, 2006; 
Svard et al., 2006; Varjosalo et al., 2006; Rohatgi & Scott, 2007; Varjosalo & Taipale, 
2007). The Ci/Gli transcription factors which are bound to these protein complexes are 
phosphorylated by several kinases, followed by binding of the phosphorylated Ci/Gli 
proteins to Slimb/β-TrCP protein which directs the (i) ubiquitin proteasome processing 
of Ci/Gli proteins into carboxy-terminus-truncated repressors that move to the nucleus 
and repress the Ci/Gli-dependent transcription of target genes, and/or (ii) the ubiquitin 
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proteasome degradation of full-length Gli transcription factors (see Section 1.3.2) 
(Figure 1.16a) (Ruiz i Altaba et al., 2002a; Wetmore, 2003; Daya-Grosjean & Couve-
Privat, 2005; Hooper & Scott, 2005; Zhang et al., 2005; Rubin & de Sauvage, 2006; 
Varjosalo & Taipale, 2007; Wang et al., 2007).   
 
In the presence of hh/HH ligand (i.e. SHH) (Figure 1.16b), activation of the pathway, 
either in Drosophila or in vertebrates, is initiated through binding of any of the three 
secreted hh/HH (i.e. SHH) ligands to patched receptor (Chen & Struhl, 1996; Marigo & 
Tabin, 1996; Stone et al., 1996) which results in loss of patched activity, and possibly 
inhibition of the catalytic activity that activated patched exerted to smoothened and 
rendered it inactive, leading to consequent activation of smoothened which transduces 
the signal from plasma membrane to the cytoplasm (Chen & Struhl, 1996; Stone et al., 
1996; Denef et al., 2000; Kalderon, 2000; Ruiz i Altaba et al., 2002a; Taipale et al., 
2002; Pasca di Magliano & Hebrok, 2003; Wetmore, 2003; Lum & Beachy, 2004; Zhu 
& Scott, 2004; Daya-Grosjean & Couve-Privat, 2005; Hooper & Scott, 2005; Rubin & 
de Sauvage, 2006; Rohatgi & Scott, 2007; Varjosalo & Taipale, 2007; Wang et al., 
2007). After HH binding in patched, followed by smoothened activation, in Drosophila 
smoothened is phosphorylated in the serine/threonine residues of its C-terminal 
cytoplasmic tail - the region responsible for binding to Cos2 that forms a complex with 
Fu, SuFu and Ci - and becomes stabilised and transduces the signal to Ci through the 
Cos2-Fu-SuFu complex. Hence, through inactivation of Cos2 and SuFu and activation 
of Fu, the protein complex dissociates from the microtubules, Ci is released from the 
complex and thus its phosphorylation and cleavage ceases, leading to its translocation to 
the nucleus, subsequent binding to DNA and transcriptional activation of downstream 
genes (see Section 1.3.2) (Ohlmeyer & Kalderon, 1998; Matise & Joyner, 1999; Denef 
et al., 2000; Methot & Basler, 2001; Cohen, 2003; Jia et al., 2003; Lum et al., 2003; 
Wetmore, 2003; Lum & Beachy, 2004; Hooper & Scott, 2005; Zhang et al., 2005; 
Kasper et al., 2006a; Rubin & de Sauvage, 2006; Wang et al., 2007). In vertebrates, 
where phosphorylation and stabilisation of the cytoplasmic tail of smoothened that 
binds to Cos2 as well as Cos2 protein and possibly Fu protein are not involved to the 
transduction of the HH signal from the plasma membrane to the cytoplasm (Murone et 
al., 2000; Chen et al., 2005; Merchant et al., 2005; Varjosalo et al., 2006; Varjosalo & 
Taipale, 2007; Wang et al., 2007), activated smoothened somehow inhibits SuFu - a 
major negative regulator of the hedgehog signalling in vertebrates that directly binds to 
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Gli/GLI proteins and which also serves as an adaptor protein that links GLI to the 
Slimb/β-TrCP-dependent proteasomal degradation/processing pathway (Stone et al., 
1999; Cheng & Bishop, 2002; Cohen, 2003; Merchant et al., 2004; Kasper et al., 2006a; 
Svard et al., 2006; Varjosalo & Taipale, 2007) - and thus through an unknown 
mechanism triggers the dissociation of Gli/GLI transcription factors from the SuFu-
Fu(?) protein complex, resulting to the inhibition of their phosphorylation and 
processing and/or degradation, leading to their translocation to the nucleus and hence 
subsequent DNA binding and transcriptional activation of HH-target genes (see Section 
1.3.2) (Matise & Joyner, 1999; Toftgard, 2000; Ruiz i Altaba et al., 2002a; Cohen, 
2003; Pasca di Magliano & Hebrok, 2003; Wetmore, 2003; Beachy et al., 2004; Lum & 
Beachy, 2004; Daya-Grosjean & Couve-Privat, 2005; Hooper & Scott, 2005; Kasper et 
al., 2006a; Rubin & de Sauvage, 2006; Rohatgi & Scott, 2007; Varjosalo & Taipale, 
2007; Wang et al., 2007; Epstein, 2008). 
 
Target genes of hh/Ci signalling in Drosophila include Wingless (Wg) and 
Decapentaplegic (Dpp) which are essential for normal embryonic development and 
differentiation of many adult tissues. These genes are the orthologues of the vertebrate 
target genes: the Wnt (WNT family) (see Section 1.4, Section 1.5.1 and Section 1.5.3) 
and the bone morphogenetic proteins (BMPs) (see Section 1.1.3.2) (Matise & Joyner, 
1999; Methot & Basler, 1999; Wicking et al., 1999; Ruiz i Altaba et al., 2002b; Cohen, 
2003; Ruiz i Altaba et al., 2003; Daya-Grosjean & Couve-Privat, 2005). Interestingly, 
both in Drosophila and in vertebrates Ptc/Ptch which is an inhibitor of the HH/Gli 
pathway, is a transcriptional target gene, suggesting a negative-feedback loop that 
restricts the extent of HH signalling (Chen & Struhl, 1996; Matise & Joyner, 1999; Ruiz 
i Altaba et al., 2002a; Cohen, 2003; Pasca di Magliano & Hebrok, 2003; Wetmore, 
2003; Beachy et al., 2004; Zhu & Scott, 2004; Daya-Grosjean & Couve-Privat, 2005; 
Athar et al., 2006; Eichberger et al., 2006; Varjosalo & Taipale, 2007). Similarly, in 
vertebrates an additional transmembrane protein, like patched, the Hh-interacting 
protein (Hip) which binds to HH proteins and reduces their range of movement by 
attenuating ligand diffusion, thereby possibly acting as a negative regulator of HH 
signalling pathway, has also been reported to be a  transcriptional target of HH/Gli 
signalling (Chen & Struhl, 1996; Chuang & McMahon, 1999; Wicking et al., 1999; 
Ruiz i Altaba et al., 2002a; Pasca di Magliano & Hebrok, 2003; Beachy et al., 2004; 
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Zhu & Scott, 2004; Daya-Grosjean & Couve-Privat, 2005; Athar et al., 2006; Varjosalo 
& Taipale, 2007).  
 
Furthermore, other target genes of HH/Gli signalling are not only Gli genes themselves, 
but also genes that are involved in proliferation (see Section 1.3.7) (i.e. PDGFRα 
(platelet-derived growth factor receptor), cyclin D, cyclin E, FOXM1 (forkhead box 
M1), apoptosis (i.e. BCL-2 (B-cell lymphoma 2), c-FLIP (c (cellular)-FAS-associated 
death domain-like IL (interleukin)-1-converting enzyme-like inhibitory protein), 
invasion and metastasis (i.e. SNAIL transcription factor (see Chapter 5, Section 
5.2.1.5)), as well as stem cell genes (i.e. SOX9 transcription factor (SRY (sex 
determining region Y)-box 9), and transcription factors which have been shown to have 
a repressor function such as FOXE1 (winged helix domain transcription factor) (overall 
see Section 1.3.6.1) (Matise & Joyner, 1999; Ruiz i Altaba et al., 2002a; Ruiz i Altaba 
et al., 2002b; Pasca di Magliano & Hebrok, 2003; Ruiz i Altaba et al., 2003; Wetmore, 
2003; Beachy et al., 2004; Daya-Grosjean & Couve-Privat, 2005; Aberger & Frischauf, 
2006; Athar et al., 2006; Kasper et al., 2006a). 
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Figure 1.16: The Shh/Gli signalling pathway. 
(a) In the absence of the Shh ligand, Ptch is unstimulated and inhibits Smo and Gli activity, as 
Gli transcription factors are retained as a complex associated with other proteins and 
microtubules in the cytoplasm and thus unable to activate transcription. Gli transcription factors 
are phosphorylated by PKA, GSK3β and CK1 proteins and then targeted for proteasomal 
degradation and/or processing through β-TrCP ubiquitin ligase. (b) Shh ligand binding 
stimulates Smo and allows Gli nuclear translocation, and thereby activating transcription. Ptc, 
Patched; Smo, Smoothened; Cos2, Cotal2; SUFU, Suppressor of Fused; Gli1, Gli2, Gli3, Gli 
zinc-finger trasncription factors; Fu, Fused; PKA, protein kinase A; GSK3β, glycogen synthase 
kinase 3β; CK1, casein kinase 1; β-TrCP, beta-transducin repeat containing protein. Modified 
from (Wetmore, 2003). 
 
 
 
Chapter 1: Introduction 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 88 
1.3.2 Gli/GLI transcription factors 
In contrast to Drosophila where all transcriptional responses to HH signalling are 
controlled by the Gli homologue Ci segment polarity gene (Cubitis interruptus) (Orenic 
et al., 1990), which can both activate and repress HH-target genes, vertebrates (mouse 
and human) have at least three distinct Gli (mouse) / GLI (human) genes, Gli1/GLI1, 
Gli2/GLI2 and Gli3/GLI3, and the proteins encoded by these Gli/GLI genes are 
transcription factors (Ruppert et al., 1988; Ruppert et al., 1990; Hui et al., 1994; 
Villavicencio et al., 2000; Ingham & McMahon, 2001; Kasper et al., 2006a).  
 
Human GLI1 (also known as GLI) is the first vertebrate GLI gene that was discovered 
and thus is the founder member of the GLI gene family (GL1, GLI2, GLI3 in humans, 
Gli1, Gli2, Gli3 in mice and Ci in Drosophila), which was originally identified as an 
amplified gene in a human glioblastoma (Kinzler et al., 1987; Kinzler et al., 1988; 
Matise & Joyner, 1999; Villavicencio et al., 2000; Cohen, 2003; Epstein, 2008). GLI1 
was also detected as an amplified gene in other cancers such as osteosarcomas, 
rhabdomyosarcomas and B cell lymphomas, while it has been classified as an oncogene 
due to its ability to transform mouse cells in cooperation with adenovirus E1A in vitro, 
and also to be tumourigenic in nude mice that have been subcutaneously injected with 
these cells (Roberts et al., 1989; Ruppert et al., 1991; Werner et al., 1997; Matise & 
Joyner, 1999; Villavicencio et al., 2000; Kasper et al., 2006a). GLI1 maps to 
chromosome 12q13, GLI2 maps to chromosome 2q14 and GLI3 maps to chromosome 
7p13 (Ruppert et al., 1990; Matsumoto et al., 1996; Reifenberger et al., 1996; 
Villavicencio et al., 2000; Cohen, 2003).  
 
All three vertebrate Gli/GLI proteins have high homology to Ci in the zinc-finger 
domain, and limited homology in a number of domains outside this region (Matise & 
Joyner, 1999). The common, highly conserved DNA binding domain (zinc-finger 
domain) of GLI1, GLI2 and GLI3 transcription factors, comprises of five conserved 
tandem C2-H2 zinc-fingers and a conservative histidine (H) - cysteine (C) linker 
sequence between zinc fingers (Ruppert et al., 1988; Pavletich & Pabo, 1993; Matise & 
Joyner, 1999; Villavicencio et al., 2000; Cohen, 2003; Kasper et al., 2006a). GLI1 and 
GLI3 proteins were shown to recognize and bind to a conserved GACCACCCA 
nucleotide sequence in the promoters of target genes (Kinzler & Vogelstein, 1990; 
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Ruppert et al., 1990; Pavletich & Pabo, 1993; Vortkamp et al., 1995), and GLI2 
recognizes and bind to a nearly identical GAACCACCCA motif (Tanimura et al., 
1998; Villavicencio et al., 2000).  
 
Gli1 and Gli2 appear to act primarily as transcriptional activators, whereas Gli3 (and at 
times Gli2) functions as a repressor (Matise & Joyner, 1999; Ruiz i Altaba, 1999b; 
Ingham & McMahon, 2001; Ruiz i Altaba et al., 2002b; Daya-Grosjean & Couve-
Privat, 2005; Kasper et al., 2006a; Wang et al., 2007; Epstein, 2008). Gli3 has also been 
reported to act to a much lesser extent as an activator (Sasaki et al., 1999; Shin et al., 
1999; Buttitta et al., 2003; Kasper et al., 2006a). In addition, in the absence of SHH 
signalling, the biological activity of Gli2 is suppressed by its N-terminal repressor 
domain since deletion of N-terminus of Gli2 converts the protein into a strong activator 
in cultured cells and in vivo, compared to full-length Gli2 protein (weaker activator), 
suggesting that both Gli2 and Gli3 have additional regulatory domains in their N-
terminal, which either through proteolytic removal or their functional inactivation via an 
unknown mechanism, might allow the full activation of Gli2 or Gli3 and their 
transcriptional activity (Sasaki et al., 1999; Kasper et al., 2006a). In addition to 
proteolytic processing, recently Speek et al. (Speek et al., 2006) showed that alternative 
splicing may be another important regulatory mechanism which causes deletion of the 
major part of repressor domain and thus is responsible for the enhanced activation of 
human GLI2 and its transcriptional activity. Speek et al. (Speek et al., 2006) identified a 
GLI2 splice variant missing the N-terminal repressor domain, encoding a protein 
isoform with activator properties only, in human gonadal tissue and several cell lines 
with comparable transcriptional activity in vitro (Speek et al., 2006; Laner-Plamberger 
et al., 2009). Although initially it was thought that human GLI2, in contrast to mouse 
Gli2, does not contain an amino-terminal repressor domain (N-terminal repressor 
domain), recently, human GLI2 was shown to include a longer variant comprising 328 
extra N-terminal amino acids (containing an N-terminal repressor domain), for which 
the name “full length GLI2” has been suggested, while denominating all previous forms 
GLI2* or GLI2∆N with reduced N-terminus (Figure 1.17A, bottom panel) (Roessler et 
al., 2005). Gli1 protein has not been found to contain any repressor domain, consistent 
with its role as a strong transcriptional activator (Dai et al., 1999; Sasaki et al., 1999). 
Therefore both full-length Gli2 (mouse and human) and Gli3 (mouse and human) 
proteins contain carboxy- and amino-terminal domains, whereas full-length Gli1 (mouse 
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and human) contains only a carboxy-terminal activator domain (Figure 1.17A, top and 
bottom panel) (Matise & Joyner, 1999; Kasper et al., 2006a). 
 
In Drosophila the single Gli orthologue Ci protein (Ci-155, full-length form) contains 
amino- and carboxy-terminal domains and functions either as a transcriptional repressor 
or Hh-dependent transcriptional activator (Aza-Blanc & Kornberg, 1999; Matise & 
Joyner, 1999; Methot & Basler, 1999; Ruiz i Altaba, 1999b; Methot & Basler, 2001; 
Lum & Beachy, 2004; Jiang, 2006). In the absence of Hh (Figure 1.16a), Ci protein 
functions as a potent transcriptional repressor of Hh target genes, due to proteolytic 
cleavage by phosphorylation of several serine residues at their C-terminal regions, in the 
cytoplasm, by protein kinase A (PKA), glycogen synthase kinase 3β (GSK3β), casein 
kinase 1 (CK1) and subsequent ubiquitination by supernumery limbs (Slimb) 
(homologous to β-TrCP in human), resulting in accumulation of nuclear protein with 
intact DNA-binding zinc fingers and amino-terminus, but missing the carboxy-terminal 
transactivation domain (Ci-75, C-terminal truncated form through proteolysis) (Aza-
Blanc et al., 1997; Jiang & Struhl, 1998; Tanimura et al., 1998; Chen et al., 1999a; 
Matise & Joyner, 1999; Methot & Basler, 1999; Lum & Beachy, 2004; Zhang et al., 
2005; Jiang, 2006). In the presence of Hh, Ci repressor (Ci-75) formation is inhibited 
and full-length (Ci-155) nuclear activators of transcription are made instead (Ohlmeyer 
& Kalderon, 1998; Chen et al., 1999a; Matise & Joyner, 1999; Methot & Basler, 1999; 
Ruiz i Altaba, 1999b; Ingham & McMahon, 2001; Methot & Basler, 2001; Ruiz i 
Altaba et al., 2002b; Lum & Beachy, 2004; Zhang et al., 2005). Ci-155 and Ci-75 have 
both unique and common targets: hh appears to be primarily repressed by Ci-75 and 
ptch activated by Ci-155, while dpp (decapentaplegic) responds to both forms (Matise 
& Joyner, 1999; Methot & Basler, 1999). 
 
Similarly, in vertebrates (Figure 1.16a), Gli3 becomes proteolytically cleaved in 
numerous serine residues at their C-terminal regions by protein kinase A (PKA), casein 
kinase 1 (CK1), and glycogen synthase kinase 3β (GSK3β) and targeted for 
ubiquitination by beta-transducin repeat containing protein (β-TrCP) ubiquitin ligase, in 
order to produce truncated transcriptional N-terminal repressors (processing) (Dai et al., 
1999; Ruiz i Altaba, 1999a; Sasaki et al., 1999; Wang et al., 2000a; Pan et al., 2006; 
Wang & Li, 2006; Pan & Wang, 2007; Wang et al., 2007). Gli2 on the other hand, 
shares with Gli3 a 44% sequence identity and conserved PKA and GSK3β 
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phosphorylation sites, but the protein is inefficiently processed in vivo (Pan et al., 2006) 
and its processing is undetectable or very low in cell culture resulting in the presence of 
the vast majority of mouse Gli2 in the full-length form and the existence of only a small 
fraction in the processed form (Matise & Joyner, 1999; Wang et al., 2000a; Pan et al., 
2006; Pan & Wang, 2007; Wang et al., 2007). However, in different cell contexts (i.e. 
frog), several protein fragments smaller than full-length Gli2 have been observed 
(Matise & Joyner, 1999; Ruiz i Altaba, 1999a; Aza-Blanc et al., 2000). In contrast, Gli1 
protein has not been found to be proteolytically processed (Dai et al., 1999; Ruiz i 
Altaba, 1999a; Sasaki et al., 1999). Importantly, Gli2, has also been shown to be 
phosphorylated by PKA, CK1 and GSK3β in its C-terminal activation domain (Pan et 
al., 2006; Riobo et al., 2006) and targeted for ubiquitination and proteasome mediated 
full protein degradation by β-TrCP ubiquitin ligase (Bhatia et al., 2006; Pan et al., 2006; 
Wang et al., 2007), as well as Gli1 (Huntzicker et al., 2006; Wang et al., 2007). Both Ci, 
Gli2 and Gli3 processing and Gli2 degradation, are inhibited by SHH signalling in vivo 
and in vitro (Ruiz i Altaba et al., 2002a; Zhang et al., 2005; Huntzicker et al., 2006; Pan 
et al., 2006; Riobo et al., 2006; Wang & Li, 2006; Wang et al., 2007).  
 
All three Gli transcription factors are known to be mediators of the SHH signalling, 
with GLI2 being the key transcriptional effector of the HH pathway in skin and other 
organs both in mice and human (see Section 1.3.3 and Section 1.3.6.2) (Sasaki et al., 
1999; Ingham & McMahon, 2001; Kasper et al., 2006a). In turn, human GLI2, has been 
shown to be present in several splice variants, α (alpha), β (beta), γ (gamma) and δ 
(delta) isoforms (Figure 1.17B), and these four isoforms encode 133-, 131-, 88-, and 86 
kDa proteins, respectively (Tanimura et al., 1998). All these isoforms are larger by ~ 30 
kDa according to the full length of human GLI2 discovered by Roessler et al. (Figure 
1.17A, bottom panel) (Roessler et al., 2005). Furthermore, GLI2 which is the gene of 
interest in my study has been reported to be implicated in many cancers including 
human BCCs, prostate and breast cancers, oral squamous cell carcinomas and 
osteosarcomas (Mullor et al., 2001; Regl et al., 2002; Ruiz i Altaba et al., 2002b; Tojo et 
al., 2003; Beachy et al., 2004; Rajagopalan & Lengauer, 2004; Regl et al., 2004b; 
Sanchez et al., 2004; Bhatia et al., 2006; O'Driscoll et al., 2006; Sterling et al., 2006; 
Thiyagarajan et al., 2007; Snijders et al., 2008; Yu et al., 2008; Hirotsu et al., 2010). 
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Figure 1.17: Mouse and human Gli/GLI transcription factors and human GLI2 
isoforms.  
(A) All full length Gli/GLI proteins contain a carboxy-terminal (C-terminal) domain required 
for transcriptional activity (Transactivation) and a zinc finger domain (DNA binding domain) 
which binds DNA in a sequence-specific manner. Mouse (top panel) and human (bottom panel) 
Gli3/GLI3 and mouse Gli2 proteins contain an amino-terminal (N-terminal) domain not present 
in Gli1/GLI1 which is involved in transcriptional repression (Repressor). Although initially it 
was thought that human GLI2 protein does not contain an amino-terminal domain (GLI2* or 
GLI2∆N), it is now clear that human GLI2 contains an amino-terminal repressor domain 
(dashed box) functionally homologous to that in mouse Gli2 (Roessler et al., 2005). (B) 
Variation in human Gli2 (hGli2) mRNA. Four isoforms hGli2 α, β, γ, δ, result from 
combinations of two independent alternative splicing processes of the GLI2 gene, forming four 
different proteins of different molecular size (Tanimura et al., 1998; Tojo et al., 2003). 
B 
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1.3.3 Hedgehog signalling pathway in development and skin 
The Hedgehog (HH) signalling pathway is one of the most fundamental and highly 
conserved pathways in embryonic development, being responsible for pattern 
formation, proliferation and differentiation of a number of different cell types and 
organs including brain, bone, skin, hair, teeth and lungs (Marigo & Tabin, 1996; 
Bellusci et al., 1997; Mo et al., 1997; Hardcastle et al., 1998; Motoyama et al., 1998b; 
St-Jacques et al., 1998; Wicking et al., 1999; Litingtung & Chiang, 2000; Park et al., 
2000; Ingham & McMahon, 2001; Ruiz i Altaba et al., 2002a; Wetmore, 2003; Daya-
Grosjean & Couve-Privat, 2005; Athar et al., 2006).  
 
As I mentioned earlier (Section 1.3.1), three hedgehog homologue proteins have been 
identified in mammals (Echelard et al., 1993; Goodrich et al., 1996; Wicking et al., 
1999; Bale & Yu, 2001; Ingham & McMahon, 2001; Hooper & Scott, 2005), of which 
the Shh is the best-characterised since it is the most potent and most broadly expressed 
in embryonic and adult tissues (Chiang et al., 1996; Ming et al., 1998; Wicking et al., 
1999; Bale & Yu, 2001; Pathi et al., 2001; Ruiz i Altaba et al., 2002b; Daya-Grosjean & 
Couve-Privat, 2005; Athar et al., 2006).  
 
In skin, the SHH pathway plays a pivotal role in maintaining the stem cell population, 
and regulating the development of hair follicles, hair cycle and sebaceous glands (Parisi 
& Lin, 1998; St-Jacques et al., 1998; Chiang et al., 1999; Wang et al., 2000b; Callahan 
& Oro, 2001; Allen et al., 2003; Ellis et al., 2003; Mill et al., 2003; Oro & Higgins, 
2003; Schmidt-Ullrich & Paus, 2005; Silva-Vargas et al., 2005; Athar et al., 2006; 
Blanpain & Fuchs, 2006; Zhou et al., 2006). In skin, SHH/GLI pathway is implicated in 
the maintenance and regulation of the epidermal stem cell population residing in the 
epidermal basal layer (interfollicular epidermis) and the hair follicle bulge (Callahan & 
Oro, 2001; Adolphe et al., 2004; Blanpain & Fuchs, 2006; Zhou et al., 2006), while in 
vitro it is also suggested that SHH/GLI signalling has a potential role in the maintenance 
and proliferation of human putative epidermal stem cells (Fan & Khavari, 1999; 
Kameda et al., 2001; Zhang & Kalderon, 2001; Zhou et al., 2006). In addition, Shh is 
also involved  in the proliferation and cell-fate specification of several stem cells such 
as neural and mesenchymal stem cells (Palma & Ruiz i Altaba, 2004; Kondo et al., 
2005).  
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The role of SHH/GLI pathway is well established in hair follicle morphogenesis and in 
adult hair cycle (St-Jacques et al., 1998; Botchkarev et al., 1999; Chiang et al., 1999; 
Wang et al., 2000b; Millar, 2002; Oro & Higgins, 2003; Schmidt-Ullrich & Paus, 2005; 
Athar et al., 2006; Blanpain & Fuchs, 2006), and its constitutive activation leads to hair 
follicle derived tumours and BCC (Dahmane et al., 1997; Oro et al., 1997; Grachtchouk 
et al., 2000; Nilsson et al., 2000; Sheng et al., 2002; Daya-Grosjean & Couve-Privat, 
2005; Hutchin et al., 2005; Huntzicker et al., 2006). Studies in normal skin of transgenic 
mice, have shown that Wnt/β-catenin is required upstream of the Bmp and Shh in 
placode formation during hair follicle morphogenesis (see Section 1.5.1), and thus 
specifying the hair follicle fate in the undifferentiated basal epidermis and initiate hair 
bud formation (Gat et al., 1998; Huelsken et al., 2001; Andl et al., 2002; Lo Celso et al., 
2004; Silva-Vargas et al., 2005; Blanpain & Fuchs, 2006). Then, it subsequently 
activates Shh signalling, which is required for the proliferation and expansion of follicle 
epithelium in order to assemble a mature follicle (St-Jacques et al., 1998; Chiang et al., 
1999; Mill et al., 2003; Lo Celso et al., 2004; Silva-Vargas et al., 2005; Blanpain & 
Fuchs, 2006). The crucial role of SHH/GLI pathway in hair follicle morphogenesis is 
underscored by the fact that loss-of-function mutations in SHH in transgenic mice are 
still permissive for hair placode and hair germ formation but are not permissive for the 
further development of the hair placodes and thus for the formation of a mature follicle 
(lack of hairs) (St-Jacques et al., 1998; Chiang et al., 1999; Wang et al., 2000b; 
Blanpain & Fuchs, 2006). In addition, mice deficient either in Shh (Shh
-/-
 mutants) or in 
Gli2 (Gli2
-/-
 mutants) exhibit an arrest in hair follicle development with reduced cell 
proliferation and Shh-responsive gene expression (Ptch1 and Gli1) (Mill et al., 2003). 
The fact that Gli2 deficient mice (Gli2
-/-
 mutants) present a phenotype similar to Shh-
null mice (Shh
-/-
 mutants), suggests that Shh is essential for embryonic hair follicle 
development and acts mainly through Gli2 (Mill et al., 2003; Blanpain & Fuchs, 2006). 
 
Therefore, SHH is expressed in the hair placode of embryonic skin (St-Jacques et al., 
1998), but is also expressed in the matrix and the developing hair germ and thus it is 
also important for follicle regeneration during the adult hair cycle (Wang et al., 2000b; 
Oro & Higgins, 2003; Silva-Vargas et al., 2005; Blanpain & Fuchs, 2006). Conditional 
disruption of SHH/GLI pathway in postnatal mice (anti-hedgehog monoclonal antibody 
treatment) during the growing (anagen) phase of the hair cycle, resulted in blockage of  
anagen progression and thus in a hairless phenotype further supporting the notion that 
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SHH/GLI pathway is required for hair growth phases of the hair cycle  in adult mice 
(Wang et al., 2000b). Similarly, treatment of postnatal transgenic mice with the SHH 
inhibitor, cyclopamine, a specific HH pathway antagonist (Taipale et al., 2000), resulted 
in the blockage of anagen and hair regeneration (Silva-Vargas et al., 2005). 
 
1.3.4 SHH signalling and disease 
The  importance of SHH/GLI signalling  in human development can be demonstrated by 
the fact that mutations in the key components of SHH/GLI signalling pathway,  can 
result in severe developmental disorders such as Holoprosencephaly (HPE) (incomplete 
separation of cerebral hemispheres, craniofacial anomalies (i.e. cyclopia)), which is 
caused by loss-of-function mutations in SHH gene (Belloni et al., 1996; Roessler et al., 
1996; Roessler et al., 2003), Greig cephalopolysyndactyly syndrome (GCPS) (a disorder 
that affects development of the limbs, head, and face), which is caused by inactivation 
mutations in GLI3 gene (Vortkamp et al., 1991), and tumour formation  such as Nevoid  
Basal Cell Carcinoma (Gorlin syndrome), which is caused by PTCH germline 
inactivation mutations (Hahn et al., 1996b; Johnson et al., 1996; Gailani & Bale, 1997), 
and is associated with developmental abnormalities (see Section 1.2.3) and familial 
multiple basal cell carcinomas (BCCs), medulloblastomas and ovarian fibromas (Gorlin, 
1987; Gorlin, 1995; Chiang et al., 1996; Ming et al., 1998; Wicking et al., 1999; 
Villavicencio et al., 2000; Bale & Yu, 2001; Mullor et al., 2002; Daya-Grosjean & 
Couve-Privat, 2005; Athar et al., 2006). A recent report indicated, that loss-of-function 
mutations in the human GLI2 gene, are associated with holoprosencephaly-like features 
(Roessler et al., 2003).  
 
1.3.5 SHH signalling and cancer 
Uncontrolled Sonic Hedgehog (SHH) signalling is implicated in tumour development in 
many tissues (Ming et al., 1998; Toftgard, 2000; Villavicencio et al., 2000; Taipale & 
Beachy, 2001; Ruiz i Altaba et al., 2002b; Pasca di Magliano & Hebrok, 2003; 
Wetmore, 2003; Beachy et al., 2004; Kasper et al., 2006a; Rubin & de Sauvage, 2006), 
predominantly BCCs in skin (Gailani et al., 1996; Hahn et al., 1996b; Johnson et al., 
1996; Gailani & Bale, 1997; Daya-Grosjean & Couve-Privat, 2005; Epstein, 2008), 
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medulloblastomas (Goodrich et al., 1997; Raffel et al., 1997; Berman et al., 2002; 
Taylor et al., 2002) and gliomas in brain (Kinzler et al., 1987; Dahmane et al., 2001), 
and rhabdosarcomas in muscle (Hahn et al., 1998; Tostar et al., 2006).  
 
It has also recently been found to be inappropriately activated in highly aggressive 
cancers in the absence of mutations in the pathway components, suggesting that 
activation of the HH pathway may occur through mechanisms other than by mutations 
of pathway components (Ruiz i Altaba et al., 2002b; Pasca di Magliano & Hebrok, 
2003; Beachy et al., 2004; Kasper et al., 2006a; Rubin & de Sauvage, 2006). These 
cancers include the digestive tract (oesophagus, stomach, biliary tract) (Berman et al., 
2003), pancreatic (Thayer et al., 2003; Hidalgo & Maitra, 2009), small-cell lung 
(Watkins et al., 2003), breast (Kubo et al., 2004; Sterling et al., 2006; Kameda et al., 
2009), ovarian (Bhattacharya et al., 2008) and prostate caners (Karhadkar et al., 2004; 
Sanchez et al., 2004; Sheng et al., 2004; Bhatia et al., 2006; Thiyagarajan et al., 2007), 
colon (Oniscu et al., 2004; Qualtrough et al., 2004; Monzo et al., 2006), liver (Huang et 
al., 2006; Eichenmuller et al., 2009) cancers, as well as the oral squamous cell 
carcinoma (Snijders et al., 2008) and osteosarcomas (Hirotsu et al., 2010). 
 
Furthermore, HH pathway in some of these cancers, not only has a pivotal role in 
tumour formation, but also in its maintenance by enhancing the survival of transformed 
cells, as has been judged by studies using cyclopamine, a specific HH pathway 
antagonist (Taipale et al., 2000), and resulting in inhibition of  growth of several 
tumours, suggesting an ongoing requirement for pathway activity in the growth of a 
series of cancers (Ruiz i Altaba et al., 2002b; Pasca di Magliano & Hebrok, 2003; 
Beachy et al., 2004; Rubin & de Sauvage, 2006). Recent evidence, also suggests that 
SHH/GLI signalling pathway is also implicated in metastasis, at least in some types of 
cancer (Beachy et al., 2004; Karhadkar et al., 2004; Sheng et al., 2004; Rubin & de 
Sauvage, 2006; Sterling et al., 2006). Accordingly, human prostate cancer metastases 
have higher HH/GLI signalling activity than do the primary tumours from which they 
arose, while augmented Hh pathway activity (GLI1 overexpression) in mice prostate 
cancer cell lines resulted in increased levels of Snail, reduced levels of E-cadherin, and 
to a metastatic phenotype in mice inoculated subcutaneously with these cells 
(Karhadkar et al., 2004). In addition, treatment with cyclopamine, of mice inoculated 
subcutaneously with highly metastatic rat prostate cancer cell lines (i.e. AT6.3), resulted 
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in complete abrogation of their capacity to metastasize to the lung (Karhadkar et al., 
2004). Similarly, SHH/GLI signalling has been reported to be involved in bone 
metastasis (Sterling et al., 2006). Overexpression of GLI2 in human breast cancer cell 
lines enhances their metastatic potential to bone, through the upregulation of 
parathyroid hormone-related peptide (PTHrP) and subsequent osteolysis, as observed in 
vitro and in mice inoculated subcutaneously with these cells (Sterling et al., 2006). 
 
1.3.6 SHH signalling and Basal cell carcinoma (BCC) 
Deregulation of the SHH pathway by mutations in the components of the pathway leads 
to constitutive activation of the SHH signalling and to development of basal cell 
carcinomas (BCCs) (Figure 1.18) (Bale & Yu, 2001; Pasca di Magliano & Hebrok, 
2003; Daya-Grosjean & Couve-Privat, 2005; Rubin & de Sauvage, 2006; Epstein, 
2008). PTCH germline inactivated mutations are present in Nevoid Basal Cell 
Carcinoma (NBCC) patients and frequent loss of heterozygosity at 9q locus (loss of the 
remaining wild-type allele of patched gene) is observed in BCCs from these patients 
(Hahn et al., 1996b; Johnson et al., 1996; Unden et al., 1996; Gailani & Bale, 1997; 
Booth, 1999; Happle, 1999; Daya-Grosjean & Couve-Privat, 2005). PTCH inactivated 
and SMO activated mutations occur frequently in sporadic BCCs and in BCCs 
associated with xeroderma pigmentosum (Gailani et al., 1996; Unden et al., 1996; 
Gailani & Bale, 1997; Soehnge et al., 1997; Unden et al., 1997; Reifenberger et al., 
1998; Xie et al., 1998; Bodak et al., 1999; Ling et al., 2001; Couve-Privat et al., 2002; 
Dicker et al., 2002; Lacour, 2002; Daya-Grosjean & Couve-Privat, 2005; Reifenberger 
et al., 2005; Teh et al., 2005), whereas SHH activated mutations are extremely rare in 
sporadic BCCs, but are present in BCCs associated with xeroderma pigmentosum 
(Reifenberger et al., 1998; Couve-Privat et al., 2004; Daya-Grosjean & Couve-Privat, 
2005).  
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Figure 1.18: Modifications of SHH pathway genes in Basal Cell Carcinomas. 
Germline mutations of the tumour suppressor gene PTCH gene are found in the nevoid basal 
cell carcinoma (NBCC) patients. Sporadic and Xeroderma Pigmentosum (XP) BCCs present 
mutations of PTCH as well as the proto-oncogenes SHH and SMO. Overexpression of 
downstream target genes is also implicated in BCC development (Daya-Grosjean & Couve-
Privat, 2005). 
 
 
The majority of BCCs are thought to be  derived from keratinocytes of the basal stem 
cell layer of the epidermis (interfollicular epidermis) which are negative for markers of 
differentiation (Miller, 1991a; Miller, 1991b; Lacour, 2002; Owens & Watt, 2003; 
Wong et al., 2003; Daya-Grosjean & Couve-Privat, 2005; Crowson, 2006; Fuchs, 
2008), such as involucrin (Murphy et al., 1984; Said et al., 1984; Sumitomo et al., 1986; 
Miller, 1991a; Fuchs, 2008), and positive for keratin 5 and keratin 14 (Miller, 1991a; 
Crowson, 2006) which are mainly expressed by cells of the basal layer of the epidermis 
(Stoler et al., 1988; Coulombe et al., 1989; Fuchs, 2008). Consistent with this notion, 
human BCCs exhibit continuous proliferation and slow growth and they also manifest a 
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stem cell gene expression profile similar to that expressed by the cells of the 
interfollicular epidermis and hair follicle bulge region, such as keratins 15 and 19, and 
α2 and β1 integrins (see Chapter 3, Section 3.3.6) (Lane et al., 1991; Miller, 1991a; 
Jones & Watt, 1993; Jones et al., 1995; Pentel et al., 1995; Kruger et al., 1999; Lyle et 
al., 1999; Morris et al., 2004; Tumbar et al., 2004; Crowson, 2006). These observations 
are consistent with the role of SHH/GLI pathway in skin, which has been shown to be 
implicated in the maintenance and regulation of the epidermal stem cell population 
residing in the epidermal basal layer (interfollicular epidermis) and the hair follicle 
bulge (Parisi & Lin, 1998; Callahan & Oro, 2001; Adolphe et al., 2004; Blanpain & 
Fuchs, 2006; Zhou et al., 2006), while in vitro it is also suggested that SHH/GLI 
signalling has a potential role in the maintenance and proliferation of human  putative 
epidermal stem cells (Section 1.3.3) (Fan & Khavari, 1999; Kameda et al., 2001; Zhang 
& Kalderon, 2001; Zhou et al., 2006). 
 
In addition, due to (i) the very well established role of SHH/GLI in hair follicle 
morphogenesis and in adult hair cycle (Section 1.3.3) (St-Jacques et al., 1998; 
Botchkarev et al., 1999; Chiang et al., 1999; Wang et al., 2000b; Millar, 2002; Mill et 
al., 2003; Oro & Higgins, 2003; Schmidt-Ullrich & Paus, 2005; Silva-Vargas et al., 
2005; Athar et al., 2006; Blanpain & Fuchs, 2006), (ii) the striking relation between 
BCC development and deregulation of the SHH pathway (Dahmane et al., 1997; Oro et 
al., 1997; Grachtchouk et al., 2000; Nilsson et al., 2000; Sheng et al., 2002; Daya-
Grosjean & Couve-Privat, 2005; Hutchin et al., 2005; Huntzicker et al., 2006), and as I 
mentioned earlier (iii) the expression of hair follicle bulge stem cell markers in human 
BCCs, basal cell carcinomas are also thought to be derived from undifferentiated cells 
of hair follicles (outer root sheath of hair follicles) (Miller, 1991b; Kruger et al., 1999; 
Lacour, 2002; Owens & Watt, 2003; Hutchin et al., 2005; Blanpain & Fuchs, 2006; 
Crowson, 2006; Huntzicker et al., 2006; Mancuso et al., 2006). 
 
However, a very recent study by Youssef et al. (Youssef et al., 2010), using conditional 
(tamoxifen administration) overexpression of a constitutively active form of mouse 
smoothened gene (SmoM2) in different cellular compartments of the skin epidermis of 
transgenic mice, under the control of specific promoters such as Keratin 14, Keratin 15, 
Keratin 19 and Shh, favours the notion that BCCs arise from the undifferentiated stem 
cells of the basal layer of the epidermis (interfollicular epidermis) and not from hair 
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follicle bulge stem cells or transit-amplifying matrix cells that reside at the base of hair 
follicle. By achieving a low level transgene induction through administration of low 
dose of tamoxifen, Youssef et al. (Youssef et al., 2010) were able to efficiently induce 
the expression of either K14-SmoM2 or K14-YFP (Yellow Fluorescent Protein) control 
in individual basal cells of the interfollicular epidermis (IFE) in transgenic mice at a 
very low frequency (4-5 cells/IFE) and to investigate the cell of origin of the arising 
BCCs from the IFE. Due to continuous epithelial renewal, several marked clones 
expressing the transgenes were progressively lost from the epidermis. By tracking their 
fate during several weeks, it was shown that the rate of decline in the abundance of 
clones in the IFE, was almost the same whether the cells expressed K14-SmoM2 or 
K14-YFP. Since K14-SmoM2 expressing clones did not persist in the epidermis longer 
than their K14-YFP expressing counterparts, it was suggested that SmoM2 expression is 
unable to oppose differentiation and/or to re-induce long-term renewing potential to 
more committed (TA) or differentiated keratinocytes. Yet, all long-term expressing 
K14-SmoM2 clones that remained in the mouse epidermis had stopped differentiation, 
adopting a placode-like shape with subsequent expression of follicular progenitor 
markers like K17, K15, and P-cadherin, and concomitant formation of BCCs, contrarily 
to K14-YFP expressing clones which either remained as columns of marked cells 
expanding from the basal to the top cornified layers or progressively differentiate and 
lost from the epidermis. This strongly suggested that the cell of origin of these BCCs is 
a long-lived resident of the interfollicular epidermis (SC), rather than a more committed 
progenitor (TA) that has re-acquired the potential to oppose differentiation and to self-
renew as a result of K14-SmoM2 overexpression. The model of BCC initiation that was 
deduced from these observations suggests that Hh activation in IFE stem cells can block 
the normal process of epidermal differentiation (affecting/increasing the self-renewal 
capacity of stem cells) whereby a stem cell would normally give rise to one stem cell 
and one committed TA daughter cell. Instead, its activation leads to the expansion of 
stem cells, with concomitant expression of follicular progenitor markers, and finally 
generation of locally invasive BCC tumours (Youssef et al., 2010).  
 
Therefore, constitutive activation of the SHH/GLI pathway in skin, could disrupt the 
epidermal homeostasis and lead to tumourigenesis with a phenotype that resembles stem 
cell characteristics (stem-like tumour phenotype), such as human BCCs (Miller, 1991a; 
Miller, 1991b; Taipale & Beachy, 2001; Ruiz i Altaba et al., 2002b; Owens & Watt, 
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2003; Pasca di Magliano & Hebrok, 2003; Perez-Losada & Balmain, 2003; Beachy et 
al., 2004; Crowson, 2006). However, whether HH/GLI signalling is inappropriately 
activated in epidermal stem cells or in commited to differentiation transit-amplifying 
cells (TA) is not yet completely resolved. Taking into account that human BCCs have 
inactivating or activating mutations of PTCH and SMO respectively (Daya-Grosjean & 
Couve-Privat, 2005; Epstein, 2008), if the oncogenic events occur in TAs, then loss of 
PTCH or gain of SMO function in TA cells resulting in ligand-independent constitutive 
activation of GLI1 and GLI2 oncogenes, and presumably activation of other oncogenic 
pathways and repression of differentiation signals, might be the initiation step in BCC 
development (Aberger & Frischauf, 2006). Further mutations such as loss of TP53 
function may promote BCC development (Ling et al., 2001; Reifenberger et al., 2005; 
Aberger & Frischauf, 2006). This scenario of course, presupposes that the effect of the 
activated GLI1 and GLI2 oncogenes is expressed immediately or very quickly, so as for 
the TA cell to acquire the long self-renewal capacity of the stem cell, and to avoid 
becoming terminally differentiated and discarded from the epidermis. 
 
However, unlike the classical step-wise model of carcinogenesis requiring multiple 
genetic lesions, SHH/GLI pathway activation alone in human keratinocytes appears to 
be sufficient to induce basal cell carcinoma features in transgenic human skin (4 weeks 
postoperatively), when grafted onto the back of nude mice (Fan et al., 1997). Moreover, 
targeted overexpression of the oncogenic forms of Smo, Gli1, Gli2 and Shh in 
epidermal cells of transgenic mice can induce the formation of BCC or BCC-like 
tumours (Fan et al., 1997; Oro et al., 1997; Grachtchouk et al., 2000; Nilsson et al., 
2000; Sheng et al., 2002; Hutchin et al., 2005; Huntzicker et al., 2006; Youssef et al., 
2010). Thus, collectively these studies suggest that a single genetic alteration is 
sufficient to induce experimentally human neoplasia in vivo. This one-hit induction of 
BCC tumourigenesis by SHH/GLI may partially explain the biologically mild 
behavioural characteristics (slow growing, locally invade, rarely metastasize), the 
absence of precursor lesions and the lack of the aggressiveness of BCCs compared to 
other malignancies characterised by multiple genetic lesions necessary for more 
aggressive behaviour (Miller, 1991a; Crowson, 2006; Khavari, 2006).  
 
Therefore, in a tumour such as BCC which might be considered as an one-hit tumour 
due to the lack of multiple genetic alterations, arguments are in favour of stem cells 
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being the appealing candidates as the ‘cell of origin’ of BCC, because of their pre-
existing capacity of self-renewal and unlimited proliferative capacity which are 
prerequisites for the extra genetic hit (one-hit) that will transform the normal cell into a 
cancer cell (see Section 1.1.5 and Section 1.1.5.2) (Miller, 1991a; Owens & Watt, 
2003; Perez-Losada & Balmain, 2003; Beachy et al., 2004; Crowson, 2006; Khavari, 
2006; Youssef et al., 2010). On the other hand  there is always the case that this ‘one 
hit’ is so strong that can target a TA cell, become expressed rapidly by the TA cell and 
concomitantly influence differentiation signals, promote long self-renewal capacity, 
transformation, expansion and finally cause BCC tumour formation, which although 
possible is quite unlikely to happen. 
 
1.3.6.1 SHH/GLI2 and human BCCs 
It is clear that altered activity of one or more members of the SHH pathway can lead to 
constitutive activation of the pathway and subsequently to BCC formation (Pasca di 
Magliano & Hebrok, 2003; Beachy et al., 2004; Daya-Grosjean & Couve-Privat, 2005; 
Rubin & de Sauvage, 2006; Epstein, 2008). Indeed upregulation of mRNA and protein 
levels of GLI2 transcription factor is frequently observed in human BCCs, as well as 
upregulation of GLI1 transcription factor, SMO and PTCH genes (Dahmane et al., 
1997; Kallassy et al., 1997; Unden et al., 1997; Ghali et al., 1999; Tojo et al., 1999; 
Zaphiropoulos et al., 1999; Bonifas et al., 2001; Mullor et al., 2001; Regl et al., 2002; 
Tojo et al., 2003; Ikram et al., 2004; Regl et al., 2004b; Daya-Grosjean & Couve-Privat, 
2005; O'Driscoll et al., 2006; Asplund et al., 2008; Epstein, 2008; Yu et al., 2008). In 
addition, Ikram et al. (Ikram et al., 2004), using in situ-hybridization, further 
demonstrated the importance of GLI2 in BCC, by showing that GLI2 is expressed not 
only in human BCC tumour islands, but also in the interfollicular epidermis and the 
outer root sheath of hair follicles in normal human skin. This observation is consistent 
since Shh/Gli2 is known to regulate hair follicle morphogenesis and growth (see 
Section 1.3.3) (St-Jacques et al., 1998; Botchkarev et al., 1999; Chiang et al., 1999; 
Wang et al., 2000b; Millar, 2002; Mill et al., 2003; Oro & Higgins, 2003; Schmidt-
Ullrich & Paus, 2005; Silva-Vargas et al., 2005; Athar et al., 2006; Blanpain & Fuchs, 
2006), and its constitutive activation leads to hair follicle derived tumours and BCC-like 
tumours (Dahmane et al., 1997; Oro et al., 1997; Grachtchouk et al., 2000; Nilsson et 
al., 2000; Sheng et al., 2002; Daya-Grosjean & Couve-Privat, 2005; Hutchin et al., 
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2005; Huntzicker et al., 2006) which are thought to arise from epidermal basal layer or 
hair follicle stem cells (Miller, 1991a; Kruger et al., 1999; Owens & Watt, 2003; Daya-
Grosjean & Couve-Privat, 2005; Hutchin et al., 2005; Blanpain & Fuchs, 2006; 
Crowson, 2006; Huntzicker et al., 2006; Mancuso et al., 2006; Youssef et al., 2010). 
Furthermore, targeted overexpression of Gli2 in epidermal cells of transgenic mice can 
induce the formation of BCC or BCC-like tumours (Grachtchouk et al., 2000; Sheng et 
al., 2002; Hutchin et al., 2005; Huntzicker et al., 2006). 
 
Further studies have also shown that constitutively active GLI2 (GLI2∆N) can regulate 
a large number of genes and plays a dual role as activator of keratinocyte proliferation 
and repressor of epidermal differentiation in HaCaT human keratinocytes, therefore its 
continuous expression by sustained HH/GLI signalling could disrupt the epidermal 
homeostasis and lead to tumourigenesis (Regl et al., 2004a; Eichberger et al., 2006). 
Moreover, the anti-apoptotic protein BCL-2 (B-cell lymphoma 2, an antagonist of the 
cell intrinsic pathway of apoptosis) (see Chapter 4, Section 4.2.5.3) is directly 
controlled by GLI1 in primary human keratinocytes (Bigelow et al., 2004) and it has 
also been identified in HaCaT human keratinocyte cell line, as a direct transcriptional 
target of GLI2 transcription factor (Regl et al., 2004b). Similarly, the apoptotic inhibitor 
c-FLIP (c (cellular)-FAS-associated death domain-like IL (interleukin)-1-converting 
enzyme-like inhibitory protein, an antagonist of the cell extrinsic pathway of apoptosis) 
(see Chapter 4, Section 4.2.5.3) has been found in HaCaT human keratinocytes to be a 
direct target of GLI2 (Kump et al., 2008), suggesting that both of them might play a role 
in BCC tumourigenesis and maintenance, since human BCCs highly express both BCL-
2 and c-FLIP protein, as well as GLI2 protein (Regl et al., 2004b; Kump et al., 2008). 
Lastly, several genes, other than BCL-2 and c-FLIP, that have been found to be 
downstream targets of GLI1 and constitutively active GLI2 (GLI2∆N) transcription 
factors, have also been reported to be upregulated in human BCCs, including PDGFRα 
(platelet-derived growth factor receptor) (target of GLI1), FOXM1 (forkhead box M1) 
(target of GLI1), Basonuclin (target of GLI2 and GLI1), HIP gene (Hh-interacting 
protein) (target of GLI2 and GLI1), SOX9 (SRY (sex determining region Y)-box 9) 
(target of GLI2) (see Chapter 3, Section 3.3.6.2) and FOXE1 (winged helix domain 
transcription factor) (target of GLI2) (Chuang & McMahon, 1999; Xie et al., 2001; 
Dicker et al., 2002; Teh et al., 2002; Tojo et al., 2002; Cui et al., 2004; Eichberger et al., 
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2004; Daya-Grosjean & Couve-Privat, 2005; Vidal et al., 2005; Crowson, 2006; 
Eichberger et al., 2006; Kasper et al., 2006a; Epstein, 2008; Vidal et al., 2008).  
 
1.3.6.2 Shh/Gli transgenic studies and BCC carcinogenesis 
Previous work from mice models further highlights the significance of Hh/Gli-
signalling activation in BCC tumourigenesis (Wicking et al., 1999; Toftgard, 2000; 
Wetmore, 2003; Daya-Grosjean & Couve-Privat, 2005; Athar et al., 2006; Kasper et al., 
2006a; Epstein, 2008).  
 
Ptch
+/-
 heterozygous knockout mice show an increased susceptibility to BCC-like 
tumour formation (trichoblastomas and BCC) in response to chronic UV radiation or to 
single dose of ionizing radiation, and those BCCs often have deletion of the wild-type 
copy of Ptch1 (Ptch loss of heterozygosity), activation of hedgehog target gene 
transcription, loss of normal hemidesmosomal components, as well as p53 inactivated 
mutations (40% of BCC-like tumours had p53 gene mutations) (Aszterbaum et al., 
1999). The importance of p53 inactivation in skin carcinogenesis, is highlighted by the 
fact that homozygous or heterozygous p53 knockout mice develop skin tumours much 
earlier than wild-type mice upon UV radiation (Jiang et al., 1999; Erb et al., 2005), 
while human BCCs exhibit a high incidence of p53 gene mutations (Barbareschi et al., 
1992; Shea et al., 1992; Grossman & Leffell, 1997; Ponten et al., 1997; Soehnge et al., 
1997; de Gruijl et al., 2001; Ling et al., 2001; Dicker et al., 2002; Lacour, 2002; Daya-
Grosjean & Couve-Privat, 2005; Reifenberger et al., 2005; Epstein, 2008). The notion 
that p53 loss markedly enhances HH-driven tumourigenesis, and thus possibly 
contributing to the development of cancers including BCCs and thus is not just a result 
of the fact that BCCs usually arise in sun-exposed skin, was first shown by the 
development of medulloblastomas in almost 100% of Ptch1
+/-
; Trp53
-/-
 mice, compared 
to an incidence of less than 10% in Ptch1
+/-
 mice with wild-type p53 (Wetmore et al., 
2001; Epstein, 2008). In addition, another study by Adolphe et al. (Adolphe et al., 2006) 
further demonstrated that conditional loss of Ptch1, upon the control of keratin 6 
promoter and topical retinoic acid treatment, in the basal cell population of mouse skin, 
induces the formation of  human BCC-like tumours (Adolphe et al., 2006). Similarly, 
Sufu
+/-
 mice, mice carrying one inactivated, mutant allele of the SHH suppressor SuFu, 
are also susceptible to BCC-like tumour development (Svard et al., 2006). 
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Furthermore, human keratinocytes over-expressing SHH, followed by seeding in human 
dermal tissue, regeneration of human skin epidermis and subsequent grafting onto the 
back of immune-deficient mice, have the power to induce BCC-like structures (Fan et 
al., 1997; Khavari, 2006), while targeted overexpression of the oncogenic forms of 
Smo, Shh, Gli1, and Gli2 in epidermal cells of transgenic mice under the control of 
specific promoters (i.e. Keratin 5 promoter), can induce the formation of BCC and 
BCC-like tumours  (Fan et al., 1997; Oro et al., 1997; Xie et al., 1998; Grachtchouk et 
al., 2000; Nilsson et al., 2000; Sheng et al., 2002; Hutchin et al., 2005; Huntzicker et al., 
2006; Youssef et al., 2010). 
 
Importantly, it seems that the degree of activation of HH signalling is correlated with 
the tumour phenotype as Grachtchouk et al. (Grachtchouk et al., 2003) showed that 
different levels of SHH/GLI signalling activity can result in distinct tumour types in 
skin. High levels of HH activation and target genes (transgenic mice overexpressing 
Gli2 under the control of keratin 5 promoter) lead to the formation of BCC-like 
tumours, whereas low levels of HH activation and target genes (transgenic mice 
overexpressing human M2SMO - mutant SMO under the control of keratin 5 promoter) 
result to the formation of hair-follicle-like tumours such as basaloid follicular 
hamartomas (Grachtchouk et al., 2003). 
 
Studies by Hutchin et al. (Hutchin et al., 2005), using a conditional Gli2 mouse model 
under the control of keratin 5 promoter to examine the role of Gli2 in established BCCs, 
showed that continuous expression of Gli2 due to sustained and uncontrolled HH 
signalling pathway, is required for BCC-like tumour proliferation and survival. 
Inactivation of the transgene upon doxycycline treatment led to reduced HH target gene 
expression and BCC regression accompanied by reduced tumour cell proliferation and 
increased apoptosis, leaving behind a small subset of non-proliferative cells which upon 
transgene reactivation could form BCC-like tumours (regressed tumours resume 
growth) (Hutchin et al., 2005). 
 
Accordingly, Gli2 knockdown via RNA interference (RNAi) inhibits BCC-like tumour 
growth in vivo (Ji et al., 2008). In this study (Ji et al., 2008), mouse Gli2 gene was 
silenced in a mouse BCC-like tumour cell line (K5-Gli2∆N2) that constitutively express 
high levels Gli2∆N2, is originated from a K5-Gli2∆N2-induced trichoblastoma and is 
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tumourigenic (Sheng et al., 2002). When the Gli2 knock down cells were injected 
subcutaneously into nude mice, they gave rise to tumours of a much slower growth rate 
(smaller size) and with disruption of the BCC-like structure characterised by lots of 
typical tumour nodules surrounded by stroma cells, possibly due to the increased 
susceptibility to apoptosis (increases cell death) and decreased vascularisation 
(decreased microvasulogenesis - formation of new blood vessels, by vascular 
endothelial cells that migrate into tissue, which are required to provide blood supply in 
tumours, a requirement for their growth) of tumour cells, compared to the tumours 
arising from control cells (K5-Gli2∆N2 cells) (Ji et al., 2008). 
 
Importantly, removal of Gli2 but not Gli1, can partially reduce the severity of the 
phenotype, mediated by HH signalling hyperactivation, in Patched knockout mice (Bai 
et al., 2002), while loss of Gli2 alone, but not of Gli1, is sufficient to cause severe 
developmental abnormalities resembling those seen in Shh knockout mice (Ding et al., 
1998; Matise et al., 1998; Park et al., 2000; Mill et al., 2003). Furthermore, Gli1 has 
been found to be dispensable for SHH-induced medulloblastoma in transgenic mice 
(overexpression of Shh (injection of the Shh-expressing retrovirus) in Gli1
-/-
 
homozygous null mutant mouse embryos resulting in tumour formation), suggesting 
that SHH signalling activation leads to Gli2 upregulation which in turns activate Gli1 
(Weiner et al., 2002). 
 
Taken together, all these mouse model studies highlight the role of Gli2 as the primary 
effector of HH signalling during development and carcinogenesis. Further support to 
this statement is provided by the fact that Gli2 has been shown to act as an upstream 
regulator of Gli1, since the absence of Gli2 function decreases the mRNA levels of Gli1 
(Ding et al., 1998; Bai et al., 2002; Mill et al., 2003). Also, overexpression of GLI2 in 
human epidermal cells induces GLI1 protein expression, whereas GLI2 is likely to be an 
indirect target of GLI1 (Regl et al., 2002). It has also been shown that GLI2 specifically 
binds to the GLI1 promoter, suggesting that GLI1 is a direct target of GLI2 (Ikram et 
al., 2004). 
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1.3.7 SHH/GLI and cell cycle regulation 
Little is known about the molecular mechanisms involved in the transformation of 
epidermal keratinocytes in response to HH/GLI signalling, despite the identification of 
the genetic hits involved in BCC development. However, several mechanisms have 
been proposed for the interactions of SHH/GLI signalling with important cell cycle 
mediators that promote cell proliferation (Ruiz i Altaba et al., 2002a; Pasca di Magliano 
& Hebrok, 2003; Wetmore, 2003; Daya-Grosjean & Couve-Privat, 2005; Aberger & 
Frischauf, 2006; Athar et al., 2006; Kasper et al., 2006a).  
 
In various cell types activation of HH pathway activity increases the expression of key 
regulators of G1/S and G2/M phase progression of the cell cycle (Kasper et al., 2006a). 
In Drosophila, Hh/Ci signalling can regulate cell proliferation in the developing eye, by 
the induction of cyclin D expression, and of the cyclin E expression which has been 
identified as a direct transcriptional target of Ci (Cubitus interruptus) (the Drosophila 
homologue of vertebrate GLI genes) (Duman-Scheel et al., 2002), and which both 
cyclin D and cyclin E are involved in G1-S transition  (Knoblich et al., 1994; Weinberg, 
1995). In vertebrates (mice), Shh protein can also stimulate and maintain the 
proliferation of cerebellar neuronal precursor cells via the regulation of D-type cyclins 
(increased mRNA and protein levels of cyclin-D1 and cyclin-D2) (Kenney & Rowitch, 
2000), while in chicken embryos Shh regulates cyclin-D1 in neural groove, during early 
steps of spinal cord development (Lobjois et al., 2004). In addition, induction of cyclin-
D2 transcription is likely to be directly controlled by Shh/Gli signalling pathway, as 
revealed by analysis in GLI1-expressing rat kidney epithelial cells and in Shh-protein 
treated murine mesodermal cells (Yoon et al., 2002; Buttitta et al., 2003). Human GLI1 
upregulates cyclin-D2 based on microarray analysis of GLI1-expressing rat kidney 
epithelial cells, and the human cyclin D2 promoter contains a GLI1-binding site (Yoon 
et al., 2002). Cyclin-D2 is upregulated both in Gli2-expressing and Shh-expressing 
murine mesodermal cells, while cyclin-D2 mRNA expression is induced in Shh-protein 
treated murine mesodermal cells even in the absence of protein synthesis (treatment 
with cyclohexamide to block protein synthesis), supporting the notion that cyclin-D2 is 
a direct target of Shh/Gli signalling pathway (Buttitta et al., 2003). Moreover, Mill et al. 
(Mill et al., 2003) showed that the transcription of Cyclin-D1 and Cyclin-D2 in 
developing mouse hair follicles, is regulated by the Shh-dependent activator function of 
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Gli2, since only ∆NGli2 (activated form of Gli2), and not full-length Gli2, can induce 
cyclin-D1 and cyclin-D2 expression in the absence of Shh. 
 
SHH expression has also been shown to increase the life-span of primary human 
keratinocytes by promoting cell proliferation, and to oppose the normal growth arrest 
(G1 cell cycle arrest) of primary epidermal keratinocytes in response to extracellular 
calcium, as well as to ectopic expression of CDKI p21
WAF1/CIP1
 (Fan & Khavari, 1999).
  
On the other hand, loss of Shh or Gli2 function in mice, leads to a significant decrease 
in the rate of cell proliferation in the developing hair follicle (arrest in hair follicle 
development) (Mill et al., 2003). Accordingly, Gli2 knockdown in a mouse BCC-like 
tumour cell line slightly reduced the cell proliferation rate (Ji et al., 2008), while GLI1 
knockdown in human gastric carcinoma cells, markedly repress cell proliferation, 
followed by a significant increase in the proportion of cells in G1 cell cycle phase and in 
the mRNA and protein levels of p21
WAF1/CIP1 
(Ohta et al., 2005).  
 
In a different context, GLI1 and GLI2 inducible expression has been shown to stimulate 
entry into the S phase of confluent growth arrested HaCaT human keratinocytes, 
whereas no difference in DNA synthesis between GLI1/or/GLI2-expressing HaCaT 
cells and control cells was detected at sub-confluent cultures (Regl et al., 2002). Further, 
inducible expression of GLI2∆N in contact inhibited (confluent) cultures of HaCaT and 
primary human keratinocytes is sufficient to stimulate DNA synthesis (G1-S 
progression), re-entry to the cell cycle, and to regulate the mRNA levels of specific cell 
cycle genes involved in G1-S and G2-M phase progression, such as cyclin D1 
(CCND1), E2F transcription factor 1 (E2F1) and cyclin B1 (CCNB1) respectively (Regl 
et al., 2004a). Moreover, a larger scale expression microarray analysis, that was 
performed using the same cell line GLI2∆N HaCaT and GLI1 HaCaT cell line, further 
showed that some proliferation associated genes, including E2F1 and cyclin B1, are 
upregulated in response to inducible expression of both GLI1 and GLI2∆N (Eichberger 
et al., 2006).  
 
In addition, a novel link between the SHH/GLI signalling and the G2-M transition has 
been observed. PTCH1 expression in human embryonic kidney cells inhibits cell 
proliferation (G2-M transition), by interacting with, and determining the subcellular 
localisation of the phosphorylated (non-active) cyclin B1 (Barnes et al., 2001). Thus, 
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PTCH1 maintains the phosphorylated cyclin B1 in the cytoplasm and prevents its 
relocalisation to the nucleus. Addition of the SHH ligand disrupts this interaction, and 
allows cyclin B1 to translocate to the nucleus, required for mitotic progression (Barnes 
et al., 2001). In the absence of Ptch1 from the basal cells in mouse skin, a large 
proportion of them exhibit nuclear accumulation not only of cyclin B1, but also of 
cyclin D1, suggesting that Ptch1 inhibits not only the G2-M transition, but also the G1-
S phase cell cycle progression (Adolphe et al., 2006). Recently, it was also shown that 
the phosphatase CDC25B, a regulator of G2-M transition (controls the entry into 
mitosis), is transcriptionally upregulated by the Shh/Gli signalling during embryonic 
development, both in chick and mice (Benazeraf et al., 2006). Additionally, Hh/Gli1 
signalling mediates regulation of the G2/M phase in neural precursors of the developing 
retina in Xenopus embryos, by transcriptionally activating important G2 phase 
regulators, such as cyclin B1 and CDC25C (Locker et al., 2006). 
 
Therefore, all these studies provide evidence for the interactions of the HH/GLI 
pathway, with components of the cell-cycle machinery which are involved in the 
progression of the cell cycle and promote cell proliferation, giving a possible 
explanation for the role of HH/GLI signalling in tumourigenesis. Increased cell 
proliferation is a hallmark of tumour formation (Hanahan & Weinberg, 2000), and thus 
cell cycle regulation is important for the maintenance of genomic integrity and is 
necessary to impose the appropriate limitations to uncontrolled proliferation (Sherr, 
1996). 
 
1.3.7.1 Checkpoint cell-cycle control mechanisms 
Checkpoints are the control mechanisms that enhance genetic fidelity by controlling the 
order and timing of cell cycle transitions and by successful completion of critical events 
such as DNA replication and chromosome segregation (Hartwell & Weinert, 1989; 
Murray, 1992; Elledge, 1996). Thus, cell cycle checkpoints monitor the structural 
integrity of chromosomes before progression through crucial cell cycle stages (Hartwell 
& Weinert, 1989; Lobrich & Jeggo, 2007). There are at least two checkpoints that 
monitor DNA damage, one at the G1/S transition and the other at the G2/M transition, 
preventing replication of damaged DNA or entry of damaged or incompletely replicated 
DNA into mitosis respectively (Kastan et al., 1992; Elledge, 1996; Bartek & Lukas, 
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2001; Taylor & Stark, 2001; Lobrich & Jeggo, 2007). There is also the mitotic 
checkpoint, that monitors the successful assembly of the spindle and prevents 
chromosome missegregation, by controlling the initiation of metaphase (Elledge, 1996; 
Rudner & Murray, 1996; Gorbsky, 1997; Musacchio & Hardwick, 2002).  
 
The tumour suppressor p53 and its direct transcriptional target p21
WAF1/CIP1
 (el-Deiry et 
al., 1994),
 
have been found to be primarily associated with both DNA damage 
checkpoints and to act as a backup mechanism in the mitotic checkpoint control, either 
by inducing cell cycle arrest and/or apoptosis (Kuerbitz et al., 1992; el-Deiry et al., 
1994; Brugarolas et al., 1995; Cross et al., 1995; Minn et al., 1996; Bunz et al., 1998; 
Khan & Wahl, 1998; Lanni & Jacks, 1998; Wang et al., 1998; Chehab et al., 1999; 
Andreassen et al., 2001a; Andreassen et al., 2001b; Taylor & Stark, 2001; Borel et al., 
2002; Margolis et al., 2003; Sherr, 2004; Castedo et al., 2006). The inactivation of 
checkpoint genes can result in gene mutations, chromosome damage, ploidy 
abnormalities (tetraploidy, polyploidy, aneuploidy), defective apoptosis, all of which 
can contribute to genomic instability (structural and/or numerical) and carcinogenesis 
(Figure 1.19) (Solomon et al., 1991; Paulovich et al., 1997; Lengauer et al., 1998; 
Stewart et al., 1999; Nowak et al., 2002; Albertson et al., 2003; Liu et al., 2004a; Nelson 
et al., 2004; Zhivotovsky & Kroemer, 2004; Jefford & Irminger-Finger, 2006; Lobrich 
& Jeggo, 2007).  
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Figure 1.19: Types of genomic instability. 
Genomic instability can be divided into chromosomal instability (CIN), and microsatellite 
instability (MSI) (due to mutated or silenced DNA-mismatch-repair genes). Chromosomal 
instability can be classified into structural and numeric. Structural chromosomal instability can 
result from mutations of the elements of the DNA-damage checkpoint (“gatekeepers”), of the 
elements of the two (non-homologous end joining and homologous recombination) DNA 
double-strand break repair mechanisms (“caretakers”), and also from telomere attrition 
(telomere shortening). Numeric chromosomal instability can result from aberrant 
tetra/polyploidisation (cells that have acquired more than two homologous sets of 
chromosomes), inappropriate centrosome duplication, or by defects in the spindle checkpoint. 
Both structural and numeric CIN tend to induce apoptosis as a default pathway that aborts 
damaged cells after DNA damage, polyploidisation, or asymmetric cell division (aneuploid 
cells, cells with chromosome complements that are not a simple multiple of the haploid set). 
Defective apoptosis increases the probability to these cells to survive, become selected and 
generate cancers (Zhivotovsky & Kroemer, 2004). 
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1.4 WNT signalling pathway 
Human BCCs show,  (a) increased levels of SHH effector genes such as GLI1 and GLI2  
(Dahmane et al., 1997; Ghali et al., 1999; Mullor et al., 2001; Regl et al., 2002; Tojo et 
al., 2003; Ikram et al., 2004; Regl et al., 2004b; O'Driscoll et al., 2006; Asplund et al., 
2008; Yu et al., 2008), (b) increased levels of WNT genes such as WNT2β, WNT5a and 
WNT7β (Bonifas et al., 2001; Mullor et al., 2001; Saldanha et al., 2004; O'Driscoll et 
al., 2006; Yu et al., 2008), as well as (c) accumulation of nuclear β-catenin (Yamazaki 
et al., 2001; El-Bahrawy et al., 2003; Saldanha et al., 2004; Yang et al., 2008a), (d) 
increased protein and mRNA levels of the β-catenin nuclear binding partner, LEF-1 
(O'Driscoll et al., 2006; Asplund et al., 2008; Kriegl et al., 2009), and (e) increased 
mRNA levels of the matrix metalloproteinases (MMP), which are known targets of β-
catenin-TCF/LEF-1 signalling and are involved in cell invasion (O'Driscoll et al., 2006; 
Yu et al., 2008). 
 
WNTs are secreted glycoproteins, lipid-modified signalling proteins, which  although 
their primary amino-acid sequence suggests that they should be quite soluble, secreted 
Wnts have been shown to be hydrophobic and thus difficult to manipulate, which was 
also further supported by the purification of active Wnts (Willert et al., 2003; Mikels & 
Nusse, 2006b; Hausmann et al., 2007). Wnts act in a wide range of developmental 
processes during embryogenesis, such as gastrulation, early pattern formation, 
organogenesis and adult tissue homeostasis (bone, gut, hair follicle), while gain-or-loss-
of-function mutations in WNT genes or Wnt pathway, lead to developmental 
abnormalities such as kidney and reproductive tract defects, as well as stem cell loss and 
cancer (Cadigan & Nusse, 1997; Wodarz & Nusse, 1998; Logan & Nusse, 2004; Nelson 
& Nusse, 2004; Nusse, 2005; Clevers, 2006; Klaus & Birchmeier, 2008; Nusse et al., 
2008; MacDonald et al., 2009). There are nineteen Wnt genes in the human genome and 
their name was derived from the Drosophila gene Wingless (Wg) and the related 
mammalian oncogene integration 1 (Int-1) (Nusse & Varmus, 1982; van Ooyen & 
Nusse, 1984; Cabrera et al., 1987; Rijsewijk et al., 1987; Cadigan & Nusse, 1997; Klaus 
& Birchmeier, 2008). Secreted Wnt proteins (ligands), bind to frizzled seven-
transmembrane span receptors (Frz) in the plasma membrane (Bhanot et al., 1996), and 
depending on the specific Wnt/Frz binding, initiate the signalling of three different 
pathways: (1) the Wnt/Ca
2+
 pathway, (2) the planar cell polarity pathway (PCP), and (3) 
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the canonical Wnt pathway (Figure 1.23) (Huelsken & Behrens, 2002; van Es et al., 
2003; Nelson & Nusse, 2004; Cadigan, 2008; Klaus & Birchmeier, 2008).  
  
β-catenin (the Drosophila version of which is Armadillo) (Nusslein-Volhard & 
Wieschaus, 1980; Wieschaus & Riggleman, 1987; Perrimon et al., 1989; Riggleman et 
al., 1990; Klaus & Birchmeier, 2008) is a protein that plays essential roles in two 
different cellular processes: calcium-dependent intercellular adhesion (McCrea & 
Gumbiner, 1991; McCrea et al., 1991; Peifer et al., 1992; Kemler, 1993; Gumbiner, 
2000; Jamora & Fuchs, 2002; Bienz, 2005; Brembeck et al., 2006) and WNT-mediated 
transcriptional activation. WNT/β-catenin signalling pathway (canonical WNT 
pathway) (Riggleman et al., 1990; Rubinfeld et al., 1993; Noordermeer et al., 1994; 
Siegfried et al., 1994; Behrens et al., 1996) is involved in a wide range of embryonic 
patterning events and adult tissue homeostasis (Cadigan & Nusse, 1997; Wodarz & 
Nusse, 1998; Clevers, 2006; Klaus & Birchmeier, 2008), and also found to contain 
cancer-causing genes (Polakis, 2000; Taipale & Beachy, 2001; Giles et al., 2003; Sherr, 
2004; Vogelstein & Kinzler, 2004). Still it is not clear if the roles of β-catenin in cell-
cell adhesion and Wnt signalling, both in development and tumourigenesis, are either 
largely independent from each other, or interrelated, since evidence occurs for both 
possibilities in different cell contexts (Cavallaro & Christofori, 2004; Gottardi & 
Gumbiner, 2004; Nelson & Nusse, 2004; Bienz, 2005; Brembeck et al., 2006). 
 
1.4.1 The role of β-catenin in calcium-dependent intercellular adhesion 
β-catenin protein was initially discovered for its role in cell-cell adhesion, as a 
component of the E-cadherin-catenin complex in the epithelial cell membrane (McCrea 
& Gumbiner, 1991; McCrea et al., 1991; Peifer et al., 1992; Kemler, 1993; Bienz, 
2005). E-cadherin (epithelial cadherin), is a calcium (Ca
2+
) - dependent, type I integral 
membrane protein, which is required to hold epithelial cells together and thus contribute 
to the formation and maintenance of a variety of solid epithelial tissues, such as skin, 
gut and lung (Gumbiner, 1996; Gumbiner, 2005).  
 
E-cadherin protein consists of a large extracellular domain, a single transmembrane 
segment and a short cytoplasmic domain (highly conserved cytoplasmic tail) (Figure 
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1.20) (Pecina-Slaus, 2003). The extracellular domain consists of five cadherin-type 
repeats (extracellular domains), that are bound together by Ca
2+
 ions to form stiff rod-
like proteins, and mediates the calcium-dependent adhesive binding function between 
adjacent cells, through homophilic protein-protein interactions of the extracellular 
domains in a process of lateral dimerization, forming the known as adherens junctions 
(Figure 1.20 and Figure 1.21) (Pokutta et al., 1994; Pecina-Slaus, 2003; Cavallaro & 
Christofori, 2004; Gumbiner, 2005). In the proximal region (juxtamembrane region) of 
its intracellular cytoplasmic domain, E-cadherin, has p120 catenin bound, of which the 
exact role is unclear but it has been suggested to regulate the structural integrity and the 
E-cadherin stability (Davis et al., 2003). In the distal part of its intracellular cytoplasmic 
domain, E-cadherin has β-catenin bound, which in turns binds to the actin binding 
protein α-catenin (adaptor protein) to bridge the extracellular adhesive activity of 
cadherins with the underlying actin cytoskeleton (Figure 1.20). α-catenin is able to 
mediate physical links to the actin cytoskeleton either by directly binding actin 
filaments or indirectly through other actin-binding proteins such as vinculin, α-actinin 
or formin-1 (Figure 1.20). Therefore, the E-cadherin-β-catenin complex serves to link 
the cytoskeletal networks of adjacent cells and thus mediates the Ca
2+
- dependent cell-
cell adhesion, which is essential for normal tissue architecture and morphogenesis 
(Figure 1.21) (Gumbiner, 1996; Gumbiner, 2000; Jamora & Fuchs, 2002; Cavallaro & 
Christofori, 2004; Nelson & Nusse, 2004; Gumbiner, 2005; Brembeck et al., 2006).  
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Figure 1.20: The cadherin-catenin protein complex. 
E-cadherin is a parallel or cis homodimer (parallel (cis) cadherin dimer) that consists of a large 
extracellular domain, a single transmembrane segment, and a short cytoplasmic domain. The 
extracellular region (extracellular domain), consists of five cadherin-type repeats (EC domains: 
extracellular cadherin domains), that are bound together by calcium ions (Ca
2+
) in a rod-like 
structure. The core-universal complex, consists of p120 catenin, which is bound to the 
juxtamembrane region of the intracellular cytoplasmic domain and β-catenin, which is bound to 
the distal part of the intracellular cytoplasmic domain, which in turns bind α-catenin. α-catenin 
bind to actin or to other actin-binding proteins such as vinculin, α-actinin and formin-1, in order 
to mediate physical links to the actin cytoskeleton (Gumbiner, 2005). 
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Figure 1.21: Schematic illustration of E-cadherin in adherens junction of adjacent 
cells. 
E-cadherin-β-catenin complex links the cytoskeletal networks of adjacent cells and thus 
mediates calcium-dependent adhesive binding function, through homophilic protein-protein 
interactions of the extracellular domains in a process of lateral dimerization, forming the known 
as adherens junctions (Pokutta et al., 1994; Pecina-Slaus, 2003; Gumbiner, 2005). 
 
 
Serine/threonine phosphorylation of β-catenin (CTNNB1 gene) or E-cadherin (CDH1 
gene) results in increased stabilisation of the cadherin-catenin complex (Lickert et al., 
2000; Bek & Kemler, 2002), while tyrosine phosphorylation of E-cadherin or β-catenin 
is correlated with loss of cadherin mediated cell-cell adhesion, and an increase in the 
level of cytoplasmic β-catenin for the latter (Roura et al., 1999; Fujita et al., 2002; 
Lilien et al., 2002; Cavallaro & Christofori, 2004; Nelson & Nusse, 2004). Loss of e-
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cadherin expression, and subsequent loss of cell-cell adhesion often occurs both (a) 
during normal developmental epithelial-mesenchymal transitions (EMTs), where 
polarized epithelial cells from a primitive epithelium are converted into motile 
mesenchymal cells (loss of the epithelial phenotype) that migrate to an extracellular 
environment and subsequently settle to other areas, a process essential for organ 
formation during embryonic development (i.e. mesoderm formation and many 
histogenic processes), as well as (b) during tumour progression (Birchmeier & Behrens, 
1994; Gumbiner, 1996; Thiery, 2002; Pecina-Slaus, 2003; Cavallaro & Christofori, 
2004; Nelson & Nusse, 2004; Gumbiner, 2005; Hugo et al., 2007). Loss of E-cadherin-
mediated cell-cell adhesion is a prerequisite for tumour cell invasion and metastasis 
formation (Birchmeier & Behrens, 1994; Cavallaro & Christofori, 2004) and loss of E-
cadherin in cancers of epithelial origin is concomitant with the progression towards 
malignancy, since there is an inverse correlation between E-cadherin levels and tumour 
grade (Birchmeier & Behrens, 1994; Hirohashi, 1998; Hirohashi & Kanai, 2003). 
Various genetic or epigenetic mechanisms, such as loss-of-function mutations of the E-
cadherin gene (Risinger et al., 1994; Berx et al., 1995), or transcriptional repression by 
transcription factors such as Snail, Slug (Batlle et al., 2000; Cano et al., 2000; Hajra et 
al., 2002) and promoter hypermethylation of the E-cadherin gene (Yoshiura et al., 1995; 
Tamura et al., 2000; Di Croce & Pelicci, 2003), respectively, have been found to cause 
downregulation/loss of E-cadherin during carcinoma progression (Strathdee, 2002; 
Thiery, 2002; Cavallaro & Christofori, 2004; Hugo et al., 2007). 
 
1.4.2 Canonical WNT/β-catenin signalling pathway 
β-catenin is the key component of the canonical Wnt signalling pathway, that functions 
by regulating the amount/stability of the co-activator β-catenin, which controls key 
developmental and tissue homeostasis gene expression programs (Huelsken & Behrens, 
2002; Logan & Nusse, 2004; Nusse, 2005; Cadigan, 2008; Klaus & Birchmeier, 2008; 
MacDonald et al., 2009). 
 
In the absence of WNT signal (Figure 1.22a), cytoplasmic β-catenin - non E-cadherin 
bound, is kept low as it is recruited in and is constantly degraded by the action of, a 
destruction complex, which is composed of the Axin, adenomatous polyposis coli 
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(APC), casein kinase 1 (CK1) and glycogen synthase kinase 3β (GSK3β) proteins 
(Behrens et al., 1998; Amit et al., 2002; Liu et al., 2002; Logan & Nusse, 2004). Both 
the scaffolding protein axin and the tumour suppressor APC protein, seem to act as 
scaffolds, positioning β-catenin and the kinases to allow efficient phosphorylation. 
Serine/threonine kinases CK1α and GSK3β sequentially phosphorylate the amino 
terminal regions (N-terminus) of β-catenin. Following phosphorylation, β-catenin is 
recognized and targeted by β-TrCP (β-transducin repeat-containing protein), a 
component of the E3 ubiquitin ligase complex, which triggers poly-ubiquitination and 
subsequent proteasomal degradation of β-catenin (Aberle et al., 1997; Jiang & Struhl, 
1998; Latres et al., 1999; Liu et al., 1999; He et al., 2004; MacDonald et al., 2009). 
Thus, free cytoplasmic β-catenin has an average half-life of ~ 30 minutes in the cell 
(Cadigan, 2008). This continual elimination of β-catenin prevents its translocation to the 
nucleus and ensures repression of Wnt target genes by recruitment of the co-repressor 
Groucho (TLE1 in human) to TCF/LEF (T-cell factor / lymphoid enhancer factor) 
transcription factors, of which repressing effect is mediated by interactions with Histone 
Deacetylases (HDAC) that are thought to make DNA refractive to transcriptional 
activation (Cavallo et al., 1998; Levanon et al., 1998; Chen et al., 1999b; Nusse, 2005; 
Klaus & Birchmeier, 2008; MacDonald et al., 2009). 
 
In the presence of WNT signal (Figure 1.22b), the Wnt/β-catenin pathway is activated. 
WNT ligands bind to the cell surface receptors in the plasma membrane, which are the 
seven-pass transmembrane Frizzled (FZD) receptor (Bhanot et al., 1996) and its co-
receptor LRP6 or its close relative LRP5 (low-density lipoprotein receptor-related 
protein 6 or 5), known as Arrow in Drosophila  (Tamai et al., 2000; Wehrli et al., 2000; 
He et al., 2004). Several inhibitors of this interaction have been identified (Klaus & 
Birchmeier, 2008), including secreted Frizzled-related proteins (SFRPs) and Wnt 
inhibitory factor 1 (WIF1) that both bind to WNTs and inhibit their activities (Finch et 
al., 1997; Rattner et al., 1997; Wang et al., 1997; Hsieh et al., 1999), secreted Dickkopfs 
(DKKs) which bind and antagonizing LRP5/LRP6 (Glinka et al., 1998), and an 
additional DKK-receptor Kremen, which inhibits the Wnt signalling pathway by 
internalization of LRP6 (endocytosis and removal from the plasma membrane) (Mao et 
al., 2002) (Figure 1.22a). In the absence of these antagonists, and upon binding of Wnt 
ligands to both FZD and LRP5/LRP6 (FZD-LRP5/6 complex) (Figure 1.22b), there is 
subsequent LRP5/LRP6 phosphorylation in its cytoplasmic tail by CK1γ and GSK3β, as 
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well as recruitment of the scaffolding protein Dishevelled (DVL) (Noordermeer et al., 
1994) to the plasma membrane, where it associates with FZD receptors, polymerises 
with other Dishevelled molecules and promotes LRP5/LRP6 phosphorylation along 
with Axin recruitment to the receptors (FZD and LRP5/LRP6) in the plasma membrane 
(Cadigan, 2008; Klaus & Birchmeier, 2008; Zeng et al., 2008; MacDonald et al., 2009). 
Interaction of Axin with phosphorylated LRP5/LRP6 and the Dishevelled polymer, 
leads to the inactivation of the destruction complex, and subsequently to the 
stabilisation of β-catenin due to the inhibition of axin-mediated β-catenin 
phosphorylation, and its translocation to the nucleus (He et al., 2004; Cadigan, 2008; 
Klaus & Birchmeier, 2008; MacDonald et al., 2009). In the nucleus, β-catenin acts as a 
transcriptional co-regulator that binds to the TCF/LEF-1 DNA-binding proteins 
(Behrens et al., 1996; Molenaar et al., 1996; Arce et al., 2006), and thereby converting 
the TCF/LEF-1 repressor complex into a transcriptional activator complex critical for 
activation of WNT target genes, by displacing Groucho/TLE (Daniels & Weis, 2005) 
and interacting with other co-activators (Klaus & Birchmeier, 2008). These co-
activators include pygopus (Drosophila) (Thompson et al., 2002), which binds to the 
amino-terminal half of β-catenin, and histone acetylase CBP (vertebrates) (CREB-
binding protein) (Hecht et al., 2000), which binds to the carboxy-terminal and is thought 
to induce chromatin remodelling that favours target gene transcription (Barker et al., 
2001; Wolf et al., 2002; Logan & Nusse, 2004; Nusse, 2005; MacDonald et al., 2009). 
However, many of these factors are likely to be gene specific, cell-type or species 
specific (Cadigan, 2008; Klaus & Birchmeier, 2008). 
 
The TCF/LEF family of DNA-bound transcription factors, which is the main partner for 
β-catenin in gene regulation, belongs to the high mobility group (HMG) DNA binding 
factors with only a single HMG box (a single homologous sequence) (Travis et al., 
1991; van de Wetering et al., 1991; Roose & Clevers, 1999; Arce et al., 2006), similar 
to SOX factors (Chapter 3, Section 3.3.6.2.) (Pevny & Lovell-Badge, 1997; Werner & 
Burley, 1997; Wegner, 1999; Kamachi et al., 2000; Wilson & Koopman, 2002). The 
HMG box is a DNA binding domain, which binds DNA in the promoter or the enhancer 
regions of other genes in a sequence-specific manner, and thus it is implicated in the 
regulation of transcription and chromatin architecture (Grosschedl et al., 1994), by  
rendering TCF/LEF or other proteins that belong to this family (SOX proteins), as 
transcription factors which either activate or repress target genes (Roose & Clevers, 
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1999; Wegner, 1999; Kamachi et al., 2000; Arce et al., 2006). Therefore, upon binding 
of the TCF/LEF factors to the specific DNA consensus sequence of other genes 
(CCTTTGWW - W represents either T or A), referred to as the WNT responsive 
element (WRE), a significant DNA bending is caused, which is thought to alter the 
chromatin structure and thus recruiting β-catenin and its co-activators to WNT target 
genes (Arce et al., 2006; MacDonald et al., 2009). In Drosophila, there is only a single 
TCF/LEF gene (dTCF or pangolin), while in mammals four TCF/LEF genes, TCF1, 
LEF-1, TCF3 and TCF4 do exist  (Roose & Clevers, 1999; Arce et al., 2006). Evidence 
for diverse actions of TCF/LEF genes during development, comes from studies in 
different organisms, which have shown, in general, that LEF-1 is mainly an activator, 
TCF1 and TCF4 can act both as repressors and activators, while TCF3 is mainly a 
repressor (Arce et al., 2006; Cadigan, 2008; MacDonald et al., 2009).  
 
The recognition of target genes from TCF/LEF factors appears to be context-dependent, 
as well as co-factor-dependent (Arce et al., 2006). Due to the weak ability of TCF/LEF 
factors for target gene recognition and the ability only for loose binding to the DNA of 
target genes, TCF/LEF factors require the recruitment of other co-factors (partners) 
including β-catenin, in order to bind and activate/suppress the correct set of target genes 
(Roose & Clevers, 1999; Arce et al., 2006). Therefore, since Wnt/β-catenin signalling 
regulates proliferation, fate specification, stem cell maintenance and differentiation in 
numerous developmental stages and adult tissue homeostasis, it is plausible that Wnt 
target genes are diverse and cell and context specific (Logan & Nusse, 2004; Vlad et al., 
2008; MacDonald et al., 2009). This means that Wnt/β-catenin signalling has distinct 
transcriptional outputs which are only expressed in certain cells, whereas in many cases 
the cell rather than the signal determines the nature of the response and the up-or-
downregulation of Wnt target genes is cell-type specific as well (Logan & Nusse, 2004; 
Nusse, 2005). However, Wnt/β-catenin signalling can also control genes that are more 
widely induced (induction of same target genes in multiple cell and tissue types), such 
as genes that are components of the Wnt/β-catenin pathway including Axin2, Frizzleds, 
β-TrCP and TCF/LEF, indicating a feedback control mechanism (Logan & Nusse, 2004; 
Klaus & Birchmeier, 2008; MacDonald et al., 2009). In addition Wnt/β-catenin 
signalling has been shown to induce expression of target genes which have been linked 
to increased cell proliferation, invasion and tumour metastasis, including cyclin D1, c-
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Myc, MMP26, MMP7, PPAP-δ and AF17 (He et al., 1998; Brabletz et al., 1999; He et 
al., 1999; Shtutman et al., 1999; Lin et al., 2001; Marchenko et al., 2002). 
 
Interestingly, studies both in Drosophila and in mammals have shown that many genes 
are downregulated in response to Wnt signalling (Logan & Nusse, 2004; Vlad et al., 
2008), suggesting that even if β-catenin typically converts the TCF/LEF factors from 
repressors to activators, the TCF/LEF-β-catenin complex is also able to repress 
transcription of certain genes, which is a  distinct process from TCF/LEF-mediated 
repression in the absence of β-catenin (Cadigan, 2008; MacDonald et al., 2009). 
Although, it is not clear which of these downregulated genes are directly or indirectly 
(through a Wnt-activated repressor protein) repressed by Wnt/β-catenin signalling, at 
least in some cases it has been confirmed that TCF/LEF-β-catenin complex directly 
mediates this repression (Piepenburg et al., 2000; Blauwkamp et al., 2008), and that in 
some of these target genes, repression required the traditional TCF/LEF-binding sites 
(Jamora et al., 2003; Theisen et al., 2007). However, the mechanism by which 
TCF/LEF-β-catenin complex exhibits repression rather than activation in certain genes 
remains unclear, and it appears to be different among the few genes studied in detail 
(Cadigan, 2008; MacDonald et al., 2009). For example, dpp (decapentaplegic - homolog 
of the vertebrate bone morphogenetic proteins/BMPs) gene in Drosophila, which is a 
morphogen necessary for the development of the leg imaginal discs of the fruit fly, is 
directly repressed via TCF/LEF-β-catenin binding to the canonical WREs on the dpp 
enhancer region by recruiting the co-repressor Brinker (BRK) (Theisen et al., 2007); 
while Ugt36Bc gene in Drosophila, an enzyme that belongs to the UDP-
glycosyltransferase superfamily and is thought to exert an effect in detoxification, is 
directly repressed via TCF/LEF-β-catenin binding to a novel TCF/LEF binding site to 
the enhancer of the Ugt36Bc gene, which mediates TCF/LEF-β-catenin repression 
instead of activation (Blauwkamp et al., 2008). 
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Figure 1.22: Canonical WNT/β-catenin pathway. 
(a) In the absence of WNT signal, cytoplasmic β-catenin (β-cat) - non E-cadherin bound, is 
phosphorylated and targeted for degradation by a complex of proteins, including Axin, APC, 
GSK3β and β-TrCP. (b) In the presence of WNT signal the degradation machinery is inhibited, 
β-catenin accumulates in the cytoplasm and translocates to the nucleus, where it interacts with 
TCF/LEF-1 transcription factor and activates transcription of targeted genes. DKK, Dickkopf; 
LRP, LDL-related receptor protein; SFRP, secreted Frizzled-related protein; WIF, Wnt inhibitory factor 
1; DVL, Dishevelled; β-TrCP, β-transducin repeat-containing protein; CK1, casein kinase 1; GSK3β, 
glycogen synthase kinase 3β; APC, adenomatous polyposis coli; TCF, T-cell factor; Lef, lymphoid 
enhancer factor;  Pygo, Pygopus; CBP, CREB-binding protein; P, phosphorylation; Ub, ubiquitylation; 
N, amino terminus; C, carboxyl terminus; (Klaus & Birchmeier, 2008; Watt & Collins, 2008).  
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1.4.3 The planar cell polarity and the Wnt/Ca2+ pathway  
The specific Wnt/Frz binding, does not only initiate the signalling of the canonical Wnt 
pathway described in Section 1.4.2, but is also capable of activating a β-catenin-
independent, non-canonical Wnt signalling cascade, which is not as well characterised 
as the canonical Wnt/β-catenin  pathway (Figure 1.23) (Huelsken & Behrens, 2002; 
Strutt, 2003; Veeman et al., 2003; Gordon & Nusse, 2006; van Amerongen et al., 2008). 
These non-canonical Wnt pathways regulate crucial cell-fate decisions and include the 
planar cell polarity pathway, which was first identified in Drosophila (McEwen & 
Peifer, 2000; Sokol, 2000; Seifert & Mlodzik, 2007), and the Wnt/Ca
2+
 pathway, which 
was first described in vertebrates (Kuhl et al., 2000a; Kuhl et al., 2000b; Saneyoshi et 
al., 2002).  
 
All epithelial cells have distinct Apical/Basal polarity. That is some proteins are 
exclusively localised to the top or the bottom of the cell and are separated from each 
other with cell junctions in order to avoid the mixing of the proteins from the two 
regions and to maintain a rigid epithelial structure (Dollar & Sokol, 2007). Thus, in 
epithelia, cells are uniformly polarized along the apical-basal axis. However, in addition 
to apical-basal polarity, cells in most tissues require positional information in the plane 
to generate polarized structures or to move or orient themselves in a directed fashion, 
like for example hairs or feathers that must point the right way on animal skin (Strutt, 
2003; Seifert & Mlodzik, 2007). This type of polarization of fields of cells that orient 
themselves relative to the plane of the tissue in which they reside, is referred to as 
planar cell polarity (PCP) and is essential for tissue functioning (Strutt, 2003; Seifert & 
Mlodzik, 2007). Therefore, Wnt/planar cell polarity pathway regulates planar cell 
polarity and morphogenetic movements (Sokol, 2000; Strutt, 2003; Seifert & Mlodzik, 
2007; Wang & Nathans, 2007). In the planar cell polarity pathway (Figure 1.23), 
activated Frizzled by WNT signal, activates Dishevelled which in turns signals to small 
GTPases Rho and Rac (members of the Ras superfamily of small guanosine 
triphosphatases - GTPases) and activates Jun N-terminal kinase (JNK), which are both 
(Rho/Rac and JNK) known to regulate cytoskeleton and specify planar cell polarity 
(Strutt et al., 1997; Boutros et al., 1998; Hall, 1998; Noselli & Agnes, 1999; McEwen & 
Peifer, 2000; Peifer & McEwen, 2002). Although it has been shown that Dishevelled 
activates both Rho (Strutt et al., 1997) and JNK (Boutros et al., 1998; Li et al., 1999) in 
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planar cell polarity pathway, it is still controversial whether the Rho family GTPases 
and particular Rac, is also involved in JNK activation by Dishevelled (Li et al., 1999; 
Habas et al., 2003; Veeman et al., 2003). 
 
The Wnt/Ca
2+
 pathway regulates cell-cell interactions and motility during development 
(Kuhl et al., 2000b; Kuhl et al., 2001; Winklbauer et al., 2001; Kohn & Moon, 2005). 
The Wnt/Ca
2+
 pathway (Figure 1.23) (Miller et al., 1999; Kuhl et al., 2000b; Huelsken 
& Behrens, 2002; Kohn & Moon, 2005), involves the binding of Wnt to the Frizzled 
receptor, which promotes Frizzled-mediated activation of pertussis toxin-sensitive 
heterotrimeric (α, β, γ) guanine nucleotide-binding proteins (G proteins) (Slusarski et 
al., 1997; Sheldahl et al., 1999; Kuhl et al., 2000a) and / or Dishevelled (Sheldahl et al., 
2003). G proteins have also been thought to transmit/mediate signals from the Frizzled 
receptors to the downstream effectors, in both the canonical Wnt and planar cell polarity 
pathways (Malbon et al., 2001; Huelsken & Behrens, 2002; Nusse, 2005; Mikels & 
Nusse, 2006b), because Frizzled receptors have seven transmembrane domains 
(serpentine receptors) like other heterotrimeric G protein-coupled receptors, and an 
heptithelical structure that is conserved among all members of the superfamily of G 
protein-coupled receptors (Slusarski et al., 1997; Dale, 1998; Kohn & Moon, 2005). 
Although, there are biochemical studies, that support this notion, of which the evidence 
is largely based on overexpression or usage of inhibitors (Slusarski et al., 1997; 
Sheldahl et al., 1999; Kuhl et al., 2000a; Wang & Malbon, 2004), there is no study to 
show natural and direct interaction of G proteins with Frizzleds. Only recently, 
Katanaev et al. (Katanaev et al., 2005) showed by genetic analysis, that G proteins are 
indeed required for Frizzled signalling (are activated in response to Fzd signalling) in 
Drosophila both in canonical Wnt and cell polarity pathway. Thus, genetic analysis in 
vertebrates is required in order to provide further support to this notion (Kohn & Moon, 
2005). Therefore, upon Dishevelled and G proteins stimulation in the Wnt/Ca
2+
 pathway 
(Figure 1.23), there is activation of the phospholipase C (PLC) (Kuhl et al., 2000b; 
Kohn & Moon, 2005), which leads to elevated Ca
2+
 levels (release of intracellular 
calcium) (Slusarski et al., 1997) and the activation of calcium sensitive enzymes such as 
protein kinase C (PKC) (Sheldahl et al., 1999) and calmodulin-dependent protein kinase 
II (CaMKII) (Kuhl et al., 2000a). The elevated levels of Ca
2+
 can activate the 
calcium/calmodulin-dependent serine/threonine phosphatase, calcineurin  which leads to 
dephosphorylation of the transcription factor NF-AT (nuclear factor of activated T cells) 
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(Crabtree & Olson, 2002). This leads to the nuclear accumulation of NF-AT, which 
activates target genes that are mainly implicated in developmental cell-cell interactions 
(Crabtree & Olson, 2002; Huelsken & Behrens, 2002; Saneyoshi et al., 2002). The 
function of calcineurin has been elucidated in great detail in the immune system, where 
it activates the T-cells through the activation of NF-AT, which translocates to the 
nucleus and upregulates the expression of proteins such as interleukin 2 which in turn 
stimulates the growth and differentiation of T-cells, but it has also been shown to be 
implicated in other systems including hematopoietic, neuronal and myogenic (Crabtree 
& Olson, 2002). Interestingly the calcineurin/NF-AT activity has also been implicated 
in primary mouse keratinocyte growth/differentiation control (Santini et al., 2001) and 
in the regulation of the hair keratinocyte differentiation and hair cycle in vivo (Gafter-
Gvili et al., 2003), while calcineurin/NF-AT have also been found to be expressed in 
human skin (predominantly in epidermal keratinocytes) and in human keratinocytes in 
culture (Al-Daraji et al., 2002).   
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Figure 1.23: WNT signalling pathways. 
The extracellular signalling molecule WNT activates three pathways: (1) The canonical Wnt/β-
catenin pathway (middle), (2) the planar cell polarity pathway (left), and the (3) the Wnt/Ca
2+
 
pathway (right). FZ, Frizzled; LRP, LDL-related receptor protein; DVL, Dishevelled; 
GSK3β, glycogen synthase kinase 3β; APC, adenomatous polyposis coli; TCF, T-cell factor; 
LEF, lymphoid enhancer factor;  Rho, Ras family-like protein; Rac, Ras family-like protein; 
JNK, Jun N-terminal kinase; G protein, pertussis toxin-sensitive heterotrimeric (α, β, γ) 
guanine nucleotide-binding proteins; Ca
2+
, calcium; PKC, protein kinase C; CaMKII, 
calmodulin-dependent protein kinase II; NF-AT, nuclear factor of activated T-cells; (Klipp & 
Liebermeister, 2006). 
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1.5 WNT/β-catenin signalling pathway in skin development and cancer 
1.5.1 Wnt/β-catenin signalling in hair follicle formation and stem cell 
regulation 
In skin, Wnt/β-catenin signalling pathway plays a crucial role in hair follicle 
morphogenesis, hair follicle stem cell maintenance and/or activation, and hair shaft 
differentiation, as well as in skin epithelial stem cell lineage selection (Gat et al., 1998; 
DasGupta & Fuchs, 1999; Huelsken et al., 2001; Millar, 2002; Alonso & Fuchs, 2003a; 
Lowry et al., 2005; Schmidt-Ullrich & Paus, 2005; Blanpain & Fuchs, 2006; Blanpain 
et al., 2007; Watt & Collins, 2008). Previous studies in normal skin of transgenic mice, 
have shown that Wnt/β-catenin is required upstream of the Bmp and Shh in placode 
formation during hair follicle morphogenesis, and thus specifying the hair follicle fate in 
the undifferentiated basal epidermis and initiate hair bud formation (Gat et al., 1998; 
Huelsken et al., 2001; Andl et al., 2002; Lo Celso et al., 2004; Silva-Vargas et al., 2005; 
Blanpain & Fuchs, 2006). Then, it subsequently activates Shh signalling, which is 
required for the proliferation and expansion of follicle epithelium in order to assemble a 
mature follicle (St-Jacques et al., 1998; Chiang et al., 1999; Mill et al., 2003; Lo Celso 
et al., 2004; Silva-Vargas et al., 2005; Blanpain & Fuchs, 2006).  
 
The importance of Wnt/β-catenin signalling pathway in skin, during embryogenesis is 
underscored by the absence of  placode formation (first stage of hair follicle 
morphogenesis-early embryonic stage) in neonate mice, upon conditional loss 
(conditional mutation under the control of K14) of β-catenin in transgenic mice 
(Huelsken et al., 2001), or upon inhibition of the Wnt/β-catenin signalling pathway by 
overexpressing Dkk1 inhibitor (Andl et al., 2002). Transgenic mice lacking the β-
catenin after hair follicle formation, exhibit complete hair loss after the first hair cycle 
and also failure of stem cell differentiation into follicular keratinocytes, but instead 
adopt an epidermal fate (Huelsken et al., 2001), while transgenic mice overexpressing a 
constitutively active form of β-catenin (N-terminal truncated) under the control of K14 
promoter in the basal layer of skin epidermis and hair follicles, display de novo hair 
follicle formation, including development of dermal papilla and sebaceous glands 
normally established only in embryogenesis and are permanent in postnatal life (Gat et 
al., 1998). Similarly, overexpression of a dominant negative form of Lef-1 (unable to 
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bind to β-catenin), under the control of K14 promoter in skin of transgenic mice, 
resulted in conversion of hair follicles into cysts of interfollicular epidermis with ectopic 
sebocytes (Niemann et al., 2002). Recently, Silva-Vargas et al. (Silva-Vargas et al., 
2005), showed that inducible stabilisation of β-catenin in the adult skin of transgenic 
mice leads to ectopic hair follicle formation from the interfollicular epidermis. In line 
with this study, Ito et al. (Ito et al., 2007), showed that upon severe wounding of the 
skin in mice, Wnt/β-catenin signalling is elevated, leading to the induction of hair 
follicle formation from the epidermal stem cells. Taken together, these studies suggest 
that fate decisions of stem cells in the skin depend on β-catenin activation/stabilisation, 
which directs lineage selection in vivo and thus specification of either interfollicular 
epidermis or hair follicle development, both in embryonic and adult epidermis (β-
catenin promotes hair follicle lineages) (Blanpain et al., 2007; Fuchs, 2008; Watt & 
Collins, 2008). 
 
Interestingly, Wnt/β-catenin is not only activated during the placode formation, but is 
also required during the adult hair cycle both for HF stem cell maintenance (Lowry et 
al., 2005), and for stem cell activation, in order to initiate the growth of a new hair 
during the telogen-to-anagen transition (transition from the quiescent to the growing 
phase of the hair cycle) (DasGupta & Fuchs, 1999; Van Mater et al., 2003; Lo Celso et 
al., 2004; Lowry et al., 2005; Blanpain & Fuchs, 2006). The role of Wnt/β-catenin 
signalling and Wnt proteins in the specification and maintenance of stem cells and stem 
cell lineages  is well established in various tissues and organs (Klaus & Birchmeier, 
2008; Nusse et al., 2008). In the small intestine of transgenic mice, Tcf4 - a nuclear 
binding partner of β-catenin, was found to maintain the crypt stem cells, since loss-of-
function mutations of the Tcf4 resulted in the complete absence of the stem cell 
compartment (Korinek et al., 1998). In addition, Wnt/β-catenin signalling has also been 
implicated in the increase of the haematopoietic stem cell renewal (Reya et al., 2003; 
Willert et al., 2003), as well as in the regulation of precursor cell maintenance in the 
central and peripheral nervous system (Lee et al., 2004; Zechner et al., 2007). In 
cultured human keratinocytes, the putative epidermal stem cells (keratinocytes with 
high proliferative potential) (Jones & Watt, 1993), express higher level of non-E- 
cadherin-associated β-catenin than transit-amplifying cells (Zhu & Watt, 1999). In 
addition, expression of stabilised β-catenin in cultured human keratinocytes, induces the 
expansion of putative epidermal stem cells, while the expression of an inactive form of 
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β-catenin induces exit from the stem cell compartment (Zhu & Watt, 1999). In contrast 
to the in vitro results, the loss of β-catenin does not seem to affect the maintenance of 
epidermal basal layer stem cells in vivo (no depletion of the interfollicular epidermal 
stem cells in skin) (Huelsken et al., 2001; Niemann et al., 2002), while, when β-catenin 
is stabilised through either genetic manipulation or wounding, epidermal basal layer 
stem cells adopt a hair follicle cell fate (Gat et al., 1998; Lo Celso et al., 2004; Silva-
Vargas et al., 2005; Ito et al., 2007). The difference between the in vitro and in vivo 
results can be attributed to the fact that in vitro, hair follicle morphogenesis is not 
permissive and thus the epidermal stem cell compartment expands upon β-catenin 
stabilisation. Another possible explanation could be that in vivo, the response of 
epidermal stem cells to β-catenin is largely dependent on the interactions with the 
underlying mesenchyme, which is absent in culture (Watt & Collins, 2008). 
 
However, postnatally, conditional targeted inducible ablation of β-catenin in adult mice 
skin, when backskin follicles are in telogen, results  in the loss of the follicle stem cell 
niche (inability of β-catenin-null skin to preserve the quiescence and the expression of 
stem cell markers in the bulge niche) and failure of bulge stem cells to undergo proper 
activation in the onset of anagen (no reinitiation of the hair cycle) (Lowry et al., 2005). 
The role of Wnt/β-catenin in anagen induction and thus in bulge stem cell activation in 
transgenic mice, is also strengthened by the fact that although, most bulge cells in the 
hair follicle appear to be in a state of Wnt inhibition during telogen (resting phase), as 
judged by the inactivation of a Wnt reporter transgene TOPGAL and the lack of 
detectable nuclear β-catenin, at the onset of anagen in TOPGAL transgenic mice, there 
is an increase in OT-promoter in the bulge region of the hair follicle (DasGupta & 
Fuchs, 1999). Therefore, stabilised β-catenin is a feature of activated stem cells that 
drive the resting follicle into active growth. Accordingly, transgenic mice expressing 
constitutive elevated levels of stabilised β-catenin in their skin, exhibit de novo 
formation of hair follicles (Gat et al., 1998), as well as, by inducing expression of 
stabilised β-catenin in telogen-phase follicles in adult epidermis of  transgenic mice, 
first, precocious re-entry into the anagen phase of hair growth occurs  (Van Mater et al., 
2003; Lo Celso et al., 2004; Lowry et al., 2005), and then de novo hair follicle 
formation from existing follicles, interfollicular epidermis and sebaceous glands (Lo 
Celso et al., 2004). Finally, the strongest Wnt/β-catenin signal, which is required 
postnatally in normal follicles, is for the terminal differentiation of cortical cells 
Chapter 1: Introduction 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 130 
(differentiated matrix cells) of the hair shaft (DasGupta & Fuchs, 1999), which is 
further supported by the fact that overexpression of stabilised β-catenin in transgenic 
mice develop pilomatricomas, which are pure masses of cortical cells (Gat et al., 1998), 
and also that (stabilising) mutations of β-catenin (CTNNB1), have been identified in 
human pilomatricomas (Chan et al., 1999a; Kajino et al., 2001; Moreno-Bueno et al., 
2001; Xia et al., 2006). 
 
Collectively, these findings underscore the sequential roles of Wnt/β-catenin in 
regulating epidermal and follicle stem cell lineage commitment and adult hair cycle, 
perhaps in a way that depends on the level of the signal (Niemann & Watt, 2002; 
Blanpain & Fuchs, 2006), as judged by gain-and-loss of function studies, using K14∆N-
β-cateninER adult mice in which the onset and duration of β-catenin activation are 
controlled by topical application of the drug 4-hydroxytamoxifen (4OHT) (Van Mater et 
al., 2003; Lo Celso et al., 2004; Silva-Vargas et al., 2005), or K14∆N-β-catenin 
hemizygous (∆N) and homozygous (∆N∆N) mice, expressing low and high doses of 
active β-catenin respectively (Lowry et al., 2005). High levels of Wnt/β-catenin 
signalling stimulate hair follicle formation, intermediate levels favour sebocyte 
differentiation and low levels convert hair follicle into interfollicular epidermis (Gat et 
al., 1998; Huelsken et al., 2001; Niemann et al., 2002; Lo Celso et al., 2004). A study 
using whole-mounts of epidermal skin of transgenic mice, showed that while low levels 
of ectopic stabilised β-catenin are required for de novo hair follicle formation from 
sebaceous glands and interfollicular epidermis, only sustained high level activation of 
ectopic stabilised β-catenin is able to induce de novo hair follicles from pre-existing 
ones (Silva-Vargas et al., 2005). Furthermore, low levels of β-catenin stabilisation are 
required for hair follicle SC maintenance, followed by higher levels of β-catenin 
stabilisation that promote hair follicle SC activation, proliferation (re-entry hair cycle) 
and follicle regeneration (Van Mater et al., 2003; Lo Celso et al., 2004; Lowry et al., 
2005). Much higher levels of β-catenin stabilisation are required for the transition from 
proliferation to differentiation of cortical cells of the hair shaft, while uncontrolled, 
constitutive β-catenin stabilisation results in pilomatricoma hair tumours (Gat et al., 
1998; DasGupta & Fuchs, 1999; Huelsken et al., 2001; Blanpain & Fuchs, 2006). 
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1.5.2 Wnt/β-catenin and cancer 
β-catenin cytoplasmic stabilisation/accumulation and subsequent nuclear translocation 
is the most common alteration observed during aberrant WNT signalling (constitutive 
activation of WNT signalling pathway), and is often implicated in the development of 
human carcinogenesis, invasion and later stages of tumour progression such as 
metastasis (Hugh et al., 1999; Polakis, 1999; Polakis, 2000; Fodde et al., 2001; Taipale 
& Beachy, 2001; Giles et al., 2003; Beachy et al., 2004; Nusse, 2005; Reya & Clevers, 
2005; Stein et al., 2006; Fuerer et al., 2008; Klaus & Birchmeier, 2008). In humans, 
CTNNB1 (β-catenin gene) (Table 1.1), APC, and in a less extent AXIN1 and AXIN2 
mutations, that generally lead to inappropriate cytoplasmic stabilisation of β-catenin, 
subsequent translocation to the nucleus and constitutive activation of target genes, are 
being involved in many cancers including colon cancer, melanoma, pilomatricoma, 
hepatocellular carcinoma, gastrointestinal tumours, ovarian carcinomas and kidney 
Wilms tumours (Polakis, 2000; Giles et al., 2003; Polakis, 2007).  
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Table 1.1: β-catenin mutations in human cancers. 
Amino acids affected by mutations in CTNNB1 gene are indicated for sequence located 
between serine-29 (S29) and lysine-49 (K49). The overall frequency (freq.) of mutations in each 
tumour type is represented as the number of tumours with mutations/total number of tumours 
analysed (Polakis, 2000).  
 
 
Truncating mutations in APC, that promote aberrant activation of WNT/β-catenin 
signalling and consequently increased cell proliferation, have been found in both 
patients with Familial Adenomatous Polyposis (FAP - an autosomal, dominantly 
inherited disease in which patients develop polyps in the colon and rectum) (Bodmer et 
al., 1987; Groden et al., 1991; Kinzler et al., 1991; Nishisho et al., 1991) and in sporadic 
colorectal cancers (Ashton-Rickardt et al., 1989; Morin et al., 1997). Also, gain-of-
function mutations of CTNNB1, that prevent phosphorylation, subsequent 
ubiquitylation and proteasomal degradation of β-catenin, are characterizing a fraction of 
sporadic colorectal human cancers (Morin et al., 1997). Similarly, loss-of-function 
mutations of AXIN1 and AXIN2 have also been detected in rare cases of colon cancer 
(Liu et al., 2000), as well as in ovarian (Wu et al., 2001) and hepatocellular cancer 
(Satoh et al., 2000).  
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In addition, APC mutations have been found in human sporadic medulloblastomas 
(brain tumours) (Huang et al., 2000) and germ-line APC mutations have been found in 
patients with Turcot’s syndrome, a tumour-predisposition syndrome characterised by 
the development of multiple colorectal adenomas and medulloblastomas (Hamilton et 
al., 1995). At the same time, mutations in target residues S33 and S37 of β-catenin, that 
block the degradation of β-catenin, have also been reported in human sporadic 
medulloblastomas (Zurawel et al., 1998; Gilbertson, 2004).  
 
Interestingly, activating (stabilising) mutations of β-catenin (CTNNB1), that prevent the 
phosphorylation-dependent, ubiquitin-mediated degradation of the protein, have been 
identified in human pilomatricomas (hair matrix cell tumourigenesis) (Chan et al., 
1999a; Kajino et al., 2001; Moreno-Bueno et al., 2001; Xia et al., 2006), while 
transgenic mice that over-express a stabilised form of β-catenin in the epidermal basal 
layer and follicle outer root sheath of the skin, develop trichofolliculomas and 
pilomatricomas (Gat et al., 1998; Lo Celso et al., 2004). 
 
Therefore, it is obvious, from all these studies, that uncontrolled WNT/β-catenin 
signalling, due to mutations of the pathway components or due to interactions with other 
inappropriate activated signalling cascades, which might cause its constitutive activation 
(cytoplasmic accumulation / nuclear relocalisation), is an important event in the genesis 
of many cancers. 
 
1.5.3 HH and WNT interaction 
Studies in different organisms, have shown that parallels and crosstalk between HH and 
WNT signalling occur both during development and tumourigenesis (Taipale & Beachy, 
2001; Alonso & Fuchs, 2003a; Beachy et al., 2004; Hooper & Scott, 2005; Blanpain & 
Fuchs, 2006; Watt & Collins, 2008). In skin, both Hh and Wnt pathways are implicated 
in  hair follicle morphogenesis and adult hair cell cycle (Millar, 2002; Schmidt-Ullrich 
& Paus, 2005; Blanpain & Fuchs, 2006). Wnt/β-catenin is required upstream of Shh in 
placode formation, during hair follicle morphogenesis (Gat et al., 1998; Huelsken et al., 
2001; Andl et al., 2002; Lo Celso et al., 2004; Silva-Vargas et al., 2005; Blanpain & 
Fuchs, 2006), while Shh signalling is required for the proliferation and expansion of 
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follicle epithelium in order to assemble a mature follicle (St-Jacques et al., 1998; 
Chiang et al., 1999; Mill et al., 2003; Silva-Vargas et al., 2005; Blanpain & Fuchs, 
2006). In response to β-catenin activation in the epidermis of transgenic mice, Shh 
signalling pathway is upregulated (Lo Celso et al., 2004; Silva-Vargas et al., 2005) with 
Shh, Ptch2, Gli1 and Gli2 being the most highly induced members of the Shh signalling 
cascade, as indicated by gene expression arrays (Silva-Vargas et al., 2005). In contrast, 
Shh expression was lost in β-catenin negative skin of transgenic mice, as confirmed by 
in situ hybridization, further suggesting that during hair development Shh is 
downstream of β-catenin (Huelsken et al., 2001). 
 
In addition, studies in human colon cancer cells have shown that suppressor of fused 
(Su(fu)), which is a negative regulator of Hh/HH signalling pathway that controls the 
nuclear/cytoplasmic distribution of Ci/Gli transcription factors including Gli2, through 
direct protein-protein interactions (Ding et al., 1999; Kogerman et al., 1999; Stone et al., 
1999; Murone et al., 2000; Barnfield et al., 2005; Varjosalo et al., 2006), is also a 
negative regulator of the WNT/β-catenin pathway (Meng et al., 2001). Therefore, Su(fu) 
apart from preventing accumulation of Gli2 in the nucleus, it has also been found to be 
in a complex with β-catenin in human colon cancer cells, and upon its overexpression to 
suppress the TCF/LEF - dependent transcription and to reduce the nuclear β-catenin 
levels by promoting its export from the nucleus (nuclear export of β-catenin) (Meng et 
al., 2001). Furthermore, the degradation process of both Ci/Gli transcription factors 
including Gli2, and β-catenin, in Drosophila and in mammalian cells, is mediated and 
regulated by Slimb/β-TrCP ubiquitin ligase (Aberle et al., 1997; Jiang & Struhl, 1998; 
Latres et al., 1999; Bhatia et al., 2006; Huntzicker et al., 2006; Pan et al., 2006). 
 
However, HH signalling has also be found to be an antagonist of WNT signalling in 
human colon cancer cells (van den Brink et al., 2004). Indian Hedgehog (Ihh), which is 
required for human and rat colonic epithelial cell differentiation in vitro and in vivo, 
suppresses WNT/β-catenin signalling in human colorectal cancer cell lines in vitro (van 
den Brink et al., 2004). At the same time, Ihh is absent from the dysplastic epithelial 
cells of human adenomatous polyps in vivo, where β-catenin is abnormally localised, 
probably due to constitutive β-catenin-Tcf signalling (van den Brink et al., 2004). In 
addition, GLI1, a mediator of HH signalling, plays an inhibitory role in the nuclear β-
catenin accumulation and the subsequent β-catenin-Tcf signalling in human colorectal 
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cancer cells in vitro, followed also by their suppression of  proliferation (Akiyoshi et al., 
2006). In line with these observations, a reverse association between GLI1 
immunostaining and nuclear β-catenin accumulation, was found in human colorectal 
carcinoma tissues (Akiyoshi et al., 2006). 
 
On the other hand, in different contexts, Wnt signalling can also be a downstream 
effector of Shh/Gli signalling pathway. Wingless (Wg), a Wnt family member, is 
directly regulated by Ci-the Drosophila Gli homologue, in Drosophila imaginal discs 
(Von Ohlen et al., 1997). In Xenopus, Gli2 the key transcriptional regulator of Hh 
signalling, affects ventro-posterior mesodermal development by regulating Branchyruy 
genes, Xho3 genes and Wnt genes, such as Wnt8 and Wnt11 (Brewster et al., 2000; 
Mullor et al., 2001; Ruiz i Altaba et al., 2003). Most recently, it was shown by Ulloa et 
al. (Ulloa et al., 2007) that Gli3, the transcriptional repressor of the Hh pathway, in the 
absence of Shh, acts by antagonising Wnt3a ligand and the active forms of the Wnt 
transcriptional effector, β-catenin, in established human and monkey cell lines and in 
mice and frog embryos. 
 
In mice, constitutive activation of β-catenin promotes hair follicle-like tumours such as 
pilomatricomas and trichofolliculomas, or BCC-like tumours (Gat et al., 1998; Nicolas 
et al., 2003; Lo Celso et al., 2004), similar to those induced by Gli1 and Gli2 - Shh 
pathway genes (Grachtchouk et al., 2000; Nilsson et al., 2000; Sheng et al., 2002; 
Hutchin et al., 2005; Huntzicker et al., 2006). In human pilomatricomas (hair matrix cell 
tumourigenesis), stabilising mutations of β-catenin have also been identified (Chan et 
al., 1999a; Kajino et al., 2001; Moreno-Bueno et al., 2001; Xia et al., 2006), while 
human BCCs show increased levels of GLI2 and GLI1 - SHH genes (Dahmane et al., 
1997; Ghali et al., 1999; Mullor et al., 2001; Regl et al., 2002; Tojo et al., 2003; Ikram 
et al., 2004; Regl et al., 2004b; O'Driscoll et al., 2006; Asplund et al., 2008; Yu et al., 
2008) and accumulation of nuclear β-catenin (Yamazaki et al., 2001; El-Bahrawy et al., 
2003; Saldanha et al., 2004; Yang et al., 2008a).  
 
In addition, analysis of gene expression in human BCCs revealed that both 
GLI1/GLI2/GLI3 (SHH mediators) and several WNT genes such as WNT2, WNT5A 
are expressed (Bonifas et al., 2001; Mullor et al., 2001; Saldanha et al., 2004), which 
was further confirmed by cDNA microarray analysis in human BCCs (O'Driscoll et al., 
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2006; Yu et al., 2008). Recently, Li et al. (Li et al., 2007) showed that in rat kidney 
epithelial cells, Gli1 acts through Wnts and Snail to promote nuclear signalling of β-
catenin, during epithelial transformation. 
 
In line with these observations, human BCCs compared to normal skin, exhibit 
increased protein and mRNA levels of LEF-1, which belongs to the family of TCF/LEF 
transcription factors and is an important nuclear binding partner for β-catenin in skin 
(O'Driscoll et al., 2006; Asplund et al., 2008; Kriegl et al., 2009), as well as increased 
mRNA levels of frizzled receptors (FZD) for WNT proteins, and matrix 
metalloproteinases (MMP) known targets of β-catenin-TCF/LEF signalling (O'Driscoll 
et al., 2006; Yu et al., 2008). However, due to the complexity and context-dependency 
of both HH and WNT pathways during development and tumourigenesis in different 
organisms, still little is known about SHH and WNT interactions in human 
carcinogenesis. 
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Aim of the project  
Taking into account the difficulty of culturing basal cell carcinomas in vitro, the 
molecular mechanisms involved in human BCC formation are poorly understood.  
 
The aim of this project is to investigate the effects of the over expression of one isoform 
of human GLI2, the GLI2-β isoform, which also lacks the N-terminal repressor domain 
and is thus constitutively active (Tanimura et al., 1998), GLI2∆N-β, (henceforth 
abbreviated to GLI2∆N), on human N/TERT keratinocytes.  
 
The GLI2-β isoform is the most prevalent in human BCCs (Tojo et al., 2003), and the 
truncated human GLI2-β/N-terminal deleted is a valuable tool to mimic the activated 
form of GLI2 (Eichberger et al., 2006). The use of the active form of GLI2, is also a 
way of partly mimicking sustained HH signalling, which is required for BCC-like 
growth, proliferation and survival in transgenic mice (Hutchin et al., 2005) and is 
implicated in human BCC development and in many other cancers (Ruiz i Altaba et al., 
2002b; Pasca di Magliano & Hebrok, 2003; Beachy et al., 2004; Daya-Grosjean & 
Couve-Privat, 2005; Rubin & de Sauvage, 2006).  
 
Therefore, GLI2∆N will be used, in order (i) to generate and characterise GLI2∆N-
expressing stable and inducible N/TERT cell lines, (ii) to study the effects of its 
overexpression in the cell cycle and ploidy status of human N/TERT keratinocytes, and 
(iii) to identify possible interactions between HH/GLI2 and WNT/β-catenin signalling 
pathways. 
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Chapter 2: Materials and Methods 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 139 
2.1 Cell lines and culture methods 
2.1.1 Plasmids and cloning 
The pCMV-EGFP-GLI2∆N expression vector was a kind gift of Prof. Fritz Aberger 
(Department of Molecular Biology, University of Salzburg, Austria). The pSIN-CMV-
EGFP plasmid (Deng et al., 1997), was kindly provided by Prof. Paul Khavari (Stanford 
University School of Medicine, CA). The pSIN-MCS vector, containing an MCS insert, 
was kindly cloned from pSIN-CMV-EGFP plasmid by Dr. Muy-Teck Teh (Clinical and 
Diagnostic Oral Sciences, Institute of Dentistry, Barts and the London School of 
Medicine and Dentistry, London, UK). The Tcf-4 responsive luciferase plasmid pGL3-
OT (OT-β-catenin responsive promoter), an improved version of TOPFLASH (Shih et 
al., 2000), was kindly provided by Prof. Bert Vogelstein (The John Hopkins Oncology 
Centre Baltimore, MD). The retroviral regulatory tTA vector (pRevTet-Off) and the 
retroviral response cloning vector (pRevTRE) were purchased from Clontech (Palo 
Alto, CA) as part of the RevTet-Off System. The pSIN-OT-Luciferase (pSIN-OT-Luc) 
reporter transduction vector, the pSIN-CMV-EGFP-GLI2∆N stable expression 
retroviral transduction vector and the pRevTRE-CMV-EGFP-GLI2∆N inducible 
expression retroviral transduction vector were all obtained by Dr Giuseppe Trigiante 
(Centre for Cutaneous Research, Institute of Cell and Molecular Science, Barts and the 
London School of Medicine and Dentistry, London, UK).  
 
2.1.2 General reagents and materials  
Puromycin and Hexadimethrine bromide (polybrene) were supplied by Sigma-Aldrich 
(Dorset, UK). Mitogens, including hydrocortisone, transferrin, liothyronine and insulin 
were all supplied by Sigma-Aldrich (Dorset, UK), while cholera toxin was obtained by 
BioMol (Exeter, UK) and epidermal growth factor (EGF) was supplied by AbD Serotec 
(Kidlington, UK). Doxycycline (Dox), Geneticin (G418) and Hygromycin B (Hygro B) 
were all obtained from Clontech (Palo Alto, CA). All cell culture was performed in a 
laminar flow hood under aseptic conditions in accordance with standard tissue culture 
technique.  All sterile disposable tissue culture flasks, plates and dishes were purchased 
from Nunc (Roskilde, Denmark). 
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2.1.3 Human immortalised N/TERT keratinocytes 
Human telomerase (h/TERT)-immortalised N/TERT-1 (N/TERT) newborn epidermal 
keratinocytes are derived from clinically normal foreskin tissue and are further 
immortalised by the addition of ectopic telomerase, followed by spontaneous 
downregulation/loss of p16
INK4a
 (Dickson et al., 2000). N/TERT keratinocytes were 
supplied by Prof. James Rheinwald (Department of Dermatology, Harvard University 
Medical School, Boston) and were cultured in complete RM+ medium. RM+ culture 
medium consists of Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 
25% (v/v) Ham’s F12 medium (PAA, Somerset, UK), 10% (v/v) foetal calf serum 
(FCS) (Biosera, East Sussex, UK), 1% (v/v), glutamine (PAA, Somerset, UK), 1% (v/v)  
penicillin/streptomycin (PAA, Somerset, UK), and various mitogens (0.4 µg/ml 
hydrocortisone, 0.1 nM cholera toxin, 5 µg/ml transferrin, 20 pM liothyronine, 5 µg/ml 
insulin and 10 ng/ml EGF-epidermal growth factor (see Appendix I)). Cells were 
grown at 37
o
C in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) air. The culture 
medium was refreshed every 2-3 days and cells were passaged according to Section 
2.1.8. 
 
2.1.4 Phoenix amphotropic cells 
Phoenix amphotropic (Phoenix A) cells (human embryonic 293T derived) were supplied 
by Prof. Garry Nolan (Nolan Lab, Medical Centre, Stanford University Medical School, 
CA). Phoenix is a retrovirus producer cell line, capable of delivering genes to dividing 
cells of most mammalian species including human (amphotropic), and are based on the 
293T cell line (a human embryonic kidney line transformed with adenovirus E1A and 
carrying a temperature sensitive T antigen co-selected with neomycin). Phoenix A cells 
were cultured in DMEM (PAA, Somerset, UK) supplemented with 10% (v/v) FCS 
(Biosera, East Sussex, UK), 1% (v/v) penicillin/streptomycin (PAA, Somerset, UK), 
and 1% (v/v) Glutamine (PAA, Somerset, UK). Cells were grown at 37
o
C in a 
humidified atmosphere of 10% (v/v) CO2/90% (v/v) air. The culture medium was 
refreshed every 2-3 days and cells were passaged according to Section 2.1.8. 
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2.1.5 Stable EGFP and EGFP-GLI2∆N-expressing cell lines 
N/TERT cells were stably transduced with retroviruses (see Section 2.3 and Section 
2.3.1) encoding, pSIN-CMV-EGFP and pSIN-CMV-EGFP-GLI2∆N (EGFP-GLI2∆N 
fusion gene; EGFP - a marker for gene expression (Chalfie et al., 1994; Kain et al., 
1995)) plasmids according to Section 2.3.5.1, to yield the SINCE and SINEG2 stable 
gene expressing cell lines respectively. Both the expression of EGFP (Enhanced Green 
Fluorescent Protein) and EGFP-GLI2∆N fusion gene (GLI2∆N - the GLI2-β isoform, 
which also lacks the N-terminal repressor domain and is thus constitutively active) are 
under the control of the CMV (cytomegalovirus gene) promoter which gives strong 
expression of target genes in a variety of mammalian cells (Davis & Huang, 1988; 
Cheng et al., 2004). SINCE and SINEG2 cells were cultured in complete RM+ medium 
at 37
o
C in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) air. The culture 
medium was refreshed every 2-3 days and cells were passaged according to Section 
2.1.8. 
 
2.1.6 Inducible EGFP-GLI2∆N-expressing cell line 
The N/TERT RevTRE-CMV-EGFP-GLI2∆N inducible cell line, referred to as NTEG2 
cell line, was prepared as recommended by the kit manufacturer (RevTet-Off System, 
Clontech Laboratories, Palo Alto, CA), by Dr Giuseppe Trigiante at Centre for 
Cutaneous Research, Institute of Cell and Molecular Science, Barts and the London 
School of Medicine and Dentistry, London, UK (see Section 2.3.5.2 and Chapter 3, 
Section 3.2.2.1, Figure 3.6) (Chang et al., 2000; Chi et al., 2005). The retrovirus-
mediated tet-regulated gene expression system (RevTet-Off) (Clontech Laboratories, 
Palo Alto, CA) combines the advantages of retroviral transfer with those of tet-
regulation and thus allows efficient and tight quantitative and temporal control of gene 
expression. In the RevTet-Off system, transcription of the gene of interest (in this study 
EGFP-GLI2∆N fusion gene) is turned off in the presence of doxycycline (a derivative 
of tetracycline), while transcription of this gene (EGFP-GLI2∆N fusion gene) is turned 
on in the absence of doxycycline. NTEG2 cells were maintained in DMEM 
supplemented with 25% (v/v) Ham’s F12 medium (PAA, Somerset, UK), 10% (v/v) 
FCS (Biosera, East Sussex, UK), 1% (v/v) Glutamine (PAA, Somerset, UK), 1% (v/v) 
penicillin/streptomycin (PAA, Somerset, UK), various mitogens (same as RM+ 
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complete medium; see Appendix I), 50 µg/ml Hygromycin B (Appendix I) and 250 
µg/ml G418 (Appendix I) and kept under Doxycycline (40 ng/ml) (Appendix I) 
repression for maintenance and characterisation studies. Due to the heterogeneity of the 
cell population, a higher concentration of Dox (10 µg/ml) (Appendix I) was used to 
maximize repression in subsequent experiments. Hygromycin B and G418 
concentrations were optimised by me according to Section 2.4 and Doxycycline 
concentrations were optimised by me according to Section 2.5. When doxycycline was 
removed, by aspirating culture medium and wash cells 4x with 1x sterile PBS (PAA, 
Somerset, UK),  the inducible cell line (NTEG2 Dox-) was cultured in DMEM 
supplemented with 25% (v/v) Ham’s F12 medium (PAA, Somerset, UK), 10% (v/v) Tet 
System Approved fetal bovine serum (Tet-FBS) (Clontech, Palo Alto, CA), 1% (v/v) 
glutamine (PAA, Somerset, UK), 1% (v/v) penicillin/streptomycin (PAA, Somerset, 
UK), 50 µg/ml Hygromycin B and 250 µg/ml G418 and various mitogens (same as 
RM+ complete medium; see Appendix I). All cells were grown at 37
o
C in a humidified 
atmosphere of 10% (v/v) CO2/90% (v/v) air. The culture medium was refreshed every 
2-3 days and cells were passaged according to Section 2.1.8. 
 
2.1.7 OT-Luciferase Reporter cell lines 
NTERT, SINEG2, SINCE and NTEG2 cells were further transduced as described in 
Section 2.3, Section 2.3.5.1 and Section 2.3.5.3, with the pSIN-OT-Luciferase (pSIN-
OT-Luc) plasmid, containing the OT-β-catenin-responsive promoter (OT), an improved 
version of TOPFLASH, which contains the TCF-4 binding sites (CCTTTGATC) 
(Korinek et al., 1997; He et al., 1998; Shih et al., 2000), to produce reporter stable 
(N/TERT-OTLuc, SINEG2-OTLuc, SINCE-OTLuc respectively) or inducible cell line 
(NTEG2-OTLuc). The OT promoter drives the expression of a luciferase gene to 
facilitate the detection of promoter activity, and indirectly β-catenin protein 
transcriptional activity. Luciferase is used as a reporter gene to provide information 
about the activity of the promoter that drives its expression. In this study, luciferase was 
used to detect and measure the activity of the OT promoter, and indirectly the 
transcriptional activity of β-catenin (see Section 2.15). Reporter stable cell lines were 
then propagated in RM+ growth medium. The reporter inducible cell line was cultured 
in RM+ growth medium, containing 100 µg/ml Hygromycin B, 500 µg/ml G418, and 
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kept under Doxycycline repression until required for experiments. All cells were grown 
at 37
o
C in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) air. The culture 
medium was refreshed every 2-3 days and cells were passaged according to Section 
2.1.8. 
 
2.1.8 Cell passaging 
All cell types described above were cultured in (T25, T75 or T150/T175) flasks 
containing 10, 20 or 30/40 ml growth medium respectively. When cells became ~ 60-
70% confluent they were passaged - i.e. the cells were lifted off the flask and re-seeded 
at a lower density to enable continued cell division. This was achieved by aspirating the 
old tissue culture media from the flask followed by a single wash with 3, 5 or 10 ml 
sterile PBS (phosphate buffered saline) (PAA, Somerset, UK) and once in pre-warmed 
3, 5 or 10 ml 1x versene (Gibco Invitrogen, Paisley, UK) to cover the bottom of T25, 
T75 or T150/T175 flasks, respectively. PBS is an isotonic, water-based, buffer solution 
that helps to maintain a constant pH (i.e. pH 7.4). Versene is an isotonic solution 
containing 0.53 mM EDTA (ethylenediaminetetraacetic acid) (0.2 g/L EDTA in 
phosphate buffered saline) that chelates cationic ions, weakening cells adhesion to the 
flask, and prevents divalent cations inhibiting trypsin enzymatic activity. The versene 
was aspirated off and replaced by 3, 5 or 10 ml pre-warmed 1x Trypsin/EDTA (PAA, 
Somerset, UK) solution (0.5 mg/ml trypsin and 0.22 mg/ml EDTA in PBS without Ca 
and Mg). Flasks were returned to the tissue culture incubator for 5-10 min. During this 
time, the trypsin cleaves the extracellular cell adhesion proteins needed for cells to 
adhere, causing the cells to lift off the flask. The detachment process was encouraged by 
tapping the flasks every few minutes and was monitored under the light microscope (see 
Section 2.2). To prevent cell death of detached keratinocytes, cells that had lifted off the 
flask after 5 min (i.e. 10 ml of trypsinised cells in a T75 flask) were transferred to a 50 
ml falcon tube containing 10 ml complete RM+ culture medium (containing either 10% 
(v/v) FCS (Biosera, East Sussex, UK) or 10% (v/v) Tet-FBS (Clontech, Palo Alto, CA), 
depending on cell type, to stop the trypsinisation), and 3, 5 or 10 ml fresh pre-warmed 
1x Trypsin/EDTA (PAA, Somerset, UK) solution was added to the remaining 
keratinocytes in the flask. The serum in the media blocks the protease activity of the 
trypsin, which would be harmful to the cells. This process was repeated several times 
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until all the keratinocytes were removed from the flask. The cells in the falcon tube 
were centrifuged at 1,000 rpm (revolutions per minute) for 5 min. The supernatant was 
aspirated and the cell pellet was resuspended in 10 ml fresh culture media. Resuspended 
cells were counted (see Section 2.1.9) using either a haemocytometer (Weber Scientific 
International Ltd, Middlesex, UK) (see Section 2.1.9.1) or a CAsy
®
 Cell Counter 
(Innovatis, Sittingbourne, UK) (see Section 2.1.9.2). Cells were then plated out for 
experiments, transferred to new flasks for propagation (at 10-20% of their original 
density) or cryopreserved for storage (see Section 2.1.10). 
 
2.1.9 Cell counting 
2.1.9.1 Haemocytometer 
After trypsinisation, resuspended cells (10 µl of cell suspension) were counted by 
pipetting under a coverslip on a gridded glass slide known as haemocytometer (Weber 
Scientific International Ltd, Middlesex, UK). To count viable cells only, a 10 µl aliquot 
of resuspended cells was diluted 1: 2 with trypan blue (Invitrogen, Paisley, UK) - 10 µl 
of cell suspension mixed with 10 µl trypan blue - and 10 µl of this solution was pipetted 
on the haemocytometer. Trypan blue is selective for membrane-damaged, non-viable 
cells, since it has a negatively charged chromophore which cannot penetrate an intact 
cell membrane. Thus viable cells appeared bright and not stained when viewed under 
the microscope (Section 2.2), whereas non-viable cells appeared dark blue. The 
haemocytometer grid arrangement has four primary squares, each containing sixteen 
squares. Cell concentration was calculated by adding up the number of cells counted in 
each of the four 4x4 square sections under a microscope (Section 2.2), dividing by four 
giving the average count and multiplying by 1x10
4
, to give cells per ml (cells/ml). If the 
cells had been counted in trypan blue for cell viability, then the average count was 
multiplied by two to allow for the 1 in 2 trypan blue to cell dilution factor. 
 
2.1.9.2 CAsy® Cell Counter  
Cell number and density of viable cells were determined using CAsy
®
 Cell Counter 
(Innovatis, Sittingbourne, UK). Cell pellets obtained by centrifugation were 
resuspended in normal growth medium (i.e. 5, 10, 20 ml depending on the confluence 
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and the size of the flask) and were added in 1:100 dilution into CasyTon
®
 (Innovatis 
Sittingbourne, UK) buffer (60 µl of cell suspension into 6 ml CasyTon
®
 buffer). Each 
sample (cell suspension) was prepared three times in CAsyTon
®
 (Innovatis 
Sittingbourne, UK) buffer, followed by triplicate measurements of 200 µl sample 
volume. Based on the dilution that is used, Casy
® 
Cell Counter calculated the 
concentration of viable cells per ml (counts/ml, cells/ml) in the original cell suspension. 
Viable cells were measured by Casy
® 
Cell Counter by excluding all counts that were of 
a size smaller that 10 µm (dead cells and debris). 
 
2.1.10 Cryopreservation and recovery of cells 
To maintain cell stocks for experiments, trypsinised cells were centrifuged at 1,000 rpm 
at room temperature and the cell pellet was resuspended in freezing medium (10% (v/v) 
dimethyl sulphoxide (DMSO) (Fisher, Leicestershire, UK), 90% (v/v) FCS (Biosera, 
East Sussex, UK)) to give a concentration of 2 million cells per ml (2x10
6
 cells/ml).  
DMSO was included in the freezing medium to prevent the formation of crystals during 
the freezing process that would otherwise lyse the cells. The DMSO/FCS cell 
suspension (1 ml) was transferred into each 1.8 ml freezing cryogenic vial (Fisher, 
Leicestershire, UK). To ensure a constant cooling rate of 1
o
C/min, the cryovials 
containing cells were transferred to isopropyl freezing container (NALGENE Cryo 1
o
C 
Freezing container, BDH Laboratories Supplies, UK) and stored at -80°C for 1 to 3 
days. The cryovials were then transferred to liquid nitrogen for long-term storage, until 
required. 
 
Cryopreserved frozen cells were recovered, by removing the vial from liquid nitrogen 
storage and thawing it rapidly at 37
o
C in a waterbath. As soon as the cell aliquot had 
thawed, the DMSO/FCS cell suspension was immediately transferred into a 15 ml 
falcon tube containing 10 ml complete culture medium (relevant to the cell type) and 
centrifuged at 1,000 rpm for 5 min to remove the DMSO (Fisher, Leicestershire, UK). 
The supernatant was discarded and the cell pellet was resuspended in complete culture 
medium. Resuspended cells were seeded in a T75 cm
2
 flask at 2 million per flask. 
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2.2 Light and Fluorescence microscopy  
Normal cultured cells, cultured cells expressing EGFP (enhanced green fluorescent 
protein) or EGFP-GLI2∆N fusion protein were visualised using a light fluorescence 
microscope (Leica DM IRB/Nicon Eclipse TE-2000-S, Leica Microsystems, Germany) 
to detect cell morphology and gene/protein expression. Images were captured with a 
digital imaging system (Leica DC2000 camera) attached to the microscope. 
 
 
2.3 Retrovirus Mediated Gene Transfer 
2.3.1 Retroviruses and Retroviral vectors 
Retrovirus mediated gene transfer (retroviral infection) represents one of the most 
efficient methods for inducing long-term, stable gene expression in human 
keratinocytes, since simple plasmid transfection methods are particularly ineffective in 
this cell type. For that purpose retroviral vectors are used to induce the expression of a 
specific gene in keratinocytes. Retroviral vectors allow the efficient integration of 
retroviral DNA into actively transcribing regions of the host genome, resulting in 
reliable and heritable expression of the gene of interest and subsequent expression of the 
protein encoded by this gene, without variability or loss of gene expression due to loss 
of the construct. Thus, retroviruses are utilized as a permanent gene delivery vehicle, 
and retroviral infection/transduction yields stable gene of interest-expressing cell lines 
(Figure 2.2). 
 
Viruses are small infectious agents that can only replicate inside the living cells or 
organisms (hosts). Although a virus may contain either DNA (DNA virus) or RNA 
(Retrovirus), their genomic structure varies greatly among different types of viruses. 
The retroviral virions consist of small enveloped particles, a capsid and the single-
stranded viral RNA (3 genes are encoded in viral RNA, gag - encodes capsid core 
proteins, pol - encodes reverse transcriptase, integrase and protease and env - encodes 
envelope antigens), and begin their cycle by entering the host target cell (Figure 2.1). 
While entering into the cell and migrating to the host cell’s nucleus, the retroviral 
particle loses its envelope and its viral capsid respectively, and thus its genetic material 
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(viral RNA) is exposed. By using the retroviral enzyme reverse transcriptase, the 
retroviral RNA is then reverse-transcribed into double stranded DNA. The next crucial 
step in the retroviral cycle is the integration of the viral DNA into the host genome. This 
is accomplished by retroviral integrase, which mediates the excision of DNA bases at 
the host genome that is necessary for the incorporation of the viral DNA (pro-viral 
stage). Once viral DNA is incorporated, the long terminal repeat (LTR - Long Terminal 
Repeat sequence, a region that contains enhancer, promoter, transcription initiation, 
transcription terminator and polyadenylation signal - U3, R, U5 regions), and 
specifically the U3 region in the 5’ LTR which normally acts as a promoter/enhancer, of 
the retrovirus will promote the transcription of viral DNA into single stranded retroviral 
RNA. The 3’ LTR (U3, R, U5 regions) of the integrated pro-viral DNA functions as the 
terminator sequence. Once the retroviral RNA is translated, it will give rise to all the 
envelope and capsid proteins and retroviral enzymes (i.e. reverse transcriptase, 
integrase) that are required to generate new retroviral particles. Once retroviral 
assembly is finished, the produced retrovirus can exit the cell and re-infect new host 
cells where it can re-initiate its infectious cycle. 
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Figure 2.1: Retroviral replication. 
This diagram depicts a typical life cycle of a retrovirus. Upon entry and migration into the host 
cell, the retrovirus looses its envelope and its viral capsid, and the exposed viral RNA is then 
reverse transcribed, through reverse transcriptase retroviral enzyme activation, into double 
stranded DNA. The latter is then integrated randomly within the host cell’s genome by a process 
that is mediated by the retroviral integrase enzyme. Following successful integration, the viral 
genome is then transcribed by the LTRs (Long Terminal Repeats) into retroviral single stranded 
RNA. Upon RNA translation, the core retroviral proteins including reverse transcriptase, 
retroviral integrase, as well as several retroviral packaging proteins such as envelope and capsid 
proteins, are being produced, which will later help in the assembly of new virions that will be 
exported from the host cell’s membrane in order to infect new host target cells. Modified from 
http://www.clontech.com/support/tools. 
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In this study, replication incompetent retroviral vectors (Table 2.1) have been used to 
allow a one-time infection of target cells and to minimize safety hazards that may arise 
from continuous spreading of replication competent retroviruses. This is achieved by 
removal of viral packaging genes from the retroviral backbone, therefore incapacitating 
the self-replication machinery of retroviral vectors. The viral packaging proteins that are 
needed for retrovirus production are instead provided in trans by retrovirus packaging 
cell systems (i.e. Phoenix and PT67 cells) (Figure 2.2A). Once the infectious, but 
replication incompetent, retroviral particles are assembled they are released from the 
packaging cells and are ready to infect new target cells (Figure 2.2B). In addition, in 
this study, pSIN (Self Inactivating) vectors (Deng et al., 1997; Zufferey et al., 1998) 
were employed, and packaging cells were transfected with these retroviral vectors 
(Figure 2.2A). These vectors were constructed by deleting the enhancer and the 
promoter sequences in the U3 region of the 3’ LTR (Long Terminal Repeat) (Deng et 
al., 1997; Zufferey et al., 1998). Therefore, upon infection of target cells with the virus 
particles carrying the 3’ LTR U3 deletion (Figure 2.2B), the retroviral RNA is reversed 
transcribed and the deletion is transferred to the 5’ LTR of the proviral DNA, and thus 
abolishing any transcriptional activity driven by the LTR in transduced cells (no full-
length vector RNA is produced in the transduced cells). Hence, gene (gene of interest) 
expression is only driven by the internal CMV promoter (Figure 2.2B) (Deng et al., 
1997). 
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Table 2.1: Constructs used for transfections in packaging cell lines and retroviral 
transductions. 
 
Construct Function Packaging 
Cell Line 
pSIN-CMV-EGFP 
Stable EGFP (Enhanced Green 
Fluorescent Protein) 
overexpression 
Phoenix A 
pSIN-CMV-EGFP-GLI2∆N 
Stable EGFP-GLI2∆N fusion 
protein overexpression (the 
GLI2-β isoform, which also 
lacks the N-terminal repressor 
domain - active form of GLI2) 
Phoenix A 
pSIN-OT-Luciferase 
Detection of β-catenin 
transcriptional activity by 
luciferase protein expression 
Phoenix A 
pRevTet-Off 
tTA (tetracycline transactivator) 
vector that regulates the activity 
of the internal gene promoter.  
PT67 
pRevTRE-CMV-EGFP-GLI2∆N 
Contains the tetracycline 
response element which is 
activated in the absence of 
tetracycline, by the tTA 
(tetracycline transactivator) 
which is present in the 
pRevTet-Off  plasmid and thus 
leads to  inducible EGFP-
GLI2∆N fusion protein 
overexpression 
PT67 
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Figure 2.2: Retroviral transduction. 
(A) The retroviral plasmids are transfected into packaging cell lines (i.e. Phoenix A or PT67), 
and following antibiotic selection, are incorporated into the host cell’s genome. Following 
integration, the retroviral plasmid DNA will be transcribed into retroviral RNA. Since the 
genome of replication incompetent retroviruses lacks the genes responsible for the production of 
retroviral assembly proteins (i.e. gag-pol, Lyt-2, Env genes), these are provided solely from the 
packaging cell line which is constitutively expressing the required components for retroviral 
particle assembly. The retroviral assembly proteins recognise the Ψ+ packaging signal in the 
transcribed RNA, which is necessary for particle formation and the inclusion of retroviral RNA 
within the assembled virions. The retroviral RNA bearing the genes of interest is packaged into 
infectious particles which are released from packaging cells and are now ready to infect the 
target cells. (B) The retroviruses are now following their normal life cycle by infecting new 
target cells. Upon entry into the host cell, the retroviral RNA is transcribed into double stranded 
DNA and is later incorporated into the host genome. Since replication incompetent virus are 
devoid of the enhancer and promoter regions of the LTRs, the expression of the transgenes is 
now only under the control of the internal promoter (i.e. CMV). Therefore, the transcribed viral 
RNA will now be translated to the protein of interest. Modified from http://www.clontech.com. 
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2.3.2 DNA and RNA quantification 
Isolated DNA and RNA were measured using NanoDrop
TM
 ND-1000 
Spectrophotometer (ThermoScientific, Cambridgeshire, UK) (see Section 2.12.4.1 for 
spectrometry principle). A sample volume of 2 µl was used following instrument 
blanking with 2 µl of sterile, nuclease (enzymes that degrade DNA and RNA) free H2O 
(Sigma-Aldrich, Dorset, UK). The concentration of the sample DNA or RNA content is 
provided in ng/µl as measured by the NanoDrop
TM
 ND-1000 Spectrophotometer 
(ThermoScientific, Cambridgeshire, UK) at 260 nm absorbance, while the quality 
(purity of DNA or RNA) of DNA and RNA content was estimated by the nucleic acid : 
protein (260 nm/280 nm) ratio. Ratio values of 1.8 - 2.0 are considered of good quality 
and samples with this ratio were therefore used for downstream applications. 
 
2.3.3 Stable transfection of packaging cells 
All transductions using pSIN based constructs (see Table 2.1 and Section 2.1.1, 
Section 2.1.5, Section 2.1.7), involved transfecting the plasmid into the Phoenix A 
packaging cell line (Section 2.1.4), using FuGENE
®
 Transfection Reagent (Roche, 
Burgess Hill, UK) (see Figure 2.2A). All transductions using RevTet and RevTRE 
constructs (see Table 2.1 and Section 2.1.6), involved transfecting the plasmid into the 
PT67 packaging cell line - cells derived from an NIH/3T3 (mouse embryonic 
fibroblasts)-based line expressing the 10A1 virus envelope (murine leukaemia virus) 
(Clontech Laboratories, Palo Alto, CA) (Miller & Chen, 1996), using FuGENE
®
 
Transfection Reagent (Roche, Burgess Hill, UK) by Dr Giuseppe Trigiante at Centre for 
Cutaneous Research, Institute of Cell and Molecular Science, Barts and the London 
School of Medicine and Dentistry, London, UK, according to manufacturer’s 
instructions (see Figure 2.2A and Chapter 3, Section 3.2.2.1, Figure 3.6). 
Transfection is the process of deliberately introducing nucleic acids such as plasmid 
DNA into cells and the term is used notably for non-viral methods. Transfection of 
animal cells typically involves opening transient pores or "holes" in the cell membrane, 
to allow the uptake of genetic material (DNA plasmid) and it can be carried out by 
mixing a cationic lipid with the gene material (DNA plasmid) in order to produce 
liposomes, which fuse with the cell membrane and deposit their cargo inside. Since the 
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DNA introduced in the transfection process is usually not integrated into the nuclear 
genome, the foreign DNA will be diluted through mitosis or degraded. Thus a marker 
gene (i.e. puromycin resistance gene) is co-transfected, which gives the cell some 
selectable advantage, such as resistance towards a certain toxin (i.e. puromycin). If the 
toxin (i.e. puromycin) is then added to the cell culture, only those cells with the marker 
gene integrated into their genomes will be able to proliferate, while other cells will die. 
After applying this selective stress (selection pressure) for some time, only the cells 
with a stable transfection remain and can be cultivated further. 
The DNA concentration (ng/µl) of the retroviral plasmids used, was measured according 
to Section 2.3.2. Phoenix A cells were firstly plated at a concentration of 4x10
5
 cells per 
6 cm dish covered with 5 ml growth medium (Section 2.1.4) to give a confluence of 
approximately 60-70%. Cells were allowed to attach to the culture dishes for 3 hours, 
and were then transfected with the retroviral plasmids mentioned at Table 2.1 and 
Section 2.1.1, Section 2.1.5 and Section 2.1.7, which also contain the puromycin 
resistance gene, using FuGENE
®
 Transfection Reagent (Roche, Burgess Hill, UK). 
FuGENE
®
 Transfection Reagent (Roche, Burgess Hill, UK) is a proprietary blend of 
lipids and other components supplied in 80% ethanol. The transfection mixture was 
prepared with a DNA : FuGENE
®
 (Roche, Burgess Hill, UK) 1 µg : 2 µl ratio as 
follows: 10 µg of DNA, 20 µl FuGENE
®
 (Roche, Burgess Hill, UK) and was brought up 
to a final volume of 70 µl with sterile PBS (PAA, Somerset, UK). The growth medium 
was changed to 2 ml per 6 cm dish and the transfection mixture was added to the cells, 
which were allowed to grow for 24 hours at 37
o
C in a humidified atmosphere of 10% 
(v/v) CO2/90% (v/v) air. The next day, the transfection medium was replaced with 
normal growth medium (Section 2.1.4) and cells were allowed to grow to confluence.  
Next, cells were passaged, according to Section 2.1.8, in a 1:3 ratio (i.e. cell pellet from 
one 6 cm dish was split into 3 x 6 cm dishes) and were plated in selection medium 
which consisted of complete growth medium (Section 2.1.4) containing 3 µg/ml 
puromycin selective toxin. Puromycin is an antibiotic that inhibits protein translation 
and therefore blocks protein synthesis. Puromycin is toxic to eukaryotic cells and it is 
used as selective agent in cell culture systems. Transfected Phoenix A cells were further 
grown for 7-10 days, in selection medium which was changed every 2-3 days, at 37
o
C 
in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) air. Then, the selection 
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medium was replaced with normal growth medium (Section 2.1.4) and cells were either 
cryopreserved as previously described in Section 2.1.10 or were used for retrovirus 
production (see Section 2.3.4). 
 
2.3.4 Retrovirus production 
Retrovirus was produced with two different approaches. First, retroviral plasmid 
transfected and puromycin selected Phoenix A cells (see Section 2.3.3), that have 
reached confluence (~ 90-100% confluent) had their medium replaced with normal 
growth medium (Section 2.1.4) without puromycin (~ half of the normal medium 
volume - i.e. instead of 20 ml in a T75 flask 10-15 ml growth medium were added) and 
cells were incubated overnight at 32
o
C in a humidified atmosphere of 10% (v/v) 
CO2/90% (v/v) air, for viral collection. Retroviral supernatants from virus-containing 
Phoenix cells were collected in 50 ml falcon tubes the next day and thereafter collected 
once daily, for 2-3 days post-confluent. Upon collection, retroviral supernatants were 
centrifuged at high speed centrifugation at 2,000 rpm for 10 minutes to remove any non-
adherent Phoenix A cells present in the medium. 
 
Second, retroviral plasmid transfected and puromycin selected Phoenix A cells (see 
Section 2.3.3), were splitted and cultured in normal growth medium without puromycin 
until they reached ~ 80-90% confluence. Then, the old medium was replaced with fresh 
medium (~ half of the normal medium volume - i.e. instead of 20 ml in a T75 flask 10-
15 ml growth medium were added) and cells were incubated for 48 hours at 32
o
C in a 
humidified atmosphere of 10% (v/v) CO2/90% (v/v) air in complete growth medium 
(Section 2.1.4) without puromycin, for viral collection. Thus, retroviral supernatants 
from virus-containing Phoenix cells were collected in 50 ml falcon tubes after 48 hours 
and again upon collection, retroviral supernatants were centrifuged at high speed 
centrifugation at 2,000 rpm for 10 minutes to remove any non-adherent Phoenix A cells 
present in the medium. 
 
In both cases, the retroviral supernatants were aliquoted and either directly used for 
transduction of N/TERT cells or frozen at -80
o
C until required. 
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2.3.5 Retroviral transduction of human N/TERT keratinocytes 
2.3.5.1 Retroviral transduction to yield stable gene-expressing cell lines 
N/TERT cells (Section 2.1.3) were stably transduced with retroviruses (see Section 
2.3.1, Figure 2.2B), encoding pSIN-CMV-EGFP and pSIN-CMV-EGFP-GLI2∆N 
plasmids, prepared as described in Section 2.3.4, to yield SINCE and SINEG2 stable-
gene expressing cell lines, respectively (see Section 2.1.5). Cells were plated 2x10
5 
cells/dish into 6 cm dishes, 24 hours before transduction. The next day, medium was 
aspirated and each dish was pre-incubated for 10 minutes at 37
o
C, in 2 ml of normal 
culture medium (depending on the cell type) containing 5 µg/ml polybrene 
(hexadimethine bromide), before replacing with 4 ml of retroviral supernatant 
containing the same concentration of polybrene (5 µg/ml), to facilitate infection. 
Polybrene is a positively charged molecule used to increase the efficiency of infection 
of certain cells with a retrovirus in cell culture and acts by neutralizing the charge 
repulsion between virions (virus particles) and sialic acid-containing molecules (sialic-
acid is found on surface membranes and contributes to creating a negative charge on the 
cell’s surface). The 6 cm dishes were then centrifuged at 350 rpm for 1 hour at 32
o
C. 
Transduced cells were then washed twice in sterile 1x PBS (PAA, Somerset, UK) and 
were incubated for at least 24 hours (24-72 hours) in normal growth medium 
(depending on the cell type) at 37
o
C in a humidified atmosphere of 10% (v/v) CO2/90% 
(v/v)  air), prior to any experiments or to cryopreservation (Section 2.1.10). Because of 
lack of selectable markers, since the puromycin resistant gene is out of the retroviral 
cassette of pSIN vector, and due to the green fluorescence emitted by EGFP or EGFP-
GLI2∆N-expressing cells, the transduced cells were FACS (Fluorescent Activating Cell 
Sorting) sorted for green fluorescence (see Section 2.8.2) and collected in order to 
enhance the percentage of cells that have acquired the retroviral construct. FACS sorted 
transduced cells were either used in experiments or were cryopreserved (Section 
2.1.10). Expression levels of both EGFP and EGFP-GLI2∆N proteins in stable 
transduced cells, which are proportional to the levels of green fluorescence, and the 
morphology of transduced cells expressing those proteins were detected by light and 
fluorescence microscopy (Section 2.2). Expression levels of both EGFP and EGFP-
GLI2∆N proteins in stable transduced cells were further detected by flow cytometry 
(Section 2.8) and western blot analysis (Section 2.12). Transcription mRNA levels of 
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full-length GLI2 and GLI2 a/β isoform in N/TERT and in stable transduced cells were 
detected by semi-quantitative and qRT-PCR (Section 2.11), while endogenous GLI2 
protein levels in N/TERT and in stable transduced cells were detected by western blot 
analysis (Section 2.12). 
 
2.3.5.2 Retroviral transduction to yield inducible gene-expressing cell line 
N/TERT cells (Section 2.1.3) were stably transduced with retroviruses (see Section 
2.3.1, Figure 2.2B), encoding pRevTRE-CMV-EGFP-GLI2∆N and pRevTet-Off 
plasmids, according to the kit manufacturer (RevTet-Off System, Clontech 
Laboratories, Palo Alto, CA) (Chang et al., 2000; Chi et al., 2005), by Dr Giuseppe 
Trigiante at Centre for Cutaneous Research, Institute of Cell and Molecular Science, 
Barts and the London School of Medicine and Dentistry, London, UK, to yield the 
N/TERT RevTRE-CMV-EGFP-GLI2∆N (NTEG2) inducible cell line (see Section 
2.1.6 and Chapter 3, Section 3.2.2.1, Figure 3.6). Retroviral supernatant was obtained 
as described previously in Section 2.3.4, but using PT67 packaging cell line (Clontech 
Laboratories, Palo Alto, CA) (Section 2.3.3) (Miller & Chen, 1996), instead of Phoenix 
A packaging cells (Section 2.1.4). Briefly, N/TERT cells were pre transduced according 
to Section 2.3.5.1 with the regulatory vector pRevTet-Off (Clontech Laboratories, Palo 
Alto, CA), to yield the founder cell line NT-TetOff. The founder cell line was selected 
with G418, and then transduced according to Section 2.3.5.1 with the expression vector 
pRevTRE-CMV-EGFP-GLI2∆N (RevTRE response plasmid) and selected with 
Hygromycin B, to yield the NTEG2 inducible cell line. Due to the very low levels of 
EGFP-GLI2∆N retroviral construct expression in human N/TERT keratinocytes, in the 
intitially constructed NTEG2 cell line by Dr Giuseppe Trigiante (Centre for Cutaneous 
Research, Institute of Cell and Molecular Science, Barts and the London School of 
Medicine and Dentistry, London, UK), I optimised further the Hygromycin B, G418 and 
Doxycycline concentrations (see Section 2.4 and Section 2.5), and I have reselected the 
cell line. In addition, after doxycycline removal NTEG2 Dox- cells were FACS sorted 
(see Section 2.8.2) and all EGFP positive cells were collected to obtain highly EGFP-
GLI2∆N expressing population, replated and cultured under the presence of 
doxycycline until required for experiments or were cryopreserved (Section 2.1.10). 
Expression levels of both EGFP and EGFP-GLI2∆N proteins in inducible transduced 
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cells after doxycycline removal, which are proportional to the levels of green 
fluorescence, and the morphology of transduced cells expressing those proteins were 
detected by light and fluorescence microscopy (Section 2.2). Expression levels of both 
EGFP and EGFFP-GLI2∆N proteins in inducible transduced cells after doxycycline 
removal were further detected by flow cytometry (Section 2.8) and western blot 
analysis (Section 2.12). 
 
2.3.5.3 Retroviral transduction to yield reporter stable and inducible gene-
expressing cell lines 
NTERT (Section 2.1.3) and SINEG2, SINCE, NTEG2 cells were further transduced 
according to Section 2.3.5.1 with the retrovirus (see Section 2.3.1, Figure 2.2B), 
encoding pSIN-OT-Luciferase (pSIN-OT-Luc) plasmid, prepared as described in 
Section 2.3.4, to produce reporter stable (N/TERT-OTLuc, SINEG2-OTLuc, SINCE-
OTLuc respectively) or inducible (NTEG2-OTLuc) cell lines (see Section 2.1.7) to 
either be used in experiments or to be cryopreserved (Section 2.1.10).  
 
 
2.4 Antibiotic selection 
Antibiotics are commonly used for the selection of cells transfected or transduced with a 
plasmid containing a selectable marker. In this study, Geneticin (G418) and 
Hygromycin B (Hygro B) were the antibiotics of choice for the generation of NTEG2 
inducible cell line. The former G418 is an aminoglycoside antibiotic and acts by 
blocking the polypeptide synthesis (protein synthesis) by inhibiting the elongation step 
in prokaryotic (i.e. bacteria) and eukaryotic cells. Hygromycin B is also an 
aminoglycoside antibiotic that kills both prokaryotic and eukaryotic cells by interfering 
with translocation and causing mistranslation at the 70S ribosome and thus inhibits 
protein synthesis. Optimal concentration for resistant clones selection in mammalian 
cells depends on the cell line used as well as on the plasmid carrying the resistance 
gene, therefore antibiotic titration should be done to find the best condition for every 
experimental system. The pRevTet-Off (Clontech Laboratories, Palo Alto, CA) plasmid, 
which was used to yield the founder cell line NT-TetOff carries the G418 resistance 
gene (Neomycin) (Section 2.3.5.2). The founder cell line was then transduced with the 
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expression vector pRevTRE-CMV-EGFP-GLI2∆N (RevTRE response plasmid) which 
carries the Hygromycin B resistance gene, to yield the NTEG2 inducible cell line 
(Section 2.3.5.2).  
 
Therefore, different concentrations of Geneticin (G418) and Hygromycin B (Hygro B) 
antibiotic selection were used in N/TERT keratinocytes, in order to identify the optimal 
concentration for selection of NTEG2 cells. N/TERT cells were seeded at 2x10
5
 cells 
per 10 cm dish and cultured in 10 ml RM+  normal growth medium per 10 cm dish and 
incubated overnight at 37
o
C in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) air 
(six 10 cm dishes for G418 selection and six 10 cm dishes for Hygromycin B selection). 
The next day, bright-field pictures using a light microscope (Section 2.2) were taken 
from each 10 cm dish and then different doses 0, 50, 100, 200, 400, 800 µg/ml of G418 
(50 mg/ml stock solution) (Appendix I) or Hygro B (50 mg/ml stock solution) 
(Appendix I) were added in cells (Day 0 selection). Cells were incubated at 37
o
C in a 
humidified atmosphere of 10% (v/v) CO2/90% (v/v) air for 8 days, replacing the 
selection medium every 4 days. The 10 cm dishes were examined every two days for 
viable cells and bright-field pictures using a light microscope (Section 2.2) were taken 
on Day 3, 5 and 8. The minimum antibiotic concentration that induced massive cell 
death after 3 days and total cell death after 8 days was chosen for antibiotic selection of 
NTEG2 inducible cell line (500 µg/ml for G418 (Appendix I) and 100 µg/ml for 
Hygromycin B (Appendix I)). NTEG2 cells cultured in the presence of Doxycycline 
were usually selected for 8-11 days and were then passaged (Section 2.1.8) and cultured 
in maintenance medium RM+ complete medium containing 250 µg/ml of G418 
(Appendix I) and 50 µg/ml of Hygromycin B (Appendix I), in presence of 
Doxycycline (Section 2.1.6 and Section 2.5). 
 
 
2.5 Doxycycline optimisation 
Doxycycline (Dox) is a member of the tetracycline antibiotics, which is commonly used 
as a broad spectrum antibiotic to treat wide range of infections such as bacterial 
infections and thus it kills only prokaryotic cells. Doxycycline is part of a class of drugs 
called tetracyclines. It decreases bacteria's ability to make protein, necessary for their 
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survival. This activity does not directly kill the bacteria, but it does inhibit their growth 
and multiplication, which gives the immune system a chance to fight the infection. 
Therefore, tetracycline antibiotics are protein synthesis inhibitors, inhibiting the binding 
of aminoacyl-tRNA to the mRNA-ribosome complex, by binding to the 30S ribosomal 
subunit in the mRNA translation complex. 
 
In this study, doxycycline was used to activate the CMV constitutive promoter and 
consequently, the expression of EGFP-GLI2∆N transgene in NTEG2 keratinocytes 
(Section 2.3.5.2). Pilot experiments were carried out, in order to optimise the 
concentration of doxycycline which provides the best ratio of induction/suppression of 
EGFP-GLI2∆N expression, without inducing any cytotoxic effects (see Section 2.7.1.1) 
on the NTEG2 cell line.  
 
Initially, NTEG2 cells were grown in the absence of doxycycline (Dox) for 48 or 72 
hours, for transgene induction, at 37
o
C in a humidified atmosphere of 10% (v/v) 
CO2/90% (v/v) air. Next, equal densities of 1x10
5
 and 2.0 x10
4 
cells per 6 cm dish, were 
seeded in two sets respectively, each set consisting of four 6 cm dishes (two sets of four 
6 cm dishes; a total of eight 6 cm dishes containing 5 ml RM+ growth medium per dish) 
and incubated at 37
o
C in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) air. 
Each set also contained four 6 cm control dishes with two negative (N/TERT wild-type 
cells to acquire background fluorescence levels) and two positive (NTEG2 cells 
cultured in the absence of Dox for transgene induction) controls. These two sets (four 
samples plus four control dishes each set) were going to be used for the investigation of 
transgene expression/suppression in two different time points (8 dishes total were 
needed for the 48 hours time-point and another 8 dishes were needed for the 5 days 
time-point). Next, cells (except controls) were grown in the presence of different Dox 
(Appendix I) concentrations (1, 100, 1000, 10000 ng/ml) for 48 hours and 5 days. All 
cells had their growth medium replaced every two days. EGFP-GLI2∆N suppression by 
doxycycline was investigated by detecting the EGFP-GLI2∆N expression (green 
fluorescence) through flow cytometry analysis (see Section 2.8) after 48 hours (1
st
 set) 
and 5 days (2
nd
 set).  
 
Initially, NTEG2 cells were grown in the absence of doxycycline (Dox) for 48 or 72 
hours, for transgene induction, at 37
o
C in a humidified atmosphere of 10% (v/v) 
Chapter 2: Materials and Methods 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 160 
CO2/90% (v/v) air. Next, equal densities of 1x10
5
 and 1.5 - 3.0 x10
5 
cells per 10 cm 
dish, were seeded in two sets respectively, each set consisting of six 10 cm dishes (two 
sets of six 10 cm dishes; a total of twelve 10 cm dishes containing 10 ml RM+ growth 
medium per dish) and incubated at 37
o
C in a humidified atmosphere of 10% (v/v) 
CO2/90% (v/v) air. These two sets were going to be used for the investigation of 
transgene expression/suppression in two different time points (6 dishes were needed for 
the 48 hours time-point and another 6 dishes were needed for the 5 days time-point). 
The same or the next day of plating, cells from both sets were treated with different 
concentrations of Dox (40 ng/ml, 1 µg/ml, 10 µg/ml) (Appendix I), in duplicates for 
each concentration. The cells were then allowed to grow for either 24 or 48 hours in the 
presence of varying Dox concentrations. Following the 24 or 48 hours incubation, Dox 
was removed (see Section 2.1.6) only from one replicate for each concentration of each 
set, so that each set would have one series of cells cultured in different concentrations of 
Dox (3 dishes) and one series of cells cultured without Dox (another 3 dishes). At this 
point therefore, both sets are identical and have been treated similarly. Then, cells of 
each set were allowed to grow for another 48 hours (1
st
 set of cells; 48 hour time-point) 
or for another 5 days (2
nd
 set of cells; 5 day time-point). All cells had their growth 
medium replaced every two days. The 1
st
 set of samples, which contained one series of 
cells (3 dishes) cultured in varying Dox concentrations for a total of 3-4 days 
(depending on the time of initial incubation in Dox) and another series of cells (3 
dishes) cultured in the absence of Dox for a total of 48 hours, were all harvested for 
total cell protein extraction (see Section 2.12.1) (named as 48 hour time-point), 
followed by western blot analysis (see Section 2.12.5). The 2
nd
 set of samples, which 
contained one series of cells (3 dishes) cultured in varying Dox concentrations for a 
total of 6-7 (depending on the time of initial incubation in Dox) days and another series 
of cells (3 dishes) cultured in the absence of Dox for a total of 5 days, were all harvested 
for total cell protein extraction (see Section 2.12.1) (named as 5 day time-point), 
followed by western blot analysis (see Section 2.12.5). The time points were named 
after the period of time that had passed after transgene induction (removal of Dox), 
since NTEG2 cells were otherwise normally maintained in Dox containing medium.  
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2.6 Rhodamine staining  
Rhodamine B is a red/violet staining dye with strong orange fluorescence (emission at 
625 nm) that is used as a histopathological stain for cornification and keratinisation, and 
is therefore a valuable marker of epidermal keratinocytes in vitro (Liisberg, 1968). 
N/TERT, SINCE, and SINEG2 keratinocytes were stained with Rhodamine B in order 
to visualise the colony forming ability and colony morphology of each cell line in 
culture (Barrandon & Green, 1987).  
 
N/TERT, SINCE, and SINEG2 keratinocytes were seeded at 8x10
4
 cells per well of a 6-
well plate in 2 ml RM+ culture medium per well and incubated at 37
o
C in a humidified 
atmosphere of 10% (v/v) CO2/90% (v/v) air. Cells were allowed to grow until N/TERT 
and SINCE controls reached confluence (6-8 days) and medium was replaced every two 
days. Keratinocytes were washed 1x in 1x PBS (Appendix I) and were immediately 
fixed with 1 ml of 4% (v/v) Formaldehyde/Formalin (Fisher, Leicestershire, UK) 
solution (Appendix I) per well,  for 20 minutes at room temperature. The cells were 
then washed 2x in 1x PBS (Appendix I) and were stained with 2 ml Rhodamine B 
(Sigma-Aldrich, Dorset UK) solution (1x PBS (Appendix I) containing 1% (w/v) 
Rhodamine B (Sigma-Aldrich, Dorset UK); 1 g Rhodamine B in 100 ml 1x PBS) per 
well, for 30 minutes at room temperature. The cells were then thoroughly washed with 
dH2O many times until all background staining was washed and only keratinocyte 
colonies were visible. Plates were then left at room temperature to completely dry prior 
to digitally capturing bright field images using Autochemi imaging system (UVP, 
Upland, CA). The plates were finally stored at room temperature.  
 
 
2.7 Cytotoxicity and proliferation assays 
2.7.1 Alamar BlueTM assay  
The Alamar Blue assay is very quick and sensitive method for detecting cellular 
viability and proliferation (Fields & Lancaster, 1993; Ahmed et al., 1994). Alamar Blue 
reagent gives a measure of viability and cell proliferation by detecting the level of 
reduction (gain of electrons) - oxidation (loss of electrons) (REDOX indicator) cycles 
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(chemical reactions in mitochondria - Krebs cycle) during cellular respiration, which is 
carried out by specific enzymes in growing metabolically active, healthy cells. Alamar 
Blue (electron acceptor) can be reduced by the whole range of the electron transport 
chain (electron donors) FMNH2, FADH2, NADH, NADPH and cytochromes, and is 
thus an excellent detector of reduction of all the elements of the electron transport chain. 
As cells being tested grow, innate metabolic activity results in a chemical reduction of 
Alamar Blue. Continued cell growth maintains a reduced environment, while inhibition 
of cell growth maintains an oxidized environment. Reduction related to cell growth 
causes the REDOX indicator (Alamar Blue) to change from oxidized (non-fluorescent, 
blue) form to reduced (fluorescent, red) form. 
 
Alamar Blue is a safe, nontoxic aqueous dye that is used to assess both cell viability and 
cell proliferation. For cell viability assessment, the innate metabolic activity of cells can 
be monitored with Alamar Blue, since in the presence of added toxic compounds such 
as antimicrobial agents, this innate metabolic activity ceases. Due to the fact that 
Alamar Blue is soluble, stable in culture medium, non-toxic, and does not alter the 
viability of cells cultured for various times, the continuous monitoring of cells in culture 
is permitted and therefore cell proliferation assessment is allowed. Furthermore, Alamar 
Blue does not interfere with the reactions of the electron transport chain and cells 
remain unaffected by its presence.  
 
The reduction of Alamar Blue yields a colorimetric change (Section 2.12.4.2) and a 
fluorescent signal (Section 2.8.1.1), which can be detected either through measuring the 
optical density of the solution (absorbance at 544 nm) using a spectrophotometer or a 
microplate reader (Section 2.12.4.1), or by detecting the fluorescent signal emitted at 
590 nm, following excitation at 544 nm using a microplate reader, respectively.  
 
2.7.1.1 Cytotoxicity 
N/TERT cells were seeded in 6 cm dishes (6.5x10
4 
cells/dish) in 1 ml RM+ culture 
medium per well and incubated at 37
o
C in a humidified atmosphere of 10% (v/v) 
CO2/90% (v/v) air. When the cells attached to the dishes, Alamar Blue
TM
 (Biosource
TM
, 
Invitrogen, Paisley, UK) solution was prepared (RM+ medium containing 10% (v/v) 
Alamar Blue
TM
) 18 ml RM+ medium + 2 ml Alamar Blue
TM
 (Biosource
TM
, Invitrogen, 
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Paisley, UK)  = 20 ml total). The medium was aspirated from the wells and 5 ml Alamar 
Blue
TM
 solution were added in each dish. Cells were incubated for 6 h at 37
o
C in a 
humidified atmosphere of 10% (v/v) CO2/90% (v/v) air (Day 0). Following the 
incubation, 100 µl of the target cell medium was obtained and added in each well of an 
opaque, flat bottomed 96-well microtiter white plate (Nunc, Roskilde, Denmark). 
Alamar Blue
TM
 (Biosource
TM
, Invitrogen, Paisley, UK) reduction (fluorescence) was 
read on a FLUOSTAR OPTIMA microplate reader (BMG LABTECH, Aylesbury, UK) 
at 544 excitation wavelength and at 590 nm emission wavelength. Next, medium 
containing the Alamar Blue
TM
 (Biosource
TM
, Invitrogen, Paisley, UK) was aspirated and 
cells were refed with fresh normal growth medium (RM+) containing different doses of 
Doxycycline (Appendix I) in each 6 cm dish (0, 1, 10, 100, 1000, 10000 ng/ml). 
Duplicates were prepared for each different concentration and also duplicates of 
medium with or without dox, without any cells, were also used as controls for 
background fluorescence. The measurements were repeated once after 48 h (Day 2) and 
once after five days (Day 5) and cytotoxicity mediated by doxycycline was measured by 
the rate of Alamar Blue
TM
 (Biosource
TM
, Invitrogen, Paisley, UK) reduction, which is 
quantified by fluorescence emission and directly reflects the amount of viable cells in 
culture. For each sample, the mean value of controls for background fluorescence was 
subtracted from all the values of all the different time points. In addition, for each 
sample, all the values for all the different time points were subtracted from the mean 
value of Day 0. 
 
2.7.1.2 Proliferation 
N/TERT, SINCE, SINEG2 cells were seeded in 12-well plates (2.5x10
4 
cells/well) in 1 
ml RM+ culture medium per well and incubated overnight at 37
o
C in a humidified 
atmosphere of 10% (v/v) CO2/90% (v/v) air. The next day, the medium was aspirated 
from the wells and Alamar Blue
TM
 (Invitrogen, Paisley, UK) solution was prepared 
(RM+ medium containing 10% (v/v) Alamar Blue
TM
) 18 ml RM+ medium + 2 ml 
Alamar Blue
TM
 (Biosource
TM
, Invitrogen, Paisley, UK) = 20 ml total) and 1 ml was 
added in each well. Cells were incubated for 6 h at 37
o
C in a humidified atmosphere of 
10% (v/v) CO2/90% (v/v) air (Day 0). Following the incubation, 100 µl of the target cell 
medium was obtained and added in each well of an opaque, flat bottomed 96-well 
microtiter white plate (Nunc, Roskilde, Denmark). Alamar BlueTM (BiosourceTM, 
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Invitrogen, Paisley, UK) reduction (fluorescence) was read on a FLUOSTAR OPTIMA 
microplate reader (BMG LABTECH, Aylesbury, UK) at 544 excitation wavelength and 
at 590 nm emission wavelength. Next, medium containing the Alamar Blue
TM
 
(Biosource
TM
, Invitrogen, Paisley, UK) was aspirated and cells were refed with fresh 
normal growth medium (RM+). Six replicate samples were prepared for each cell line 
and also six replicate samples of medium without cells were also used as controls for 
background fluorescence. The measurements were repeated once everyday for seven 
days. The cell growth rate was measured by the rate of Alamar Blue
TM
 (Biosource
TM
, 
Invitrogen, Paisley, UK) reduction, which is quantified by fluorescence emission and 
directly reflects the amount of viable cells in culture. For each cell line, the mean value 
of controls for background fluorescence was subtracted from all the values of all the 
different time points. In addition, for each cell line, the mean value of Day 0 was 
subtracted from all the values of all the different time points. 
 
Samples were analysed in six replicates and statistical analysis was performed using the 
Microsoft Excel’s software for student’s t test analysis (see Section 2.16).  
 
2.7.2 MTT assay 
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay is a 
method for detecting cellular viability and proliferation and is a rapid colorimetric 
analysis (Section 2.12.4.2) of mitochondrial reductase activity in metabolically active 
cells (Mosmann, 1983). The MTT is a yellow tetrazolium salt (synthetic organic 
heterocyclic compound) that is reduced to a purple formazan (formazans are artificially 
formed chromogenic products as a result of tetrazolium salt reduction) in the 
mitochondria of actively growing cells. MTT reagent gives a measure of viability and 
cell proliferation by detecting the level of reduction (gain of electrons) - oxidation (loss 
of electrons) (REDOX indicator) cycles (chemical reactions in mitochondria - Krebs 
cycle) during cellular respiration, which is carried out by specific enzymes in growing 
metabolic active, healthy cells. MTT (electron acceptor) can be reduced by the electron 
donors of the electron transport chain, FMNH2, FADH2, NADH, and NADPH but not 
by cytochromes. As cells being tested grow, innate metabolic activity results in a 
chemical reduction of MTT. Continued cell growth maintains a reduced environment, 
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while inhibition of cell growth maintains an oxidized environment. Reduction related to 
cell growth causes the REDOX indicator (MTT) to change from oxidized (yellow 
tetrazolium salt) form to reduced (purple formazan) form. This reduction takes place 
only when mitochondrial reductase enzymes are active, and therefore conversion can be 
directly related to the number of viable cells. The purple formazan crystals are insoluble 
to aqueous solutions and are therefore solubilised by the addition of isopropanol or by a 
mixture of isopropanol : DMSO. The absorbance of the final coloured solution is 
directly proportional to the percentage of actively growing cells in a given sample, and 
can be spectrophotometrically quantified at 500-600 nm in a spectrophotometer or a 
standard microplate reader (Section 2.12.4.1). In contrast to Alamar Blue, MTT is 
highly toxic to the cells and therefore it is not possible to use the same cells throughout 
a time course proliferation experiment. Thus, the same number of cells needs to be 
plated separately for each additional time point. 
 
N/TERT, SINCE and SINEG2 cells were seeded at 1.3x10
4
 cells per well of seven 
separate (one for each time point) 24-well plates in 500 µl RM+ culture medium per 
well and incubated overnight at 37
o
C in a humidified atmosphere of 10% (v/v) 
CO2/90% (v/v) air. Additionally, three separate  24-well plates (each of them containing 
six wells for each time point) containing only 500 µl RM+ culture medium per well 
without cells were prepared and incubated overnight at 37
o
C in a humidified atmosphere 
of 10% (v/v) CO2/90% (v/v) air. The next day, MTT (Sigma-Aldrich, Dorset, UK) 
solution was prepared (RM+ medium containing 10% (v/v) of MTT stock solution 5 
mg/ml) (Appendix I) (18 ml RM+ medium + 2 ml from 5 mg/ml MTT (Sigma-Aldrich, 
Dorset, UK) = 20 ml total). The culture media was aspirated from the wells of one 24-
well plate containing cells from each cell line and also from another 24-well plate 
containing six replicate samples of medium without cells and 500 µl of MTT solution 
(Appendix I) was added to each well and incubated for 2 h at 37°C in a humidified 
atmosphere of 10% (v/v) CO2/90% (v/v) air (Day 0). Medium was replaced to the 
remaining 24-well plates, which were further incubated at 37
o
C in a humidified 
atmosphere of 10% (v/v) CO2/90% (v/v) air. The MTT solution was then aspirated and 
500 µl of isopropanol (Fisher, Leicestershire, UK) was added to each well to dissolve 
the formazan crystals. The 24-well plate was briefly shaken and the isopropanol 
solution was mixed thoroughly by pipetting to ensure complete solubilisation of the 
crystals. 100 µl of the solution from each well was transferred to a well of a clear, flat 
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bottomed 96-well plate (Nunc, Roskilde, Denmark). The absorbance (optical density) 
was measured at 560 nm, using a 96-well microplate reader (FLUOSTAR OPTIMA 
microplate reader, BMG LABTECH, Aylesbury, UK). Six replicate samples were 
prepared for each cell line for each time-point and also six replicate samples of medium 
without cells were prepared for each time-point and were used as controls for 
background absorbance. The measurements were repeated once everyday for seven days 
and medium was replaced every two days in the remaining 24-well plates. The cell 
growth rate was measured by the rate of MTT (Sigma-Aldrich, Dorset, UK) reduction, 
which is quantified by absorbance (optical density) and directly reflects the amount of 
viable cells in culture. For each cell line, the mean value of controls for background 
absorbance was subtracted from all the values of all the different time points. In 
addition, for each cell line, the mean value of Day 0 was subtracted from all the values 
of all the different time points.  
 
Samples were analysed in six replicates and statistical analysis was performed using the 
Microsoft Excel’s software for student’s t test analysis (see Section 2.16).  
 
2.7.3 Population Doublings 
In contrast to Alamar Blue and MTT proliferation assays which give an indication of the 
amount of viable cells, solely depending upon of a cell’s intrinsic metabolic activity and 
therefore its ability to reduce chemical reagents, assessing the number of population 
doublings (PD) allows the identification of the number of times the cell population 
doubles in number, during the course of culture. Therefore, the calculation of population 
doublings of cells in culture provides an estimation of the number of times that a cell is 
doubled (divides) with a specified amount of time. In cases of primary human cells, the 
PD is mainly used to estimate the total life-span of cells in culture since growth ceases 
after a limited amount of cell divisions (Rheinwald et al., 2002). However, in 
immortalised cells lines such as N/TERT, PD calculation provides useful information 
about the speed and consistency of cell division throughout a period of time (growth 
potential of cells).  
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To measure the cumulative population doublings over a period of time, N/TERT, 
SINCE and SINEG2 keratinocytes were initially plated at 1x10
5 
or 2x10
5
 per 6 cm dish 
in 5 ml RM+ growth medium and incubated at 37
o
C in a humidified atmosphere of 10% 
(v/v) CO2/90% (v/v) air (Day 0). After 4 days (~ 60-80% confluent), cells were washed 
once with 1x sterile PBS (PAA, Somerset, UK) and then trypsinised until all the cells 
had detached (see Section 2.1.8). The trypsin reaction was inhibited by transferring the 
trypsinised cells to 50 ml falcon tubes containing complete RM+ growth medium at a 
ratio of 1:1 (v/v) trypsinised cells to RM+ culture medium. Cells were then centrifuged 
at 1,000 rpm for 5 minutes and were counted using the CAsy
®
 Cell Counter (see 
Section 2.1.9.2) (Day 4). Cells were then re-plated at 1x10
5 
or 2x10
5
 per 6 cm dish in 5 
ml RM+ growth medium and were allowed to grow for another 4 days at 37
o
C in a 
humidified atmosphere of 10% (v/v) CO2/90% (v/v) air (Day 4). Next cells were 
washed, trypsinised, counted and replated following the same procedure as described 
above (Day 8). The procedure of re-plating and counting was performed every 4 days 
for a total period of 16 days.  
 
Keratinocyte population doublings were calculated as follows: PD = 3.32 x [log10 (N1) - 
log10 (N0)], where N1 = total yield (total output) and N0 = initial number of seeded 
keratinocytes. For example, if N1 = 1x10
6
 and N0 = 2x10
5
, then the population 
doublings that these cells have undergone is PD = 2.32. This means that each cell will 
have doubled on average 2.32 times during the incubation period. Therefore, all PD 
values were individually collected (once every 4 days) and were used cumulatively. For 
example, if the PD value for the first 4 days incubation (Day 4) was PD = 2.32 and then 
for the second incubation period (another 4 days) (Day 8) was PD = 3.3, then the 
cumulative PD value is PD = 2.32 + 3.3, PD = 5.62 for a total time of 8 days, that is 
each cell has doubled, on average, 5.62 times during a total period of 8 days.  
 
 
Chapter 2: Materials and Methods 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 168 
2.8 Flow Cytometry (FCM) Analysis and Fluorescent Activated Cell 
Sorting (FACS)  
2.8.1 Flow cytometry 
Flow cytometry is a powerful technique for the analysis of multiple parameters of 
individual cells within heterogeneous populations. Flow cytometers are used in a range 
of applications from immunophenotyping, to ploidy and cell cycle analysis, to cell 
counting and GFP (green fluorescent protein) expression analysis and to detection of 
apoptosis. The flow cytometer performs this analysis by passing thousands of cells per 
second through a laser beam and capturing the light and colour discriminated 
fluorescence that emerges from each cell as it passes through. The data gathered can be 
analysed statistically by flow cytometry software to report cellular characteristics such 
as size, internal complexity, phenotype, and health. Thus, analysis and differentiation of 
the cells is based on size and granularity and whether the cell is carrying fluorescent 
molecules (fluorochromes) either in the form of antibodies or dyes (cell surface (i.e. 
receptors) or intracellular (i.e. DNA) epitope detection) 
(http://probes.invitrogen.com/resources/education/tutorials/), 
(http://www.icms.qmul.ac.uk/flowcytometry/flowcytometry/). 
 
2.8.1.1 Fluorochromes 
Fluorochromes/fluorophores (i.e. FITC - fluorescein isothiocyanate, PI - propidium 
iodide, Cy5 - cyanine 5, Hoechst-33342, DAPI - 4',6-diamidino-2-phenylindole, GFP - 
green fluorescent protein, EGFP - enhanced green fluorescent protein) are essentially 
dyes or proteins, which accept light energy (i.e. from a laser or lamp) at a given 
wavelength and re-emit it at a longer wavelength. These two processes are called 
excitation and emission respectively. The process of emission follows extremely 
rapidly, commonly in the order of nanoseconds, and is known as fluorescence. Light is a 
form of electromagnetic energy that travels in waves. These waves have both frequency 
and length, the latter of which determines the colour of light. The light that can be 
visualized by the human eye represents a narrow wavelength band (380-700 nm) 
between ultraviolet (UV) and infrared (IR) radiation. Red light is at the longer 
wavelength end (lower energy) and violet light at the shorter wavelength end (higher 
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energy). When light is absorbed by a fluorochrome (absorption), its electrons become 
excited and move from a resting state to a maximal energy level called the ‘excited 
electronic singlet state’. The amount of energy required will differ for each 
fluorochrome and is depicted as Eexcitation. This state only lasts for 1-10 nanoseconds 
because the fluorochrome undergoes internal conformational change and, in doing so, 
releases some of the absorbed energy as heat. The electrons subsequently fall to a lower, 
more stable, energy level called the ‘relaxed electronic singlet state’. As electrons 
steadily move back from here to their ground state they release the remaining energy 
(Eemission) as fluorescence. The energy in the emitted light is dependent on the energy 
level to which the fluorophore is excited, and that light has a specific wavelength, and, 
consequently, a specific fluorescence colour (i.e. FITC fluorochrome; laser excitation at 
488 nm, maximum absorbance 490 nm - blue colour, maximum emission 525 nm - 
green fluorescence colour)  
(www.abdserotec.com/uploads/Flow-Cytometry.pdf). 
 
2.8.1.2 Flow cytometer 
The flow cytometer (Figure 2.3) consists of the fluidic system, a light source, collection 
optics (lenses, filters, mirrors), electronics and a computer to translate signals to data 
(www.abdserotec.com/uploads/Flow-Cytometry.pdf), 
(http://probes.invitrogen.com/resources/education/tutorials/), 
(http://www.icms.qmul.ac.uk/flowcytometry/flowcytometry/). 
The fluidic system (flow cell, nozzle) (Figure 2.3), carries and aligns the initially 
randomly distributed cells so that they pass single file through the light beam for 
sensing (through the interrogation point, where the laser and the sample intersect and 
the optics collect the resulting scatter and fluorescence), and takes away the waste. For 
accurate data collection, it is important that particles or cells are passed through the 
laser beam one at a time. Most flow cytometers accomplish this by injecting the sample 
stream containing the cells (central channel/core) into a flowing stream of sheath fluid 
(an outer sheath that contains faster flowing fluid). Thus, the sample stream becomes 
compressed to roughly one cell in diameter and this effect is called hydrodynamic 
focusing. When the sample leaves the flow cell the stream is in laminar flow in air. The 
lasers (Figure 2.3) are the light source for scatter and fluorescence. The light source of 
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choice, the laser (more than one lasers can be used simultaneously), emits coherent light 
at a specified wavelength (i.e. 480 nm) and as a cell passes through the laser, it will 
refract or scatter light at all angles. The optics (lenses, filters, mirrors) (Figure 2.3), 
gather and direct this light. Thus, scattered light is focused through, and collected by, 
two lenses, one set in front of the light source (forward scatter channel (FSC)) and one 
set at right angles (side scatter channel (SSC)), which direct the light to the appropriate 
detectors (receive the light) (Figure 2.3). Therefore, forward scatter, is the amount of 
light that’s scattered in the forward direction as laser light strikes the cell, and is roughly 
proportional to the cell size, while light scattering at larger angles, for example to the 
side, depends on the granularity and the inner structural complexity inside the cell (i.e., 
shape of the nucleus, the amount and type of cytoplasmic granules or the membrane 
roughness). 
 
Flow cytometers use separate fluorescence (FL-) channels to detect light emitted. The 
emitted fluorescent light, coming from labelled cells (i.e. FITC, PE) as they pass 
through the laser, travels along the same path as the side scatter signal and it is directed 
through a series of filters/mirrors (optics), which block certain wavelengths by 
absorption, while transmitting (passing) others, so that particular wavelength ranges are 
delivered to the appropriate detectors (controlled specificity of detection) (Figure 2.3). 
When a filter is placed at a 45
o
 angle to the oncoming light it becomes a dichroic 
filter/mirror. This type of filter performs two functions, first, to pass specified 
wavelengths in the forward direction and, second, to deflect blocked light at a 90
o
 angle 
(Figure 2.3).  
 
Finally, through the electronics and the peripheral computer system, the signals from the 
detectors are converted into digital data and the necessary analysis is performed (Figure 
2.3). When light hits a photodetector, a small current (a few microamperes) is generated 
and thus is translated into a voltage pulse which is proportional to the total number of 
light photons received by the detector. This voltage is then amplified by a series of 
electronics into electrical signals large enough (5-10 volts) to be plotted graphically.  
The measurement from each detector is referred to as a ‘parameter’ i.e. forward scatter, 
side scatter or fluorescence and the data acquired in each parameter are known as the 
‘events’ and refer to the number of cells displaying the physical feature or marker of 
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interest. The data generated by flow-cytometers can be plotted in a single dimension, to 
produce a histogram, or in two-dimensional (2D) dot plots. 
 
These data can give information for the physical characteristics and the fluorescence 
intensity of cells. Because small cells produce a small amount of forward scatter and 
large cells produce a large amount of forward scatter, the magnitude of the voltage pulse 
recorded for each cell is roughly proportional to the cell size. Similarly, cells with low 
internal complexity produce a small amount of side scatter and cells with high internal 
complexity produce a large amount of side scatter, and therefore the magnitude of the 
voltage pulse recorded for each cell is roughly proportional to the internal complexity of 
the cell. In addition, fluorescence data is collected generally in the same way as forward 
and side scatter data. In a population of labelled cells, some will be brighter than others. 
As each cell crosses the path of the laser, a fluorescence signal is generated which is 
directed to the appropriate detector, where it is translated into a voltage pulse 
proportional to the amount of fluorescence emitted (fluorescence intensity).  
 
Both FSC and SSC are unique for every cell, and a combination of the two (two-
dimensional dot plots) may be used to differentiate different cell types in a 
heterogeneous sample (gate cells according to physical characteristics), such as in a 
typical whole blood cell analysis. The different physical properties of lymphocytes, 
which are small cells possessing low internal complexity; monocytes which are 
medium-sized cells with slightly more internal complexity, and neutrophils and other 
granulocytes which are large cells that have a lot of internal complexity, allow them to 
be distinguished from each other. Moreover, FSC and SCC data analysis may be used to 
eliminate results from unwanted particles (gating) i.e. dead cells, clumps and debris. For 
instance, subcellular debris and clumps can be distinguished from single cells by size, 
estimated by forward scatter, while dead cells have lower forward scatter and higher 
side scatter than living cells.  
 
All Flow Cytometry analytical runs in my study were performed on a BD LSRII fitted 
with a Blue Argon Laser 488 nm, violet diode 405 nm, red diode 633 nm and a UV laser 
325 nm (BD Biosciences, San Jose, CA), using the BD FACSDiva Software (BD 
Biosciences, San Jose, CA), by Gary Warnes at FACS Lab, Institute of Cell and 
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Molecular Science, Barts and the London Queen Mary’s School of Medicine and 
Dentistry, Whitechapel, London, UK.  
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Figure 2.3: Primary systems of the flow cytometer. 
The primary systems of the flow cytometer are: the fluidic system, which presents samples to 
the interrogation point and takes away the waste; the lasers, which are the light source for 
scatter and fluorescence; the optics (lenses, filters, filter/mirrors), which gather and direct the 
light; the detectors, which receive the light; and, the electronics and the peripheral computer 
system, which convert the signals from the detectors into digital data and perform the necessary 
analysis. FSC, Forward Scatter Channel; SSC, Side Scatter Channel; FL-1, Fluorescence-1 
channel; FL-2, Fluorescence-2 channel; FL-3, Fluorescence-3 channel; FITC, fluorescein 
isothiocyanate; GFP, Green Fluorescent Protein; PE, phycoerythrin; PI, propidium iodide; PE-
Cy5, phycoerythrin Cy (cyanine) 5). Modified from  
http://probes.invitrogen.com/resources/education/tutorials/ 
www.abdserotec.com/uploads/Flow-Cytometry.pdf 
https://www1.imperial.ac.uk/.../flow/flowcytometrycourse/lectures/ 
www1.ic.ac.uk/resources/A9F73252-D531-4631-A768-F14356B9E9E1/ 
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2.8.1.3 Hoechst-33342 staining and flow cytometry 
Hoechst-33342 (Sigma-Aldrich, Dorset, UK) is a fluorescent DNA (nucleic-acid) dye, 
that intercalates into the minor groove of double-stranded DNA and binds preferentially 
to A (Adenine) - T (Thymine) base pairs (Shapiro, 1981a; Shapiro, 1981b). In contrast 
to DAPI and to PI, Hoechst-33342 (Sigma-Aldrich, Dorset, UK) has an additional ethyl 
group which renders it more lipophilic and thus more able to cross intact cell 
membranes. Therefore, cells do not require permeabilisation for Hoechst-33342 (Sigma-
Aldrich, Dorset, UK) staining/labelling and this allows live cell cycle analysis and 
detection of EGFP fluorescence at the same time (cells expressing EGFP protein or 
EGFP-GLI2∆N fused protein). Hoechst-33342 (Sigma-Aldrich, Dorset, UK) fluorescent 
DNA dye is suitable for flow cytometric analysis because it binds to DNA in a linear 
manner and thus as DNA content of a cell increases, the fluorescent signal from the 
DNA dye increases proportionally in a linear manner (Shapiro, 1981a; Shapiro, 1981b). 
Hoechst-33342 (Sigma-Aldrich, Dorset, UK) is excited at 350 nm and emitted at 461 
nm giving a blue fluorescent colour. For that reason a UV laser 325 nm was used for 
flow cytometry analysis and fluorescence was detected at 440 nm using the UV 440/40 
nm channel on the BD LSRII (BD Biosciences, San Jose, CA). EGFP (enhanced green 
fluorescent protein, a mutant derivative of green fluorescent protein (GFP)) is a protein 
which exhibits bright green fluorescence when exposed to blue light. EGFP is excited at 
488 nm and emitted at 509 nm giving a green fluorescent colour, similar to FITC 
(fluorescein isothiocyanate) which is excited at 490 nm and emitted at 525 nm. For that 
reason, a Blue Argon laser 488 nm was used for flow cytometry analysis and 
fluorescence was detected at 530 nm, using the FITC 440/40 nm channel on the BD 
LSRII (BD Biosciences, San Jose, CA). 
 
For Hoechst-33342 (Sigma-Aldrich, Dorset, UK) staining, equal number 1x10
6
 or 6x10
5
 
of N/TERT, SINCE, and SINEG2 cells were seeded in 10 cm dishes, and harvested 
either 24 or 48 hr after plating, respectively (~ 60% confluent). Similarly, equal number 
3x10
5
 or 1x10
5
 of N/TERT and NTEG2 cells were seeded in 10 cm dishes, and 
harvested either 72 hr or 6 days after plating, respectively (~ 60% confluent) (48 hr or 5 
days after doxycycline removal respectively). Doxycycline was removed in NTEG2 
cells 24 hr after plating (NTEG2 Dox-).  
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Cells were washed once with 1x sterile PBS (PAA, Somerset, UK) and then trypsinised 
until all the cells had detached (see Section 2.1.8). The trypsin reaction was inhibited by 
transferring the trypsinised cells to 50 ml falcon tubes containing complete RM+ growth 
medium at a ratio of 1:1 (v/v) trypsinised cells to RM+ culture medium. Cells were then 
centrifuged at 1,000 rpm for 5 minutes. After washing each pellet with 10 ml 1x sterile 
PBS (PAA, Somerset, UK), and centrifuging at 1,000 rpm for 5 minutes, each cell pellet 
was resuspended in 2 ml 1x sterile PBS (PAA, Somerset, UK) containing 10 µg/ml  
Hoechst-33342 (Sigma-Aldrich, Dorset, UK) (2 ml 1x sterile PBS + 2 µl 10 mg/ml 
Hoechst-33342; 1:1000 dilution) (see Appendix I). Resuspended cells were incubated 
for 1 hr at 37
o
C in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) air, and were 
shaken every 10 minutes. Then, cells were filtered through a 70 µm strainer (BD Falcon 
Cell strainers, BD Biosciences, San Jose, CA) (minimise doublets and clumps) and were 
transferred in sterile 5 ml polystyrene round bottom FACS tubes (BD Falcon tubes, BD 
Biosciences, San Jose, CA), which were kept on ice and were given for flow cytometry 
analysis, where the same number of events was acquired for each sample (25,000-
50,000 events). 
 
Cells stained with Hoechst-33342 (Sigma-Aldrich, Dorset, UK), were analysed both for 
DNA content and green fluorescence (EGFP) that corresponds to exogenous EGFP 
protein and EGFP-GLI2∆N fusion protein. First, a 2D dot plot representing cell size and 
granularity was created for each sample (Figure 2.4A). This is derived from the 
Forward (cell size) and Side scatter (granularity) values (FSC versus SSC) and is useful 
for cell population gating according to physical characteristics of cells (P1) and thus for 
the exclusion of cell debris as well as of dead cells, which have lower forward scatter 
and higher side scatter than living cells (see Section 2.8.1.2). Next, a 2D doublet 
exclusion plot was made for the gated (P1) cells, to distinguish cell clumps, aggregates 
of G1 cells and G1 cell doublets from G2/M cells for each sample (Figure 2.4B). 
Doublets of G1 cells have the same DNA content as G2/M cells and in order to 
distinguish them, the instrument can separate these by measuring the time it takes for 
the two types of cells to pass through the laser beam by a fluorescent parameter Width 
(W) measurement. Doublets and aggregates of cells take longer to pass through the laser 
of the flow cytometer and thus appear higher up on the fluorescent width scale (W) 
(Figure 2.4B). Therefore the 2D doublet exclusion plot represents the fluorescent Area 
(A) scale (440/40 nm Ho33342 UV-A(rea)) which is the DNA content according to the 
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blue fluorescence emitted by Hoechst-33342 dye and the fluorescent Width (W) scale 
(440/40 nm Ho33342 UV-W(idth)) which is the time it takes for a cell to pass through 
the laser beam (Figure 2.4B). Thus, cells were gated (P2) using specific values, which 
correspond to DNA content from 2N up to 16N and only to single cells so that the 
G2/M population contains only single mitotic cells (Figure 2.4B).  
 
This single cell gate (P2) population of cells was next examined and gated for levels of 
green fluorescence (EGFP fluorescence) in a 2D (440/40 nm Ho33342 UV-A(rea) -
DNA content versus FITC 530/30 nm-A(rea) - EGFP fluorescence) dot plot (Figure 
2.4D). Cells are gated as EGFP positive (Q2) or EGFP negative (Q4) depending on the 
levels of background auto-fluorescence acquired from the analysis of a reference wild-
type cell line, in this case N/TERT (Figure 2.4C). Last, for each sample, one-
dimensional histograms, representing the relative DNA content of cells (440/40 nm 
Ho33342 UV-A(rea) - blue fluorescence emitted by Hoechst-33342) and thus the cell 
cycle profile, were drawn for EGFP positive (Q2) (Figure 2.4E i), EGFP negative (Q4) 
(Figure 2.4E ii), and for the overall population (P2) (Figure 2.4E iii) with gates P3, P4, 
P5, P6 and P7 gating on G1 (2N), S, G2/M (4N), >4N, 8N respectively. The gating of 
cells (FSC, SSC, DNA content, doublet exclusion, green fluorescence) were initially 
acquired using the reference wild-type cell line (N/TERT) and remained constant in 
subsequent sample analysis.  
 
Samples were analysed either in duplicates or triplicates and statistical analysis was 
performed using the Microsoft Excel’s software for student’s t test analysis (see Section 
2.16).  
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Figure 2.4: Hoechst-33342 live cell cycle analysis and EGFP fluorescence detection. 
(A) Initial cell population gating (P1) for each sample is placed on FSC versus SSC (cell size 
versus granularity) 2D dot plot. Debris and dead cells appear to the left and upwards of healthy 
cell analysis gate (P1). (B) This cell population gate (P1) is then placed on 440/40 nm Ho33342 
UV-W(idth) versus 440/40 nm Ho33342 UV-A(rea) (blue fluorescence emitted by Hoechst-
33342 representing DNA content versus the time it takes for a cell to pass through the laser 
beam) 2D dot plot. Doublets and clumps appear to the right of single cell analysis gate (P2). (D) 
This single cell gate (P2) population of cells is then placed on 440/40 nm Ho33342 UV-A(rea) 
versus FITC 530/30 nm-A(rea) (blue fluorescence emitted by Hoechst-33342 representing DNA 
content versus EGFP fluorescence) 2D dot plot. EGFP positive (Q2) and EGFP negative (Q4) 
cells are gated depending on the levels of background auto-fluorescence acquired from the 
analysis of a reference wild-type cell line, N/TERT (C). (E) Finally, single cell EGFP positive 
gate (Q2) (i), single cell EGFP negative gate (Q4) (ii), and single cell overall gate (P2) (iii) are 
separately displayed as histograms, using the 440/40 nm Ho33342 UV-A(rea) (blue 
fluorescence emitted by Hoechst-33342), representing the DNA content and thus the cell cycle 
profile with gates such as P3, P4, P5, P6 and  P7 for the overall cell cycle profile (iii) gating on 
G1 (2N), S, G2/M (4N), >4N, 8N respectively. N, haploid number.  
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2.8.1.4 PI staining and flow cytometry 
Propidium iodide (PI) (Sigma-Aldrich, Dorset, UK) is a fluorescent DNA (nucleic-acid) 
dye, that intercalates into the major groove of double-stranded DNA and thus allows 
cell cycle analysis in fixed cells (since cell membrane integrity excludes propidium 
iodide from staining viable and early apoptotic cells) and detection of the sub-diploid 
population of cells. PI (Sigma-Aldrich, Dorset, UK) fluorescent DNA dye is suitable for 
flow cytometric analysis because it binds to DNA in a linear manner and thus as DNA 
content of a cell increases, the fluorescent signal from the DNA dye increases 
proportionally in a linear manner (Krishan, 1990). In addition, propidium iodide 
(Sigma-Aldrich, Dorset, UK) staining in permeabilised cells facilitates the 
discrimination of cells with reduced DNA content, due to DNA fragmentation (sub-
G1/sub-diploid populations). When cells are permeabilised, the apoptosis-mediated 
fragmented DNA multimers leak out of the cell, and therefore the resulting stained by 
propidium iodide (Sigma-Aldrich, Dorset, UK) sub-G1 populations, represent late 
apoptotic/dead cells (cells with fragmented DNA), and thus used for detection of later 
stages of apoptosis (Riccardi & Nicoletti, 2006). However, in order to be seen in the 
SubG1 area, a cell must have lost enough DNA to appear there; so if cells enter 
apoptosis from the S or G2/M phase of the cell cycle or if there is an aneuploid 
population undergoing apoptosis, they may not appear in the sub-G1 peak, since 
although they loose DNA due to fragmentation, their overall DNA content will still be 
≥2N (http://www.icms.qmul.ac.uk/flowcytometry/flowcytometry/). In addition, DNA 
fragmentation is not only a characteristic of cells undergoing late stage of apoptosis but 
also of cells undergoing cell death due to necrosis, rendering difficult the discrimination 
between the apoptotic and necrotic cells in sub-G1 population. Necrosis is premature 
death of cells due to infection, toxins, trauma and cancer and it typically begins with 
swelling, chromatin digestion, and disruption of plasma membrane, while late necrosis 
is characterised by extensive DNA hydrolysis, vacuolation of the endoplasmic 
reticulum, organelle breakdown and thus cell lysis (Brown & Attardi, 2005). For those 
reasons, and in order to further confirm the results obtained by propidium iodide 
staining and flow cytometry analysis, cellular apoptosis was also measured using Cy
TM
5 
Annexin V antibody (BD Pharmingen
TM
, BD Biosciences, San Jose, CA) staining and 
flow cytometry analysis (see Section 2.8.1.5). 
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PI (Sigma-Aldrich, Dorset, UK) is excited at 488 nm and emitted at 619 nm giving a 
yellow fluorescent colour, similar to PE (phycoerythrin) which is excited at 490 nm and 
emitted at 578 nm. For that reason a Blue Argon laser 488 nm was used for flow 
cytometry analysis and fluorescence was detected at 575 nm using the PE 575/26 nm 
channel on the BD LSRII (BD Biosciences, San Jose, CA).  
 
For PI (Sigma-Aldrich, Dorset, UK) staining and cell cycle analysis, equal number 
3x10
5
 or 1.5x10
5 
of N/TERT, SINCE, and SINEG2 cells were seeded in 6 cm dishes, 
and harvested either 24 hr or 4 days after plating, respectively (~ 50-70% confluent) and 
fixed. Similarly, equal number 1.5x10
5
 of N/TERT, SINCE, and SINEG2 cells were 
seeded in 6 cm dishes, and were either mock treated or UVB treated 72 hr after plating 
(~ 50-60% confluent) (see Section 2.13). 24 hr after UVB treatment, mock and UVB 
treated cells were harvested and fixed.  
 
Culture media from each of the 6 cm petri dishes (either UVB or non-UVB treated) 
were collected to include any detached dead or apoptotic cells that may be floating in 
the medium. Therefore, supernatants (culture media) from each 6 cm dish were 
collected in 50 ml falcon tubes and adherent cells were washed once with 1x sterile PBS 
(PAA, Somerset, UK) and then trypsinised until all the cells had detached (see Section 
2.1.8). Trypsinised cells were transferred in the 50 ml falcon tubes containing the 
corresponding supernatant (RM+ growth medium) that included any floating cells at a 
ratio of 1:1 (v/v) trypsinised cells to RM+ culture medium supernatant including 
floating cells. Thus the trypsin reaction was inhibited and cells were centrifuged at 
1,500 rpm for 5 minutes. Once the centrifugation was finished, the supernatant was 
aspirated and each pellet was resuspended in 5 ml 1x sterile PBS (PAA, Somerset, UK) 
and spun again at 1,500 rpm for 5 minutes. After centrifugation the supernatant was 
discarded and each cell pellet was resuspended in 1 ml of ice-cold 70% (v/v) ethanol 
(Fisher, Leicestershire, UK) (see Appendix I) (added dropwise) while vortexing to 
ensure fixation of all cells and minimise clumping, and incubated for 2 h at 4
o
C or for 
up to 1 week most at 4
o
C.  
 
After 2 h incubation at 4
o
C cells in the 15 ml falcon tubes were vortexed and then were 
transferred in 1.5 ml microcentrifuge tubes (Eppendorf, Cambridge, UK) and were 
centrifuged at 6,000 rpm for 2 minutes. Supernatant was aspirated and each pellet was 
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washed in 1 ml 1x sterile PBS (PAA, Somerset, UK) and centrifuged at 6,000 rpm for 2 
minutes. Cell pellets were then resuspended in 1 ml 100 mM NaCitrate (Sigma-Aldrich, 
Dorset, UK) (see Appendix I) each, and centrifuged at 6,000 rpm for 2 minutes. Hence, 
supernatant was aspirated and each pellet was resuspended in 300-500 µl PI/RNaseA 
mixture (50 µg/ml Propidium Iodide, 125 µg/ml RNase A, 38 mM NaCitrate, 1x sterile 
PBS; all supplied by Sigma-Aldrich, Dorset, UK  whereas 1x sterile PBS was supplied 
by PAA, Somerset, UK) (see Appendix I). PI (Sigma-Aldrich, Dorset, UK) can also 
bind to RNA and thus it is necessary to treat cells with RNase A (Sigma-Aldrich, 
Dorset, UK) (see Appendix I) for optimal DNA resolution. Resuspended cells were 
incubated for 10-20 minutes in the dark at room temperature. Cells were then vortexed 
and transferred in sterile 5 ml polystyrene round bottom FACS tubes (BD Falcon tubes, 
BD Biosciences, San Jose, CA), which were kept on ice and were given for flow 
cytometry analysis, where the same number of events was acquired for each sample 
(25,000-50,000 events). 
 
Cells stained with PI (Sigma-Aldrich, Dorset, UK), were analysed for DNA content. 
First, a 2D dot plot representing cell size and granularity was created for each sample 
(Figure 2.5A). This is derived from the Forward (cell size) and Side scatter 
(granularity) values (FSC versus SSC) and is useful for cell population gating according 
to physical characteristics of cells (P1) and thus for the exclusion of cell debris which 
have lower forward scatter than living cells (see Section 2.8.1.2). Next, a 2D doublet 
exclusion plot was made for the gated (P1) cells, to distinguish cell clumps, aggregates 
of G1 cells and G1 cell doublets from G2/M cells for each sample (Figure 2.5B). 
Doublets of G1 cells have the same DNA content as G2/M cells and in order to 
distinguish them, the instrument can separate these by measuring the time it takes for 
the two types of cells to pass through the laser beam by a fluorescent parameter Width 
(W) measurement. Doublets and aggregates of cells take longer to pass through the laser 
of the flow cytometer and thus appear higher up on the fluorescent width scale (W) 
(Figure 2.5B). Therefore the 2D doublet exclusion plot represents the fluorescent Area 
(A) scale (PE 575/26 nm-A(rea)) which is the DNA content according to the yellow 
fluorescence emitted by propidium iodide (PI) dye and the fluorescent Width (W) scale 
(PE 575/26 nm-W(idth)) which is the time it takes for a cell to pass through the laser 
beam (Figure 2.5B). Thus, cells were gated (P2) using specific values, which 
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correspond to DNA content from 2N up to 16N and only to single cells so that the 
G2/M population contains only single mitotic cells (Figure 2.5B).  
This single cell gate (P2) population of cells was displayed as a one-dimensional 
histogram, representing the relative DNA content of cells (PE 575/26 nm-A(rea) - 
yellow fluorescence emitted by PI) and thus the cell cycle profile, with gates P3, P4, P5, 
P6, P7, P8 and P9 gating on sub-G1, G1 (2N), S, G2/M (4N), >4N, 8N, >8N with 0.2%, 
45.7%, 20.9%, 21.5%, 8.6%, 2.0% and 0.9% respectively. The gating of cells (FSC, 
SSC, DNA content, doublet exclusion) were initially acquired using the reference wild-
type cell line (N/TERT) and remained constant in subsequent sample analysis.  
 
Samples were analysed either in duplicates or triplicates and statistical analysis was 
performed using the Microsoft Excel’s software for student’s t test analysis (see Section 
2.16).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2: Materials and Methods 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 182 
 
 
 
 
Figure 2.5: PI (propidium iodide) cell cycle analysis. 
(A) Initial cell population gating (P1) for each sample is placed on FSC versus SSC (cell size 
versus granularity) 2D dot plot. Debris appear to the left of cell analysis gate (P1). (B) This cell 
population gate (P1) is then placed on PE 575/26 nm-W(idth) versus PE 575/26 nm-A(rea) 
(yellow fluorescence emitted by propidium iodide (PI) representing DNA content versus the 
time it takes for a cell to pass through the laser beam) 2D dot plot. Doublets and clumps appear 
to the right of single cell analysis gate (P2). (C) This single cell gate (P2) population of cells is 
then displayed as histogram, using the PE 575/26 nm-A(rea) (yellow fluorescence emitted by 
propidium iodide (PI), representing the DNA content and thus the cell cycle profile with gates 
such as P3, P4, P5, P6, P7, P8 and P9 gating on sub-G1, G1 (2N), S, G2/M (4N), >4N, 8N, >8N 
with 0.2%, 45.7%, 20.9%, 21.5%, 8.6%, 2.0% and 0.9% respectively. N, haploid number. 
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2.8.1.5 CyTM5 Annexin V staining and flow cytometry 
Annexin V, is a Ca
2+
 dependent phospholipid-binding protein that has a high affinity for 
membrane phosholipid phosphatidylserine (PS), and binds to cells with exposed PS 
(Raynal & Pollard, 1994). In apoptotic cells, the membrane phosholipid 
phosphatidylserine (PS) is translocated from the inner to the outer leaflet of the plasma 
membrane, thereby exposing PS to the external cellular environment and thus enabling 
the binding of Annexin V to it (Koopman et al., 1994; Martin et al., 1995). Due to the 
fact that externalization of PS occurs in the earlier stages of apoptosis (Martin et al., 
1995), Annexin V staining is used to identify apoptosis at an earlier stage, compared to 
assays based on nuclear changes (DNA fragmentation), such as propidium iodide 
staining.  
In my study, the fluorophore-labelled antibody, Cy
TM
5 Annexin V antibody (BD 
Pharmingen
TM
, BD Biosciences, San Jose, CA) was used. Annexin V is conjugated with 
Cy
TM
5 (Cyanine
TM
5) fluorochrome (see Section 2.8.1.1) and this format retains its high 
affinity for PS and thus serves as a sensitive probe for flow cytometric analysis of cells 
that undergoing apoptosis. Therefore, the labelled antibody is added to the cell sample 
and binds to a specific molecule on the cell surface (i.e. PS) or in other cases inside the 
cell. When laser light of the right wavelength strikes the fluorophore (i.e. Cy
TM
5), a 
fluorescent signal is emitted and detected by the flow cytometer.  
Cy
TM
5 Annexin V (BD Pharmingen
TM
, BD Biosciences, San Jose, CA) staining 
precedes the loss of membrane integrity which accompanies the latest stages of cell 
death resulting from either apoptotic (see Chapter 4, Section 4.2.1.2) or necrotic 
processes (see Section 2.8.1.4). For that reason, DAPI (- 4',6-diamidino-2-phenylindole) 
(Sigma-Aldrich, Dorset, UK) was also used for staining along with Cy
TM
5 Annexin V 
(BD Pharmingen
TM
, BD Biosciences, San Jose, CA) in order to discriminate late 
apoptotic or dead/necrotic cells which have lost membrane integrity, from early 
apoptotic cells which still have intact membranes, by dye exclusion. DAPI (Sigma-
Aldrich, Dorset, UK) is a fluorescent DNA (nucleic-acid) dye, that intercalates into the 
minor groove of double-stranded DNA and binds preferentially to A (Adenine) - T 
(Thymine) base pairs of  dead, damaged or fixed/permeabilised cells since it is unable to 
cross intact cell membranes of viable healthy cells (Kubista et al., 1987; Barcellona et 
al., 1990).  
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Cy
TM
5 (BD Pharmingen
TM
, BD Biosciences, San Jose, CA) is excited at 649 nm and 
emitted at 670 nm giving a red fluorescent colour, similar to APC (allophycocyanin) 
which is excited at 650 nm and emitted at 661 nm. For that reason a red diode 633 nm 
was used for flow cytometry analysis and fluorescence was detected at 660 nm using the 
APC 660/20 nm channel on the BD LSRII (BD Biosciences, San Jose, CA). DAPI 
(Sigma-Aldrich, Dorset, UK) is excited at 350 nm and emitted at 461 nm giving a blue 
fluorescent colour. For that reason a UV laser 325 nm was used for flow cytometry 
analysis and fluorescence was detected at 440 nm using the UV 440/40 nm channel on 
the BD LSRII (BD Biosciences, San Jose, CA). 
 
For Cy
TM
5 Annexin V (BD Pharmingen
TM
, BD Biosciences, San Jose, CA) and DAPI 
staining followed by flow cytometry analysis, equal number 3x10
5 
- 5x10
5
 of N/TERT, 
SINCE, and SINEG2 cells were seeded in 6 cm dishes, and harvested either 24 or 48 
hours after plating, in order to detect any GLI2∆N oncogene-induced apoptosis or cell 
death. Similarly, equal number 3x10
5 
- 5x10
5
 of N/TERT, SINCE, and SINEG2 cells 
were seeded in 6 cm dishes, and were either mock treated or UVB treated 24 hr after 
plating (~ 50-60% confluent) (see Section 2.13), in order to detect UVB-induced 
apoptosis. 24hr after UVB treatment, mock and UVB treated cells were harvested. In 
addition, 5 extra 6 cm dishes of each cell line were seeded and harvested in order to be 
used as controls to set up flow cytometry (Figure 2.6). These controls include (1) 
unstained cells, (2) cells stained with Cy
TM
5 Annexin V antibody alone (BD 
Pharmingen
TM
, BD Biosciences, San Jose, CA), (3) cells stained with DAPI alone 
(Sigma-Aldrich, Dorset, UK), (4) untreated (wild-type) populations stained both with 
Cy
TM
5 Annexin V antibody (BD Pharmingen
TM
, BD Biosciences, San Jose, CA) and DAPI 
(Sigma-Aldrich, Dorset, UK), used to define the basal level of apoptotic and dead cells 
for each cell line and (5) positive control staining with Cy
TM
5 Annexin V antibody (BD 
Pharmingen
TM
, BD Biosciences, San Jose, CA) and DAPI (Sigma-Aldrich, Dorset, 
UK), on a cell line which is induced to undergo apoptosis, that is UVB-treated N/TERT 
cells. 
 
Culture media from each of the 6 cm petri dishes (either UVB or non-UVB treated) 
were collected to include any detached dead or apoptotic cells that may be floating in 
the medium. Therefore, supernatants (culture media) from each 6 cm dish were 
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collected in 50 ml falcon tubes and adherent cells were washed once with 1x sterile PBS 
(PAA, Somerset, UK) and then trypsinised until all the cells had detached (see Section 
2.1.8). Trypsinised cells were transferred in the 50 ml falcon tubes containing the 
corresponding supernatant (RM+ growth medium) that included any floating cells at a 
ratio of 1:1 (v/v) trypsinised cells to RM+ culture medium supernatant including 
floating cells. Thus, the trypsin reaction was inhibited and cells were centrifuged at 
2,000 rpm for 5 minutes. Once the centrifugation was finished, the supernatant was 
aspirated and each pellet was resuspended in 5 ml of 1x sterile iced-cold PBS (PAA, 
Somerset, UK) and spun again at 2,000 rpm for 5 minutes. 
 
After centrifugation, each cell pellet was resuspended in 100 µl of 1x Annexin V 
Binding Buffer solution (BD Pharmingen
TM
, BD Biosciences, San Jose, CA) (1x 
Binding Buffer solution; 1 ml of 10x Annexin V Binding Buffer solution (BD 
Pharmingen
TM
, BD Biosciences, San Jose, CA) in 9 ml dH2O, kept on ice) and 5 µl 
Cy
TM
5 Annexin V antibody (BD Pharmingen
TM
, BD Biosciences, San Jose, CA) (1:20 
dilution) (except (1) and (3) controls where only 100 µl of 1x Annexin V Binding 
Buffer solution, BD Pharmingen
TM
, BD Biosciences, San Jose, CA, were added). 
Resuspended cells were transferred in sterile 5 ml polystyrene round bottom FACS 
tubes (BD Falcon tubes, BD Biosciences, San Jose, CA), were gently vortexed and were 
incubated for 15 min at room temperature in the dark. Then, 400 µl of 1x Annexin V 
Binding Buffer solution (BD Pharmingen
TM
, BD Biosciences, San Jose, CA) was added 
per sample and samples were kept on ice. Finally, DAPI (Sigma-Aldrich, Dorset, UK) 
was added at a final concentration of 200 ng/ml per sample (5 µl of 20 µg/ml DAPI per 
500 µl sample) (see Appendix I) (except (1) and (2) controls) 1 - 2 minutes before the 
cells were given for flow cytometry analysis, where the same number of events was 
acquired for each sample (20,000-30,000 events). 
 
Cells stained with Cy
TM
5 Annexin V antibody (BD Pharmingen
TM
, BD Biosciences, 
San Jose, CA) and DAPI (Sigma-Aldrich, Dorset, UK), were analysed for apoptosis and 
cell death. First, a 2D dot plot representing cell size and granularity was created for each 
sample (Figure 2.6A). This is derived from the Forward (cell size) and Side scatter 
(granularity) values (FSC versus SSC) and is useful for cell population gating according 
to physical characteristics of cells (P1) and thus for the exclusion of cell debris which 
have lower forward scatter than living cells (see Section 2.8.1.2). Next, the cell gate 
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(P1) population of cells, was displayed as a quadrant two-dimensional (2D) dot plot, 
representing  the fluorescent Area (A) scale (Annexin V APC 660/20 nm-A(rea)) which 
is indicative of the number of apoptotic cells binding Annexin V (Annexin V positive 
cells) according to the red fluorescence emitted by Cy
TM
5 dye conjugated to Annexin V 
antibody (BD Pharmingen
TM
, BD Biosciences, San Jose, CA) and the fluorescent Area 
(A) scale (DAPI UV 440/40 nm-A(rea)) which is indicative of the number of dead cells 
(DAPI positive cells) according to the blue fluorescence emitted by DAPI dye (Sigma-
Aldrich, Dorset, UK), with gates Q3, Q4, Q2 and Q1 gating on viable non-apoptotic 
cells (DAPI (-) Annexin V (-) cells), early apoptotic cells that bind Annexin V (DAPI (-
) Annexin V (+) cells), late apoptotic/dead cells that are binding Annexin V and taking 
up DAPI (DAPI (+) Annexin V (+) cells) and dead cells that take up DAPI but do not 
bind Annexin V (DAPI (+) Annexin V (-) cells), with 0.3%, 5.5%, 82.4% and 11.8% 
respectively (Figure 2.6F and Chapter 4, Section 4.2.5.2, Figure 4.15). The gating of 
cells was initially acquired using the reference wild-type cell line (N/TERT) and the 
five different controls (Figure 2.6A, B, C, D, E, F).  
 
Samples were analysed in duplicates and statistical analysis was performed using the 
Microsoft Excel’s software for student’s t test analysis (see Section 2.16). 
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Figure 2.6: Cy
TM
5 Annexin V staining and flow cytometry analysis. 
(A) Initial cell population gating (P1) for each sample is placed on FSC versus SSC (cell size 
versus granularity) 2D dot plot. Debris appear to the left of cell analysis gate (P1). (B, C, D, E, 
F) This cell population gate (P1) is then displayed as quadrant two dimensional (2D) dot plots 
using the Annexin V APC 660/20 nm-A(rea) versus DAPI UV 440/40 nm-A(rea) (red 
fluorescence emitted by Cy
TM
5 dye conjugated to Annexin V antibody which is indicative of the 
number of apoptotic cells binding Annexin V versus blue fluorescence emitted by DAPI which 
is indicative of the number of dead cells), with gates Q3, Q4, Q2 and Q1 gating on live non-
apoptotic cells  (DAPI (-) Annexin V (-) cells), early apoptotic cells that bind Annexin V (DAPI 
(-) Annexin V (+) cells), late apoptotic/dead cells that are binding Annexin V and taking up 
DAPI (DAPI (+) Annexin V (+) cells) and dead cells that take up DAPI but do not bind 
Annexin V (DAPI (+) Annexin V (-) cells), with 0.3%, 5.5%, 82.4% and 11.8% respectively 
(F). (B, C, D, E, F) Controls used to set up compensation and quadrants for flow cytometry 
analysis: (B) unstained N/TERT cells, (C) N/TERT cells stained with Cy
TM
5 Annexin V 
antibody alone, (D) N/TERT cells stained with DAPI alone, (E) untreated (wild-type N/TERT) 
populations stained with Cy
TM
5 Annexin V antibody and DAPI, used to define the basal level of 
apoptotic and dead cells (F) positive control staining with Cy
TM
5 Annexin V antibody and 
DAPI, on a cell line which is induced to undergo apoptosis, that is UVB-treated N/TERT cells. 
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2.8.2 FACS sorting 
Fluorescence-activated cell sorting (FACS) (Figure 2.7) is a specialized type of flow 
cytometry (Section 2.8.1) which is used to separate cells according to subtype or 
epitope expression (cells labeled with fluorescently tagged antibodies, fluorescent dyes 
or fluorescent expressing proteins) for further biological studies. Thus, FACS provides a 
method for sorting a heterogeneous mixture of biological cells into two or more 
containers, one cell at a time, based upon the specific light scattering and fluorescent 
characteristics of each cell, typically through a process which is known as electrostatic 
droplet deflection (Willis, 2004). 
After the sample is hydrodynamically focused (see Section 2.8.1.2), into a thin stream 
so that cells pass singly through an exit nozzle (flow cell) the stream is in laminar flow 
in air. The further away from the flow cell, the more unstable the stream becomes, 
eventually breaking up into droplets. To sort accurately, the stream needs to be precisely 
and reproducibly forming droplets at the same point. This is done by acoustic waves 
applied to the nozzle; the waves travel down the stream allowing droplet formation and 
break-off point to be stabilised. Thus through hydrodynamic focusing and the stabilised 
break-off, a particle or cell of interest passing in the stream will be partitioned into 
individual droplets (http://flow.csc.mrc.ac.uk/). 
 
Therefore, after hydrodynamic focusing each particle or cell is probed with a beam of 
light from the laser and a computer registers its physical and fluorescent properties (see 
Section 2.8.1.2) and the scatter and fluorescence signal is compared to the 
predetermined sort criteria set on the computer (Figure 2.7A, B, C, D). If the cell 
matches the selection criteria, an electric charge is applied to the stream. Electrostatic 
charging actually occurs at a precise moment called the ‘break-off point’, which 
describes the instant the droplet containing the cell of interest separates from the stream. 
Thus, when the cell to be sorted reaches the break-off point, an electric charge is applied 
to the stream and as the drop leaves the stream and is no longer attached to the stream 
the charge on the stream is reset to zero and the droplet with the cell of interest retains 
the applied charge (http://flow.csc.mrc.ac.uk/), (www.abdserotec.com/uploads/Flow-
Cytometry.pdf). The droplets eventually pass through a strong electrostatic field (a pair 
of charged metal plates), and are deflected left or right based on their charge (deflected 
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away from the plate of opposite charge) and collected to collection tubes or into a waste 
container. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Fluorescent Activated Cell Sorting (FACS). 
A schematic of fluorescence activated cell sorting (FACS). Sort criteria for EGFP-expressing 
cells are shown in panels A-D. (A) A normal non-EGFP expressing wild-type cell line (i.e. 
N/TERT) is used to select for cells (P1) according to size (FSC) and granularity (SSC) as shown 
in the 2D dot plot. (B) The same cells are used to detect levels of background auto-fluorescence 
as plotted in the histogram. The threshold for green fluorescence (GFP fluorescence) is set 
accordingly (set of the gates), for the discrimination of EGFP negative from positive (P2) cells. 
(C) An inducible EGFP expressing cell line (N/TERT-EGFP-GLI2∆N, NTEG2 Dox-) is the cell 
line of interest used for sorting, and thus cells are firstly selected (P1) according to the FSC and 
SSC profiles as obtained previously. (D) The cells are then selected (gated) according to the 
levels of green fluorescence (EGFP fluorescence) (P2). All cells detected within the specified 
range of FSC and SSC (P1) (C), and green fluorescence positivity (P2) (D), will satisfy the 
sorting criteria and will thus be sorted in the collection tubes.  
Modified from http://flow.csc.mrc.ac.uk/. 
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All fluorescent activated cell sorting (FACS) runs (sorting based on enhanced green 
fluorescence protein - EGFP levels), in my study, were performed in a BD FACSAria 
Cell Sorter fitted with a Blue Argon Laser 488 nm, violet diode 405 nm, and red diode 
633 nm (BD Biosciences, San Jose, CA), by Gary Warnes at FACS Lab of Cell and 
Molecular Science, Barts and the London Queen Mary’s School of Medicine and 
Dentistry, Whitechapel, London, UK.  
 
N/TERT wild-type cells (see Section 2.1.3) and stable expressing-EGFP and EGFP-
GLI2∆N transduced (4 days after infection) N/TERT keratinocytes (see Section 
2.3.5.1), or selected (see Section 2.4) and inducible expressing EGFP-GLI2∆N 
(NTEG2 Dox-, removal of Dox for 5 days) transduced N/TERT keratinocytes (see 
Section 2.3.5.2), plated in either 6 or 10 cm dishes, were trypsinised (see Section 2.1.8) 
and centrifuged at 1,000 rpm for 5 minutes. After washing each pellet with 10 ml 1x 
sterile PBS (PAA, Somerset, UK) and centrifuging at 1,000 rpm for 5 minutes, cell 
pellets were resuspended in 2 ml of 1x sterile PBS (PAA, Somerset, UK) each, and were 
then passed through a 70 µm strainer (BD Falcon Cell strainers, BD Biosciences, San 
Jose, CA) (minimise doublets and clumps). Cells were transferred in sterile 5 ml 
polystyrene dual-position snap-cap round bottom FACS tubes (BD Falcon tubes, BD 
Biosciences, San Jose, CA), which were kept on ice and were given for FACS analysis. 
N/TERT wild-type cells were used for obtaining basal levels of green fluorescence 
(background auto-fluorescence), and all cells above this basal threshold were considered 
as being EGFP positive fluorescent cells and were thus collected in either sterile 5 ml 
polystyrene dual-position snap-cap round bottom FACS tubes (BD Falcon tubes, BD 
Biosciences, San Jose, CA) or in sterile 1.5 ml microcentrifuge tube (Eppendorf, 
Cambridge, UK, depending on the number of the collected cells, containing 1 ml and 
500 µl respectively, of the appropriate normal culture medium for each cell line. 
Collected cell were either plated immediately after collection in 24, 12 or 6-well plates 
or in T25 flask, containing normal growth medium (growth medium depending on the 
cell line), or were centrifuged at 1,000 rpm for 5 minutes and then the pellet was 
resuspended in 2 ml of culture medium and plated in the appropriate normal culture 
medium for each cell line. FACS sorted and replated cells were either used in 
experiments or were cryopreserved (Section 2.1.10). 
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2.9 Hoechst-33342 staining and replating 
For Hoechst-33342 staining and replating cells were seeded at equal densities and as 
soon as they reached 50-60% confluence they were washed, trypsinised and stained 
with 10 µg/ml  Hoechst-33342 (Sigma-Aldrich, Dorset, UK) (2 ml 1x sterile PBS + 2 µl 
10 mg/ml Hoechst-33342; 1:1000 dilution) (see Appendix I) following the same 
procedure as described in Section 2.8.1.3. Cells were then counted using a 
haemocytometer (Section 2.1.9.1) and were reseeded in 10 cm dishes at a density of 
3x10
5
 cells/dish. Digital bright-field and fluorescent images were captured 24, 48, 72 hr, 
(~ 30-60 % confluent throughout the experiment) after plating using a fluorescence 
microscope (Section 2.2). 
 
 
2.10 DAPI staining and Binucleate cells counting 
For DAPI staining and binucleate cells counting, equal number 1.2x10
5 
N/TERT, 
SINCE, and SINEG2 cells were seeded per well in a 6 well plate. 72 hours after plating 
(~ 40-60 % confluent), cells were washed 1x in 1x sterile PBS (PAA, Somerset, UK) 
and were fixed in 4% (v/v) Formaldehyde/Formalin (Fisher, Leicestershire, UK) 
solution (Appendix I) for 20 minutes at room temperature and were either stored at 4
o
C 
until required or were immediately stained with DAPI. Cells were washed 2x in 1 ml 
per well of 1x sterile PBS (PAA, Somerset, UK) and were incubated in 1 ml per well of 
1x sterile PBS (PAA, Somerset, UK) containing 200 ng/ml DAPI (Sigma-Aldrich, 
Dorset, UK) (Appendix I)  for 10 minutes at room temperature in the dark. Finally cells 
were washed 1x in 1 ml of 1x sterile PBS (PAA, Somerset, UK) per well and were then 
covered in 1-2 ml of 1x sterile PBS (PAA, Somerset, UK) per well.  
 
Digital bright-field and fluorescent images (~ 15 images (fields) per cell line in two 
replicate wells) were captured using a fluorescence microscope (see Section 2.2). The 
bi-nucleated (tetraploid) cells per field (image) were counted using Adobe Photoshop 
CS4 Extended. The percentage of bi-nucleated cells per field was derived by counting 
the number of cells with two nuclei over the total number of cells per field. Thus, the 
percentage of bi-nucleated cells per field (x) was calculated as follows: x = Number of 
Bi-nucleate Cells x 100 / Total Number of Cells. For example if a field of cells had a 
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total amount of 80 cells, of which, 9 were bi-nucleated, then x = 9 x 100 / 80, then x = 
11.25 %. An average of approximately 300 - 350 cells were counted for each cell line in 
total. Only bi-nulceated cells were counted in this analysis, while all multi-nucleated 
cells were included in the total number of cells per field. Cells undergoing mitosis were 
also counted as two mononuclear cells. 
 
 
2.11 Absolute Quantitative Real-time PCR (qRT-PCR) and Semi-
Quantitative PCR 
Polymerase chain reaction (PCR) is a commonly used method to amplify DNA 
sequences of interest and can be used to detect mRNA expression by amplification of a 
target region of a gene’s cDNA, using oligonucleotide primers complementary to 
flanking cDNA sequences.  
 
Absolute quantitative real-time PCR (qRT-PCR) is used for the accurate quantification 
of the copy number of a gene of interest in a given cell sample. The template of a qRT-
PCR reaction can be cDNA, converted from isolated total RNA (see Section 2.11.1) by 
reverse transcription as described in Section 2.11.2. qRT-PCR is a kinetic PCR reaction 
which provides real time information about the amplification of cDNA template 
(Figure 2.8A). The template cDNA is mixed with Syber (SYBR) Green I Master 
(Roche, Burgess Hill, UK), which is an asymmetrical fluorescent dye that stably binds 
to random sites of double stranded DNA. During cDNA amplification (Figure 2.8A) the 
qRT-PCR instrument records the level of green fluorescence emitted by double strand 
DNA-bound SYBR Green I Master (Roche, Burgess Hill, UK), and these readings are 
repeated for each PCR cycle. Therefore, a real-time cDNA amplification curve 
(fluorescence/time or cycle, y/x axis) is finally produced based on the levels of 
fluorescence present in each amplification cycle (Figure 2.8A). By comparing these 
values to a standard curve produced by serial dilutions of a known amount of cDNA 
template (see Section 2.11.6), it is possible to calculate the absolute template copy 
number in the unknown samples. This method differs qualitatively and quantitatively 
from conventional semi-quantitative PCR (see Section 2.11.8), since only the former 
can accurately quantify the copy number of template cDNA present in the original 
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sample, while the latter indicates the final amplified PCR products. Although semi-
quantitative PCR can offer information about the presence or absence of a specific 
product, the relative abundance of copy number is often subjective since it is based on 
visual confirmation and/or manual signal analysis. Furthermore, by using qRT-PCR the 
specificity of product amplification is also confirmed by melting analysis performed at 
the end of the qRT-PCR run (Figure 2.8B). During melting analysis, the qPCR 
amplified products are initially melted at 95
o
C followed by a cooling to 65
o
C where all 
qPCR products become double stranded through annealing after 30 sec, emitting high 
fluorescence signal. Then qPCR products become gradually melted and single stranded, 
when subjected to increasing temperature incubations from 65
o
C up to 99
o
C and the 
green fluorescence signal is acquired continuously. The fluorescent signal will suddenly 
drop once the melting temperature (DNA product denaturation; dsDNA conversion to 
two single strands where SYBR Green I (Roche, Burgess Hill, UK) is not bound to) for 
a specific qPCR product is reached, thus producing a melting curve (fluorescence 
intensity/temperature, (y/x axis), which is also depicted as a single peak representing the 
product’s melting temperature (fluorescence intensity/temperature, (y/x axis) (Figure 
2.8B). Therefore, a single peak indicates the presence of a single amplified product, 
whereas multiple peaks indicate the presence of multiple unspecific PCR products that 
melt at different temperatures.  
 
Absolute quantitative Real Time-PCR (qRT-PCR) in this study was performed using 
Light Cycler
®
 480 SYBR green I Master (Roche, Burgess Hill, UK). Semi-quantitative 
PCR (PCR) in this study was performed using Verity 96-well Thermal Cycler (Applied 
Biosystems, Carlsbad, CA). 
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Figure 2.8: Amplification and melting analysis in qRT-PCR. 
(A) Amplification cycle. Each amplification cycle consists of three cycling temperature steps 
including denaturation (95
o
C), primer annealing (60
o
C), and extension (72
o
C). Fluorescence is 
acquired at the end of extension step at 76
o
C when all products are double stranded and after a 
number of cycles the amplification curve for each sample is obtained. (B) Melting analysis. 
Modified from Dr Muy-Teck Teh, LightCycler LC480 Protocol for Absolute Gene 
Quantification, Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and the 
London School of Medicine and Dentistry, London, UK. 
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2.11.1 Total RNA Extraction from cultured cells 
Cells were seeded in 6 cm dishes (~ 5x10
5
 cells/dish) and total RNA was extracted 
either 24 or 48 hours after plating. The work surface and pipettes were prepared with 
RNase Zap (Ambion, Cambridgeshire, UK) to remove enzymes that digest RNA and all 
steps were performed at room temperature. Total RNA was extracted from cells using 
RNeasy Mini Kit (Qiagen, West Sussex, UK). Semi-confluent cultures (50-65% 
confluent dishes) were harvested in 350 µl of RLT lysis buffer (Qiagen, West Sussex, 
UK) containing 10 µl/ml β-mercaptoethanol (β-ME) (Sigma-Aldrich, Dorset, UK). RLT 
buffer acts to lyse the cells (Qiagen, West Sussex UK) and contains guanidine 
isothiocyanate, which deactivates RNase enzymes that would otherwise degrade 
extracted RNA. Next, cell lysates were collected in eppendorf tubes (Eppendorf, 
Cambridge, UK) and were either snap frozen in dry ice and kept at -80
o
C for long-term 
storage, or processed immediately to the next step. Cell lysates were homogenized by 
passing them through QIAshredder columns inside 2 ml collection tubes (Qiagen, West 
Sussex, UK) and centrifuged at 13,200 rpm for 2 minutes followed by column removal. 
Next, 350 µl of 70% (v/v) ethanol (Fisher, Leicestershire, UK) (see Appendix I) was 
added to each lysate and mixed by pipetting, to precipitate RNA. Then, the 350 µl of 
sample were loaded into an RNeasy Mini Spin column inside 2 ml collection tubes 
(Qiagen, West Sussex, UK) and centrifuged at 10,000 rpm for 15 seconds. Upon 
centrifugation RNA was adhered to the column and the flow-through was discarded. 
Then the columns were rinsed by loading 700 µl RW1 buffer (Qiagen, West Sussex, 
UK) and centrifuging at 10,000 rpm for 15 seconds. Then, the columns were washed 
again by adding 500 µl RPE buffer (Qiagen, West Sussex, UK) and centrifuging at 
10,000 rpm for 15 seconds. This was repeated with a further 500 µl RPE buffer, but 
centrifuged at 10,000 rpm for 1 minute to dry the column. Finally, the column was 
transferred to a fresh RNase-free microcentrifuge tube (Qiagen, West Sussex, UK) and 
the RNA was eluted by adding 20-30 µl RNase-free water (Qiagen, West Sussex, UK) 
to the column and centrifuging for 10,000 rpm for 1 min. The RNA concentration was 
measured with NanoDrop
TM
 ND-1000 (ThermoScientific, Cambridgeshire, UK) (see 
Section 2.3.2) and RNA was stored at -80°C until required. 
Chapter 2: Materials and Methods 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 196 
2.11.2 Reverse Transcriptase cDNA Synthesis 
Reverse transcriptase is an enzyme that transcribes single stranded RNA into double 
stranded DNA. Reverse transcriptases were first identified in tumour viruses (Baltimore, 
1970; Temin & Mizutani, 1970).  The reverse transcriptase used in this study in order to 
convert total RNA into complementary DNA (cDNA) (First-strand cDNA synthesis) is 
the AMV (Avian Myeloblastosis Virus - tumour virus) Reverse Transcriptase (Promega, 
Hampshire, UK) that synthesizes single-stranded cDNA from total isolated RNA 
(Dasgupta et al., 2006).  
 
Purified RNA (1-3 µg of total isolated RNA, as described in Section 2.11.1) was 
reverse transcribed into cDNA with the Reverse Transcription Kit (Promega, 
Hampshire, UK) with very few modifications to manufacturer’s protocol. Initially, 
isolated RNA and the components of the Reverse Transcription Kit (Promega, 
Hampshire, UK) were defrosted and a mastermix was prepared in an RNase-free 
eppendorf tube (Eppendorf, Cambridge, UK), as well as 1 µg/10 µl RNA from the RNA 
sample was prepared (i.e. Sample 1 RNA concentration ng/µl: 1 µg RNA = 3 µl from 
the RNA sample → 3 µl RNA + 7 µl RNase-free water = 10 µl  thus final concentration 
1 µg/10 µl = 0.1 µg/µl = 100 ng/µl) in an RNase-free eppendorf tube (Eppendorf, 
Cambridge, UK). A typical reverse transcription reaction to convert 1 µg of total RNA 
contained the following (all reagents were supplied with Reverse Transcription Kit from 
Promega, Hampshire, UK): 
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Component                                          Amount 
MgCl2, 25mM 4.0 µl  
Reverse Transcription 10xBuffer  2.0 µl 
dNTPs Mixture, 10mM   2.0 µl 
Oligo(dT)15 Primers (0.5 µg/µl)  0.5 µl 
Random Primers (0.5 µg/µl)   0.5 µl 
RNAsin®     0.5 µl 
AMV Reverse Trascriptase (15 units/µl) 1.0 µl 
Nuclease-free water                             4.5 µl 
 
Mastermix                                           15 µl 
 
RNA*      10 µl (1 µg; 100 ng/µl RNA)  
   
Total      25 µl 
 
* For more than 1µg of RNA, the reaction volume was increased accordingly 
 
 
Mastermix 15 µl was added in 10 µl RNA sample. Reaction (25 µl) was mixed by 
vortexing and then pulse centrifuged, before incubating at room temperature for 10 
minutes. This allowed the hybridisation of Oligo(dT)15 and random primers to the RNA. 
The transcripts were reverse transcribed to cDNA by incubating at 42
o
C for 30 minutes. 
AMV reverse trascriptase was inactivated and prevented from binding to cDNA by 
incubating at 75
o
C for 5 minutes. Then samples were centrifuged at 8,000 rpm for 5 sec.  
Finally, the Reverse Transciption mixture (25 µl) was diluted (1:3) with 50 µl of 
Nuclease-free molecular biology grade H2O (Reverse Transcription Kit, Promega, 
Hampshire, UK or Sigma-Aldrich, Dorset, UK) (i.e. 25 µl + 50 µl → 75 µl final 
volume) and kept in ice if being used immediately in downstream PCR applications, or 
stored at  -20
o
C until required. 
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2.11.3 Primer design 
The cDNA accession numbers of genes of interest were obtained using the online NCBI 
database, and were then used in Roche’s Universal Probe Library tool for primer design 
(https://www.roche-applied-science.com/sis/rtpcr/upl/index.jsp?id=UP030000).  
 
Primer sequences (see Table 2.3) were selected on the basis of size (70-120 bp) and 
were all verified on BLAST tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to ensure high 
specificity to target product.  
 
Primer sequences for BCL-2 (Regl et al., 2004b) and GLI2 a/β (Regl et al., 2002) were 
chosen from previously published papers, as well as POLR2A and YAP1 (Gemenetzidis 
et al., 2009). E-cadherin primers were kindly provided by Dr Adrian Biddle, Centre for 
Cutaneous Research, Institute of Cell and Molecular Science, Barts and the London 
School of Medicine and Dentistry, London, UK), and Involucrin (IVL), Integrin β1, 
POLR2A and YAP1 were kindly provided by Dr Muy-Teck Teh, Clinical and 
Diagnostic Oral Sciences, Institute of Dentistry, Barts and the London School of 
Medicine and Dentistry, London, UK). 
 
2.11.4 Primer preparation and validation by qRT-PCR 
The primers used in this study were either custom-designed, as described in Section 
2.11.3 and ordered from Sigma-Aldrich, Dorset, UK, or were purchased as pre-designed 
and validated primers from Qiagen, West Sussex, UK. The preparation of custom 
primers is described below. 
 
The lyophilised forward and reverse primers were each diluted in the necessary volume 
of sterile 1x TE buffer (1x Tris-EDTA buffer; 10 mM Tris, 1 mM EDTA pH 8.0) as 
stated by Sigma-Aldrich (Dorset, UK) primer concentration datasheet, to obtain a final 
primer concentration of 100 µM per primer. This original solution was mixed 
thoroughly by vortexing and pulse spin at a table-top microcentrifuge and was stored at 
-20
o
C until required. This original solution is referred to as the stock primer solution. 
The 500 µl working primer aliquots were prepared by 1:20 dilution of the forward and 
reverse primer in the same solution to obtain a final concentration of 5 µM for each 
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primer (25 µl of Forward primer + 25 µl of Reverse primer + 450 µl of nuclease-free 
water (Sigma-Aldrich, Dorset, UK) = 500 µl of F+R primers at 5 µM each). Working 
primer aliquots were mixed thoroughly by vortexing and pulse spin at a table-top 
microcentrifuge and were stored at -20
o
C until required. For each 10 µl qRT-PCR 
reaction, only 1 µl of the working primer solution was used (1:10 dilution; 1 µl of F + R 
primers at 5 µM each + 9 µl of qRT-PCR reaction = 10 µl of qRT-PCR reaction, 0.5 µM 
final primer concentration for each primer). For the preparation of standard curves 
where 50 µl of qRT-PCR reaction is prepared for each given gene (see Section 2.11.6), 
the concentration for each primer is increased up to 0.7 µM (1:7.14 dilution; 7 µl of F + 
R primers at 5 µM each + 43 µl of qRT-PCR reaction = 50 µl of qRT-PCR reaction, 0.7 
µM final primer concentration for each primer). 
 
For the preparation of commercially available Qiagen primers (10x QuantiTect Primer 
assay, Qiagen, West Sussex, UK), the vial with the lyophilised mix of forward and 
reverse primer pair was centrifuged at a table-top microcentrifuge and was reconstituted 
in 1.1 ml sterile 1x TE buffer (1x Tris-EDTA buffer; 10 mM Tris, 1 mM EDTA pH 
8.0), mixed thoroughly by vortexing and aliquoted in 200 µl working aliquots and 
stored at -20
o
C until required (working primer solution). Each 10x QuantiTect Primer 
assay is sufficient for 200 x 50 µl reactions as stated by Qiagen (West Sussex, UK), 
indicating that for each 50 µl reaction, 5 µl of the 10x QuantiTect Primer assay are used. 
Therefore, in this study for each 10 µl qRT-PCR reaction, only 1 µl of the working 
primer solution (1:10 dilution; 1 µl of F + R primers 10x QuantiTect Primer assay + 9 µl 
of qRT-PCR reaction = 10 µl of qRT-PCR reaction with 1x QuantiTect Primer assay) 
was used. The primer concentrations and sequences are proprietary and were not 
disclosed within the Qiagen (West Sussex, UK) product information. 
 
To validate that the selected primers are specific for the gene of interest (amplify only 
one product), a qRT-PCR run was set up using cDNA from the target cell line (i.e. 
N/TERT) and/or a cocktail of oral human normal and neoplastic keratinocytes (provided 
by Dr Muy-Teck Teh, Clinical and Diagnostic Oral Sciences, Institute of Dentistry, 
Barts and the London School of Medicine and Dentistry, London, UK) as templates. 
Primer pair and cDNA, prepared as described in Section 2.11.1 and Section 2.11.2, and 
Light Cycler
®
 480 SYBR Green I Master (Roche, Burgess Hill, UK) were defrosted and 
Syber (SYBR) Green I Master Mix reaction (qRT-PCR) was performed. Light Cycler
®
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480 SYBR Green I Master (2x concentrated) (Roche, Burgess Hill, UK) is a ready to 
use hot-start Taq DNA polymerase reaction buffer containing dNTP mix (dUTP instead 
of dTTP), SYBR Green I dye, and MgCl2, containing also 6x10
-6
% Blue dye 
Bromophenol Blue (BPB) (Sigma-Aldrich, Dorset, UK) to visually assist sample 
loading in qPCR 96-well white opaque plates (Roche, Burgess Hill, UK). A 0.001% 
BPB solution was prepared (80 µl of 1.5% BPB in 1 ml dH2O (nuclease-free water, 
Sigma-Aldrich, Dorset, UK)) and 30 µl from this solution were added in 5 ml bottle of 
2x SYBR Green I Master (Roche, Burgess Hill, UK) (6x10
-6
 % Blue dye Bromophenol 
Blue). Then 1 ml aliquots were prepared and kept at -20
o
C until required and once 
defrosted were kept at 4
o
C for 1 month. A qRT-PCR reaction for each pair of primers 
was therefore prepared as follows: 
 
Component                                      Amount 
2x SYBR Green I MASTER  4 µl 
5 µM F/R Primer    1 µl 
dH2O (nuclease-free water)  4.5 µl (0.5 µl extra to correct for pipetting error) 
 
Master Mix    9.5 µl 
 
Only 9 µl were used from the master mix to correct for pipetting error, and were added 
on top of the template cDNA. 
 
Master Mix    9 µl 
Template cDNA   2 µl 
 
Total volume/well 10 + 1 µl (1 µl extra to compensate for 
evaporation during preparation) 
 
First, 2 µl of the template cDNA were loaded in each well of the 96-well plate (Roche, 
Burgess Hill, UK). An extra well with 2 µl of nuclease-free dH2O (Sigma-Aldrich, 
Dorset, UK) instead of template cDNA was loaded as a negative control. After the 
master mix was prepared, it was thoroughly mixed by vortexing and then 9 µl were used 
for each sample and for negative control. Next, the plate was covered with a sealing foil 
provided by Roche, Burgess Hill, UK, and was centrifuged for 30 sec at 3,000 rpm 
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(centrifuge plate for 30 sec using a bench top centrifuge and hold down the quick spin 
button for 30 sec until reaches the 3,000 rpm), prior to starting the absolute quantitative 
Real Time-PCR (qRT-PCR) run on Light Cycler
® 
480 instrument (Roche, Burgess Hill, 
UK).  
 
The samples were run on a typical qRT-PCR amplification protocol (Table 2.2) 
including an initial incubation at 95
o
C for 5 minutes, to allow for the activation of 
polymerase, linearization of cDNA, and the reduction of primer dimers in the PCR 
mixture. This is followed by 45 cycles of (see Section 2.11, Figure 2.8A): 
 
- 95oC for 10 sec to allow DNA denaturation so that the double stranded DNA is 
opened into two single strands (single-stranded DNA).  
- 60oC for 6 sec for primer annealing to allow the forward and reverse primers to 
bind to the single stranded DNA. 
- 72oC typically for 6 sec for product elongation (incubation time here dependent 
on the length of the product; 1 sec/25 base pairs). This will allow sufficient time 
for the elongation of the newly synthesised DNA strand. 
 
Fluorescence readings were acquired at 76
o
C for 1 sec (at the end of the extension), 
once per cycle, when all PCR products are double stranded (see Figure 2.8A). Samples 
were then subjected to a melting curve analysis (Table 2.2), which begins after the final 
qPCR amplification cycling step, to confirm amplification specificity of the PCR 
products (see Section 2.11, Figure 2.8B). Melting analysis is performed by 1 cycle of: 
 
- 95oC for 30 sec in order to melt all qPCR products and to become single-
stranded qPCR products (denaturation). 
- 65oC for 30 sec in order to cool down and all qPCR products through annealing 
to become double stranded after 30 sec and thus the fluorescence signal is 
maximum. 
- 65oC to 99oC gradual heating of qPCR products. During this gradual heating 
(0.11
o
C/1 sec), fluorescence is continuously acquired (65
o
C, dsDNA qPCR 
products, high fluorescence to 99
o
C, ssDNA qPCR products, no fluorescence) to 
generate a melting curve to determine the melting profiles (number of peaks and 
melting temperature for each peak) of qPCR products in each well. Therefore, a 
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single peak indicates the presence of a single amplified product, whereas 
multiple peaks indicate the presence of multiple unspecific PCR products that 
melt at different temperatures. 
 
Melting analysis run, terminates at 40
o
C. After confirmation of a single melting peak 
following melting curve analysis, amplified PCR products were further visualised by 
agarose gel electrophoresis as described below in Section 2.11.5 (see Chapter 3, 
Section 3.2.1.3, Figure 3.2A i, ii and Figure 3.2B i, ii). 
 
 
 
Table 2.2: Conditions for qRT-PCR amplification and melting analysis. 
 
Stage Function Temperature 
(
 o
C) 
Time Number 
of cycles 
1 
Denaturation 
Initial Denaturation 95 5 min 1 
Denaturation 95 10 sec 
Annealing 60 6 sec 
Extension 72 6 sec 
2 
Amplification 
Fluorescence 
acquisition 
76 1 sec 
45 
Melting 95 30 sec 
Cooling/Annealing 65 30 sec 
3 
Melting 
analysis 
Gradual heating 
(0.11 
o
C/sec) and 
Fluorescence 
acquisition 
65-99 continuous 
1 
4 
Termination 
Cooling/Termination 40 30 sec 1 
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2.11.5 Agarose gel electrophoresis 
Agarose gel electrophoresis is a method used to separate DNA or RNA. Nucleic acid 
molecules are separated by size. This is achieved by moving negatively charged nucleic 
acid molecules through an agarose matrix with an electric field (electrophoresis) that 
forces the DNA to migrate toward the positive potential (anode). Thus, shorter 
molecules move faster and migrate further than longer ones because of the separating 
effect of the gel.  
 
Amplified qPCR products were run on 2% Agarose gel for visualisation of product size 
and the validation of single-product amplification (see Chapter 3, Section 3.2.1.3, 
Figure 3.2A ii and Figure 3.2B ii). Agarose gel was prepared by diluting 2 g of 
agarose (Sigma-Aldrich, Dorset, UK) in 100 ml of 1x TAE (Tris base/Acetic 
acid/EDTA) buffer (1x TAE; 50 ml 10x TAE buffer from  Invitrogen (Paisley, UK) + 
450 ml dH2O = 500 ml). The 500 ml mixture was heated to boiling temperature and was 
then allowed to cool down to 60
o
C prior to adding 1 µg/ml Ethidium Bromide (Sigma-
Aldrich, Dorset, UK). Ethidium bromide intercalates with DNA and this causes the 
ethidium bromide molecule to strongly fluoresce when exposed to UV light.  This 
allows for the location of DNA to be visualised on the gel under UV light. 
 
Once the agarose gel was solidified, it was placed in a gel tank, which was pre-filled 
with 1x TAE running buffer (Invitrogen, Paisley, UK). The amplified qPCR products 
were loaded typically at 2 µl/well, while in the case that product amplification was less 
efficient, up to 5 µl/well of the qPCR product were used. For semi-quantitative PCR 
(Section 2.11.8), the whole reaction volume of 10 µl was used for visualisation of the 
PCR amplified products.  The qPCR amplified products were mixed in 1:1 ratio with 2x 
loading dye buffer (75% (v/v) Glycerol, 0.075% (v/v) Bromophenol Blue, 0.075% (v/v) 
Xylene Cyanol; all supplied by Sigma-Aldrich, Dorset, UK) (see Appendix I) (i.e. 5 µl 
PCR product + 5 µl 2x loading dye = 10 µl total volume) and were loaded in each well 
of the pre-prepared agarose gel. The samples were run against 1 Kb plus DNA ladder (1 
µg/ml) (Invitrogen, Paisley, UK) to estimate the product size. The 1 Kb plus DNA 
ladder (1 µg/ml) (Invitrogen, Paisley, UK) was initially diluted 1:2.5 in 2x loading dye 
buffer (250 µl of DNA ladder + 375 µl of 2x loading dye buffer = 600 µl) to finally 
obtain a concentration of 0.4 µg/µl (working solution), and stored at -20
o
C until 
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required. 5 µl of the 1 Kb plus ladder (Invitrogen, Paisley, UK) working solution were 
used per well. The samples were run at a constant voltage of 120 V for ~ 30 min until 
DNA migration was evident. qPCR products were visualised by UV light and a gel 
image was captured in the Autochemi imaging system (UVP, Upland, CA). 
 
2.11.6 Generation of standard curves 
Absolute quantification for a single gene is achieved by performing a standard curve 
using PCR product standard dilution series. The gene copy number of an unknown 
sample will be calculated based on the standard curve of that gene. The Light Cycler
® 
480 operating software (Roche, Burgess Hill, UK) will automatically calculate the gene 
copy numbers in unknown samples based on the standard curve fitting, using a novel 
non-linear algorithm.  
 
To acquire a standard curve for each gene, the primer pair (5 µM) (see Section 2.11.4) 
was initially mixed with SYBR green I Master (2x concentrated) (Roche, Burgess Hill, 
UK) and a template cDNA (cocktail from a wide range of oral human normal and 
neoplastic derived keratinocytes, provided by Dr Muy-Teck Teh, Clinical and 
Diagnostic Oral Sciences, Institute of Dentistry, Barts and the London School of 
Medicine and Dentistry, London, UK and/or N/TERT target cell line) in the following 
reaction mixture followed by vortexing: 
 
Component     Amount 
2x SYBR Green I MASTER   20 µl 
dH2O (nuclease-free water)     20 µl 
Template cDNA    5 µl 
5 µM F/R Primer    7 µl 
Total volume 50 + 2 µl (2 µl extra to compensate for 
evaporation during preparation) 
 
Only 50 µl were used from the master mix/template cDNA mixture to correct for 
pipetting error, and were added in each well. The qPCR-96 well plate was centrifuged 
for 30 sec at 3,000 rpm as described in Section 2.11.4, prior to starting the absolute 
quantitative Real Time-PCR (qRT-PCR) run on Light Cycler
® 
480 instrument (Roche, 
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Burgess Hill, UK). The above qRT-PCR reactions were run on a typical amplification 
protocol as described in Section 2.11.4 and Table 2.2. 
 
2.11.6.1 Purification of qPCR product 
Amplified qPCR product (double-stranded DNA) was then purified using QIAquick 
PCR Purification kit (Qiagen, West Sussex, UK) in order to obtain the amplified 
product for the specific gene of interest and to use it as template for the serial dilutions, 
which are necessary for the establishment of the standard curve.  
 
The amplified qPCR product (1 volume) was mixed by pipetting up and down with 5x 
volume of PB buffer (Qiagen, West Sussex, UK) (i.e. 50 µl qPCR product + 250 µl PB 
buffer) in an 1.5 ml microcentrifuge tube (Eppendorf, Cambridge, UK) and the colour 
of the mixture was turned to yellow. The mixture was placed in a QIAquick spin 
column inside 2 ml collection tube (Qiagen, West Sussex, UK) and was spun at 13,200 
rpm on a table top centrifuge for 1 minute. Upon centrifugation DNA was adhered to 
the column and the flow-through was discarded. QIAquick spin column inside 2 ml 
collection tube was then washed once in 750 µl PE buffer (Qiagen, West Sussex, UK), 
before centrifugation at 13,200 rpm for 1 minute. After centrifugation the flow-through 
was discarded and the QIAquick spin column inside 2 ml collection tube was further 
spun at 13,200 rpm for 1 minute to completely dry the filter. After centrifugation the 2 
ml collection tube was discarded and the QIAquick spin column (Qiagen, West Sussex, 
UK) was placed in a clean 1.5 ml microcentrifuge tubes (Eppendorf, Cambridge, UK). 
To elute bound DNA, 20-30 µl of dH2O (nuclease-free water, Sigma-Aldrich, Dorset, 
UK) were added to the centre of the QIAquick spin column (Qiagen, West Sussex, UK) 
and let to stand for 1 min, before centrifugation at 13,200 rpm for 1 minute. After 
centrifugation the QIAquick spin column (Qiagen, West Sussex, UK) was discarded and 
the eluted DNA (20-30 µl) was collected in the 1.5 ml microcentrifuge tube (Eppendorf, 
Cambridge, UK). 
 
2.11.6.2 Calculation of the total number of copies in the purified qPCR product 
Purified DNA concentration was measured using 2 µl from the eluted DNA (20-30 µl) 
and a NanoDrop
TM
 ND-1000 Spectrophotometer (ThermoScientific, Cambridgeshire, 
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UK) as described in Section 2.3.2, of which ideally the concentration should be above 
15 ng/µl.  
 
Purified DNA concentration was used to calculate the absolute copy number of 
amplified qPCR products contained in the remaining eluted DNA sample (18-28 µl; 2 µl 
used for DNA concentration measurement) using the equation below (based on the 
Avogadro’s constant where 1 mole 6.02 x 10
23
):  
 
 
 
- base pair: qPCR product size, product length i.e. GLI2 a/β amplicon size 194 bp  
- 660 g/mole: average weight of one bp 
- 1x109 ng/g: in order to convert g/mole into ng/mole 
- DNA conc. (ng/µl): concentration of the eluted DNA 
- vol. (µl): qPCR template volume (eluted DNA volume) 
 
 
2.11.6.3 Standard serial dilutions 
To make standard dilution series of the of the purified qPCR product, a stock solution of 
a concentration of 10
11
 copies per 2 µl (because 2 µl will be used for qPCR reaction (see 
Section 2.11.6.4) by multiplying the number of copies of template in the sample (see 
Section 2.11.6.2) by 2, then dividing by 10
11
copies  minus the original volume (18-28 
µl) in order to obtain the volume of nuclease-free dH2O (Sigma-Aldrich, Dorset, UK) 
needed to be added to make 10
11
 copies/2 µl concentration stock. This was made by 
using the following equation:  
 
 
 
 
 
Number of molecules or 
number of copies of 
template in the sample. 
6.02 x 1023 molecules/mole
(base pair) (660 g/mole of base pair) (1x109 ng/g)
x DNA conc. (ng/µl) x vol. (µl) = 
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Then the 10
11
 copies/2 µl concentration stock was diluted using 25 µg/ml tRNA (Sigma-
Aldrich, Dorset, UK; 25 µg/ml: 25 µl from stock 10 mg/ml tRNA into 10 ml dH2O -
nuclease-free (Sigma-Aldrich, Dorset, UK) to make 250 µg/10ml or 25 µg/ml solution 
(1:400 dilution) and kept it at -20
o
C until required). tRNA was used as a DNA carrier in 
order to prevent the qPCR products from sticking to the walls of the 1.5 ml 
microcentrifuge eppendorf tubes (Eppendorf, Cambridge, UK).  The serial 100-fold and 
10-fold dilutions (10
2
 - 10
9 
cDNA copies/ 2 µl) of the 10
11
 copies/2 µl amplified qPCR 
products were prepared in tRNA carrier as follows: 
 
• 1011/2 µl (DNA copies/2 µl) stock. 
• To make 109/2 µl from 1011, 2 µl of 1011 were added into 198 µl tRNA (25 
µg/ml); 1:100 dilution. 
• To make 107/2 µl from 109, 2 µl of 109 were added into 198 µl tRNA (25 µg/ml); 
1:100 dilution. 
• To make 106/2 µl from 107, 20 µl of 107 were added into 180 µl tRNA (25 
µg/ml); 1:10 dilution. 
• To make 105/2 µl from 106, 20 µl of 106 were added into 180 µl tRNA (25 
µg/ml); 1:10 dilution. 
• To make 104/2 µl from 105, 20 µl of 105 were added into 180 µl tRNA (25 
µg/ml); 1:10 dilution. 
• To make 103/2 µl from 104, 20 µl of 104 were added into 180 µl tRNA (25 
µg/ml); 1:10 dilution. 
• To make 102/2 µl from 103, 20 µl of 103 were added into 180 µl tRNA (25 
µg/ml); 1:10 dilution. 
 
6.02 x 1014
(base pair) (660)
x DNA conc. x vol.     x 2
1011
- vol. = 
Volume required to dilute 
original stock DNA to give 
1011 per 2 µl concentration
Number of copies of template in the sample
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Standard dilution series were thoroughly mixed by vortexing stored at -20
o
C until 
required. 
 
2.11.6.4 Standard curve qRT-PCR reaction 
A qRT-PCR run was prepared, using the standard dilution series range of 10
2
-10
6 
for 
each gene. A single qRT-PCR reaction was prepared as follows:  
 
Component                                      Amount 
2x SYBR Green I MASTER  4 µl 
5 µM F/R Primer    1 µl 
dH2O (nuclease-free water)  4.5 µl (0.5 µl extra to correct for pipetting error) 
 
Master Mix    9.5 µl 
 
Only 9 µl were used from the master mix to correct for pipetting error, and were added 
on top of the template cDNA. 
 
Master Mix    9 µl 
Template cDNA   2 µl 
 
Total volume/well 10 + 1 µl (1 µl extra to compensate for 
evaporation during preparation) 
 
First, standards were defrosted and mixed thoroughly by vortexing, before loading 2 µl 
of the template cDNA in each well of the 96-well plate (Roche, Burgess Hill, UK). An 
extra well with 2 µl of nuclease-free dH2O (Sigma-Aldrich, Dorset, UK) instead of 
template cDNA was loaded as a negative control. After the master mix was prepared, it 
was thoroughly mixed by vortexing and then 9 µl were used for each sample and for 
negative control. Next, the plate was covered with a sealing foil provided by Roche, 
Burgess Hill, UK, and was centrifuged for 30 sec at 3,000 rpm (centrifuge plate for 30 
sec using a bench top centrifuge and hold down the quick spin button for 30 sec until 
reaches the 3,000 rpm), prior to starting the absolute quantitative Real Time-PCR (qRT-
PCR) run on Light Cycler
® 
480 instrument (Roche, Burgess Hill, UK). The samples 
Chapter 2: Materials and Methods 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 209 
were run on a typical qRT-PCR amplification protocol as described in Section 2.11.4 
and Table 2.2. 
 
Amplification curves for each dilution series were obtained (see Chapter 3, Section 
3.2.1.3, Figure 3.2B iii) and standard curves for each given gene were thus calculated 
by the LightCycler
®
 480 qPCR software program (Roche, Burgess Hill, UK) (see 
Chapter 3, Section 3.2.1.3, Figure 3.2B iv), and were thereafter used for absolute copy 
number quantitative PCR (see Section 2.11.7). 
 
2.11.7 Gene Amplification by qRT-PCR 
All qRT-PCR experiments for the expression analysis of genes (gene amplification) 
used in this study were performed according to the protocols described in Section 
2.11.4 and Section 2.11.6.4. In addition all primers and primer sequences are listed in 
primer table (Table 2.3). 
 
Using the GeNorm algorithm analysis method (Vandesompele et al., 2002), and the 
LightCycler
®
 480 Relative Quantification Software program (Roche, Burgess Hill, UK) 
(with built-in multiple reference genes normalisation algorithm, Roche, Burgess Hill, 
UK), of the 8 reference genes (GAPDH, RPLPO, YAP1, UBC, HPRT1, POLR2A, 
ESD, 18S), two were identified as being most reliable and stable reference genes: 
polymerase (RNA) II (DNA directed) polypeptide A (POLR2A) and Yes-associated 
protein 1 (YAP1) across a large panel of normal and cancer human cells and tissues (the 
analysis of housekeeping genes was performed by Dr Muy-Teck Teh, Clinical and 
Diagnostic Oral Sciences, Institute of Dentistry, Barts and the London School of 
Medicine and Dentistry, London, UK (Gemenetzidis et al., 2009)). POLR2A and YAP1 
were used as reference genes for all subsequent qRT-PCR experiments to calculate 
target gene expression levels. Given that the LightCycler
®
 480 Relative Quantification 
Software program (Roche, Burgess Hill, UK) was fast, convenient and produces highly 
similar results to the GeNorm analysis method, all subsequent data analysis was 
performed using the LightCycler
®
 480 qPCR software program (Roche, Burgess Hill, 
UK) to expedite work flow. Samples were analysed in triplicates and values of 
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statistical significance were calculated using GraphPad’s InStat Software (V2-04a; 
Graph-Pad Software, San Diego, CA) for student’s t test analysis (see Section 2.16).  
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Table 2.3: Primer table.      * N/A: Non/Applicable 
 
Genes Forward (F) and Reversed (R) 
Primer Nucleotide Sequence (5’-3’) 
Product (bp) 
BCL2-F 
BCL2-R 
TGGACAACCATGACCTTGGACAATCA 
TCCATCCTCCACCAGTGTTCCCATC 
198 
CDKN1A-F 
CDKN1A-R 
*N/A. Commercially available  
by Qiagen, West Sussex, UK  
Cat. No: QT00062090 
79 
c-MYC-F 
c-MYC-R 
TTTTTCGGGTAGTGGAAAACC 
GAGGTCATAGTTCCTGTTGGTG 
80 
E-Cadherin-F 
E-Cadherin-R 
GAACGCATTGCCACATACAC 
AGCACCTTCCATGACAGACC 
160 
GLI2 α/β-F 
GLI2 α/β-R 
GGGTCAACCAGGTGTCCAGCACTGT 
GATGGAGGGCAGGGTCAAGGAGTTT 
194 
GLI2-F 
GLI2-R 
*N/A. Commercially available  
by Qiagen, West Sussex, UK  
Cat. No: QT00018648 
116 
Integrin β1-F 
Integrin β1-R 
CGATGCCATCATGCAAGT 
AGTGAAACCCGGCATCTG 
95 
IVL-F 
IVL-R 
TGCCTGAGCAAGAATGTGAG 
TTCCTCATGCTGTTCCCAGT 
83 
POLR2A-F 
POLR2A-R 
GCAAATTCACCAAGAGAGACG 
CACGTCGACAGGAACATCAG 
72 
SNAIL1-F 
SNAIL1-R 
GCTGCAGGACTCTAATCCAGA 
ATCTCCGGAGGTGGGATG 
84 
SNAIL2-F 
SNAIL2-R 
ACAGCGAACTGGACACACAT 
GATGGGGCTGTATGCTCCT 
113 
SOX2-F 
SOX2-R 
GGGGGAATGGACCTTGTATAG 
GCAAAGCTCCTACCGTACCA 
85 
WNT11-F 
WNT11-R 
TGTGCTATGGCATCAAGTGG 
GCACCTGTGCAGACACCA 
108 
WNT5A-F 
WNT5A-R 
*N/A. Commercially available  
by Qiagen, West Sussex, UK  
Cat. No: QT00025109 
105 
WNT7A-F 
WNT7A-R 
GGGACTATGAACCGGAAAGC 
CCAGAGCTACCACTGAGGAGA 
103 
YAP1-F 
YAP1-R 
CCCAGATGAACGTCACAGC 
GATTCTCTGGTTCATGGCTGA 
82 
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2.11.8 Gene Amplification by semi-quantitative PCR 
Semi-quantitative PCR analysis was performed in Verity 96-well Thermal Cycler 
(Applied Biosystems, Carlsbad, CA) for the visualisation of GLI2 (whole gene 
amplification or α/β isoform specific amplification) gene mRNA expression. The cDNA 
template samples were prepared in 0.2 ml PCR tubes (Eppendorf, Cambridge UK) for 
ease of use. The PCR reaction for each gene was prepared as previously described in 
Section 2.11.4 and Section 2.11.6.4. Each PCR reaction therefore contained the 
following: 
 
Component                                      Amount 
2x SYBR Green I MASTER  4 µl 
5 µM F/R Primer    1 µl 
dH2O (nuclease-free water)  4.5 µl (0.5 µl extra to correct for pipetting error) 
 
Master Mix    9.5 µl 
 
Only 9 µl were used from the master mix to correct for pipetting error, and were added 
on top of the template cDNA. 
 
Master Mix    9 µl 
Template cDNA   2 µl 
 
Total volume/PCR tube 10 + 1 µl (1 µl extra to compensate for 
evaporation during preparation) 
 
First, 2 µl of the template cDNA were loaded in each 0.2 ml PCR tubes (Eppendorf, 
Cambridge UK). An extra 0.2 ml PCR tube (Eppendorf, Cambridge UK) with 2 µl of 
nuclease-free dH2O (Sigma-Aldrich, Dorset, UK) instead of template cDNA was also 
prepared as a negative control. After the master mix was prepared, it was thoroughly 
mixed by vortexing and then 9 µl were used for each sample and for negative control. 
Next, samples were run on the same PCR amplification protocol as previously described 
in Section 2.11.4, Table 2.2 with the only difference that the thermal cycles were 
reduced to 36 for GLI2 full-length and POLR2A, and to 27 and 30 for GLI2 a/β and 
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POLR2A respectively,  to avoid saturation of PCR product amplification. Once the PCR 
thermal cycles were finished, the samples were maintained at a constant temperature of 
4
o
C until they were used for agarose gel electrophoresis in order to visualise the 
expression levels of each gene as described in Section 2.11.5. The whole volume of the 
PCR reaction (10 µl) was loaded on 2% agarose gel following 1:1 ratio with 2x loading 
dye buffer (see Appendix I) (10 µl of PCR product + 10 µl of 2x loading dye buffer). 
All samples were run against 1 Kb plus DNA ladder (Invitrogen, Paisley, UK) at a 
constant voltage of 120 V for ~ 30 min, until DNA separation was evident. PCR 
products were visualised by UV light and a gel image was captured in the Autochemi 
imaging system (UVP, Upland, CA). 
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2.12 Protein extraction and Western Blotting analysis 
Different methods of protein isolation were utilised, depending on the distribution of the 
protein in the cell. Two different buffers where used for total protein isolation, including 
mainly 1x RIPA buffer (which is a very strong lysis buffer) and 1x Reporter Lysis 
Buffer (Promega, Southampton, UK) (a weaker reporter lysis buffer) in some cases. For 
nuclear and cytosolic protein isolation, the Nuclear Extraction Kit (Imgenex, San Diego, 
CA) was chosen for β-catenin protein analysis, since β-catenin is located in the 
membrane and the cytoplasm (where it is degraded) and upon activation of WNT 
signalling pathway it accumulates in the cytoplasm and translocates to the nucleus and 
forms a complex with TCF/LEF transcription factor and thus activates transcription of 
target genes. 
 
2.12.1 Total Protein Extraction from cultured cells 
For total protein extraction, equal number 3x10
5 
- 1x10
6
 of N/TERT, SINCE, and 
SINEG2 cells were seeded in 10 cm dishes, and harvested either 24, 48 or 72 hr after 
plating (semi-confluent). Similarly, equal number 3x10
5
 or 1x10
5
 of N/TERT and 
NTEG2 cells were seeded in 10 cm dishes, and harvested either 72 hr or 6 days after 
plating, respectively (semi-confluent) (48 hr or 5 days after doxycycline removal 
respectively). Doxycycline was removed in all NTEG2 cells 24 hr after plating (NTEG2 
Dox-).  
 
Total cell proteins were extracted from cultured cells in 1x RIPA buffer. Culture media 
was aspirated from cells in 10 cm petri dishes, and cells were washed twice in ice-cold 
10 ml PBS (Appendix I), and then incubated in ice-cold 100-500 µl 1x RIPA buffer (50 
mM Tris base, pH 7.3, 150 mM NaCl, 0.1% (v/v) SDS, 1% (v/v) Nonidet P-40, 10 mM 
sodium orthovanadate (Na3VO4 - phosphatase inhibitor); all from Sigma-Aldrich, 
Dorset, UK) (see Appendix I) (lysis buffer volume was depending on the confluence of 
the cells). Lysis buffer also contained freshly added protease inhibitor cocktail 1x CM 
EDTA-free (complete mini EDTA-free protease inhibitor cocktail tablets, Roche 
Diagnostics, Burgess Hill UK) (see Appendix I), to prevent degradation of proteins of 
interest by proteases after cell lysis. Cells were kept on ice for 20 minutes prior to 
collecting the cell lysates. The protein was harvested, by scraping, in 1.5 ml 
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microcentrifuge tubes (Eppendorf, Cambridge, UK), and cell lysates were then 
centrifuged at 14,000 rpm at 4°C for 20 min in a microcentrifuge, to remove cell debris. 
Supernatants were then collected as whole protein lysates and transferred to clean in 1.5 
ml microcentrifuge tubes (Eppendorf, Cambridge, UK). The supernatants were snap 
frozen in dry ice before being stored at -80°C until required. The protein concentration 
of the supernatant was determined by using Dc Protein Assay Kit (BioRad, 
Hertfordshire, UK) (Section 2.12.4.2). 
 
Alternatively, total cell proteins were extracted from cultured cells in 1x Reporter Lysis 
Buffer (Promega, Southampton, UK). Culture media was aspirated from cells in 10 cm 
petri dishes, and cells were washed twice in ice-cold 10 ml PBS (Appendix I), and then 
incubated in 100-300 µl 1x Reporter Lysis Buffer (Promega, Southampton, UK) (for 1 
ml 1x Reporter Lysis Buffer; 200 µl 5x Reporter Lysis Buffer (Promega, Southampton, 
UK) diluted in 800 µl sterile distilled water (PAA, Somerset, UK) - 1:5 dilution) (lysis 
buffer volume was depending on the confluence of the cells). Lysis buffer also 
contained freshly added protease inhibitor cocktail 1x CM EDTA-free (complete mini 
EDTA-free protease inhibitor cocktail tablets, Roche Diagnostics, Burgess Hill UK) 
(see Appendix I). Cells were kept on ice for 20 minutes prior to collecting the cell 
lysates. The protein was harvested, by scraping, in 1.5 ml microcentrifuge tubes 
(Eppendorf, Cambridge, UK), and cell lysates were then centrifuged at 14,000 rpm at 
4°C for 20 min in a microcentrifuge, to remove cell debris. Supernatants were then 
collected as whole protein lysates and transferred to clean in 1.5 ml microcentrifuge 
tubes (Eppendorf, Cambridge, UK). The supernatants were snap frozen in dry ice before 
being stored at -80°C until required. The protein concentration of the supernatant was 
determined by using the Bio-Rad Protein Assay System (BioRad, Hertfordshire, UK) 
(Section 2.12.4.2). 
 
2.12.2 Total Protein Extraction from UV and non-UV treated cells 
For total protein extraction, equal number 3x10
5
 of N/TERT, SINCE, and SINEG2 cells 
were seeded in 6 cm dishes, and were either mock treated or UVB treated 24 or 48 hr 
after plating (semi-confluent) (see Section 2.13). 24 hr after UVB treatment, mock and 
UVB treated cells were harvested.  
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Total cell proteins were extracted from UV and non-UV treated cultured cells in 1x 
RIPA buffer. For the extraction of total protein from UV irradiated cells (see Section 
2.13), culture media from each of the 6 cm petri dishes were collected to include any 
dead or apoptotic cells that may be floating in the medium following irradiation. Control 
non-UV treated cells were processed similarly. Therefore, supernatants (culture media) 
were collected in 15 ml falcon tubes and cells were centrifuged at 1,100 rpm for 5 
minutes. At the same time, the culture dishes were placed on ice and the cells attached 
in the 6 cm petri dishes were washed with 5 ml of ice-cold PBS (Appendix I) and were 
lysed in 50-100 µl of ice-cold 1x RIPA buffer (see Appendix I), (lysis buffer volume 
was depending on the confluence of the cells). Lysis buffer also contained freshly added 
protease inhibitor cocktail 1x CM EDTA-free (complete mini EDTA-free protease 
inhibitor cocktail tablets, Roche Diagnostics, Burgess Hill UK) (see Appendix I). Once 
the centrifugation of floating dead cells was finished, the supernatant was discarded and 
cells were washed with 5 ml of ice-cold PBS and cells were spun again at 1,100 rpm for 
5 minutes. The supernatant was discarded and the cell pellet was directly lysed by the 
addition of 50-100 µl ice-cold 1x RIPA buffer (see Appendix I), containing also a 
freshly added protease inhibitor cocktail 1x CM EDTA-free (complete mini EDTA-free 
protease inhibitor cocktail tablets, Roche Diagnostics, Burgess Hill UK) (see Appendix 
I). The solution was mixed thoroughly by repeated pipetting. The lysed pellets were 
now added to the 6 cm culture dishes, which contain the previously lysed attached cells 
(total 100-200 µl ice-cold 1x RIPA buffer, depending on confluence). The culture dishes 
were incubated on top of ice for an additional 20 minutes for complete lysis. The protein 
was harvested, by scraping, in 1.5 ml microcentrifuge tubes (Eppendorf, Cambridge, 
UK), and cell lysates were then centrifuged at 14,000 rpm at 4°C for 20 min in a 
microcentrifuge, to remove cell debris. Supernatants were then collected as whole 
protein lysates and transferred to clean in 1.5 ml microcentrifuge tubes (Eppendorf, 
Cambridge, UK). The supernatants were snap frozen in dry ice before being stored at -
80°C until required. The protein concentration of the supernatant was determined by 
using Dc Protein Assay Kit (BioRad, Hertfordshire, UK) (Section 2.12.4.2). 
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2.12.3 Subcellular Protein Extraction from cultured cells 
Cells for whole protein extraction and cells for subcellular fractionation were cultured at 
the same time in separate 10 cm dishes, for each experiment. When cells reached 50-
70% confluence they were harvested for whole protein (half of the 10 cm dishes) using 
1x RIPA buffer, containing also a freshly added protease inhibitor cocktail 1x CM 
EDTA-free (complete mini EDTA-free protease inhibitor cocktail tablets, Roche 
Diagnostics, Burgess Hill UK) (Appendix I) as described in Section 2.12.1, while 
fractionation was performed in the cells in the remaining 10 cm dishes, by sequential 
extraction of cytosolic and nuclear proteins using the Nuclear Extraction Kit (Imgenex, 
San Diego, CA). 
 
Culture media was aspirated from cells in each 10 cm petri dish, and cells were washed 
twice with 5 ml of ice-cold 1x PBS/PMSF (Imgenex, San Diego, CA) (see Appendix I). 
Cells were harvested by scraping from the 10 cm petri dishes and were transferred in 15 
ml falcon tubes, followed by centrifugation at 1,000 rpm for 5 minutes in a cold 
centrifuge. After centrifugation, the supernatant was discarded and the pellet from each 
10 cm dish was kept in ice.  
 
In order to obtain the cytoplasmic fraction, the pellet was resuspended in 1 ml of ice-
cold  1x Hypotonic Buffer (Imgenex, San Diego, CA) (see Appendix I) by pipetting up 
and down several times and was transferred to a pre-chilled 1.5 ml microcentrifuge tube 
(Eppendorf, Cambridge, UK). The resuspended cells were kept on ice for 15 min. Then 
50 µl of detergent solution (Imgenex, San Diego, CA) was added to the resuspended 
cells and cells were vortexed vigorously for 10 sec. The cells were centrifuged for 30 
sec at 14,000 rpm at 4°C in a microcentrifuge. The supernatant, which is the 
cytoplasmic fraction, was carefully removed into a pre-chilled 1.5 ml microcentrifuge 
tube (Eppendorf, Cambridge, UK) and stored at -80°C until required. The remaining 
pellet is the nuclear fraction. 
 
In order to collect the nuclear fraction, the nuclear pellet was resuspended in 100 µl 
Nuclear Lysis Buffer (Imgenex, San Diego, CA) (see Appendix I) by pipetting up and 
down. The suspension was vortexed vigorously and was incubated at 4°C for 30 
minutes on a rocking platform. After incubation, the suspension was vortexed again for 
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30 sec and was centrifuged at 14,000 rpm for 10 min at 4°C in a microcentrifuge. Then 
the supernatant, which is the nuclear fraction, was transferred into a pre-chilled 1.5 ml 
microcentrifuge tube (Eppendorf, Cambridge, UK) and stored at -80°C until required. 
 
2.12.4 Protein measurement using colorimetric assays and spectrometry 
2.12.4.1 Spectrometry 
Spectrometry is widely used for the accurate determination of the concentration of a 
given chemical. The instrument that is commonly used to measure the amount of protein 
in a given solution is the spectrophotometer, or a microplate reader. The measurement 
of concentration of a given substance relies on the property of chemical structures to 
absorb light (absorption). Absorption refers to the physical process of absorbing light 
(electromagnetic energy) and is the way by which the energy of a photon is taken up by 
matter, typically the negatively charged electrons of an atom (basic unit of matter). 
Absorption is mathematically quantified as absorbance (or optical density) and is 
calculated by the detection instrument. A light source illuminates the sample of interest 
with a specified wavelength (maximum absorbance wavelength) (i.e. specified by a 
monochromator) and a light detector which is placed on the other side of the beam and 
measures how much of the initial light is transmitted through the actual sample and 
therefore, how much of the initial light is absorbed by the sample. The amount of light 
absorbed is therefore proportional to the amount of the chemical compound present in 
the sample. This method has many applications including the detection of protein and 
nucleic acid concentrations.  
 
2.12.4.2 Colorimetric assays and protein measurement 
Assays for the detection of protein are also known as colorimetric assays and their 
detection requires the presence of light in the visible spectrum 380-700 nm. For 
example, Bio-Rad Protein Assay System (Bradford assay) (BioRad, Hertfordshire, UK) 
can be used for the determination of protein concentration by using a standard 
spectrophotometer or microplate reader (see Section 2.12.4.1) which illuminates the 
samples with a light at 595 nm wavelength. The determination of protein concentration 
is based on the absorbance of Coomassie
®
 Brilliant Blue G-250 dye - green colour - 
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(Bio-Rad Protein Assay Reagent, BioRad, Hertfordshire, UK) which changes to blue by 
binding to protein in the sample. The bound, and therefore blue, form of the dye has a 
maximal absorption rate at 595 nm. Therefore the increase of absorbance is proportional 
to the amount of bound dye (blue) and therefore to the amount of protein present in the 
original sample. Similar to this principle, the Dc Protein Assay Kit (BioRad, 
Hertfordshire, UK) is based on the reaction of protein with an alkaline copper tartrate 
solution and Folin reagent which leads to the development of blue colour with 
maximum absorbance at 750 nm (also measured at 650 nm).   
Protein concentrations were measured either using the Bio-Rad Protein Assay System 
(Bradford Assay) (BioRad, Hertfordshire, UK) or the Dc (Detergent compatible) protein 
Assay Kit (BioRad, Hertfordshire, UK), depending on which extraction buffer was 
used. 
Protein concentrations of cell lysates harvested in 1x Reporter Lysis Buffer (Promega, 
Southampton, UK) were measured using the Bio-Rad Protein Assay System (BioRad, 
Hertfordshire, UK). First, a protein standard curve (Figure 2.9A) was generated by 
using bovine serum albumin (BSA) protein samples (New England Biolabs (NEB), 
Manchester, UK) of known concentrations, which had been diluted in the same lysis 
buffer (1x Reporter Lysis Buffer, Promega, Southampton, UK) as the samples to be 
analysed. Stock BSA concentration 10 mg/ml (NEB, Manchester, UK) was diluted 1:10 
(1 mg/ml) in 1x Reporter Lysis Buffer (Promega, Southampton, UK); 100 µl BSA stock 
+ 900 µl 1x Reporter Lysis Buffer = 1 ml total volume, and was aliquoted in 100 µl per 
1.5 ml microcentrifuge tubes (Eppendorf, Cambridge, UK) which were either kept in ice 
or being stored at -80
o
C until required. Next, the 5x Bio-Rad Protein Assay Reagent 
(Bio-Rad Protein Assay System, Hertfordshire, UK) was diluted in dH2O (6 ml of 5x 
Bio-Rad Protein Assay Reagent in 24 ml dH2O). A series of different protein dilutions 
in a final volume of 2 ml was made to contain the following concentrations: 0, 1, 2, 4, 8, 
12, 16, 20, 30, and 40 µg/2 ml. A sample protein dilution, prepared in a 15 ml falcon 
tube, contained the following: 2 µl BSA (1 µg/µl) + 2 µl 1x Reporter Lysis Buffer + 2 
ml of 1x Bio-Rad Protein Assay Reagent, to give for example a concentration of 2 µg/2 
ml (1 µg/ml). All samples were thoroughly mixed by vortexing and were incubated for 
10 minutes at room temperature. The intensity of the solution colour in each 15 ml 
falcon tube was proportional to the amount of protein. Next, samples were transferred 
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from the 15 ml falcon tubes to 1.5-3.0 ml cuvettes (Plastibrand, Sigma-Aldrich, Dorset, 
UK) and the absorbance (optical density) of each sample was measured at 595 nm at a 
Beckman Coulter DU800 spectrophotometer (Beckman Coulter, High Wycombe, UK). 
After obtaining absorbance values, a standard curve was plotted (where x = BSA 
protein concentration (µg/2 ml) and y = absorbance (optical density) at 595 nm), and the 
equation of the line of the best fit was acquired from Microsoft Excel, as well as the R
2
 
value which is a quantitative value known as goodness of fit. R
2
 values close to 1 
indicate a good fit (Figure 2.9A).  
To measure the protein concentration in unknown samples, 2 µl of protein lysates were 
mixed with 2 µl of 1x Reporter Lysis buffer (Promega, Southampton, UK) and 2 ml of 
1x Bio-Rad Protein Assay Reagent (BioRad, Hertfordshire, UK). Next, the same 
procedure as the one mentioned above was followed. After obtaining absorbance values 
for all unknown samples, the standard curve equation (i.e. y = 0.031x; where y is the 
optical density and x is the quantity of protein) (Figure 2.9A) was used to calculate the 
amount of protein that was initially present in 2 ml of solution. Since 2 µl of the protein 
lysate were initially added, the protein concentration of unknown samples (mg/ml or 
µg/µl) was deduced. For example, if absorbance = 0.465, then the protein contained in 2 
ml of solution is 15 µg (according to equation x = 0.465/0.031). If 2 µl of lysate were 
initially added, then protein concentration of unknown sample is 15 µg / 2 µl = 7.5 
µg/µl. 
Protein concentrations of cell lysates harvested in 1x RIPA buffer, Hypotonic and 
Nuclear Buffers (Imgenex, San Diego, CA) were measured using the Dc Protein Assay 
Kit (BioRad, Hertfordshire, UK). First, a protein standard curve (Figure 2.9B) for each 
buffer was generated by using bovine serum albumin (BSA) protein samples (NEB, 
Manchester, UK) of known concentrations which had been diluted in the same lysis 
buffer as the samples to be analysed. First, BSA protein samples of different 
concentrations (final volume of 10 µl in lysis buffer) were added in each of 10 wells of 
a clear, flat bottomed 96-well plate (Nunc, Roskilde, Denmark). The BSA protein 
amounts (1 mg/ml; prepared from a 10 mg/ml stock solution as I described above using 
the appropriate lysis buffer) that were used in each well were as follows: 0, 0.5, 1, 1.5, 
2, 3, 4, 5, 6, 7, 8 and 9 µg. A sample protein dilution, prepared in a 1.5 ml 
microcentrifuge eppendorf tube (Eppendorf, Cambridge, UK), contained the following: 
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2 µl BSA (1 µg/µl) + 8 µl lysis buffer, to give for example a concentration of 2 µg/10 µl 
or 0.2 µg/µl. Next, 25 µl of Reagent A (Reagent A; 20 µl Reagent S for each ml of 
Reagent A, i.e. Reagent S 20 µl + Reagent A 980 µl = 1 ml Reagent A, Dc Protein 
Assay Kit, BioRad, Hertfordshire, UK) was added in each well. Following gentle 
rocking, 200 µl of Reagent B (Dc Protein Assay Kit, BioRad, Hertfordshire, UK) were 
added on top and mixed well. Plates were then incubated at room temperature for 15 
minutes, prior to measuring the absorbance (optical density) of each sample. The 
intensity of the solution colour in each well was proportional to the amount of protein. 
Thus, absorbances were measured at 650 nm in VICTOR
2 
Multilabel Counter; Wallac 
Oy, Turku,
 
Finland. After obtaining absorbance values, a standard curve was plotted 
(where x = BSA protein concentration (µg/10 µl) and y = absorbance (optical density) at 
650 nm), and the equation of the line of the best fit was acquired from Microsoft Excel, 
as well as the R
2
 value (Figure 2.9B).  
To measure the protein concentration in unknown samples, 1 or 2 µl of protein lysates 
were mixed with 9 or 8 µl of lysis buffer respectively (total volume 10 µl). Next, the 
same procedure as the one mentioned above was followed. After obtaining absorbance 
values for all unknown samples, the standard curve equation (i.e.  y = 0.0205x + 0.0385; 
where y is the optical density and x is the quantity of protein) (Figure 2.9B) was used to 
calculate the amount of protein that was initially present in 10 µl of lysis buffer. 
According to whether 1 or 2 µl of the protein lysate was added, the protein 
concentration of unknown samples (mg/ml or µg/µl) can be deduced. For example, if 
absorbance = 0.125, then the protein contained in 10 µl of solution is 4.2 µg (according 
to equation x = (0.125-0.0385) / 0.0205). If 2 µl of lysate were initially added, then 
protein concentration of unknown sample is 4.2 µg / 2 µl = 2.1 µg/µl. 
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Figure 2.9: Protein concentration standard curves. 
(A) Example of a Bio-Rad Protein Assay standard curve. (B) Example of a Dc Protein Assay 
standard curve. 
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2.12.5 Western Blotting analysis 
Western blotting can be used to estimate the abundance of a specific protein in a cellular 
sample. Following extraction, proteins are firstly denatured to break any protein-protein 
interactions. Then, denatured proteins are run in a sodium dodecyl sulphate (SDS) gel 
which allows their efficient separation according to their molecular size. SDS applies a 
negative charge to denatured proteins on the gel, thus allowing the protein to be 
separated in the polyacrylamide gel by means of electrophoresis. When proteins are 
sufficiently separated on the SDS-polyacrylamide gel, they are then transferred to 
nitrocellulose membranes which are specialised membranes, with a high affinity for 
protein binding. Since SDS applies a negative charge to separated proteins on the gel, it 
allows the protein to be transferred from the SDS-polyacrylamide gel to the membrane 
by means of electrophoresis. Following transfer, the protein of interest can be accurately 
detected by incubating the membrane with a highly specific antibody (primary 
antibody) raised against the protein of interest. Next, a secondary antibody raised in the 
same species as the primary one, is used in order to detect the primary antibody, which 
is now bound on the protein of interest. Secondary antibodies are typically coupled to 
horseradish peroxidase (HRP) for their easy detection.  Bound secondary antibodies can 
therefore be detected by chemi-luminescence due to a chemical reaction with the 
addition of ECL plus (GE Healthcare, Buckinghamshire, UK). Chemiluminescence is 
the emission of light as a result of a chemical reaction and it differs from fluorescence 
(see Section 2.8.1.1) in that the electronic excited state is derived from the product of a 
chemical reaction, rather than the more typical way of creating electronic excited states 
namely absorption (see Section 2.12.4.1). HRP reacts with a lumigen PS-3 acridan 
substrate in the ECL plus solution and converts it to an acridinium ester intermediate. 
The ester intermediate reacts with peroxide in alkaline conditions to emit a light signal 
that is detected using an autoradiography film  (Veitch, 2004). 
 
2.12.5.1 SDS-Polyacrylamide Gel Electrophoresis (PAGE) 
Extracted proteins were diluted in 5x SDS sample buffer (0.31 M Tris-HCl, pH 6.8, 
0.25 M DTT (dithiothreitol), 0.1% (v/v) Bromophenol Blue, 50% (v/v) Glycerol, 10% 
(w/v) SDS; all supplied by Sigma-Aldrich, Dorset, UK) (see Appendix I) and briefly 
denatured for 5 min at 100°C, before loading on either standard freshly made 8% or 
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10% SDS-polyacrylamide mini gels (with a 5% stacking gel) (see Appendix I) or pre-
cast 4-12% NuPAGE® (Invitrogen, Paisley, UK) mini gels. In most experiments the 
standard freshly made 8% or 10% SDS-polyacrylamide mini gels (with a 5% stacking 
gel) were used instead of the pre-cast 4-12% NuPAGE® (Invitrogen, Paisley, UK) mini 
gels. First, according to the protein concentration (µg/µl) obtained from protein 
measurement (Section 2.12.4) the amount of protein and of sample buffer was 
calculated as follows:  to load 5 µg per lane from a protein sample with 0.5 µg/µl protein 
concentration, 10 µl from the protein sample will be taken and will be mixed with 2.5 µl 
5x sample buffer (1:4 ratio; 10 µl lysate / 4 = 2.5 µl sample buffer) and were kept on ice 
until denaturation and loading step. Then, either a freshly made 8% or 10% SDS-
polyacrylamide mini gel (with a 5% stacking gel) (see Appendix I)  that was prepared 
in a Mighty Small dual gel Caster (Hoefer, Holliston, MA) or a pre-cast 4-12% 
NuPAGE® (Invitrogen, Paisley, UK) mini gel, were assembled into a Mighty Small II 
complete gel elecrophoresis tank (Hoefer, Holliston, MA) or into a Novex Mini-cell gel 
electrophoresis tank (Invitrogen, Paisley, UK), respectively, according to 
manufacturer’s instructions. The Mighty Small II complete gel elecrophoresis tank 
(Hoefer, Holliston, MA) was filled with standard 1x SDS based running buffer (25 mM 
Tris base, 192 mM Glycine, 0.1% SDS; all from Sigma-Aldrich, Dorset, UK) (1x SDS 
running buffer; 100 ml 10x SDS running buffer + 900 ml dH2O = 1 L) (see Appendix I) 
and the Novex Mini-cell gel electrophoresis tank (Invitrogen, Paisley, UK) with 
NuPAGE
®
 MES-SDS running buffer (Invitrogen, Paisley, UK). Equal protein amount 
(µg) (briefly denatured) for each sample, was loaded into the lanes of the gel, ranging 
from 2 µg up to 30 µg and in one case 60 µg. In addition, 10 µl of Precision Plus Protein 
(All Blue Standards) standard molecular weight marker (Bio-Rad Laboratories, 
Hertfordshire, UK) was loaded into one lane of the gel, in order to determine protein 
size. 
 
Gels were typically run (proteins were separated) at a constant rate of 90 V, until 
molecular weight marker (Precision Plus Protein All Blue Standards; Bio-Rad 
Laboratories, Hertfordshire, UK) separation was evident, after which point voltage was 
increased to 120 V until the dye front reached the base of the gel or even for longer if 
the protein of interest was of a high molecular weight. 
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2.12.5.2 Immunoblot analysis 
Proteins were then transferred from the either the SDS-polyacrylamide gel or from the 
pre-cast 4-12% NuPAGE® (Invitrogen, Paisley, UK) gel to a Hybond-C extra 
nitrocellulose membrane (Amersham, GE Healthcare, Buckinghamshire, UK) in a Bio-
Rad transfer tank (Bio-Rad Laboratories, Hertfordshire, UK) containing 1x Transfer 
Buffer (25 mM Tris base, 192 mM Glycine, 20% (v/v) methanol; all supplied by Sigma-
Aldrich, Dorset, UK, whereas methanol was obtained by Fisher, Leicestershire, UK) (1x 
Transfer buffer; 100 ml 10x Transfer buffer + 200 ml methanol + 700 ml dH2O = 1 L) 
(see Appendix I) at a constant current of 400 mA for 90 minutes or at constant 20 V for 
overnight transfer at 4
o
C.  
After transfer, the membrane was removed and immediately immersed in 1x TBS (1x 
TBS; 100 ml 10x TBS + 900 ml dH2O = 1 L) or 1x TBS containing 0.1% Tween-20 
(Sigma-Aldrich, Dorset UK) (TBS/T; 1x TBS/T; 100 ml 10x TBS + 899 ml dH2O + 1 
ml Tween-20 = 1 L) (see Appendix I) or 1x PBS containing 0.1% Tween-20 (Sigma-
Aldrich, Dorset UK) (PBS/T; 1x PBS/T; 100 ml 10x PBS + 899 ml dH2O + 1 ml 
Tween-20 = 1 L) (see Appendix I) and kept in the fridge if not immediately used.  
The success of the transfer was estimated by checking that the protein marker was 
present on the membrane, as well as by performing Ponceau staining. Ponceau S 
(Sigma-Aldrich, Dorset UK) is a sodium salt routinely used for the rapid, but reversible, 
detection of protein bands on nitrocellulose membranes. To visualise protein, the 
nitrocellulose membrane was rinsed 2x with dH2O and was then immersed in Ponceau S 
(diluted 1:10 in dH2O) (Sigma-Aldrich, Dorset UK) for a few seconds until protein 
bands were visible. Next, the membrane was rinsed 2x in dH2O and then was 
thoroughly washed with TBS/T or PBS/T until no protein bands were anymore visible. 
Membrane was then stored for short time at 4
o
C in TBS, TBS/T or PBS/T for future 
use, or was immediately used for immunoblotting. 
The membrane was then blocked in 5% (w/v) non-fat dry milk in TBS, TBS/T or PBS/T 
(see Appendix I), according to Table 2.4, for 30 min at room temperature under 
continuous agitation on a rocking platform. The membrane has a high affinity for 
protein binding and therefore during membrane blocking, the milk proteins will cover 
all the sites of the membrane, which are not occupied by cellular proteins. This way, the 
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primary antibodies will not bind at non-specific sites of the membrane, and will thus 
only recognise the proteins of interest. 
Next, the membrane was probed with 6-10 ml of primary antibody diluted in either 3% 
milk TBS/T or PBS/T or 5% milk TBS, TBS/T or PBS/T, for 2 hours at room 
temperature or was incubated overnight at 4
o
C according to Table 2.4, under continuous 
agitation on a rocking platform. Primary antibodies used are listed in antibody table 
(Table 2.4). 
The membrane was washed 3x in 3% milk TBS/T or PBS/T or 5% milk TBS, TBS/T or 
PBS/T (same buffer as the primary antibody) for 5 minutes each wash, under continuous 
agitation on a rocking platform at room temperature, prior to incubation with secondary 
antibody. Secondary antibody was diluted in 12-15 ml of 3% milk TBS/T or PBS/T or 
5% milk TBS, TBS/T or PBS/T (same buffer as the primary antibody) and membranes 
were incubated under continuous agitation on a rocking platform for 1.5 hours at room 
temperature, according to Table 2.4. Secondary antibodies used were polyclonal rabbit 
anti-mouse immunoglobulin/HRP (DakoCytomation, Cambridgeshire, UK), polyclonal 
goat anti-rabbit immunoglobulin/HRP (DakoCytomation, Cambridgeshire, UK) and 
polyclonal rabbit anti-goat immunoglobulin/HRP (DakoCytomation, Cambridgeshire, 
UK).  
The membrane was washed again 3x for 5 minutes in 3% milk TBS/T or PBS/T or 5% 
milk TBS/T or PBS/T (same buffer as the primary antibody), under continuous agitation 
on a rocking platform at room temperature, except for the membrane probed for anti-
active-β-catenin antibody which was washed in TBS containing 0.05% Tween-20. The 
membranes were then rinsed 2 x with 1x TBS (1x TBS; 100 ml 10x TBS + 900 ml 
dH2O = 1 L) or 1x PBS (1x PBS; 100 ml 10x PBS + 900 ml dH2O = 1 L) (see 
Appendix I) prior to immunodetection.  
Immunodetection (visualisation of protein bands) was performed with enhanced chemi-
luminescence detection reagent ECL plus (Amersham, GE Healthcare, 
Buckinghamshire, UK) according to manufacturer’s instructions, using 1 ml of reagent 
per membrane. The membrane was wrapped in plastic bag (Medium Duty 250 Gauge 
Polythene, Layflat Tubing, Davpak, Derby, UK) and the resulting chemi-luminescence 
was visualised by exposing the membrane to light-sensitive Hyperfilm (Amersham, GE 
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Healthcare, Buckinghamshire, UK) for 1 sec to 30 min, depending on band intensity, in 
a dark room (illuminated by a safety light). The film was developed using a 
Hyperprocessor automatic autoradiography film processor (Amersham, GE Healthcare, 
Buckinghamshire, UK) or manually by immersing the film briefly in developer (Kodak, 
New York, USA), rinsing briefly in tap water and then immersing in fixer (Kodak, New 
York, USA), rinsing briefly in tap water and leaving it to dry. Following 
autoradiography the membrane was briefly washed 2 x in 1x TBS or 1x PBS (see 
Appendix I), before being stored in either 1x TBS or 1x PBS at 4
o
C.  
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Table 2.4: Antibodies and conditions for Western Blotting. 
 
Antigen 
Supplier and 
Antibody 
(Cat. No) 
Blocking 
conditions 
Primary antibody 
dilution,  dilution 
buffer and 
incubation 
Secondary  
antibody 
dilution,  
dilution buffer 
and incubation 
14-3-3σ 
14-3-3σ (N-14) 
sc-7681, goat 
polyclonal, 
Santa Cruz, 
Heidelberg, 
Germany 
5% milk PBS/T,  
30 min,  
*RT 
1:500 in  
5% milk PBS/T,  
overnight at 4
o
C  
1:2000 in  
5% milk PBS/T, 
1
1/2
 hr at RT 
Active-β- 
catenin 
Anti-Active-β- 
catenin (anti-
ABC), clone 
8E7,  
05-665, mouse 
monoclonal, 
Upstate,  
Lake Placid, 
NY, USA 
5% milk TBS,  
30 min,  
RT 
1:400 in  
5% milk TBS,  
overnight at 4
o
C  
1:1000 in  
5% milk TBS,  
1
1/2
 hr at RT 
BCL-2 
Bcl-2 (100) 
sc-509, mouse 
monoclonal, 
Santa Cruz, 
Heidelberg, 
Germany 
5% milk TBS/T,  
30 min,  
RT 
1:1000 in  
3% milk TBS/T,  
overnight at 4
o
C  
1:1000 in  
3% milk TBS/T,  
1
1/2
 hr at RT 
Caspase-3 
Caspase-3 
9662, rabbit 
polyclonal, 
Cell Signalling,  
Danvers, MA, 
USA 
5% milk TBS/T,  
30 min,  
RT 
1:1000 in  
5% milk TBS/T,  
overnight at 4
o
C  
1:5000 in  
5% milk TBS/T,  
1
1/2
 hr at RT 
c-MYC 
c-Myc (9E10) 
sc-40, mouse 
monoclonal, 
Santa Cruz, 
Heidelberg, 
Germany 
5% milk TBS/T,  
30 min,  
RT 
1:1000 in  
5% milk TBS/T,  
overnight at 4
o
C  
1:1000 in  
5% milk TBS/T,  
1
1/2
 hr at RT 
EGFP 
GFP 
ab-290, rabbit 
polyclonal, 
Abcam , 
Cambridge, 
UK 
5% milk PBS/T,  
30 min,  
RT 
1:1000 in  
5% milk PBS/T,  
2 hr at RT or 
overnight at 4
o
C 
1:1000 in  
5% milk PBS/T,  
1
1/2
 hr at RT 
GAPDH 
GAPDH 
ab9485, rabbit 
polyclonal, 
Abcam , 
Cambridge, 
UK 
5% milk TBS/T,  
30 min,  
RT 
1:1000 in  
5% milk TBS/T,  
2 hr at RT 
1:1000 in  
5% milk TBS/T,  
1
1/2
 hr at RT 
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GLI2 
GLI2 (H300) 
sc-28674, 
rabbit 
polyclonal, 
Santa Cruz, 
Heidelberg, 
Germany 
5% milk TBS/T,  
30 min,  
RT 
1:5000 or 
1:500 in  
3% milk TBS/T,  
overnight at 4
o
C  
1:2000 in  
3% milk TBS/T,  
1
1/2
 hr at RT 
Lamin-β1 
Lamin-β1 
sc-28674, 
rabbit 
polyclonal, 
Imgenex,  
San Diego,  
CA, USA 
5% milk TBS/T,  
30 min,  
RT 
1:500 in  
5% milk TBS/T,  
overnight at 4
o
C  
1:1000 in  
5% milk TBS/T,  
1
1/2
 hr at RT 
p21
WAF1/CIP1  
p21 (187) 
sc-817, mouse 
monoclonal, 
Santa Cruz, 
Heidelberg, 
Germany 
5% milk TBS/T,  
30 min,  
RT 
1:500 in  
3% milk TBS/T,  
overnight at 4
o
C  
1:1000 in  
3% milk TBS/T,  
1
1/2
 hr at RT 
p53 
p53 (DO1), 
mouse 
monoclonal,  
CRUK 
5% milk TBS/T,  
30 min,  
RT 
1:10000 in  
5% milk TBS/T,  
2 hr at RT 
1:1000 in  
5% milk TBS/T,  
1
1/2
 hr at RT 
β-actin 
Anti-β-actin 
(AC-15) 
A 1978, mouse 
monoclonal, 
Sigma-Aldrich, 
Dorset, 
UK 
5% milk TBS/T,  
30 min,  
RT 
1:100000 or 
1:1000000  in  
5% milk TBS/T,  
2 hr at RT 
1:1000 or 
1:2000 in  
5% milk TBS/T,  
1
1/2
 hr at RT 
β-catenin 
beta-catenin 
(CAT-5H10) 
13-8400, 
mouse 
monoclonal, 
Zymed, 
San Fransisco, 
CA, USA 
5% milk TBS/T,  
30 min,  
RT 
1:5000 in  
5% milk TBS/T,  
2 hr at RT 
1:1000 in  
5% milk TBS/T,  
1
1/2
 hr at RT 
*RT: Room Temperature 
 
2.12.5.3 Western Blot Membrane Stripping for Reprobing 
Hybond-C extra nitrocellulose membrane (Amersham, GE Healthcare, 
Buckinghamshire, UK) can be re-used to probe with other antibodies, for detection of 
another protein of interest, by stripping the membrane. Thus, an additional protein of a 
similar molecular size can be detected following the removal of the primary antibody 
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binding (membrane stripping). In addition, in case where a primary polyclonal antibody 
(less specific then monoclonal ones with multiple unspecific bands) is used, stripping is 
necessary to avoid background signal in subsequent blots, even if the molecular sizes of 
proteins of interest are completely different. This method is also used in the case where 
the second (‘new’) antibody to be used is raised in the same species as the ‘older’ one. 
Membrane stripping will thus clear the membrane of any primary antibody bound to its 
target proteins from the first immunoblotting, and will therefore prevent its repeated 
detection by the subsequent incubation with secondary antibody. This is particularly 
useful in cases of detection of housekeeping gene products, such as β-actin protein, 
which is used to confirm equal protein loading between samples. 
Previously probed membranes were stripped, by incubating the membrane with 15-20 
ml (sufficient volume to ensure that membrane is completely covered) Restore Plus 
Western Blot Stripping Buffer (Pierce, Thermo Fisher Scientific, Nortumberland, UK). 
Membranes were incubated in Restore Plus for 15-30 minutes at room temperature, 
followed by thorough washing 3x for 5 minutes in TBS/T or PBS/T at room 
temperature to completely remove the stripping buffer, under continuous agitation on a 
rocking platform. Membranes were then blocked and re-probed with primary and 
secondary antibody according to Section 2.12.5.2 and Table 2.4. 
 
 
2.13 UVB-irradiation 
Initially, the growth medium of semi-confluent (50-65%) cells grown in 6 cm or 10 cm 
dishes was aspirated. The culture dishes were then inserted in the ultraviolet cross-linker 
(UVP, Cambridge, UK) and the lids were removed. Cells were irradiated with UVB at 
different doses (10-30 mJ/cm
2
), and fresh growth medium was replaced immediately 
after UVB exposure. Routine calibration was performed to ensure UVB emission peak 
at 312 nm which is physiologically relevant to skin photobiology. Similar procedure 
was followed for the control cells except the UVB-exposure step (non-UVB treated 
control cells). 
 
UVB and non UVB-treated cells, 24 hours after UVB exposure, were either used for 
whole protein extraction (Section 2.12.2) followed by western blot analysis (Section 
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2.12.5) in order to check the levels of several cell cycle or apoptotic proteins such as 
p53, p21
WAF1/CIP1
, Bcl-2 and Caspase-3 (Section 2.12.5.2, Table 2.4), or were used for 
PI (Propidium Iodide) (Section 2.8.1.4) or Cy
TM
5 Annexin V antibody staining (Section 
2.8.1.5), both followed by flow cytometry analysis, in order to check apoptosis and cell 
death. 
 
 
2.14 M-FISH 
M-FISH (multiplex-fluorescent in situ hybridization) (Figure 2.10) is a molecular 
cytogenetic method that allows colour karyotyping of human chromosomes by painting 
each chromosome with a unique colour and thus allows the examination of the 24 
human chromosomes in metaphase cells (spectral karyotyping). The simultaneous and 
unequivocal discrimination of all human chromosomes in different colours is of great 
clinical importance and allows the cytogenetic analysis of numerical (i.e. aneuploidy) 
and structural (i.e. translocations, terminal and interstitial deletions, insertions, 
amplifications) chromosomal aberration in pre- and postnatal diagnostics and cancer 
cytogenetics (Schrock et al., 1996; Speicher et al., 1996; Speicher & Ward, 1996; 
McNeil & Ried, 2000; Strefford et al., 2001; Trask, 2002; Strachan & Read, 2004b). 
 
The M-FISH technique requires the preparation of metaphase chromosome spreads and 
the usage of a 24-colour chromosome painting probe. Thus, cells of interest need to be 
treated with colcemid in order to obtain metaphase cells. Colcemid, a closely related to, 
but less-toxic compound than colchicine, is a mitotic inhibitor, which inactivates spindle 
fiber formation (depolymerises microtubules and thus limits microtubule formation), 
and thus arresting cells in metaphase (chromosomes do not align in the spindle fiber and 
there is no chromosome segregation) (see Chapter 4, Section 4.2.6, Figure 4.19), 
allowing cell harvest and metaphase spread preparation and karyotyping to be 
performed (Taylor, 1965; Sluder, 1991; Rieder & Palazzo, 1992). 
 
Next, already prepared metaphase spreads are hybridised with the labelled DNA probe, 
the WCP
®
 (Whole Chromosome Paint) DNA probe (24-colour chromosome painting 
probe, combination of fluorophore-labelled painting probe), which involves the precise 
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annealing of denatured (single stranded) DNA probe to target chromosomal DNA in 
specimens that are fixed and mounted to slides (in situ hybridisation). The WCP
®
 DNA 
probes (Vysis, Abbott Molecular, Maidenhead Berkshire, UK) are directly labelled with 
five different fluorophores in a combinatorial labelling format to provide 24 distinct 
colours (one colour for each human chromosome) when analysed with SpectraVysion 
Imaging System (Vysis, Abbott Molecular, Maidenhead Berkshire, UK). Thus, once 
pure DNA (human chromosomes) has been isolated (i.e. through FACS), a 
fluorochrome must be incorporated into the DNA probe in a reaction known as labelling 
(i.e. probes can be labelled by using PCR) (Figure 2.10a) (McNeil & Ried, 2000; 
Trask, 2002). The fluorophores that are directly attached to the WCP
®
 DNA probes 
(Vysis, Abbott Molecular, Maidenhead Berkshire, UK) include: SpectrumAqua
TM
, 
SpectrumGreen
TM
, SpectrumGold
TM
, SpectrumRed
TM
 and SpectrumFRed
TM
. Cot-1
® 
DNA is also included in the probe mixture (24-colour chromosome painting probe, 
combination of fluorophore-labelled painting probe) to suppress the hybridisation of 
sequences that are common to various chromosomes (repetitive sequences of the 
genome) and thus to avoid non-specific hybridisation of the WCP
®
 DNA probe (Vysis, 
Abbott Molecular, Maidenhead Berkshire, UK) (Figure 2.10a). Cot-1
® 
DNA is 
enriched in repetitive sequences and by binding to repetitive sequences in the 
fluorescently tagged probes, it suppress their hybridisation to target chromosomes. 
 
Visualisation of the M-FISH hybridisation requires a fluorescence microscope with a set 
of optical filters spaced across the spectral interval 350-770 nm that give a high degree 
of discrimination between all possible fluorochrome pairs and a highly sensitive area 
imager, a camera. Thus, in order to evaluate a metaphase spread, six images are 
captured in six different filters (the five fluorochromes used for probe labelling and 
DAPI used to counterstain all chromosomes), and are analysed by a specific software, 
which generates a composite image in which each chromosome is given a different 
pseudocolour depending on the fluorophore composition (Figure 2.10b) and allows 
karyotyping (Schrock et al., 1996; Speicher et al., 1996; Trask, 2002; Strachan & Read, 
2004b). 
 
The M-FISH hybridisation and analysis for this study were performed in Dr Yong-Jie 
Lu’s laboratory at Centre for Molecular Oncology and Imaging, Institute of Cancer, 
Barts and the London School of Medicine and Dentistry, Charterhouse square, London. 
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Figure 2.10: Principle of M-FISH. 
(a) First, 24 flow-sorted human chromosomes (chromosomes 1-22, X and Y) are 
combinatorially labelled with at least one, and as many as five, fluorochrome combinations to 
create a unique spectral colour for each chromosome pair. Aliquotes of the ‘painted’ 
chromosomes are pooled together with an excess of Cot-1 DNA which is used to suppress 
repetitive sequences in the genome. The M-FISH probe mixture is then hybridised to a 
metaphase chromosome preparation at 37
o
C for 24-72 hours. Next, detection of the hybridised 
sample takes place by washing slides to remove unbound nucleotides and also by using DAPI 
counterstaining of chromosomes. Visualisation of the M-FISH hybridisation requires the use of 
a fluorescence microscope with a series of excitation and emission filters corresponding to 
different fluorochromes and a camera. Images for each metaphase spread are captured in five 
different filters and are analysed by a specific computer software, which generates a composite 
image, in which each chromosome is given a different pseudocolour depending on the 
fluorophore composition (b), as well as in DAPI filter. Modified from (McNeil & Ried, 2000; 
Trask, 2002). 
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2.14.1 Colcemid treatment of cells 
2.14.1.1 Colcemid treatment and cell cycle analysis  
N/TERT, SINCE and SINEG2 cells were plated at 7.8x10
5
 cells per 10 cm dish, in four 
replicates (a total of twelve 10 cm dishes containing 10 ml RM+ growth medium per 
dish) and incubated at 37
o
C in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) 
air. Medium was replaced every two days and 72 hours after plating (~ 60-75% 
confluent) N/TERT, SINCE and SINEG2 cells were either treated in duplicates for each 
cell line with 0.04 µg/ml colcemid (+) (Invitrogen, Paisley, UK) (4 µl from 10 µg/ml 
stock colcemid solution in HBSS-Hank’s Buffered Salt Solution (Invitrogen, Paisley, 
UK) in 1 ml RM+ growth medium; 1:250 dilution) for 2 hours and 15 minutes (six 10 
cm dishes) or mock treated (-) in duplicates for each cell line (six 10 cm dishes), and 
were all incubated at 37
o
C in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) air. 
After the 2 hours and 15 minutes incubation, cells treated with colcemid (+) along with 
the mock treated (-) cells, were either harvested and Hoechst-33342 (Sigma-Aldrich, 
Dorset, UK) stained followed by flow cytometry analysis both for DNA content and 
green fluorescence (EGFP) according to Section 2.8.1.3, or were fixed and PI stained 
followed by flow cytometry analysis for DNA content according to Section 2.8.1.4, in 
order to check the cell cycle prior to metaphase spreads preparation.  
 
2.14.1.2 Colcemid treatment and preparation of metaphase slides  
N/TERT, SINCE and SINEG2 cells were plated at 1x10
6
 cells per T75 flask in 20 ml 
RM+ growth medium per flask and incubated at 37
o
C in a humidified atmosphere of 
10% (v/v) CO2/90% (v/v) air. Medium was replaced every two days and 72 hours after 
plating (~ 60-75% confluent) N/TERT, SINCE and SINEG2 cells were treated with 
0.04 µg/ml colcemid (+) (Invitrogen, Paisley, UK) (4 µl from 10 µg/ml stock colcemid 
solution in HBSS-Hank’s Buffered Salt Solution (Invitrogen, Paisley, UK) in 1 ml RM+ 
growth medium; 1:250 dilution) for 2 hours and 15 minutes, and were incubated at 37
o
C 
in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) air. After the 2 hours and 15 
minutes incubation, all cells treated with colcemid (+) were collected and used for the 
preparation of metaphase slides (see Section 2.14.2). 
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2.14.2 Metaphase slide preparation 
N/TERT, SINCE and SINEG2 cells, treated with colcemid (+) (Section 2.12.4.1), were 
washed once with 1x sterile PBS (PAA, Somerset, UK) and then trypsinised until all the 
cells had detached (see Section 2.1.8). The trypsin reaction was inhibited by 
transferring the trypsinised cells to 50 ml falcon tubes containing complete RM+ growth 
medium at a ratio of 1:1 (v/v) trypsinised cells to RM+ culture medium. Cells were then 
centrifuged at 1,000 rpm for 6 minutes. The supernatant was aspirated very carefully so 
as to avoid discarding cells and each pellet was resuspended in 8-10 ml (depending on 
cell number) pre-warmed (incubated at 37
o
C) 0.075 M KCl (Sigma-Aldrich, Dorset, 
UK) (Appendix I), mixed completely and incubated at 37
o
C in a humidified 
atmosphere of 10% (v/v) CO2/90% (v/v) air, for 20 minutes. KCl is a hypotonic 
solution, which has lesser osmotic pressure than the solution on the other side of the 
cell’s membrane. Osmotic pressure is the pressure applied by a solution to prevent the 
inward flow of water across a semi-permeable membrane. Therefore, KCl hypotonic 
solution flows into the cell and thus disrupts the cell’s membrane and increases cell 
volume. Then, 1 ml of fix solution (100% methanol (Fisher, Leicestershire, UK) : 100% 
acetic acid (Fisher, Leicestershire, UK) = 3 : 1 ratio) (Appendix I) was added in each 
resuspended pellet and it was completely mixed by using a plastic Pasteur pipette. Next, 
cells were centrifuged at 1,100 rpm for 6 minutes, the supernatant was gently discarded 
by using a plastic Pasteur pipette, and 10 ml of fix solution (Appendix I) was added in 
each pellet, mixed completely using a plastic Pasteur pipette, followed by incubation at 
room temperature for 15 minutes. Resuspended cell pellets were then centrifuged at 
1,100 rpm for 6 minutes and the supernatant was gently discarded by using a plastic 
Pasteur pipette. Again 10 ml of fix solution (Appendix I) was added in each pellet, 
mixed completely using a plastic Pasteur pipette, and incubated at room temperature for 
15 minutes. Resuspended cell pellets were either stored at 4
o
C or were immediately 
used for the preparation of metaphase slides. Resuspended cells were centrifuged at 
1,100 rpm for 6 minutes and the supernatant was gently discarded by using a plastic 
Pasteur pipette. 10-20 drops of fix solution (Appendix I) were added in each pellet 
(depending on cell number), using a plastic Pasteur pipette and mixed completely. Then, 
two drops of fix solution with cells were dropped on each slide (new, cleaned and pre-
treated microscope glass slides), using a plastic Pasteur pipette. The new microscope 
glass slides (Berliner Glas KG Herbert Kubatz, Berlin, Germany) that were used for the 
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metaphase cells were cleaned by 100% ethanol (Fisher, Leicestershire, UK) and then 
treated in 100% acetic acid (Fisher, Leicestershire, UK) overnight at room temperature 
in a fume hood. Then, slides were washed using distilled water and were kept in the 
distilled water at 4
o
C until used for dropping the cell suspension. The water was allowed 
to drain from the slide so that a thin film of water remains and then 2-3 drops of the cell 
suspension were dropped down the length of the slide, starting at the frosted end. The 
slide was held at a 45º angle while dropping the cell suspension and then slides were 
placed at a 45º angle and were left to air dry (metaphase slides). Slides (metaphase 
slides) were then stored at -20
o
C. Metaphase cells on the slides were evaluated under a 
light microscope (Section 2.2) for cell density and metaphase spreading. Metaphase 
slides should have optimum cell density so that the density is neither too sparse or too 
high, and also optimum spreading (not inadequate or over-spreading) so that the cell 
boundaries and the majority of chromosomes are distinguishable. The resulting 
metaphase cells should have minimal overlaps and no visible cytoplasm surrounding the 
chromosomes, with chromosomes appearing flat and gray (see Chapter 4, Section 
4.2.6, Figure 4.21). 
 
2.14.3 Hybridisation 
The metaphase slides were taken from -20
o
C and according to the characteristics 
mentioned above (Section 2.14.2), a target area (approximately 22 mm x 22 mm) with 
good quality metaphase cells in each metaphase slide was selected and marked with a 
pencil on the side of the slide. Slides were then heated on a hot plate at 65
o
C for 30 
minutes, followed by enzymatic treatment (protease treatment). Enzymatic treatment 
changes the accessibility of the chromosomal DNA, by removing the cytoplasmic 
proteins of the cell membrane, since for optimum hybridisation to occur the 
chromosomal DNA must be readily accessible to the DNA M-FISH probes. Therefore, 
40 µl of the RNase A (Sigma-Aldrich, Dorset, UK) working solution (Appendix I) was 
applied to the target region of each slide and a 22 x 50 mm glass coverslip (VWR, 
Leicestershire, UK) was applied. Next, the slides were placed in a pre-warmed (to 37
o
C) 
humidified box (Vysis, Abbott Molecular, Maidenhead Berkshire, UK) and incubated at 
37
o
C for 30 minutes. The humidified box (pre-hybridisation sealed box) (Vysis, Abbott 
Molecular, Maidenhead Berkshire, UK) was containing 3-4 filter papers soaked in 2x 
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Saline Sodium Citrate (SSC) (Vysis, Abbott Molecular, Maidenhead Berkshire, UK) 
solution (Appendix I) so as to be humid, and it was warmed in a 37
o
C incubator. After 
incubation, the glass coverslip was removed and the slides were washed 2x for 5 
minutes each in 2x SSC (Vysis, Abbott Molecular, Maidenhead Berkshire, UK) solution 
(Appendix I) inside a glass Coplin jar. Then, the slides were placed in another pre-
warmed (in 37
o
C water bath) glass Coplin jar containing the pepsin (Vysis, Abbott 
Molecular, Maidenhead Berkshire, UK) working solution (Appendix I) at 37
o
C (in 
37
o
C water bath) for 5 minutes. Next, the slides were washed 2x for 5 minutes each in 
1x PBS (Appendix I) inside a glass Coplin jar and were then placed in another glass 
Coplin jar containing the formaldehyde (Fisher, Leicestershire, UK) fixation solution 
(Appendix I) at room temperature for 2 minutes. Slides were then washed 2x for 5 
minutes each in 1x PBS (Appendix I) inside a glass Coplin jar and were dehydrated by 
being placed sequentially in glass Copling jars containing 70% (v/v) (Appendix I), 85% 
(v/v) (Appendix I) and 100% (v/v) ethanol (Fisher, Leicestershire, UK) (Appendix I) 
for 2 minutes in each one, and were left to air dry.  
 
The next step was the denaturation of the slides in order for the double stranded DNA to 
become single stranded due to high temperatures, which occurs when the hydrogen 
bonds between the strands are broken at high temperatures. The slides were immersed in 
a pre-warmed to 72±1
o
C glass Coplin jar containing the denaturation solution 
(Appendix I) for 2 minutes at 72±1
o
C (in 72±1
o
C water bath) in a fume hood. The glass 
Coplin jar containing the denaturation solution (Appendix I) was placed in a 72±1
o
C 
water bath in a fume hood approximately 30 minutes prior to use to bring the 
denaturation solution to 72±1
o
C. Slides were then dehydrated by being placed 
sequentially in glass Copling jars containing 70% (v/v) (Appendix I), 85% (v/v) 
(Appendix I) and 100% (v/v) ethanol (Fisher, Leicestershire, UK) (Appendix I) for 1 
minute in each one, and were placed on a 46
o
C heat plate to evaporate remaining 
ethanol and warm the slide.  
 
Next, SpectraVysion
TM
 DNA probe (Vysis, Abbott Molecular, Maidenhead Berkshire, 
UK) was hybridised to the chromosomes in the target area of the slides and was allowed 
to anneal. Thus, 10 µl of the denatured SpectraVysion
TM
 DNA probe (Vysis, Abbott 
Molecular, Maidenhead Berkshire, UK) were applied in the dark to the target area in 
each slide (slides have already being placed on a 46
o
C heat plate) and a 22 x 22 mm 
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glass coverslip (VWR, Leicestershire, UK) was applied. Then, the glass coverslip was 
sealed with rubber cement to prevent evaporation during hybridisation and the slides 
were placed in the pre-warmed (to 37
o
C) humidified box (hybridisation box) (Vysis, 
Abbott Molecular, Maidenhead Berkshire, UK), containing 3-4 filter papers soaked in 
2x Saline Sodium Citrate (SSC) (Vysis, Abbott Molecular, Maidenhead Berkshire, UK) 
solution (Appendix I) so as to be humid, and incubated at 37
o
C for either 48 or 72 
hours. Prior to use, the SpectraVysion
TM
 DNA probe (Vysis, Abbott Molecular, 
Maidenhead Berkshire, UK) was taken from -20
o
C, was defrosted at room temperature 
and then was centrifuged 2-3 seconds using a microcentrifuge. The probe (Vysis, 
Abbott Molecular, Maidenhead Berkshire, UK) was then warmed at 37
o
C for 5 minutes 
using a water bath in order for the probe to become resolubilised. Then, the probe 
(Vysis, Abbott Molecular, Maidenhead Berkshire, UK) was vortexed and centrifuged 2-
3 seconds to bring all the contents to the bottom of the tubes and 35 µl were transferred 
in a 0.5 ml microcentrifuge tubes (Eppendorf, Cambridge, UK) in darkness. At the same 
time that the slides were placed to denaturation solution (Appendix I), the DNA probe 
(Vysis, Abbott Molecular, Maidenhead Berkshire, UK) was also placed in 80±1
o
C water 
bath for 5 minutes in the dark so as to become denatured. The denaturation of the probe 
(Vysis, Abbott Molecular, Maidenhead Berkshire, UK) was timed so that it is 
approximately the same time as the specimen slide denaturation. 
 
After 48 or 72 hours of hybridisation the slides were washed to remove any excess 
probe that is non-specifically bound, and were prepared for capturing images. The glass 
coverslips were removed from the slides and the slides were immediately immersed in a 
pre-warmed to 72±1
o
C glass Coplin jar containing 0.4x SSC/0.3% NP-40 (NP-40 was 
supplied by Vysis, Abbott Molecular, Maidenhead Berkshire, UK) wash solution 
(Appendix I) for 2 minutes at 72±1
o
C (in 72±1
o
C water bath) in the dark. The slides 
were initially agitated for 1-3 seconds and were then left for 2 minutes in 0.4x 
SSC/0.3% NP-40 wash solution (Appendix I). The glass Coplin jar containing the 0.4x 
SSC/0.3% NP-40 wash solution (Appendix I) was placed in a 72±1
o
C water bath 
approximately 30 minutes prior to use to bring the wash solution to 72±1
o
C. Next, the 
slides were immersed in a glass Coplin jar containing 2x SSC/0.1% NP-40 wash 
solution (Appendix I) for 5 sec - 1 min at room temperature in the dark. The slides were 
initially agitated for 1-3 seconds and were then left for 5 sec - 1 min in 2x SSC/0.1% 
NP-40 wash solution (Appendix I). Slides were then drained by tiling in darkness and 
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20 µl DAPI III counterstain (Vysis, Abbott Molecular, Maidenhead Berkshire, UK) 
were applied to the target area of each slide in darkness and a 22 x 22 mm glass 
coverslip (VWR, Leicestershire, UK) was applied. The slides were left at 4
o
C for 30 
minutes and then images were captured. Slides were stored for short term at 4
o
C. 
 
M-FISH was visualised by fluorescence microscopy (Strefford et al., 2001; Mao et al., 
2008). The whole hybridisation target area of the slide was scanned in order to locate 
high quality metaphase spreads by using the yellow or red filter set, using an Olympus 
Provis AX70 (Olympus, London, UK) fluorescent microscope with an M-FISH filter 
configuration (Vysis, Abbott Molecular, Maidenhead Berkshire, UK) (a series of 
excitation and emission filters corresponding to different fluorochromes (Section 
2.8.1.1)). Next, M-FISH images of metaphase spreads were auto-captured in six 
different filters, by acquiring the images in the following fluorophore (see Section 
2.8.1.1) sequences: 1
st
 Spectrum Gold (excitation 530 nm and emission 555 nm), 2
nd
 
Spectrum Far Red (excitation 655 nm and emission 675 nm), 3
rd
 Spectrum Aqua 
(excitation 433 nm and em 480 nm), 4
th
 Spectrum Red (excitation 592 nm and emission 
612 nm), 5
th
 Spectrum Green (excitation 497 nm and emission 524 nm) and 6
th
 DAPI 
(excitation 367 nm and emission 452 nm), using a Photometric Sensys Camera 
(Perceptive Scientific Inc., Chester, UK) and a composite image representing each of 
the six fluorophore image captures was presented in the monitor. This sequence of 
image capture is important in order to minimise photodegradation effects on the five 
probe fluorophores, thereby providing higher quality images. M-FISH images of 
metaphase spreads were analysed using the computer software SpectroVision (Vysis, 
Abbott Molecular, Maidenhead Berkshire, UK) which generates a pseudocolored image 
for each metaphase spread, where each chromosome has a different pseudocolour 
depending on its fluorophore composition (Figure 2.10b) and thus allows the 
karyotypic analysis. More than ten M-FISH karyotypes were analysed for each cell line. 
 
 
2.15 Luciferase reporter assays on stable and inducible cell lines 
Genetic reporter systems have contributed greatly to the study of eukaryotic gene 
expression and regulation. Reporter genes, such as firefly luciferase, are frequently used 
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as indicators of transcriptional activity in cells. Typically, a reporter gene is joined to a 
promoter sequence in an expression vector that is transferred into cells. Following 
transfer, the cells are assayed for the presence of the reporter by directly measuring the 
reporter protein itself or the enzymatic activity of the reporter protein. 
In this study, luciferase reporter assay (Bright-Glo
TM
 Luciferase Assay System, 
Promega, Southampton, UK) was used to detect and measure the activity of the OT 
promoter, and indirectly the transcriptional activity of β-catenin. The OT-β-catenin-
responsive promoter (OT) is an improved version of TOPFLASH, which contains the 
TCF-4 binding sites (CCTTTGATC) (Korinek et al., 1997; He et al., 1998; Shih et al., 
2000). The OT promoter drives the expression of a luciferase gene to facilitate the 
detection of promoter activity, and indirectly β-catenin protein transcriptional activity. 
Thus, luciferase is used as a reporter gene to provide information about the activity of 
the promoter that drives its expression.  
 
Therefore, pSIN-OT-Luciferase (pSIN-OT-Luc) retroviral vector contains a luciferase 
gene downstream of the OT promoter, which is comprised of three repeats of the wild-
type Tcf-4 binding site (CCTTTGATC) (Figure 2.11 i and Section 2.1.1, Section 
2.3.1). Tcf-4 binds in a sequence-specific fashion to the regulatory sequences (Tcf-4 
binding sites of the OT promoter) of specific target genes (in this case luciferase gene), 
while β-catenin supplies a transactivation domain and thus transcriptional activation of 
target genes occurs only when Tcf-4 is associated with β-catenin. Therefore, β-catenin 
through binding to Tcf-4 (protein-protein interaction) activates the OT promoter which 
then drives the expression of luciferase (Luc) gene (Figure 2.11 ii). The latter is an 
enzyme that catalyses the mono-oxygenation of the beetle luciferin protein (lyophilised 
Bright-Glo
TM
 Luciferase Assay Substrate provided by (Promega, Southampton, UK)) in 
the presence of ATP (Adenosine Triphosphate), Mg
2+
 (Magnesium), and O2 (Molecular 
Oxygen) (Figure 2.11 ii). This leads to the production of luciferin protein with 
luminescent properties (Figure 2.11 ii). The levels of luciferase enzyme are thus 
measured by detection of luminescence by standard microplate readers (Figure 2.11 ii). 
Luminescence or otherwise bioluminescence is the emission of light as a result of a 
chemical reaction and it differs from fluorescence (see Section 2.8.1.1) in that the 
electronic excited state is derived from the product of a chemical reaction, rather than 
the more typical way of creating electronic excited states namely absorption (see 
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Section 2.12.4.1). Bioluminescence is a subset of chemiluminescence (see Section 
2.12.5), where the light producing reaction occurs inside a cell. In the context used 
herein, luminescence indirectly reports the activity levels of the OT promoter, and 
therefore the relative abundance of transcriptionally active β-catenin. 
 
 
 
Figure 2.11: Principle of luciferase reporter assay. 
(i) pSIN-OT-Luciferase (pSIN-OT-Luc) retroviral vector contains a luciferase gene downstream 
of the OT promoter, which is comprised of three repeats of the wild-type Tcf-4 binding site 
(CCTTTGATC) (Section 2.1.1 and Section 2.3.1) (Shih et al., 2000). (ii) Tcf-4 binds to the 
Tcf-4 binding sites of the OT promoter and β-catenin through binding to Tcf-4 (protein - protein 
interaction) activates the OT promoter which then drives the expression of luciferase (Luc) 
gene. Firefly luciferase is an enzyme that catalyzes an oxidation reaction (Luciferin substrate + 
ATP + O2 → Oxyluciferin + AMP + PP1 + CO2 + Light) to yield light, usually in the green to 
yellow region, typically 550-570 nm. Mono-oxygenation of the beetle luciferin protein is 
catalyzed by luciferase in the presence of ATP (Adenosine Triphosphate), Mg
2+
 (Magnesium), 
and O2 (Molecular Oxygen) and this leads to the production of oxyluciferin protein with 
luminescent properties. The levels of luciferase enzyme measured by luminometer. PP1, 
pyrophosphate; AMP, adenosine monophosphate; CO2, carbon dioxide. 
 
 
For the luciferase reporter assay, NTERT, SINEG2, SINCE cells, were transduced, as 
previously described (see Section 2.3, Section 2.3.5.1 and Section 2.3.5.3) with pSIN-
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OT-Luciferase (pSIN-OT-Luc) retroviral plasmid, and were left to express the transgene 
for 72 hr prior to harvesting for luciferase activity and protein content measurement 
(Section 2.12.4). Transduced cells were split according to Section 2.1.8 and seeded in 
6-well plates (16.8x10
4 
cells/well), in triplicates (n=3 for each cell type), 48 hr after 
viral infection. The next day (72 hr post-infection) cells were lysed and examined for 
luciferase activity and protein content (Section 2.12.4).  
 
N/TERT and NTEG2 cells were transduced, as previously described (see Section 2.3, 
Section 2.3.5.1 and Section 2.3.5.3) with pSIN-OT-Luciferase (pSIN-OT-Luc) 
retroviral vector and were left to express the transgene for 5 days prior to harvesting for 
luciferase activity and protein content measurement (Section 2.12.4). Transduced cells 
were splitted according to Section 2.1.8 and seeded in 6-well plates (4.2x10
4 
cells/well), 
in triplicates (n=3 for each cell type), 48 hr after viral infection. The next day (72 hr 
post-infection) doxycycline was removed from transduced cells for another 48 hr 
(NTEG2 Dox-). Day 5 post-transduction, cells were lysed and examined for luciferase 
activity and protein content (Section 2.12.4).  
 
The seeded NTERT, SINCE, SINEG2 and N/TERT, NTEG2 cells in 6-well plates, after 
3 and 5 days post-infection respectively, had reached ~ 40-50% confluence and were 
washed once with 2 ml sterile PBS (PAA, Somerset, UK). Cells in each well were then 
incubated in 55 µl of 1x Reporter Lysis Buffer (Promega, Southampton, UK) (5x 
Reporter Lysis Buffer (Promega, Southampton, UK) diluted in sterile distilled water 
(PAA, Somerset, UK) - 1:5 dilution) for 10 min at room temperature to allow cell lysis. 
The protein was harvested in 1.5 ml microcentrifuge tubes (Eppendorf, Cambridge, 
UK).  
 
All cell lysates were assayed for luciferase activity using the Bright-Glo
TM
 Luciferase 
Assay System (Promega, Southampton, UK). Cell lysates were vortexed for 5 sec and 
from each 55 µl cell lysate, 50 µl were transferred to the luminometer plate well 
(opaque, flat bottomed white 96-well plate, Nunc, Roskilde, Denmark), while the rest 5 
µl were kept in ice and used for protein concentration measurement using the Bio-Rad 
Protein Assay System (BioRad, Hertfordshire, UK) (Section 2.12.4), or were stored at -
80
o
C if were not immediately measured. Bright-Glo
TM
 Assay reagent (LAR) (Promega, 
Southampton, UK) (the lyophilised Bright-Glo
TM
 Luciferase Assay Substrate (Promega, 
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Southampton, UK) was reconstituted with 10 ml of Bright-Glo
TM
 Luciferase Assay 
Buffer (Promega, Southampton, UK) until completely dissolved and it was aliquoted 
and stored at -80
o
C) was thawed, kept in dark,  equilibriated to room temperature since 
luciferase activity is temperature dependent, and vortexed. LAR (Promega, 
Southampton, UK) was added in each well of the luminometer plate at equal volume 
(50 µl) to the cell lysate and samples were mixed by quick pipetting. Luminencence was 
measured immediately (to avoid loss of luminescence signal) after exposure for 20 sec 
for each well, using a FLUOSTAR OPTIMA microplate reader (BMG LABTECH, 
Aylesbury, UK). Prior to luminescence measurement the plate was briefly shaken for 7 
sec by the FLUOSTAR OPTIMA microplate reader (BMG LABTECH, Aylesbury, 
UK) to ensure complete sample mixing with the LAR (Promega, Southampton, UK) 
reagent. 
 
Luminescence data of each sample were normalized to protein content (luciferase/µg) 
(i.e. protein concentration µg/µl of cell lysate x 50 µl of volume of cell lysate = protein 
µg in 50 µl cell lysate → luminescence/protein µg in 50 µl cell lysate = luciferase/µg).  
 
Samples were analysed in duplicates or triplicates and statistical analysis was performed 
using the Microsoft Excel’s software for student’s t test analysis (see Section 2.16).  
 
 
2.16 Statistical analysis 
Almost all experiments have been repeated at least three times and statistical analysis 
was performed using either the Microsoft Excel’s software for student’s t test analysis 
or the GraphPad’s InStat Software (V2-04a; Graph-Pad Software, San Diego, CA) for 
student’s t test analysis. Statistical significance was expressed as a probability value (P) 
which represents the probability of two comparing groups being the same. The smaller 
the P value the more significant the differences between two comparing groups (* 
P≤0.05 - significant, ** P≤0.01 - very significant, *** P≤0.001 - extremely significant).    
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2.17 Organotypic cultures and Immunohistochemistry 
In order to mimic physiological skin conditions in vitro, NTEG2 induced and uninduced 
keratinocytes were grown in organotypic three-dimensional cultures, by Nafeesa Ali at 
Centre for Cutaneous Research, Institute of Cell and Molecular Science, Barts and the 
London School of Medicine and Dentistry, London, UK, under conditions that can 
support the proliferation and differentiation of epidermal keratinocytes and mimic their 
in vivo pattern of growth and differentiation (Contard et al., 1993; Ojeh et al., 2001). 
Therefore, a three-dimension in vitro functional reconstruction of skin epithelium can be 
achieved by the culture of keratinocytes on the papillary surface of the de-epidermalised 
dermis (DED) either in the presence or absence of extra fibroblasts, which allows a 
better representation of the in vivo situation, compared to monolayer culture models. 
The procedure entails the culture of primary fibroblasts, preferentially derived from the 
tissue of interest (i.e. skin fibroblasts), within the reticular side of the DED. After 
fibroblasts are established and have migrated within the DED (usually within 24 hours), 
skin keratinocytes are placed on the papillary surface of the DED, and are then allowed 
to grow for an initial period of 24 - 48 hours. After this stage, the organotypic rafts are 
raised to the air-liquid interface to allow keratinocyte differentiation and the induction 
of tissue keratinisation. 
 
The organotypic keratinocyte cultures were performed as previously described (Ojeh et 
al., 2001) by Nafeesa Ali at Centre for Cutaneous Research, Institute of Cell and 
Molecular Science, Barts and the London School of Medicine and Dentistry, London, 
UK. Briefly, glycerol-preserved skin (Euro Skin Bank, Beverwijk, Holland) was washed 
three to five times in 1x PBS and incubated in 1x PBS containing 1% antibiotic-
antimycotic solution (PAA, Somerset, UK) at 37
o
C in a humidified atmosphere of 10% 
(v/v) CO2/90% (v/v) air for up to 10 days. Epidermis was then mechanically removed 
using forceps, and de-epidermalised dermis (DED) was cut into 6 sections (I, II, III, IV, 
V, and VI) of 1.5 x 1.5 cm squares each one and placed in a 6-well culture plate. The 
DED was placed in three of the six wells (I, II, III) with the papillary dermal surface on 
the underside and in the other three (IV, V, VI) on topside. Stainless steel rings were 
placed on top of the dermis of the I, II, III wells, and normal human dermal fibroblasts 
(5x10
5
 cells) were seeded into the rings on the reticular dermal surface. On IV, V, VI 
wells some culture medium was added, to prevent the DED from drying. After a 24 h-
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incubation, the DED was inverted on I, II, III wells, to orient the papillary dermal 
surface on top before the rings were replaced and keratinocytes (3x10
5
cells) were 
seeded inside the rings (N/TERT cells seeded on I and IV  wells and NTEG2 (induced 
and uninduced) cells seeded on II, III, V, VI wells). After 2 days, the DED composite 
was raised to the air-liquid interface in the same orientation, by placing on stainless 
steel grids for 14 days. The medium was refreshed every 2-3 days.  After 14 days, the 
composites were removed from the grids, fixed in 4% (v/v) formaldehyde and 
embedded in paraffin wax. Paraffin processed tissue sections were cut at 4 µm thickness 
and transferred on to microscope slides.  
 
Immunohistochemistry is a method to detect the abundance and the localisation of a 
protein of interest, within a tissue. This is achieved by the use of highly specific 
antibodies that have been raised against a protein/antigen of interest. The first step of 
immunohistochemistry includes the successful blocking of antigen sites on the tissue, 
which serves to increase the specificity of the subsequent antibody binding by using 
serum (i.e. goat serum). Next, the primary antibody is used to detect the protein of 
interest within the tissue (skin section). After washing off unbound primary antibody 
with buffer, the secondary antibody which detects the primary antibody is applied to 
skin section. Secondary antibody is raised in the same species as the primary one and is 
typically conjugated to enzyme or a fluorochrome for the easy detection. In this study, 
enzyme conjugated secondary antibodies were used for the detection of antigen 
abundance in normal and BCC (Section 2.18) human biopsies. Such secondary 
antibodies are directly conjugated to an enzyme, usually horseradish peroxidase or 
alklaline phosphatase. For enzyme-linked secondary antibody, a substrate (i.e. DAB; 
3,3’- diaminobenzidine) is applied, which is converted into an insoluble coloured 
product by the respective enzyme. This reaction leads to the production of brown stain 
wherever the secondary, and hence the primary, antibodies are bound and indirectly 
indicate the levels of a target protein present in the tissue sample. 
 
Thus, β-catenin was immunostained with a mouse monoclonal antibody (Zymed, San 
Fransisco, CA) on tissue sections as described (Ghali et al., 1999) and the reaction 
product was visualised using diaminobenzidine (DAB) as a chromogenic substrate. In 
addition, deparaffinised sections were counterstained with haematoxylin (blue dye that 
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stains cell nucleus) and eosin (red dye that stains cytoplasm, collagen) for histological 
examination. 
 
 
2.18 BCC tissues and Immunohistochemistry 
A cohort of 16 patients’ tissue samples (BCC paraffin blocks) comprising normal skin 
epithelium, and tissues derived from diverse human BCC subtypes, including nodular, 
superficial, infiltrative and morpheaform along with a p21
WAF1/CIP1
 primary antibody 
(p21
WAF1/CIP1
 (DCS60), 2946, mouse monoclonal antibody; Cell Signaling, Danvers, 
MA; 1:125 dilution) were supplied to the pathology lab at the Pathology Department of 
the Institute of Cancer, Barts and the London School of Medicine and Dentistry, 
Charterhouse square, London, UK. Tissue processing and immunohistochemistry (see 
Section 2.17) were performed by Dr Mohammed Ikram at the Pathology Department of 
the Institute of Cancer, Barts and the London School of Medicine and Dentistry, 
Charterhouse square, London, UK.  
 
Briefly, 4 µm tissue sections were cut from the BCC blocks and transferred on to 
charged microscope slides. The slides were dried in a 37
o
C oven over night and then run 
on Ventana discovery platform (Ventana Molecular Discovery Systems S.A., France) 
with an automated protocol including deparaffinisation, primary antibody incubation, 
secondary antibody incubation, DAB application, Haematoxylin and Bluing Reagent 
counterstaining and finally slides cleaning. 
 
After the run was completed the slides were placed in soapy tap water and rinsed under 
the tap for 1 min and then placed in dH2O. Next, the slides were immersed in a series of 
solvents (3 min to each one) such as ethanol and xylene, to ensure that samples were 
completely dehydrated prior to examination. Finally, slides were mounted and cover 
slipped and stored at room temperature. 
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keratinocyte cell lines 
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3.1 Introduction 
The importance of the Sonic Hedgehog (SHH) pathway as a causative agent in Basal 
Cell Carcinomas (BCC) is well known in the literature. Taking into account the 
difficulty of culturing basal cell carcinomas in vitro, the molecular mechanisms 
involved in human BCC formation are poorly understood.  
 
In the present study, a constitutively active form of human GLI2-β isoform (GLI2 - a 
SHH mediator gene) that lacks the N-terminal repressor domain (Tanimura et al., 1998), 
GLI2∆N-β (GLI2∆N), and h/TERT (human telomerase reverse transcriptase) 
immortalised human skin keratinocytes (N/TERT-1) (Dickson et al., 2000) were used in 
order to generate and characterise N/TERT cell lines, either stably or conditionally 
expressing an EGFP-GLI2∆N fusion protein, and to investigate the effects of GLI2∆N 
overexpression in human keratinocytes. 
 
The telomerase immortalised cell line, N/TERT-1 (N/TERT) (Dickson et al., 2000) was 
chosen to examine GLI2∆N effects, because of its genotype, which is comparable to 
primary human keratinocytes. This line retains a functional p53/p21
WAF1/CIP1 
pathway, 
contrarily to other keratinocyte cell lines such as HaCaT (Boukamp et al., 1988; 
Lehman et al., 1993), and while it has a potentially unlimited lifespan because of 
abrogated senescence, it is neither tumour derived nor malignant. There are only two 
genetic hits involved in its creation, that is ectopic telomerase expression and 
spontaneous downregulation/loss of p16
INK4a 
(Dickson et al., 2000; Rheinwald et al., 
2002). In addition, N/TERT keratinocytes retain normal differentiation characteristics 
and are able to give rise to stratified epithelium in organotypic cultures (Dickson et al., 
2000). 
 
The reason for choosing isoform β out of the four GLI2 isoforms, is because GLI2-β 
mRNA expression is the predominant isoform in human BCCs (Tojo et al., 2003). 
Moreover, the truncated human GLI2-β/N-terminal deleted (GLI2∆N), chosen for this 
study, is a valuable tool to mimic the activated form of GLI2 (Eichberger et al., 2006). 
The human full length GLI2 shows relatively weaker transactivation in vitro, compared 
to GLI2*, and unlike full length GLI2, GLI2* is able to produce basal cell carcinoma-
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like downgrowths originating directly from the epidermis of transgenic mice (Roessler 
et al., 2005).  
 
In addition, the use of the active form of GLI2, is a way of partly mimicking SHH 
signalling. Expression of the constitutively active form of Gli2 (∆NG2) in vitro shows 
increased transcriptional activity and has the ability to induce transcriptional activation 
of all the Shh target genes, in isolated presomitic mesoderms, compared to the full-
length Gli2 (Sasaki et al., 1999; Buttitta et al., 2003). In vivo, in transgenic mice, ∆NG2, 
unlike full-length Gli2, is also able to mimic Shh-induced gene expression in dorsal 
neural tube (Sasaki et al., 1999). Interestingly, transgenic mice with overexpression of 
the N-terminal deletion of Gli2 in the epidermis under the control of K5 promoter, not 
only develop BCCs but also a variety of other skin tumours resembling human 
trichoblastomas, cylindromas, basaloid follicular hamartomas, in contrast to mice with 
epidermal overexpression of the full-length Gli2 that develop only BCCs (Sheng et al., 
2002). The difference between the transgenic mice overexpressing full length Gli2 (K5-
Gli2) and those overexpressing the N-terminal deleted Gli2 (K5-Gli2∆N2), is not only 
restricted to the occurrence of multiple skin tumour types in K5-Gli2∆N2 mice 
compared to the single tumour type in K5-Gli2 mice, but is also reflected on their 
phenotype which is characterised by (a) earlier development of visible skin 
abnormalities, (b) highly variable tumour growth rates, and (c) preference for different 
body sites (Sheng et al., 2002). Furthermore, in mice, hair follicle development requires 
Shh-dependent Gli2 activator function in the epidermis (Mill et al., 2003). In the 
absence of Shh, only the constitutively active form of Gli2 (∆NGli2) (under the control 
of K5 promoter), that closely resembles the human GLI2∆N, can rescue the follicular 
development, activate Shh-responsive gene expression, and promote cell proliferation 
by inducing cyclin-D1 and cyclin-D2 expression in Shh
-/-
 transgenic mice (Mill et al., 
2003).  
 
Therefore, since continued HH signalling, is required for BCC-like growth, proliferation 
and survival in transgenic mice (Hutchin et al., 2005), and is also implicated in human 
BCC development  and in many other cancers (Ruiz i Altaba et al., 2002b; Pasca di 
Magliano & Hebrok, 2003; Beachy et al., 2004; Daya-Grosjean & Couve-Privat, 2005; 
Rubin & de Sauvage, 2006), GLI2∆N could be a useful tool to partly mimic the 
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constitutive activation of HH signalling and to study the molecular mechanism of 
human BCC carcinogenesis in vitro. 
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3.2 Results 
3.2.1 Generation and characterisation of EGFP-GLI2∆N stable cell line 
3.2.1.1 Generation of EGFP-GLI2∆N stable cell line 
The stable N/TERT cell lines expressing the EGFP-GLI2∆N (EGFP-GLI2∆N fusion 
protein) and the EGFP (Enhanced Green Fluorescent Protein) protein were generated 
according to the procedures described in Materials and Methods (Chapter 2, Section 
2.1.5 and Section 2.3.5.1). Due to lack of selectable markers, transduced cells were 
sorted by FACS for green fluorescence (EGFP fluorescence) and collected (Chapter 2, 
Section 2.8.2), in order to enhance the percentage of cells that have been efficiently 
transduced. 
 
3.2.1.2 Expression levels of the SINCE and SINEG2 constructs 
The SINEG2 cell line was characterised for the expression of EGFP-GLI2∆N fusion 
protein, by fluorescence microscopy (Chapter 2, Section 2.2), flow cytometry 
(Chapter 2, Section 2.8), and western blot analysis (Chapter 2, Section 2.12). 
Representative pictures of EGFP (SINCE) and EGFP-GLI2∆N (SINEG2) expressing 
cell lines are shown in Figure 3.1A.  
 
Both cell lines were initially sorted for green fluorescence emission using FACS 
(Chapter 2, Section 2.8.2), after transduction with EGFP and EGFP-GLI2∆N retroviral 
vectors. N/TERT wild-type cells were used for obtaining basal levels of green 
fluorescence intensity (Figure 3.1B i), and all cells above this basal threshold were 
considered as being positive and were thus collected and replated in normal growth 
medium. Flow cytometry of sorted cells confirmed the existence of a high fluorescence 
subpopulation (86.2% EGFP+) of SINCE cells (Figure 3.1B ii), and the existence of a 
high fluorescence subpopulation (95.2% EGFP+) of SINEG2 cells (Figure 3.1B iii), but 
of lower green fluorescence intensity compared to SINCE cells.  
 
Further immunoblotting against EGFP (Figure 3.1C), revealed a band at the predicted 
size for the EGFP-GLI2∆N fusion protein (~ 180 kDa). β-actin was used as loading 
control. 
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Figure 3.1: EGFP-GLI2∆N stable expression in N/TERT human keratinocytes.  
(A) Representative pictures of EGFP-GLI2∆N fusion protein and EGFP stably expressing 
N/TERT cells were taken at x20 magnification, under brightfield and UV excitation for EGFP 
fluorescence, showing clear expression of EGFP-GLI2∆N (SINEG2) and EGFP (SINCE) 
proteins. The EGFP-GLI2∆N fusion protein localisation is mainly nuclear and partly 
cytoplasmic. (B) Flow cytometry analysis of wild-type N/TERT cells (i), used as reference cell 
line, against both SINCE (ii) and SINEG2 (iii) cell line, showing the presence of distinct 
populations of EGFP expressing cells. (C) Immunoblotting of SINCE and SINEG2 cell protein 
extracts against anti-EGFP antibody revealed the presence of a band at the predicted size of 
EGFP-GLI2∆N fusion protein at ~ 180 kDa. β-actin (~ 42 kDa) confirmed equal protein loading 
for both samples. 
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3.2.1.3 Transcription and endogenous protein levels of GLI2 in N/TERT human 
keratinocytes 
To obtain information on the transcription levels of GLI2 in N/TERT keratinocytes, the 
mRNA expression levels of GLI2 were examined by quantitative real-time PCR (qRT-
PCR) (Chapter 2, Section 2.11). Specific intron spanning primers were used, to detect 
full length GLI2 (GLI2) mRNA as well as mRNA templates that correspond only to α 
and β isoforms of GLI2 (GLI2 α/β) (Chapter 2, Section 2.11.3 and Section 2.11.7, 
Table 2.3). GLI2 full length and GLI2 α/β primers specificity and efficient 
amplification was confirmed by melting peak analysis (Chapter 2, Section 2.11.4)  
(Figure 3.2A i and Figure 3.2B i) and further visualized on a 2% DNA agarose gel, 
showing amplification of a single product of the corresponding size (Chapter 2, 
Section 2.11.5) (Figure 3.2A ii and Figure 3.2B ii).  
 
The qRT-PCR amplification products were purified and 10-fold serial dilutions were 
made in order to generate a standard curve (Chapter 2, Section 2.11.6). This allowed 
accurate quantification of the absolute mRNA copy number of each target gene in qRT-
PCR analytical runs using LightCycler 480 software (Chapter 2, Section 2.11.7). 
Representative amplification curves of serially diluted GLI2 full length (Figure 3.2A 
iii) and GLI2 α/β (Figure 3.2B iii) products, and the resulting standard curves are 
shown (Figure 3.2A iv and Figure 3.2B iv). 
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Figure 3.2: Validation of GLI2 specific primers and standard curves creation.  
(A) Melting curve analysis (i) showed the presence of a single peak which signifies the presence 
of a single product, produced by qRT-PCR. qRT-PCR products were run on 2% agarose gel (ii) 
to confirm the presence of a single product of 116 bp. Ten fold serial dilutions of GLI2 full 
length template was used to generate a standard curve comprising 1000-100,000 copies. qRT-
PCR amplification curves (iii) and the resulting standard curve (iv) are shown. (B) Melting 
curve analysis (i) showed the presence of a single peak which signifies the presence of a single 
product produced by qRT-PCR. qRT-PCR products were run on a 2% agarose gel (ii) to 
confirm the presence of a single product of 194 bp. Ten fold serial dilutions of GLI2 α/β 
isoforms template was used to generate a standard curve comprising 100-100,000 copies. qRT-
PCR amplification curves (iii) and the resulting standard curve (iv) are shown. 
 
 
 
 
Chapter 3: Generation and characterisation of stable and inducible GLI2-expressing cell lines 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 255 
To examine GLI2 transcription levels, RNA was harvested from N/TERT, SINCE, and 
SINEG2 keratinocytes (Chapter 2, Section 2.11.1). cDNA from these samples was 
subjected to qRT-PCR using GLI2 full length and α/β isoform specific primers 
(Chapter 2, Section 2.11.7). Relative mRNA copy numbers were obtained after 
normalization with two housekeeping genes, POLR2A (polymerase (RNA) II (DNA 
directed) polypeptide A) and YAP1 (Yes-associated protein 1). Results show the clear 
mRNA expression of both full length GLI2 (*** P≤0.001) (Figure 3.3A i) and GLI2 α/β 
(*** P≤0.001) (Figure 3.3B i) genes in SINEG2 cells, while endogenous transcription 
levels in N/TERT and SINCE control cells were low but detectable (Figure 3.3A i and 
Figure 3.3B i). The higher abundance of GLI2 α/β over GLI2 full length in SINEG2 
cells probably reflects the fact that SINEG2 cell line is transduced with retroviral 
construct bearing only the β isoform of GLI2∆N. The fold difference of GLI2 mRNA 
induction between SINEG2 and control N/TERT and SINCE cells, is likely to be an 
overestimation of the actual differences in mRNA copy numbers, since GLI2 
endogenous levels of both N/TERT and SINCE cells were very low, consistent with the 
very low expression of GLI2 in normal human skin (O'Driscoll et al., 2006). A semi-
quantitative approach (Chapter 2, Section 2.11.8) was also used to display the clear 
induction of GLI2 and GLI2 α/β transcription in SINEG2 keratinocytes (Figure 3.3A ii 
and Figure 3.3B ii). 
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Figure 3.3: Quantification of GLI2 mRNA expression in N/TERT keratinocytes.  
(A) RNA was harvested from N/TERT, SINCE, and SINEG2 cells to examine the levels of 
GLI2 expression using primers specific for full length GLI2. Quantitative RT-PCR analysis of 
GLI2 full length expression (i) and semi-quantitative PCR (ii) analysis, show the presence of 
high levels of GLI2 mRNA expression in SINEG2 cells compared to N/TERT and SINCE, cells 
where GLI2 mRNA expression is low but detectable. Each bar represents a mean ± s.e.m of 
triplicate samples. *** P≤0.001. (B) RNA was harvested from N/TERT, SINCE, and SINEG2 
cells to examine the levels of GLI2 expression using primers to amplify α/β isoforms of GLI2. 
Quantitative RT-PCR analysis of GLI2 α/β isoforms expression (i) and semi-quantitative PCR 
(ii) analysis show the presence of high GLI2 α/β expression in SINEG2 cells compared to 
N/TERT and SINCE cells where GLI2 α/β mRNA expression is low but detectable. Each bar 
represents a mean ± s.e.m of triplicate samples. *** P≤0.001. POLR2A (polymerase (RNA) II 
(DNA directed) polypeptide A) was used as a housekeeping gene control for all samples in 
semi-quantitative PCR. 
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Since the transcriptional activity of GLI2 was low in N/TERT as well as in SINCE 
control keratinocytes, the endogenous protein levels were examined. Total protein 
extracts from N/TERT, SINCE and SINEG2 keratinocytes were immunoblotted against 
anti-GLI2 antibody (Chapter 2, Section 2.12.1 and Section 2.12.5). Expectedly, GLI2 
protein levels were only detectable in SINEG2 keratinocytes (Figure 3.4A). 
Immunoblotting revealed the presence of exogenous EGFP-GLI2∆N protein at the 
predicted size of ~ 180 kDa, but also showed the presence of endogenous GLI2 protein 
at around ~ 150 kDa (Figure 3.4A). In order to confirm the presence of endogenous 
GLI2 protein at the predicted molecular size (~ 150 kDa) as previously shown for 
SINEG2 cells (Figure 3.4A), high concentrations of N/TERT and SINCE protein 
extracts (30 µg of protein lysates) were separately immunoblotted against anti-GLI2 
antibody (Figure 3.4B). Low but detectable levels of GLI2 protein were found (Figure 
3.4B) at the same molecular size (~ 150 kDa) as in SINEG2 cells. This is in line with 
the very low transcription levels detected in both N/TERT and SINCE cells, as well as 
with the high rate of GLI2 protein turnover (Bhatia et al., 2006; Huntzicker et al., 2006; 
Pan et al., 2006). 
 
The above data suggested that exogenous GLI2∆N protein had an effect on the 
regulation of endogenous protein in SINEG2 cells. At this point, it is difficult to 
delineate the reason for endogenous GLI2 upregulation, but this data may suggest the 
presence of a positive feedback loop whereby exogenous GLI2∆N stimulates the 
expression of endogenous GLI2. Alternatively, the presence of excessive EGFP-
GLI2∆N protein in SINEG2 cells may cause a significant delay to the rapid proteasome 
mediated degradation of the endogenous GLI2 protein levels. 
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Figure 3.4: Detection of GLI2 endogenous and EGFP-GLI2∆N exogenous protein 
levels.  
(A) N/TERT, SINCE, and SINEG2 cells were harvested and total protein was immunoblotted 
against anti-GLI2 antibody and anti-β-actin as a protein loading control. Endogenous GLI2 (~ 
150 kDa) and exogenous EGFP-GLI2∆N (~ 180 kDa) proteins were detected in SINEG2 cells 
while GLI2 endogenous levels were almost absent from N/TERT and SINCE control cells. (B) 
N/TERT and SINCE protein lysates of higher protein concentration (30 µg protein lysates), 
were separately immunoblotted against anti-GLI2 antibody to confirm the presence of 
endogenous GLI2 protein at the predicted molecular size of approximately ~ 150 kDa. Again, β-
actin was used as protein loading control. 
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3.2.1.4 Gene targets of GLI2∆N in N/TERT human keratinocytes 
The expression profile of SINEG2 keratinocytes was further examined by investigating 
the expression (either mRNA or protein levels) status (Chapter 2, Section 2.11 and 
Section 2.12) of two genes that have been shown to be either positively or negatively 
regulated both in response to GLI2∆N and in human BCCs. The anti-apoptotic gene, 
BCL-2 (B-cell lymphoma 2), was previously identified as direct transcriptional target of 
GLI2 transcription factor (Regl et al., 2004b). In addition, GLI2 and BCL-2 are often 
co-expressed in human basal cell carcinomas (Regl et al., 2004b). Consistently the 
mRNA expression levels of BCL-2 were significantly elevated by 11-fold in SINEG2 
keratinocytes, compared to N/TERT and SINCE controls (** P≤0.01) (Figure 3.5A).  
 
Inducible expression of GLI2∆N in HaCaT keratinocytes results in downregulation of 
c-MYC (Regl et al., 2004a; Eichberger et al., 2006), and more importantly, c-MYC 
mRNA and protein levels are significantly suppressed in human BCCs (Bonifas et al., 
2001; Regl et al., 2002; O'Driscoll et al., 2006; Asplund et al., 2008). SINEG2 
keratinocytes displayed a similar expression pattern, whereby c-MYC mRNA 
expression (Figure 3.5B), as well as protein levels (Figure 3.5C), were reduced when 
compared to N/TERT and SINCE keratinocytes (* P≤0.05). 
 
Therefore, SINEG2 keratinocytes display an expression pattern for BCL-2 and c-MYC 
that is similar to what is previously reported in other systems, as well as to the 
molecular signature of human basal cell carcinomas.  
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Figure 3.5: BCC associated markers expression in SINEG2 keratinocytes.  
RNA was harvested from N/TERT, SINCE, and SINEG2 cells to examine the levels of BCL-2 
(A) and c-MYC (B) expression by qRT-PCR, using primers specific for each gene. Quantitative 
RT-PCR analysis of BCL-2 and c-MYC show an increase and a decrease respectively in 
SINEG2 cells, compared to N/TERT and SINCE control cells. Each bar represents mean fold 
induction/or suppression relative to N/TERT (arbitrary value of 1) ± s.e.m of triplicate samples. 
* P≤0.05, **P≤.0.01. (C) N/TERT, SINCE, and SINEG2 cells were harvested and total protein 
was immunoblotted against anti-c-MYC antibody (~ 60 kDa) and anti-β-actin (~ 42 kDa) as a 
protein loading control. SINEG2 cells show a significant decrease of the c-MYC protein levels 
compared to N/TERT and SINCE cells. 
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3.2.2 Generation and characterisation of EGFP-GLI2∆N inducible cell line 
3.2.2.1 Generation 
The preparation of the inducible cell line, NTEG2, provided by Dr Giuseppe Trigiante 
(Centre for Cutaneous Research, Institute of Cell and Molecular Science, Barts and the 
London School of Medicine and Dentistry, London, UK), was based on the RevTet-
OFF regulatory system (Clontech Laboratories, Palo Alto, CA), as previously described 
in Materials and Methods (Chapter 2, Section 2.1.6 and Section 2.3.5.2). In the 
retrovirus-mediated tet-regulated gene expression system (RevTet-Off system), 
transcription of the gene of interest (in this study EGFP-GLI2∆N fusion gene) is turned 
off in the presence of Doxycycline (a derivative of tetracycline) (Dox+), while 
transcription of this gene (EGFP-GLI2∆N fusion gene) is turned on in the absence of 
Doxycycline (Dox-) (Figure 3.6). For the generation of the NTEG2 cell line, 
heterogeneous cell populations were used in order to avoid any clone specific effects. 
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Figure 3.6: Generation of NTEG2 inducible cell line (RevTet-Off system).  
Diagram illustrating the principle of induction and/or repression of EGFP-GLI2∆N fusion 
protein under the control of Doxycycline (Dox). Tetracycline controlled transactivator (tTA) 
(RevTet-Off Regulatory plasmid) binds to tetracycline response element (TRE) (RevTRE 
Response plasmid) to activate transgene transcription mediated by the CMV promoter in the 
absence of doxycycline. tTA binding is repressed in the presence of doxycycline. The tTA 
regulatory element is a fusion tetracycline-dependent protein which consists of the tetR and the 
vp16. tetR is a tetracycline repressor found in E.Coli, while vp16 is a transcriptional activator 
protein isolated from Herpes Simplex Virus. In the absence of Doxycycline (Dox-), the tTA 
binds to the TRE which consists of the tetO and a CMV promoter. The tetO operator consists of 
an array of direct repeats which are recognized by the tetR protein. Binding of the tTA (tetR + 
vp16) to the tetO sequence leads to the activation of the CMV promoter, which then drives the 
expression of the transgene (EGFP-GLI2∆N fusion protein). In the presence of Doxycycline 
(Dox+), the tetracycline repressor (tetR) is inactivated, tetO becomes inactive, and therefore the 
CMV promoter is silenced. 
 
 
3.2.2.2 Selection of NTEG2 cells 
Different concentrations of G418 and Hygromycin B selection were used, in order to 
identify the optimal concentration for selection (Chapter 2, Section 2.4) (Figure 3.7). 
The minimum antibiotic concentration that induced massive cell death after 3 days and 
total cell death after 8 days was chosen for each antibiotic. The final concentrations 
used for selection of the NTEG2 cell line, were 500 µg/ml for G418 and 100 µg/ml for 
Hygromycin B, and for maintenance 250 µg/ml and 50 µg/ml respectively. 
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Figure 3.7: Antibiotic selection of N/TERT cell line.  
N/TERT cells were seeded in equal densities and cultured in normal growth medium with 0, 50, 
100, 200, 400, 800 µg/ml of either G418 (A) or Hygro B (B) for the total period of 8 days. The 
minimum antibiotic concentration that induced massive cell death after 3 days and total cell 
death after 8 days was chosen for antibiotic selection of NTEG2 inducible cell line. 
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3.2.2.3 FACS Sorting 
Following 8-11 days of drug selection, and induction for 5 days, NTEG2 (NTEG2 Dox-
) cells were sorted by FACS (Chapter 2, Section 2.8.2), and all EGFP positive and 
negative cells were gated as shown previously (Figure 3.1B i) using N/TERT as a 
reference cell line to obtain baseline values of green fluorescence. All EGFP+ cells 
were collected, replated and cultured under the presence of doxycycline. 
 
3.2.2.4 Doxycycline optimisation 
Pilot experiments were carried out, in order to optimise the concentration of 
doxycycline which provides the best ratio of induction/suppression of EGFP-GLI2∆N 
expression, without inducing any cytotoxic effects on the NTEG2 cell line (Chapter 2, 
Section 2.5). Initially, NTEG2 cells were grown in the absence of doxycycline (Dox) 
for 48 or 72 hours, for transgene induction.  
 
Next, cells were grown in the presence of different Dox concentrations (1, 100, 1000, 
10000 ng/ml) and EGFP-GLI2∆N suppression was investigated by flow cytometry 
analysis after 48 hours (Figure 3.8A) and 5 days (Figure 3.8B). The presence of Dox 
suppressed transgene expression in a dose-dependent manner. Fluorescence levels were 
reduced by 2 fold after 48 hours incubation in the presence of maximum Dox 
concentration (10000 ng/ml) (Figure 3.8A). After 5 days of doxycycline treatment, an 
even stronger suppression was observed, where EGFP-GLI2∆N fluorescence levels 
reached ~ 8% (4 fold suppression) (Figure 3.8B). Data are representative of two 
independent experiments. 
 
To further confirm that Dox efficiently suppressed EGFP-GLI2∆N protein levels, 
NTEG2 cells were incubated in 40 ng/ml, 1 µg/ml, and 10 µg/ml of Dox for 6 days 
(Dox (+) cells), and protein extracts were prepared and immunoblotted against anti-
EGFP antibody (Figure 3.8C). At the same time another set of NTEG2 cells was 
initially treated with 40 ng/ml, 1 µg/ml, and 10 µg/ml of Dox for 24 hr and was 
thereafter cultured in the absence of Dox for 5 days (Dox (-) cells) and protein extracts 
were prepared and immunoblotted against anti-EGFP antibody (Figure 3.8C). 
Consistent with flow cytometry analysis, EGFP-GLI2∆N protein suppression showed a 
dose-dependent effect. The concentration range between 40 ng/ml and 10 µg/ml of Dox, 
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is sufficient to suppress EGFP-GLI2∆N. However, total suppression was not observed 
indicating the presence of background levels of EGFP-GLI2∆N protein in control 
NTEG2 Dox (+) cells.  
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Figure 3.8: Doxycycline optimisation. 
NTEG2 cells were grown for 48 or 72 hours in the absence of Dox. Next, cells were treated with 
different concentrations of Dox (1, 100, 1000, 10000 ng/ml) and EGFP-GLI2∆N expression 
was analysed by flow cytometry analysis after 48 hours (A) and 5 days (B). A dose-dependent 
suppression of EGFP-GLI2∆N fluorescence is observed in response to Dox treatment. Data are 
representative of two independent experiments. (C) NTEG2 cells were treated with 40 ng/ml, 1 
µg/ml, and 10 µg/ml of Dox for 6 days (Dox (+) cells and at the same time another set of 
NTEG2 cells was were treated with 40 ng/ml, 1 µg/ml, and 10 µg/ml of Dox for 24 h which was 
thereafter cultured in the absence of Dox for 5 days (Dox (-) cells). Protein extracts were 
prepared prior to immunoblotting analysis against anti-EGFP antibody. β-actin was used as 
protein loading control. Clear EGFP-GLI2∆N protein suppression is observed in this range of 
Dox concentration (40 ng/ml - 10 µg/ml). Strongest transgene suppression was observed with 10 
µg/ml of Dox.  
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In order to rule out the possibility that Dox is inducing any cytotoxic effects on NTEG2 
cell line, a cytotoxicity assay was performed (Chapter 2, Section 2.7.1.1). N/TERT 
cells were grown in the absence or presence of Dox (1, 10, 100, 1000, 10000 ng/ml) for 
48 hours and 5 days, and cell cytotoxicity was measured by Alamar Blue
TM
 reduction 
(Chapter 2, Section 2.7.1 and Section 2.7.1.1) (Figure 3.9). Results showed that this 
range of Dox concentration did not significantly affect the growth rate of N/TERT cells 
(Figure 3.9). Data are representative of two independent experiments each of them 
consisting of duplicate samples. 
 
 
 
 
 
Figure 3.9: N/TERT cytotoxicity in the presence of Dox. 
N/TERT cells were grown in the absence or presence of Dox (1, 10, 100, 1000, 10000 ng/ml) 
for 48 hours and 5 days, and fluorescence intensity produced by Alamar Blue
TM
 reduction was 
measured in order to assess Dox mediated cytotoxicity. The increasing concentrations of Dox 
did not induce significant effects in the growth rate of N/TERT cells. Each data point in the 
graphs represents a mean ± s.e.m of duplicate samples, relative to the baseline values obtained 
at Day 0. All the values for all the different time points were subtracted from the mean value of 
Day 0. 
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3.2.2.5 Expression levels of NTEG2 
Significant induction of protein levels was evidenced under fluorescent microscopy 
(Chapter 2, Section 2.2), 5 days after removal of Dox, as shown in Figure 3.10A ii, iii, 
while no induction of EGFP-GLI2∆N fusion protein was observed in NTEG2 cells 
under the presence of doxycycline (Figure 3.10A i).  
 
Subsequent flow cytometry analysis (Chapter 2, Section 2.8) of NTEG2 cells showed 
an increased percentage of EGFP+ cells when Dox was removed (Figure 3.10B ii), but 
also a small baseline induction of fluorescence even in Dox treated cells (Figure 3.10B 
i).  
 
Immunoblotting (Chapter 2, Section 2.12) for EGFP-GLI2∆N fusion protein 
confirmed GLI2∆N induction in NTEG2 cells upon removal of Dox in comparison with 
baseline leak (Figure 3.10C). β-actin was used as loading control.  
 
Because pooled (FACS sorted EGFP+) NTEG2 cells were used, variation was observed 
in the levels of GLI2∆N expression (EGFP intensity), between different clones in 
NTEG2 culture (compare Figure 3.10A ii and Figure 3.10A iii). To control for this 
variation, the levels of EGFP-GLI2∆N induction/suppression were always measured by 
flow cytometry and immunoblotting prior to carrying out experiments, to ensure similar 
levels of GLI2∆N expression between experiments.   
 
The GLI2 transcription factor is normally present in both the cytoplasm and the nucleus, 
and its subcellular localisation and stability is dependent upon Hedgehog (HH) 
signalling and stimulation (Murone et al., 2000; Roessler et al., 2003; Barnfield et al., 
2005; Pan et al., 2006; Varjosalo et al., 2006). Accordingly, I found that EGFP-GLI2∆N 
was detected in both the cytoplasm and the nucleus of both SINEG2 (Figure 3.1A) and 
NTEG2 cells (Figure 3.10A ii, iii). 
 
GLI2 transcription factor undergoes rapid proteasome mediated degradation, as a barrier 
to human tumourigenesis (Bhatia et al., 2006; Huntzicker et al., 2006; Pan et al., 2006). 
This suggests that constitutive activation of the transgene may be necessary to achieve 
maximum levels of EGFP-GLI2∆N accumulation. In line with this, in this study it is 
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observed that while EGFP intensity is similar in both the stable and inducible cell lines 
(by flow cytometry analysis), the proportion of EGFP positive cells in SINEG2 stable 
cell line, is significantly higher than that observed in the induced NTEG2 cells (compare 
Figure 3.1B iii with Figure 3.10B ii).  
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Figure 3.10: Characterisation of NTEG2 inducible cell line.  
(A) Representative pictures of NTEG2 cells in the presence (i) or absence (ii, iii) of 
doxycycline. Varying levels of EGFP-GLI2∆N expression were observed possibly due to the 
heterogeneity of NTEG2 cell population. (B) Flow cytometry analysis of NTEG2 cell line in the 
presence or absence of doxycycline. Clear induction of EGFP-GLI2∆N is shown in Dox (-) 
cells (ii) while background activity of EGFP-GLI2∆N is also evidenced in the presence of 
doxycycline (i) represented by the small population detected above threshold levels of 
fluorescence obtained from wild-type N/TERT cells. (C) Immunoblotting analysis of NTEG2 
cells in the presence or absence (5 days) of doxycycline against anti-EGFP antibody. Significant 
induction of the transgene is observed in Dox (-) cells, while background levels of induction are 
also present, as evidenced by previous flow cytometry analysis. β-actin confirms equal protein 
loading for both samples. 
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3.2.3 The effect of GLI2∆N on cell morphology and growth 
3.2.3.1 Cell morphology 
Stable expression of GLI2∆N in N/TERT keratinocytes resulted in the manifestation of 
a phenotype that contains a morphologically heterogeneous cell population that was 
different from wild-type N/TERT and SINCE control keratinocytes. These phenotypic 
differences became more obvious at approximately ten days after infection (eight days 
after FACS sorting). No differences between the morphologies of N/TERT and SINCE 
cells were detected before and after FACS sorting, indicating that the phenotypic 
differences in SINEG2 cells were GLI2∆N specific. SINEG2 cells display a compact 
morphology and tend to give rise to tight colonies (Figure 3.11C-H) compared to 
N/TERT and SINCE cells that tend to form more loosely associated colonies which are 
well spread in culture (Figure 3.11A, B). Although the majority of SINEG2 
keratinocytes comprising such colonies, appear to be very cohesive, it can be noted that 
few cells mainly located at the periphery of such colonies, are more loosely attached 
(Figure 3.11D, E). These loosely attached cells are not always associated with tight 
colonies and can also be found scattered throughout the culture (Figure 3.11H) or 
forming loose colonies (Figure 3.11I). A high proportion of SINEG2 keratinocytes, 
forms islands of compact colonies that do not appear to merge, even in confluent 
cultures. However, a smaller number of colonies appear to be joined (Figure 3.11D, E, 
H) by groups of keratinocytes that have characteristics resembling the peripheral cells 
of tight colonies. This may suggest a more migratory behaviour for peripheral 
keratinocytes, which are able to detach from the bulk of tight colonies and mediate or 
initiate the apparent colony merging. However, all these morphological differences were 
less pronounced when the cells were seeded at higher densities. 
 
Importantly, these phenotypic characteristics (tight, round, smooth colonies consisting 
of small with high nuclear to cytoplasmic ratio cells) are also observed in a proportion 
of human epidermal keratinocyte clones, that appear to be relatively undifferentiated 
and posses a capacity of self-renewal. Such clones of keratinocytes (holoclones) are 
considered to be the in vitro analogue of keratinocyte stem cells (Barrandon & Green, 
1987). 
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Figure 3.11: Phenotype of GLI2∆N-expressing 
N/TERT keratinocytes. 
SINEG2 cells display a compact morphology which is   
characterised by the presence of tight colonies comprised of 
small and very cohesive cells (C-H) compared to N/TERT 
and SINCE cells (A, B). The presence of more loose keratinocytes can be noted in the periphery 
of some colonies (D, E), scattered throughout the culture (H), and in more loose colonies (I). 
Although SINEG2 cells form compact islands of keratinocytes, in the same culture other 
colonies can be found joined together (F, G). Peripheral cells which appear to be more detached 
from the main colony might have a more migratory phenotype which might be responsible for 
the colony joining (F, G). 
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Confluent N/TERT and SINCE cultures (initially seeded at low density) show a uniform 
growth pattern, and contain cells with high nuclear/cytoplasmic ratio as well as large 
and more flattened cells indicating the presence of proliferative and differentiating 
keratinocytes respectively (Figure 3.12 i A, B). In contrast, cultures of SINEG2 
keratinocytes grown for the same period of time retain the compact morphology and are 
characterised by round colonies with smooth perimeters (Figure 3.12 i C, D). Again, a 
smaller proportion of SINEG2 derived keratinocyte colonies, are found joined together, 
while retaining a tight morphology and the presence of peripheral loosely attached 
keratinocytes (Figure 3.12 i E).  
 
To obtain a clearer picture depicting the growth patterns of the whole culture, N/TERT, 
SINCE and SINEG2 keratinocytes were seeded at low densities (clonal growth) and 
were allowed to grow until N/TERT and SINCE control cells reached confluence. By 
staining keratinocytes with Rhodamine B (Chapter 2, Section 2.6), it is clear that while 
N/TERT and SINCE keratinocytes can form a uniform monolayer culture, the vast 
majority of GLI2∆N expressing keratinocytes form tightly packed colonies (Figure 
3.12 ii). This again shows that this is not a localised effect in small proportion of the 
culture, but a rather strong phenotypic outcome of GLI2∆N overexpression. 
 
A similar effect was observed with inducible expression of GLI2∆N in distinct colonies, 
but the overall effect was considerably weaker (Figure 3.10A ii). This apparent 
discrepancy could be attributed to several factors. The inducible system used to 
overexpress GLI2∆N resulted in weaker expression of the transgene when compared to 
stable transduction of N/TERT keratinocytes. Furthermore, the background activation of 
the uninduced control N/TERT cells may have led to an underestimation of the effect 
produced by GLI2∆N. Last, the transient short-term (maximum of five days) induction 
of GLI2∆N using the inducible system, combined with the low levels of transgene 
expression may not be sufficient to elicit the strong phenotype observed in stably 
transduced keratinocytes. 
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Figure 3.12: GLI2∆N induces changes in cell morphology of N/TERT 
keratinocytes. 
(i) Confluent cultures of N/TERT, SINCE, and SINEG2 keratinocytes are shown (A-E). 
SINEG2 keratinocytes tend to have a compact morphology and form tightly packed colonies 
with smooth perimeters (C, D) compared to N/TERT and SINCE cells that display a well spread  
monolayer culture (A, B). Although very few large joined colonies are found together in 
SINEG2 monolayer culture, they still retain a tight and highly compact phenotype (E). (ii) 
NTERT, SINCE, and SINEG2 keratinocytes were seeded at low density and were allowed to 
grow until control NTERT and SINCE keratinocytes became confluent. Next, cells were stained 
with Rhodamine B to macroscopically examine the colony forming efficiency and colony 
morphology of cells. In contrast to control NTERT and SINCE cells which formed a spread and 
confluent monolayer culture, SINEG2 keratinocytes grew into small, tightly packed, round 
colonies which are easily discernable with Rhodamine B staining.  
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3.2.3.1.1 Integrin β1, involucrin and SOX2 expression in GLI2∆N-expressing 
N/TERT cells 
This basal-like phenotype of SINEG2 keratinocytes in culture could be attributed to a 
disruption of the differentiation process probably, due to downregulation and/or 
upregulation of differentiation and stem cell genes respectively. Consistently with the 
resistance to differentiation of BCC cells (Murphy et al., 1984; Said et al., 1984; 
Sumitomo et al., 1986; Miller, 1991a), it has been previously shown in confluent GLI2 
expressing HaCaT keratinocytes, that GLI2 represses genes that are involved in 
differentiation (Regl et al., 2004a), as well as opposing differentiation in organotypic 
cultures (Snijders et al., 2008). However, integrin beta 1 (ITGB1) gene, which is a 
marker of undifferentiated keratinocytes in the basal layer of the epidermis  (Adams & 
Watt, 1991; Jones et al., 1995) and of which both in vitro and in vivo loss is associated 
with the onset of keratinocyte terminal differentiation (De Strooper et al., 1989; 
Peltonen et al., 1989; Adams & Watt, 1990; Nicholson & Watt, 1991; Hotchin et al., 
1995), was found to be upregulated both in confluent and high-calcium confluent 
contact inhibited GLI2 HaCaT keratinocytes (Regl et al., 2004a). This suggests that 
while control cells arrest and downregulate β1 integrin levels upon confluence or high-
calcium confluent induced differentiation, GLI2 HaCaT cells oppose this effect (no cell 
cycle arrest and suppression of differentiation markers) and maintain an immature 
population of keratinocytes with high β1 integrin levels (result of disrupted 
differentiation). Alternatively, the upregulation of β1 integrin levels can be a result of 
GLI2 induced expression independently of any differentiation stimulus (high-calcium 
confluence) in which case, it can contribute to the suppression of keratinocyte 
differentiation (one of the causes of disrupted differentiation). 
 
In order to confirm which of these two possibilities occurs, GLI2∆N along with control 
cells were grown in normal culture conditions (sub-confluent) without any extra 
stimulus for differentiation and RNA was harvested (Chapter 2, Section 2.11.1). 
Expression analysis (Chapter 2, Section 2.11) showed that SINEG2 keratinocytes 
exhibit increased mRNA levels of β1 integrin gene (~ 2-fold) compared to N/TERT and 
SINCE cells (*** P≤0.001) (Figure 3.13A), in line with the results of a previous large-
scale microarray analysis in GLI2 HaCaT cells (Eichberger et al., 2006). This suggests 
that integrin β1 induction is likely to be a result of GLI2∆N overexpression, rather than 
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an outcome of suppressed differentiation observed in confluent or high-calcium 
confluent cultures.  
 
Involucrin (IVL gene) is the major soluble cytoplasmic protein precursor of the 
cornified envelope (stratum corneum) in human stratified squamous epithelia and is 
expressed in the mature cells of the upper stratum spinosum and stratum granulosum 
layers of human epidermis (see Chapter 1, Section 1.1.1) (Rice & Green, 1977; 
Murphy et al., 1984; Candi et al., 2005). Therefore, since involucrin is a well 
established marker for keratinocyte terminal differentiation in vivo and in vitro (Rice & 
Green, 1979; Watt, 1983), its mRNA levels were checked both in control and SINEG2 
keratinocytes. Expression analysis (Chapter 2, Section 2.11) showed that SINEG2 
keratinocytes exhibit decreased mRNA levels of involucrin (~ 5-fold), compared both to 
N/TERT and SINCE control cells (*** P≤0.001) (Appendix II), further confirming the 
undifferentiated phenotype of SINEG2 keratinocytes. 
 
The undifferentiated phenotype of SINEG2 keratinocytes could also be accompanied by 
an expression profile that is reminiscent of that observed in the more immature 
populations of keratinocyte stem cells. This will not be a surprise knowing that in skin 
SHH/GLI pathway is implicated in the maintenance and regulation of the epidermal 
stem cell population residing in the epidermal basal layer (interfollicular epidermis) and 
the hair follicle bulge (Callahan & Oro, 2001; Adolphe et al., 2004; Blanpain & Fuchs, 
2006; Zhou et al., 2006), while in vitro it is also suggested that SHH/GLI signalling has 
a potential role in the maintenance and proliferation of human  putative epidermal stem 
cells (Fan & Khavari, 1999; Kameda et al., 2001; Zhang & Kalderon, 2001; Zhou et al., 
2006). In addition, GLI1 overexpression in N/TERT keratinocytes induces and 
suppresses a number of stem and non stem cell associated genes respectively  (Kasper et 
al., 2006b; Neill et al., 2008). At the same time, BCCs which are characterised as 
undifferentiated tumours (expression of keratins 5 and 14 which are mainly expressed 
by basal cells (Stoler et al., 1988; Coulombe et al., 1989; Fuchs, 2008)) (Miller, 1991a; 
Crowson, 2006), manifest a stem cell gene profile similar to that expressed by the cells 
of the interfollicular epidermis and hair follicle bulge region, such as keratins 15 and 19, 
and α2 and β1 integrins (Lane et al., 1991; Miller, 1991a; Jones & Watt, 1993; Jones et 
al., 1995; Pentel et al., 1995; Kruger et al., 1999; Lyle et al., 1999; Morris et al., 2004; 
Tumbar et al., 2004; Crowson, 2006). 
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Additionally, integrin β1 which was found to be overexpressed upon GLI2∆N induction 
(Figure 3.13A), is not only a marker for undifferentiated cells, but it is also a valuable 
marker to enrich for epidermal keratinocyte stem cells in vitro, by selecting the cells 
with the highest levels of β1 integrins (Jones & Watt, 1993; Jones et al., 1995). In 
addition, its high levels are required for the maintenance of human epidermal stem cell 
compartment in vitro (Zhu et al., 1999), suggesting either a possible role of GLI2∆N in 
this process or an ability of GLI2∆N to induce a stem cell associated phenotype and 
gene expression in N/TERT keratinocytes. 
 
Consistent with this notion, another well characterised stem cell associated gene, SOX2 
(SRY (sex determining region Y)-box 2), was found to be dramatically upregulated in 
SINEG2 keratinocytes (~ 3x10
3
-fold), compared to both N/TERT and SINCE controls 
(*** P≤0.001) (Figure 3.13B), similarly to what was found by Snijders et al. (Snijders et 
al., 2008) in GLI2∆N HaCaT keratinocytes. The relative fold mRNA induction could be 
an overestimate due to the very low background levels of SOX2 mRNA observed in 
control N/TERT and SINCE keratinocytes (Ct value > 31). Nevertheless, this 
remarkable induction in GLI2∆N expressing N/TERT keratinocytes, suggests that 
SOX2 may be a direct downstream target of GLI2∆N in human keratinocytes. This is 
also strengthened by the fact that a number of potential GLI2 consensus-binding sites 
are present in SOX2-promoter (Snijders et al., 2008). However, this remains to be 
elucidated by more specifically designed assays to prove protein (GLI2) - chromatin 
(SOX2 promoter) interaction. Importantly, in mice, it was very recently found that Gli2 
can regulate the expression of SOX2 in developing neuroepithelial cells via direct 
binding to the SOX2 enhancer region (Takanaga et al., 2009). Loss of Gli2 (Gli2∆C or 
Gli2 shRNA) suppresses the expression of SOX2, and induces premature neuronal 
differentiation of developing neuroepithelial cells (Takanaga et al., 2009), further 
supporting the role of GLI2 in opposing differentiation and possibly in the maintenance 
of stem cells. 
 
SOX2 is a transcription factor which is involved in organ development and in 
determining stem cell fate and properties. SOX2 plays a key role in maintaining 
embryonic stem cell pluripontency both in mice (Masui et al., 2007; Niwa, 2007) and 
human (Fong et al., 2008), in regulating neural and retinal cell progenitors (Graham et 
al., 2003; Taranova et al., 2006) and in development of the sensory organs of the inner 
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ear (Kiernan et al., 2005). In addition, SOX2 in the epithelial context, is required for the 
differentiation of endodermal progenitor cells of the mouse tongue into taste bud cells 
(highly expressed) versus keratinocytes, while it is also expressed in the basal epithelial 
cells of the tongue (Okubo et al., 2006). Its overexpression in basal epithelial cells of the 
tongue in transgenic mice, causes complete suppression of the differentiation of the 
filiform keratinocytes (Okubo et al., 2006). Consistently, expression of SOX2 gene, has 
also been reported in poorly differentiated tumours such as breast, as well as in gliomas 
which are also associated with activated hedgehog signalling and GLI1/2 
overexpression (Kinzler et al., 1987; Dahmane et al., 2001; Kubo et al., 2004; Sterling 
et al., 2006; Clement et al., 2007; Ben-Porath et al., 2008; Chen et al., 2008; Kameda et 
al., 2009).  
 
These results point to the fact that the expression profile of SINEG2 keratinocytes may 
be directly linked to the phenotypic characteristics observed in culture. Excepting that 
the expression patterns of SINEG2 cell line come in agreement with previous 
observations in other cell lines, these results show a novel phenotypic outcome induced 
by GLI2∆N, which could be, at least partly, attributed to the basal stem-cell like 
expression signature displayed in SINEG2 keratinocytes and can suggest that GLI2 
might block keratinocyte differentiation by upregulating stem cell genes. 
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Figure 3.13: GLI2∆N induces the expression of basal undifferentiated keratinocyte 
and stem cell associated genes.  
RNA was harvested from N/TERT, SINCE, and SINEG2 cells to examine the levels of Integrin 
β1 (A) and SOX2 (B) mRNA expression using primers specific for each gene. Quantitative RT-
PCR analysis of Integrin β1 and SOX2 showed an increase in expression of both genes in 
SINEG2 cells compared to N/TERT and SINCE control cells. Each bar represents mean fold 
induction relative to N/TERT (arbitrary value of 1) ± s.e.m of triplicate samples. *** P≤0.001.  
 
 
3.2.3.2 Cell growth 
Normally, cells in culture undergo three phases that describe their rate of cell growth. 
Cells, when first introduced into culture, do not begin to divide immediately but there is 
a delay in time that is called the lag and is referred to as the ‘lag phase’ growth (sparse 
cells). During this time, there is very little change in the number of cells, but a lot of 
synthetic activity occurs that both supports the cells and prepares them for future cell 
division (Martin, 1994). 
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Following the lag phase, most of the cell population divides continuously for a limited 
period of time and two new cells are created every time a cell divides. The increase in 
cell number during this phase is logarithmic and so called ‘log phase’ growth 
(subconfluent cells) (Martin, 1994). 
 
This does not continue indefinitely and the rate of growth of the population slows down. 
This final phase of growth is known as the ‘plateau’ or ‘stationary phase’ (confluent 
cells), in which only some cells in culture are proceeding through the cell cycle and 
dividing. When the cells are contact inhibited, the growth in the plateau phase is zero 
and the graph will appear flat for this phase (Martin, 1994). Therefore, normal cells 
grown in vitro undergo cell cycle arrest as soon as they reach confluence, a process 
frequently suppressed in tumourigenic cells. 
 
 
Due to the diverse morphological characteristics of SINEG2 keratinocytes, the effect of 
GLI2∆N expression in the growth rate of N/TERT keratinocytes was examined.  
 
First, the proliferation rates of N/TERT, SINCE, and SINEG2 keratinocytes were 
assessed during the period of 7 days by the use of Alamar Blue
TM
 proliferation assay 
(Chapter 2, Section 2.7.1 and Section 2.7.1.2) (Figure 3.14A). The rate of Alamar 
Blue
TM
 reduction is quantified by fluorescence emission, and directly reflects the 
amount of viable cells in culture. The results indicated a clear reduction in the 
proliferation rate of SINEG2 keratinocytes compared to both N/TERT and SINCE 
controls. N/TERT and SINCE control cells have reached confluence by day 4, and 
hence the growth curve representing their growth rate has thereafter reached a plateau. 
On the other hand, SINEG2 cells were still at the log phase of cell growth, suggesting a 
significant reduction in cell numbers.  
 
At the same time, the proliferation rates of all three cell lines were also assessed by the 
rate of MTT reduction (Chapter 2, Section 2.7.2) that reflects a measure of viable cells 
(Figure 3.14B), to further validate the above findings. Again, GLI2∆N expressing 
keratinocytes showed a pronounced delay in cell growth and could not reach the 
proliferation rate of neither N/TERT nor SINCE keratinocytes by the end of the time-
course. By day 7, N/TERT and SINCE cells start reaching the resting phase, while 
SINEG2 cells are still in the log phase. 
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Figure 3.14: Growth characteristics of GLI2∆N expressing N/TERT keratinocytes. 
(A) N/TERT, SINCE, and SINEG2 keratinocytes were grown for a period of seven days and 
their growth rates were measured by the fluorescence intensity produced by Alamar Blue
TM
 
reduction. SINEG2 display a significantly reduced growth rate compared to both N/TERT and 
SINCE control keratinocytes. (B) The proliferation rate of keratinocytes was also assayed by the 
rate of MTT reduction during the period of seven days in culture. Again, GLI2∆N expressing 
N/TERT keratinocytes display a significantly slower growth rate compared to both N/TERT and 
SINCE control keratinocytes. Each data point in the graphs represents a mean ± s.e.m of six 
replicate samples, relative to the baseline values obtained at Day 0. All the values for all the 
different time points were subtracted from the mean value of Day 0. *** P≤0.001. 
Chapter 3: Generation and characterisation of stable and inducible GLI2-expressing cell lines 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 282 
However, it is important to note that both these assays give an indication of the amount 
of viable cells, solely depending upon of a cell’s intrinsic metabolic activity and 
therefore, its ability to reduce chemical reagents. Consequently, if the metabolic activity 
of a given population is altered, the calculation of cell growth could potentially be 
inaccurately measured.  
 
Therefore, the growth potential of N/TERT, SINCE, and SINEG2 keratinocytes was 
also investigated during long term culture by assessing the number of population 
doublings for each given cell line (Chapter 2, Section 2.7.3) (Figure 3.15). Population 
Doublings (PD) represent the number of times the cell population doubles in number, 
during the course of culture. Cells were passaged every four days for the total period of 
16 days and the number of cumulative population doublings for each cell line was 
calculated as described in Materials and Methods (Chapter 2, Section 2.7.3 and 
Section 2.1.9.2).  
 
It was observed that GLI2∆N expressing keratinocytes had undergone significantly less 
population doublings (10 PD), compared to N/TERT and SINCE (14 PD both), further 
confirming their reduced proliferation rate. The marked reduction in population 
doublings shown here, suggests fewer mitotic divisions for GLI2∆N expressing 
keratinocytes, possibly as a result of either a slow cell cycle, or inappropriate execution 
of mitosis.   
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Figure 3.15: The effect of GLI2∆N in long term culture. 
N/TERT, SINCE, and SINEG2 cells were serially passaged every 4 days for a total of 16 
consecutive days. Equal numbers of keratinocytes were seeded and the total output of cells was 
measured at the end of each time point to obtain population doublings values. GLI2∆N 
expressing N/TERT keratinocytes have undergone significantly less population doublings after 
16 days in culture compared to the N/TERT and SINCE cells, reflecting their reduced growth 
rate. Each data point in the graph represents the PD which was calculated by using the mean ± 
s.e.m of three replicate measurements, as described in Materials and Methods (Chapter 2, 
Section 2.7.3 and Section 2.1.9.2). 
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3.3 Discussion 
3.3.1 Generation, expression and characterisation of GLI2∆N in N/TERT 
human keratinocytes 
Differential expression of the SHH effector, GLI2, is an important step in the formation 
of human Basal Cell Carcinoma, since upregulation of GLI2 is frequently observed in 
human BCCs (Mullor et al., 2001; Regl et al., 2002; Tojo et al., 2003; Ikram et al., 
2004; Regl et al., 2004b; O'Driscoll et al., 2006; Asplund et al., 2008; Yu et al., 2008). 
In addition, targeted overexpression of Gli2 in epidermal cells of transgenic mice can 
induce the formation of BCC or BCC-like tumours (Grachtchouk et al., 2000; Sheng et 
al., 2002; Hutchin et al., 2005; Huntzicker et al., 2006). The in vitro equivalent of such a 
model would require the forced induction of an active form of GLI2 oncogene in the 
context of epidermal keratinocytes. Herein, overexpression of the constitutively active 
form of human GLI2-β isoform (GLI2∆N) (most prevalent isoform in human BCCs) 
(Tanimura et al., 1998; Tojo et al., 2003) was achieved in immortalised human 
epidermal keratinocytes N/TERT-1 (N/TERT) (Dickson et al., 2000), using both a 
stable and an inducible system. N/TERT keratinocytes are derived from normal human 
foreskin keratinocytes, and were subsequently immortalised by ectopic expression of 
h/TERT and have spontaneous downregulation/loss of p16
INK4a
 (Dickson et al., 2000; 
Rheinwald et al., 2002). The employment of this cell line is advantageous in the aspect 
that it has a functional p53/p21
WAF1/CIP1
 pathway contrarily to the highly aneuploid 
HaCaT keratinocytes (Boukamp et al., 1988; Lehman et al., 1993), and retains normal 
differentiation mechanisms (Dickson et al., 2000).  
 
Stable transduction of N/TERT keratinocytes with pSINEGFP-GLI2∆N resulted in the 
generation of a cell line that showed strong transgene mRNA expression and production 
of high protein levels of EGFP-GLI2∆N (Figure 3.1). The use of high efficiency 
mediated gene transfer method described here, allows strong and long term induction of 
transgene expression without the undesirable effects of antibiotic selection (Deng et al., 
1997). However, maximum purity of EGFP-GLI2∆N transduced keratinocytes was 
achieved by FACS.  
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It has been previously shown by in situ-hybridization, that GLI2 mRNA is mainly 
expressed in the interfollicular epidermis and the outer root sheath of hair follicles in 
normal skin, and in BCC tumour islands (Ikram et al., 2004). During the 
characterisation of stably transduced keratinocytes, it was observed that N/TERT and 
SINCE (EGFP alone transduced) keratinocytes showed low but detectable mRNA levels 
of endogenous GLI2 (Ct value GLI2 > 31, Ct value GLI2 a/β > 25), as well as very low 
endogenous GLI2 protein levels (Figure 3.3). This is in line with endogenous mRNA 
copy number of GLI2 that also detected in trace amounts (Ct value > 32) in human 
primary skin keratinocytes (Regl et al., 2002), as well as in normal human skin 
(O'Driscoll et al., 2006). The detection of low endogenous GLI2 protein levels is 
consistent with the fact that in normal cells, GLI2 protein undergoes rapid proteasome 
mediated degradation as a barrier to tumourigenesis (Bhatia et al., 2006; Huntzicker et 
al., 2006; Pan et al., 2006). 
 
 In addition to the high levels of ectopic GLI2∆N protein, SINEG2 keratinocytes also 
displayed elevated levels of endogenous GLI2 protein (Figure 3.4). This may suggest 
the presence of a positive feedback loop whereby exogenous GLI2∆N stimulates the 
expression of endogenous GLI2. In support of this, the induction of GLI2∆N in HaCaT 
keratinocytes, results in a rapid elevation of GLI1 mRNA, followed by stimulation of 
endogenous GLI2 mRNA expression (Regl et al., 2002). This suggests that GLI2∆N 
may be indirectly involved in an autoregulatory mechanism, possibly through its direct 
downstream target GLI1 (Ikram et al., 2004). At the same time, it is possible that the 
presence of excessive EGFP-GLI2∆N protein in SINEG2 cells may cause a significant 
delay to the rapid proteasome mediated degradation of the endogenous GLI2 protein 
levels.  
 
Induction of GLI2∆N can result in the activation and/or suppression of a plethora of 
genes in HaCaT keratinocytes, as previously reported (Regl et al., 2004a; Eichberger et 
al., 2006). In accordance with previous observations, SINEG2 keratinocytes displayed a 
dramatic upregulation in the transcription levels of anti-apoptotic factor BCL-2 (Figure 
3.5A), a direct downstream target of GLI2 both in human primary and HaCaT 
keratinocytes (Regl et al., 2004b). Consistently, BCL-2 and GLI2 are often co-
expressed in BCC tumours (Regl et al., 2004b). Furthermore, both the mRNA and 
protein levels of c-MYC (Figure 3.5B, C) have been reported to be suppressed in 
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human BCCs (Bonifas et al., 2001; Regl et al., 2002; Asplund et al., 2008; Kriegl et al., 
2009), as well as in response to transient induction of GLI2∆N in HaCaT keratinocytes 
(Regl et al., 2004a; Eichberger et al., 2006). SINEG2 keratinocytes also displayed a 
significant reduction in c-MYC protein and mRNA levels compared to wild-type and 
EGFP transduced N/TERT keratinocytes. Thus, both BCL-2 and c-MYC, BCC 
molecular markers, that have been previously shown to be activated and suppressed 
respectively, upon GLI2∆N activation in other in vitro systems, were appropriately 
regulated in my system. These results indicate the relevance of this in vitro model 
system to HH/GLI induced gene expression patterns in BCC. 
 
The development of an inducible RevTet-OFF system provides significant benefit to the 
investigation of GLI2∆N mediated effects, by allowing the induction of the transgene 
only at desired time points, upon removal of doxycycline (Figure 3.6). This is 
especially useful since the induction and subsequent repression of transgene expression 
can significantly increase the specificity of any downstream observations. However, 
there are several disadvantages associated with the generation of the N/TERT inducible 
system (NTEG2) described here. 
 
First, it is worth mentioning that the presence of high, but non-toxic (Figure 3.9), levels 
of doxycycline did not result in complete suppression of the transgene (Figure 3.8). 
This led to the undesirable effect of background GLI2∆N activation in uninduced 
control cells (Figure 3.8 and Figure 3.10). Given the very low endogenous levels of 
GLI2 present in normal N/TERT keratinocytes, as mentioned above, even a small 
background activation of the transgene may lead to the underestimation of any 
downstream effects produced in induced GLI2∆N NTEG2 keratinocytes. Furthermore, 
the protein levels of GLI2∆N after removal of doxycycline were considerably lower 
compared to SINEG2 stably transduced keratinocytes. This could be attributed to the 
fact that the CMV promoter driving the expression of GLI2∆N in NTEG2 cells, is under 
the control of a tetracycline response element, as opposed to the constitutively active 
CMV promoter present in the pSINEGFP-GLI2∆N construct, that was used to generate 
the SINEG2 cell line. Last, in an effort to avoid any clone specific effects, the NTEG2 
cells were generated as a polyclonal population of transduced keratinocytes. This could 
have led to the apparent heterogeneity in terms of EGFP-GLI2∆N expression. Despite 
the drawbacks associated with the generation of this cell line, the data obtained by the 
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use of either the inducible or the stably transduced N/TERT cell lines, were comparable 
and highly reproducible. 
 
3.3.2 Localisation of GLI2∆N in N/TERT keratinocytes 
The intracellular localisation of GLI2∆N in N/TERT keratinocytes was primarily 
nuclear both in stable and inducible cell line (Figure 3.1 and Figure 3.10). However, a 
smaller proportion of cells displayed cytoplasmic localisation of the protein. These 
observations are consistent with previous reports showing that there is 
nuclear/cytoplasmic shuttling of GLI2 depending on hFu and hSuFu proteins 
respectively, which is required for protein degradation (Murone et al., 2000; Barnfield 
et al., 2005; Varjosalo et al., 2006). This also provides evidence that exogenous 
GLI2∆N protein is regulated in a similar fashion to the endogenous wild-type GLI2 
protein. This is in line with the fact that the active form of GLI2 (GLI2∆N) can only 
partly mimic the activated SHH/GLI pathway, since GLI2 subcellular localisation and 
stability is dependent upon SHH signalling stimulation (Pan et al., 2006). 
 
3.3.3 GLI2∆N opposes contact inhibition 
Sustained induction of GLI2∆N in stably transduced N/TERT keratinocytes (SINEG2) 
produced a strong phenotype that was mainly related to the colony formation of 
keratinocytes (Figure 3.11 and Figure 3.12). SINEG2 cells tend to grow by forming 
tight colonies of cohesive keratinocytes, as opposed to the more spread monolayer 
cultures observed in normal N/TERT and SINCE controls. Interestingly, basal cell 
carcinomas are characterised by their tight and compact morphology. Recently, it was 
also shown that forced expression of GLI1, a downstream target of GLI2, can also 
induce tight colony formation in N/TERT keratinocytes (Neill et al., 2008). Normal 
cells grown in vitro undergo cell cycle arrest as soon as they reach confluence, a process 
frequently suppressed in tumourigenic cells. Therefore, despite their highly compact 
appearance, SINEG2 colonies tend to grow to a considerable size, possibly indicating 
that these cells are irresponsive to contact inhibition mechanisms. In support of that, 
inducible expression of GLI2∆N in contact inhibited (confluent) cultures of HaCaT 
keratinocytes is sufficient to stimulate DNA synthesis (G1-S progression), re-entry to 
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the cell cycle and to regulate the mRNA levels of specific cell cycle genes (Regl et al., 
2004a). In addition, the expression of G1-S and G2-M phase progression genes was 
examined in contact-inhibited primary human keratinocytes showing similar results as 
in HaCaT cells (Regl et al., 2004a).  
 
Further evidence comes from the fact that SHH stimulation can oppose growth arrest of 
primary epidermal keratinocytes in response to extracellular calcium as well as to 
ectopic expression of CDKI p21
WAF1/CIP1
 (Fan & Khavari, 1999).
 
Keratinocytes undergo 
terminal differentiation during epithelial cell renewal (see Chapter 1, Section 1.1.1), 
which is preceded by cell growth arrest (Potten & Morris, 1988; Fuchs, 1990; Fuchs, 
1993; Steven & Steinert, 1994; Fuchs, 2008). This process can be efficiently reproduced 
in vitro, in response to elevated concentrations of extracellular calcium (Hawley-Nelson 
et al., 1980; Hennings et al., 1980; Boyce & Ham, 1983; Pillai et al., 1990; Li et al., 
1995; Bikle et al., 2004; Xie et al., 2005). The relevance of calcium-induced 
differentiation in vitro to the in vivo situation is evidenced by the steep gradient of 
calcium within the epidermis, with the highest levels in the uppermost suprabasal (most 
differentiated-nucleated) layers (Menon et al., 1985; Bikle et al., 2004). Application of 
high extracellular calcium concentration both in mice and human primary epidermal 
keratinocytes in culture, inhibits the rate of DNA synthesis and induces the production 
of differentiation markers, such as K1, K10, involucrin and loricrin (Fuchs, 1990; 
Fuchs, 1993; Steven & Steinert, 1994; Candi et al., 2005; Fuchs, 2008). Thus, Fan and 
Khavari (Fan & Khavari, 1999) showed that the presence of activated SHH signalling in 
confluent primary human epidermal keratinocytes opposes the cell cycle inhibitory 
effects (G0/G1 arrest) of this in vitro stimulus of epithelial differentiation. Another 
important cell cycle regulator, which is known to be responsible for mediating cell 
growth arrest prior to terminal keratinocyte differentiation and of other cell types, and 
thus irreversible commitment to differentiation, is CDKI p21
WAF1/CIP1
 (Jiang et al., 1994; 
Steinman et al., 1994; Missero et al., 1995; Missero et al., 1996; Tron et al., 1996; Di 
Cunto et al., 1998; Todd & Reynolds, 1998; Topley et al., 1999; Dotto, 2000). The same 
study showed that SHH overexpressing primary human keratinocytes can also 
antagonize the growth inhibitory effects (G1 arrest) induced by ectopic expression of 
p21
WAF1/CIP1
 (Fan & Khavari, 1999).  
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3.3.4 Morphological heterogeneity in N/TERT GLI2∆N-expressing colonies 
The strong phenotype induced by GLI2∆N in N/TERT keratinocytes, is mainly 
characterised by the presence of large compact, cohesive colony islands, comprised of 
small dense cells with a high ratio of nuclear to cytoplasmic volume (Figure 3.11 and 
Figure 3.12). However, there is a considerable degree of heterogeneity in SINEG2 
cultures. In addition to tightly packed keratinocyte colonies, SINEG2 cultures also 
contain more loosely attached cells that can be either found scattered throughout the 
culture, arranged in small loose colonies, or at the peripheries of bigger compact 
colonies. Although normal N/TERT and SINCE keratinocyte cultures may contain such 
keratinocyte populations, their presence becomes more pronounced in a background of 
tightly packed colonies, observed in SINEG2 culture.  
 
Primary human epidermal keratinocytes also display significant heterogeneity in 
culture, and their morphology is closely linked to their proliferative and self-renewal 
capacity (Barrandon & Green, 1987). Specifically, epidermal keratinocytes can form 
regular, round, large, compact colonies with smooth perimeters consisting of small, 
tightly-packed cells (holoclones), smaller highly irregular colonies with loosely packed 
large-flattened cells (paraclones), as well as colonies with intermediated features of both 
holoclones and paraclones, with smaller size than holoclones and irregular perimeter 
(meroclones). Each has different capacities for multiplication, and they can be 
distinguished by the marked difference in the frequency with which they give rise to 
terminal progeny. Holoclones have the ability of self-renewing and the greatest growth 
potential since under standard conditions fewer than 5% of the colonies formed by the 
cells of a holoclone abort and terminally differentiate. In contrast, paraclones may grow 
rapidly at first but they have a short replicative lifespan in total, since after 15 cell 
generations cells uniformly become growth arrested and terminally differentiated. The 
meroclone contains a mixture of cells of different proliferative potential, dividing only 
for limited generations and is considered as a transitional stage between the holoclones 
and the paraclones, as it gives rise to paraclones with appreciable frequency and are 
consumed by this conversion. The transitions from holoclone to meroclone to paraclone 
are unidirectional, and the result is progressively restricted growth potential (Barrandon 
& Green, 1987).  
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It is therefore thought that the cells of a holoclone are the in vitro analogue of 
keratinocyte stem cells (Barrandon & Green, 1987), according to the definition of 
Lajtha (Lajtha, 1979) that stem cells are cell types capable of extensive self renewal 
throughout adult life and also have the ability to produce daughters that undergo 
terminal differentiation, while the cells of the meroclone and paraclone are early and 
late transit-amplifying cells (differentiated) respectively. It has also been shown that 
keratinocyte cultures containing holoclones, when they are grafted to humans they can 
regenerate epidermis that persists for years (Gallico et al., 1984) indicating the self 
renewing capacity of holoclones, as well as that stem cells are not lost in culture. 
 
Thus, it is apparent that at least some of the morphological characteristics of holoclones 
(regular, large compact with smooth perimeter colonies consisting of small dense cells), 
described in normal epidermal keratinocytes, can be observed in a large proportion of 
SINEG2 keratinocyte colonies and thus SINEG2 cells resemble in some aspects the 
phenotypical stem cell characteristics. 
 
A similar hierarchy has been suggested for cells derived from a number of different 
epithelial tumours. It has been reported that cell lines derived from head and neck 
squamous cell carcinoma epithelial tumours show patterns resembling those of primary 
normal keratinocytes, in that they can form heterogeneous colonies in vitro (holoclone/ 
meroclone/paraclone series of colony morphologies), with malignant holoclones being 
round colonies consisting of tightly packed cells, smaller than the cells of malignant 
meroclones or paraclones, highly proliferative and solely responsible for regenerating 
each cell line (Locke et al., 2005; Harper et al., 2007). Similar phenomenon was 
observed in a breast and prostate carcinoma cell lines (Locke et al., 2005; Li et al., 
2008). Moreover, in prostate carcinoma cell lines, holoclones can not only regenerate all 
distinguishable colony types, but can also initiate serially transplantable tumours in 
nude mice (Li et al., 2008).  
 
Importantly, malignant holoclone derived cells, retain the expression of normal 
keratinocyte associated stem cell genes, including β1 integrin, E-cadherin and β-catenin 
compared to malignant meroclone and paraclone derived cells (Locke et al., 2005; 
Harper et al., 2007; Li et al., 2008).  
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In addition to epithelial tumours, another example of tumour heterogeneity in vitro is 
that of a non epithelial tumour such as glioma, the generation of which, is closely linked 
to GLI gene amplification (Kinzler et al., 1987). Human glioma derived cells can give 
rise (a) to tight round-shaped colonies with small and compact cells, (b) to intermediate 
colony less smooth than the tight colony, composed of inner cells closely packed, and of 
peripheral cells with flat plasma migrated out and finally (c) to the loose colony, which 
is the most irregular one and is composed of scattered flat plasma cells (Zhou et al., 
2009). Each of them resembles holoclones, meroclones and paraclones of primary 
epidermal keratinocytes respectively, while similar morphological heterogeneity is also 
observed in SINEG2 keratinocytes in vitro. 
 
In addition to their self renewal capacity and regeneration of all different colony types, 
glioma derived holoclones are poorly differentiated and display an expression profile 
reminiscent of that observed in neural stem cells, in contrast to paraclones and 
meroclones. In particular, they show elevated levels of neural stem cell associated genes 
including NESTIN and SOX2, which have also been shown to be expressed in response 
to GLI1 and GLI2∆N respectively (Kasper et al., 2006b; Snijders et al., 2008; Zhou et 
al., 2009). Thus, Zhou et al. (Zhou et al., 2009) indicates that colony morphology is 
reliable in distinguishing colonies enriched for stem cells (‘cancer stem cells’) from 
glioma cell lines, as it has been previously stated for other epithelial tumour cell lines 
(Locke et al., 2005; Harper et al., 2007; Li et al., 2008; Zhou et al., 2009). 
 
Morphological heterogeneity is typical of malignant cell lines and tumours and has 
usually been attributed to genetic instability and the selection for cells that can adapt to 
the tumour microenvironment (clonal evolution) (Weiss, 2000). However, studies since 
1977, due to the similarity of normal stem cells and a subpopulation of tumourigenic 
cells within the tumour in terms of self renewal capacity, extensive proliferative 
potential and the ability to give rise to phenotypically heterogeneous cells that exhibit 
various degrees of differentiation, suggest an underlying stem cell related pattern 
(Hamburger & Salmon, 1977). Recent evidence, including the studies mentioned above, 
strongly support the notion that the cancer stem cell model plays a major role in tumour 
heterogeneity (Hamburger & Salmon, 1977; Reya et al., 2001) and that tumourigenic 
cells can be thought of as cancer stem cells that undergo an aberrant and poorly 
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regulated process of organogenesis analogous to what normal stem cells do (Reya et al., 
2001). 
 
The cancer stem cell theory initially predicted that cancer arises from a normal stem cell 
that has acquired an ability for uncontrolled proliferation and therefore capable of 
initiating a tumour. The resultant cancer stem cell will continuously replenish the 
tumour population with more committed progenitors that are responsible for tumour 
expansion but not tumour maintenance, as well as with more differentiated cells of little 
growth potential (Lobo et al., 2007). This hypothesis can be supported by a study of 
Holland et al. (Holland et al., 2000), which demonstrated that glioma tumour 
development in mice, a brain tumour which is linked to GLI gene overexpression 
(Kinzler et al., 1987), arises from a nestin-positive progenitor population rather than 
from differentiated astrocytes, upon activation of Ras and Akt in both subpopulations. 
 
Initial studies by Bonnet and Dick (Bonnet & Dick, 1997), showed that a small 
proportion of acute myeloid leukaemia (AML) cells that are characterised by a CD34
+
 
CD38
-
 expression profile similar to normal haematopoietic stem cells, are highly 
clonogenic in vitro and are the only cells capable of transferring the disease from human 
patients to sublethally irradiated non-obese diabetic (NOD) severe combined 
immunodeficient (SCID) mice. Thus, the  fact that only a minute proportion of tumour 
cells were able to initiate cancer formation, when transplanted into nude mice, further 
supported the idea that the disease is initiated and maintained by a small subset of 
tumour cells, namely cancer stem cells (Bonnet & Dick, 1997; Reya et al., 2001). 
Moreover, the common expression signature between normal and cancer haematopoietic 
stem cells (Bonnet & Dick, 1997), has fuelled attempts to provide a functional link 
between a stem cell expression profile and the tumour initiation potential of putative 
cancer stem cells. Others studies, have focused on the phenotypic similarities between 
normal and cancer stem cells, showing that only holoclone derived prostate tumour cells 
are capable of initiating tumours, when transplanted into NOD/SCID mice (Li et al., 
2008).  
 
However, the recent demonstration that adult fibroblasts can be reprogrammed into 
pluripotent embryonic stem cell-like cells, raises the possibility that combined 
expression of stem cell associated factors and specific oncogenes could also induce a 
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non differentiated state in cancer cells (Takahashi et al., 2007; Yu et al., 2007). 
Therefore, it cannot be definitively determined whether the stem cell signature in 
several tumours is inherited from stem cell-of-origin, or is reactivated during the course 
of tumour progression (Ben-Porath et al., 2008). In addition, despite the suggested stem 
cell origin of tumours, the ability of more committed progenitor cells to initiate tumour 
formation after genetic manipulation, indicating that cancer cells can undergo 
progressive de-differentiation during their development, has led further studies to refer 
to cancer stem cells as being any cell within a tumour that possesses the capacity to self-
renew and to give rise to heterogeneous lineages of cancer cells that comprise the 
tumour (Clarke et al., 2006).  
 
Nevertheless, the mutagenic background already present in malignant cells makes it 
very difficult to draw any parallels between stem cells in normal tissues and those of 
malignant tumours. Given that genomic instability, that generates the genetic and 
epigenetic changes, is a widespread feature in many malignancies, and that homeostatic 
control mechanisms are frequently perturbed, it is difficult to attribute tumour 
heterogeneity to a stem cell pattern similar to that observed in normal healthy tissues.  
 
In addition, despite the demonstration that cancer arises from a very small number of 
tumour cells (~ 1/10
6
), recent studies have thrown a lot of doubt on that model, by 
making assay modifications regarding the immune systems of recipient mice, in an 
effort to create an environment similar to what normal human tumour cells would be 
expected to encounter in an immunocompatible background (Clarke et al., 2006). 
Notably, as little as 10 pre-B/B lymphoma cells were sufficient to initiate lymphomas 
when transplanted back to syngenic animals, while enrichment for cells expressing stem 
cell associated markers did not preferentially increase tumour incidence (Kelly et al., 
2007). More recently, by using NOD/SCID Il2rg
-/-
 mice that lack natural-killer cell 
activity, a study demonstrated that 1 in 9 cells could induce the formation of melanomas 
in mice, contradicting the previously reported estimate of 1 in 46,700 cells (Quintana et 
al., 2008). More importantly, the same study concluded that melanoma tumours could 
arise from all cell subtypes irrespectively of stem cell gene expression status (Quintana 
et al., 2008). Therefore, it is obvious from these studies that modifications in 
xenotransplantation assays can dramatically increase the detectable frequency of cells 
with tumourigenic potential. 
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Although the abundance of tumour initiating cells may be higher that previously 
thought, in some types of cancer, still the possibility that some human cancers follow a 
cancer-stem cell model cannot be ruled out, and their tumourigenic properties need to be 
further investigated, since their characterisation will provide additional insight into the 
molecular mechanisms of cancer initiation and maintenance. However, cells should be 
interrogated by optimised and multiple methods, and given that even normal adult stem 
cells are still poorly characterised due to the lack of specific stem cell markers, 
expression of potential stem cell or cancer stem cell markers should always be linked to 
functional assays, such as in vivo regeneration of the tissue of origin (Clarke et al., 
2006). 
 
3.3.5 GLI2∆N opposes epithelial differentiation  
Differentiation of human epidermis is associated with a series of morphological and 
biochemical changes as cells (transit-amplifying cells) migrate from the proliferative 
and mitotic basal cell layer through the non proliferative, post-mitotic but metabolically 
active spinous, granular and corneum layers where the terminal phase of maturation is 
completed (Fuchs, 1990). Keratinocytes in each of these layers are expressing different 
molecular markers such as keratins, involucrin, filaggrin, and loricrin (see Chapter 1, 
Section 1.1.1) (Fuchs, 1990; Fuchs, 1993; Candi et al., 2005; Fuchs, 2008). 
 
Defective terminal differentiation in culture is a consistent characteristic of malignantly 
transformed keratinocytes (Rheinwald & Beckett, 1980). Human BCCs are thought to 
be derived from keratinocytes of the basal stem cell layer of the epidermis 
(interfollicular epidermis) which are negative for markers of differentiation (see 
Chapter 1, Section 1.3.6) (Miller, 1991a; Owens & Watt, 2003; Daya-Grosjean & 
Couve-Privat, 2005; Crowson, 2006; Fuchs, 2008). Also due to the activation role of 
SHH in hair follicle morphogenesis and the striking relation between BCCs and 
deregulation of the SHH pathway in BCC tumourigenesis (Dahmane et al., 1997; Oro et 
al., 1997; Grachtchouk et al., 2000; Nilsson et al., 2000; Sheng et al., 2002; Daya-
Grosjean & Couve-Privat, 2005; Hutchin et al., 2005; Huntzicker et al., 2006), BCCs 
are also thought to be derived from undifferentiated cells of hair follicles (Kruger et al., 
1999; Owens & Watt, 2003; Hutchin et al., 2005; Blanpain & Fuchs, 2006; Crowson, 
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2006; Huntzicker et al., 2006; Mancuso et al., 2006). However, a very recent study by 
Youssef et al. (Youssef et al., 2010), using conditional overexpression of  a constitutive 
active form of mouse smoothened gene in transgenic mice under the control of specific 
promoters, favours the notion that BCCs arise from the undifferentiated cells of the 
basal layer of the epidermis (interfollicular epidermis). 
 
Consistently with the resistance to differentiation of BCC cells (Murphy et al., 1984; 
Said et al., 1984; Sumitomo et al., 1986; Miller, 1991a), it has been previously shown in 
confluent GLI2 expressing HaCaT keratinocytes, using cDNA-array technology, that 
GLI2 represses genes that are expressed in differentiating or terminally differentiated  
keratinocytes or are involved in promoting keratinocyte  differentiation (Regl et al., 
2004a). GLI2 expressing keratinocytes are also shown to maintain basal expression 
patterns in response to high-calcium induced differentiation, and to repress the 
expression of epidermal differentiation genes (cytokeratin 1, cytokeratin 10, involucrin, 
SPRR2A, loricrin) in primary human epidermal and in confluent  HaCaT keratinocytes 
(Regl et al., 2004a). Snijders et al. (Snijders et al., 2008) also showed that GLI2 
expressing HaCaT keratinocytes oppose differentiation in organotypic cultures, due to 
the fact that very few and sparse individual cells in the GLI2-expressing reconstructs 
stained positively for cytokeratin 10/13 and involucrin but not at all for loricrin 
(differentiation markers),  compared to the uniform staining observed in the upper, more 
differentiated layers of the epidermis formed by control cells. 
 
By contrast, GLI2 expression both in confluent and high-calcium confluent contact 
inhibited HaCaT keratinocytes led to increased mRNA levels of integrin beta1 (ITGB1) 
gene (Regl et al., 2004a), which is a marker of undifferentiated keratinocytes in the 
basal layer of the epidermis (Adams & Watt, 1991; Jones et al., 1995). 
 
In line with these previous studies, SINEG2 cells maintained basal-like phenotype in 
culture (Figure 3.11 and Figure 3.12), and the mRNA levels of involucrin were 
downregulated (Appendix II), whereas the mRNA levels of integrin β1 were 
upregulated, compared to the control cells (Figure 3.13A), suggesting that induction of 
β1 integrin by GLI2∆N in normal culture conditions (sub-confluent) contributes to the 
suppression of keratinocyte differentiation. 
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Integrins primarily serve as link between the extracellular matrix and the cytoskeleton, 
by mediating the attachment of cells to the extracellular matrix (Hynes, 1992), but are 
also believed to play a role in cell-cell adhesion, migration, programmed cell death, 
tissue organization and differentiation (Adams & Watt, 1989; Adams & Watt, 1990; 
Carter et al., 1990; Larjava et al., 1990; Tenchini et al., 1993; Brakebusch et al., 1997). 
Integrins are heterodimeric transmembrane receptors consisting of one α and a β subunit  
and the combination of the α and β subunit determines the ligand specificity of the 
integrin receptor (van der Flier & Sonnenberg, 2001).  
 
In skin, several integrin receptors are expressed by the epidermal keratinocytes 
including α2β1 (collagen receptor), α3β1 (laminin 5 receptor), α6β4 (laminin receptor), 
α5β1 (fibronectin receptor) (Watt, 2002). Basal keratinocytes attach to the underlying 
basement membrane that contains a range of extracellular matrix proteins including 
laminin, fibronectin and type IV collagen, via integrins and in normal undamaged 
epidermis integrin expression is confined mainly to the basal layer of proliferating 
keratinocytes and outer root sheath of hair follicles including the bulge, but are largely 
absent from the suprabasal layers of terminally differentiating cells (Adams & Watt, 
1991; Jones et al., 1995; Lyle et al., 1998; Huelsken et al., 2001; Watt, 2002). However, 
during wound healing or in certain pathological conditions such as psoriasis, there is 
expression of integrins in the suprabasal, differentiating cell layers and is generally 
associated with hyperproliferation and/or abnormal terminal differentiation (Hertle et 
al., 1992; Watt & Hertle, 1994). Immunofluorescence studies have shown that β1 
integrins are not only found as clusters interspersed with hemidesmosomes on the basal 
surface of the basal cells (focal adhesions) in the epidermis, but also around the entire 
periphery of these cells (De Strooper et al., 1989; Peltonen et al., 1989; Jensen et al., 
1999; van der Flier & Sonnenberg, 2001). 
 
Studies in human BCCs have shown that there is selective expression of β1 integrins in 
a manner resembling that of human epidermis (Peltonen et al., 1989; Miller, 1991a; 
Pentel et al., 1995). Localisation of β1 integrins was demonstrated to the peripheral 
layer containing the basal cells with the most intense staining on the surface of the cells 
that interfaced with the basement membrane (Peltonen et al., 1989). However, in areas 
of fragmentation and discontinuity, a suprabasal intercellular staining pattern of integrin 
receptors was observed instead of an epithelial-mesenchymal interface expression 
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pattern, suggesting that these areas may represent sites of invasion of this locally 
destructive tumour (Peltonen et al., 1989). 
 
 In culture, keratinocytes synthesize and deposit the major basement membrane 
components (i.e. fibronectin, laminin, collagen IV), even though the proteins are not 
organized into a recognizable basement membrane (Alitalo et al., 1982; Brown & 
Parkinson, 1983; Kubo et al., 1984; O'Keefe et al., 1984; Oguchi et al., 1985; Bohnert et 
al., 1986), supporting the idea that epidermal keratinocytes are responsible for the 
synthesis of at least some of the components of the basement membrane in human skin 
(Brown & Parkinson, 1983). 
 
In human epidermis, irreversible withdrawal from the cell cycle in the basal layer 
(Potten & Morris, 1988), along with loss of integrins expression from the cell surface 
(De Strooper et al., 1989; Peltonen et al., 1989) and loss of adhesiveness to a range of 
extracellular matrix proteins, initiate  terminal differentiation (Adams & Watt, 1990). 
 
In addition, when normal human keratinocytes are placed in suspension as single cells 
they withdraw from the cell cycle, and undergo terminal differentiation (Green, 1977) in 
a two stage process. In the first stage, there is loss of integrin-ligand binding ability that 
occurs on commitment to terminal differentiation (Adams & Watt, 1990; Hotchin & 
Watt, 1992; Hotchin et al., 1993). This ensures that early terminal differentiation is 
linked to detachment of keratinocytes from the underlying basement membrane and 
migration to the suprabasal layers (Adams & Watt, 1990). In the second stage, on overt 
terminal differentiation, integrins are lost from the cell surface (Adams & Watt, 1990; 
Hotchin et al., 1995) and there is a decrease in the transcription levels of the integrin 
genes (Nicholson & Watt, 1991; Hotchin & Watt, 1992). This can be partially inhibited 
by extracellular matrix proteins such as fibronectin (Adams & Watt, 1989) or by 
adhesion-blocking  antibodies to β1 integrins (Adams & Watt, 1990; Watt et al., 1993). 
It thus appears that ligation of β1 integrins is a negative regulator of terminal 
differentiation. However, it seems that the inhibition of terminal differentiation by β1 
integrins is not simply a consequence of β1 mediated adhesion, but it appears that the 
mechanism by which β1 integrins regulate the onset of terminal differentiation is 
distinct from the mechanism by which they mediate keratinocyte adhesion. Integrin-
mediated keratinocyte adhesion and spreading to the extracellular matrix involves 
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clustering of integrins in focal contacts and polymerization of the actin cytoskeleton 
(Hynes, 1992). In contrast, the inhibition of suspension-induced terminal differentiation 
does not involve or require neither receptor clustering nor polymerization of the actin 
cytoskeleton (Watt et al., 1993; Levy et al., 2000). Even though there are potential 
limitations of suspension induced terminal differentiation, the loss of the cell surface 
integrins and the decrease in β1 integrins mRNA levels that occur in suspension do 
parallel the in vivo situation (De Strooper et al., 1989; Peltonen et al., 1989; Adams & 
Watt, 1990; Adams & Watt, 1991; Nicholson & Watt, 1991; Hotchin & Watt, 1992). 
 
The implication of β1 integrins in the regulation of differentiation  and proliferation of 
keratinocytes, is shown also by studies in mice in which  ectopic expression  of α2, α5 
and β1 integrin in the suprabasal layers of transgenic mice resulted in 
hyperproliferation, perturbed keratinocyte differentiation and a psoriasis-like phenotype 
(Carroll et al., 1995). In addition, conditional ablation of β1 integrin gene in mouse 
epidermis caused severe hair loss due to reduced proliferation of hair matrix 
keratinocytes, lack of hair follicles and sebaceous glands decreased proliferation of the 
interfollicular epidermis and blistering (Brakebusch et al., 2000; Raghavan et al., 2000). 
However, mice lacking the α3β1 integrin show no evidence of reduced epidermal 
proliferation or abnormal differentiation suggesting that removal of all β1 integrins is 
required for a decrease in proliferation and an increase in the proportion of 
differentiating cells (DiPersio et al., 2000). In vitro, β1-null keratinocytes were 
characterised by poor adhesion to extracellular matrix proteins and a 5-fold increase in 
the proportion of terminally differentiated cells compared to β1-positive keratinocytes 
(Grose et al., 2002). On the other hand, in vivo β1-null keratinocytes do not all undergo 
spontaneous terminal differentiation like cultured keratinocytes that are held in 
suspension, probably due to the maintenance of the intercellular contacts, and to the 
presence of an abnormal, but existing basement membrane (Grose et al., 2002). 
 
Therefore, the basal-like phenotype of GLI2-expressing cells in vitro and in organotypic 
cultures, along with the increase and decrease of the transcription levels of  the integrin 
β1 and involucrin genes respectively, and the GLI2 predominant expression in region of 
normal skin and BCC where undifferentiated and proliferating cells are located (Ikram 
et al., 2004), suggests that GLI2 opposes differentiation.  
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3.3.6 GLI2∆N induces stem cell expression pattern in N/TERT 
keratinocytes 
Stem cells (SC) are the subpopulation of keratinocytes that are responsible for renewing 
the epidermis throughout adult life giving rise to the differentiating cells of the 
interfollicular epidermis (IFE), hair follicles (HF) and sebaceous glands (SG) (Watt, 
2001; Watt, 2002; Blanpain et al., 2007). Thus, it appears to be at least three distinct 
niches of skin epidermal stem cells, the follicle bulge, the base of the sebaceous glands 
and the basal layer of the epidermis and it also seems that these three progenitor 
populations share a few common expression markers such as K5, K14, p63, E-cadherin, 
α3β1 and α6β4 integrins as well as reduced levels of desmosomes and increased levels of 
adherens junctions (see Chapter 1, Section 1.1.5) (Fuchs, 2008).  
 
In skin, SHH/GLI pathway is implicated in the maintenance and regulation of the 
epidermal stem cell population residing in the epidermal basal layer (interfollicular 
epidermis) and the hair follicle bulge (Callahan & Oro, 2001; Adolphe et al., 2004; 
Blanpain & Fuchs, 2006; Zhou et al., 2006), whereas continuous activation of this 
pathway is associated with the initiation and growth of many types of human cancer 
(Beachy et al., 2004). Thus, constitutive activation of the SHH/GLI pathway in skin, 
could disrupt the epidermal homeostasis and lead to tumourigenesis with a phenotype 
that resembles stem cell characteristics (stem-like tumour phenotype), such as BCCs, 
which have been suggested to arise from epidermal basal layer or hair follicle stem cells 
(Miller, 1991a; Kruger et al., 1999; Owens & Watt, 2003; Daya-Grosjean & Couve-
Privat, 2005; Hutchin et al., 2005; Blanpain & Fuchs, 2006; Crowson, 2006; Huntzicker 
et al., 2006; Mancuso et al., 2006), with a very recent study in transgenic mice 
favouring more the stem cells of the basal layer as the cell of origin of BCCs (see 
Chapter 1, Section 1.3.6)  (Youssef et al., 2010).  
 
This notion is further supported not only by the continuous proliferation, slow growth 
and resistance to differentiation of human BCC cells (expression of keratins 5 and 14 
which are mainly expressed by basal cells (Stoler et al., 1988; Coulombe et al., 1989; 
Fuchs, 2008)) (Miller, 1991a; Crowson, 2006), but also by the fact that human BCCs 
manifest a stem cell gene profile similar to that expressed by the cells of the 
interfollicular epidermis and hair follicle bulge region, such as keratins 15 and 19, and 
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α2 and β1 integrins (Lane et al., 1991; Miller, 1991a; Jones & Watt, 1993; Jones et al., 
1995; Pentel et al., 1995; Kruger et al., 1999; Lyle et al., 1999; Morris et al., 2004; 
Tumbar et al., 2004; Crowson, 2006). In addition, BCCs display a reduced or even 
absent EGFR1 (epidermal growth factor receptor 1) expression compared with normal 
epidermis (Nazmi et al., 1990; Krahn et al., 2001; O'Driscoll et al., 2006; Rittie et al., 
2007), of which low expression is another characteristic of epidermal stem cells 
(Fortunel et al., 2003; Jensen & Watt, 2006). Similarly, human BCCs also exhibit 
reduced expression of c-MYC proto-oncogene (Bonifas et al., 2001; Regl et al., 2002; 
O'Driscoll et al., 2006; Asplund et al., 2008), of which low expression is thought to be 
necessary for epidermal stem cell maintenance (Gandarillas & Watt, 1997; Arnold & 
Watt, 2001; Watt et al., 2008). 
 
Stem cell gene expression patterns have also been reported in other poorly differentiated 
tumours such as breast, as well as in gliomas which are also associated with activated 
hedgehog signalling and GLI1/2 overexpression (Kinzler et al., 1987; Dahmane et al., 
2001; Kubo et al., 2004; Sterling et al., 2006; Clement et al., 2007; Ben-Porath et al., 
2008; Chen et al., 2008; Kameda et al., 2009).  
 
In vitro studies also suggest that SHH/GLI signalling has a potential role in the 
maintenance and proliferation of human  putative epidermal stem cells of the skin (Fan 
& Khavari, 1999; Kameda et al., 2001; Zhang & Kalderon, 2001; Zhou et al., 2006). In 
addition, Shh is also involved  in the proliferation and cell-fate specification of several 
stem cells such as neural and mesenchymal stem cells (Palma & Ruiz i Altaba, 2004; 
Kondo et al., 2005). 
 
Therefore, both these in vitro and in vivo studies, suggest that despite the reported 
effects of GLI2 in suppressing genes associated with differentiation, the more basal 
phenotype observed in SINEG2 keratinocytes could also be partly explained by an 
induction of stem cell genes by GLI2 and thus block of differentiation. Interestingly, 
GLI1 overexpression in N/TERT keratinocytes can induce the expression of a network 
of stem cell associated genes, including  K19, K15, TNC and NESTIN (Kasper et al., 
2006b), as well as it reduces the levels of the negative stem cell marker CD71 gene, 
which encodes the transferrin receptor (Tani et al., 2000; Kasper et al., 2006b) and the 
levels of  the epidermal growth factor receptor (EGFR), consistent with  the acquisition 
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of a stem cell gene expression profile (Fortunel et al., 2003; Jensen & Watt, 2006; Neill 
et al., 2008). In addition, inducible expression of GLI2 in HaCaT keratinocyte also 
resulted in the upregulation SOX2 neural stem cell marker (Snijders et al., 2008), and 
induction of epidermal stem cell marker integrin β1 in  HaCaT keratinocytes (Regl et 
al., 2004a; Eichberger et al., 2006).  
 
In agreement with these studies, SINEG2 keratinocytes displayed a dramatic 
upregulation in the transcription levels of SOX2 (Figure 3.13B), as well as an increase 
in the mRNA levels of β1 integrin gene (Figure 3.13A). 
 
3.3.6.1 Integrin β1 stem cell marker 
 
Due to the major role of integrins in regulating differentiation and also due to their 
increased levels of expression in regions where stem cells are suggested to be located 
(Jones & Watt, 1993; Jones et al., 1995; Lyle et al., 1998; Jensen et al., 1999), it is 
plausible to suggest that integrins could provide a valuable marker for epidermal 
keratinocyte stem cells. Indeed, both in cultures of primary human keratinocytes (Jones 
& Watt, 1993) and in keratinocytes isolated directly from neonatal foreskin epidermis 
(Jones et al., 1995), it is possible to enrich for stem cells by selecting the cells that have 
the highest levels of β1 integrins (Watt, 1998; Watt, 2002). Stem cells (20%) express 2-
fold higher levels of β1 integrins than do transit-amplifying cells (20%), which is also 
accompanied by a 4-fold higher colony forming efficiency of the high β1 integrin cells 
compared to the low β1 integrin expressing cells (Jones & Watt, 1993; Jones et al., 
1995). In addition, cells with characteristics of stem and transit-amplifying cells can be 
identified and isolated on the basis of their adhesive properties both in human (Jones & 
Watt, 1993; Jones et al., 1995) and mice (Bickenbach & Chism, 1998). Human basal 
cells, that express high levels of β1 integrins and adhere rapidly to fibronectin, type IV 
collagen and the extracellular matrix deposited by cultured keratinocytes (KECM), were 
enriched for cells capable of forming large, actively growing colonies, a typical 
characteristic of stem cells in vitro (Jones & Watt, 1993; Jones et al., 1995). Human 
basal cells that express lower levels of β1 integrins and adhere more slowly to the 
extracellular matrix proteins, tend to form small (fewer than 32 cells), abortive colonies 
in which the cells underwent terminal differentiation after 1 to 5 rounds of division 
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within 14 days, as indicated by expression of involucrin protein, and thus displaying 
characteristics of transit-amplifying cells (Jones & Watt, 1993; Jones et al., 1995). 
Therefore, both cultured human keratinocytes and keratinocytes isolated directly from 
skin hold the same relationship between increased β1 integrin expression, enhanced 
adhesiveness and high proliferative potential in vitro (Jones & Watt, 1993; Jones et al., 
1995), while keratinocytes directly prepared from skin, selecting for high β1 integrin 
expression and rapid adhesion to type IV collagen were also able to reconstitute an 
epidermis when grafted onto nude mice (Jones et al., 1995). Moreover, high levels of β1 
integrins are required for the maintenance of human epidermal stem cell compartment in 
vitro. Zhu et al. (Zhu et al., 1999), by retrovirally introducing a dominant negative 
integrin mutation into human epidermal keratinocytes (downregulation of β1 protein 
expression and β1-mediated adhesion function), and carrying out clonogenic assays, 
showed that reduction of β1 integrin levels stimulate keratinocytes to exit from the stem 
cell compartment, and behave like transit-amplifying cells forming small, abortive 
colonies and differentiating within a few rounds of division, accompanied by reduced 
activation of mitogen-activated protein kinase (MAPK) (Zhu et al., 1999). 
 
3.3.6.2 SOX2 stem cell marker 
 
SOX genes are transcription factors, that belong to a superfamily of genes, characterised 
by a homologous sequence known as the high-mobility-group (HMG) box, and they are 
conserved throughout the animal kingdom, while playing key roles in a number of 
developmental processes (Pevny & Lovell-Badge, 1997; Wegner, 1999). SOX genes 
have been identified on the basis of their homology to the HMG box of the testis-
determining gene Sry, also referred to as the Sry box (Sox stands for Sry-related HMG 
box), which gene resides on the Y chromosome of the mouse and human (Gubbay et al., 
1990; Sinclair et al., 1990; Pevny & Lovell-Badge, 1997; Kamachi et al., 2000). The 
mammalian SOX family comprises 20 genes, almost all of which show at least 50% 
amino acid similarity with the HMG box in Sry and can be divided into 10 subgroups 
on the basis of sequence similarity and genomic organization (Bowles et al., 2000; 
Kamachi et al., 2000). 
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This HMG box is a DNA binding domain, which mediates DNA-binding of Sox 
proteins to specific DNA sequences in the promoter or the enhancer of other genes and 
thus renders them transcription factors which either activate or repress target genes 
(Wegner, 1999; Kamachi et al., 2000). All SOX factors appear to recognize only a 
similar and specific DNA binding motif, while the L-shaped HMG domain binds to 
DNA in the minor groove and the DNA strand exhibits a bend, a widened in the minor 
groove and is helically unwound (Werner et al., 1995; Werner & Burley, 1997; Wegner, 
1999; Wilson & Koopman, 2002). Thus, SOX proteins may have an extra role apart 
from functioning as classical transcription factors, since they also seem to function as 
architectural components of chromatin by organizing local chromatin structure and 
allowing other transcription factors to bind the major groove and/or facilitating the 
formation of protein complexes (Pevny & Lovell-Badge, 1997; Wegner, 1999; Wilson 
& Koopman, 2002; Dong et al., 2004). 
 
It is currently accepted that the binding of SOX proteins to DNA is weaker than for 
most of the classical transcription factors. Thus, the transcription activity of SOX 
proteins requires recruitment of other protein partners, which stabilise the binding of the 
transcription factor complex to DNA (Kamachi et al., 2000; Wilson & Koopman, 2002). 
Thus, this combination of SOX factors with different protein partners (cell-type- or 
tissue-specific partner proteins) in order to direct gene expression, required for a 
specific cell type (cell specificity of SOX proteins), is the way by which each SOX 
factor recognizes each appropriate target gene or set of target genes, given that all SOX 
factors recognize the same core binding motif (Pevny & Lovell-Badge, 1997; Kamachi 
et al., 1999; Kamachi et al., 2000; Wilson & Koopman, 2002). This notion is also 
strengthened by the fact that each given cell type can co-express a number of SOX 
factors, while a single SOX factor is expressed in a variety of cellular contexts, is able 
to regulate different set of target genes in different tissues, and is able to participate in 
the differentiation of  a wide  variety of cells in embryonic development (Pevny & 
Lovell-Badge, 1997; Kamachi et al., 2000; Wilson & Koopman, 2002). Moreover 
sequences outside the HMG box may facilitate protein-protein interaction between the 
SOX and partner factors and also influence partner selection and thus the specificity of 
SOX proteins (Kamachi et al., 1999; Wilson & Koopman, 2002). 
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SOX2 (SRY (sex determining region Y)-box 2), is a transcription factor which is 
involved in organ development and in determining stem cell fate and properties by 
being paired off with cell-type- or tissue-specific partner factors (Kamachi et al., 1999; 
Kamachi et al., 2000; Boyer et al., 2005). SOX2 plays a key role in maintaining 
embryonic stem cell pluripontency, both in mice (Avilion et al., 2003; Masui et al., 
2007; Niwa, 2007) and human (Boyer et al., 2005; Fong et al., 2008), in regulating 
neural and retinal cell progenitors (Zappone et al., 2000; Graham et al., 2003; Kondo & 
Raff, 2004; Taranova et al., 2006), and in development of the sensory organs of the 
inner ear (Kiernan et al., 2005). SOX2 is also expressed in the endoderm of foregut-
derived organs, including tongue, oesophagus, trachea and proximal lung and stomach 
(Que et al., 2007). 
 
In addition, SOX2 in the epithelial context, is required for the differentiation of 
endodermal progenitor cells of the mouse tongue into taste bud cells (highly expressed) 
versus keratinocytes, while it is also expressed in the basal epithelial cells of the tongue 
(Okubo et al., 2006). Its overexpression in basal epithelial cells of the tongue in 
transgenic mice, causes complete suppression of the differentiation of the filiform 
keratinocytes (Okubo et al., 2006). Similarly, constitutive overexpression of SOX2 in 
mouse neural stem cells inhibits their differentiation and results in the maintenance of 
progenitor characteristics (Graham et al., 2003), while its inhibition or its complete 
depletion by RNA interference results in their premature exit from the cell cycle and 
differentiation into neurons (Graham et al., 2003; Kondo & Raff, 2004), indicating the 
essential role of SOX2 in maintaining stem cells in different tissues. 
 
Like other developmental regulatory factors, the improper functioning of SOX genes 
has been linked to a number of severe clinical disorders, indicating that the expression 
of SOX factors in different tissues is functionally significant. SOX2 mutations have 
been shown to cause anopthalmia (Fantes et al., 2003), a severe structural malformation 
of the eye, while heterozygous loss of function of SOX2 is associated with anopthalmia-
oesophageal-genital (AEG) syndrome (Williamson et al., 2006).  
 
It has also been shown that there is a link between SOX factors and cancer (Xia et al., 
2000; Dong et al., 2004). Although SOX genes such as SOX1, SOX2, SOX3 etc. are 
expressed during early development, they are almost absent, or expressed at low levels 
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in adult tissues, while they are found highly overexpressed in different types of cancer 
supporting the hypothesis that cancer progression often reflects a reversal of normal 
development (Gure et al., 2000; Dong et al., 2004). SOX2 has been found amplified in 
many different types of cancer, including small cell lung and prostate cancer (Gure et 
al., 2000; Sattler et al., 2000) which are also associated with activated hedgehog 
signalling and GLI1/2 overexpression (Watkins et al., 2003; Karhadkar et al., 2004; 
Sanchez et al., 2004; Sheng et al., 2004; Bhatia et al., 2006; Thiyagarajan et al., 2007). 
Interestingly, SOX9, a master regulator gene for cartilage differentiation was found to 
have an unexpected but essential role in the development and maintenance of the mice 
hair in skin (Vidal et al., 2005). Sox9 was found to be expressed in the outer root sheath, 
as well as in the bulge of the hair follicle (hair stem cell compartment) during hair 
development, indicating a role of it in the maintenance of hair bulge stem cells (Vidal et 
al., 2005). Its crucial role in hair differentiation was also demonstrated by the fact that 
skin deleted for Sox9 (Sox9 knockout mice), developed initially abnormal hair and 
followed by complete loss of external hair (alopecia) (Vidal et al., 2005). Most 
importantly, Sox9 showed a dramatic protein reduction both in mice Shh
-/-
 and in Gli2
-/-
 
sections, while basal cell carcinoma samples from K5:∆NGli2 mice were expressing 
high levels of Sox9, suggesting an activation of Sox9 by Gli2 (Vidal et al., 2005). 
Consistently SOX9 was found upregulated in four out of four human BCC tumours 
(Vidal et al., 2005), as well as in all subtypes of human BCC tested in another study 
(Vidal et al., 2008). In addition, expression of SOX2 gene, has also been reported in 
poorly differentiated tumours such as breast, as well as in gliomas which are also 
associated with activated hedgehog signalling and GLI1/2 overexpression (Kinzler et 
al., 1987; Dahmane et al., 2001; Kubo et al., 2004; Sterling et al., 2006; Clement et al., 
2007; Ben-Porath et al., 2008; Chen et al., 2008; Kameda et al., 2009).  
 
Therefore, the remarkable induction of SOX2 in GLI2∆N expressing N/TERT 
keratinocytes (Figure 3.13B), suggests that SOX2 may be a direct downstream target of 
GLI2∆N in human keratinocytes. This is also strengthened by the fact that a number of 
potential GLI2 consensus-binding sites are present in SOX2-promoter (Snijders et al., 
2008). Importantly in mice, it was very recently found that Gli2 can regulate the 
expression of SOX2 in developing neuroepithelial cells via direct binding to the SOX2 
enhancer region (Takanaga et al., 2009). Loss of Gli2 (Gli2∆C or Gli2 shRNA) 
suppresses the expression of SOX2, and induces premature neuronal differentiation of 
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developing neuroepithelial cells (Takanaga et al., 2009), further supporting the role of 
GLI2 in opposing differentiation and possibly in the maintenance of stem cells. 
 
3.3.7 GLI2∆N downregulates c-MYC 
Another important trait of SINEG2 keratinocytes is that of reduced c-MYC proto-
oncogene mRNA and protein levels (Figure 3.5B, C). Although significant, this finding 
was not unprecedented since c-MYC transcription is repressed in response to inducible 
expression of GLI2∆N in HaCaT keratinocytes (Regl et al., 2004a; Eichberger et al., 
2006) and it nicely correlates with the expression pattern of human BCCs, which show 
significant c-MYC reduction in both mRNA (Bonifas et al., 2001; Regl et al., 2002; 
O'Driscoll et al., 2006) and protein levels (Asplund et al., 2008).  
 
c-MYC is an oncoprotein known to induce proliferation (G1 to S phase transition), 
transformation and apoptosis in mammalian cells (DePinho et al., 1991; Amati & Land, 
1994). Overexpression of c-MYC induces proliferation and neoplastic transformation in 
many cell types, while downregulation of c-MYC accompanies differentiation of a 
range of cell types (DePinho et al., 1991). In addition, the level of c-MYC mRNA 
decreases when human keratinocytes undergo suspension or TPA induced terminal 
differentiation in vitro (Gandarillas & Watt, 1995; Hurlin et al., 1995). Consistently, in 
human interfollicular epidermis c-MYC protein is predominantly detected in the basal 
cell layers (proliferative cells), while it is almost undetectable in the terminally 
differentiating suprabasal layers (Bull et al., 2001). In human hair follicles, c-MYC 
protein was detected both in the bulb (base of the follicle) which contains a highly 
proliferative population of hair follicle epithelial cells and in the bulge, a region which 
is believed to contain stem cells, consistent with the proposed role of c-MYC as a key 
regulator of keratinocyte cell proliferation (Bull et al., 2001). Surprisingly, c-MYC 
protein was also detected in the terminally differentiating matrix cells that lie above the 
bulb and give rise to the hair fiber, suggesting, according to the authors, that c-MYC 
downregulation may not be essential for hair matrix cells to terminally differentiate 
(Bull et al., 2001).  
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Unexpectedly, a novel biological role of c-MYC in promoting differentiation of human 
keratinocytes in vitro, was revealed by Gandarillas and Watt (Gandarillas & Watt, 
1997). When c-MYC (MycER - C-terminus of Myc is fused to the ligand binding 
domain of a mutant oestrogen receptor and thus c-MYC is only active when cells are 
exposed to 4-hydroxy-Tamoxifen (4OHT)) was overexpressed in primary human 
keratinocytes, keratinocyte proliferation was decreased and accompanied by induction 
of terminal differentiation, increased  percentage of abortive colonies, and a decrease in 
the levels of β1 integrin, contradicting the expected hyperproliferative or apoptotic 
response observed in other cell types (Gandarillas & Watt, 1997). In the same study, 
when keratinocyte stem cells were distinguished from transit-amplifying cells through 
FACS, according to their β1 integrin expression levels (high and low respectively), it 
was clear that c-MYC over-expressing cells contained significantly less stem cells 
compared to the controls, as evidenced by the reduced clonogenic capacity of both 
β1
high
 and  β1
low
 c-MYC over-expressing cells in vitro;  indicating that overexpression 
of c-MYC has led to the depletion of epidermal stem cells from keratinocyte culture 
(Gandarillas & Watt, 1997). Moreover, when keratinocytes overexpressing c-MycER 
were seeded on dead, de-epidermalized dermis, they formed an abnormal epidermis. 
The reconstructed epidermis of c-MycER keratinocytes was mainly characterised by 
premature differentiation, as evidenced by decreased and increased number of 
proliferating cells and cells initiating terminal differentiation in the basal layer 
respectively, and abnormal accumulation of cells in the final stages of terminal 
differentiation (Gandarillas & Watt, 1997; Watt et al., 2008). This suggests that low 
levels of c-MYC are required for stem cells to proliferate, while sustained or high levels 
of c-MYC drive keratinocytes from the stem to the transit amplifying compartment, and 
thus stimulate terminal differentiation, rendering c-MYC a strong regulator of stem cell 
maintenance (Gandarillas & Watt, 1997). 
 
 Thus, in an attempt to combine the findings that c-MYC can stimulate both 
proliferation and terminal differentiation in human keratinocytes, it has been proposed 
by Gandarillas and Watt (Gandarillas & Watt, 1997) that since stem cells are often 
quiescent in vivo,  activation of c-MYC leads to stem cell proliferation; sustained or 
high level c-MYC activation stimulates proliferating stem cells to enter the transit 
amplifying proliferating compartment and initiate terminal differentiation as a fail-safe 
mechanism to prevent uncontrolled proliferation of epidermal stem cells, and thereby to 
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protect the epidermis from the potentially oncogenic effects of sustained c-MYC 
activation (Watt et al., 2008).  
 
This model was supported by further studies both in vitro and in vivo (Watt et al., 2008). 
In vitro it was shown that leucine-rich repeats and immunoglobulin-like domains 1 
(Lrig1), which is an EGF receptor antagonist and a putative stem cell marker, maintains 
epidermal stem cells in a quiescent non-dividing state, partly by negatively regulating c-
MYC transcription (reduced activation of c-MYC in response to EGF) (Jensen & Watt, 
2006). Downregulation of Lrig1 triggers stem cell proliferation as a result of EGF 
stimulation and of c-MYC expression - moderate increase in c-MYC which is not 
sufficient to stimulate terminal differentiation, consistent with the notion that low levels 
of c-MYC are required for keratinocyte stem cell maintenance and proliferation (Jensen 
& Watt, 2006). 
 
In vivo, constitutive over-expression of wild-type c-Myc (Waikel et al., 2001) or 
inducible c-MycER (Arnold & Watt, 2001), targeted via keratin 14 promoter to the 
basal layer of the epidermis and the hair follicles of transgenic mice skin, causes 
progressive and irreversible changes of the epidermis (Watt et al., 2008). Sustained 
overexpression of c-Myc for 5 months resulted in  (i) gradual loss of the hair in adult 
mice, (ii) epidermal hyperplasia and in some areas complete epidermal loss, (iii) 
development of spontaneous ulcerated lesions in areas of chronic mechanical stress such 
as behind the ears, due to severe impairment in wound healing probably as a result of 
impaired migration of keratinocytes in response to wounding, and finally in (iv) 
reduction of the number of stem cells in the 3 month old c-Myc mice compared to the 
control, as judged by the 75% reduction of the label retaining cells (LRCs) (Waikel et 
al., 2001). In addition, β1 integrin which is essential for the stem cell maintenance was 
found unusually reduced in the epidermis of the c-Myc overexpressing mice, which in 
combination with the other phenotypic differences, suggests a depletion of epidermal 
stem cells by high levels of c-Myc (Waikel et al., 2001). 
 
Continuous activation of c-Myc by the application of 4OHT (c-MycER) for 1 month in 
the basal layer of the transgenic mice epidermis and hair follicles via the keratin 14 
promoter, caused stimulation of proliferation, as judged by the increase in the number of 
Ki67 positive cells, predominantly in  the basal layer of the interfollicular epidermis, but 
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also in the outer root sheath of the hair follicles, thickening and hyperproliferation of the 
epidermis, and increased numbers of sebocytes along with development of abnormal 
hair follicles with often missing hair fibers (Arnold & Watt, 2001). However, it did not 
cause impaired terminal differentiation of the interfollicular epidermis which would 
reflect a possible neoplastic conversion of basal cells (Arnold & Watt, 2001). Instead, 
keratinocytes were terminally differentiated into interfollicular epidermis with increased 
number of suprabasal layers - reflecting that the thickening is due to increased number 
of differentiating layers rather than basal layers, and into sebaceous glands at the 
expense of the hair lineage differentiation (Arnold & Watt, 2001). Most importantly, 
activation of c-Myc even by a single application of 4OHT was as efficient as repeated 
doses in inducing the phenotype, while this c-Myc-induced phenotype continued to 
develop even after grafting of treated skin to untreated immunocompromised recipient 
mice (Arnold & Watt, 2001). Therefore, both these in vivo studies suggest that elevated 
expression of c-Myc depletes the epidermal stem cells by recruitment of stem cells into 
the cell cycle, irreversible exit from the stem cell compartment and stimulation of 
terminal differentiation. 
 
Alternatively, epidermal deletion of c-Myc via the K5 promoter resulted in impaired 
wound healing, thinning of the interfollicular epidermis and premature differentiation 
possibly due to a proliferation defect (Zanet et al., 2005). Furthermore, there was 
insufficient expansion of the stem cell compartment (impaired stem cell self-renewal) as 
measured by a reduction in the number of BrdU label retaining cells, further suggesting  
that low levels of c-Myc are required for stem cell maintenance (Zanet et al., 2005). 
Therefore, in the absence of c-Myc, stem cells might be able to divide but their 
daughters cannot amplify and thus undergo premature differentiation. Thus stem cells 
would be triggered to divide and differentiate more frequently to replenish the epidermis 
and their compartment might be depleted over time (Zanet et al., 2005). However, in 
another study where c-Myc was selectively deleted in adult epidermis via 4OHT 
activation of K5 promoter, there were no abnormalities in the overall epidermal 
morphology, the thickness and the hair follicles and sebaceous glands appeared normal 
(Oskarsson et al., 2006). There were also no changes in proliferation or expression of 
differentiation markers suggesting that loss of c-Myc in some extent might be 
compensated by expression of other Myc genes such as N-Myc (Oskarsson et al., 2006). 
The discrepancy between those two studies might be due to the use of a non-inducible 
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transgene that already eliminates c-Myc during embryogenesis (Zanet et al., 2005), 
rather than in the adult epidermis (Oskarsson et al., 2006). 
 
Finally, c-MycER over-expression in the suprabasal, post-mitotic cell layers of the mice 
epidermis via the involucrin promoter, disrupts the differentiation programme and 
triggers proliferation of the differentiated post-mitotic keratinocytes (Pelengaris et al., 
1999). This leads to induction of papillomatosis together with angiogenesis, changes 
that both resemble hyperplastic actinic keratosis, a commonly observed human 
precancerous epithelial lesion, revealing the oncogenic potential of c-Myc (Pelengaris et 
al., 1999). However, the phenotype is entirely reversible on withdrawal of 4OHT, 
suggesting that cells with activated c-MycER upon withdrawal of 4OHT are being lost 
from the tissue through terminal differentiation and thus the differentiation compartment 
will be replenished by a pool of stem cells that are not expressing c-MycER (Arnold & 
Watt, 2001). Moreover, c-MycER induced lesions did not convert into malignant 
tumours indicating that further mutations might need to be acquired, for complete 
transformation and tumourigenesis (Pelengaris et al., 1999). 
 
Overall, both from studies in human keratinocytes in culture and in various mice models 
it can be concluded that within the epidermis, c-MYC can act both as an agent that 
promotes differentiation of stem cells as well as an oncogene, depending on where in 
the epidermis it is expressed, the levels and the duration of its expression as well as the 
time of the observation (Watt et al., 2008).  
 
Therefore, low levels of c-MYC might also contribute to the undifferentiated stem cell 
like phenotype of GLI2∆N expressing cells and possibly to the role of GLI2∆N in 
opposing differentiation and in the induction or maintainance of stem cell characteristics 
in cells, resembling in some aspects the gene expression of basal cell carcinomas. 
 
3.3.8 Poor adhesion of GLI2∆N-expressing cells to the extracellular surface 
in culture 
Another property of keratinocyte stem cells is that of strong adhesion to the 
extracellular matrix. Immature populations of basal epidermal keratinocytes have been 
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identified by differential expression of β1 integrins (Jones & Watt, 1993; Jones et al., 
1995). Positive fractions of integrin β1 human epidermal keratinocytes have shown a 
superior capacity for rapid adhesion to extracellular matrices (Collagen IV, Fibronectin 
and extracellular matrix deposited by cultured keratinocytes) (Jones & Watt, 1993; 
Jones et al., 1995). It will be therefore expected that SINEG2 cells, that exhibit high 
levels of integrin β1 compared to the controls, will adhere more efficiently to the 
extracellular surface during culture conditions. However, it was observed that even 
though SINEG2 cells displayed a very cohesive phenotype (cell-cell interaction), at the 
same time they displayed a significant delay in terms of adhesion to substrate (culture 
vessel) (cell-substrate interaction) and were also very easily detached by trypsinisation, 
compared to control N/TERT and SINCE cells. Often, GLI2∆N keratinocytes needed 
more than 18 hours to completely attach to the substrate, with a few cells permanently 
remaining in suspension. This difference between the SINEG2 cell-cell and cell-
substrate interactions is probably due to the different set of proteins, such as cadherins 
(adherens-junctions and desmosomes) and integrins (focal adhesions and 
hemidesmosomes) respectively, which are responsible for the implementation of those 
two processes (Garrod, 1993; Nievers et al., 1999; van der Flier & Sonnenberg, 2001). 
Given that the mechanism by which β1 integrins regulate the onset of terminal 
differentiation is distinct from the mechanism by which they mediate keratinocyte 
adhesion (Watt et al., 1993; Levy et al., 2000), and since the attachment efficiency  of 
SINEG2 in culture vessels coated with any of the  integrin β1 ligands such as collagen, 
laminin or fibronectin was not examined in my study, a possible explanation for this 
deficiency could be the improper production of basement membrane proteins by 
SINEG2 cells, as well as the possible absence of other integrins necessary for anchorage 
to the basement membrane from SINEG2 cells. 
 
Consistent with these notions, and with the decreased ability of SINEG2 keratinocytes 
for attachment to culture substrate, is also the poor adhesion to collagen/fibroblast 
layers, that was recently observed in GLI2∆N-expressing HaCaT GLI2 keratinocyte  
tissue reconstructs (Snijders et al., 2008), suggesting a defect in the structural link 
between the GLI2-expressing keratinocytes and the extracellular matrix. Indeed, the 
expression of components of the basement membrane zone in GLI2-expressing HaCaT 
GLI2 cells was abnormal. There was complete loss of integrin β4 (ITGB4), compared to 
the linear pattern in the basal keratinocyte layer of the controls, and only a few, and not 
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limited to the basal layer HaCaT GLI2 cells, were expressing laminin 5γ-2 (LAMC2 - a 
major constituent of the basement membrane zone), while in controls the staining was 
intense in the cytoplasm of keratinocytes in the basal layer and at the dermal-epidermal 
junctions (Snijders et al., 2008). 
 
Malignant transformation is characterised by disruption of cytoskeletal organization, 
decreased adhesion, and altered adhesion dependent responses (Mizejewski, 1999). 
Thus altered epidermal integrin expression (downregulation, upregulation and/or altered 
distribution in the epidermis) may contribute to a transformed cell phenotype 
(Mizejewski, 1999; Watt, 2002). Focal or generalized loss of integrins is a feature of 
oral squamous cell carcinoma (Bagutti et al., 1998), while focal α6β4 integrin loss in 
tumours such as oral squamous cell carcinoma tend to correlate with loss of basement 
membrane proteins and has been proposed to participate in invasion (Downer et al., 
1993).  
 
Integrin β4 participates in the formation of hemidesmosomes (Dowling et al., 1996), 
which are protein complexes in the inner basal surface of keratinocytes in the epidermis, 
and are anchoring the cell to the underlying basement membrane, by connecting the 
intermediate keratin filaments with the extracellular matrix (Borradori & Sonnenberg, 
1999; Nievers et al., 1999; van der Flier & Sonnenberg, 2001). Thus α6β4 integrin, as a 
component of hemidesmosomes, is primarily concentrated in the basement membrane 
zone and genetic ablation of the α6 or β4 integrin gene in mice resulted in a complete 
absence of hemidesmosomes, creating large blisters between the dermis and the 
epidermis, displaying only a very  fragile attachment  to the basal lamina and exhibiting 
signs of degeneration and tissue disorganization (Dowling et al., 1996; Georges-
Labouesse et al., 1996; van der Neut et al., 1996). In addition, the existence of clusters 
of basal keratinocytes found in the suprabasal layers of the β4-null mouse epidermis, 
suggests that either there is clonal expansion of keratinocytes that have escaped 
detachment-induced cell death, or that basal cells became catapulted into the suprabasal 
layers, due to disrupted basement membrane adhesion (Dowling et al., 1996; Watt, 
2002). 
 
Interestingly, the observations that GLI2 overexpression disrupts both the normal 
adhesion capacity of cells to attach to the extracellular surface and the normal 
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expression pattern of keratinocyte-derived proteins linking the epithelium to the stroma, 
made from GLI2∆N overexpressing N/TERT (SINEG2) keratinocytes in vitro, and 
from reconstructs of HaCaT GLI2∆N-overexpressing keratinocytes respectively, 
correlate with the findings in human BCCs. Although histochemical studies in human 
BCCs have shown a continuous band of collagen and laminin around nodular islands of 
BCC, indicating an intact basement membrane in micronodular or more aggressive BCC 
subtypes such as infiltrative, morpheaform and basosquamous, there are broad regions 
of discontinuity or absence of this basement membrane (Miller, 1991a; Crowson, 2006). 
In addition, occasional discontinuities have been observed with fingerlike cytoplasmic 
projections extended into the stroma of these regions (Miller, 1991a). These 
observations suggested that in nodular BCC subtype, epidermal tumour cells following 
local invasion, may cease migration and produce distinct continuous basal lamina, 
similar to that of the normal dermal-epidermal junction (a barrier for further invasion), 
while in more aggressive BCC subtypes there is loss of the basal lamina in foci of 
ongoing tumour invasion (McArdle et al., 1984; Miller, 1991a). Thus, factors that might 
contribute to this initial local invasion of all BCC subtypes including nodular BCCs, as 
well as in the ongoing invasion of the more aggressive BCCs, are the (i) discontinuity of 
the basement membrane zone due to its impaired formation from the epidermal tumour 
cells, (ii) the induction of factors from the epidermal tumour cells which stimulate 
fibroblasts from the stroma to proliferate and release of collagenase, an enzyme which is 
required for the initiation of collagen breakdown and is thus important in the 
pathogenesis of soft tissue destruction in vivo (Bauer et al., 1977; Hernandez et al., 
1985), along with (iii) the upregulation of transmembrane matrix metalloproteinases 
(MMPs) in epidermal tumour cells, which are able to degrade all kinds of proteins of the 
extracellular matrix (Miller, 1991a; Nagase & Woessner, 1999; Westermarck & Kahari, 
1999; Crowson, 2006; Page-McCaw et al., 2007). 
 
Comparable to the in vitro studies, the existence of retraction spaces observed around 
the human nodular and superficial BCC tumour islands with mucin deposition (slit-like 
retractions of the palisaded basal cells from the subjacent stroma), indicates reduced 
adhesion between keratinocytes of the basement membrane and the stroma (BCC 
loosely adhere to the collagen), probably due to collagenase upregulation by adjacent 
fibroblasts and thus reduction of collagen, as well as to mucin production from the 
epidermal tumour cells and to the absence of type VII collagen anchoring fibrils 
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(another component of the basement membrane secreted by fibroblasts, which connects 
the basement membrane to the stromal collagen) (Miller, 1991a; Hollingsworth & 
Swanson, 2004; Crowson, 2006). 
  
The existence of these retraction spaces also within the basement membrane in all types 
of human BCCs, is suggestive of a decrease in numbers of hemidesmosomes (Miller, 
1991a), the formation of which requires the presence of integrin β4 (Dowling et al., 
1996), which in turn is markedly suppressed in GLI2∆N expressing keratinocytes 
(Snijders et al., 2008). Indeed, hemidesmosomes cover the 45% of the basal area  in 
normal basal cells, while in BCCs including nodular ones, they occupy only 7% (Miller, 
1991a), further suggesting an impaired tumour cell-basement membrane and basement 
membrane-stroma attachment. 
 
3.3.9 GLI2∆N overexpression does not accelerate proliferation in culture 
Contradictory to the oncogenic properties of GLI2∆N transcription factor, its 
overexpression resulted in significant reduction of N/TERT keratinocyte proliferation 
(Figure 3.14 and Figure 3.15). The marked reduction in cell proliferation could be 
attributed to a variety of factors including cell cycle arrest, impaired or delayed mitosis, 
apoptosis and/or cell death, or poor adhesion to the substrate.  
 
Notably, this ability of SINEG2 cells resembles the slow growing nature of human basal 
cell carcinomas as well as the slow cycling status of keratinocytes stem cells (Miller, 
1991a; Potten & Booth, 2002; Crowson, 2006). The ability to grow at slow rates, but for 
longer period of time is an attribute characterising stem cells in vitro (Potten & Booth, 
2002). However, much like any immortalised cell line, the nature of N/TERT 
keratinocytes, does not allow the identification of a distinct population of cells with 
ability for prolonged growth in vitro. Therefore, the effect of GLI2∆N overexpression, 
in the cell cycle dynamics and the long term proliferative potential, of finitely 
replicating primary human epidermal keratinocytes, could be of great interest. 
 
A reduced growth rate in response to GLI2∆N overexpression was also previously 
reported in HaCaT keratinocytes (Snijders et al., 2008). However, large scale expression 
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microarray analysis in the same cell line, carried out from another group, has revealed 
that several proliferation associated genes (i.e. CCND1, E2F1, CCNB1, PCNA), are 
upregulated in transcript levels in response to transient induction of GLI2∆N (Regl et 
al., 2004a). This study was conducted in confluent, contact inhibited keratinocytes 
strongly suggesting that GLI2∆N is stimulating cell cycle re-entry, opposing contact 
inhibition (Regl et al., 2004a). In addition, qRT-PCR analysis of the levels of expression 
of some of these associated genes (i.e. CCND1, CCNB1) in contact-inhibited human 
primary keratinocytes confirmed the proliferative expression profile of the contact-
inhibited GLI2-expressing cells (Regl et al., 2004a). Thus, the differences in 
proliferation associated gene expression are likely to be reflecting the inability of 
normal control keratinocytes to proliferate under confluent conditions, compared to 
GLI2∆N expressing cells, and do not predict that GLI2∆N overexpression can confer 
any proliferative advantage (more rapid cell cycle) under normal steady state culture 
conditions, compared to the controls. In support, while at post confluent HaCaT 
keratinocytes expression of GLI2∆N induces a two-fold increase in BrdU-incorporation 
(DNA synthesis) compared to control cells, at sub-confluence there is no difference in 
BrdU-incorporation between GLI2∆N-expressing HaCaT cells and controls (Regl et al., 
2002). In addition, induction of GLI2∆N in tissue reconstructs, increases the proportion 
of Ki-67 (proliferation marker) positive keratinocytes compared to the controls, but does 
not induce an increase in the mitotic index of HaCaT keratinocytes, as judged by 
phosphohistone H3-PHH3 staining (Hendzel et al., 1997; Snijders et al., 2008).  
 
However, the same group (Regl et al., 2004a) using the same cell line (GLI2∆N HaCaT) 
performed another, larger scale expression microarray analysis in non-confluent HaCaT 
cells and showed that some proliferation associated genes are upregulated in response to 
inducible expression of GLI2∆N (Eichberger et al., 2006). Strikingly though, the same 
GLI2∆N HaCaT cell line that was used by Eichberger et al. (Eichberger et al., 2006) for 
microarray analysis, not only had no proliferative advantage (more rapid cell cycle) 
compared to the control, but instead it showed a reduced growth rate in culture, as 
reported by Snijders et al. (Snijders et al., 2008).  
 
The proliferative activity in normal epidermis is restricted to the basal layer, since only 
the innermost basal layer of the epidermal cells has the capacity for DNA synthesis and 
mitosis (Fuchs, 1990). All keratinocytes leaving the basal membrane shift to program of 
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gene expression leading to terminal differentiation (Fuchs, 1990). Thus, keratinocytes in 
the suprabasal layers of the epidermis are postmitotic and any proliferative activity in 
the suprabasal layers could indicate an impaired differentiation program. Accordingly, 
Snijders et al. (Snijders et al., 2008) showed that induction of GLI2∆N results in 
inappropriate keratinocyte proliferation across all epithelial layers, as opposed to control 
HaCaT keratinocytes where proliferation (only a few cells) is strictly confined to the 
basal layers of reconstructed epithelium. Therefore, although keratinocytes are 
inappropriately in cycle in all layers of the epithelium, GLI2∆N expression did not 
result in accelerated cell division (Snijders et al., 2008).  
 
The reasons behind the observed delay in the growth of SINEG2 keratinocytes will be 
discussed more extensively in the next chapter (Chapter 4, Section 4.3.1.1). Although 
it is possible that poorly adhering SINEG2 keratinocytes resume normal cell cycle later 
than N/TERT and SINCE keratinocytes, loss of cells either through apoptosis or cell 
death is not likely to be responsible for this effect as none of the associated features (i.e. 
membrane blebbing, floating or necrotic cells, increase in trypan blue positive cells) 
were observed during routine keratinocyte culture.  
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3.4 Summary 
In this chapter, evidence is provided for the efficient stable transduction of N/TERT 
keratinocytes with pSINEGFP-GLI2∆N which results in the generation of a cell line 
that showed strong transgene mRNA expression and production of high protein levels. 
Similarly, in the inducible system significant induction of GLI2∆N protein levels were 
observed, but without avoiding a background GLI2∆N activation in uninduced control 
cells. In addition, previously established gene targets of GLI2∆N and BCC molecular 
markers, such as BCL-2 and c-MYC, were appropriately regulated in my system, 
indicating the relevance of my in vitro model system to HH/GLI induced gene 
expression patterns in human BCC. Importantly, GLI2∆N-expressing keratinocytes 
manifest a phenotype with a considerable degree of heterogeneity, which is mainly 
characterised by compact, undifferentiated, basal-like keratinocyte colonies, similar to 
the undifferentiated phenotype of human BCCs. This basal-like phenotype of SINEG2 
keratinocytes is in accordance with, and can be attributed to, the ability of GLI2∆N to 
suppress differentiation, through the downregulation of genes responsible for the onset 
of differentiation such as c-MYC, of differentiation markers such as involucrin and of 
stem cell markers such as integrin β1 and SOX2, as observed in my study and which is 
in line with previous studies. Moreover, in this chapter it was observed that GLI2∆N 
overexpression disrupts the normal adhesive capacity of cells to attach to the 
extracellular surface, as judged by the delay that cells display in terms of adhesion to the 
substrate and their easy detachment upon trypsinisation, compared to the control cells. 
Finally, overexpression of GLI2∆N in human N/TERT keratinocytes does not seem to 
accelerate proliferation in culture, as revealed by the reduced growth rate of SINEG2 
keratinocytes compared to control cells. 
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GLI2∆N overexpression induces numerical and 
structural chromosomal instability in N/TERT human 
keratinocytes  
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4.1 Introduction 
Although little is known about the role of the SHH/GLI2 on the cell cycle, several 
mechanisms have been proposed for the interactions of SHH/GLI signalling with 
important cell cycle mediators that promote cell proliferation, including cyclin D1, 
cyclin B1 and CDC25B (M-phase inducer phosphatase 2), which have been described 
more extensively in Chapter 1, Section 1.3.7 (Barnes et al., 2001; Ruiz i Altaba et al., 
2002a; Pasca di Magliano & Hebrok, 2003; Wetmore, 2003; Daya-Grosjean & Couve-
Privat, 2005; Aberger & Frischauf, 2006; Athar et al., 2006; Benazeraf et al., 2006; 
Kasper et al., 2006a).  
 
In support of that, loss of Shh or Gli2 function in mice leads to a significant decrease in 
the rate of cell proliferation in the developing hair follicle (Mill et al., 2003). In 
addition, SHH expression can oppose growth arrest (G1 arrest) of primary human 
epidermal keratinocytes in response to extracellular calcium as well as to ectopic 
expression of CDKI p21
WAF1/CIP1
 (Fan & Khavari, 1999). Accordingly, inducible 
expression of GLI2∆N in contact inhibited (confluent) cultures of HaCaT and primary 
human keratinocytes is sufficient to stimulate DNA synthesis (G1-S progression), re-
entry to the cell cycle and to regulate the mRNA levels of specific cell cycle genes 
involved in G1-S and G2-M phase progression, such as cyclin D1 (CCND1), E2F 
transcription factor 1 (E2F1) and cyclin B1 (CCNB1) respectively (see Chapter 3, 
Section 3.3.3) (Regl et al., 2002; Regl et al., 2004a). Moreover, a larger scale 
expression microarray analysis, that was performed using the same cell line (GLI2∆N 
HaCaT), further showed that some proliferation associated genes, including E2F1 and 
cyclin B1, are upregulated in response to inducible expression of GLI2∆N (see Chapter 
3, Section 3.3.9) (Eichberger et al., 2006).  
 
However, it has not yet been reported that keratinocytes expressing GLI2 have an 
accelerated proliferation rate in normal culture conditions. Instead, the same inducible 
GLI2∆N HaCaT cell line that was used by Eichberger et al. (Eichberger et al., 2006) for 
microarray analysis, showed no proliferative advantage (more rapid cell cycle) 
compared to the control, whereas it showed a reduced growth rate in culture, as reported 
by Snijders et al. (Snijders et al., 2008). Similarly, a reduced growth rate in response to 
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GLI2∆N overexpression was observed in my system (see Chapter 3, Section 3.2.3.2, 
Figure 3.14 and Figure 3.15) (see Chapter 3, Section 3.3.9). 
 
Therefore, in this chapter, I have investigated the effect of GLI2∆N, on the cell cycle of  
N/TERT keratinocytes, and on checkpoints genes that control the cell cycle, the 
regulation of which is important for the maintenance of genomic integrity and  
necessary to impose the appropriate limitations to uncontrolled proliferation (Sherr, 
1996). In addition, factors such as cell cycle arrest, impaired or delayed mitosis, 
apoptosis and/or cell death, which might have contributed in the reduced rate of 
N/TERT keratinocytes proliferation upon GLI2∆N induction, are also examined in this 
chapter. 
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4.2 Results 
4.2.1 GLI2∆N induces G2/M increase, tetraploidy and polyploidy in 
Human Keratinocytes 
4.2.1.1 GLI2∆N induces G2/M increase  
Several oncogenes have been implicated in the regulation of cell cycle specific genes, 
promoting cell survival and increased proliferation rate. However, the oncogenic stress 
response can vary depending upon the different cell context. It has been shown that 
oncogenic Ras activation can increase the proliferation of aberrant cells, but can also 
lead to growth arrest and/or senescence when induced in primary cells with intact 
tumour suppressor responses (Di Micco et al., 2006; Sarkisian et al., 2007).  
 
Therefore, I sought to investigate the effects of GLI2∆N oncoprotein expression in 
N/TERT cells which have a functional p53/p21
WAF1/CIP1
, diploid genome and retain 
normal epidermal keratinocyte differentiation in organotypical cultures (Dickson et al., 
2000). 
  
Flow cytometry analysis was used, after Hoechst-33342 staining (see Chapter 2, 
Section 2.8.1 and Section 2.8.1.3) (Shapiro, 1981a; Shapiro, 1981b), to investigate the 
effect of stable EGFP-GLI2∆N expression on the cell cycle of N/TERT keratinocytes. 
Equal number of N/TERT, SINCE, and SINEG2 cells were seeded and harvested after 
48 hrs (~ 60% confluent) for flow cytometry analysis both for DNA content and green 
fluorescence (EGFP) which corresponds to exogenous EGFP protein and EGFP-
GLI2∆N fusion protein. GLI2∆N-expressing keratinocytes, showed a significant 
increase in the G2/M population, when compared to both EGFP control and wild-type 
N/TERT cells (Figure 4.1A i).  
 
Then, the same approach was used to investigate the cell cycle of NTEG2 cells, after the 
induction of EGFP-GLI2∆N, by removal of dox for 5 days (Figure 4.2A i). Cells were 
stained with Hoechst-33342 and analysed both for DNA content and green fluorescence 
(EGFP) which corresponds to exogenous EGFP-GLI2∆N fusion protein (see Chapter 
2, Section 2.8.1 and Section 2.8.1.3). After gating on EGFP+/- cells and doublet 
discrimination with width and area parameters, using N/TERT as a reference cell line, 
Chapter 4: GLI2∆N induces numerical and structural chromosomal instability 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 322 
the cell cycle of EGFP+/- cells was determined. The EGFP negative (Dox+) and 
positive (Dox-) populations were discriminated and their cell cycle profiles were 
obtained. EGFP positive (Dox-) cells, show a marked increase in G2/M phase, 
compared to EGFP negative (Dox+) cells, which comes in total agreement with the 
results obtained from stable expression of GLI2∆N in N/TERT keratinocytes, 
suggesting a strong correlation between EGFP-GLI2∆N fusion protein expression and 
an increase in G2/M phase.  
 
Experiments for both cell lines were repeated three separate times, and average values 
are presented in the tables shown in Figure 4.1A ii and Figure 4.2A ii, and in graphs 
plotted Figure 4.1B and Figure 4.2B, to indicate the statistically significant (** 
P≤0.01) differences in the percentages of G2/M populations in both cell lines examined.  
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Figure 4.1: Stable expression of GLI2∆N induces G2/M arrest in N/TERT cells.  
(A) Flow cytometry analysis of stable EGFP-GLI2∆N cell line (SINEG2) against both N/TERT 
and SINCE control cells after Hoechst-33342 staining (i). After doublet discrimination with 
width and area parameters, cells were discriminated according to DNA content and the cell 
cycle profile was obtained. A significant increase in the cell population at the G2/M boundary is 
evidenced in the SINEG2 cell line, compared to both N/TERT and SINCE cells. Average values 
of three independent experiments are presented (ii). (B) Graphical presentation of the 
percentage of G2/M populations, to indicate the significant differences in the presence or 
absence of EGFP-GLI2∆N expression. Each bar represents the mean values ± s.e.m of three 
independent experiments. ** P≤0.01.  
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Figure 4.2: Inducible expression of GLI2∆N induces G2/M arrest in N/TERT cells.  
(A) Flow cytometry analysis of NTEG2 cell line (i). After gating on EGFP+/- cells and doublet 
discrimination with width and area parameters, using N/TERT as a reference cell line, the cell 
cycle of EGFP+/- cells was determined. EGFP negative cells were obtained from Dox+ samples 
and were compared to EGFP positive cells obtained from NTEG2 cells, in the absence of 
doxycycline for 5 days (Dox- samples). A G2/M phase increase is evidenced in EGFP positive 
(Dox-) populations, compared to the EGFP negative (Dox+) populations. Average values of 
three independent experiments are presented (ii). (B) Graphical presentation of the percentage 
of G2/M populations, to indicate the significant differences in the presence or absence of EGFP-
GLI2∆N expression. Each bar represents the mean values ± s.e.m of three independent 
experiments. ** P≤0.01.  
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4.2.1.2 GLI2∆N does not cause increased cell death or apoptosis  
Given the slow growth profile of stable GLI2∆N-expressing cells (SINEG2), observed 
in Chapter 3, Section 3.2.3.2 (Figure 3.14 and Figure 3.15), and the increase in their 
G2/M phase (Figure 4.1), compared both to N/TERT and SINCE control cells, it was 
investigated whether there is any evidence of increased apoptosis or cell death, by using 
Annexin V staining and flow cytometry analysis (see Chapter 2, Section 2.8.1 and 
Section 2.8.1.5). 
 
Apoptosis, or programmed cell death, is a normal physiologic process, which occurs 
during embryonic development as well as in the maintenance of tissue homeostasis 
(Taylor et al., 2008). Apoptosis can be detected by different methods including, 
Annexin V staining (early stage of apoptosis) (Vermes et al., 1995), PI-staining and 
flow cytometry analysis to detect cells with sub-G1 content (late stage of apoptosis) 
(Riccardi & Nicoletti, 2006), and caspase activation (late stage of apoptosis) (Riedl & 
Shi, 2004). During apoptosis, cells acquire certain morphological features, including 
shrinkage, loss of plasma membrane (membrane blebbing), condensation of the 
cytoplasm and the nucleus (pyknosis), followed by DNA fragmentation (Taylor et al., 
2008). Annexin V, is a Ca
2+
 dependent phospholipid-binding protein that has a high 
affinity for membrane phosholipid phosphatidylserine (PS), and binds to cells with 
exposed PS (Raynal & Pollard, 1994). In apoptotic cells, the membrane phosholipid 
phosphatidylserine (PS) is translocated from the inner to the outer leaflet of the plasma 
membrane, thereby exposing PS to the external cellular environment and thus enabling 
the binding of Annexin V to it (Koopman et al., 1994; Martin et al., 1995). Due to the 
fact that externalisation of PS occurs in the earlier stages of apoptosis (Martin et al., 
1995), Annexin V staining is used to identify apoptosis at an earlier stage, compared to 
assays based on nuclear changes (DNA fragmentation), such as propidium iodide 
staining. DAPI (Kubista et al., 1987; Barcellona et al., 1990) was also used for staining 
along with Annexin V in order to discriminate late apoptotic or dead cells which have 
lost membrane integrity from early apoptotic cells which still have intact membranes, 
by dye exclusion (see Chapter 2, Section 2.8.1.5). 
 
Equal number of N/TERT, SINCE, and SINEG2 cells were seeded and harvested after 
48 hrs for Annexin V (Cy
TM
5 Annexin V) and DAPI staining, followed by flow 
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cytometry analysis. Results clearly show that upon induction of GLI2∆N oncogene, 
there is no difference in any of the three different subpopulations of cells (live, early 
apoptotic, late apoptotic/dead cells), between control and GLI2∆N-expressing cells 
(Figure 4.3). Therefore, activation of GLI2∆N in N/TERT cells does not cause any 
increased apoptosis or cell death. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Annexin V staining in N/TERT, SINCE and SINEG2 cells.  
N/TERT, SINCE and SINEG2 cells were stained with Cy
TM
5 Annexin V and DAPI for the 
detection of apoptotic and dead cells respectively. The percentage of cells representing the early 
(Annexin V (+) DAPI (-)) and late (Annexin V (+) DAPI (+)) apoptotic or dead populations, do 
not show significant differences between all three different cell lines. Expectedly, the 
percentage of cells in the remaining live (Annexin V (-) DAPI (-)) populations are similar in 
both control and GLI2∆N-expressing cells, suggesting that GLI2∆N upregulation does not 
cause cell death or apoptosis in N/TERT keratinocytes. Each bar represents the mean values ± 
s.e.m of three independent experiments each of which consisted of duplicate samples. 
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4.2.1.3 GLI2∆N induces numerical chromosomal instability in human N/TERT 
keratinocytes 
The marked increase of cells in G2/M phase could indicate a G2/M block, and thus a 
G2/M checkpoint activation, and/or an increase of cells with DNA content of 4N (G2/M 
phase), indicating abnormal accumulation of tetraploid/bi-nucleated cells in response to 
GLI2∆N induction. 
 
Thus, in order to investigate the cell cycle profile of stable GLI2∆N over-expressing 
N/TERT cells more extensively, propidium iodide staining (Krishan, 1990) was used for 
flow cytometry analysis (see Chapter 2, Section 2.8.1 and Section 2.8.1.4). Equal 
number of N/TERT, SINCE, and SINEG2 cells were seeded and stained for propidium 
iodide, followed by flow cytometry analysis for DNA content. The cell area parameters 
were increased in order to check for the existence of cells with DNA content more than 
4N, where N is the haploid number, which represents one complete set of chromosomes 
(23 chromosomes). Doublets were excluded by adjustment of the width and area 
parameters.  
 
In addition, propidium iodide staining in permeabilised cells facilitates the 
discrimination of cells with reduced DNA content, due to DNA fragmentation (sub-G1 
populations). When cells are permeabilised, the apoptosis-mediated fragmented DNA 
multimers leak out of the cell, and therefore the resulting stained by propidium iodide 
sub-G1 populations, represent late apoptotic/dead cells (cells with fragmented DNA), 
and thus used for detection of later stages of apoptosis (see Chapter 2, Section 2.8.1.4) 
(Riccardi & Nicoletti, 2006). 
 
The sub-G1 population for all three cell lines was at basal levels, with no significant 
differences (Figure 4.4 i, ii, iii), indicating that overexpression of GLI2∆N does not 
seem to cause any cell death or apoptosis, reconfirming the data from Section 4.2.1.2. 
However, GLI2∆N expressing N/TERT cells again showed an increase in G2/M phase 
and a 3 fold increase in the cell population containing DNA 8N (Figure 4.4 iii) 
compared both to N/TERT and SINCE control cells (Figure 4.4 i, ii). This 8N 
population represents cells, which are known as polyploid cells, cells that have acquired 
more than two homologous sets of chromosomes. Polyploid populations (8N) are 
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represented by a clear peak appearing at the far right of the flow cytometry trace (see 
inset Figure 4.4 iii). Data are representative of three independent experiments. 
 
Further flow cytometry analysis in Hoechst-33342 stained cells, showed that SINEG2 
cells have a significant increase in the percentage of polyploid cells (>4N and 8N), 
compared to N/TERT and SINCE cells (Figure 4.5 i, ii). Four independent experiments, 
each of them consisting of duplicate or triplicate samples, were carried out with both 
Hoechst-33342 and Propidium Iodide staining, and similar results were obtained. 
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Figure 4.4: GLI2∆N induces polyploidy in N/TERT keratinocytes. 
Propidium iodide staining, followed by flow cytometry analysis to obtain cell cycle distribution 
of N/TERT (i), SINCE (ii), and SINEG2 (iii) cells. Sub-G1 trace was negligible for all cell lines 
examined. Flow cytometry analysis revealed a G2/M phase increase in SINEG2 cells (iii) and a 
3 fold increase in the percentage of cells with DNA content 8N, represented by a clear peak 
appearing at the far right of the flow cytometry trace (see inset, iii). N: haploid number. Data 
are representative of three independent experiments. 
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Figure 4.5: GLI2∆N induces polyploidy in N/TERT keratinocytes. 
Graphical representation of the percentage of polyploid (i) 8N and (ii) >4N cells, for each cell 
line after Hoechst-33342 staining and flow cytometry analysis. SINEG2 cells have significantly 
higher (** P≤0.01) percentage of polyploid cells in culture. Each bar represents the mean values 
± s.e.m of duplicate samples. ** P≤0.01. N: haploid number. 
 
 
These results suggest that the increase in G2/M population, observed both by Hoechst-
33342 staining (Figure 4.1 and Figure 4.2), and by propidium iodide staining (Figure 
4.4), might be due to the increase of bi-nucleated/tetraploid cells (DNA content 4N) 
upon GLI2∆N induction, which precede the formation of polyploid and aneuploid cells 
and can lead to genomic/chromosomal instability (Storchova & Pellman, 2004; Ganem 
et al., 2007). Tetraploidy, is a feature that is commonly seen in human cancer, including 
human BCCs (Miller, 1991a; Rajagopalan & Lengauer, 2004; Shi & King, 2005; 
Olaharski et al., 2006; Weaver & Cleveland, 2006; Ganem et al., 2007; Storchova & 
Kuffer, 2008), and has been reported as an early step in human tumourigenesis and as a 
contributing factor in the generation of aneuploid tumours (Shackney et al., 1989; 
Galipeau et al., 1996; Storchova & Pellman, 2004; Zhivotovsky & Kroemer, 2004; 
Fujiwara et al., 2005; Ganem et al., 2007; Storchova & Kuffer, 2008; Holland & 
Cleveland, 2009).  
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Tetraploidy and polyploidy can result from a variety of alterations (Figure 4.6) 
(Storchova & Pellman, 2004); either as a result of (a) endoreplication - DNA replication 
in the absence of complete mitosis, a normal developmental program, observed in the 
megakaryocyte (Ravid et al., 2002), yielding mononucleated tetraploid cells, which lead 
to the formation of terminally differentiated non-dividing polyploid cells, (b) cell fusion 
due to viruses (Vignery, 2000; Taylor, 2002; Duelli & Lazebnik, 2007), yielding 
binucleated tetraploid cells, (c) centrosome overduplication (centrosome amplification), 
yielding either mononucleated or binucleated tetraploid cells (Nigg, 2002; Fukasawa, 
2007), (d) failure in centrosome duplication, yielding mononucleated tetraploid cells 
(Nigg, 2002; Fukasawa, 2007), (e) DNA damage (Olive et al., 1996; Waldman et al., 
1996; Bunz et al., 1998), or as a result of (f) abortive cell cycle - a failure in executing a 
crucial step in the cell division process, yielding either mononucleated tetraploid cells 
due to karyokinesis failure, or bi-nucleated tetraploid cells due to cytokinesis failure. 
Abortive cell cycle may arise from a wide variety of defects in different aspects of cell 
division, such as failure of spindle assembly and chromosome segregation, cytokinesis 
failure, and microtubule stabilisation or destabilisation by agents such as taxol or 
nocodazole respectively (Andreassen et al., 1996; Minn et al., 1996; Lanni & Jacks, 
1998; Andreassen et al., 2001b; Storchova & Pellman, 2004; Zhivotovsky & Kroemer, 
2004). In all the aforementioned situations, apart from the developmental process of 
megakaryocytes, tetraploid cells can either undergo bipolar and symmetric divisions, 
leading to the formation of polyploid cells, or multipolar and asymmetric divisions, 
yielding aneuploid progenies with chromosome complements that are not a simple 
multiple of the haploid set (gain and loss of chromosomes), depending on the 
centrosome clustering (Figure 4.6) (Storchova & Pellman, 2004; Quintyne et al., 2005; 
Basto et al., 2008; Kwon et al., 2008). Aneuploidy is consistently observed in virtually 
all cancers, including human BCCs (Buchner et al., 1985; Miller, 1991a; Herzberg et 
al., 1993; Fortier-Beaulieu et al., 1994; Lengauer et al., 1997; Lengauer et al., 1998; 
Staibano et al., 2001; Ashton et al., 2005; Weaver & Cleveland, 2006; Storchova & 
Kuffer, 2008).  
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Figure 4.6: Several routes to tetraploidy, polyploidy and aneuploidy. 
Tetraploidy and polyploidy can result from a variety of alterations; (a) Cell fusion, (b) 
Endoreplication, (c) Abortive cell cycle. Tetraploid cells can either undergo bipolar and 
symmetric divisions (a), (c), leading to the formation of polyploid cells, or multipolar and 
asymmetric divisions (a), (c), yielding aneuploid progenies with chromosome complements that 
are not a simple multiple of the haploid set (gain and loss of chromosomes), depending on the 
centrosome clustering (Storchova & Pellman, 2004). 
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In order to examine if there are any tetraploid, polyploid or aneuploid phenotypic 
characteristics in my cell culture, and in order to verify (quantify) that there is an 
increase in tetraploid cells in SINEG2 cultures, two different experiments were carried 
out.  
 
First, SINEG2 cells were stained with Hoechst-33342 in suspension for 1 hour, were 
replated in culture for 24, 48 and 72 hours (see Chapter 2, Section 2.9), and 
representative pictures were taken (Figure 4.7). The presence of enlarged, bi-nucleated 
and multi-nucleated cells in SINEG2 culture (Figure 4.7 a, b, c, d), provided further 
support for the existence of tetraploid and polyploid / aneuploid cells respectively, 
indicating a failure in the cytokinesis process. An example of a tetraploid cell (4N) is 
shown in Figure 4.7 c, pointed out by a black arrow, a polyploid cell (8N) is shown in 
Figure 4.7 d (ii) pointed out by a red arrow, an aneuploid cell (3N) is shown in Figure 
4.7 c, pointed out by a red arrow, and an example of a cell undergoing karyokinesis with 
no cytokinesis is shown in Figure 4.7 a, i (see inset), pointed out by a red arrow. 
 
Second, N/TERT, SINCE and SINEG2 cells were plated, fixed, stained with DAPI, and 
bi-nucleated cells (tetraploids) in all three cell lines were counted under the fluorescent 
microscope (see Chapter 2, Section 2.10). More than 300 cells were counted for each 
different cell line. The percentage of bi-nucleated cells per field was derived by 
counting the number of cells with two nuclei over the total number of cells per field (see 
Chapter 2, Section 2.10). Cells undergoing mitosis were counted as two mononuclear 
cells. SINEG2 cultures showed a significantly elevated percentage (~ 3.5 fold increase) 
of bi-nucleated cells (~ 19%), compared to both control cell lines (~ 5%) (Figure 4.8). 
This difference in bi-nucleated cells (~ 14%), is consistent with the differences in G2/M 
populations between control (N/TERT, SINCE) and SINEG2 keratinocytes (~ 11-15%), 
as evidenced from flow cytometry analysis (Figure 4.1 and Figure 4.4). This suggests 
that the accumulation of SINEG2 cells at G2/M (DNA content, 4N), observed by flow 
cytometry, is mostly due to the presence of bi-nucleated tetraploid cells as a result of a 
cytokinesis defect, rather than due to the activation of G2/M checkpoint of diploid cells. 
This is further supported by the fact that, when at least some of these cells eventually 
divide, they give rise to cells with DNA content N>4, and 8N, rather than to normal 
diploid keratinocytes (Figure 4.4 and Figure 4.7). However, it cannot be excluded 
completely that there might be a transient arrest of diploid cells due to the activation of 
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the mitotic spindle checkpoint. Therefore, the G2/M peak in the cell cycle profile of the 
SINEG2 cells (Figure 4.4 iii) consists of (a) G2/M diploids (diploid cells in G2/M 
phase undergoing division), (b) bi-nucleated/tetraploid cells (Figure 4.8), cells that 
have acquired more than two homologous sets of chromosomes (4N) after an abortive 
cell cycle (i.e. cytokinesis failure of a G2/M diploid cell) which are now in a G1 
biochemical state, (c) bi-nucleated/tetraploid cells (4N) in a G1 biochemical state 
(Figure 4.8), that arise from the bipolar and symmetric divisions of the 
octoploid/polyploid (8N) cells, and possibly to a lesser extent of (d) diploid cells 
undergoing a transient mitotic arrest. Accordingly, the 8N peak in the cell cycle profile 
of the SINEG2 cells (Figure 4.4 iii) consists of G2/M tetraploids (tetraploid cells in 
G2/M phase undergoing division) and polyploid cells, cells that have acquired more 
than two homologous sets of chromosomes (8N) after an abortive cell cycle (i.e. 
cytokinesis failure of a G2/M tetraploid cell) and are now in a G1 biochemical state. 
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Figure 4.7: Phenotypic characteristics of tetraploid, polyploid and aneuploid cells 
in GLI2∆N-expressing keratinocytes. 
Representative pictures taken from Hoechst-33342 stained SINEG2 cell line at x20 
magnification, showing the presence of bi- and multi-nucleated cells. Black arrows indicate bi-
nucleated cells (4N) and red arrows indicate multi-nucleated (>4N) cells. DNA was detected by 
Hoechst-33342 staining (blue). Insets a (i) and d (ii), show magnified images indicated by 
asterisk, of the nuclear region of the corresponding photos. Black arrow in picture c points out a 
tetraploid cell (4N); Red arrow in picture c points out an aneuploid cell (3N); Black arrow in 
picture d (ii) points out a polyploid cell (8N); Inset a (i) is an example of a cell undergoing 
karyokinesis with no cytokinesis.  
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Figure 4.8: GLI2∆N increases bi-nucleated cells in culture. 
N/TERT, SINCE and SINEG2 cells were stained with DAPI to visualize nuclear DNA. By 
calculating the average percentage of bi-nucleated cells per field, it was evidenced that SINEG2 
cells display a significant increase (~ 3.5 fold) in the population of bi-nucleated (tetraploid) 
cells. Each bar represents the mean values of bi-nucleated cells per field ± s.e.m of 7 fields for 
N/TERT and SINCE, and 13 fields for SINEG2. Total count ~ 300 cells per cell line. ** 
P≤0.01. 
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4.2.1.4 14-3-3σ (14-3-3 sigma) is downregulated in GLI2∆N-expressing 
keratinocytes 
The scope of my study was not to find out how the tetraploids arise, but how they 
survive and are maintained in culture, and whether these populations could give rise to 
cells with structural chromosomal instability. However, recently a study from Wilker et 
al. (Wilker et al., 2007) demonstrated that 14-3-3σ (stratifin) is an important regulator of 
the mitotic cap-independent translation (Pyronnet et al., 2001; Cormier et al., 2003; 
Holcik & Sonenberg, 2005; Wynshaw-Boris, 2007), and its loss leads to the improper 
mitotic cap-independent translation of PITSLRE/CDK11
p58
 (endogenous internal 
ribosomal entry site (IRES)-dependent form of the cyclin-dependent kinase Cdk11) 
protein and improper localisation of Polo-like kinase-1 (Plk1) (loss of Polo-like kinase-
1 protein in the midbody during mitosis, a protein which is required for cytokinesis). 
Both these proteins are important executioners of mitosis  (Neef et al., 2003; Liu et al., 
2004b; Petretti et al., 2006; Hu et al., 2007), and the deregulation of 
PITSLRE/CDK11
p58
 mitotic cap-independent translation by 14-3-3σ knockdown, leads 
to cytokinesis failure and accumulation of binucleate cells (Wilker et al., 2007).  
 
In addition, the ability of 14-3-3 proteins to bind to a variety of functionally diverse 
signalling proteins including kinases and phosphatases, allows them to play important 
roles in a wide range of regulatory processes, including cell-cycle regulation (Yaffe, 
2002; Hermeking, 2003). 14-3-3σ is a direct transcriptional target of p53 after DNA 
damage (Hermeking et al., 1997), of which elevated levels enforce a G2/M cell cycle 
arrest by binding and sequestering Cdc2/cyclin B1 complexes in the cytoplasm 
(Hermeking et al., 1997; Chan et al., 1999b), and are required for the maintenance of  a 
stable G2/M cell cycle arrest after DNA damage (Chan et al., 1999b). Moreover, 14-3-
3σ is also thought to be a negative regulator of G1/S progression by binding to, and 
inhibiting the activities of both CDK2 and CDK4 (Laronga et al., 2000). Importantly, 
14-3-3σ is abundantly expressed in the differentiated suprabasal layers of human 
epidermis, and its downregulation results in immortalization of primary human 
keratinocytes, suggesting a role of 14-3-3σ downregulation in maintaining epidermal 
stem cells and promoting cell transformation (Dellambra et al., 2000). Consistent with 
the latter, 14-3-3σ is frequently lost in many cancers including breast and prostate, 
either due to hypermethylation of its promoter (transcriptional silencing), or induction 
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of its proteasomal degradation (Ferguson et al., 2000; Umbricht et al., 2001; 
Hermeking, 2003; Lodygin et al., 2004; Lodygin & Hermeking, 2005; Mhawech et al., 
2005; Lodygin & Hermeking, 2006). Similarly, human BCCs, exhibit partial or 
complete loss of 14-3-3σ protein expression, due to CpG-hypermethylation of the 14-3-
3σ promoter (Lodygin et al., 2003). 
 
Therefore, due to the accumulation of binucleated/tetraploid cells, probably due to 
cytokinesis failure, in SINEG2 cultures (Figure 4.8), and taking into account that 
human BCCs exhibit low or event absent protein levels of 14-3-3σ, as well as the role of 
14-3-3σ in facilitating cytokinesis, I checked the protein levels of 14-3-3σ. 14-3-3 sigma 
was found to be downregulated in GLI2∆N-expressing keratinocytes compared to both 
N/TERT and SINCE controls (Figure 4.9), suggesting a possible contribution of the 
low levels of 14-3-3σ in the production and accumulation of tetraploid cells in SINEG2 
keratinocytes, as well as in the progression of these cells through G1/S and G2/M 
phases of the cell cycle, yielding polyploid and aneuploid cells. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: GLI2∆N downregulates 14-3-3 sigma. 
Immunoblotting analysis for 14-3-3σ (~ 30 kDa) protein, on N/TERT, SINCE, SINEG2 whole 
cell lysates. β-actin (~ 42 kDa), was used as loading control. SINEG2 cells show a remarkable 
decrease in the 14-3-3σ protein levels, compared both to N/TERT and SINCE control cells. 
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4.2.2 GLI2∆N enhances the survival of tetraploid/polyploid human 
keratinocytes 
The mechanism that has been suggested to be responsible for the restricted growth 
potential and the elimination of the tetraploid/polyploid cells, is the so-called 
“tetraploidy checkpoint” (Zhivotovsky & Kroemer, 2004). Tetraploid/polyploid cells 
resulting either from karyokinesis or cytokinesis failure, show limited growth potential 
in the absence of anti-apoptotic activation. Tetraploids that result from karyokinesis 
failure normally undergo a transient G2/M cell cycle arrest, and through a process 
which is known as ‘mitotic slippage’, they escape this G2/M arrest and permanently 
arrest in G1 phase, following activation of a p53/p21
WAF1/CIP1
-dependent checkpoint, 
known as the “tetraploidy checkpoint”, which finally triggers apoptosis. Similarly, 
tetraploids arising from cytokinesis failure permanently arrest in G1 phase, following 
activation of the p53/p21
WAF1/CIP1
-dependent checkpoint and subsequent activation of 
apoptosis (Lane, 1992; Lanni & Jacks, 1998; Andreassen et al., 2001a; Andreassen et 
al., 2001b; Borel et al., 2002; Margolis et al., 2003; Storchova & Pellman, 2004; 
Zhivotovsky & Kroemer, 2004; Castedo et al., 2006) (Figure 4.10). It has been 
previously suggested that overexpressed BCL-2 inhibits apoptosis after a failed cell 
division, resulting in the generation of tetraploid/polyploid cells with enhanced survival, 
while it can also favour multipolar and asymmetric divisions of tetraploid cells, which  
leads to aneuploidy and numerical chromosomal instability (Figure 4.10) (Minn et al., 
1996; Nelson et al., 2004; Zhivotovsky & Kroemer, 2004; Castedo et al., 2006).  
 
Thus, in order to check if this ‘tetraploidy checkpoint’ is functional in the p53 wild-
type-GLI2∆N expressing N/TERT keratinocytes, and to further investigate the cause of 
the cell cycle effects presented, the protein levels of the anti-apoptotic protein BCL-2 
(Bcl-2), which has been shown to be direct target of GLI2∆N in HaCaT keratinocytes 
(Regl et al., 2004b), were examined. In addition, the levels of p53 which has been 
observed to be partially responsible for the limited life-span of polyploid cells, were 
examined. Next, the protein levels of p21
WAF1/CIP1 
(p21) cyclin dependent kinase (CDK) 
inhibitor – a direct transcriptional target of p53 (el-Deiry et al., 1994) – were 
investigated in order to look further into the control of G1 phase of these cells. N/TERT, 
SINCE and SINEG2 whole protein lysates (Chapter 2, Section 2.12.1) were 
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immunoblotted (Chapter 2, Section 2.12.5) against anti-p53, anti-Bcl-2 and anti-
p21
WAF1/CIP1
 antibodies, while β-actin was used as a loading control (Figure 4.11).  
 
Bcl-2 protein was massively up-regulated in SINEG2 cell line, which could explain the 
apoptotic resistance/survival of tetraploid/polyploid populations, especially in the 
absence of p53 checkpoint activation. Indeed, there was no detection of p53 protein 
stabilisation in SINEG2 cells compared to SINCE and wild-type N/TERT cells. 
However, p21
WAF1/CIP1 
protein was almost absent from GLI2∆N expressing cells, 
indicating abnormal G1 checkpoint control, and the ability of GLI2∆N to downregulate 
indirectly p21
WAF1/CIP1 
in a p53-independent manner. In addition, p21
WAF1/CIP1
 protein 
plays a pivotal role in centrosome overduplication (Duensing et al., 2006) and in 
preventing endoreduplication and tetraploidisation (Stewart et al., 1999), and thus its 
downregulation could explain the occurrence and maintenance of a high percentage of 
tetraploid/polyploid cells in SINEG2 culture. The experiment was repeated three 
separate times giving identical results, clearly suggesting that the ‘teraploidy 
checkpoint’ is not functional in GLI2∆N-expressing cells. 
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Figure 4.10: The fate of tetraploid/polyploid cells. 
Tetraploid/polyploid cells normally undergo apoptosis, following the activation of a 
p53/p21
WAF1/CIP1
-dependent checkpoint. In the presence of an anti-apoptotic factor, such as 
BCL-2 and due to its overexpression, there is inhibition of apoptosis, which favours multipolar 
and asymmetric divisions and therefore results in aneuploidy and numerical chromosomal 
instability. nC is the number of chromosomes (Zhivotovsky & Kroemer, 2004). 
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Figure 4.11: Dysfunctional ‘tetraploidy checkpoint’ in GLI2∆N-expressing human 
keratinocytes. 
Immunoblotting analysis for p53 (~ 53 kDa), Bcl-2 (~ 26 kDa), and p21
WAF1/CIP1 
(~ 21 kDa) 
proteins, on N/TERT, SINCE, SINEG2 whole cell lysates. β-actin (~ 42 kDa), was used as 
loading control. SINEG2 cells show similar levels of p53 protein compared to N/TERT and 
SINCE, a remarkable increase of the anti-apoptotic Bcl-2 protein, and a significant decrease of 
the CDK inhibitor p21
WAF1/CIP1 
protein levels. 
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4.2.3 GLI2∆N downregulates p21WAF1/CIP1 in a p53-independent manner 
In response to a range of stresses, including oncogene overexpression and DNA 
damage, p53 becomes stabilised and activated, followed by activation of its targets and 
causing cells to undergo either cell cycle arrest and/or apoptosis (Vousden & Lu, 2002; 
Brown & Attardi, 2005). 
 
Thus, the tumour suppressor p53 and its direct transcriptional target, p21
WAF1/CIP1
,
 
have 
been found to be primarily associated with both DNA damage checkpoints (G1/S and 
G2/M checkpoints), and to act as a backup mechanism in the mitotic checkpoint control, 
by inducing cell cycle arrest and/or apoptosis, preventing the survival of tetraploid cells 
yielded from defects during mitosis (see Chapter 1, Section 1.3.7.1 and Chapter 4, 
Section 4.2.2) (Kuerbitz et al., 1992; el-Deiry et al., 1994; Brugarolas et al., 1995; Cross 
et al., 1995; Minn et al., 1996; Bunz et al., 1998; Khan & Wahl, 1998; Lanni & Jacks, 
1998; Wang et al., 1998; Chehab et al., 1999; Andreassen et al., 2001a; Andreassen et 
al., 2001b; Taylor & Stark, 2001; Borel et al., 2002; Margolis et al., 2003; Sherr, 2004; 
Castedo et al., 2006). Inactivation of checkpoint genes can result in gene mutations, 
chromosome damage, ploidy abnormalities, defective apoptosis, all of which can 
contribute to genomic instability and carcinogenesis (Paulovich et al., 1997; Lengauer et 
al., 1998; Stewart et al., 1999; Nowak et al., 2002; Zhivotovsky & Kroemer, 2004; 
Jefford & Irminger-Finger, 2006; Lobrich & Jeggo, 2007). 
 
Since p53 protein levels were unchanged in the presence of tetraploid populations in 
GLI2∆N-expressing keratinocytes (Figure 4.11), it was investigated whether non-
mutated p53 could still be normally activated by other stimuli, such as UVB (solar 
ultraviolet B radiation)-induced DNA damage (Maltzman & Czyzyk, 1984; Cox & 
Lane, 1995; Maccubbin et al., 1995). UV (ultraviolet) light (UVB irradiation, 280-320 
nm) is known to induce immunosuppression and DNA breaks and local DNA damages 
in exposed cells (skin keratinocytes) (Brash & Haseltine, 1982; Grossman & Leffell, 
1997; Soehnge et al., 1997; Lodish et al., 1999a; Erb et al., 2005; Erb et al., 2008). 
However, the cells including skin cells have important mechanisms to protect them 
against genomic instability and subsequent tumour formation due to persistent DNA 
damage, in which p53 tumour suppressor and its targets play a critical role (anti-cancer 
activity) (Soehnge et al., 1997). p53 nuclear phosphoprotein, known as the ‘guardian of 
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the genome’ is stabilised and activated after DNA damage, and induces arrest in cell 
proliferation at the G1/S and G2/M phases, through the activation of cyclin-dependent 
kinase inhibitors, such as p21
 WAF1/CIP1
 and 14-3-3σ, in order to provide sufficient time 
for DNA damage repair (Levine et al., 1991a; Lane, 1992; Levine, 1997; Vousden & 
Lu, 2002; Lobrich & Jeggo, 2007). Cyclin-dependent kinases (CDKs), along with their 
cyclin partners, are responsible for the transitions of the eukaryotic cell cycle and are 
positive regulators that facilitate cell cycle progression (Cox & Lane, 1995; Sherr & 
Roberts, 1995; Taylor & Stark, 2001; Lobrich & Jeggo, 2007). Both p21
 WAF1/CIP1
 and 
14-3-3σ, direct transcriptional targets of p53, are cyclin-dependent kinase inhibitors 
(CKIs) (negative regulators of cell cycle), which bind and inhibit kinase activity of 
various cyclin/cyclin-dependent kinase complexes and thus stop either G1/S or G2/M 
cell cycle progression after DNA damage (Gu et al., 1993; Harper et al., 1993; Xiong et 
al., 1993; el-Deiry et al., 1994; Cox & Lane, 1995; Hermeking et al., 1997; Chan et al., 
1999b; Laronga et al., 2000; Taylor & Stark, 2001; Lobrich & Jeggo, 2007). If DNA 
repair is not possible, then the DNA damaged cells are eliminated through apoptosis 
under the control of p53 gene (Levine et al., 1991a; Levine, 1997; Ashkenazi, 2002; 
Vousden & Lu, 2002; Zhivotovsky & Kroemer, 2004; Brown & Attardi, 2005; Erb et 
al., 2008; Taylor et al., 2008).  
 
Therefore the protein levels of p53 and the levels of its downstream direct target, 
p21
WAF1/CIP1
,
 
were also examined after UVB treatment, in order to further investigate if 
the downregulation of p21
WAF1/CIP1 
upon GLI2∆N induction, is p53-independent, as 
observed in Section 4.2.2. 
 
SINCE and SINEG2 cells were either mock treated (-) or exposed to UVB irradiation 
(10 mJ/cm
2
) (+) (Chapter 2, Section 2.13), 48 hours (~ 65% confluent) after plating. 
Cells were harvested 24 hours after UVB irradiation, and whole protein lysates 
(Chapter 2, Section 2.12.2) were immunoblotted (Chapter 2, Section 2.12.5) against 
anti-p53 and anti-p21 antibodies, while β-actin was used as a loading control (Figure 
4.12). Although p53 was upregulated upon UVB treatment both in SINEG2 and SINCE 
control cells, p21
WAF1/CIP1
 was only upregulated in control cells, but not in GLI2∆N 
expressing keratinocytes. This observation clearly suggests that (a) p53 is functional and 
is induced by UVB-mediated DNA damage in both SINCE and SINEG2 cells, but not 
in the presence of tetraploid cells, and that (b) p53-mediated induction of p21
WAF1/CIP1
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after UVB irradiation is only functional in SINCE control cells and not in GLI2∆N-
expressing cells. This further confirms that the downregulation of p21
WAF1/CIP1
 by 
GLI2∆N induction, occurs in a p53-independent manner, not only in the presence of 
tetraploid cells, but also in response to UVB-induced DNA damage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: GLI2∆N-mediated p21 downregulation is p53 independent in UVB 
treated cells. 
Immunoblotting analysis for p53 and p21 proteins on UV (+) and non-UV (-) SINCE and 
SINEG2 whole cell lysates. β-actin was used as loading control. p53 protein is upregulated both 
in SINCE control and in SINEG2 cells upon UVB exposure, while p21 is only increased in 
control cells and not in GLI2∆N-expressing cells after UVB-induced DNA damage. 
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4.2.4 p21WAF1/CIP1 expression in human BCCs 
The data presented here (see Chapter 3, Section 3.2.1.4), as well as in previous studies, 
suggest that the overexpression of GLI2∆N in cultured human epidermal keratinocytes 
can induce expression patterns that are very similar to those observed in human BCC 
tumours in vivo. In addition to showing increased and suppressed BCL-2 and c-MYC 
expressions respectively (Chapter 3, Section 3.2.1.4, Figure 3.5), SINEG2 
keratinocytes showed a remarkable suppression in p21
WAF1/CIP1
 protein levels (Figure 
4.11 and Figure 4.12). Therefore, it was investigated whether this in vitro finding was 
physiologically relevant to the in vivo situation in human BCC tumours, since GLI2 and 
BCL-2 have already been shown to be co-expressed in human BCCs (Regl et al., 
2004b), and c-MYC to be largely downregulated (Bonifas et al., 2001; Regl et al., 2002; 
O'Driscoll et al., 2006; Asplund et al., 2008).  
 
Thus, the protein expression levels of p21
WAF1/CIP1
 (p21) were examined in a cohort of 
16 patients’ tissue samples comprising normal skin epithelium, and tissues derived from 
diverse human BCC subtypes, including nodular, superficial, infiltrative and 
morpheaform. Tissue processing and immunohistochemistry were performed by Dr 
Mohammed Ikram at the Pathology Department of the Institute of Cancer, Barts and the 
London School of Medicine and Dentistry, Charterhouse square, London, UK (see 
Chapter 2, Section 2.18). 
 
The expression of p21
WAF1/CIP1
 (p21) in normal epidermis showed a diffuse pattern with 
p21 protein being mainly detected in the non-proliferating suprabasal layers of the 
epithelium with very few positive stained cells in the basal layer (Figure 4.13A). In 
contrast, p21
WAF1/CIP1
 (p21) was largely absent from human BCC tumour islands in all 
the three different subtypes, with the exception of individual positively stained cells 
(Figure 4.13B, C, D). The clear downregulation of p21 was even more evident in 
superficial BCCs, where p21 expression is suddenly lost in the developing tumour, 
when compared to the immediately adjacent normal epithelium (Figure 4.13C), 
suggesting that p21 is massively downregulated in tumour cells. Overall, these data 
show that GLI2∆N-mediated p21 downregulation in vitro, absolutely correlates with the 
p21 expression pattern in human BCCs in vivo. 
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Figure 4.13: p21
WAF1/CIP1
 is almost absent in human BCCs. 
Representative pictures from the immunohistochemistry for p21
WAF1/CIP1
 protein on a panel of 
formalin fixed, paraffin embedded (A) normal human skin, (B) nodular human BCC, (B inset) 
magnified region of nodular BCC, (C) superficial human BCC and (D) infiltrative human BCC, 
showing the clear downregulation of p21
WAF1/CIP1
 in human BCC tumours, compared both to 
normal control skin (A) and to normal epidermis adjacent to the BCC tumour (C). 
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4.2.5 GLI2∆N expressing cells are resistant to UVB-induced apoptosis  
Apoptosis, as I mentioned in Section 4.2.1.2, is a normal physiologic process, which 
occurs during embryonic development, as well as in maintenance of tissue homeostasis 
(Taylor et al., 2008), while its deregulation (inactivation) leads to a variety of human 
pathologies, including cancer (Hanahan & Weinberg, 2000; Igney & Krammer, 2002; 
Brown & Attardi, 2005). Apoptosis can be mediated either by intrinsic or extrinsic 
pathways, depending on the origin of death stimuli, while cross-talk between them is 
possible. The intrinsic pathway is mediated by mitochondria, and is triggered in 
response to an oncogene, defective cell cycle, and/or DNA damage (death stimuli that 
are generated from within the cell), whereby the extrinsic pathway is mediated by the 
binding of an extracellular death ligand (i.e. FASL) to its cell-surface death receptor 
(i.e. FAS) (Figure 4.17) (Ashkenazi, 2002; Green & Kroemer, 2004; Riedl & Shi, 2004; 
Green, 2005; Taylor et al., 2008).  
 
Since there was no activation of apoptosis upon GLI2∆N oncogene induction 
(oncogenic stress), which was followed by subsequent tetraploidy and polyploidy 
formation (abortive cell cycle) (Figure 4.3 and Figure 4.11), I checked if GLI2∆N-
expressing keratinocytes are also resistant in another stimulus, which also causes p53-
mediated apoptosis, such as UV light (UVB treatment) (Levine, 1997). Ultraviolet (UV) 
radiation is the carcinogenic factor in sunlight (Soehnge et al., 1997). Although, 
together solar ultraviolet B (UVB, 280-320nm) irradiation with solar ultraviolet A 
(UVA, 320-400nm) irradiation can initiate transformation of skin epidermal cells and 
accelerate carcinogenesis, UVA has been shown to be less effective than UVB, 
concerning the transforming potential (less carcinogenic) (Grossman & Leffell, 1997; 
Soehnge et al., 1997; Erb et al., 2008). Thus, UVB irradiation is known to be one of the 
main risk and etiological factors in human skin BCC formation, since the most frequent 
mutations found in particular genes in human BCCs, have the ‘UV signature’ of UV-
light mediated mutations (Grossman & Leffell, 1997; Soehnge et al., 1997; Brash & 
Ponten, 1998; Armstrong & Kricker, 2001; de Gruijl et al., 2001; Ehrhart et al., 2003). 
These specific mutations in DNA, are consistently associated with UV radiation, and are 
characterised by C (cytosine) to T (thymine) or CC to TT transitions at dipyrimidine 
sites, induced by UVB-radiation (Brash & Haseltine, 1982; Grossman & Leffell, 1997). 
Therefore, these C to T transition mutations serve as molecular fingerprints for DNA 
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damaged by UVB, and are found in the two genes that are most correlated with human 
BCC development, the p53 and PTCH genes (Grossman & Leffell, 1997; Soehnge et 
al., 1997; Brash & Ponten, 1998; de Gruijl et al., 2001; Ling et al., 2001; Dicker et al., 
2002; Lacour, 2002; Daya-Grosjean & Couve-Privat, 2005; Reifenberger et al., 2005; 
Epstein, 2008). UVB irradiation is known to be responsible for a 65-75% of p53 
mutations and a 40-50% of PTCH mutations in human sporadic BCCs (Demirkan et al., 
2000; Lacour, 2002; Bolshakov et al., 2003; Daya-Grosjean & Couve-Privat, 2005; 
Reifenberger et al., 2005). The importance of p53 inactivation in skin carcinogenesis is 
highlighted by the fact that homozygous or heterozygous p53 knockout mice develop 
skin tumours much earlier than wild-type mice upon UV radiation (Jiang et al., 1999; 
Erb et al., 2005). 
 
In my system (N/TERT keratinocytes), the p53/p21
WAF1/CIP1
 pathway is functional and 
not mutated contrarily to other keratinocyte cell lines such as HaCaT (Boukamp et al., 
1988; Lehman et al., 1993; Dickson et al., 2000; Rheinwald et al., 2002). Thus, p53 was 
shown to be upregulated upon UVB-induction both in GLI2∆N-expressing and control 
keratinocytes (Figure 4.12). On the other hand, p21
WAF1/CIP1
 was only upregulated in 
the control cells after UVB-induction (Figure 4.12), while it was downregulated before 
(Figure 4.11) and after (Figure 4.12) UVB treatment in SINEG2 cells, compared to the 
control cells, indicating a defective cell cycle/growth arrest that prevents the UVB-DNA 
damaged SINEG2 cells to be repaired (uncontrolled cell proliferation). At the same 
time, BCL-2 (anti-apoptotic factor, antagonist of p53-mediated apoptosis) was found to 
be highly upregulated before (Figure 4.11) and after (Figure 4.18) UVB treatment in 
GLI2∆N-expressing keratinocytes compared to the controls, suggesting also a defective 
apoptosis procedure in the non-repaired UVB-DNA damaged SINEG2 keratinocytes 
(loss of apoptosis). Thus, I checked if GLI2∆N-expressing cells are resistant not only in 
cell cycle failure-mediated apoptosis as observed in Figure 4.3, but also in UVB-
mediated apoptosis, which would be consistent with the resistance in apoptosis, 
mediated by intrinsic or extrinsic pathways, of human BCCs (Regl et al., 2004b; Erb et 
al., 2005; Erb et al., 2008; Kump et al., 2008). Three different apoptotic assays were 
carried out for this purpose including (i) PI staining, (ii) Annexin V staining, both of 
which were followed by flow cytometry analysis, and (iii) detection of caspase-3 
activation. 
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4.2.5.1 PI staining in UV and non-UV SINEG2 keratinocytes 
Propidium iodide (PI) staining in permeabilised cells facilitates the discrimination of 
cells with reduced DNA content, due to DNA fragmentation (sub-G1 populations). 
When cells are permeabilised, the apoptosis-mediated fragmented DNA multimers leak 
out of the cell, and therefore the resulting stained by propidium iodide sub-G1 
populations, represent late apoptotic/dead cells (cells with fragmented DNA), and thus 
used for detection of later stages of apoptosis (Riccardi & Nicoletti, 2006).  
 
Equal number of SINCE and SINEG2 cells were seeded and were either mock treated (-
) or exposed to UVB irradiation (10 mJ/cm
2
) (+) (see Chapter 2, Section 2.13), 72 
hours (~ 65% confluent) after plating. Cells were harvested 24 hours after UVB 
irradiation, and stained with propidium iodide, followed by flow cytometry analysis in 
order to detect cells with sub-G1 content (see Chapter 2, Section 2.8.1.4) (Figure 
4.14). Results clearly show that SINCE control keratinocytes showed increased 
apoptosis/death in response to UVB (10 mJ/cm
2
) (+) (7.1%) (Figure 4.14 ii), compared 
to mock treated SINCE cells (0.40%) (Figure 4.14 i), as evidenced by the marked 
increase in the percentage of sub-G1 populations (P3). Contrarily, in response to the 
same dose of UVB irradiation (10 mJ/cm
2
), SINEG2 keratinocytes displayed only a 
marginal increase in the percentage of sub-G1 (P3) keratinocytes (+) (2.7%) (Figure 
4.14 iv), compared to the mock treated SINEG2 cells (-) (0.2%) (Figure 4.14 iii), 
suggesting a resistance of GLI2∆N-expressing keratinocytes in late UVB-mediated 
apoptosis and cell death.  
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Figure 4.14: Induction of GLI2∆N protects against UVB-induced apoptosis and 
cell death.  
SINCE (i, ii) and SINEG2 (iii, iv) keratinocytes were either mock treated (-), or UVB irradiated 
(10 mJ/cm
2
) (+), and were allowed to grow for 24 hours prior to staining with propidium iodide 
and flow cytometry analysis. SINCE keratinocytes (ii) showed increased apoptosis/death in 
response to UVB (10 mJ/cm
2
) (+), as evidenced by the marked increase in the percentage of 
sub-G1 populations (P3). In contrast, SINEG2 keratinocytes (iv) displayed a marginal increase 
in the percentage of sub-G1 (P3) keratinocytes in response to the same dose of UVB irradiation, 
suggesting a resistance of GLI2∆N-expressing cells to apoptosis and cell death.  
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4.2.5.2 Annexin V staining in UV and non-UV SINEG2 keratinocytes 
Annexin V staining is used to identify apoptosis at an earlier stage (early apoptotic 
marker) (Vermes et al., 1995), compared to assays based on nuclear changes (DNA 
fragmentation) such as propidium iodide staining (see Chapter 2, Section 2.8.1.5 and 
Chapter 4, Section 4.2.1.2). DAPI (Kubista et al., 1987; Barcellona et al., 1990) is also 
used for staining along with Annexin V in order to discriminate late apoptotic or dead 
cells which have lost membrane integrity, from early apoptotic cells which still have 
intact membranes, by dye exclusion. Two different doses of UVB radiation were used 
(10 mJ/cm
2
 and 30 mJ/cm
2
) (see Chapter 2, Section 2.13), in order to check if the 
resistance observed in SINEG2 cells in UVB 10 mJ/cm
2
-mediated apoptosis (Figure 
4.14) is also retained in higher doses of UVB irradiation (30 mJ/cm
2
).                                                                                                                                                                                                                                                                                                      
 
Firstly, in order to check if the assay is functional in wild-type N/TERT keratinocytes, 
N/TERT keratinocytes were seeded, were mock treated (no UVB) 24 hr after plating 
and were allowed to grow for another 24 hours. Cells were analysed by flow cytometry 
(non-stained) in order to obtain values of background fluorescence (Figure 4.15 i). 
Then, mock, no UVB-treated (0 mJ/cm
2
) N/TERT cells were stained with DAPI and 
Cy
TM
5 Annexin V antibody prior to flow cytometry analysis and based on background 
fluorescence values, keratinocyte populations were further distributed into live (Q3) 
DAPI (-) Annexin V (-), early apoptotic (Q4) DAPI (-) Annexin V (+), late 
apoptotic/dead (Q2) DAPI (+) Annexin V (+), and dead (Q1) DAPI (+) Annexin V (-) 
cells (Figure 4.15 ii). Next, two different UVB doses were used in order to verify that 
the percentage of early apoptotic cells is proportionally increased along with the UVB 
dose (Figure 4.15 iii, iv). N/TERT keratinocytes were irradiated with UVB (10 mJ/cm
2
) 
24 hr after plating and were allowed to grow for 24 hours prior to staining with DAPI 
and Cy
TM
5 Annexin V for flow cytometry analysis. A clear apoptotic response can be 
seen in UVB irradiated keratinocytes as evidenced by the increase of early apoptotic 
(6.0%) populations (Figure 4.15 iii). N/TERT keratinocytes were also irradiated with 
UVB (30 mJ/cm
2
) 24 hr after plating and were allowed to grow for 24 hours prior to 
staining with DAPI and Cy
TM
5 Annexin V for flow cytometry analysis. The apoptotic 
response of N/TERT keratinocytes is further enhanced, as evidenced by significant 
increases in early apoptotic (11.8%), as well as in late apoptotic/dead (5.5%) 
keratinocyte populations (Figure 4.15 iv). 
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Secondly, equal number of N/TERT, SINCE and SINEG2 cells were seeded and were 
either mock treated (0 mJ/cm
2
) or exposed to UVB irradiation (10 mJ/cm
2
 and 30 
mJ/cm
2
), 24 hours (~ 65% confluent) after plating. Cells were harvested 24 hours after 
UVB irradiation, and stained with both DAPI and Cy
TM
5 Annexin V antibody, followed 
by flow cytometry analysis resulting in the discrimination of early apoptotic DAPI (-) 
Annexin (+) and late apoptotic/dead DAPI (+) Annexin (+) populations (Figure 4.16). 
Results show that SINEG2 keratinocytes display a reduction in the percentage of early 
apoptotic and late apoptotic/dead cells not only in response to low (10 mJ/cm
2
), but also 
to high (30 mJ/cm
2
) doses of UVB irradiation (~ 9% early apoptotic cells), compared to 
both N/TERT (~ 24% early apoptotic cells) and SINCE (~ 24% early apoptotic cells) 
control keratinocytes (Figure 4.16).  
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Figure 4.15: Cy
TM
5 Annexin V staining in control and UVB-treated N/TERT 
keratinocytes. 
(i) N/TERT keratinocytes were mock treated (no UVB) and were allowed to grow for 48 hours 
after plating. Cells were analysed by flow cytometry (non-stained) in order to obtain values of 
background fluorescence (x axis; APC/Annexin V, y axis; DAPI). (ii) Next, mock, no UVB-
treated (0 mJ/cm
2
) N/TERT cells were stained with DAPI and Cy
TM
5 Annexin V antibody prior 
to flow cytometry analysis and based on background fluorescence values, keratinocyte 
populations were further distributed into live (Q3) DAPI (-) Annexin V (-), early apoptotic (Q4) 
DAPI (-) Annexin V (+), late apoptotic/dead (Q2) DAPI (+) Annexin V (+), and dead (Q1) 
DAPI (+) Annexin V (-) cells. (iii) N/TERT keratinocytes were irradiated with UVB (10 
mJ/cm
2
) 24 hr after plating and were allowed to grow for 24 hours prior to staining with DAPI 
and Cy
TM
5 Annexin V antibody for flow cytometry analysis. A clear apoptotic response can be 
seen in UVB irradiated keratinocytes as evidenced by the increase of early apoptotic 
populations. (iv) N/TERT keratinocytes were irradiated with UVB (30 mJ/cm
2
) 24 hr after 
plating and were allowed to grow for 24 hours prior to staining with DAPI and Cy
TM
5 Annexin 
V for flow cytometry analysis. The apoptotic response of N/TERT keratinocytes is further 
enhanced, as evidenced by significant increases in early apoptotic, as well as in and late 
apoptotic/dead keratinocyte populations. 
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Figure 4.16: GLI2∆N-expressing cells are resistant in apoptosis mediated by high 
doses of UVB.   
N/TERT, SINCE, and SINEG2 keratinocytes were either mock treated (0 mJ/cm
2
), or UVB 
irradiated with 10 or 30 mJ/cm
2
. Cells were allowed to grow for 24 hours prior to harvesting and 
staining with both DAPI and Cy
TM
5 Annexin V antibody for the discrimination of early 
apoptotic (DAPI (-) Annexin V (+)) and late apoptotic/dead (DAPI (+) Annexin V (+) and 
DAPI (+) Annexin V (-)) populations. SINEG2 keratinocytes display a reduction in the 
percentage of early and late apoptotic/dead populations in response to low and high dose of 
UVB irradiation (10 and 30 mJ/cm
2
) compared to both N/TERT and SINCE control 
keratinocytes. Each bar represents the mean values ± s.e.m of duplicate samples.  * P≤0.05, ** 
P≤0.01, *** P≤0.001. 
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4.2.5.3 Reduced Caspase-3 activation in SINEG2 keratinocytes 
Caspases (Cysteine aspartic acid proteases) are a conserved family of enzymes that 
control all steps of apoptosis either mediated by the intrinsic or the extrinsic pathway 
(Figure 4.17), by initiating and executing the intracellular cascade of events that result 
in protein and nucleic acid cleavage and ultimately, in the irreversible commitment of a 
cell to die (Riedl & Shi, 2004; Taylor et al., 2008). Caspases are produced in every cell 
as inactive precursors called procaspases, and must undergo proteolytic activation 
during apoptosis by specific initiation mechanisms including (i) exposure to another 
activated caspase, (ii) autocatalysis, or (iii) association with an activator protein such as 
Apaf-1 (apoptotic-protease-activating factor-1) and cytochrome c (Hengartner, 2000; 
Riedl & Shi, 2004). The apoptotic caspases can be divided into two types: the ‘initiator’ 
caspases (i.e. caspase-2, -8, -9 and -10) and the ‘effector’ or ‘executioner’ caspases (i.e. 
caspase-3, -6 and -7). The initiator caspases are auto-activated (self-cleavage) and their 
activation is facilitated by specific activator proteins. Then, initiator caspases act by 
activating effector caspases through cleavage at specific internal Asp residues (Riedl & 
Shi, 2004). Once activated, the effector caspases, proteolytically cleave a broad set of 
target proteins, that are major components of the cytoskeleton and the nuclear envelope, 
play central role in the breakdown of nuclear DNA, and are involved in essential 
functions within the cell, all of which lead to cell death (Riedl & Shi, 2004; Taylor et 
al., 2008).  
 
In order to further confirm the resistance of GLI2∆N-expressing cells in UVB-induced 
apoptosis, the protein levels of Caspase-3, which is a critical executioner of apoptosis, 
were examined in SINEG2 and SINCE control cells. The reason for choosing caspase-3 
instead of any other caspases is because the activation of the effector caspase-3 during 
apoptosis can be mediated both by the cell intrinsic pathway, of which BCL-2 is an 
antagonist and by the cell extrinsic pathway of which c-FLIP is an antagonist (Figure 
4.17).  
 
The anti-apoptotic gene, BCL-2 (B-cell lymphoma 2) and its protein product, belongs to 
the BCL-2 superfamily consisting of proteins with pro-apoptotic (BAX, BAK, BID, 
NOXA, PUMA) and anti-apoptotic (BCL-2, BCL-XL) activities, of which a dynamic 
equilibrium is necessary for the proper execution of apoptosis (Cory & Adams, 2002; 
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Youle & Strasser, 2008). BCL-2 membrane protein, is residing at the mitochondrial, 
nuclear and endoplasmic reticulum membranes, and is one of the major anti-apoptotic 
factor of the intrinsic pathway of apoptosis (p53-dependent apoptosis), while its 
overexpression inhibits cell death  and contributes to tumour formation, including skin 
carcinogenesis (Vaux et al., 1988; Hockenbery et al., 1990; Hockenbery, 1995; 
Rodriguez-Villanueva et al., 1998; Jiang & Milner, 2003; Lessene et al., 2008; Youle & 
Strasser, 2008). In normal human epidermis, BCL-2 is exclusively expressed in the 
basal layer of the epidermis (Rodriguez-Villanueva et al., 1995; Delehedde et al., 1999), 
and is directly controlled by GLI1 in primary human keratinocytes (Bigelow et al., 
2004). It has also been identified as a direct transcriptional target of GLI2 transcription 
factor (Regl et al., 2004b) and thus, consistent with this finding, BCL-2 was found to be 
upregulated in GLI2∆N-expressing keratinocytes (Chapter 3, Section 3.2.1.4, Figure 
3.5A and Chapter 4, Section 4.2.2, Figure 4.11). In addition, BCL-2 undergoes an 
increase in expression in many cancers (Igney & Krammer, 2002; Lessene et al., 2008), 
including human BCCs (Rodriguez-Villanueva et al., 1995; Delehedde et al., 1999; 
Regl et al., 2004b).  
 
c-FLIP (c (cellular)-FAS-associated death domain-like IL (interleukin)-1-converting 
enzyme-like inhibitory protein) is a protein-deficient caspase homolog, which in 
contrast to caspases lacks the key features that are required for the proteolytic activity of 
caspases and the subsequent substrate catalysis (Tschopp et al., 1998). c-FLIP is a 
cytoplasmic inhibitor of the extrinsic apoptotic pathway at the level of caspase-8, since 
it binds to FADD (FAS-associated death domain) and caspase-8, and thus prevents both 
the binding of caspase-8 to various death receptors and its activation (Irmler et al., 1997; 
Tschopp et al., 1998; Ashkenazi, 2002; Opferman, 2008). The ratio of c-FLIP to 
caspase-8 is critical for the assembly of the DISC (death-inducing signalling complex), 
and therefore for the balance between proliferation and apoptosis which is required for 
tissue homeostasis (Tschopp et al., 1998). Upregulation of c-FLIP has been associated 
with diverse hematologic cancer cell lines (Shain et al., 2002; Thomas et al., 2002), 
while high c-FLIP levels have been detected in certain tumour cell lines that are 
resistant to apoptosis mediated by death receptors (Hahne et al., 1996; Irmler et al., 
1997), suggesting that abnormal regulation of c-FLIP expression may contribute to 
tumourigenesis (Tschopp et al., 1998). According to the latter, c-FLIP was found to be a 
direct target of GLI2, and to be highly expressed in human BCCs (Kump et al., 2008), 
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suggesting that c-FLIP induced by GLI2 is responsible for the resistance of BCCs to 
apoptosis mediated by the extrinsic pathway. 
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Figure 4.17: Apoptosis signalling pathways. 
Apoptosis can be mediated either by the intrinsic or the extrinsic pathway, depending on the 
origin of the death stimulus. The intrinsic pathway, is p53-dependent, mediated by 
mitochondria, and is triggered in response to an oncogenic stress and/or DNA damage. In 
response to apoptotic stimuli, there is activation of pro-apoptotic proteins of the BCL-2 
superfamily (PUMA, NOXA, BAX and BAK), which in turn cause the release of several 
proteins such as cytochrome c, SMAC (second mitochondria-derived activator of caspases) / 
DIABLO (direct inhibitor of apoptosis (IAP)-binding protein with low pI) from the 
intermembrane space of mitochondria, into the cytoplasm. Cytochrome c binds to and activates 
the APAF1 (apoptotic-protease-activating factor-1) protein in the cytoplasm that mediates the 
activation of the apoptosis-initiating protease caspase-9, which in turns cleaves and activates the 
executioner proteases caspase-3, -6, and 7. The extrinsic pathway is mediated by the binding of 
an extracellular death ligand to its cell-surface death receptor, which leads to the formation of a 
death-inducing signalling complex (DISC), that involves FADD (FAS-associated death domain) 
and caspase 8, -10, which then cleaves and activates the effector caspase-3, -6, -7. The extrinsic 
pathway can crosstalk to the intrinsic pathway through the caspase 8-mediated cleavage of BID 
(BCL-2 superfamily member), which then triggers the release of mitochondrial proteins. BCL-2 
and its relative BCL-XL  are  prosurvival proteins (anti-apoptotic) that antagonize intrinsic-
pathway mediated apoptosis, and c-FLIP antagonizes death ligand/receptor-mediated apoptosis 
(Ashkenazi, 2002).  
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Therefore, in order to confirm the involvement of BCL-2 in the resistance of SINEG2 
cells in UVB-mediated apoptosis and to check the levels of cleaved active caspase-3, 
equal number of SINCE and SINEG2 cells were seeded and were either mock (-) treated 
(0 mJ/cm
2
) or exposed to UVB irradiation (+) (10 mJ/cm
2
) (see Chapter 2, Section 
2.13), 24 hours (~ 65% confluent) after plating (Figure 4.18B). SINCE and SINEG2 
keratinocytes were harvested for total protein (see Chapter 2, Section 2.12.2), 24 hr 
after UVB 10 mJ/cm
2
 (+), or mock (-) 0 mJ/cm
2
 treatment. Total protein extracts were 
immunoblotted (see Chapter 2, Section 2.12.5) against anti-Bcl-2 (top panel) and anti-
full length and cleaved Caspase-3 (middle panel) antibodies, while β-actin (bottom 
panel) was used as protein loading control (Figure 4.18B). Normally, upon UVB 
treatment full length caspase-3 (~ 35 kDa) is proteolytically processed into a large 
fragment (~ 19 kDa) and a smaller one (~ 17 kDa) and then induces apoptosis. The 
absence of activated (cleaved) Caspase-3 and the high levels of Bcl-2 expression in 
SINEG2 cells following UVB-irradiation, compared to SINCE control cells, further 
confirm the resistance of SINEG2 keratinocytes to p53-mediated apoptosis, probably as 
a consequence of high BCL-2 expression directly induced by GLI2∆N. 
 
Due to the fact that caspase-3 protein is a late apoptotic marker compared to Annexin V 
protein, the same batch of cells was also checked for Annexin V protein levels (Figure 
4.18A). Equal number of SINCE and SINEG2 cells were seeded and were either mock 
treated (0 mJ/cm
2
) or exposed to UVB irradiation (10 mJ/cm
2
) (see Chapter 2, Section 
2.13), 24 hours (~ 65% confluent) after plating. Cells were harvested 24 hours after 
UVB irradiation, and stained with both DAPI and Annexin V antibody, followed by 
flow cytometry analysis (see Chapter 2, Section 2.8.1.5), resulting in the 
discrimination of early apoptotic DAPI (-) Annexin (+) and late apoptotic/dead DAPI 
(+) Annexin (+) populations. Results show that SINEG2 keratinocytes display a 
reduction in the percentage of early apoptotic cells in response to UVB irradiation (~ 
1.0% early apoptotic cells), compared to SINCE (~ 4.0% early apoptotic cells) control 
keratinocytes (Figure 4.18A).  
 
Overall, the results indicate that GLI2∆N-expressing keratinocytes are resistant both in 
early (Figure 4.18A) and late (Figure 4.18B) UVB mediated apoptosis, and suggest 
that BCL-2 is central in apoptosis prevention by GLI2∆N overexpression. 
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Figure 4.18: GLI2∆N-expressing cells are resistant both in UVB-mediated early 
and late apoptosis.  
(A) SINCE and SINEG2 keratinocytes were either mock (0 mJ/cm
2
) or UVB (10 mJ/cm
2
) 
treated. Cells were allowed to grow for 24 hr prior to staining with Annexin V and DAPI 
staining, for the discrimination of early apoptotic and late apoptotic/dead cells respectively. The 
results clearly indicate that SINEG2 cells are less susceptible to UVB-induced early apoptosis 
compared to SINCE control cells. Each bar represents mean values ± s.e.m of duplicate 
samples. * P≤0.05. (B) SINCE and SINEG2 keratinocytes were harvested for total protein, 24 
hr after UVB 10 mJ/cm
2
 (+), or mock (-) 0 mJ/cm
2
 treatment. Total protein extracts were 
immunoblotted against anti-Bcl-2 (~ 26 kDa) (top panel) and anti-full length (~ 35 kDa) and 
cleaved Caspase-3 (~ 19, 17 kDa) (middle panel) antibodies. β-actin (bottom panel) was used as 
protein loading control. The absence of activated (cleaved) Caspase-3 in SINEG2 cells, a late 
apoptotic marker, following UVB-irradiation, further confirms the apoptotic resistance of 
SINEG2 keratinocytes compared to SINCE cells. 
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4.2.6 GLI2∆N induces numerical and structural chromosomal instability as 
revealed by 24 colour FISH karyotyping analysis 
Cancer is a complex disease, with multiple genes in diverse pathways involved in its 
initiation, progression, invasion and metastasis (Jefford & Irminger-Finger, 2006). In 
fact, it is widely accepted that the sequential accumulation of mutations that activate 
oncogenes and disrupt tumour suppressor genes, combined with multiple cycles of 
clonal selection and evolution facilitate the process of carcinogenesis (Nowell, 1976; 
Cahill et al., 1999; Hanahan & Weinberg, 2000; Jefford & Irminger-Finger, 2006). One 
of the hallmarks of cancer is genetic/genomic instability and is reflected in the 
heterogeneity seen within individual tumours and among tumours of the same type 
(Cahill et al., 1999; Hanahan & Weinberg, 2000; Mitelman et al., 2003). Genomic 
instability refers to a set of events capable of causing unscheduled alterations either of a 
temporary or permanent nature within the genome (Jefford & Irminger-Finger, 2006). 
Thus, genomic instability is the failure to transmit an accurate copy of the entire 
genome from one cell to its two daughter cells (Zhivotovsky & Kroemer, 2004). 
Although it has been debated for years if genomic instability is a cause or a 
consequence of tumourigenesis, it now appears that genomic instability not only 
possibly drives tumourigenesis, but is at least a factor in tumour progression by 
generating mutations in oncogenes and tumour suppressor genes (Cahill et al., 1999; 
Nowak et al., 2002; Jefford & Irminger-Finger, 2006; Halazonetis et al., 2008; Negrini 
et al., 2010). Spontaneous mutations happen once every hundred thousand cell divisions 
and cancers initially were thought to develop, because cells acquire a discrete small 
number of key mutations. However, recent findings by large scale sequencing projects 
in many different types of human cancers and cancer cell lines, show that most tumours 
harbour much more mutations responsible for tumourigenesis, than initially thought, 
further supporting the existence of genomic instability, which might facilitate and drive 
tumour development by increasing the spontaneous mutation rate (Sjoblom et al., 2006; 
Storchova & Kuffer, 2008; Negrini et al., 2010).  
 
Genomic instability can be divided into two major groups; instability occurring at the 
chromosomal level (CIN-chromosomal instability), and at the nucleotide level (MSI-
microsatellite instability) (Zhivotovsky & Kroemer, 2004; Jefford & Irminger-Finger, 
2006). Instability at the nucleotide level occurs due to faulty DNA repair pathways such 
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as base excision repair and nucleotide excision repair, and includes instability of 
microsatellite repeat sequences (MSI) caused by defects in the mismatch repair pathway 
due to mutations in, or silencing of, DNA-mismatch-repair genes (Lengauer et al., 1998; 
Zhivotovsky & Kroemer, 2004; Jefford & Irminger-Finger, 2006). Chromosomal 
instability (CIN), defines the existence of accelerated rate of chromosomal alterations, 
and it can be classified into (i) structural chromosomal instability - inversions, deletions, 
amplifications, duplications, and translocations of chromosomal segments that arise 
from breaks in DNA and defects in the repair mechanisms including homologous and 
non-homologous end joining, and  (ii) numerical chromosomal instability - gains or 
losses of whole chromosomes, including monoploidy, polyploidy, aneuploidy that 
originate from errors in chromosome separation during cell division (mitosis) (see 
Chapter 1, Section 1.3.7.1, Figure 1.19) (Richardson & Jasin, 2000; Khanna & 
Jackson, 2001; Zhivotovsky & Kroemer, 2004; Jefford & Irminger-Finger, 2006; 
Lobrich & Jeggo, 2007; Pellman, 2007; Aguilera & Gomez-Gonzalez, 2008). Cancer 
cells, often display numerical changes in the whole chromosomes, coupled with 
structural chromosomal alterations which are an established cause of cancer, and of 
which the most frequent in cancer genotypes are the translocations (Solomon et al., 
1991; Lengauer et al., 1998; Saunders et al., 2000; Nowak et al., 2002; Albertson et al., 
2003; Futreal et al., 2004; Jefford & Irminger-Finger, 2006; Pellman, 2007). 
 
Inactivation of checkpoint genes  (i.e. due to an oncogene overexpression) can result in 
gene mutations, chromosome damage, ploidy abnormalities, all of which can contribute 
to genomic instability and carcinogenesis (see Chapter 1, Section 1.3.7.1, Figure 1.19)  
(Paulovich et al., 1997; Lengauer et al., 1998; Stewart et al., 1999; Nowak et al., 2002; 
Liu et al., 2004a; Jefford & Irminger-Finger, 2006; Lobrich & Jeggo, 2007). Moreover, 
another important factor that can favour genomic instability is disabled apoptosis. The 
processes that lead either to structural or to numeric chromosomal instability tend to 
induce apoptosis as a default pathway that aborts damaged cells after DNA damage, 
polyploidisation, or asymmetric cell division (Ashkenazi, 2002; Nelson et al., 2004; 
Zhivotovsky & Kroemer, 2004; Castedo et al., 2006; Ganem et al., 2007; Taylor et al., 
2008). Defective apoptosis increases the probability for these cells to survive, further 
accumulate genomic changes and become selected and generate cancers (Zhivotovsky 
& Kroemer, 2004). 
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In addition, ploidy abnormalities (monoploidy, polyploidy, aneuploidy) are widespread 
features of human cancer. Tetraploidy, is a feature that is commonly seen in human 
cancer, including human BCCs (Miller, 1991a; Rajagopalan & Lengauer, 2004; Shi & 
King, 2005; Olaharski et al., 2006; Weaver & Cleveland, 2006; Ganem et al., 2007; 
Storchova & Kuffer, 2008), and has been reported as an early step in human 
tumourigenesis and as a contributing factor in the generation of aneuploid tumours 
(transient intermediates on the road to aneuploidy and tumourigenesis) (Shackney et al., 
1989; Galipeau et al., 1996; Barrett et al., 2003; Storchova & Pellman, 2004; 
Zhivotovsky & Kroemer, 2004; Fujiwara et al., 2005; Olaharski et al., 2006; Ganem et 
al., 2007; Storchova & Kuffer, 2008; Holland & Cleveland, 2009). Aneuploidy, is 
consistently observed in virtually all cancers, including human BCCs (Buchner et al., 
1985; Miller, 1991a; Herzberg et al., 1993; Fortier-Beaulieu et al., 1994; Lengauer et 
al., 1997; Lengauer et al., 1998; Staibano et al., 2001; Ashton et al., 2005; Carless et al., 
2006; Weaver & Cleveland, 2006; Storchova & Kuffer, 2008), and it can be either a 
result of a transient chromosome missegregation event at some point in the development 
of the tumour that leads to a stably propagated and inherited abnormal karyotype (stably 
aneuploid tumour cells), or a result of an underlying chromosomal instability that leads 
to an increased rate of gain or loss of whole chromosomes during cell division (unstable 
aneuploid tumour cells) (Lengauer et al., 1997; Lengauer et al., 1998; Saunders et al., 
2000; Lingle et al., 2002; Holland & Cleveland, 2009). In proof of the latter, not only 
many cancers are aneuploid, but individual cells within the same tumour manifest 
karyotypic (numerical and structural variations) and phenotypic (metastatic capacity, 
drug sensitivity, growth rates, morphology) heterogeneity, reflecting the persistent 
generation of new chromosomal variations, an inevitable consequence of chromosomal 
instability (Nowell, 1976; Shapiro et al., 1981; Frentz & Moller, 1983; Frentz et al., 
1985; Cowan, 1992; Duesberg et al., 1998; Cahill et al., 1999; Jin et al., 2001; Mitelman 
et al., 2003; Saunders, 2005; Negrini et al., 2010). Thus, this heterogeneity, might 
suggest that tumour cells are the progeny of a genetically unstable single cell (due to a 
‘mutator’ that generate genomic instability), which continues to acquire chromosomal 
abnormalities over time, including those (i.e. gene mutations) that cause cancer 
(Nowell, 1976; Duesberg et al., 1998; Cahill et al., 1999). 
 
Tetraploid cells (DNA content 4N) caused by replication of genomic DNA but without 
proper cell division, precede the formation of polyploid and aneuploid cells. In addition, 
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the uncontrolled proliferation of chromosomally unstable tetraploid cells, triggers 
numerical chromosomal instability (rate of change in chromosome number due to 
increased rate of chromosome missegregation), aneuploidy (state of an altered 
chromosome number), and cell transformation and tumourigenesis (Storchova & 
Pellman, 2004; Fujiwara et al., 2005; Duelli et al., 2007; Ganem et al., 2007; Holland & 
Cleveland, 2009). Most importantly, tetraploid cells apart from being more susceptible 
to chemically induced, as well as spontaneous transformation, than diploid cells, are 
also more prone to acquire structural genomic instability both in vitro (tetraploid-
derived cells exhibit structural chromosomal rearrangements) and in vivo (Fujiwara et 
al., 2005; Duelli et al., 2007). According to the latter, mice tetraploid-derived tumours 
display large-scale numerical and structural (non-reciprocal translocations, double 
minute chromosomes) chromosomal aberrations, indicating that tetraploidy and 
uncontrolled proliferation promotes further aneuploidy and chromosomal instability 
(Fujiwara et al., 2005; Holland & Cleveland, 2009). 
 
Since upon GLI2∆N induction in human keratinocytes there is increased 
tetraploidisation, along with ploidy abnormalities (polyploidy, aneuploidy), inactivation 
of cell cycle genes that control the proliferation of tetraploid cells and defective 
apoptosis, I investigated whether GLI2∆N overexpression can also induce structural 
genomic instability in human keratinocytes, to promote malignant transformation, and if 
tetraploid populations which are more susceptible to acquire structural genomic 
alterations, could give rise to tetraploid and/or aneuploid progenies with structural 
chromosomal rearrangements. 
  
Therefore, in order to detect any structural chromosomal abnormalities and to further 
confirm the numerical chromosomal abnormalities in GLI2∆N-expressing 
keratinocytes, a technique known as M-FISH (multiplex-fluorescent in situ 
hybridization) was used. M-FISH is a molecular cytogenetic method that allows colour 
karyotyping of human chromosomes by painting each chromosome with a unique 
colour (Chapter 2, Section 2.14) (Schrock et al., 1996; Speicher et al., 1996; Speicher 
& Ward, 1996; McNeil & Ried, 2000; Strefford et al., 2001; Trask, 2002; Strachan & 
Read, 2004b). 
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As described in Materials and Methods (Chapter 2, Section 2.14), M-FISH technique 
requires the preparation of metaphase chromosome spreads and the usage of a 24-colour 
chromosome painting probe. Thus, equal number of N/TERT, SINCE, and SINEG2 
keratinocytes were seeded and were either mock treated (-) or treated with colcemid (+) 
for 2 hours and 15 minutes (Chapter 2, Section 2.14.1 and Section 2.14.2), 72 hrs (~ 
60-75% confluent) after plating. Colcemid, a closely related to, but less-toxic compound 
than colchicine, is a mitotic inhibitor, which inactivates spindle fiber formation 
(depolymerises microtubules and thus limits microtubule formation), and thus arresting 
cells in metaphase (Figure 4.19), allowing cell harvest and karyotyping to be performed 
(Taylor, 1965; Sluder, 1991; Rieder & Palazzo, 1992). 
 
Then, some of the N/TERT, SINCE and SINEG2 cells treated with colcemid (+) along 
with the mock treated (-) cells, were harvested and Hoechst-33342 stained followed by 
flow cytometry analysis both for DNA content and green fluorescence (EGFP) 
(Chapter 2, Section 2.14.1.1) (Figure 4.20), in order to check the cell cycle prior to 
metaphase spreads preparation. Consistent with previous observations (Section 4.2.1.1 
and Section 4.2.1.3, Figure 4.1, Figure 4.2 and Figure 4.4, Figure 4.8), SINEG2 
keratinocytes showed a significant increase in G2/M populations (P5) (Figure 4.20 v, 
vi), when compared to either SINCE (Figure 4.20 iii, iv) or N/TERT control 
keratinocytes (Figure 4.20 i, ii). In addition to the increased percentage of G2/M 
(tetraploid cells), SINEG2 keratinocytes display a nearly 3-fold increase in >4N and 8N 
(P15) polyploid populations (Figure 4.20 v, vi), compared to both N/TERT (Figure 
4.20 i, ii) and SINCE (Figure 4.20 iii, iv) control cells, which is in agreement with 
previous experiments (Section 4.2.1.3, Figure 4.4, Figure 4.5 and Figure 4.8). This 
effect is evident either with (+) 2 hours and 15 minutes or without (-) treatment of 
keratinocytes with colcemid.  
 
As a result of its inhibitory activity, colcemid induced a partial arrest of control 
keratinocytes in G2/M phase (P5) (Figure 4.20 ii, iii). In addition, the dividing 
populations with DNA content 8N (P15) were also arrested after treatment with 
colcemid in control keratinocytes (Figure 4.20 ii, iii). It is noteworthy that the effect of 
colcemid on SINEG2 keratinocytes produced slightly different results. The G2/M 
population (P5) of SINEG2 cells showed no increase after colcemid treatment (Figure 
4.20 v, vi). However, there was significant arrest in cells with DNA content 8N (P15) 
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(Figure 4.20 v, vi). As previously mentioned (Section 4.2.1.3), the cell populations 
with DNA content 4N (P5) of SINEG2 keratinocytes (depicted in flow cytometry as a 
G2/M peak), is largely composed of bi-nucleated/tetraploid keratinocytes (~ 19%) 
(Figure 4.8), while the 8N (P15) population partially represents the mitotic tetraploid 
population (G2/M tetraploids undergoing division). Since colcemid acts to inhibit the 
mitotic process, it seems that SINEG2 keratinocytes with DNA content 4N (P5) (G2/M 
peak; bi-nucleated/tetraploid cells) were not affected by the treatment, as opposed to the 
dividing tetraploid keratinocytes (8N) (P15), which showed a significant arrest as a 
result of the mitotic block induced by colcemid treatment. Data are representative of 
two independent experiments either using Hoechst-33342 (Chapter 2, Section 2.14.1.1) 
or PI staining (see Chapter 2, Section 2.14.1.1), each of them consisting of duplicate 
samples. 
 
The rest of the N/TERT, SINCE and SINEG2 cells treated with colcemid (+) for 2 
hours and 15 minutes, were harvested, fixed and used in order to prepare metaphase 
spreads on slides (Figure 4.21), according to the protocols described in Materials and 
Methods (Chapter 2, Section 2.14.1.2 and Section 2.14.2). Already prepared 
metaphase spreads were hybridised with the labelled DNA probe (see Chapter 2, 
Section 2.14.3). Pictures were taken for each hybridised metaphase spread in five 
different filters, and were analysed by a specific software, which generates a composite 
image in which each chromosome is given a different pseudocolour depending on the 
fluorophore composition, as well as in DAPI filter (see Chapter 2, Section 2.14.3) 
(Schrock et al., 1996; Speicher et al., 1996; Trask, 2002; Strachan & Read, 2004b). M-
FISH analysis revealed a stable near-diploid male karyotype with the presence of an 
extra chromosome 20 (trisomy 20) in all three keratinocyte cell lines N/TERT, SINCE 
and SINEG2 and in all metaphases analysed. Therefore, each of these three cell lines 
has a karyotype of (47,XY,+20) (two sets of chromosomes per cell, with an additional 
copy of chromosome 20) (Figure 4.22, Figure 4.23 and Figure 4.24). Trisomy 20 was 
a widespread feature, which was further confirmed by 10K SNP (Single Nucleotide 
Polymorphisms) array analysis, performed by Dr Muy-Teck Teh, Clinical and 
Diagnostic Oral Sciences, Institute of Dentistry, Barts and the London School of 
Medicine and Dentistry, London, UK (see Appendix III). No structural chromosome 
aberrations clonal or non-clonal were detected in the control N/TERT and SINCE 
keratinocyte cell lines (Figure 4.22 and Figure 4.23).  
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However SINEG2 keratinocytes manifested both numerical and structural chromosome 
aberrations (Figure 4.25, Figure 4.26, Figure 4.27, Figure 4.28, Figure 4.29 and 
Figure 4.30). Based on metaphase chromosome counting, approximately 7% of 
SINEG2 cells had DNA content 8N (94 chromosomes, (94, XXYY, +20, +20)) (Figure 
4.25), representing (G2/M tetraploids) tetraploids in metaphase (G2/M tetraploids), and 
~ 60% were near-tetraploid aneuploid cells with random gains and losses of 
chromosomes (i.e. 73 chromosomes) (Figure 4.26), in contrast to control cells of which 
only ~ 10% had DNA content 8N (tetraploids in metaphase). The structural 
chromosomal rearrangements were found in ~ 36% (5/14 metaphases) of SINEG2 
keratinocytes (Figure 4.27, Figure 4.28, Figure 4.29 and Figure 4.30), including non-
reciprocal unbalanced translocations and double minute chromosomes. Chromosomal 
translocation is a chromosome abnormality, caused by rearrangement of segments 
between non-homologous chromosomes, due to chromosome breakage. Non-reciprocal 
translocations, are one-way translocations in which two chromosomes break and only 
one segment from each chromosome joins together with another non-homologous 
chromosome, while the other segment from each chromosome is lost or joins with 
additional chromosomes (Lengauer et al., 1998; Albertson et al., 2003). Reciprocal 
translocations involve the breakage of two non-homologous chromosomes, and the 
exchange of segments between those two non-homologous chromosomes. 
Translocations can also be either balanced – no portions of the genome are lost or 
gained during exchange of chromosome material, or unbalanced – unequal exchange of 
chromosome material resulting in extra or missing portions of the genome (Lengauer et 
al., 1998; Albertson et al., 2003). Double minute chromosomes, are restricted regions of 
the genome which have been separated from the main chromosome body and amplified, 
and the amplified sequences present in small acentric fragments (double minutes) 
interspersed in the genome (Lengauer et al., 1998; Albertson et al., 2003; Gebhart, 
2005). A clonal (detected in two or more metaphases) chromosome rearrangement, 
t(7;14), was found in three SINEG2 metaphases (~ 21%) (Figure 4.27, Figure 4.28 and 
Figure 4.29). Interestingly, this specific translocation was detected both in a diploid cell 
(portion of the genome (7p) is gained - partial trisomy of chromosome 7p) (Figure 
4.27), and in two near-tetraploid aneuploid cells (Figure 4.28 and Figure 4.29). A non 
clonal unbalanced translocation t(9;14) was also detected in a near-tetraploid aneuploid 
SINEG2 keratinocyte. In addition, double minutes originating from chromosome 8 were 
observed in one cell (Figure 4.30). 
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Overall, these results suggest that GLI2∆N induces a level of genomic instability in 
N/TERT human keratinocytes, and strikingly the presence of the clonal translocation 
t(7;14) in a diploid cell and the presence of a pair of t(7;14) in near-tetraploid aneuploid 
cells, suggest that the ability of GLI2∆N to induce structural chromosomal aberrations 
is independent of its ability to induce tetraploidisation which however definitely seems 
to contribute to the overall chromosomal instability that GLI2∆N-expressing cells 
exhibit. 
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Figure 4.19: Stages of Mitosis. 
Mitosis (M phase) is the process of nuclear division plus cytokinesis, which results in the 
production of two identical daughter cells from a single parent cell. M phase starts at the end of 
G2 phase and ends at the start of the next G1 phase. It includes the five stages of nuclear 
division (mitosis), as well as cytoplasmic division (cytokinesis). The five stages of nuclear 
division are the prophase, prometaphase, metaphase, anaphase and telophase. Interphase, 
where the cell prepares itself for cell division, is preceeding of all the stages of mitosis, and is 
not part of mitosis. Interphase is divided into three phases, G1 (first gap), S (synthesis), and G2 
(second gap). A cell grows during G1 phase, continues to grow as it duplicates its chromosomes 
during S phase and grows more and prepares for mitosis during G2 phase. In prophase, the 
chromatin, which is diffuse in interphase, condenses into chromosomes. Each chromosome has 
duplicated in S phase and now consists of two sister chromatids bound together at the 
centromere. The mitotic spindle begins to form in the cytoplasm. In prometaphase, the nuclear 
envelope disassembles and microtubules invade the nuclear space. During metaphase the 
chromosomes align at the equatorial plate (metaphase plate) and are held in place by 
microtubules (kinetochore microtubules) attached to the mitotic spindle and to part of the 
centromere. In anaphase, chromosomes have separated into their two sister chromatids which 
are moving to opposite poles (each chromatid now called a chromosome). In telophase, 
daughter chromosomes arrive at the poles and the kinetochore microtubules disappear. The 
condensed chromatin expands and the nuclear envelope reappears. During cytokinesis, the 
cytoplasm divides by a process known as cleavage, where the cell membrane pinches inward to 
form a cleavage furrow, where the metaphase plate used to be, which gradually narrows and 
finally breaks leaving two separate daughter cells (Alberts et al., 1994; Lodish et al., 1999b; 
Strachan & Read, 2004a). royaleb.wordpress.com/2009/04/27/mitosis/. 
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Figure 4.20: Colcemid treatment and cell cycle analysis in N/TERT, SINCE and 
SINEG2 cells. 
Flow cytometry analysis of SINEG2 (v, vi) keratinocytes with (+) or without (-) colcemid 
treatment for 2 hours and 15 minutes, against both N/TERT (i, ii) and SINCE (iii, iv) control 
cells, after Hoechst-33342 staining. After doublet discrimination with width and area 
parameters, cells were discriminated according to DNA content and cell cycle profile was 
obtained. A significant increase in the cell population at the G2/M-4N (P5) and G2/M-8N (P15) 
boundaries, is evidenced in the SINEG2 (v, vi) cell line, with (+) or without (-) colcemid 
treatment, compared to both N/TERT (i, ii) and SINCE (iii, iv) cells. Colcemid treatment 
induces mitotic arrest both in G2/M populations (P5) and in cell populations with DNA content 
8N (P15) in control N/TERT (i, ii) and SINCE (iii, iv) cells. In contrast, colcemid treatment 
induces mitotic arrest only in SINEG2 (v, vi) populations with DNA content 8N (P15), and not 
in G2/Mphase (P5) of SINEG2 (v, vi) keratinocytes. N: haploid number. Data are representative 
of two independent experiments. 
 
Chapter 4: GLI2∆N induces numerical and structural chromosomal instability 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 372 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.21: Metaphase spread. 
Representative picture of a metaphase spread taken from SINEG2 cell line at x20 magnification, 
showing individual replicated and condensed mitotic chromosomes. The two sister chromatids 
of the mitotic chromosomes are joined at the centromere and are distinct. Inset shows magnified 
chromosomes from this particular metaphase spread.  
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Figure 4.22: A representative karyotype of an N/TERT keratinocyte after DNA 
hybridised of the metaphase spread using M-FISH.  
(A) N/TERT male metaphase spread as a DAPI image. (B) The same metaphase spread 
hybridised with colour-coded chromosome probes and captured as a pseudocoloured image. (C) 
Final M-FISH karyotype for the N/TERT cell (47, XY, +20).  
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Figure 4.23: A representative karyotype of a SINCE keratinocyte after DNA 
hybridised of the metaphase spread using M-FISH.  
(A) SINCE male metaphase spread as a DAPI image. (B) The same metaphase spread 
hybridised with colour-coded chromosome probes and captured as a pseudocoloured image. (C) 
Final M-FISH karyotype for the SINCE cell (47, XY, +20).  
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Figure 4.24: A representative karyotype of a SINEG2 keratinocyte after DNA 
hybridised of the metaphase spread using M-FISH. 
(A) SINEG2 male metaphase spread as a DAPI image. (B) The same metaphase spread 
hybridised with colour-coded chromosome probes and captured as a pseudocoloured image. (C) 
Final M-FISH karyotype for the SINEG2 cell (47, XY, +20).  
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Figure 4.25: A representative karyotype of a SINEG2 keratinocyte after DNA 
hybridised of the metaphase spread using M-FISH.  
(A) SINEG2 male metaphase spread as a DAPI image. (B) The same metaphase spread 
hybridised with colour-coded chromosome probes and captured as a pseudocoloured image. (C) 
Final M-FISH karyotype for the SINEG2 cell (94, XXYY, +20, +20). A representative 
metaphase spread and karyotype of a tetraploid SINEG2 cell with DNA content 8N (4 sets of 
chromosomes) in metaphase (G2/M tetraploid).  
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Figure 4.26: A representative karyotype of a SINEG2 keratinocyte after DNA 
hybridised of the metaphase spread using M-FISH.  
(A) SINEG2 male metaphase spread as a DAPI image. (B) The same metaphase spread 
hybridised with colour-coded chromosome probes and captured as a pseudocoloured image. (C) 
Final M-FISH karyotype for the SINEG2 cell. A representative metaphase spread and karyotype 
of an aneuploid (near-tetraploid aneuploid) SINEG2 cell displaying 73 chromosomes with 
losses and gains of many chromosomes. This is an example of a tetraploid cell that might have 
undergone multipolar and asymmetric divisions, yielding aneuploid progenies. 
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Figure 4.27: A representative karyotype of a SINEG2 keratinocyte after DNA 
hybridised of the metaphase spread using M-FISH.  
(A) SINEG2 male metaphase spread as a DAPI image. (B) The same metaphase spread 
hybridised with colour-coded chromosome probes and captured as a pseudocoloured image. (C) 
Final M-FISH karyotype for the SINEG2 cell (47, XY, -7, +del7q, -14, +der(14)t(7;14) +20). A 
representative metaphase spread and karyotype of a diploid SINEG2 cell show the clonal non-
reciprocal unbalanced translocation t(7;14) (white arrows). 
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Figure 4.28: A representative karyotype of a SINEG2 keratinocyte after DNA 
hybridised of the metaphase spread using M-FISH.  
(A) SINEG2 male metaphase spread as a DAPI image. (B) The same metaphase spread 
hybridised with colour-coded chromosome probes and captured as a pseudocoloured image. (C) 
Final M-FISH karyotype for the SINEG2 cell. A representative metaphase spread and karyotype 
of an aneuploid (near-tetraploid aneuploid) SINEG2 cell show the clonal translocation t(7;14) 
(white arrows).  
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Figure 4.29: A representative karyotype of a SINEG2 keratinocyte after DNA 
hybridised of the metaphase spread using M-FISH.  
(A) SINEG2 male metaphase spread as a DAPI image. (B) The same metaphase spread 
hybridised with colour-coded chromosome probes and captured as a pseudocoloured image. (C) 
Final M-FISH karyotype for the SINEG2 cell. A representative metaphase spread and karyotype 
of an aneuploid (near-tetraploid aneuploid) SINEG2 cell show the clonal translocation t(7;14) 
(white arrows).  
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Figure 4.30: A representative picture of a SINEG2 keratinocyte after DNA 
hybridised of the metaphase spread using M-FISH.  
(A) SINEG2 male metaphase spread as a DAPI image. (B) The same metaphase spread 
hybridised with colour-coded chromosome probes and captured as a pseudocoloured image. A 
representative metaphase spread of an aneuploid (near-tetraploid aneuploid) SINEG2 cell shows 
the presence of double minute chromosomes (white arrows). M-FISH analysis reveals that the 
origin of the double minute chromosomes is chromosome 8. 
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4.3 Discussion 
4.3.1 GLI2∆N induces numerical chromosomal instability in human 
N/TERT keratinocytes 
4.3.1.1 GLI2∆N-induced tetraploidy is responsible for the observed delay in the 
growth of SINEG2 keratinocytes 
 
The general consensus regarding the SHH/GLI signalling pathway in skin is that it 
drives cell proliferation and hence its members are proto-oncogenes. The genetic 
analysis of Gorlin or nevoid basal cell carcinoma (NBCC) syndrome, an autosomal 
dominant hereditary disease which predisposes patients to the early development of 
multiple BCCs (Gorlin, 1987; Gorlin, 1995), has been shown that is linked to 
deregulation of the PTCH/SMO interaction due to inactivating PTCH (Patched) 
mutations, and thus leading to constitutive activation of the SHH/GLI pathway 
promoting proliferation in the absence of the ligand (Hahn et al., 1996b; Johnson et al., 
1996; Unden et al., 1996; Gailani & Bale, 1997; Unden et al., 1997; Booth, 1999; 
Happle, 1999; Ling et al., 2001; Daya-Grosjean & Couve-Privat, 2005). In addition, 
inactivation of PTCH and activation of SMO (Smoothened) mutations occur frequently 
in sporadic BCCs and in BCCs associated with xeroderma pigmentosum, whereas both 
sporadic and hereditary human BCCs contain p53 mutations (Barbareschi et al., 1992; 
Shea et al., 1992; Gailani et al., 1996; Unden et al., 1996; Gailani & Bale, 1997; 
Grossman & Leffell, 1997; Ponten et al., 1997; Unden et al., 1997; Xie et al., 1998; 
Bodak et al., 1999; Ling et al., 2001; Dicker et al., 2002; Lacour, 2002; Daya-Grosjean 
& Couve-Privat, 2005; Reifenberger et al., 2005; Teh et al., 2005). Furthermore, direct 
overexpression of Gli2, as well as of other members of the SHH/GLI signalling 
pathway, in mice, directly leads to BCC or BCC-like tumour susceptibility (Fan et al., 
1997; Oro et al., 1997; Xie et al., 1998; Grachtchouk et al., 2000; Nilsson et al., 2000; 
Sheng et al., 2002; Hutchin et al., 2005; Huntzicker et al., 2006; Youssef et al., 2010). 
 
However, despite the identification of the genetic hits involved in BCC development, 
little is known about the molecular mechanisms involved in the transformation of 
epidermal keratinocytes in response to HH/GLI signalling. In this respect, several 
mechanisms have been proposed in different organisms, including interactions of 
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SHH/GLI signalling with important cell cycle mediators that promote cell proliferation, 
such as cyclin D1, cyclin B1 and CDC25B (M-phase inducer phosphatase 2) (see 
Chapter 1, Section 1.3.7) (Barnes et al., 2001; Ruiz i Altaba et al., 2002a; Pasca di 
Magliano & Hebrok, 2003; Wetmore, 2003; Daya-Grosjean & Couve-Privat, 2005; 
Aberger & Frischauf, 2006; Athar et al., 2006; Benazeraf et al., 2006; Kasper et al., 
2006a). In mouse skin, loss of Shh or Gli2 function, leads to a significant decrease in 
the rate of cell proliferation in the developing hair follicle (Mill et al., 2003), while 
recent works by Regl et al. (Regl et al., 2004a) and Eichberger et al. (Eichberger et al., 
2006), using cDNA-array based gene expression techniques, have shown that inducible 
overexpression of GLI2∆N in either confluent or sub-confluent human skin epidermal 
HaCaT keratinocytes, induces a number of genes involved in G1-S phase and G2-M 
phase progression of the cell cycle (see Chapter 1, Section 1.3.7 and Chapter 4, 
Section 4.1). On the other hand, it has not been reported that keratinocytes expressing 
GLI2 have an accelerated proliferation rate in normal culture conditions, and no one has 
shown the cell cycle profile of keratinocytes expressing GLI2. Instead, a reduced 
growth rate in response to GLI2∆N overexpression was observed in N/TERT 
keratinocytes in my system (see Chapter 3, Section 3.2.3.2, Figure 3.14 and Figure 
3.15) (see Chapter 3, Section 3.3.9), while the same inducible GLI2∆N HaCaT cell 
line that was used by Eichberger et al. (Eichberger et al., 2006) for microarray analysis, 
had no proliferative advantage (no faster cell cycle) compared to the control, it showed 
a reduced growth rate in culture, as reported by Snijders et al. (Snijders et al., 2008). 
 
Several reasons might have contributed to the observed delay in the growth of SINEG2 
keratinocytes in my study, including cell cycle arrest, impaired or delayed mitosis and 
apoptosis and/or cell death. However, the GLI2∆N induction in N/TERT keratinocytes, 
did not result in increased apoptosis or cell death, as judged by the Annexin V and 
Annexin V / DAPI positive cells (Figure 4.3), and by the propidium iodide stained cells 
with sub-G1 content (Figure 4.4). In addition, cell cycle analysis of N/TERT 
keratinocytes expressing GLI2∆N, showed that SINEG2 keratinocytes displayed an 
increase in the G2/M phase, representing bi-nucleated/tetraploid cells (Figure 4.1, 
Figure 4.2 and Figure 4.8), as well as an increase in the cells with DNA content >4N 
and 8N, representing G2/M-tetraploid (tetraploids undergoing division), polyploid and 
aneuploid cells (Figure 4.4, Figure 4.5 and Figure 4.7). Taken together these findings, 
indicate that overexpression of GLI2∆N interferes with normal cell cycle completion 
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through the G2/M phase and mitotic division, possibly due to cytokinesis failure and 
therefore increasing the chromosomal complement of the cells. Hence, a proportion of 
GLI2∆N cells fail to divide upon completion of mitosis (cytokinesis failure) yielding bi-
nucleated tetraploid cells (a dividing cell giving rise to one G1 bi-nucleated daughter 
cell instead of two G1 daughter cells), a fact that might contribute to the low cell counts 
obtained from long term culture, and explain the significant reduction of cumulative 
population doublings in GLI2∆N overexpressing keratinocytes. 
 
It has been previously shown that either bi-nucleated or mono-nucleated tetraploid, 
polyploid and aneuploid cells exhibit a prolonged mitosis compared to diploid cells 
(Gisselsson et al., 2008; Storchova & Kuffer, 2008; Yang et al., 2008b). Therefore, 
overexpression of GLI2∆N leads to delayed exit form mitosis of tetraploid cell, and 
allows the generation of polyploid and aneuploid progenies with enhanced viability. 
This observation is highly consistent with Sotillo et al. (Sotillo et al., 2007), which 
showed that inducible overexpression of Mad2 oncogene in MEF cells from transgenic 
mice, leads to the accumulation of bi-nucleated tetraploid and mono-nucleated 
aneuploid MEFs, with a much slower growth rate than their normal counterparts (Sotillo 
et al., 2007). 
 
Recently, it has also been demonstrated that the chromosome complement and the 
amount of centrosomes present during division, are both very important determinants of 
the duration of mitosis in human normal and cancer cells (Yang et al., 2008b). In the 
same study, it was shown that the duration of the mitotic process was proportional to the 
modal chromosome number of each cell (i.e. 4N bi-nucleated cells, originated from 
cytokinesis failure due to cytochalasin treatment, took longer (>2x) than 2N diploid 
cells to enter anaphase) (Yang et al., 2008b). While the slower rate of mitotic 
progression was attributed both to the increased chromosome and centrosome numbers, 
the latter showed to have a much stronger influence since diploid cells with artificially 
introduced additional centrosomes were 3x slower than tetraploid cells with artificially 
normalised centrosome numbers, compared to normal diploid cells (Yang et al., 2008b).  
 
Abnormally increased centrosome numbers can lead to the formation of multipolar 
spindles (defect in chromosome segregation), which have been shown to display 
significant mitotic delay and to be responsible for the longer duration of mitosis in 
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tetraploid, polyploid and aneuploid cells, due to the delay in satisfaction of the spindle 
assembly checkpoint (SAC) (SAC prolongs mitosis until all kinetochores are stably 
attached to spindle microtubules) (Rieder et al., 1994; Gisselsson et al., 2008; Storchova 
& Kuffer, 2008; Yang et al., 2008b). The prolongation in the division of bi-nucleated 
tetraploid cells can be alleviated when the spindle assembly checkpoint is abrogated 
through the introduction of a dominant-negative form of Mad2 (Mad2-∆C), further 
supporting the role of SAC in impairing the mitotic process (Yang et al., 2008b). 
Although cells with multipolar spindles are stalled in mitosis, this transient block 
imposed by the SAC is eventually bypassed, and cells are allowed to complete either 
multipolar (mainly transformed cells) or bipolar divisions and exit mitosis (mitotic 
slippage) (Gisselsson et al., 2008; Yang et al., 2008b). 
 
Therefore, the existence of tetraploid, polyploid and aneuploid cells in GLI2∆N-
expressing keratinocyte cultures, followed by prolonged mitosis, could explain why 
overall SINEG2 keratinocytes exhibit a reduced growth rate in culture.  
 
 
4.3.1.2 Ploidy abnormalities (tetraploidy, aneuploidy) induced by GLI2∆N in 
N/TERT keratinocytes are hallmarks of cancer  
The increase of bi-nucleated/tetraploid cells (DNA content 4N), observed upon GLI2∆N 
induction in N/TERT keratinocytes (Figure 4.1, Figure 4.2, Figure 4.4 and Figure 
4.8), apart from being a possible explanation for the slow growth rate of keratinocytes, 
it may also contribute to cell transformation and carcinogenesis by preceding the 
formation of polyploid and aneuploid cells and leading to genomic/chromosomal 
instability (Storchova & Pellman, 2004; Ganem et al., 2007). Tetraploidy is a feature 
that is commonly seen in human cancer, including human BCCs (Miller, 1991a; 
Rajagopalan & Lengauer, 2004; Shi & King, 2005; Olaharski et al., 2006; Weaver & 
Cleveland, 2006; Ganem et al., 2007; Storchova & Kuffer, 2008), and has been reported 
as an early step in human tumourigenesis and as a contributing factor in the generation 
of aneuploid tumours (Shackney et al., 1989; Galipeau et al., 1996; Storchova & 
Pellman, 2004; Zhivotovsky & Kroemer, 2004; Fujiwara et al., 2005; Ganem et al., 
2007; Storchova & Kuffer, 2008; Holland & Cleveland, 2009).  
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4.3.1.2.1  Aneuploidy and cancer 
Aneuploidy is often caused by errors in chromosome partitioning during mitosis, due to 
defects in mitotic checkpoint signalling, sister chromatid cohesion defects, merotelic 
attachment, and due to acquisition of extra centrosomes leading either to multipolar 
mitotic divisions and thus whole chromosome missegregation, and unequal distribution 
of chromosomes in daughter cells, or to centrosome clustering into two groups that will 
allow cells to divide in a bipolar fashion but with increased risk of incorrect kinetochore 
microtubule attachments and thus leading to aneuploidy (Figure 4.31) (Fukasawa, 
2007; Holland & Cleveland, 2009). Each centrosome consists of two centrioles and in 
order to ensure bipolar mitotic spindle formation, the single centrosome of a cell 
duplicates precisely once prior to mitosis (Hinchcliffe & Sluder, 2001). Thus, during 
centrosome duplication the two centrioles separate, followed by de novo synthesis of a 
single daughter centriole adjacent to each of the older centrioles during S phase 
(Hinchcliffe & Sluder, 2001). Extra centrosome acquisition, can be due to centrosome 
malfunctions, such as centrosome overduplication, centrosome fragmentation and loss 
of centriole cohesion in a diploid cell, or generation of tetraploidy (Nigg, 2002; 
Fukasawa, 2007; Holland & Cleveland, 2009).  
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Figure 4.31: Roads to aneuploidy. 
There are several pathways by which cells might gain or loose chromosomes, and thus generate 
aneuploidy; (a) Defects in mitotic checkpoints, which allow cells to enter anaphase in the 
presence of unattached or misaligned chromosomes, (b) Cohesion defects, leading to premature 
loss of sister chromatid cohesion and chromosome missegregation, (c) Merotelic attachments, 
occur when one kinetochore is attached to microtubules from both poles of the spindle, leading 
to chromosome missegregation and to exclusion of the lagging chromatid from both daughter 
cells during cytokinesis, (d) Acquisition of extra centrosomes, leading to multipolar mitotic 
spindle formation, followed either by centrosome clustering where cells are allowed to divide in 
a bipolar fashion but with an increased risk of  merotelic attachments, or by multipolar mitotic 
divisions producing three or more highly aneuploid daughter cells (Holland & Cleveland, 2009). 
Centrosomes (black arrow) are small cytoplasmic organelles that are the microtubule 
(cytoskeletal protein)-organizing centre of animal cells (nucleation and organization of 
microtubules) and are also crucial in the organization of spindle poles and the completion of 
cytokinesis. Each centrosome consists of a pair of centrioles (black lines) which are open-ended 
cylinders comprised of nine sets of triplet microtubules linked together and embedded in a 
matrix of pericentriolar material (Doxsey, 2001; Duensing & Munger, 2001; Hinchcliffe & 
Sluder, 2001; Nigg, 2002). 
 
centrosome
centrioles
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Aneuploidy is consistently observed in virtually all cancers, including human BCCs, 
both in early stages of many tumour types (probably a result of mutations, in a set of 
genes that are specifically involved in maintaining chromosome stability, or in other 
genes and through other mechanisms i.e. radiation which damages the spindle apparatus 
and causes aneuploidy (Duesberg & Rasnick, 2000; Li et al., 2000)) and in mature 
tumours, and this is why it has been proposed to play a role both in tumourigenesis and 
in tumour progression (Buchner et al., 1985; Miller, 1991a; Herzberg et al., 1993; 
Fortier-Beaulieu et al., 1994; Lengauer et al., 1997; Lengauer et al., 1998; Staibano et 
al., 2001; D'Assoro et al., 2002; Nowak et al., 2002; Ashton et al., 2005; Carless et al., 
2006; Weaver & Cleveland, 2006; Storchova & Kuffer, 2008). Thus, apart from the fact 
that aneuploidy precedes transformation as it is found in pre-cancerous lesions of the 
cervix (Ried et al., 1999; Duensing & Munger, 2004), head and neck (Ai et al., 2001), 
colon (Ried et al., 1999; Cardoso et al., 2006), oesophagus (Doak et al., 2004), bone 
marrow (Amiel et al., 2005), breast (Medina, 2002) and skin (Dooley et al., 1993), it 
also disrupts global transcription by causing misregulation of growth-promoting and 
growth-restricting genes (Upender et al., 2004), further supporting the notion that it 
might have a role in tumourigenesis (Weaver & Cleveland, 2006).  
 
In addition, aneuploidy can be either a result of a transient chromosome missegregation 
event at some point in the development of the tumour that leads to a stably propagated 
and inherited abnormal karyotype (stably aneuploid tumour cells), or a result of an 
underlying chromosomal instability that leads to an increased rate of gain or loss of 
whole chromosomes during cell division (unstable aneuploid tumour cells) (Lengauer et 
al., 1997; Lengauer et al., 1998; Saunders et al., 2000; Lingle et al., 2002; Holland & 
Cleveland, 2009). Hence, the karyotypic/chromosomal instability of a cancer cell, is 
proportional to its degree of aneuploidy (ratio of the ploidy of a given cell versus the 
ploidy of a normal cell of the same species), suggesting that the more aneuploid the cell 
(abnormal number of chromosomes), the more unstable is the karyotype (Lengauer et 
al., 1997; Duesberg et al., 1998; Duesberg & Rasnick, 2000). Although it is not yet clear 
how aneuploidy can trigger tumourigenesis, the most likely scenario is that aneuploidy, 
due to changes in chromosome copy number, allows oncogene amplification or loss of 
tumour-suppressor genes (Torres et al., 2008; Holland & Cleveland, 2009). There are 
also non-neoplastic aneuploidies, which typically involve the loss or the gain of only 
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one or very few chromosomes (Harnden et al., 1976; Galloway & Buckton, 1978; 
Duesberg & Rasnick, 2000). 
 
The notion that aneuploidy might have a causative role in cancer lies back in 1914, 
when Theodor Boveri (Boveri, 2008) first suggested that malignancy is due to a 
disorder in the chromosome constitution of the cell (abnormal chromosome constitution 
/ aneuploidy), that this karyological disorder is initiated most commonly by 
abnormalities of mitosis (multipolar mitosis) and that centrosomes malfunction might 
be involved and be the major source of instability (Balmain, 2001; Hardy & Zacharias, 
2005; Bignold et al., 2006; Boveri, 2008; Harris, 2008a; Harris, 2008b; Holland & 
Cleveland, 2009). However, even if for more than 100 years aneuploidy has been 
proposed to drive / promote tumour formation (Boveri, 2008), it is still hotly debated 
whether aneuploidy is a cause or a consequence of malignant transformation, mainly 
due to the genetic complexity of aneuploid cells (Storchova & Pellman, 2004; Weaver 
& Cleveland, 2006; Holland & Cleveland, 2009). Each aneuploid tumour, is aneuploid 
on its own way and has its own particular abnormal chromosome content, and thus its 
own abnormal characteristics, a fact that complicates the identification of mutations that 
result in aneuploidy, or the identification of general features common to aneuploid 
tumour cells (Storchova & Pellman, 2004; Pellman, 2007). In addition, although 
aneuploidy correlates with transformation, the difficulty of generating experimentally 
aneuploidy, without causing other cellular defects such as DNA damage (i.e. 
suppressing genes that they do not participate in cellular functions other than 
chromosome segregation, or using drugs that are not mutagenic), partly restricts the 
testing and the confirmation of the hypothesis that aneuploidy drives/causes 
tumourigenesis (Weaver & Cleveland, 2006). 
 
However, a recent study made by Weaver et al., (Weaver et al., 2007), using mouse 
cells and mice with reduced levels of the mitosis-specific, centromere-linked motor 
protein CENP-E (involved in aligning chromosomes normally on the mitotic spindle 
and in modulating the spindle checkpoint), is in favour of the idea that chromosome 
missegregation and its associated aneuploidy drives malignant transformation as Boveri 
had initially proposed (Pellman, 2007). Cells and mice with reduced levels of the 
CENP-E were shown to develop aneuploidy (single-chromosomal aneuploidy, near-
diploid aneuploidy) and chromosomal instability in vitro and in vivo, as well as to 
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develop spontaneous tumourigenesis in vivo in aged mice, but only at a modest 
frequency (Weaver et al., 2007). Most strikingly though, aneuploidy from whole single-
chromosome loss (or gain) in heterozygous CENP-E knockout mice, was reported to 
strongly delay in vivo tumourigenesis after loss of the p19/ARF tumour-suppressor gene 
(Weaver et al., 2007). This observation suggests that low levels of aneuploidy and 
chromosomal instability, due to reduction of CENP-E, promote tumour initiation and 
progression, whereas high levels, due to an additional genetic damage (loss of the 
p19/ARF), are protective (Weaver et al., 2007). 
 
Therefore, although it is clear from this and from other studies that aneuploidy is able to 
trigger tumourigenesis, as well as to increase the risk of neoplastic transformation and to 
facilitate tumour progression (Weaver & Cleveland, 2006; Holland & Cleveland, 2009), 
many factors might affect the overall outcome of aneuploidy. The balance between 
aneuploid cells to become tumourigenic or growth-arrested following cell death, may be 
controlled by the different paths to aneuploidy (i.e. through single-chromosomal 
missegregation or tetraploidy intermediate), the different cell types, the different genetic 
contexts and the levels of genomic instability (Pellman, 2007). High levels of genomic 
instability in a near-diploid aneuploid cell would be fatal to the cell, and would decrease 
the fitness of this cell, compared to a diploid cell with intact genome (Cahill et al., 
1999). Thus, the ‘just right’ levels of genomic instability that will still be compatible 
with survival and sufficient enough to generate new genomic variants are required in a 
cell, in order for the cell to become transformed (Cahill et al., 1999; Storchova & 
Kuffer, 2008).    
 
4.3.1.2.2 Tetraploidy and cancer 
Separately from chromosome missegregation, or abnormal centrosome numbers during 
mitosis that can result in aneuploidy, tetraploidy (genome doubling) is an alternative 
mechanism through which diploid cells can evolve into highly aneuploid cells, by 
chromosomal loss from a tetraploid intermediate (Shackney et al., 1989; Ganem et al., 
2007; Storchova & Kuffer, 2008; Torres et al., 2008; Holland & Cleveland, 2009).  
 
Most importantly, tetraploidy is not just a harmless side effect of cancer-promoting 
chromosome instability, but it has its own tumourigenic potential, since only tetraploid 
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(generated by transient exposure to an actin inhibitor, dihydrocytochalasin B (DCB), 
that prevents remodelling of the cytoskeleton and thus causes failure of cytokinesis), 
and not diploid, p53 null mouse mammary epithelial cells promote tumourigenesis after 
subcutaneous injection into nude mice (Fujiwara et al., 2005). Also, tetraploid p53 null 
cells and not diploid p53 null cells promoted chemically-induced in vitro transformation 
(Fujiwara et al., 2005). In addition, Duelli et al. (Duelli et al., 2007) recently showed 
that only tetraploid, generated by MPMVE viral-induced cell-cell fusion, and not 
diploid human fibroblasts co-expressing E1A and HRAS1 oncogenes, are able to 
promote tumourigenesis when transplanted into nude mice (Ganem et al., 2007; Holland 
& Cleveland, 2009). In both these studies, tetraploidy in culture increased the 
proportion of highly aneuploid cells (whole-chromosome aneuploidy), and of cells with 
structural chromosomal rearrangements (Fujiwara et al., 2005; Duelli et al., 2007), 
whereas mice tetraploid-derived tumours also displayed large-scale structural 
chromosomal aberrations (Fujiwara et al., 2005). 
 
Further evidence, supporting the notion that tetraploids are transient intermediates on 
the road to aneuploidy, and of which uncontrolled proliferation might promote cellular 
transformation and tumourigenesis (at least in some tumour types), is multifold and 
comes from studies of tissue cultured cells, animal models, and from human patients 
(Shackney et al., 1989; Storchova & Pellman, 2004; Ganem et al., 2007; Storchova & 
Kuffer, 2008; Holland & Cleveland, 2009). First, some tumours have a tetraploid or 
near-tetraploid DNA content (tetraploid, near-tetraploid, polyploid karyotypes) (Kaneko 
& Knudson, 2000; Mitelman et al., 2003; Rajagopalan & Lengauer, 2004; Storchova & 
Pellman, 2004; Weaver & Cleveland, 2006; Storchova & Kuffer, 2008), while the 
number of chromosomes in some tumour cells is often very high, which is difficult to 
explain by a repeated accumulation of chromosomes at each division (Storchova & 
Kuffer, 2008). Second, the majority of tumours contain aneuploid cells that possess 
multiple centrosomes, which might reflect a previous history of cell division failures 
and tetraploidy (i.e. cytokinesis failure), without of course excluding the possibility of 
centrosome overduplication (Lingle et al., 1998; Pihan et al., 1998; Brinkley, 2001; 
Doxsey, 2001; D'Assoro et al., 2002; Nigg, 2002; Fukasawa, 2005; Saunders, 2005; 
Fukasawa, 2007). Centrosome abnormalities have been reported to arise at early stages 
of tumour formation and to expand parallel to tumour progression (Pihan et al., 2001; 
Shono et al., 2001; Pihan et al., 2003). Third, multipolar mitosis of tetraploid cells, that 
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have acquired extra centrosomes, leads to aneuploidy (Andreassen et al., 1996; 
Andreassen et al., 2001b; Borel et al., 2002; Margolis et al., 2003; Storchova & 
Pellman, 2004).  
 
Fourth, tumour suppressor proteins, such as breast cancer type 2 susceptibility protein 
(BRCA2), large tumour suppressor homologue 1 (LATS1) and  adenomatous polyposis 
coli (APC), that have been found to be inactivated in human cancers (aneuploid 
tumours), have been shown to be implicated in cytokinesis (BRCA2 and LATS1), 
whereas their inactivation leads to cytokinesis failure and increases the percentage of 
tetraploid/polyploid cells (BRCA2, LATS1 and APC) (Daniels et al., 2004; Yang et al., 
2004; Caldwell et al., 2007; Ganem et al., 2007; Storchova & Kuffer, 2008; Holland & 
Cleveland, 2009). In addition, lack of the kinesin motor protein KIF4, which has been 
reported to be necessary for cytokinesis (Zhu & Jiang, 2005), from mouse embryonic 
stem cells, results in increased tetraploidy/polyploidy, subsequent aneuploidy, and 
enhanced tumourigenesis in vivo when cells lacking KIF4 were injected subcutaneously 
into nude mice (Mazumdar et al., 2006). Importantly KIF4 was found to be absent, or 
expressed at low levels in 35% of tested human tumour samples (Mazumdar et al., 
2006). Fifth, the two proteins p53 and Rb, (along with p21 and p16) that have been 
implicated in the prevention of further proliferation of tetraploid and aneuploid cells 
(Minn et al., 1996; Lanni & Jacks, 1998; Andreassen et al., 2001a; Andreassen et al., 
2001b; Borel et al., 2002; Meraldi et al., 2002; Margolis et al., 2003), are commonly 
absent or non-functional in human cancers (Weinberg, 1995; Sherr, 1996; Sherr & 
McCormick, 2002; Storchova & Pellman, 2004; Ganem et al., 2007; Storchova & 
Kuffer, 2008).  
 
Finally but most importantly, consistent with the causative role of tetraploidy at least in 
some types of cancer, and with the long-standing hypothesis that a tetraploid 
intermediate has a crucial role in the development of aneuploidy and chromosomal 
instability (aneuploidy develops through chromosomal loss from a tetraploid 
intermediate) in some solid tumours (Shackney et al., 1989), an increase in tetraploid 
population of cells have been detected in early-stage cancers either in mice or human 
model systems (Cowell & Wigley, 1980; Ornitz et al., 1987; Levine et al., 1991b; 
Galipeau et al., 1996; Southern et al., 1997; Barrett et al., 2003; Olaharski et al., 2006; 
Storchova & Kuffer, 2008; Holland & Cleveland, 2009). Studies from human patients 
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with a premalignant condition known as Barrett’s oesophagous that leads to the 
development of esophageal adenocarcinoma (early dysplasia to malignancy), have 
revealed inactivation/loss of p16 gene, followed by loss of p53 gene and a significant 
increase of tetraploid cells (increase of 4N populations in diploid cells), before gross 
aneuploidy occurs (Galipeau et al., 1996; Barrett et al., 1999). This suggests that 
tetraploid populations in premalignant cells are predisposed to further 
genomic/chromosomal instability during neoplastic progression, leading to the 
evolution of aneuploid cells, and through clonal expansion to progression to cancer 
(Galipeau et al., 1996; Reid et al., 1996; Barrett et al., 1999; Barrett et al., 2003; Maley 
et al., 2004; Maley, 2007). Similarly, studies from human patients with either normal, 
low or high-grade squamous intraepithelial lesions, showed that tetraploidy and 
chromosomal instability occur during the early stages of cervical carcinogenesis, 
predisposing cervical cells to the formation of aneuploidy (Olaharski et al., 2006). 
Further evidence, to the notion that polyploid/aneuploid cells are commonly found in 
tumours of all stages, and that tetraploid cells occur as an early step in tumourigenesis 
preceding aneuploidy, comes also from studies using mice models of pancreatic cancer 
(Ornitz et al., 1987; Levine et al., 1991b). Expression of SV40 (simian virus 40) in 
mouse pancreatic cells leads to a multistep pathway of neoplastic progression, 
characterised by a progression from normal pancreas to hyperplasia, to dysplasia, and 
ultimately to carcinoma, accompanied by accumulation of tetraploid cells in the early 
stages of tumour formation, and the subsequent appearance of aneuploid cells (diploid 
(normal, hyperplasia) to tetraploid (dysplasia) to aneuploid (neoplastic tissues) (Ornitz 
et al., 1987). 
 
Therefore, according to all these studies described above, there is compelling evidence 
to suggest that the uncontrolled proliferation of tetraploid cells is able to promote / 
enhance cellular transformation and tumour formation, probably due to the increased 
chromosomal instability that tetraploid cells provoke, both in mammalian and in yeast 
cells (i.e. tetraploidy in mammalian cells → acquisition of extra centrosomes → errors 
in the division of tetraploid cells and/or multipolar divisions (defect in chromosome 
segregation, whole chromosome mis-segregation i.e. multipolar mitosis leads to 
chromosomal instability due to unsynchronized sister-chromatid separation, high 
frequency of non-disjunction, and subsequent occurrence of diplochromosomes - sister 
chromatids remain attached in their centromeres (Gisselsson et al., 2008)) → gain/loss 
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of chromosomes (oncogene amplification and/or reduction of tumour suppressor genes 
due to changes in copy number) → aneuploidy → further chromosomal instability due 
to the unbalanced gene expression of the aneuploid cells (gene expression imbalances 
might lead to an increase in the rate of spontaneous DNA damage, by altering cellular 
processes that produce or repair the normally low level of spontaneous DNA damage) 
→ acquisition of transforming mutations that promote cancer) → selection → cancer 
(Nowell, 1976; Cowell & Wigley, 1980; Shackney et al., 1989; Mayer & Aguilera, 
1990; Cahill et al., 1999; Fujiwara et al., 2005; Storchova et al., 2006; Ganem et al., 
2007; Storchova & Kuffer, 2008). Although multiple centrosomes, which lead to the 
formation of multipolar spindles and consequently to aneuploidy and chromosomal 
instability, can arise either in a diploid cell (centrosome overduplication / amplification) 
or through the formation of a tetraploid cell (cell fusion and/or failure in cytokinesis) 
(Nigg, 2002; Fukasawa, 2007), there is probably a striking difference in the fate of those 
two cells. A diploid cell with increased chromosomal instability (acquisition of extra 
centrosomes) would probably die after losing multiple chromosomes in a multipolar 
division (aberrant mitosis) (producing highly unstable aneuploid progeny but not 
viable), while a tetraploid/polyploid cell by doubling the genome, might have a higher 
chance of survival after multipolar divisions, because of a higher redundancy in 
chromosomal content (producing unstable aneuploid progeny but still viable and able to 
generate new genomic variants) (Shackney et al., 1989; Storchova & Kuffer, 2008).  
 
The extra sets of chromosomes in tetraploid cells and/or near-tetraploid aneuploid cells, 
might mask (protect against) the effects of deleterious mutations, by the buffering 
effects of the extra normal chromosomes (Ganem et al., 2007; Storchova & Kuffer, 
2008; Holland & Cleveland, 2009). This possibly allows cells to survive for longer in 
the presence of ongoing DNA damage and allow more time for cells to acquire and 
accumulate growth-promoting and transforming mutations, providing another 
explanation for the tumour-promoting activity of tetraploidy and subsequent aneuploidy 
(Shackney et al., 1989; Ganem et al., 2007; Storchova & Kuffer, 2008; Holland & 
Cleveland, 2009). Consistently, two studies based on budding yeast evolution 
experiments, have clearly shown the positive effects that ploidy seems to exhibit on 
fitness of the cells (Paquin & Adams, 1983; Thompson et al., 2006). Haploid mutator 
budding yeast (mismatch repair defective) had no growth advantage versus haploid non-
mutators. In contrast, diploid mutator had a growth advantage not only over diploid 
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non-mutators, but also over haploid mutators in long-term evolution experiments, 
suggesting that in the presence of increased mutations, increased ploidy can offer an 
overall growth advantage (Thompson et al., 2006; Ganem et al., 2007). 
 
4.3.1.2.3 Possible mechanisms through which GLI2∆N induces tetraploidy in 
human N/TERT keratinocytes 
As mentioned in Section 4.2.1.3, tetraploidy can result from a variety of alterations 
(Figure 4.6) (Storchova & Pellman, 2004) including (a) endoreplication (Ravid et al., 
2002), (b) cell fusion due to viruses (Vignery, 2000; Taylor, 2002; Duelli & Lazebnik, 
2007), (c) centrosome overduplication (centrosome amplification) (Nigg, 2002; 
Fukasawa, 2007), (d) failure in centrosome duplication (Nigg, 2002; Fukasawa, 2007), 
(e) DNA damage (Olive et al., 1996; Waldman et al., 1996; Bunz et al., 1998), or as a 
result of (f) abortive cell cycle due to defects in different aspects of cell division, such 
as failure of spindle assembly and chromosome segregation (failure in karyokinesis),  
microtubule stabilisation or destabilisation by agents such as taxol or nocodazole, 
respectively (failure in karyokinesis), and cytokinesis failure (Andreassen et al., 1996; 
Minn et al., 1996; Lanni & Jacks, 1998; Andreassen et al., 2001b; Storchova & 
Pellman, 2004; Zhivotovsky & Kroemer, 2004).  
 
In addition, defects in some genes can lead to tetraploidisation, which subsequently 
leads to aneuploidy, chromosomal instability and tumourigenesis (Storchova & Kuffer, 
2008; Holland & Cleveland, 2009). Thus, apart from some tumour suppressor genes 
which have been linked to tetraploidisation and its tumourigenic potential (see Section 
4.3.1.2.2) (inactivation of tumour suppressor proteins, such as BRCA2, LATS1, and 
APC) (Daniels et al., 2004; Yang et al., 2004; Caldwell et al., 2007; Ganem et al., 2007; 
Storchova & Kuffer, 2008; Holland & Cleveland, 2009), there are also several 
established oncogenes that have been reported to induce tetraploidisation (Storchova & 
Kuffer, 2008; Holland & Cleveland, 2009). For instance, overexpression of Aurora A 
kinase in human and mouse cell lines, which has a role in bipolar spindle formation and 
is frequently overexpressed in human cancers (breast, colon, ovarian, pancreatic) 
(Meraldi et al., 2004), results in cytokinesis failure and accumulation of bi-
nucleated/tetraploid cells and subsequent centrosome amplification (Meraldi et al., 
2002). In addition, overexpression of Aurora A in the mammary gland of mice leads to 
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an increase in the generation of tetraploidy, chromosomal instability and subsequent 
formation of mammary tumours (Zhang et al., 2004; Wang et al., 2006). This specific 
phenotype induced by overexpression of Aurora A in cell lines as well as in the 
mammary gland of mice models was significantly exacerbate, and the tumour incidence 
in these mice models was significantly increased, in a p53 mutation background 
(absence of the tumour suppressor p53 protein) (Meraldi et al., 2002; Wang et al., 
2006).  
 
Similarly, overexpression of Eg5 (Kif11) in mice, a motor protein that belongs to the 
BimC family of kinesin-related proteins and has a role in bipolar spindle formation and 
is often overexpressed in tumours (Carter et al., 2006; Saijo et al., 2006), resulted both 
in accumulation of mono-nucleated tetraploid and polyploid cell in mouse embryonic 
fibroblasts from the transgenics, and in the formation of tumours in mice models with 
widespread aneuploidy and chromosomal instability (Castillo et al., 2007). Accordingly, 
Mad2, a central component of the spindle assembly checkpoint that blocks separation of 
sister chromatids until microtubule attachment to kinetochore is complete, and which is 
inhibited by the retinoblastoma tumour suppressor (Rb) pathway, has also been reported 
to be expressed at high levels in a number of human cancers (retinoblastoma, B-cell 
lymphoma, neuroblastoma, liver and lung cancer) (Hernando et al., 2004). Conditional 
overexpression of Mad2 in mice, resulted in the accumulation of bi-nucleated tetraploid 
and aneuploid cells (numerical chromosomal instability), and to a significant increase in 
the number of chromosomal breaks, end-to-end fusions (dicentric chromosomes) and 
other structural chromosomal aberrations (structural chromosomal instability) (Sotillo et 
al., 2007). Importantly, transgenic mice overexpressing Mad2, developed a wide range 
of tumours with extensive chromosomal rearrangements (Sotillo et al., 2007). Finally, 
high-risk HPV type 16 E6 and E7 oncoproteins can induce abnormal centrosome 
numbers followed by nuclear atypias (multi-nucleation) (Duensing et al., 2000; 
Duensing et al., 2001; Duensing & Munger, 2003), as well as both structural and 
numerical chromosomal instability (Duensing & Munger, 2002; Patel et al., 2004), in 
primary human keratinocytes. E6 oncoprotein induces the degradation of p53 protein, 
while E7 can abrogate the suppressive function of Rb tumour suppressor, and also limit 
the function of p21
WAF1/CIP1
 (Vousden, 1994; Jones et al., 1997; Duensing & Munger, 
2003). Overexpression of both E6 and E7 oncogenes in primary human epidermal 
keratinocytes induces tetraploidy, possibly as a result of the transcriptional deregulation 
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of many mitosis regulatory genes (Patel et al., 2004). In addition, primary human 
keratinocytes overexpressing either E6 or E7 or both, resulted in increased tetraploidy, 
and subsequent polyploidy, after nocodazole treatment, possibly due to the 
downregulation of p53/p21
WAF1/CIP1
 and Rb proteins (Thomas & Laimins, 1998; Patel et 
al., 2004). An important observation is that primary human keratinocytes 
overexpressing HPV type oncoproteins are allowed to enter anaphase despite the 
formation of multipolar spindles, and they can further display structural chromosomal 
aberrations, as evidenced by the presence of DNA breaks and anaphase bridges 
(Duensing & Munger, 2002). 
 
Similar to all these reports, in my study, overexpression of GLI2∆N in human N/TERT 
keratinocytes, an oncogene which is frequently overexpressed in human cancers related 
with aneuploidy and chromosomal instability (see Section 4.3.1.2.1), including human 
BCCs, prostate and breast cancers, osteosarcomas and oral squamous cell carcinomas 
(Mullor et al., 2001; Regl et al., 2002; Ruiz i Altaba et al., 2002b; Tojo et al., 2003; 
Beachy et al., 2004; Ikram et al., 2004; Rajagopalan & Lengauer, 2004; Regl et al., 
2004b; Sanchez et al., 2004; Bhatia et al., 2006; O'Driscoll et al., 2006; Perez-Ordonez 
et al., 2006; Sterling et al., 2006; Weaver & Cleveland, 2006; Thiyagarajan et al., 2007; 
Asplund et al., 2008; Snijders et al., 2008; Storchova & Kuffer, 2008; Yu et al., 2008; 
Hirotsu et al., 2010), resulted in accumulation of bi-nucleated/tetraploid cells due to 
cytokinesis failure (Figure 4.1, Figure 4.2, Figure 4.4 and Figure 4.8), presence of 
polyploid and aneuploid cells (Figure 4.4, Figure 4.5 and Figure 4.7), and both 
numerical and structural chromosomal instability (Figure 4.25, Figure 4.26, Figure 
4.27, Figure 4.28, Figure 4.29 and Figure 4.30), revealing new mechanisms by which 
GLI2 might exert its tumourigenic effect. Two possible mechanisms could be 
responsible for the GLI2∆N-induced tetraploidisation. First, GLI2∆N might trigger 
tetraploidisation, by indirectly downregulating 14-3-3σ (stratifin) (Figure 4.9). 14-3-3 
sigma (14-3-3σ) is an important regulator of the mitotic cap-independent translation 
(Pyronnet et al., 2001; Cormier et al., 2003; Holcik & Sonenberg, 2005; Wynshaw-
Boris, 2007), and its loss leads to the improper mitotic cap-independent translation of 
PITSLRE/CDK11
p58
 (endogenous internal ribosomal entry site (IRES)-dependent form 
of the cyclin-dependent kinase Cdk11) protein and improper localisation of Polo-like 
kinase-1 (Plk1) (loss of Polo-like kinase-1 protein in the midbody during mitosis, a 
protein which is required for cytokinesis). Both these proteins are important 
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executioners of mitosis  (Neef et al., 2003; Liu et al., 2004b; Petretti et al., 2006; Hu et 
al., 2007), and the deregulation of PITSLRE/CDK11
p58
 mitotic cap-independent 
translation by 14-3-3σ knockdown, leads to cytokinesis failure and accumulation of 
binucleate/tetraploid cells as reported by Wilker et al. (Wilker et al., 2007). Second, 
GLI2∆N might trigger tetraploidisation, by indirectly downregulating p21
WAF1/CIP1 
(p21) 
cyclin dependent kinase (CDK) inhibitor (Figure 4.11). p21
WAF1/CIP1
 protein plays a 
pivotal role in centrosome homeostasis, as well as in the prevention of polyploidisation 
(Stewart et al., 1999; Duensing et al., 2006). Although many studies have shown that 
p21 deficiency causes the development of abnormal centrosome numbers (Fukasawa et 
al., 1996; Bunz et al., 1998; Mantel et al., 1999; Matsumoto et al., 1999; Tarapore et al., 
2001), it is not clear whether the accumulation of extra centrosomes in the absence of 
p21 is a solely secondary phenomenon of cell division failure and polyploidisation, or if 
it can also be a genuine phenomenon. However, a recent study by Duensing et al. 
(Duensing et al., 2006) using a novel marker for maternal centrioles, Cep170, showed 
that knock-down of p21 protein expression in murine myeloblasts, triggers the 
development of excessive centriole numbers in the presence of only one or two maternal 
centrioles (overduplication of centrioles), and to a much lesser extent, the accumulation 
of centrioles in p21-deficient cells due to cytokinesis failure and polyploidisation. 
Therefore, the downregulation of p21
WAF1/CIP1
 by GLI2∆N in human N/TERT 
keratinocytes, might induce centrosome overduplication followed by cytokinesis failure, 
and resulting in genome doubling and increased bi-nucleated tetraploidy (Fukasawa, 
2007). 
 
A low, but detectable proportion of wild-type N/TERT and SINCE control populations 
was presented with DNA content N>4 and 8N (Figure 4.4, Figure 4.5 and Figure 4.8). 
This suggests the presence of spontaneously arising tetraploid and polyploid cells within 
the normal population. This is in agreement with a recent report by Shi and King (Shi & 
King, 2005), showing that human N/TERT keratinocytes have low rates of 
chromosomal non-disjunction during normal bipolar mitoses (both copies of a 
chromosome segregate to the same daughter cell), which leads to the generation of bi-
nucleated tetraploid progenies (~ 2%) due to cytokinesis failure (cleavage furrow 
regression), instead of aneuploid progenies (Shi & King, 2005; Ganem et al., 2007). The 
majority of these wild-type p53 N/TERT tetraploid cells (60%) do not proceed to the 
next division, and from the rest 40% that proceeds to the next cell division only 35% 
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form multipolar spindle (Shi & King, 2005). In contrast, in the p53-suppresed HeLa 
(human cervical cancer) cells (~ 8% bi-nucleated tetraploid cells due to chromosome 
non-disjunction and cytokinesis failure), bi-nucleated/tetraploid cells almost universally 
divide, and from these, 94% form multipolar spindle (Shi & King, 2005). The fact that 
the majority of N/TERT bi-nucleated tetraploids did not proceed to the next division, 
suggests the existence of a checkpoint (though a leaky checkpoint in N/TERT cells, 
since a minority of tetraploid cells proceed to the next division, probably due to p16 
downregulation that N/TERT immortalised cells exhibit (Dickson et al., 2000)) and 
thus, activation of oncogenes and/or loss of tumour suppressor genes might be 
necessary at a subsequent step, enabling bi-nucleated/tetraploid cells to proliferate 
inappropriately and/or to promote multipolar division, which can give rise to highly 
aneuploid progenies (Margolis, 2005; Shi & King, 2005). Consistently, a recent study 
by Thompson and Compton (Thompson & Compton, 2008) showed that elevating 
chromosome missegregation rates alone in human cultured cells is not sufficient to 
convert stable, near-diploid cells into highly aneuploid cells with karyotypes that 
resemble those of tumour cells. Therefore, the overexpression of GLI2∆N oncogene not 
only can trigger tetraploidisation, but also may allow the propagation of arising 
tetraploids and of the resulting aneuploids. 
 
4.3.1.3 Uncontrolled proliferation of tetraploid and aneuploid cells through 
impaired cell cycle arrest and apoptosis 
In the absence of anti-apoptotic activation, tetraploid and aneuploid cells, in a variety of 
cell types, show limited growth potential as they normally undergo cell cycle arrest 
and/or apoptosis following activation of  p53 and several p53-targeted genes (i.e. p21) 
(see Section 4.2.2) (Lane, 1992; Lanni & Jacks, 1998; Andreassen et al., 2001a; 
Andreassen et al., 2001b; Borel et al., 2002; Chen et al., 2003; Margolis et al., 2003; 
Storchova & Pellman, 2004; Zhivotovsky & Kroemer, 2004; Castedo et al., 2006). 
Tetraploidy activates cell death pathways and most of the resulting tetraploid cells 
undergo apoptosis, which seems to be mainly p53-dependent and mitochondrial-
mediated (Chen et al., 2003; Castedo et al., 2006; Ganem et al., 2007; Storchova & 
Kuffer, 2008).  
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4.3.1.3.1 GLI2∆N upregulates BCL-2 in N/TERT keratinocytes 
It has been previously suggested that overexpressed BCL-2 inhibits apoptosis after a 
failed cell division (human and mouse cells treated either with nocodazole-mitotic 
inhibitor or cytochalasin-cytokinesis inhibitor), resulting in the generation of tetraploid 
cells with enhanced survival, while defective apoptosis due to BCL-2 overexpression 
can also favour multipolar and asymmetric divisions of tetraploid cells, which leads to 
aneuploidy and numerical chromosomal instability (Minn et al., 1996; Nelson et al., 
2004; Zhivotovsky & Kroemer, 2004; Castedo et al., 2006). BCL-2 is one of the major 
anti-apoptotic factors of the intrinsic pathway of apoptosis (p53-dependent apoptosis) 
(see Section 4.2.5.3) (Hockenbery et al., 1990; Hockenbery, 1995; Youle & Strasser, 
2008), and it has also been identified as a direct transcriptional target of GLI2 
transcription factor (Regl et al., 2004b). Consistently, BCL-2 was found to be 
upregulated in GLI2∆N-expressing keratinocytes (Chapter 3, Section 3.2.1.4, Figure 
3.5A and Chapter 4, Figure 4.11), while SINEG2 cells did not exhibit any increased 
apoptotic activity (oncogenic stress and/or cell cycle failure-mediated apoptosis) 
compared to the N/TERT and SINCE control cells (Figure 4.3 and Figure 4.4). This 
suggests that the enhanced survival of tetraploid GLI2∆N-expressing cells and the 
subsequent formation of GLI2∆N aneuploid progenies may be attributed to the 
increased levels of BCL-2.  
 
In addition, overexpression of BCL-2 in human N/TERT keratinocytes upon GLI2∆N 
induction, may not only be contributing to the enhanced survival of tetraploid and 
aneuploid cells, but also to the resistance of GLI2∆N-keratinocytes to UVB-mediated 
apoptosis (p53-dependent apoptosis) observed in my study (see Section 4.2.5 and 
Figure 4.14, Figure 4.16, Figure 4.18) and consistent with the resistance to apoptosis, 
mediated by intrinsic or extrinsic pathways, of human BCCs (Regl et al., 2004b; Erb et 
al., 2005; Erb et al., 2008; Kump et al., 2008). Accordingly, Rodriguez-Villanueva et al. 
(Rodriguez-Villanueva et al., 1998) using a transgenic mouse model with human BCL-2 
overexpressed in the epidermis under the control of human keratin 1 promoter, showed 
both in vivo and in vitro that keratinocytes with increased levels of BCL-2 had a 
reduced rate of apoptosis upon UVB treatment, and were more susceptible to skin 
tumour formation in response to chemical carcinogens compared to control 
keratinocytes, suggesting that impaired apoptosis is a critical step in tumour 
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development. Similarly, in human BCCs, which are resistant in apoptosis (Regl et al., 
2004b; Erb et al., 2005; Erb et al., 2008; Kump et al., 2008) and UVB is known to be 
one of the main risk and etiological factor (Grossman & Leffell, 1997; Soehnge et al., 
1997; Armstrong & Kricker, 2001; de Gruijl et al., 2001; Ehrhart et al., 2003; Erb et al., 
2008), both GLI2 and BCL-2 are co-expressed (Regl et al., 2004b), while increased 
levels of BCL-2 have also been reported (Rodriguez-Villanueva et al., 1995; Delehedde 
et al., 1999; Regl et al., 2004b). In support of the role of GLI2∆N in apoptotic resistance 
of human BCCs through the upregulation of BCL-2, and c-FLIP (see Section 4.2.5.3) 
(Kump et al., 2008), Ji et al. (Ji et al., 2008) showed that Gli2 gene silencing in vivo 
renders cells susceptible to apoptosis (increases cell death). In this study, mouse Gli2 
gene was silenced in a mouse BCC-like tumour cell line (K5-Gli2∆N2) that 
constitutively express high levels Gli2∆N2, and is originated from a K5-Gli2∆N2-
induced trichoblastoma (Ji et al., 2008). When the Gli2 knock down cells were injected 
subcutaneously into nude mice, they gave rise to tumours of a much slower growth rate, 
partly due to the increased susceptibility to apoptosis of tumour cells, compared to the 
tumours arising from control cells (Ji et al., 2008). Finally, BCL-2 undergoes an 
increase in expression in many other cancers (Igney & Krammer, 2002; Lessene et al., 
2008), further supporting the notion that its overexpression inhibits cell death  and 
contributes to tumour formation, including skin carcinogenesis (Vaux et al., 1988; 
Hockenbery et al., 1990; Hockenbery, 1995; Rodriguez-Villanueva et al., 1998; Jiang & 
Milner, 2003; Lessene et al., 2008; Youle & Strasser, 2008). 
 
4.3.1.3.2 GLI2∆N downregulates p21WAF1/CIP1 and 14-3-3σ in a p53-independent 
manner in human N/TERT keratinocytes 
The tumour suppressor p53 and its direct transcriptional target p21
WAF1/CIP1
 (el-Deiry et 
al., 1994),
 
have been found to be primarily associated with both DNA damage 
checkpoints (G1/S and G2/M checkpoints), and to act as a backup mechanism in the 
mitotic checkpoint control, either by inducing cell cycle arrest and/or apoptosis, 
preventing the survival of tetraploid cells yielded from defects during mitosis (see 
Chapter 1, Section 1.3.7.1 and Chapter 4, Section 4.2.2, Section 4.2.3) (Kuerbitz et 
al., 1992; el-Deiry et al., 1994; Brugarolas et al., 1995; Cross et al., 1995; Minn et al., 
1996; Bunz et al., 1998; Khan & Wahl, 1998; Lanni & Jacks, 1998; Wang et al., 1998; 
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Chehab et al., 1999; Andreassen et al., 2001a; Andreassen et al., 2001b; Taylor & Stark, 
2001; Borel et al., 2002; Margolis et al., 2003; Sherr, 2004; Castedo et al., 2006).  
 
Therefore, p53 tumour suppressor and its targets play a critical role (anti-cancer 
activity) in the mechanisms that protect cells, including skin cells, against genomic 
instability which can be caused due to DNA damage (i.e. DNA breaks either due to 
replication errors, UVB radiation or oncogene amplification), and subsequent tumour 
formation due to persistent DNA damage (Soehnge et al., 1997). Stabilisation and 
activation of p53 after DNA damage, induces arrest in cell proliferation at the G1/S and 
G2/M phases, through the activation of its direct transcriptional targets such as 
p21
WAF1/CIP1
 and 14-3-3σ cyclin-dependent kinase inhibitors (negative regulators of cell 
cycle), in order to provide sufficient time for DNA damage repair (Levine et al., 1991a; 
Lane, 1992; el-Deiry et al., 1994; Hermeking et al., 1997; Levine, 1997; Dhar et al., 
2000; Khanna & Jackson, 2001; Vousden & Lu, 2002; Lobrich & Jeggo, 2007). If DNA 
repair is not possible, then the DNA damaged cells are eliminated through apoptosis 
under the control of p53 gene (Levine et al., 1991a; Levine, 1997; Ashkenazi, 2002; 
Vousden & Lu, 2002; Zhivotovsky & Kroemer, 2004; Brown & Attardi, 2005; Erb et 
al., 2008; Taylor et al., 2008). Therefore, the downregulation of p21 before (Figure 
4.11), and after UVB treatment (Figure 4.12), and the downregulation of 14-3-3 sigma 
(Figure 4.9), indirectly by GLI2∆N, may relax the DNA damage checkpoints, possibly 
allowing cells with DNA breaks to propagate unrepaired to the next cell cycles, yielding 
cells with structural chromosomal abnormalities, enhancing their survival, and thus 
triggering genomic instability and tumour formation.  
 
Similarly, in response to ploidy abnormalities, even if p53 and p21
WAF1/CIP1
do not 
primarily participate in checkpoint function in mitosis, they both play a role as a backup 
mechanism, so-called “tetraploidy checkpoint”, in cells that have evaded transient 
mitotic arrest, imposed by an abortive cell cycle (see Section 4.2.2) (Minn et al., 1996; 
Lanni & Jacks, 1998; Andreassen et al., 2001a; Andreassen et al., 2001b; Borel et al., 
2002; Margolis et al., 2003; Storchova & Pellman, 2004; Zhivotovsky & Kroemer, 
2004). Although the universality and the existence of a so called “tetraploidy 
checkpoint” has been debated (Uetake & Sluder, 2004; Wong & Stearns, 2005) and 
suggested that the fate of tetraploid cells depends on the cell type and genetic context, it 
is widely acknowledged that tetraploid cells at least in some cell types, resulting either 
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from karyokinesis or cytokinesis failure or both, permanently arrest in G1 phase, an 
arrest which mainly depends on p53 and p21
WAF1/CIP1
, as well as on Rb function 
(Andreassen et al., 2001b; Borel et al., 2002; Margolis et al., 2003; Ganem et al., 2007; 
Storchova & Kuffer, 2008). Activation of p53 and p21
WAF1/CIP1 
upon tetraploidisation, 
finally triggers apoptosis as I mentioned earlier, and thereby prevents the propagation of 
errors of defective mitosis and the generation of polyploid cells, possible precursors of 
aneuploid cells and chromosomal instability (Lane, 1992; Minn et al., 1996; Lanni & 
Jacks, 1998; Andreassen et al., 2001a; Andreassen et al., 2001b; Borel et al., 2002; 
Chen et al., 2003; Margolis et al., 2003; Storchova & Pellman, 2004; Zhivotovsky & 
Kroemer, 2004; Fujiwara et al., 2005; Castedo et al., 2006). Therefore, even if a 
‘tetraploidy checkpoint’ that senses the ploidy abnormality exists and triggers 
permanent arrest in tetraploid cells, or tetraploidy due to aberrant mitosis causes 
damages in the mitotic apparatus and/or cytoskeleton, DNA damages, or centrosome 
abnormalities (centrosome damage / centrosomal stress) which in turn activates G1 
arrest and cell death, the resulted G1 arrest will be in both cases  p53 and p21
WAF1/CIP1
 
dependent (Aylon et al., 2006; Srsen et al., 2006; Ganem et al., 2007; Storchova & 
Kuffer, 2008). However, neither loss of p53 nor Rb suppression leads to gross 
aneuploidy that often accompanies tumourigenesis in the absence of other metabolic 
defects, further suggesting that p53 and Rb are not responsible for the formation of 
tetraploid and aneuploid cells, but are members of G1 surveillance mechanisms that 
normally would prevent the cell cycle progression of the arising tetraploid and 
aneuploid cells (Borel et al., 2002; Bunz et al., 2002; Margolis et al., 2003). 
 
The reduction of p21
WAF1/CIP1
 protein levels in combination with the lack of p53 
stabilisation, observed in my stable GLI2∆N expressing cell line (Figure 4.11), first 
indicates an abnormal G1 checkpoint control, whereby cells are allowed to progress 
through S phase after aberrant mitotic exit. This implies that a proportion of arising 
tetraploid cells in this culture evade to a G1-like biochemical state and were allowed to 
reinitiate DNA replication, as indicated by the presence of cells with DNA content 8N 
(polyploid cells and tetraploid mitotic cells) and DNA content >4N (aneuploid cells), 
leading to numerical chromosomal instability (Figure 4.4, Figure 4.5 and Figure 4.7). 
In addition, p21
WAF1/CIP1
 protein plays a pivotal role in centrosome overduplication (see 
Section 4.3.1.2.3) (Duensing et al., 2006), and in preventing endoreduplication and 
tetraploidisation (Stewart et al., 1999), and thus its downregulation could explain the 
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occurrence and maintenance of a high percentage of tetraploid and polyploid cells in 
SINEG2 culture (Figure 4.4, Figure 4.5 and Figure 4.8). The absence of p21
WAF1/CIP1
 
in DNA damaged (γ irradiation) human colorectal cancer cells leads to the escape of 
cells from the growth inhibition normally conferred by p53/p21, followed by DNA 
synthesis (endoreduplication) and giving rise to polyploid cells, while its absence in 
human haematopoietic cells causes re-replication, centrosome overduplication and 
polyploidy in response to nocodazole treatment (Mantel et al., 1999; Zhivotovsky & 
Kroemer, 2004). However, the activation of p21
WAF1/CIP1
 and inhibition of cyclin E/cdk2 
activity prevents endoreduplication and polyploidy in human colon cancer cells in 
response to nocodazole (Stewart et al., 1999). In addition, Shen et al. (Shen et al., 2005) 
showed, using a mouse model and a mouse cell line, that ATM (DNA damage 
checkpoint protein kinase mutated in ataxia telangiectasia) and p21 cooperate to impede 
tumourigenesis by suppressing aneuploidy development, while p21 acts as a tumour 
suppressor specifically in a genetically unstable background (ATM
-/-
), by suppressing 
further numerical chromosomal instability. ATM
-/-
p21
-/-
 mice had an increased 
frequency of tumour development (carcinomas and sarcomas) with aneuploidy and 
intratumoural heterogeneity (chromosomal instability), as judged by cytogenetic 
analysis (Shen et al., 2005). Loss of p21 in ATM
-/-
 mouse embryonic fibroblasts 
exacerbated the percentage of tetraploid, polyploid and aneuploid metaphases and thus 
the development of further numerical chromosomal instability (Shen et al., 2005).  
 
Furthermore, ectopic overexpression of p21
WAF1/CIP1 
in p53-defective human brain 
tumour cells, inhibits proliferation, aneuploidy and tumourigenicity of the cells (Chen et 
al., 1996). Overexpression of p21
WAF1/CIP1
 in vitro resulted in reduced cell proliferation 
as demonstrated by increased cell doubling time and G1-arrested cell cycle, in inhibition 
of the accumulation of aneuploid cells upon nocodazole treatment, and in reduced 
tumourigenic potential as indicated by the loss of anchorage-independent growth in soft 
agar (Chen et al., 1996). Subcutaneous injection of control cells and cells 
overexpressing p21
WAF1/CIP1
 in nude mice, further supported the alteration of the 
malignant phenotype of p21
WAF1/CIP1
-expressing cells, and the prevention of tumour 
formation in vivo, since no tumour was observed post cell implantation in mice, 
compared to the control cells that formed large tumours (Chen et al., 1996). In addition, 
although there are conflicting data in the role of p21
WAF1/CIP1
 as a tumour suppressor in 
skin carcinogenesis, several studies have shown that loss of p21
WAF1/CIP1
 in 
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keratinocytes with chemical-induced carcinogenesis, or in keratinocytes overexpressing 
oncogenes such as ras, or in keratinocytes missing genes such as c-myc and Notch1 
while overexpressing ras, is able to enhance neoplasia (Missero et al., 1996; Philipp et 
al., 1999; Topley et al., 1999; Weinberg et al., 1999; Dotto, 2000; Weinberg & Denning, 
2002; Nicolas et al., 2003; Oskarsson et al., 2006). 
 
Therefore, the role p53 and p21
WAF1/CIP1
 to protect cells from genomic instability, either 
caused by UVB-induced DNA damage or ploidy abnormalities, and subsequent 
tumourigenesis, is further supported by the fact that many human cancers associated 
with tetraploidy and aneuploidy have commonly  the  p53, p21
WAF1/CIP1
 and Rb proteins 
absent or non-functional (Weinberg, 1995; Sherr, 1996; Sherr & McCormick, 2002; 
Storchova & Pellman, 2004; Bott et al., 2005; Ganem et al., 2007; Storchova & Kuffer, 
2008), including human BCCs which have very frequently inactivated p53 mutations 
mainly caused by UVB radiation (Demirkan et al., 2000; Lacour, 2002; Bolshakov et 
al., 2003), and almost absence of p21
WAF1/CIP1
 protein as observed in my study (Figure 
4.13). Similarly, 14-3-3σ is frequently lost in many cancers including breast and 
prostate (Ferguson et al., 2000; Umbricht et al., 2001; Hermeking, 2003; Lodygin et al., 
2004; Lodygin & Hermeking, 2005; Mhawech et al., 2005; Lodygin & Hermeking, 
2006), including human BCCs which exhibit partial or complete loss of 14-3-3σ protein 
expression (Lodygin et al., 2003). 
 
Second, the reduced levels of p21
WAF1/CIP1
 protein, along with the unchanged levels of 
p53 protein, underscore the fact that GLI2∆N negatively regulates p21
WAF1/CIP1 
independently of p53 (Figure 4.11). In accordance, when keratinocytes were exposed to 
UVB irradiation, which is known to stimulate p53-mediated induction of p21
WAF1/CIP1 
(Levine et al., 1991a; Lane, 1992; Levine, 1997; Vousden & Lu, 2002; Lobrich & 
Jeggo, 2007), p53 was upregulated both in SINEG2 and SINCE control cells, whereas 
p21
WAF1/CIP1
 was only upregulated in control cells, but not in GLI2∆N expressing 
keratinocytes (Figure 4.12). This observation further confirms that the downregulation 
of p21
WAF1/CIP1
 by GLI2∆N induction occurs in a p53-independent manner, not only in 
the presence of tetraploid cells, but also in response to UVB-induced DNA damage. 
Consistently, transcription of p21
WAF1/CIP1
 has been reported to be downregulated upon 
inducible GLI2∆N induction in confluent contact-inhibited and sub-confluent HaCaT 
keratinocytes (Regl et al., 2004a; Eichberger et al., 2006), which are known to harbour 
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inactivated p53 mutations (both alleles of the HaCaT cell line are mutated in the p53 
gene) (Boukamp et al., 1988; Lehman et al., 1993), and thus further confirm the ability 
of GLI2∆N to downregulate p21
WAF1/CIP1 
in a p53-independent manner. In support of 
the latter, GLI1 a downstream target of GLI2 in human keratinocytes (Regl et al., 2002; 
Ikram et al., 2004), has also been reported to negatively regulate p21
WAF1/CIP1 
independent of  p53 in human gastric carcinoma cells (Ohta et al., 2005). SHH and 
GLI1 have been found to be highly expressed in human gastric carcinoma cells and 
tissues (Ohta et al., 2005). Knock-down of GLI1 in human gastric carcinoma cells 
resulted in a significant increase in the proportion of cells in G1 phase and in the 
upregulation of transcription and protein levels of p21
WAF1/CIP1
 but not of p53 (Ohta et 
al., 2005). Similar results were obtained by treatment of human gastric cells with 
cyclopamine in order to inhibit SHH/GLI signalling, whereas Gli1 expression 
suppressed the cyclopamine-induced increase in p21
WAF1/CIP1
 (Ohta et al., 2005). The 
authors suggested the possibility of SHH/GLI pathway to cross talk with other 
signalling pathways including PI(3)K (phosphatidylinositol-3-OH kinase), which have 
been shown to repress the expression of p21
WAF1/CIP1
 in a p53-independent manner in 
tumour cells (Massague, 2004; Seoane et al., 2004; Ohta et al., 2005). 
 
In view of the strongly activating properties of the GLI2∆N transcription factor 
(constitutively active form of GLI2 lacking the N-terminal repressor domain), 
repression of p21
WAF1/CIP1
 and of 14-3-3σ in my system is likely to be indirect, possibly 
by GLI2∆N specific and direct activation of a transcriptional repressor, such as FOXE1 
(forkhead transcription factor) (Eichberger et al., 2004; Eichberger et al., 2006), which 
has been shown to have a repressor function (Zannini et al., 1997; Perrone et al., 2000) 
and to be specifically expressed in basal undifferentiated keratinocytes of the epidermis 
and highly expressed in human BCCs (Eichberger et al., 2004). In addition, GLI2∆N 
could regulate p21 and 14-3-3σ in post-translational level by activating proteins 
necessary for their protein degradation. Finally, another possible explanation for the 
downregulation of p21 and 14-3-3σ upon GLI2∆N induction, could be the CpG 
hypermethylation of their promoter (epigenetic mechanism). Many gene promoters have 
CpG islands, which are regions of DNA with higher concentration of CpG sites 
(Cytosine-phosphate-Guanine sites - regions of DNA where a cytosine nucleotide 
occurs next to a guanine nucleotide in the linear sequence of bases) (Jaenisch & Bird, 
2003; Lodygin & Hermeking, 2005; Lodygin & Hermeking, 2006). Cytosines in CpG  
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islands are methylated (addition of a methyl group) by methyltransferases (DNMTs) to 
form a 5-methylcytosine, allowing the  recognition by specific proteins that recruit 
chromatin remodelling factors and histone deacetylases resulting in decreased 
transcriptional activity of the chromatin (Jaenisch & Bird, 2003; Lodygin & Hermeking, 
2005; Lodygin & Hermeking, 2006). CpG islands, often in cancer cells acquire 
abnormal hypermethylation, which results in transcriptional silencing and leads to the 
loss of gene function (i.e. loss of a tumour suppressor gene function through an 
epigenetic mechanism) (Jaenisch & Bird, 2003; Lodygin & Hermeking, 2005; Lodygin 
& Hermeking, 2006).  
 
Strikingly, methyltransferases which are over-expressed in many types of human 
tumour cells (Robertson et al., 1999), have been reported to cooperate with oncogenes 
including c-fos in the transformation of primary mouse fibroblasts cells, suggesting that 
oncogenes transform cells through alterations in DNA methylation by overexpressing 
DNMTs (Bakin & Curran, 1999). Accordingly, loss of Rb (retinoblastoma tumour 
suppressor protein), following activation of E2F1 transcription factor has been shown to 
promote aberrant expression of DNMT in human and murine prostate epithelial cells 
(McCabe et al., 2005). Most importantly, 14-3-3 sigma which is downregulated in 
GLI2∆N-expressing keratinocytes, has been reported  to be frequently lost in many 
cancers such as breast and prostate due to hypermethylation of its promoter (Ferguson et 
al., 2000; Umbricht et al., 2001; Hermeking, 2003; Lodygin et al., 2004; Lodygin & 
Hermeking, 2005; Mhawech et al., 2005; Lodygin & Hermeking, 2006), while human 
BCCs exhibit partial or complete loss of 14-3-3σ protein expression, due to CpG-
hypermethylation of the 14-3-3σ promoter (Lodygin et al., 2003). Similarly, p21, which 
is suppressed upon GLI2∆N induction in human keratinocytes and is lost in many 
cancers including prostate cancer, was also found to be inactivated in metastatic 
prostatic cancer human cell lines (where HH/GLI activation has been previously shown 
to be implicated (see Chapter 1, Section 1.3.5) (Karhadkar et al., 2004; Sheng et al., 
2004; Bhatia et al., 2006; Thiyagarajan et al., 2007)), by promoter hypermethylation 
(Bott et al., 2005). 
 
Therefore, it is plausible to imagine that GLI2∆N downregulates p21 or 14-3-3σ or 
both, by inducing the overexpression of DNMTs, followed by gene promoter 
hypermethylation and thus gene silencing. It would be interesting to treat SINEG2 and 
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control cells with either 5-azacytidine (azacytidine) or 5-aza-2’deoxycytidine 
(decitabine), which are demethylating agents (Issa & Kantarjian, 2005; Gore et al., 
2006), and check if expression of p21 and/or 14-3-3σ is reactivated in SINEG2 cells.  
 
 
4.3.2 Downregulation of p21WAF1/CIP1 and 14-3-3σ might contribute to the 
GLI2∆N-mediated resistance to differentiation in vitro and in vivo 
In normal human epidermis, BCL-2 is exclusively expressed in the basal layer of the 
epidermis (Rodriguez-Villanueva et al., 1995; Delehedde et al., 1999), while 14-3-3σ is 
abundantly expressed in the differentiated suprabasal layers of human epidermis 
(Dellambra et al., 2000). The distribution of both BCL-2 and 14-3-3σ protein in normal 
human skin indicates that the overexpression of BCL-2 and the downregulation of 14-3-
3σ upon GLI2∆N induction, might contribute to the undifferentiated phenotype 
observed in SINEG2 keratinocytes (see Chapter 3, Section 3.2.3.1 and Section 
3.2.3.1.1, Figure 3.13).  
 
Similarly, the expression of p21
WAF1/CIP1
 in normal human epidermis showed a diffuse 
pattern, with p21
WAF1/CIP1
 protein being mainly detected in the non-proliferating 
suprabasal layers of the epithelium with very few positive stained cells in the basal layer 
(Figure 4.13A), consistent with the role of p21
WAF1/CIP1
 in  promoting  G1 arrest (cell 
growth arrest) of keratinocytes prior to terminal keratinocyte differentiation and thus 
irreversible commitment to differentiation (see Chapter 3, Section 3.3.3) (Potten & 
Morris, 1988; Steinman et al., 1994; Missero et al., 1995; Missero et al., 1996; Tron et 
al., 1996; Di Cunto et al., 1998; Todd & Reynolds, 1998; Topley et al., 1999; Dotto, 
2000). Therefore, the downregulation of p21
WAF1/CIP1
 observed upon GLI2∆N induction 
in vitro (Figure 4.11), further confirms the undifferentiated phenotype of SINEG2 cells, 
and it also supports the notion that GLI2∆N suppresses keratinocyte differentiation 
through the downregulation of genes responsible for the onset of differentiation, 
including p21
WAF1/CIP1
, c-MYC (see Chapter 3, Section 3.2.1.4, Figure 3.5B and 
Section 3.3.7) and of differentiation markers such as involucrin (see Chapter 3, 
Section 3.2.3.1.1, Appendix II and Section 3.3.5) and 14-3-3σ (stratifin), as well as 
through the upregulation of stem cell markers such as integrin β1 and SOX2 (see 
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Chapter 3, Section 3.2.3.1.1, Figure 3.13, Section 3.3.6, Section 3.3.6.1 and Section 
3.3.6.2). Importantly, it has been suggested that similar to c-MYC, suppression of  
p21
WAF1/CIP1
 and 14-3-3 sigma, are implicated in the maintenance of epidermal stem 
cells (Topley et al., 1999; Dellambra et al., 2000; Dotto, 2000). Downregulation of 14-
3-3σ results in immortalization of primary human keratinocytes (escape senescence by 
maintenance of telomerase activity and by downregulating p16), indicating a role in 
maintaining epidermal stem cells and promoting cell transformation (Dellambra et al., 
2000). Mouse keratinocytes derived from p21
-/-
 mice have been reported to contain a 
significantly increased number of cells with clonogenic potential and high rates of 
adherence, lesser commitment to differentiation, and the ability to generate all types of 
terminally differentiated keratinocytes that are present in vivo (interfollicular epidermis 
and hair follicles) (Topley et al., 1999). 
 
Consistent with the undifferentiated phenotype of human BCCs (Miller, 1991a; 
Crowson, 2006), different subtypes of human BCCs showed almost absence of 
p21
WAF1/CIP1
 protein, with the exception of individual positively stained cells (Figure 
4.13B, C, D), indicating that GLI2∆N-mediated p21
WAF1/CIP1
 downregulation in vitro 
(Figure 4.11 and Figure 4.12), absolutely correlates with the p21
WAF1/CIP1 
expression 
pattern in human BCCs in vivo. Similarly, 14-3-3σ protein which was found to be 
downregulated in GLI2∆N-expressing keratinocytes (Figure 4.9), is partially or 
completely lost in human BCCs due to CpG-hypermethylation of the 14-3-3σ promoter 
(Lodygin et al., 2003). These observations further strengthen the notion that 
overexpression of GLI2∆N in cultured human keratinocytes can elicit gene expression 
patterns, similar to those observed in human BCCs in vivo. However, it is possible that 
the downregulation of p21
WAF1/CIP1
 and 14-3-3σ protein in human BCCs reflect the 
expression pattern of the suggested cell of origin for these tumours, which is the 
undifferentiated basal epidermal stem cell (see Chapter 1, Section 1.3.6). Even if that 
is the case, the expression of GLI2∆N may contribute to the maintenance of this gene 
expression signature. Finally, the possibility that the suppression of p21 protein in 
human BCCs is due to the frequently observed p53 inactivation mutations (Barbareschi 
et al., 1992; Shea et al., 1992; Grossman & Leffell, 1997; Ponten et al., 1997; Soehnge 
et al., 1997; de Gruijl et al., 2001; Ling et al., 2001; Dicker et al., 2002; Lacour, 2002; 
Daya-Grosjean & Couve-Privat, 2005; Reifenberger et al., 2005; Epstein, 2008), cannot 
be ruled out. 
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4.3.3 GLI2∆N induces structural chromosomal instability in human 
N/TERT keratinocytes 
Stable overexpression of GLI2∆N in human N/TERT keratinocytes causes 
chromosomal instability, which is one of the major hallmarks of cancer (see Section 
4.2.6) (Hanahan & Weinberg, 2000), including both numerical (tetraploidy, polyploidy, 
aneuploidy) (Figure 4.25 and Figure 4.26), and structural chromosome aberrations, 
such as chromosomal translocations and double minute chromosome, as observed using 
M-FISH and karyotype analysis (Figure 4.27, Figure 4.28 Figure 4.29 and Figure 
4.30).  
 
Consistent with my data, overexpression of other oncogenes, such as Mad2 in mice (see 
Section 4.3.1.2.3), apart from resulting  in the accumulation of tetraploid and aneuploid 
cells (numerical chromosomal instability), also showed also a significant increase in the 
number of DNA breaks and structural chromosomal aberrations (structural 
chromosomal instability) (Sotillo et al., 2007). Importantly, transgenic mice 
overexpressing Mad2, developed a wide range of tumours with extensive chromosomal 
rearrangements (Sotillo et al., 2007). My results are also in agreement with previous 
studies (see Section 4.3.1.2.2), which have shown that the proliferation of tetraploid, 
compared to diploid cells in culture, in the presence of an oncogene or in the absence of 
tumour suppressor gene, give rise to the accumulation of both numerical (aneuploidy) 
and structural chromosomal abnormalities (i.e. non-reciprocal translocations, double 
minute chromosomes) (Fujiwara et al., 2005; Duelli et al., 2007; Holland & Cleveland, 
2009). Similarly, mice tetraploid-derived tumours display large-scale numerical and 
structural chromosomal aberrations (Fujiwara et al., 2005). Therefore, since 
uncontrolled tetraploidy in these studies, is coupled with massive chromosomal 
instability (numerical and structural) (Fujiwara et al., 2005; Duelli et al., 2007) and in 
vitro chemically induced transformation (Fujiwara et al., 2005), as well as with 
spontaneous in vivo transformation (Fujiwara et al., 2005; Duelli et al., 2007), it would 
be interesting to check if GLI2∆N-expressing keratinocytes that exhibit both 
uncontrolled tetraploidy and numerical and structural chromosomal instability, have 
also a potential to in vitro transformation, by assaying the growth of the cells in soft 
agar, which is a known attribute of many transformed cells (Traul et al., 1979; Traul et 
al., 1981). 
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However, it remains yet unclear how increased ploidy (tetraploidy) promotes structural 
chromosomal abnormalities. Taking into account that structural chromosome 
abnormalities (i.e. translocations) have been suggested to arise from breaks in DNA 
(DNA double strand breaks) during DNA replication or mitosis and improper DNA 
repair (Paulovich et al., 1997; Lengauer et al., 1998; Richardson & Jasin, 2000; Khanna 
& Jackson, 2001; Zhivotovsky & Kroemer, 2004; Jefford & Irminger-Finger, 2006; 
Lobrich & Jeggo, 2007; Pellman, 2007; Aguilera & Gomez-Gonzalez, 2008; Nambiar et 
al., 2008), two major sources of chromosomal rearrangements have been recommended 
(Ganem et al., 2007; Storchova & Kuffer, 2008; Holland & Cleveland, 2009).  
 
First, tetraploidy might increase the rate of spontaneous DNA damage and breakage 
(Ganem et al., 2007; Storchova & Kuffer, 2008). The acquisition of double the amount 
of DNA content of a tetraploid cell, might result in twice the amount of spontaneous 
DNA damage during S phase, which leads to increased requirement for, or even 
saturation, of DNA repair processes, as observed in budding-yeast tetraploids (increased 
requirement of tetraploid cells for homologous recombination genes compared to 
diploid cells, given that the length of the cell cycle, and specifically S phase is not 
increased with higher ploidy) and possibly inefficient repair (Storchova et al., 2006; 
Ganem et al., 2007; Storchova & Kuffer, 2008). Indeed, wild-type yeast tetraploid cells 
have been reported to accumulate DNA damage and to be more sensitive to agents that 
damage DNA by inducing double-strand-breaks (not sensitive to UV light), compared to 
their diploid counterparts (Storchova et al., 2006). Similarly, human tetraploid 
fibroblasts appear to be more sensitive to DNA damaging agents (ionizing radiation) 
relative to normal diploid fibroblasts (Hau et al., 2006). Moreover, whole chromosome 
missegregation in tetraploid cells and subsequent near-tetraploid aneuploidy, which may 
lead to unbalanced gene expression, might also cause an increase in the rate of 
spontaneous DNA damage, by altering the expression of genes which are involved in 
cellular processes that produce or repair the normally low level of spontaneous DNA 
damage (Ganem et al., 2007). Furthermore, abnormal mitosis and  mitotic arrest induced 
in human cells by transient nocodazole (or colcemid) treatment leads to the 
accumulation of DNA breaks in both diploid and tetraploid cells (Quignon et al., 2007). 
Prolonged nocodazole treatment in human cells, results in the accumulation of DNA 
breaks in the arising tetraploid cells originated through mitotic slippage, and in the 
absence of DNA damage checkpoint activation and apoptosis, leads to the formation of 
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mitotic tetraploid cells with structural chromosomal rearrangements (Quignon et al., 
2007). Finally, the possibility that chaotic multipolar mitosis may directly break 
chromosomes (Jannink et al., 1996; Storchova & Kuffer, 2008), as well as the 
likelihood that aberrant cytokinesis (i.e. premature cytokinesis) can lead to the trap, 
damage and break of chromosomes through the cleavage furrow machinery (Jannink et 
al., 1996; Mendoza & Barral, 2008; Storchova & Kuffer, 2008), cannot be excluded. 
 
Second, tetraploidy as I mentioned in Section 4.3.1.2.2 may enhance the fitness of cells 
containing broken or rearranged chromosomes, through the buffering effect of extra 
normal chromosomes, and thus give to these cells a proliferative advantage (Ganem et 
al., 2007; Storchova & Kuffer, 2008). 
 
Strikingly though, even if structural chromosomal abnormalities such as double minute 
chromosomes (Figure 4.30) and translocations (Figure 4.28 and Figure 4.29) were 
found in near-tetraploid aneuploid cells upon GLI2∆N induction, the clonal 
translocation t(7;14) was not only present in near-tetraploid aneuploid cells, but also in a 
diploid SINEG2 keratinocyte (Figure 4.27). This observation suggests that the ability of 
GLI2∆N to induce structural chromosomal aberrations is independent of its ability to 
induce tetraploidisation which however definitely seems to contribute to the overall 
chromosomal instability that GLI2∆N-expressing cells exhibit.  
 
The existence of this clonal translocation in a diploid SINEG2 cell can be explained by 
the fact that GLI2∆N in human N/TERT keratinocytes, downregulates and upregulates 
crucial components of the DNA damage checkpoints and apoptosis, respectively, such 
as p21 and 14-3-3 sigma and BCL-2 (Figure 4.9 and Figure 4.11), which are 
responsible for the detection of cells with DNA breaks, and the activation of repair 
mechanisms, or if repair is not possible, their elimination through apoptosis (see 
Section 4.2.6 and Section 4.3.1.3.2) (Dhar et al., 2000; Richardson & Jasin, 2000; 
Khanna & Jackson, 2001; Zhivotovsky & Kroemer, 2004; Lobrich & Jeggo, 2007; 
Aguilera & Gomez-Gonzalez, 2008; Taylor et al., 2008). Therefore, GLI2∆N, by 
relaxing the DNA damage checkpoints and inhibiting the apoptotic machinery, possibly 
allows diploid cells (as well as tetraploid and aneuploid cells) with DNA breaks, 
originated by spontaneous replication errors or by other causes, to propagate unrepaired 
to the next cell cycles, yielding cells with structural chromosomal abnormalities 
Chapter 4: GLI2∆N induces numerical and structural chromosomal instability 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 413 
(dicentric chromosomes, translocations, double minute chromosomes), with enhanced 
survival and with the potential of clonal selection and transformation. Furthermore, 
GLI2∆N might downregulate proteins that are involved in DNA repair mechanisms and 
thus further increasing subsequent genomic instability (Lobrich & Jeggo, 2007; 
Aguilera & Gomez-Gonzalez, 2008; Negrini et al., 2010). Another possible alternative, 
responsible for the presence of chromosomal rearrangements could be telomere 
dysfunction (telomere attrition) (Artandi et al., 2000; Zhivotovsky & Kroemer, 2004; 
Jefford & Irminger-Finger, 2006). Telomere (cap the ends of chromosomes, thereby 
preventing them from being recognized as double strand breaks) shortening or mutation 
of telomere binding proteins cause telomere uncapping, that can lead to end-to-end 
fusions and to the formation of dicentric chromosomes (chromosomes that carry two 
centromeres, which can also been formed by unrepaired DNA breaks), leading to 
breakage-fusion-bridge (BFB) cycles and subsequent generation of cells with structural 
chromosomal abnormalities (i.e. translocations) (Artandi et al., 2000; Zhivotovsky & 
Kroemer, 2004). However, telomere shortening is unlikely to occur in my system since 
N/TERT keratinocytes are stably expressing telomerase (h/TERT), which is responsible 
for telomere elongation (Dickson et al., 2000; Rheinwald et al., 2002).  
 
Finally, GLI2∆N oncogene might induce structural chromosomal rearrangements and 
thus structural chromosomal instability, through a mechanism that causes DNA breaks 
and involves DNA replication stress (Aguilera & Gomez-Gonzalez, 2008; Halazonetis 
et al., 2008; Negrini et al., 2010). DNA replication stress is defined as inefficient DNA 
replication that causes DNA replication forks to progress slowly or stall. In the absence 
of the S-phase checkpoint activation replication forks can collapse, the replisome 
disassembles (dissociation of the replication proteins from the DNA), which in turn 
leads to formation of DNA breaks (Lobrich & Jeggo, 2007; Aguilera & Gomez-
Gonzalez, 2008). Therefore, GLI2∆N oncogene might induce stalling and collapse of 
DNA replication forks, leading to the formation of DNA breaks and to subsequent 
formation of chromosomal rearrangements and genomic instability, by impairing the 
DNA damage response (G1/S and G2/M checkpoints) and apoptotic pathways 
(Halazonetis et al., 2008; Negrini et al., 2010). In support of the latter, several studies 
have reported the presence of DNA breaks induced by replication stress (as judged by 
the allelic imbalances (loss of heterozygosity) in common fragile sites - specific 
genomic sites which are prone to DNA breaks, when DNA replication is compromised 
Chapter 4: GLI2∆N induces numerical and structural chromosomal instability 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 414 
and are also associated with hotspots for translocations, gene amplifications and other 
chromosomal alterations (Aguilera & Gomez-Gonzalez, 2008)) in both human 
precancerous lesions and human cancers, in the absence of telomere attrition or 
mutations in genes responsible for genome integrity in precancerous lesions, but in the 
presence of activated oncogenes (Bartkova et al., 2005; Gorgoulis et al., 2005; 
Halazonetis et al., 2008; Negrini et al., 2010). The formation of DNA breaks in 
precancerous lesions is followed by activation of DNA damage response mechanisms 
and apoptosis, whereas loss of p53 function is accompanied by the ability of cells to 
escape apoptosis and/or senescence effects and subsequent conversion of precancerous 
lesions to cancerous (Bartkova et al., 2005; Gorgoulis et al., 2005; Halazonetis et al., 
2008; Negrini et al., 2010). In addition, overexpression of several oncogenes such as 
RAS, cyclin E and E2F1 in various cell types and model systems resulted in the 
presence of DNA replication stress (prematurely terminated replicated forks) and the 
induction of DNA breaks (Gorgoulis et al., 2005; Bartkova et al., 2006; Di Micco et al., 
2006; Halazonetis et al., 2008; Negrini et al., 2010). 
 
Overall, regardless of the mechanism by which chromosomal rearrangements do occur 
in SINEG2 cultures, their presence is reflective of genomic instability, and their 
importance is underscored by the fact that structural chromosomal abnormalities are an 
established cause of cancer and are often found in many cancer cells (Solomon et al., 
1991; Lengauer et al., 1998; Saunders et al., 2000; Nowak et al., 2002; Albertson et al., 
2003; Mitelman et al., 2003; Futreal et al., 2004; Jefford & Irminger-Finger, 2006; 
Mitelman et al., 2007; Pellman, 2007). Both chromosomal translocations and double 
minute chromosomes, observed in GLI2∆N-expressing keratinocytes, are frequently 
observed in many cancers (Barker, 1982; Solomon et al., 1991; Cowan, 1992; Lengauer 
et al., 1998; Albertson et al., 2003; Mitelman et al., 2003; Gebhart, 2005; Jefford & 
Irminger-Finger, 2006; Mitelman et al., 2007; Nambiar et al., 2008). Unbalanced 
translocations lead to breakpoint gene alterations, as well as to chromosome arm copy-
number changes. Thus, unbalanced chromosomal rearrangements may result in the gain 
of genetic material - i.e. partial trisomy of 7p (Figure 4.27), containing tumour-growth 
promoting genes, or loss of genetic material encoding tumour suppressor genes.  
Balanced translocations lead to either deregulation of genes in one of the breakpoints or 
to the formation of a hybrid chimeric gene which occurs through the fusion of two 
genes, generating a hybrid protein with altered properties (Rowley, 2001; Greaves & 
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Wiemels, 2003; Mitelman et al., 2007). Two of the most well-characterised examples of 
balanced translocations, have been reported in hematologic malignancies and are the 
t(9;22)(q34;q11) (CML-chronic myelogenous leukaemia) and t(8;14)(q24;q32) 
(Burkitt’s lymphoma) (Figure 4.32A, B) (Rowley, 2001; Greaves & Wiemels, 2003; 
Mitelman et al., 2007; Nambiar et al., 2008). The t(9;22)(q34;q11) results in the 
Philadelphia chromosome, which originates by the fusion of the BCR (gene A) and 
ABL (gene B) genes, resulting to a hybrid BCR-ABL fusion protein, with increased 
tyrosine kinase activity (encodes an unregulated, cytoplasm targeted tyrosine kinase that 
allows the cells to proliferate without being regulated by cytokines and thus allows the 
cells to become cancerous) (Figure 4.32b) (Rowley, 2001; Mitelman et al., 2007; 
Nambiar et al., 2008). The t(8;14)(q24;q32) results in the abnormal timing and levels of 
MYC gene expression, due to the juxtaposition of the IGH (immunoglobulin heavy 
chain gene) promoter region (gene A promoter) next to the coding region of MYC 
oncogene (gene B coding region) (Figure 4.32a). Thus, MYC gene is constitutively 
activated, because its expression is driven by immunoglobulin promoter/enhancer 
elements (Rowley, 2001; Mitelman et al., 2007; Nambiar et al., 2008).  
 
Double minute chromosomes (Figure 4.30) along with the homogeneously staining 
regions (HSR-amplified sequences incorporated into chromosomes as tandem arrays or 
inverted repeats), are defined as the cytogenetic equivalents of amplified DNA 
sequences, extrachromosomally amplified copies and intrachromosomally amplified 
copies respectively, possibly containing a gene or genes that give selective advantage to 
the progression of the cancer (Barker, 1982; Cowell, 1982; Solomon et al., 1991; 
Lengauer et al., 1998; Albertson et al., 2003; Gebhart, 2005). Although the mechanisms 
that generate double minute chromosomes are not fully understood, similarly to 
translocations, it has been suggested that replication errors and DNA double strand 
breaks near the amplified segment in cells lacking robust checkpoints, followed by 
incorrect or/no repair of DNA breaks and in some cases by breakage-fusion-bridge 
cycles, may be involved (Solomon et al., 1991; Lengauer et al., 1998; Singer et al., 
2000; Savelyeva & Schwab, 2001; Gebhart, 2005; Albertson, 2006). A classic example 
of gene amplification in tumour cells is the amplification of N-myc oncogene that 
occurs in ~ 30% of advanced neuroblastomas. In normal cells N-myc is localised as a 
single copy on chromosome 2, whereas tumour cells with amplification have up to 
several hundred copies generally located in an HSR (direct tandem repeats) on another 
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chromosome (chromosome 11) (Seeger et al., 1985; Solomon et al., 1991; Lengauer et 
al., 1998; Savelyeva & Schwab, 2001; Albertson et al., 2003; Gebhart, 2005; Albertson, 
2006). Another example is the amplification of EGFR oncogene that occurs in 40% of 
gliomas, and is present in double minute chromosomes (Vogt et al., 2004; Albertson, 
2006) .  
 
 
 
 
 
 
Figure 4.32: Chromosomal translocations and their consequences.  
(A) The Philadelphia chromosome in chronic myelogenous leukaemia, which originates through 
the translocation t(9;22)(q34;q11), (b) results in the formation of a fusion/chimeric protein 
BCR-ABL with an enhanced function (enhanced tyrosine kinase activity) (Rowley, 2001). (B) 
The translocation t(8;14)(q24;q32), the most common translocation  in Burkitt’s lymphoma  (a) 
results in the deregulation of MYC gene through its juxtaposition next to the promoter of the 
immunoglobulin heavy chain (IGH) gene (Rowley, 2001). Modified from 
www.meb.uni-bonn.de/cancer.gov/CDR0000257989.html 
http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=hmg&part=A2342 
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In contrast to the stepwise model of carcinogenesis requiring multiple genetic 
alterations, human BCCs have been shown experimentally (in vivo human-tissue cancer 
models) to be able to originate by only one hit (overexpression of SHH and thus 
deregulation of SHH/GLI pathway) (Fan et al., 1997; Khavari, 2006). This observation 
may account for the fact that BCC is the most common malignancy, as well as for the 
absence of precursor lesions in arising BCCs and their failure to metastasize, compared 
to other cancers with more aggressive behaviour (Miller, 1991a; Wong et al., 2003; 
Daya-Grosjean & Couve-Privat, 2005; Crowson, 2006). However, genetically 
engineered human tissue cancer models have their limitations and restrictions, and thus 
the possibility that cytogenetic disruptions might facilitate the more rapid emergence of 
these cancers by altering core oncogenic networks cannot be excluded. According to the 
latter, while human cells initially had been reported to become transformed after a long 
latent period without widespread genetic changes, due to coexpression of the SV40 
large T antigen (oncogene), the telomerase catalytic subunit hTERT and oncogenic ras, 
later examination showed that a majority of these cells had increased tetraploidy, non-
diploid aneuploid karyotype and structural chromosomal translocations (Hahn et al., 
1999; Li et al., 2000; Zimonjic et al., 2001).  
 
The techniques that are used for the detection of genomic instability in vitro and in vivo 
are of great importance. Recently, it was shown by Mao et al. (Mao et al., 2008) that 
diploid cancer cell lines that have previously been described with cytogenetically 
normal diploid karyotypes, had all subtle genomic copy number changes as revealed by 
high resolution 500K SNP (single-nucleotide polymorphism) array analysis. This 
observation indicates that also other tumours previously reported with normal 
karyotypes might have subtle genetic alterations. 
 
Therefore, although human BCCs, and especially nodular ones, are considered quite 
stable as observed by 10K SNP microarray (loss of heterozygosity study) (Teh et al., 
2005), other cytogenetic studies have shown that there is a reasonable degree of 
genomic instability, still smaller compared to other cancers, which increases in the more 
aggressive forms of BCCs (Ashton et al., 2005; Carless et al., 2006). Overall, the 
incidence of tetraploidy and subsequent aneuploidy in human BCCs is 9-40%, whereas 
different subgroups of BCC, mainly the more aggressive ones (i.e. superficial, 
infiltrative) have been shown to have much higher aneuploidy rates such as 50-80% 
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(Frentz & Moller, 1983; Buchner et al., 1985; Miller, 1991a; Herzberg et al., 1993; 
Fortier-Beaulieu et al., 1994; Staibano et al., 2001; Ashton et al., 2005; Carless et al., 
2006; Weaver & Cleveland, 2006). More recently, it was shown that aneuploidy may be 
a risk factor for the frequent local recurrence of human BCC tumours (development of 
secondary BCCs) (Janisson-Dargaud et al., 2008). In this case study, comparing patients 
with recurrent (group 1) and non-recurrent BCC (group 2) with a follow-up time ≥ 5 
years, a significant association between recurrences and an abnormal DNA content 
(aneuploidy) was observed (Janisson-Dargaud et al., 2008). The majority (78%) of  
patients who experienced local recurrences had aneuploid primary tumours (nodular and 
superficial BCCs) (group 1), while aneuploidy was observed only in 32% of patients 
with tumours without recurrence (group 2) (Janisson-Dargaud et al., 2008). These 
observations along with my data, suggest that activation of GLI2∆N is able to induce a 
degree of genomic instability and according to the extent to which the SHH/GLI 
pathway is deregulated and the genetic background in which this disruption occurs, may 
influence subsequent genetic events that lead to tumour progression (Hoban et al., 
2006). This is consistent with the study of Grachtchouk et al. (Grachtchouk et al., 2003), 
which showed that different levels of SHH/GLI signalling activity can result in distinct 
tumour types in skin, and it also provides an explanation for the wide phenotypic 
diversity of human BCCs (several histological subtypes associated with more or less 
aggressive phenotypes) (Hoban et al., 2006). 
 
The oncogenic activity of GLI2 interferes with a multitude of biological processes, 
leading to the inhibition of apoptosis, resistance to growth arrest, and suppression of 
epithelial differentiation, as observed by me and others (Aberger & Frischauf, 2006; 
Snijders et al., 2008). Therefore, at least in the case of GLI2, three of the most important 
obstacles that potential tumour cells need to evade, are overcome by the activation of a 
single oncogene. It therefore follows that simple activation of GLI2 alone might suffice 
for the generation of a more indolent type of tumours, such as nodular BCCs, without 
the presence of widespread genomic instability (no need for persistent generation of 
new chromosomal variations), while the progression to more aggressive BCC variants 
may have a stronger requirement for additional genetic changes, as previously 
suggested. 
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However, it is nearly impossible to exclude the occurrence of a transient state of 
instability during an undefined period of tumour’s history (i.e. human BCC), since 
every investigation is a snap-shot that captures only an instantaneous picture of the life 
of the tumour (Heim et al., 1988; Lengauer et al., 1998). Thus, a diploid or near-diploid 
homogeneous tumour that is observed at the time of analysis, might have been preceded 
by a population of uncontrolled tetraploid cells that become aneuploid with increased 
numerical and structural chromosomal instability (acquisition of genetic alterations 
necessary for cell transformation-activation of growth promoting genes) and increased 
chromosome loss, forming heterogeneous populations, which through a process known 
as genomic convergence (clonal adaptation) are eliminated all apart from one or a few 
clones that have been selected and form the pseudo monoclonal near-diploid 
homogeneous tumour (Nowell, 1976; Heim et al., 1988; Shackney et al., 1989; Cahill et 
al., 1999; Fukasawa, 2005). 
 
Overall, it is important to note that the effects of GLI2∆N observed in a human 
keratinocyte cell line in vitro cannot be readily assimilated to the genotype of BCC 
tumours in vivo. The former demonstrates the ability of GLI2∆N oncogene to disturb 
the mitotic process and therefore lead to genomic instability regardless of the influences 
of the surrounding environment, while the latter is the outcome of sequential intrinsic 
and extrinsic events that collectively may lead to the generation of a tumour that is 
genetically more stable compared to other malignant neoplasms. This is an important 
observation as it highlights the potential importance of GLI2 oncogene activation in the 
initiation and/or promotion of genomic instability in other biological settings. The 
upregulation of GLI2 in tumour cells with a more permissive or molecularly aberrant 
background, compared to those of BCC, could further promote genomic instability. This 
view is supported by the fact that GLI2 oncogene is significantly upregulated in 
numerous human tumours that, contrarily to BCC, are known to display a high degree of 
genomic instability (Ruiz i Altaba et al., 2002b; Beachy et al., 2004; Sanchez et al., 
2004; Bhatia et al., 2006; Perez-Ordonez et al., 2006; Sterling et al., 2006; Weaver & 
Cleveland, 2006; Thiyagarajan et al., 2007; Snijders et al., 2008; Storchova & Kuffer, 
2008; Hirotsu et al., 2010). 
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4.4 Summary 
In this chapter it is shown that over-expression of GLI2∆N can interfere with normal 
cell cycle control of human N/TERT keratinocytes, and induces significant ploidy 
abnormalities, which could be partly responsible for their reduced growth rate, without 
causing any cell death or increased apoptosis. Upon GLI2∆N induction in human 
N/TERT keratinocytes, there is (i) increased tetraploidisation, followed by subsequent 
polyploidy and aneuploidy, (ii) inactivation of cell cycle genes such as p21
WAF1/CIP1
 and 
14-3-3σ that control the generation of tetraploid cells, as well as the proliferation of 
tetraploid and DNA damaged cells, with no change in p53 protein levels and (iii) 
defective apoptosis, possibly through the upregulation of the anti-apoptotic protein 
BCL-2, which is responsible for the elimination of tetraploid / polyploid / aneuploid 
cells (Figure 4.33). Consistently with the downregulation of p21
WAF1/CIP1
 in vitro, 
p21
WAF1/CIP1
 protein in this study was also found to be almost absent in human BCC 
tumours. In addition, in this chapter, evidence was provided for the ability of GLI2∆N 
to induce not only numerical chromosomal instability in human keratinocytes, but also 
structural genomic instability, as judged by the structural chromosomal aberrations 
observed in GLI2∆N-expressing keratinocytes, using M-FISH karyotype analysis 
(Figure 4.33). Furthermore, ultraviolet B (UVB, 290-320 nm) is known to be one of the 
most important etiological factors in BCC formation. In this study, it is shown that 
GLI2∆N induction in human N/TERT keratinocytes, renders cells resistant, not only to 
tetraploidy-mediated apoptosis, but also to UVB-mediated apoptosis possibly through 
the activation of BCL-2 gene and protein upregulation, whereas the upregulation of p53 
and the concomitant downregulation of p21
WAF1/CIP1
 protein after UVB treatment in 
GLI2∆N-expressing keratinocytes further confirms that GLI2∆N downregulates 
p21
WAF1/CIP1
 in a p53-independent manner. Collectively, these observations give new 
insights into the possible mechanisms through which GLI2∆N might exert its 
tumourigenic potential.  
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Figure 4.33: GLI2∆N induces numerical and structural chromosomal instability.  
Diagram illustrating a potential mechanism for the effects of GLI2∆N in genomic integrity. 
Under normal conditions (left-hand panel), spontaneously arising tetraploid cells are blocked by 
the stabilisation of p53 followed by activation of p21, resulting in G1/S arrest and apoptosis. 
Upon GLI2∆N induction (left-hand panel), there is accumulation of bi-nucleated tetraploid cells 
(increased tetraploidisation), possibly due to cytokinesis failure through the downregulation of 
14-3-3σ. Tetraploid cells, in the presence of GLI2∆N, proliferate to the next cell cycles and 
have enhanced survival, due to the absence of p53 stabilisation, the downregulation of p21 and 
the upregulation of Bcl-2, which overall inhibit G1/S arrest and apoptosis, resulting in the 
presence of polyploid and aneuploid cells and of near-tetraploid aneuploid cells with structural 
chromosomal aberrations (translocations and double minute chromosomes). The ability of 
GLI2∆N to cause structural chromosomal instability in human N/TERT keratinocytes is 
independent from its ability to induce tetraploidisation, as judged by the clonal translocation 
observed in a diploid cell. 
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5.1 Introduction 
In skin, the Shh pathway plays a pivotal role in maintaining the stem cell population, 
and in regulating the development of hair follicles, adult hair cycle, and sebaceous 
glands (Parisi & Lin, 1998; St-Jacques et al., 1998; Chiang et al., 1999; Wang et al., 
2000b; Callahan & Oro, 2001; Allen et al., 2003; Ellis et al., 2003; Oro & Higgins, 
2003; Schmidt-Ullrich & Paus, 2005; Athar et al., 2006; Blanpain & Fuchs, 2006; Zhou 
et al., 2006), while Wnt/β-catenin signalling pathway also plays an important role in 
hair follicle morphogenesis, hair follicle stem cell maintenance and/or activation, and 
hair shaft differentiation (Gat et al., 1998; DasGupta & Fuchs, 1999; Huelsken et al., 
2001; Alonso & Fuchs, 2003a; Lowry et al., 2005; Schmidt-Ullrich & Paus, 2005; 
Blanpain & Fuchs, 2006; Blanpain et al., 2007; Watt & Collins, 2008). Previous studies 
in normal skin of transgenic mice, have shown that Wnt/β-catenin is required upstream 
of the Bmp and Shh in placode formation during hair follicle morphogenesis, and thus 
specifying the hair follicle fate in the undifferentiated basal epidermis and initiate hair 
bud formation (Gat et al., 1998; Huelsken et al., 2001; Andl et al., 2002; Lo Celso et al., 
2004; Silva-Vargas et al., 2005; Blanpain & Fuchs, 2006). Then, it subsequently 
activates Shh signalling, which is required for the proliferation and expansion of follicle 
epithelium in order to assemble a mature follicle (St-Jacques et al., 1998; Chiang et al., 
1999; Mill et al., 2003; Lo Celso et al., 2004; Silva-Vargas et al., 2005; Blanpain & 
Fuchs, 2006).  
 
However in different contexts, such as in Xenopus, Wnt signalling can also be a 
downstream effector of Shh/Gli signalling pathway (Mullor et al., 2001). Gli2, the key 
transcriptional regulator of Hh signalling, affects ventro-posterior mesodermal 
development by regulating Wnt genes, such as Wnt8 and Wnt11 (Mullor et al., 2001). 
 
In mice, constitutive activation of β-catenin promotes hair follicle-like tumours such as 
pilomatricomas and trichofolliculomas, or BCC-like tumours (Gat et al., 1998; Nicolas 
et al., 2003; Lo Celso et al., 2004), similar to those induced by Gli1 and Gli2 - Shh 
pathway genes (Grachtchouk et al., 2000; Nilsson et al., 2000; Sheng et al., 2002; 
Hutchin et al., 2005; Huntzicker et al., 2006). In human pilomatricomas (hair matrix cell 
tumourigenesis), stabilising mutations of β-catenin have also been identified (Chan et 
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al., 1999a; Kajino et al., 2001; Moreno-Bueno et al., 2001; Xia et al., 2006), while 
human BCCs show increased levels of GLI2 and GLI1 - SHH genes (Dahmane et al., 
1997; Ghali et al., 1999; Mullor et al., 2001; Regl et al., 2002; Tojo et al., 2003; Ikram 
et al., 2004; Regl et al., 2004b; O'Driscoll et al., 2006; Asplund et al., 2008; Yu et al., 
2008), as well as increased activation of WNT genes such as WNT2, WNT5A (Bonifas 
et al., 2001; Mullor et al., 2001; Saldanha et al., 2004; O'Driscoll et al., 2006; Yu et al., 
2008), and accumulation of nuclear β-catenin (Yamazaki et al., 2001; El-Bahrawy et al., 
2003; Saldanha et al., 2004; Yang et al., 2008a).  
 
In addition, compared to normal skin, human BCCs exhibit increased protein and 
mRNA levels of LEF-1, which belongs to the family of TCF/LEF transcription factors, 
and is an important nuclear binding partner for β-catenin in skin (O'Driscoll et al., 2006; 
Asplund et al., 2008; Kriegl et al., 2009). In line with this, human BCCs also exhibit 
increased mRNA levels of matrix metalloproteinases (MMP), which are known targets 
of β-catenin-TCF/LEF signalling and are involved in cell invasion (O'Driscoll et al., 
2006; Yu et al., 2008). 
 
Therefore, even though little is  known about SHH/GLI and WNT/β-catenin interactions 
in human tumourigenesis, studies in different organisms have shown that parallels and 
crosstalk between HH and WNT signalling, occur both during development and 
tumourigenesis, as described more extensively in the main introduction (Chapter 1, 
Section 1.5.3).  
 
In the absence of WNT signal, cytoplasmic β-catenin (non-E-cadherin bound) 
(CTNNB1) is phosphorylated and targeted for degradation by a complex of proteins 
including axin, adenomatous polyposis coli (APC) protein, glycogen synthase kinase 
(GSK)-3β and β-TrCP. In the presence of WNT signal, the degradation machinery is 
inhibited, β-catenin accumulates in the cytoplasm and translocates to the nucleus, where 
it interacts with the TCF/LEF transcription factor and activates gene expression 
(Polakis, 2000; Huelsken & Behrens, 2002; Nelson & Nusse, 2004; Klaus & 
Birchmeier, 2008; MacDonald et al., 2009). Aberrant WNT/β-catenin signalling, due to 
mutations of the pathway components, that lead to cytoplasmic β-catenin stabilisation 
and its subsequent nuclear translocation, has been found to be implicated not only in 
human skin cancer (pilomatricoma), but also in many other human cancers, as described 
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in the main introduction (Chapter 1, Section 1.5.2) (Polakis, 2000; Giles et al., 2003; 
Polakis, 2007; Fuerer et al., 2008; Klaus & Birchmeier, 2008). 
 
Therefore, in this chapter, I have investigated whether GLI2∆N is able to activate 
mediators of the Wnt/β-catenin pathway in human N/TERT keratinocytes, and to 
regulate β-catenin localisation and transcriptional activation. 
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5.2 Results 
5.2.1 HH/GLI2∆N and WNT/β-catenin interactions 
5.2.1.1 GLI2∆N induces nuclear re-localisation of β-catenin in N/TERT cells 
In the present study, I investigated whether GLL2∆N expression can alter the sub-
cellular distribution of β-catenin by means of its re-localisation to the nucleus, which is 
an important step required for the transcriptional activation of downstream genes, since 
β-catenin is very tightly controlled and undergoes rapid degradation in the cytoplasm. 
SINCE and SINEG2 cells were seeded at equal densities and harvested for whole, 
cytoplasmic and nuclear protein fractions (see Chapter 2, Section 2.12.1 and Section 
2.12.3). Cell lysates were then subjected to immunoblotting for β-catenin (see Chapter 
2, Section 2.12.5) (Figure 5.1). GAPDH and Lamin B1 were used as cytoplasmic and 
nuclear markers respectively, to confirm successful fractionation. β-actin was used as 
loading control. The distribution of β-catenin was altered in SINEG2 cells (Figure 5.1 
ii). Increased nuclear, and decreased cytoplasmic β-catenin, was observed in SINEG2 
cells, compared to SINCE cells (Figure 5.1 i), indicating protein re-localisation from 
the cytoplasm to the nucleus. Overall levels of β-catenin were similar in both SINCE 
and SINEG2 cell lines (Figure 5.1 iii).  
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Figure 5.1: GLI2∆N induces nuclear translocation of β-catenin.  
Immunoblotting analysis after whole, cytoplasmic and nuclear protein fractionation on SINCE 
(i) and SINEG2 (ii) cell lines. Whole, cytoplasmic and nuclear protein fractions were prepared 
and samples were run on SDS PAGE gel. Membrane was probed against β-catenin antibody (~ 
92 kDa), to examine its subcellular distribution. Lamin-B1 (~ 66 kDa) and GAPDH (~ 35 kDa) 
antibodies were used as nuclear and cytoplasmic markers respectively, to confirm successful 
fractionation. β-actin (~ 42 kDa) was used as loading control. β-catenin was found to be mainly 
localised in the cytoplasm of SINCE control cells with little protein being present in the nucleus 
(i). In contrast, β-catenin distribution was altered in EGFP-GLI2∆N expressing SINEG2 cells, 
indicating β-catenin translocation from the cytoplasm to the nucleus (ii). Overall levels of β-
catenin were similar in both SINEG2 and SINCE control cells (iii). 
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5.2.1.2 GLI2∆N expression causes β-catenin nuclear relocalisation in organotypic 
cultures. 
In order to mimic physiological skin conditions in vitro, NTEG2 induced and uninduced 
cells were grown in organotypic three-dimensional cultures, by Nafeesa Ali at Centre 
for Cutaneous Research, Institute of Cell and Molecular Science, Barts and the London 
School of Medicine and Dentistry, London, UK, under conditions that can support the 
proliferation and differentiation of epidermal keratinocytes and mimic their in vivo 
pattern of growth and differentiation (see Chapter 2, Section 2.17) (Contard et al., 
1993; Ojeh et al., 2001). The localisation of β-catenin following conditional expression 
of GLI2∆N in N/TERT keratinocytes (NTEG2 induced), was investigated by 
immunohistochemistry on organotypic sections (Figure 5.2 i), using an anti-β-catenin 
antibody. In experiments carried out by Nafeesa Ali at Centre for Cutaneous Research, 
Institute of Cell and Molecular Science, Barts and the London School of Medicine and 
Dentistry, London, UK, strong membranous, with limited nuclear, staining of β-catenin 
was detected in uninduced NTEG2 control cells (Figure 5.2 i). Conversely, in the 
NTEG2, GLI2∆N induced cells (Figure 5.2 ii), β-catenin was no longer predominantly 
membranous, but instead mainly nuclear in a subset of cells, and prevalently so in the 
basal layer of the organotypic cultures. The data generated using this in vitro skin model 
support the results obtained using stable EGFP-GLI2∆N expressing cells, further 
suggesting an active role for GLI2∆N in the nuclear relocalisation of β-catenin in 
human keratinocytes.   
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Figure 5.2: GLI2∆N expression causes β-catenin nuclear relocalisation in 
organotypic cultures.  
NTEG2 cells (Dox+ / Dox-) were grown on organotypic three dimensional cultures by Nafeesa 
Ali at Centre for Cutaneous Research, Institute of Cell and Molecular Science, Barts and the 
London School of Medicine and Dentistry, London, UK). Paraffin-embedded sections from 
organotypic cultures of NTEG2 (Dox+) and NTEG2 (Dox-) were stained using anti-β-catenin 
antibody. Increased nuclear staining of β-catenin was observed in induced NTEG2 organotypic 
culture (ii). Strong staining of nuclear β-catenin was present mainly in the basal layer of NTEG2 
(Dox-) (ii), compared to membranous localisation of β-catenin in NTEG2 (Dox+) (i) 
organotypic cultures. 
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5.2.1.3 GLI2∆N induces β-catenin dependent transactivation 
WNT pathway activation leads to the inhibition of β-catenin degradation, followed by 
its stabilisation to the cytoplasm, and its subsequent translocation to the nucleus, where 
it associates with the T-cell factor/lymphoid enhancer (TCF/LEF) family of 
transcription factors (McArdle et al., 1984; Behrens et al., 1996; Molenaar et al., 1996; 
Polakis, 2000; Huelsken & Behrens, 2002; Arce et al., 2006). This results in the 
transactivation of WNT target genes, including cyclin D1, c-Myc, MMP26, MMP7, 
PPAP-δ and AF17, which have been linked to increased cell proliferation, invasion and 
tumour metastasis (He et al., 1998; Brabletz et al., 1999; He et al., 1999; Shtutman et 
al., 1999; Lin et al., 2001; Marchenko et al., 2002). To test whether the increased 
nuclear β-catenin, due to the GLI2∆N activation, is also transcriptionally active, the 
well characterised OT-β-catenin responsive promoter (improved version of 
TOPFLASH) containing the TCF-4 binding sites (CCTTTGATC), was used (Korinek 
et al., 1997; He et al., 1998; Shih et al., 2000). 
 
Initially, the levels of EGFP-GLI2∆N induction in NTEG2 cell line, 48 hr and 5 days 
after removal of Dox were investigated, by immunoblotting against anti-EGFP antibody 
(Figure 5.3A). β-actin was used as protein loading control. N/TERT cells were also 
used as internal controls, due to background activation levels of GLI2∆N in Dox+ 
NTEG2 cells, as evidenced on Figure 5.3A.  
 
Both N/TERT and NTEG2 cells were transduced with SIN-OT-Luc retrovirus 
containing the OT-β-catenin responsive promoter, in order to assess the transcriptional 
activity of β-catenin (see Chapter 2, Section 2.1.7 and Section 2.3.5.3). Cells were left 
to express the transgene for 72 hr, and harvested 48 hr after removal of Dox. This time 
point was selected instead of 5 days, in order to achieve maximum expression of the 
transgene (OT promoter) with insignificant difference in the induction of EGFP-
GLI2∆N fusion protein (Figure 5.3A). Next, cells were lysed and luciferase activity and 
total protein content were measured (see Chapter 2, Section 2.15 and Section 2.12.4). 
NTEG2 (Dox-) cells showed a significant increase (~ 2.4 fold) in β-catenin 
transcriptional activation when compared to NTEG2 (Dox+) (** P≤0.01) and N/TERT 
cells (*** P≤0.001) (Figure 5.3B). The increase in activity observed in uninduced 
NTEG2 cells (NTEG2 Dox+), compared to N/TERT cells can possibly be attributed to 
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incomplete repression of GLI2∆N in the presence of Dox. Three independent 
experiments, each of them consisting either of duplicate or triplicate samples, were 
carried out and similar results were obtained. 
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Figure 5.3: Inducible GLI2∆N expression causes β-catenin transcriptional 
activation. 
(A) Immunoblotting of NTEG2 inducible cell line lysates against anti-EGFP antibody, in the 
presence or absence of doxycycline, for 48 hr and 5 days. Results indicated high levels of 
EGFP-GLI2∆N fusion protein induction before the experiment.  Also, immunoblotting analysis 
revealed a small difference in protein induction/repression levels between the two time points. 
β-actin was used as protein loading control. 48 hr of doxycycline withdrawal was the time-point 
of choice in order to achieve significant induction of EGFP-GLI2∆N and maximum expression 
of SIN-OT-Luc reporter vector. (B) N/TERT and NTEG2 cells were transduced with SIN-OT-
Luciferase vector and expressed the transgene for 72 hr, followed by doxycycline removal for 
another 48 hr. Day 5 post-transduction, lysates were prepared and examined for luciferase 
activity and protein content. OT-β-catenin responsive promoter was significantly induced in 
NTEG2 Dox- cells (~ 2.4 fold) compared to both N/TERT (*** P≤0.001) and NTEG2 Dox+ 
(** P≤0.01) cells. The increase in luciferase activity observed in uninduced NTEG2 cells 
(NTEG2 Dox+), compared to N/TERT cells can possibly be attributed to incomplete repression 
of GLI2∆N in the presence of Dox. Each bar represents a mean ± s.e.m of normalised to protein 
content triplicate samples. 
Chapter 5: HH/GLI2∆N and WNT/β-catenin interactions in N/TERT human keratinocytes 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 433 
Due to the continuous phosphorylation of β-catenin in the cytoplasm, followed by 
subsequent proteasome-mediated degradation, the levels of active, dephosphorylated β-
catenin protein are kept at very low levels (Aberle et al., 1997; Behrens et al., 1998; 
Jiang & Struhl, 1998; Latres et al., 1999; Amit et al., 2002; Liu et al., 2002; van Es et 
al., 2003; Nusse, 2005; Klaus & Birchmeier, 2008; MacDonald et al., 2009). Therefore, 
the levels of active-β-catenin in the NTEG2 induced cells were examined. NTEG2 
induced cells were lysed 48 hr after Dox removal (see Chapter 2, Section 2.12.1) and 
subjected to immunoblotting for EGFP and active-β-catenin (see Chapter 2, Section 
2.12.5) (Figure 5.4), with β-actin as loading control. The levels of active free β-catenin 
protein were significantly higher in the induced NTEG2 cells (NTEG2 Dox-), compared 
to uninduced control cells (NTEG2 Dox+), further indicating the activation of β-catenin. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: GLI2∆N expression causes an increase in active β-catenin levels.  
Active (dephosphorylated) β-catenin levels (~ 92 kDa) are increased in induced NTEG2 cells 
compared to the uninduced control cells. Active β-catenin levels in cell lysates from induced 
and uninduced NTEG2 cells were analysed by immunoblotting with anti-active-β-catenin 
antibody. The EGFP-GLI2∆N protein levels after 48 hr removal of doxycycline are also shown 
for reference and β-actin was used as loading control.  
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Then, β-catenin transactivation assay was repeated in the stably expressing cell line 
SINEG2, for further confirmation. N/TERT, SINCE, and SINEG2 cells were transduced 
with the SIN-OT-Luc retrovirus (see Chapter 2, Section 2.1.7 and Section 2.3.5.3) and 
were left to express the transgene for 72 hr prior to harvesting for luciferase activity and 
protein content measurement (see Chapter 2, Section 2.15 and Section 2.12.4). Again, 
GLI2∆N expressing keratinocytes showed a significant increase in the transactivation of 
β-catenin (~ 2.4 fold), when compared to both N/TERT (** P≤0.01) and SINCE cells (** 
P≤0.01) (Figure 5.5B). The levels of GLI2∆N expression in the cells are reported for 
reference (Figure 5.5A). Three independent experiments, each of them consisting either 
of duplicate or triplicate samples, were carried out and similar results were obtained. 
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Figure 5.5: Stable GLI2∆N expression in N/TERT keratinocytes causes β-catenin 
transcriptional activation. 
(A) Immunoblotting of SINEG2 and SINCE protein lysates against anti-EGFP antibody, 
indicating high levels of EGFP-GLI2∆N expression. β-actin was used as loading control. (B) 
N/TERT, SINCE, and SINEG2 cells were transduced with SIN-OT-Luc retrovirus and 
expressed the transgene for 72 hr. Lysates were prepared and examined for luciferase activity 
and protein content. OT-β-catenin responsive promoter was significantly induced in EGFP-
GLI2∆N stably expressing cells (~ 2.4 fold), when compared to both SINCE and N/TERT 
controls (** P≤0.01). Each bar represents a mean ± s.e.m of normalised to protein content 
triplicate samples. 
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5.2.1.4 GLI2∆N induces the expression of WNT genes in human N/TERT 
keratinocytes 
It has been previously reported that WNT genes are activated in human BCCs (in vivo 
tumourigenesis) (Bonifas et al., 2001; Mullor et al., 2001; Saldanha et al., 2004; 
O'Driscoll et al., 2006; Yu et al., 2008), where GLI2 is highly expressed (Mullor et al., 
2001; Regl et al., 2002; Tojo et al., 2003; Ikram et al., 2004; Regl et al., 2004b; 
O'Driscoll et al., 2006; Asplund et al., 2008; Yu et al., 2008), as well as  in frog embryo 
animal cap explants injected with Gli2 and Gli3 mRNA (embryonic development) 
(Mullor et al., 2001), and in rat kidney epithelial cells upon Gli1 induction (in vitro 
transformation) (Li et al., 2007). 
 
Thus, in order to determine whether aberrant GLI2∆N expression may be influencing 
the canonical Wnt/β-catenin pathway through alterations in WNT ligand expression in 
human N/TERT keratinocytes, quantitative RT-PCR analysis of different WNT ligands 
was performed (see Chapter 2, Section 2.11 and Section 2.11.7). Stable expression of 
GLI2∆N in human N/TERT keratinocytes, results in the upregulation of WNT5A (~ 5 
fold) (Figure 5.6A), WNT7A (~ 3 fold) (Figure 5.6B) and WNT11 (~ 400 fold) 
(Figure 5.6C) genes, compared to wild-type and EGFP-expressing N/TERT 
keratinocytes (*** P≤0.001), suggesting a possible implication of these WNT genes in 
the nuclear translocation of β-catenin, and its subsequent transcriptional activation upon 
GLI2∆N induction. The relative fold mRNA induction of WNT11 could be an 
overestimation, due to the very low background levels of WNT11 mRNA observed in 
control N/TERT and SINCE keratinocytes (Ct >31). 
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Figure 5.6: Stable GLI2∆N expression in N/TERT keratinocytes induces WNT 
genes expression. 
RNA was harvested from N/TERT, SINCE, and SINEG2 cells to examine the levels of WNT5A 
(A), WNT7A (B), and WNT11 (C) mRNA expression using primers specific for each gene. 
Quantitative RT-PCR analysis of WNT5A, WNT7A and WNT11 showed an increase in 
expression of all the three genes in SINEG2 cells compared to N/TERT and SINCE control 
cells. Each bar represents mean fold induction relative to N/TERT (arbitrary value of 1) ± s.e.m 
of triplicate samples. *** P≤0.001.  
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5.2.1.5 GLI2∆N induces the expression of SNAIL1, SNAIL2 but not of E-
CADHERIN genes 
In addition to its function in Wnt signalling pathway and to its presence in the 
cytoplasm, β-catenin also exists in a different functional pool in the epithelial cell 
membrane, where it tightly binds to the intracellular cytoplasmic domain of the 
transmembrane protein E-cadherin (epithelial cadherin), and to the actin binding protein 
α-catenin and forms the cadherin-catenin complex (E-cadherin/β-α-catenin complex), 
necessary for calcium-dependent cell-cell adhesion interactions (see Chapter 1, Section 
1.4.1) (McCrea & Gumbiner, 1991; Gumbiner, 2000; Jamora & Fuchs, 2002; Cavallaro 
& Christofori, 2004; Nelson & Nusse, 2004; Gumbiner, 2005; Brembeck et al., 2006). 
Serine/threonine phosphorylation of β-catenin (CTNNB1) or E-cadherin (CDH1), 
results in increased stabilisation of the cadherin-catenin complex (Lickert et al., 2000; 
Bek & Kemler, 2002), while tyrosine phosphorylation of E-cadherin or β-catenin is 
correlated with loss of cadherin mediated cell-cell adhesion, and an increase in the level 
of cytoplasmic β-catenin for the latter (Roura et al., 1999; Fujita et al., 2002; Lilien et 
al., 2002; Cavallaro & Christofori, 2004; Nelson & Nusse, 2004). 
 
Still it is not clear if the roles of β-catenin in cell-cell adhesion and Wnt signalling, both 
in development and tumourigenesis, are either largely independent from each other, or 
interrelated, since evidence occurs for both possibilities in different cell contexts 
(Cavallaro & Christofori, 2004; Gottardi & Gumbiner, 2004; Nelson & Nusse, 2004; 
Bienz, 2005; Brembeck et al., 2006). According to the latter, loss of E-cadherin during 
developmental epithelial-mesenchymal transitions or during tumour progression 
(Birchmeier & Behrens, 1994; Gumbiner, 1996; Thiery, 2002; Pecina-Slaus, 2003; 
Cavallaro & Christofori, 2004; Nelson & Nusse, 2004; Gumbiner, 2005; Hugo et al., 
2007), could promote loss of cell-cell adhesion, release of the membranous β-catenin to 
the cytoplasm, accumulation of β-catenin in the cytoplasm and subsequent translocation 
to the nucleus (increased Wnt/β-catenin signalling). 
 
Recently, Li et al. (Li et al., 2007) showed that Gli1 acts both through Wnts and Snail 
(Snail homologue 1 of Drosophila) to switch β-catenin during rat kidney epithelial 
transformation. Snail belongs to a family of zinc-finger transcription factors and it was 
originally identified in Drosophila as a factor in the control of gastrulation and essential 
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for mesoderm formation (Nieto, 2002). Snail1 or Snail (Snail homologue 1 of 
Drosophila), and its close family member Snail2 or Slug (Snail homologue 2 of 
Drosophila) are both expressed in fibroblasts and have a major role not only to the 
mesoderm formation, but also in the formation of neural crest, both of which processes 
require large-scale cell movements, and delamination from the tissue of origin triggered 
by epithelial-mesenchymal transitions (EMT), followed by migration (Nieto, 2002). In 
addition, Snail and Slug not only trigger EMT during development, but also during 
tumourigenesis and progression of epithelial malignant tumours, while at the same time 
there is evidence for their implication in regulating cell death or survival (Batlle et al., 
2000; Hajra et al., 2002; Nieto, 2002; Thiery, 2002; Nelson & Nusse, 2004; Hugo et al., 
2007). Moreover, Snail1 has been found to be a direct target of Gli1 in rat kidney 
epithelial cells (Louro et al., 2002; Li et al., 2006), and to act as transcriptional 
suppressor of E-cadherin gene, by direct binding to the E-boxes of E-cadherin promoter, 
resulting in EMT activation and converting epithelial cells to mesenchymal during 
development and tumour progression (Batlle et al., 2000; Cano et al., 2000). 
 
Thus, according to Li et al. (Li et al., 2007), Snail is a downstream target of Gli1, which 
downregulates E-cadherin, and synergistically with Wnt activation, promotes β-catenin 
cytoplasmic and nuclear relocalisation, in rat kidney epithelial cells. Since GLI2 is an 
upstream regulator of GLI1 (Ding et al., 1998; Bai et al., 2002; Regl et al., 2002; Mill et 
al., 2003; Ikram et al., 2004), it is plausible to imagine that this may have a positive 
contribution to the β-catenin accumulation in the cytoplasm and its subsequent 
translocation to the nucleus. 
 
Therefore, in order to test if the nuclear translocation of β-catenin in the N/TERT 
keratinocytes upon GLI2∆N induction, observed in our study, is not only due to the 
WNT genes activation, but also due to the induction of SNAIL1 (human SNAIL 
homologue 1 of Drosophila) directly by GLI2∆N or mediated through GLI1 activation, 
following subsequent suppression of E-cadherin, quantitative RT-PCR analysis of 
SNAIL1, SNAIL2 (human SNAIL homologue 2 of Drosophila) and E-cadherin genes 
was performed (Chapter 2, Section 2.11 and Section 2.11.7). Stable expression of 
GLI2∆N in human N/TERT keratinocytes, results in upregulation of SNAIL1 (~ 2.8 
fold) (Figure 5.7A), and to a lesser extent, of SNAIL2 (~ 1.7 fold) (Figure 5.7B), while 
the transcription levels of E-cadherin were unchanged (Figure 5.7C), compared to wild-
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type and EGFP-expressing N/TERT keratinocytes (** P≤0.01). This suggests that even 
though both SNAIL1 and SNAIL2 are upregulated in GLI2∆N expressing cells, there is 
no downregulation of E-cadherin and thus membranous-β-catenin bound to E-cadherin 
is not contributing to the β-catenin cytoplasmic stabilisation, accumulation, and 
subsequent translocation to the nucleus upon GLI2∆N induction.  
 
 
 
 
 
 
 
 
Figure 5.7: Stable GLI2∆N expression in N/TERT keratinocytes induces SNAIL1 
and SNAIL2 genes expression with no effect in the expression of E-cadherin gene.  
RNA was harvested from N/TERT, SINCE, and SINEG2 cells to examine the levels of SNAIL1 
(A), SNAIL2 (B), and E-cadherin (C) mRNA expression using primers specific for each gene. 
Quantitative RT-PCR analysis of SNAIL1, SNAIL2 and E-cadherin showed an increase in 
expression of both SNAIL genes in SINEG2 cells compared to N/TERT and SINCE control 
cells, but no difference in expression of E-cadherin gene. Each bar represents mean fold 
induction relative to N/TERT (arbitrary value of 1) ± s.e.m of triplicate samples. ** P≤0.01.  
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5.3 Discussion 
5.3.1 GLI2∆N mediates β-catenin nuclear translocation and transcriptional 
activation in human N/TERT keratinocytes 
WNT/β-catenin signalling pathway plays crucial role in a wide range of developmental 
processes during embryogenesis and during adult tissue homeostasis, while 
uncontrolled WNT/β-catenin signalling, due to mutations of the pathway components, 
or due to interactions with other inappropriately activated signalling cascades, which 
might cause constitutive activation of β-catenin (cytoplasmic accumulation / nuclear 
relocalisation), is an important event in the genesis of many cancers (Clevers, 2006; 
Klaus & Birchmeier, 2008; MacDonald et al., 2009). 
 
Studies in different organisms, have shown that parallels and crosstalk between HH and 
WNT signalling occur both during development and tumourigenesis (Taipale & Beachy, 
2001; Alonso & Fuchs, 2003a; Beachy et al., 2004; Hooper & Scott, 2005; Blanpain & 
Fuchs, 2006; Watt & Collins, 2008). However, due to the complexity and context-
dependency of both HH and WNT pathways during development and tumourigenesis in 
different organisms, still little is known about SHH and WNT interactions in human 
carcinogenesis. 
 
In normal skin, both Hh and Wnt pathways are implicated in hair follicle morphogenesis 
and adult hair cell cycle (Millar, 2002; Schmidt-Ullrich & Paus, 2005; Blanpain & 
Fuchs, 2006). Wnt/β-catenin is required upstream of Shh in placode formation, during 
hair follicle morphogenesis (Gat et al., 1998; Huelsken et al., 2001; Andl et al., 2002; 
Lo Celso et al., 2004; Silva-Vargas et al., 2005; Blanpain & Fuchs, 2006), while Shh 
signalling is required for the proliferation and expansion of follicle epithelium in order 
to assemble a mature follicle (St-Jacques et al., 1998; Chiang et al., 1999; Mill et al., 
2003; Silva-Vargas et al., 2005; Blanpain & Fuchs, 2006).  
 
Active Wnt/β-catenin signalling in adult transgenic mice was found to activate Shh/Gli 
signalling, and to promote de novo hair follicle morphogenesis (Gat et al., 1998; Lo 
Celso et al., 2004; Silva-Vargas et al., 2005; Ito et al., 2007), while constitutive 
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activation of β-catenin results in the development of hair follicle tumours such as 
pilomatricomas and trichofolliculomas (Gat et al., 1998; Lo Celso et al., 2004). 
 
Human BCCs show,  (a) increased levels of SHH effector genes such as GLI1 and GLI2  
(Dahmane et al., 1997; Ghali et al., 1999; Mullor et al., 2001; Regl et al., 2002; Tojo et 
al., 2003; Ikram et al., 2004; Regl et al., 2004b; O'Driscoll et al., 2006; Asplund et al., 
2008; Yu et al., 2008), (b) increased levels of WNT genes such as WNT2β, WNT5a and 
WNT7β (Bonifas et al., 2001; Mullor et al., 2001; Saldanha et al., 2004; O'Driscoll et 
al., 2006; Yu et al., 2008), as well as (c) accumulation of nuclear β-catenin (Yamazaki 
et al., 2001; El-Bahrawy et al., 2003; Saldanha et al., 2004; Yang et al., 2008a), (d) 
increased protein and mRNA levels of the β-catenin nuclear binding partner, LEF-1 
(O'Driscoll et al., 2006; Asplund et al., 2008; Kriegl et al., 2009), and (e) increased 
mRNA levels of several matrix metalloproteinases (MMPs), which are known targets of 
β-catenin-TCF/LEF-1 signalling and are involved in cell invasion (O'Driscoll et al., 
2006; Yu et al., 2008). 
 
In my study, a new connection between Hh and Wnt pathways in human epidermal cells 
was found for the first time, demonstrating that β-catenin is a downstream effector of 
SHH/GLI pathway and that GLI2∆N is a novel regulator of β-catenin, as judged by the 
fact that, upon constitutive activation of SHH/GLI2 signalling, by overexpressing 
GLI2∆N oncogene in cultured human keratinocytes, there is subsequent activation of 
Wnt/β-catenin pathway. 
 
β-catenin, the downstream mediator of the canonical WNT pathway, is usually confined 
to the cell membrane in an adhesion complex including E-cadherin (McCrea et al., 
1991; Peifer et al., 1992; Kemler, 1993; Nelson & Nusse, 2004; Bienz, 2005) and in the 
cytoplasm. The cytoplasmic concentration of non-E-cadherin bound β-catenin, in the 
absence of Wnt ligand, is tightly controlled by cellular phosphorylation and 
proteasomal-mediated degradation mechanisms, which modulate its nuclear re-
localisation and hence its transcriptional activity (Aberle et al., 1997; Behrens et al., 
1998; Jiang & Struhl, 1998; Latres et al., 1999; Amit et al., 2002; Liu et al., 2002; van 
Es et al., 2003; Nusse, 2005; Klaus & Birchmeier, 2008; MacDonald et al., 2009).  
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The overexpression of GLI2∆N has a marked effect on β-catenin localisation. This 
study provides evidence of nuclear accumulation of β-catenin induced by stable 
expression of GLI2∆N in N/TERT human keratinocytes (Figure 5.1). This nuclear re-
localisation of β-catenin was also observed after inducible GLI2∆N induction in three 
dimensional organotypic cultures (Figure 5.2), a model that mimics patterns of 
proliferation and differentiation of normal human skin in vivo (Contard et al., 1993; 
Ojeh et al., 2001). Strong nuclear localisation of β-catenin was observed in a subset of 
the GLI2∆N-induced cells in the basal layer of the organotypic skin cultures, compared 
to the membranous staining of the uninduced control cells. In line with the nuclear 
translocation of β-catenin in GLI2∆N expressing cells, elevated levels of active-β-
catenin (non-phosphorylated) were also observed in GLI2∆N induced human N/TERT 
keratinocytes (Figure 5.4). Furthermore, it is shown that β-catenin re-localisation to the 
nucleus, results in its transcriptional activation, both in stable and inducible GLI2∆N 
expressing cells, as determined by the transactivation of the OT-β-catenin responsive 
promoter (Figure 5.3 and Figure 5.5). It is worth mentioning here that recently Park et 
al. (Park et al., 2009) showed that telomerase can interact with BRG1 (protein-protein 
interaction) which in turn binds to β-catenin (protein-protein interaction) and enhances 
its transcriptional activity as judged by the activation of TOPFLASH and several WNT-
dependent genes such as cyclin-D1, c-myc and Axin 2. Knowing that N/TERT 
keratinocytes, used in my study, have been immortalised with human telomerase reverse 
transcriptase (h/TERT) (Dickson et al., 2000) it is possible that these cells have 
intrinsically enhanced activity of the OT-β-catenin responsive promoter. However, even 
if this is the case it would not have an impact on the overall result (Figure 5.3 and 
Figure 5.5) since all three cell lines (controls and GLI2∆N-expressing cells) used in my 
experiments contain the same genetic background and therefore expressing similar 
levels of h/TERT. 
 
These observations suggest a direct link between the SHH/GLI2 and the WNT/β-catenin 
signalling pathway, and are in keeping with previous reports describing Hh/Gli-Wnt/β-
catenin crosstalk, both during embryonic processes in the frog embryo (Mullor et al., 
2001), and in vitro transformation of rat kidney epithelial cells (Li et al., 2007). Mullor 
et al. (Mullor et al., 2001) has reported that expression of different Wnts, including 
Wnt5A, 7B, 8 and 11 are induced in Xenopus animal cap explants injected with Gli2 
and Gli3 mRNA, while Wnt 8 and Wnt 11 are required for Gli2/3-induced ventro-
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posterior mesodermal development, as judged by the blockade of this morphogenetic 
response to Gli2, upon inhibition of Wnt signalling. Furthermore, Li et al. (Li et al., 
2007) demonstrates that Gli1 induces Wnts (Wnt2b, 4, 7) and promotes β-catenin 
cytoplasmic and nuclear relocalisation in rat kidney epithelial cells, during epithelial 
transformation. Inhibition of Wnt/β-catenin signalling, by using a dominant negative 
form of Tcf4, represses the Gli1-mediated transformation of rat kidney epithelial cells in 
vitro, as indicated by the reduced foci formation in soft agar (Li et al., 2007). In 
addition, Alvarez-Medina et al. (Alvarez-Medina et al., 2009) showed that Shh pathway 
is required upstream of the canonical Wnt/β-catenin signalling, to control neural 
progenitor proliferation in chick embryos. Therefore, in developing vertebrate nervous 
system, the cell cycle progression of the neural progenitors is co-ordinately regulated, 
by activated Shh signalling which subsequently activates Wnt/β-catenin pathway, 
followed by activation of cyclin-D1 (Wnt/β-catenin target gene) and thus progression 
through the G1 phase of the cell cycle (Alvarez-Medina et al., 2009). 
 
Most recently, in line with my data, it was demonstrated that canonical WNT/β-catenin 
signalling is essential for the tumourigenic response to deregulated HH signalling (BCC 
carcinogenesis, basaloid follicular hamartomas), both in mice and humans, and it is 
downstream of HH signalling in basaloid follicular hamartomas in transgenic mice 
(Roop & Toftgard, 2008; Yang et al., 2008a). Yang et al. (Yang et al., 2008a), first 
established that there is significant molecular resemblance between human superficial 
basal cell carcinoma and the human embryonic hair bud, by using early-stage follicle 
lineage markers, including K17, Sox9 and CDP. Then, by using a mouse model with 
conditional activation of Hh signalling in skin, achieved by using the human M2SMO 
oncogene (activated smoothened mutant) (Xie et al., 1998; Grachtchouk et al., 2003) 
under the K5 promoter regulation, further molecular similarity was confirmed between 
the embryonic mouse hair buds and the de novo epithelial hair buds formed in the 
M2SMO mice skin, in a normally hairless region (Yang et al., 2008a). Conditional 
expression of M2SMO in the skin of transgenic mice for longer, resulted in the 
progression of the de novo epithelial hair buds to form basaloid follicular hamartomas, a 
benign hair follicle tumour associated with deregulated Hh signalling both in mice and 
humans (Grachtchouk et al., 2003; Jih et al., 2003). The presence of active Wnt/β-
catenin signalling induction upon deregulated Hh signalling in M2SMO-expressing 
mice, was first established by the increased levels of nuclear β-catenin both in the 
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M2SMO-induced mouse epithelial buds, and in the peripheral cells of the M2SMO-
induced mouse follicular hamartomas (Yang et al., 2008a). Similarly, nuclear β-catenin 
was also detected in the normal mouse and human embryonic epithelial hair buds, 
consistent with the notion that Wnt/β-catenin pathway is activated during early stages of 
hair follicle morphogenesis, as well as in the neoplastic cells of the human superficial 
BCCs (Yang et al., 2008a). Secondly, non-phosphorylated (active) β-catenin was 
detected in protein lysates from M2SMO-transgenic mouse skin, while little or no 
expression was detected in the protein lysates from the control non-transgenic hairless 
mouse skin (Yang et al., 2008a). Finally, increased expression of Wnt ligands, including 
Wnt 4, 5a, and 11, and Wnt/β-catenin signalling target genes, including Axin2 and 
cyclin-D1, were observed in M2SMO-expressing mice, while inhibition of the canonical 
Wnt/β-catenin pathway in M2SMO-expressing mice by using the DKK inhibitor, 
resulted in suppression of both epithelial hair bud formation and basaloid follicular 
hamartoma, as well as in expression of β-catenin only in the cytoplasm (Yang et al., 
2008a). 
 
Thus, both the data from my study in GLI2∆N-expressing human N/TERT 
keratinocytes, which are consistent with gene and protein expression profiling data of 
human BCCs (Yamazaki et al., 2001; El-Bahrawy et al., 2003; O'Driscoll et al., 2006; 
Asplund et al., 2008; Yu et al., 2008; Kriegl et al., 2009), and the analysis reported by 
Yang et al. (Yang et al., 2008a) in M2SMO-expressing mice, which is also consistent 
with the presence of nuclear β-catenin in a subset of BCC-like tumours in conditional 
Ptch1-inactivated mice (Adolphe et al., 2006), suggest that activated canonical Wnt/β-
catenin signalling is required downstream of HH/GLI pathway during skin 
tumourigenesis both in vitro and in vivo, whereas this relationship between the two 
signalling pathways is reversed during hair follicle development (epithelial hair bud 
formation) (Figure 5.8) (Roop & Toftgard, 2008). 
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Figure 5.8: Signalling events in basal cell carcinoma and hair follicle buds.  
(a) In basal cell carcinoma uncontrolled Hh signalling leads to the induction of the canonical 
Wnt/β-catenin signalling, which is essential for subsequent tumour development. (b) In hair 
follicle buds activation of Wnt/β-catenin signalling precedes, and leads to, the induction of 
Hh/Gli signalling, which is required for the proliferation and expansion of follicle epithelium in 
order to assemble a mature hair follicle (Roop & Toftgard, 2008).  
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Furthermore, the strong nuclear localisation of β-catenin, that was observed in the basal 
layer of the organotypic skin cultures (Figure 5.2), the most proliferative layer of the 
epidermis (Fuchs, 1990), is consistent with the known WNT/β-catenin signalling role in 
cell proliferation, since nuclear β-catenin localisation has been found to peak in the 
G2/M cell cycle phase (Olmeda et al., 2003). In line with this, increased ectopic 
epidermal expression of β-catenin in basal keratinocytes results in de novo hair follicle 
morphogenesis and tumour formation in transgenic mice models (Gat et al., 1998; Xia 
et al., 2001; Nicolas et al., 2003; Lo Celso et al., 2004; Hardman et al., 2005; Silva-
Vargas et al., 2005; Ito et al., 2007). Furthermore, the nuclear localisation of β-catenin, 
observed in a proportion of cells in the basal layer of the organotypic skin cultures is 
consistent with the invasive pattern of both β-catenin and its nuclear binding partner 
LEF-1 in human BCCs. This pattern displayed an intense nuclear expression at the 
invasive margins (basaloid cells), whereas cells in the tumour centre lack nuclear 
expression of both β-catenin and LEF-1 (Kriegl et al., 2009), suggesting a possible 
contribution to the ability of human BCCs to invade locally (see Chapter 3, Section 
3.3.8), possibly through the activation of matrix metalloproteinases (MMPs) by β-
catenin/LEF-1. MMPs (matrixins) are enzymes, which are able to degrade all kinds of 
the extracellular matrix proteins and are essential during development and tissue 
remodelling, whereas their upregulation is often found in human diseases and cancer 
(Nagase & Woessner, 1999; Westermarck & Kahari, 1999; Curran & Murray, 2000; 
Stamenkovic, 2000; Page-McCaw et al., 2007). Similarly, accumulation of nuclear β-
catenin was preferentially observed in the outer-most cells of the undifferentiated 
basaloid follicular hamartomas, which were formed in response to ectopic Hh signalling 
in the epidermis of transgenic mice (mice expressing M2SMO oncogene-activated 
smoothened mutant), followed by subsequent Wnt/β-catenin signalling activation (Yang 
et al., 2008a). 
  
In addition, it is also believed that in the most proliferative layer of the epidermis, the 
basal layer, a subpopulation of keratinocytes, known as epidermal stem cells, reside 
(Chapter 1, Section 1.1.5 and Section 1.1.5.1) (Potten, 1974; Fuchs, 2008). Thus, the 
fact that only a small proportion of epidermal keratinocytes with activated Hh 
signalling, exhibit active Wnt/β-catenin signalling in my study, as well as in the analysis 
reported by Yang et al. (Yang et al., 2008a), suggests that the ability to respond to Hh 
signalling with increased Wnt/β-catenin expression and subsequent BCC formation, is 
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restricted to a small subset of epidermal cells (Roop & Toftgard, 2008). This small 
population of cells is thought to correspond to the stem cell compartment, where 
activation of Wnt/β-catenin and Shh signalling is found during normal skin 
development, and is required for their maintenance (Chapter 1, Section 1.5.1 and 
Chapter 3, Section 3.3.6) (Callahan & Oro, 2001; Adolphe et al., 2004; Beachy et al., 
2004; Blanpain & Fuchs, 2006; Zhou et al., 2006; Roop & Toftgard, 2008). This is 
consistent with the notion that constitutive activation of the SHH/GLI pathway in skin 
and subsequent activation of Wnt/β-catenin pathway (signalling pathways with major 
developmental functions), could disrupt epidermal homeostasis and lead to 
tumourigenesis, with a phenotype that resembles stem cell characteristics (stem-like 
tumour phenotype), such as BCCs, which have been suggested to arise from epidermal 
basal layer or hair follicle stem cells (see Chapter 1, Section 1.3.6 and Chapter 3, 
Section 3.3.6), and have been considered as an one-hit tumour, due to the lack of 
multiple genetic alterations, and their biologically mild behavioural characteristics (slow 
growing, locally invade, rarely metastasize) (Chapter 1, see Section 1.2.1) (Miller, 
1991a; Fan et al., 1997; Oro et al., 1997; Kruger et al., 1999; Grachtchouk et al., 2000; 
Nilsson et al., 2000; Sheng et al., 2002; Owens & Watt, 2003; Hutchin et al., 2005; 
Blanpain & Fuchs, 2006; Crowson, 2006; Huntzicker et al., 2006; Mancuso et al., 2006; 
Youssef et al., 2010). Thus, in line with this, arguments are in favour of stem cells being 
the appealing candidates as the ‘cell of origin’ of BCC, because of their pre-existing 
capacity of self-renewal and unlimited proliferative capacity, which are prerequisites for 
the extra genetic hit (one-hit) that will transform the normal cell into a cancer cell 
(Beachy et al., 2004; Khavari, 2006; Youssef et al., 2010).  
 
In support of these arguments, and of previous studies showing that stabilised Wnt/β-
catenin signalling is required for hair follicle SC maintenance and activation (Chapter 
1, Section 1.5.1) (DasGupta & Fuchs, 1999; Van Mater et al., 2003; Lo Celso et al., 
2004; Lowry et al., 2005; Blanpain & Fuchs, 2006), a recent report by Malanchi et al. 
(Malanchi et al., 2008) demonstrated that in murine skin β-catenin signalling is essential 
for maintaining a population of cells in early epidermal tumours, characterised by 
phenotypic and functional similarities to normal bulge skin stem cells (including 
expression of CD34 and SOX9). This population contains cells referred to as cancer 
stem cells (see Chapter 3, Section 3.3.4 (Beachy et al., 2004)), with high tumourigenic 
capacity, indicated by the initiation of secondary tumours, which resembled the 
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architecture of the parental tumours, while ablation of β-catenin gene in the already 
established parental early epidermal tumours, results in the loss of this subpopulation of 
cells and complete tumour regression characterised by extensive terminal differentiation 
(Malanchi et al., 2008). 
 
Finally, the nuclear translocation of β-catenin and its subsequent transcriptional 
activation might not only be mediated by the TCF/LEF-1 transcription factors, as it is 
observed by the increased activity of the OT-β-catenin responsive promoter, which 
contains the binding sites of the TCF-4, in GLI2∆N-expressing keratinocytes (Figure 
5.3), but also by the SOX transcription factors. SOX factors belong to the superfamily 
of the high mobility group DNA binding factors, same as the TCF/LEF-1 transcription 
factors (see Chapter 3, Section 3.3.6.2 and Chapter 1, Section 1.4.2). The binding of 
both SOX and TCF/LEF-1 factors to DNA is weaker than for most transcription factors, 
and thus recruitment of other protein partners (cell-type or tissue specific) is required 
for their transcriptional activity (Pevny & Lovell-Badge, 1997; Kamachi et al., 1999; 
Kamachi et al., 2000; Wilson & Koopman, 2002). SOX2, is a transcription factor, 
which is involved in organ development and in determining stem cell fate and 
properties, while it has been consistently reported to be upregulated in poorly 
differentiated tumours such as breast, as well as in gliomas which are also associated 
with activated hedgehog signalling and GLI1/2 overexpression (see Chapter 3, Section 
3.2.3.1.1 and Section 3.3.6.2) (Kinzler et al., 1987; Dahmane et al., 2001; Kubo et al., 
2004; Sterling et al., 2006; Clement et al., 2007; Ben-Porath et al., 2008; Chen et al., 
2008; Kameda et al., 2009). Interestingly, a recent study demonstrated that β-catenin is 
a transcription partner for SOX2, and that SOX2 and β-catenin act in synergy in the 
transcription regulation of cyclin-D1, and therefore facilitating the G1/S transition and 
increasing the proliferation of breast cancer cells (Chen et al., 2008). Thus, due to the 
massive upregulation and high availability of SOX2 (Chapter 3, Section 3.2.3.1.1, 
Figure 3.13), along with the nuclear accumulation of β-catenin in GLI2∆N-expressing 
keratinocytes (Figure 5.1), it is plausible to imagine that this might be another 
mechanism of β-catenin-mediated transcriptional activation, giving more insights to the 
tumourigenic role of GLI2. 
 
 
 
Chapter 5: HH/GLI2∆N and WNT/β-catenin interactions in N/TERT human keratinocytes 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 450 
5.3.2 β-catenin is not a transcriptional activator of c-MYC in N/TERT 
human keratinocytes 
As I mentioned in the main introduction (Chapter 1, Section 1.4.2), the transcriptional 
targets of TCF/LEF-1- β-catenin complex are diverse, and cell-type and context specific 
(Logan & Nusse, 2004; Vlad et al., 2008; MacDonald et al., 2009). Therefore, while 
different MMPs (matrixins), are known targets of β-catenin in colon and other epithelial 
cancers (Brabletz et al., 1999; Marchenko et al., 2002), and they have been found to be 
upregulated in human BCCs (Miller, 1991a; O'Driscoll et al., 2006; Yu et al., 2008) and 
GLI2-expressing HaCaT keratinocytes (Regl et al., 2004a; Eichberger et al., 2006), c-
MYC which is a well established target of β-catenin in colon cancer cells (He et al., 
1998; Klaus & Birchmeier, 2008), is downregulated both in human BCCs (Bonifas et 
al., 2001; Regl et al., 2002; O'Driscoll et al., 2006; Asplund et al., 2008) and in 
GLI2∆N-expressing N/TERT keratinocytes (Chapter 3, Section 3.2.1.4, Figure 3.5B, 
C), whereas nuclear β-catenin is expressed in both. Similarly, c-myc was not found 
upregulated by stabilised β-catenin or Gli1-induced β-catenin in rat kidney epithelial 
cells (Kolligs et al., 1999; Li et al., 2007), and is repressed in response to inducible 
expression of GLI2∆N in HaCaT keratinocytes (Regl et al., 2004a; Eichberger et al., 
2006).  
 
Collectively these findings along with my data, suggest that c-MYC is not a 
transcriptional target of β-catenin or β-catenin is not a transcriptional activator of c-
MYC in human keratinocytes in vitro, consistent with their diverse roles observed in 
skin, both in vitro and in vivo (see Chapter 3, Section 3.3.7 and Chapter 1, Section 
1.5.1) (Watt & Collins, 2008), and with the undifferentiated basal-like phenotype and 
stem-cell gene expression pattern, observed in GL2∆N-expressing N/TERT 
keratinocytes (Chapter 3, Section 3.2.3.1, Figure 3.11, Figure 3.12, Appendix II and 
Section 3.2.3.1.1, Figure 3.13). In vitro, putative epidermal stem cells express lower 
levels of c-MYC (Gandarillas & Watt, 1997; Jensen & Watt, 2006) and higher levels of 
β-catenin (Zhu & Watt, 1999), compared to the transit-amplifying cells, while for the 
expansion of the epidermal stem cell compartment, stabilised β-catenin expression and 
low levels of c-MYC are required (Gandarillas & Watt, 1997; Zhu & Watt, 1999), since 
ectopic overexpression of c-MYC in primary human keratinocytes in vitro promotes 
their terminal differentiation (Gandarillas & Watt, 1997). In vivo, in the presence of 
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stabilised β-catenin, there is expansion of the epidermal stem cell compartment and 
induction of de novo hair follicle formation (Gat et al., 1998; Lo Celso et al., 2004; 
Silva-Vargas et al., 2005; Ito et al., 2007), while overexpression of c-myc, depletes the 
epidermal stem cell compartment and induces differentiation of keratinocytes into 
interfollicular epidermis and sebaceous glands (Arnold & Watt, 2001; Waikel et al., 
2001).  
 
The different effects that c-MYC and β-catenin exert in the lineage selection of 
epidermal stem cells, was further confirmed in an immortalised human sebocyte cell 
line, which can be induced to differentiate into mature sebocytes by growing the cells to 
high density (Lo Celso et al., 2008). Stabilised β-catenin stimulates interfollicular 
epidermis differentiation, as indicated by the increased number of positive stained cells 
for involucrin and cornifin, while c-MYC stimulates sebaceous gland differentiation, as 
indicated by the increase in the number and size of cytoplasmic lipid droplets, present in 
the c-MycER transduced sebocyte cells following two days tamoxifen treatment to 
activate c-MYC  (Lo Celso et al., 2008). Interestingly, Indian Hedgehog (Ihh) which is 
usually upregulated in mice and human sebaceous glands, human differentiated 
immortalised sebocyte cells and in human and mouse sebaceous tumours (Niemann et 
al., 2003; Takeda et al., 2006), was found to be a direct target gene of c-MYC (c-MYC 
binds to the promoter of Ihh in primary human keratinocytes) (Lo Celso et al., 2008), 
while it is known that β-catenin increases Shh expression during ectopic hair follicle 
formation in transgenic mice (Gat et al., 1998; Lo Celso et al., 2004; Silva-Vargas et al., 
2005). Additional data on the mutual antagonism between c-Myc and β-catenin in the 
lineage specification in the epidermis, came from bitransgenic mice that co-expressed 
both stabilised β-cateninER and activated c-MycER under the control of K14 promoter 
(Lo Celso et al., 2008). In these bitransgenic mice, there was inhibition of β-catenin-
mediated formation of ectopic hair follicles in the interfollicular epidermis by c-Myc, 
whereas β-catenin blocked c-Myc-induced sebocyte terminal differentiation (Lo Celso 
et al., 2008). 
 
Therefore, future studies with the GLI2∆N-expressing keratinocytes are required, in 
order to evaluate already existing, and to identify new, candidate target genes of β-
catenin, which are probably implicated in the tumourigenic role of GLI2∆N both in 
vitro and in vivo. 
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5.3.3 GLI2∆N may mediate β-catenin activation through WNT genes 
upregulation 
WNTs, which are secreted lipid-modified glycoproteins, activate both canonical and 
non-canonical Wnt pathways, and are involved in multiple developmental events during 
embryogenesis and adult tissue homeostasis, whereas their upregulation has been 
associated with cancer (see Chapter 1, Section 1.4) (Wodarz & Nusse, 1998; Huelsken 
& Behrens, 2002; Logan & Nusse, 2004; Hausmann et al., 2007). However, prior to the 
discovery of the Frizzled and LRP co-receptor, and due to the fact that Wnt proteins are 
hydrophobic/insoluble proteins, Wnt proteins were difficult to manipulate. Therefore, 
all the initial studies on the effects of Wnt proteins, were solely based on gene transfer 
experiments in different animal models or cell culture systems, without regard to the 
cellular context in which they were overexpressed (van Amerongen et al., 2008). Thus, 
based on these early studies, Wnts were classified into two functional categories, the 
‘canonical’ Wnts (including Wnt1, and Wnt8) and the ‘non-canonical’ Wnts (including 
Wnt5A and Wnt11) (van Amerongen et al., 2008). However, further studies using 
purified active Wnt proteins and identifying Wnt ligand receptors, suggested that Wnt 
themselves are not intrinsically canonical or non-canonical, but that their signalling 
output (activation of canonical or non-canonical pathways) is determined by distinct 
sets of receptors (Frizzleds and LRPs) (Umbhauer et al., 2000; Holmen et al., 2002; Liu 
et al., 2003; Tamai et al., 2004; Liu et al., 2005; van Amerongen et al., 2008).   
 
Wnt5A, is one of the Wnts with dual signalling capabilities, since prior to the existence 
of soluble active Wnt proteins, it was found to be associated with non-canonical Wnt 
signalling (Wnt/Ca
2+
 pathway) and to inhibit Wnt/β-catenin pathway either by 
promoting the degradation of β-catenin protein (Topol et al., 2003), or by inhibiting β-
catenin-TCF-mediated transcription (Ishitani et al., 1999; Ishitani et al., 2003). 
Recently, Mikels and Nusse (Mikels & Nusse, 2006a) showed, by using purified active 
soluble Wnt5a protein, that Wnt5a functions according to receptor availability. When 
Wnt5a binds to Frizzled 4 and LRP5, it activates canonical Wnt/β-catenin pathway, as 
judged by co-expression of Frizzled 4 and LRP5 in Wnt5a-treated human embryonic 
kidney cells and subsequent activation of a β-catenin responsive luciferase reporter 
construct (Mikels & Nusse, 2006a). In contrast,  when Wnt5a  binds to the single-pass 
transmembrane receptor Ror2 (orphan tyrosine kinase 2), it inhibits canonical Wnt/β-
Chapter 5: HH/GLI2∆N and WNT/β-catenin interactions in N/TERT human keratinocytes 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 453 
catenin signalling without affecting β-catenin protein levels, but rather affecting the β-
catenin-TCF-mediated transcription and also without inducing increased cellular 
calcium levels (Mikels & Nusse, 2006a). Consistently, co-injection of Wnt5a RNA with 
Frizzled 4 RNA, and co-injection of Wnt5a RNA with Frizzled 5 RNA, leads to the 
activation of Wnt/β-catenin target genes in Xenopus animal caps, and in the activation 
of Wnt/β-catenin signalling in Xenopus embryos inducing axis duplication respectively 
(He et al., 1997; Umbhauer et al., 2000). 
 
Similarly to Wnt5A, Wnt7A is also a dual signalling Wnt, depending on receptor 
availability. When, Frizzled 5 is expressed in human endometrial cells, treated with 
purified active soluble Wnt7a protein, there is activation of the canonical Wnt/β-catenin 
pathway, whereas when Frizzled 10 is expressed in Wnt7a-treated human endometrial 
cells, there is activation of the non-canonical Wnt pathway, the planar cell polarity 
pathway (Carmon & Loose, 2008). Wnt11 has also been found to be implicated in the 
non-canonical planar cell polarity pathway in zebrafish (Marlow et al., 2002), while it 
was recently found that Wnt11 is a direct target of the canonical Wnt/β-catenin pathway 
in mouse myoblast cell lines and in mouse developing heart, which in turn activates the 
non-canonical planar cell polarity pathway, essential for the cell movements required 
for morphogenesis of the cardiac outflow tract (Zhou et al., 2007). At the same time, 
Wnt11 activates the canonical Wnt/β-catenin signalling cascade in the early Xenopus 
embryo, required for axis formation (Tao et al., 2005), further suggesting a possible 
activation of different receptors in each of these organisms. Interestingly, both Wnt11-
Frizzled 5 and Wnt5A-Frizzled 5 fusion proteins, caused axis duplication, when 
separately injected as mRNA in Xenopus embryos, indicating an activated canonical 
Wnt pathway, while both Wnt11-Frizzled 5 and Wnt5A-Frizzled 5 fusion proteins 
synergised with LRP6 to activate Wnt/β-catenin pathway, indicated by increased 
transcriptional activity of the TOPFlash reporter promoter in human embryonic kidney 
cells (Holmen et al., 2002). 
 
Gene expression studies, both in embryonic mouse skin and in normal human 
keratinocytes, have shown that all the three Wnt5a, Wnt7a and Wnt11 genes are 
expressed in embryonic mouse skin (Reddy et al., 2001), while in normal human 
keratinocytes only Wnt5a and Wnt7a are expressed, along with several Frizzled 
receptors including Frizzled 4 and Frizzled 5 (Yang et al., 2006). Importantly, Wnt5a 
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was found upregulated in mouse hair follicles at early morphogenetic stages (dermal 
condensation), but not at the earliest (promotion of placode), as confirmed by in situ 
hybridization, while both Wnt5a and Wnt11 are expressed in specific  subsets of cells in 
mature anagen hair follicle (outer root sheath and outer layers of the inner root sheath), 
in mouse skin (Reddy et al., 2001). Therefore, these observations suggest that Wnt5a 
has a crucial role in hair follicle morphogenesis. Strikingly,the same study showed that 
Wnt5a is not expressed in early hair follicle morphogenesis in the absence of Shh (Shh -
/- mouse embryos), strongly suggesting that Wnt5a is a target of Shh in hair follicle 
morphogenesis, and although in the earliest stages of hair follicle development (placode 
promotion) the Wnt genes (Wnt10a and Wnt 10b) are upstream of the Shh, in later 
stages (dermal condensation) Wnt genes (Wnt5a) lie downstream of the Shh (Reddy et 
al., 2001). 
 
Analysis of gene expression in human BCCs by using both PCR and cDNA 
microarrays, revealed that several WNT and Frizzled genes are upregulated including, 
WNT5A, WNT7A, WNT11 and Frizzled 5 (Bonifas et al., 2001; Mullor et al., 2001; 
Saldanha et al., 2004; O'Driscoll et al., 2006; Yu et al., 2008). Therefore, since these 
WNT genes are known to be implicated in the activation of the canonical Wnt/β-catenin 
pathway, I checked whether these WNTs were increased in GLI2∆N-epressing cells and 
found upregulation of WNT5A, 7A and 11 (Figure 5.6); consistent with the results 
obtained from gene analysis in human BCCs and in M2SMO-induced basaloid follicular 
hamartoma in mice (Yang et al., 2008a). In addition, my results are in line with previous 
studies in different organisms, which have reported that Wnt genes are activated, in frog 
embryo animal cap explants injected with Gli2 and Gli3 mRNA (embryonic 
development) (Mullor et al., 2001), and in rat kidney epithelial cells upon Gli1 
induction (in vitro transformation) (Li et al., 2007). 
 
Therefore, given that the availability of different Frizzled receptors to the WNT ligand 
binding can influence the output of the WNT signal, it would be interesting to examine 
whether, and which, FZD receptors are overexpressed in response to GLI2∆N induction 
in human N/TERT keratinocytes. In addition, the fact that the expression of several 
WNT ligands is induced in response to GLI2∆N overexpression raises the possibility 
that at least some of these WNT genes are direct downstream targets of GLI2 
transcription factor. By using chromatin immunoprecipitation experiments, it can be 
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examined whether there is any direct protein (GLI2) : DNA (WNT genes promoters) 
interactions, thus offering a possible explanation for the activation of WNT genes, and 
especially that of WNT11, which showed remarkable induction in response to GLI2∆N 
upregulation. It is also important to understand, whether overexpression of WNT genes 
is solely responsible for β-catenin activation. A direct approach would be to block WNT 
ligand binding to FZD and LRP5/LRP6 receptors, by using DKK1 inhibitor, and then 
assess the levels of β-catenin transcriptional activity. Finally, it will be interesting to 
investigate whether any of the dual signalling Wnts that were found upregulated in 
mine, and previous studies, upon activation of the HH/GLI2 signalling, activate the non-
canonical Wnt pathways, which might be important and have a role in HH/GLI2-
mediated BCC tumourigenesis. 
 
5.3.4 GLI2∆N induces expression of molecular markers of EMT, without 
mediating suppression of E-cadherin or any morphological changes in 
vitro 
The fact that Gli1 was found to be an upstream regulator of Snail (Snail homologue 1 of 
Drosophila) (Louro et al., 2002; Li et al., 2006), which is a transcriptional repressor of 
E-cadherin, and to act both through Wnts and Snail to promote nuclear signalling of β-
catenin during epithelial transformation (Li et al., 2007), and also knowing that GLI2 is 
an upstream regulator of GLI1 (Ding et al., 1998; Bai et al., 2002; Regl et al., 2002; 
Mill et al., 2003; Ikram et al., 2004),  suggest that these interactions may have a positive 
effect on β-catenin translocation to the nucleus of GLI2∆N-expressing human N/TERT 
keratinocytes, thereby providing a further mechanism for the SHH/GLI-WNT/β-catenin 
crosstalk. The roles of β-catenin in cell-cell adhesion and Wnt signalling (see Chapter 
1, Section 1.4 and Chapter 5, Section 5.2.1.5), both in development and 
tumourigenesis, can be both independent from each other, or interrelated, since evidence 
occurs for both possibilities in different cell contexts (Cavallaro & Christofori, 2004; 
Gottardi & Gumbiner, 2004; Nelson & Nusse, 2004; Bienz, 2005; Brembeck et al., 
2006), Thus, according to the latter, the nuclear relocalisation and transcriptional 
activation of β-catenin in the nucleus of GLI2∆N-expressing keratinocytes, might not 
only be due to the WNT genes activation, but also due to the direct (GLI2∆N→ 
SNAIL1), or indirect (GLI2∆N→ GLI1→ SNAIL1) induction of SNAIL1, resulting in 
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subsequent suppression of E-cadherin, which might lead in the release of membranous 
β-catenin in the cytoplasm.  
 
However, my results suggested that there is no contribution of the membranous E-
cadherin bound β-catenin to the accumulation of the cytoplasmic β-catenin and its 
subsequent translocation to the nucleus since the upregulation of both SNAIL1 and its 
close family member SNAIL2 genes upon GLI2∆N induction in N/TERT keratinocytes, 
was not accompanied by suppression of E-cadherin gene (Figure 5.7). 
 
The unchanged transcription levels of E-cadherin (Figure 5.7) are consistent with the 
phenotypic characteristics of GLI2∆N-expressing cells. E-cadherin is required to hold 
epithelial cells together, while downregulation of E-cadherin expression leads to loss of 
cell-cell adhesion (see Chapter 1, Section 1.4.1) (Gumbiner, 1996; Gumbiner, 2005). 
Downregulation of E-cadherin expression often occurs both during normal 
developmental epithelial-mesenchymal transitions (EMT) and during tumour 
progression, when cells change their epithelial morphology to a motile mesenchymal 
one (i.e. spindle like morphology with abundant membrane extensions and long 
filaments resembling filopodia, fibroblast-like phenotype (Lee et al., 2006)) (Birchmeier 
& Behrens, 1994; Gumbiner, 1996; Thiery, 2002; Pecina-Slaus, 2003; Cavallaro & 
Christofori, 2004; Nelson & Nusse, 2004; Gumbiner, 2005; Hugo et al., 2007). Most of 
the GLI2∆N-expressing cells do not exhibit any of these mesenchymal characteristics as 
described in Chapter 3, Section 3.3.4, and  are mainly characterised by the presence of 
large compact, cohesive colony islands, comprised of small dense cells with a high ratio 
of nuclear to cytoplasmic volume (Chapter 3, Section 3.2.3.1, Figure 3.11 and Figure 
3.12). Similarly, Yang et al. (Yang et al., 2008a) reported no downregulation of E-
cadherin in the M2SMO-induced buds, compared to the normal embryonic hair buds 
where suppression of E-cadherin was detected. These observations are also in keeping 
with the expression pattern of E-cadherin in human BCCs. While nodular and 
superficial BCCs express nuclear β-catenin (Yamazaki et al., 2001; El-Bahrawy et al., 
2003; Saldanha et al., 2004; Yang et al., 2008a), they exhibit an epithelial cell 
phenotype with a palisading of columnar cells at the periphery of tumour nodules, and 
the expression of E-cadherin is preserved in most of these tumours (Kriegl et al., 2009). 
On the other hand, infiltrative BCCs, which are more locally invasive and aggressive, 
but not metastatic, represent morphologically EMT-like changes, including reduction of 
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cell-cell interactions and single cell dissociation, accompanied by reduced expression of 
E-cadherin (Pizarro et al., 1994; Pizarro et al., 1995; Fuller et al., 1996; Shirahama et 
al., 1996; Tada et al., 1996; Kooy et al., 1999; Pizarro, 2000; Tada et al., 2000; 
Saldanha et al., 2004), consistent with the role of E-cadherin in tumour cell invasion, 
but not with its role in metastasis (see Chapter 1, Section 1.4.1) (Birchmeier & 
Behrens, 1994; Hirohashi, 1998; Hirohashi & Kanai, 2003; Cavallaro & Christofori, 
2004). However, there are a few cases in which E-cadherin is preserved even in 
infiltrative human BCCs, suggesting that other mechanisms in cancer cells can 
overcome the invasive-suppressor function of E-cadherin (Pizarro et al., 1994).  
 
SNAIL1 and SNAIL2 are molecular markers for epithelial-mesenchymal transitions, 
which occur both during development, and during tumourigenesis and progression of 
epithelial malignant tumours, and act as transcriptional repressors of the E-cadherin 
gene (see Section 5.2.1.5) (Batlle et al., 2000; Cano et al., 2000; Hajra et al., 2002; 
Nieto, 2002; Thiery, 2002; Hugo et al., 2007). The fact that GLI2∆N activates SNAIL1 
and SNAIL2 in vitro (Figure 5.7), suggests that although HH/GLI prepares cells for 
EMT, is not sufficient to complete the process in N/TERT human keratinocytes, since 
there is no downregulation of E-cadherin or any morphological signs of EMT-process. 
This does not necessary mean that activated HH/GLI pathway is incompatible with 
EMT and metastasis, but that the effect might be context dependent (Karhadkar et al., 
2004; Sheng et al., 2004; Bhatia et al., 2006; Sterling et al., 2006; Thiyagarajan et al., 
2007). Accordingly, human prostate cancer metastases have higher HH/GLI signalling 
activity than do the primary tumours from which they arose, while augmented Hh 
pathway activity (GLI1 overexpression) in mice prostate cancer cell lines resulted in 
increased levels of Snail, reduced levels of E-cadherin, and to a metastatic phenotype in 
mice inoculated subcutaneously with these cells (see Chapter 1, Section 1.3.5) 
(Karhadkar et al., 2004). 
 
Another possibility would be, that since EMT largely depends on the interactions 
between the epithelial keratinocytes and the underlying mesenchyme (Radisky, 2005), 
the absence of this interaction in vitro, could abolish the effects of EMT related gene 
expression. Furthermore, it would be important to examine the protein levels of SNAIL 
in GLI2∆N overexpressing keratinocytes and whether these are sufficient to suppress 
gene expression, since only stabilised forms of SNAIL can act as transcriptional 
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repressors of target genes. Even in the case of adequate protein stabilisation, it could be 
possible that the expression of E-cadherin is also regulated by other genes, thereby 
opposing SNAIL mediated suppression.  
 
Alternatively, E-cadherin suppression could be a feature of isolated keratinocytes within 
the population, with an increased capacity to invade. In that case, suppression of E-
cadherin would be undetectable in a monolayer in vitro system such as the one used 
here. It would be therefore interesting to investigate the expression pattern of E-
cadherin in an organotypic model of epidermis, and observe whether its expression is 
altered in a specific subset of GLI2∆N keratinocytes, and how this correlates with their 
ability to invade the tissue. In a recent study from Snijders et al. (Snijders et al., 2008), 
where GLI2-HaCaT-expressing keratinocytes were used, it was shown that inducible 
expression of GLI2 resulted in the invasion of GLI2-HaCaT keratinocytes into the 
collagen/fibroblast layers, as individual cells or small groups of cells. Surprisingly, the 
GLI2-HaCaT invading cells apart from having downregulated E-cadherin, which is 
associated with increased cell invasion, they also had downregulated the expression of 
GLI2 responsive genes, including BCL-2 and SOX2 (Snijders et al., 2008). However, 
the observations that the HH/GLI2 responsive genes are downregulated in the invading 
GLI2-HaCaT cells, and the suggestion from the authors that GLI2 activation needs to be 
downregulated/suppressed in order for the cells to invade, is contradictory to studies (in 
situ hybridisation and  cDNA microarrays) in  different subtypes of human BCCs, that 
have clearly shown that GLI2 is significantly upregulated in all the different BCC 
subtypes, including the aggressive ones consisting of the infiltrative and 
morpheaform/sclerosing (similar to infiltrative ones) human BCCs (Ikram et al., 2004; 
Crowson, 2006; O'Driscoll et al., 2006; Yu et al., 2008). In addition, SOX9, which is a 
downstream target of GLI2 (see Chapter 3, Section 3.3.6.2) (Vidal et al., 2005), was 
found to be upregulated in all subtypes of human BCC tested, including the infiltrative 
ones (Vidal et al., 2008). Therefore, at this stage, all these alternatives are equally likely 
to be the explanation of the non suppression of E-cadherin by SNAIL in my system, and 
further studies are required to discriminate between them.  
 
Most importantly, the fact that in GLI2∆N-expressing cells there is upregulation of 
SNAIL1, but not suppression of E-cadherin (Figure 5.7), and thus no release of the 
membranous β-catenin, which could possibly contribute to the increased β-catenin 
Chapter 5: HH/GLI2∆N and WNT/β-catenin interactions in N/TERT human keratinocytes 
The role of GLI2 in Human Basal Cell Carcinoma tumourigenesis 459 
transcriptional activation, is in line with a recent study of Stemmer at al. (Stemmer et 
al., 2008). Stemmer at al. (Stemmer et al., 2008) demonstrated that SNAIL1 binds to β-
catenin (protein-protein interactions), and promotes its transcriptional activity, through 
its carboxy-terminal zinc-finger domain, and not through its amino-terminal domain, 
which represses transcription of target genes, including E-cadherin, by recruiting 
histone deacetylases (Nieto, 2002). Therefore, SNAIL is a dual-function transcription 
factor, and suppression of E-cadherin by SNAIL is not required for the stimulation of β-
catenin dependent transactivation in human embryonic kidney cells (Stemmer et al., 
2008). In support of this, overexpression of SNAIL in human colorectal cancer cell lines 
leads to increased expression of Wnt target genes, including Axin2 and survivin, while 
knockdown (siRNA) of SNAIL in these cell lines resulted to reduced expression of 
WNT target genes, whereas no change in E-cadherin mRNA and protein levels was 
observed (Stemmer et al., 2008). This further suggests that endogenous SNAIL co-
activates WNT target gene expression, without requiring suppression of E-cadherin by 
SNAIL (Stemmer et al., 2008). Interestingly, another study showed that upregulation of 
Axin2 by canonical Wnt/β-catenin signalling activation, increases/stabilises Snail1 
protein levels (Axin2 sequesters GSK3β from the nucleus leaving Snail1 in its non-
phosphorylated transcriptionally active form) leading to EMT in breast cancer cells 
(Yook et al., 2006). 
 
Therefore, taking into account that the mechanisms by which SNAIL exerts its role as a 
co-activator of β-catenin and/or as a repressor of E-cadherin, are largely independent 
from each other and context specific, I suggest that GLI2∆N-induced SNAIL1, may act 
as a co-activator of nuclear β-catenin rather than as a repressor of E-cadherin. 
Consistently, Gli1-induced mouse skin lesions, resembling infiltrating human BCCs, 
were found to have both increased expression of Snail and downregulation of E-
cadherin (Li et al., 2006), while nodular human BCCs, which in most cases preserve E-
cadherin, were also found to have increased expression of SNAIL (Louro et al., 2002).  
 
Finally, with respect to Wnt signalling, the upregulation of SNAIL2 upon GLI2∆N 
induction in human N/TERT keratinocytes (Figure 5.7), is consistent with the study of 
Vallin et al. (Vallin et al., 2001), which suggested that Slug (SNAIL2) in Xenopus is a 
direct target of LEF-1/β-catenin complex, as judged by the presence of a functional 
binding site for LEF-1 in the promoter of Slug gene. 
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5.4 Summary 
The SHH and WNT pathways play pivotal roles in development and stem cell 
maintenance in adult tissues. They are also implicated in the aetiology of various 
cancers such as colorectal and hepatoblastoma (WNT), medulloblastoma and BCC 
(SHH). The crosstalk between these pathways has not been fully investigated in human 
cells, although the potential benefits which would result from the targeted inhibition of 
either pathway, or both pathways, in the treatment of their associated cancers, makes 
them attractive targets. Most importantly, it is essential to be able to target tumour 
associated aberrant pathways without interfering significantly with the physiological 
relevant ones (Taipale & Beachy, 2001) and moreover, without stimulating undesirable 
cross-talk between pathways. Knowledge of the relationship between WNT and SHH 
would provide just this kind of information.  
 
Thus, in this chapter, evidence is provided of SHH/GLI2 - WNT/β-catenin signalling 
interactions in human keratinocytes for the first time. Induction of GLI2∆N in N/TERT 
keratinocytes promotes nuclear relocalisation of β-catenin and enhances its 
transcriptional activation, possibly through WNT genes upregulation and SNAIL1 
induction, a co-activator of β-catenin. These results suggest, that WNT/β-catenin 
signalling is required downstream of SHH/GLI2 signalling, and that GLI2∆N is a novel 
regulator of β-catenin, and may play an important role in its activation in human basal 
cell carcinoma. 
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Sonic Hedgehog signalling (SHH) activation plays an important role in the direction of 
embryonic development and it has been involved in the development of human 
malignancies. Abnormal SHH stimulation leads to increased transcriptional activation 
of its downstream effector, GLI2, which is implicated in the pathogenesis of a variety of 
human tumours, including human basal cell carcinoma (BCC). Nevertheless, little is 
still known about the molecular mechanisms underlying the tumourigenic role of GLI2 
in human epidermal keratinocytes.  
 
This study examined the effects of inducible and stable overexpression of GLI2∆N 
(constitutively active form of GLI2 isoform β, lacking the N-terminal repressor domain) 
oncogenic transcription factor, on telomerase immortalised human epidermal 
keratinocytes (N/TERT). The findings showed that overexpression of GLI2∆N in 
human N/TERT keratinocytes can produce gene expression patterns and phenotypic 
characteristics reminiscent of those observed in human BCC in vivo and of other 
systems reported in vitro. More specifically, overexpression of GLI2∆N induced the 
expression of its downstream target BCL-2, while it also led to a reduction in the 
expression levels of c-MYC, which is an expression pattern previously reported in 
human BCCs. GLI2∆N overexpression also produced a strong phenotype in human 
keratinocytes, which displayed significant heterogeneity in culture with the majority of 
cells being organised in small compact, undifferentiated, basal-like (stem cell-like) 
keratinocyte colonies resembling the undifferentiated phenotype of human BCCs. The 
macroscopic appearance of these cells (basal-like phenotype) was matched with a basal 
gene expression profile induced by GLI2∆N, as was judged by the suppression of 
differentiation specific markers (an important hallmark of cancer), such as involucrin, of 
genes responsible for the onset of keratinocyte differentiation including p21
WAF1/CIP1
, 
14-3-3σ, and c-MYC, and of stem cell related genes such as integrin β1 and SOX2, 
which is keeping with previous reports on the effects of GLI2∆N in other keratinocyte 
cell lines. Importantly, this expression pattern of GLI2∆N-expressing keratinocytes is in 
line with the molecular signature of human BCCs. In addition, the overexpression of 
GLI2∆N not only did not accelerate the proliferation rates of N/TERT keratinocytes, but 
instead led to a significant reduction in the growth rate of keratinocytes in culture, 
without causing any cell death or increased apoptosis. 
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Despite the similarities between GLI2∆N overexpressing human keratinocytes in vitro, 
and human BCCs in vivo, this study unveiled a novel role for GLI2∆N in cell cycle 
control and the maintenance of genomic integrity of human cells. It was found that 
expression of GLI2∆N in N/TERT keratinocytes was alone sufficient to induce 
significant ploidy abnormalities, which is a hallmark of many cancers. These ploidy 
abnormalities could also be partly responsible for the reduced growth rate of GLI2∆N-
expressing keratinocytes, which however did not show any evidence of increased cell 
death or apoptosis in response to GLI2∆N overexpression. Upon GLI2∆N induction, 
N/TERT human keratinocytes displayed (i) increased tetraploidisation as evidenced by 
an increase in G2/M phase of the cell cycle and binucleate cell counting, followed by 
subsequent polyploidy and aneuploidy as evidenced by cell cycle analysis, (ii) 
inactivation of cell cycle regulator genes such as p21
WAF1/CIP1
 and 14-3-3σ that control 
the generation of tetraploid cells, as well as the proliferation of tetraploid and DNA 
damaged cells, with no change in p53 protein levels and (iii) defective apoptosis, 
possibly through the upregulation of the anti-apoptotic protein BCL-2, which is 
responsible for the elimination of tetraploid / polyploid / aneuploid cells and is 
otherwise activated in response to tetraploidisation. This provided the first evidence that 
GLI2∆N promotes the generation of tetraploid progenies in human keratinocytes 
propably via cytokinesis failure (binucleate tetraploids), while inactivating the growth 
inhibitory mechanisms that normally limit their survival and expansion, leading to 
aneuploidy and genomic instability. Consistently, GLI2∆N overexpressing N/TERT 
keratinocytes showed evidence not only of numerical chromosomal instability, but also 
of structural genomic instability, another hallmark of many cancers, as was judged by 
structural chromosomal aberrations, such as translocations and double minute 
chromosomes, which were evident following M-FISH karyotype analysis.  
 
Furthermore, consistent with the downregulation of p21
WAF1/CIP1
 in vitro, p21
WAF1/CIP1
 
protein in this study was also found to be almost absent in human BCC tumours, while 
forced expression of GLI2∆N in human N/TERT keratinocytes rendered cells resistant 
not only to tetraploidy-mediated apoptosis (cell cycle failure-mediated apoptosis), but 
also to UVB-mediated apoptosis (DNA damage-mediated apoptosis), consistent with 
the resistance of human BCCs in apoptosis mediated either by intrinsic or extrinsic 
pathways. The apoptotic resistance of GLI2∆N overexpressing N/TERT keratinocytes 
to the strong apoptotic stimuli, UVB (UVB, 290-320 nm) irradiation, which is known to 
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be one of the most important etiological factors in BCC formation, is possibly achieved 
through the activation of BCL-2 gene and protein upregulation, whereas the 
upregulation of p53 and the concomitant suppression of p21
WAF1/CIP1
 proteins after UVB 
treatment in GLI2∆N-expressing keratinocytes, further confirms that downregulation of 
p21
WAF1/CIP1
 upon GLI2∆N induction occurs in a p53-independent manner. Tetraploidy, 
which has its own tumourigenic potential, along with aneuploidy, genomic instability 
and defective apoptosis, are all features of many human cancers in which GLI2 has been 
shown to be involved, including human BCCs. Therefore, collectively these 
observations provide new insights into how GLI2∆N might exert its tumourigenic 
potential, and may explain why its upregulation is also implicated in a variety of human 
malignancies besides human BCCs. 
 
The SHH and WNT pathways play pivotal roles in development and stem cell 
maintenance in adult tissues and their deregulation is often implicated in various cancers 
including colorectal cancer and hepatoblastoma (WNT), medulloblastoma and BCC 
(SHH). The activation of β-catenin is the most common alteration observed during 
aberrant WNT signalling and is often implicated in human carcinogenesis and 
metastasis. Athough little is known about SHH/GLI and WNT/β-catenin interactions in 
human tumourigenesis, several studies in different organisms have shown that parallels 
and crosstalk between HH and WNT signalling, occur both during development and 
tumourigenesis. This study provided evidence for the first time of a new connection 
between SHH/GLI2 and WNT/β-catenin pathways in human epidermal keratinocytes. 
GLI2∆N induction in human N/TERT keratinocytes promoted the nuclear accumulation 
of β-catenin in keratinocyte cell culture and in the basal layer of organotypic skin rafts, 
similar to human BCCs where accumulation of nuclear β-catenin has been previously 
reported. In addition, several WNT and SNAIL genes were found to be upregulated 
upon GLI2∆N induction, while β-catenin transcriptional activity was increased upon 
stable and conditional expression of GLI2∆N, suggesting the activation of β-catenin-
dependent transcription of WNT target genes. These observations also suggested that 
GLI2∆N enhances the nuclear relocalisation and the transcriptional activation of β-
catenin, possibly through WNT genes upregulation and SNAIL1 induction, a co-
activator of β-catenin.  Collectively, these data indicated that WNT/β-catenin signalling 
is required downstream of SHH/GLI2 signalling, and that GLI2∆N is a novel regulator 
of β-catenin, and may play an important role in its activation in human basal cell 
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carcinoma and possibly in other cancers with aberrant activation of WNT/β-catenin 
pathway. 
 
Overall, this study has provided multiple lines of evidence to support that GLI2 might 
exert its tumourigenic effect on human cells by affecting multiple processes such as 
epithelial differentiation, cell cycle control and the maintenance of genomic integrity, as 
well as the regulation of WNT/β-catenin pathway gene expression. More importantly, 
the effects of GLI2∆N in human N/TERT keratinocytes are highly relevant to the 
biology of human BCCs, rendering this system a useful model for studying BCC 
biogenesis and survival in vitro. 
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Appendices 
 
Appendix  I. Standard reagents, buffers and cell culture supplements 
 
Cell culture 
 
1x RM+ supplements (various mitogens) in 500 ml media 
Supplement        Final Concentration 
Hydrocortisone     0.4 µg/ml 
Insulin       5 µg/ml 
Epidermal Growth Factor    10 ng/ml 
Cholera Toxin       0.1 nM 
Transferrin       5 µg/ml 
Liothyronine       20 pM 
 
Making up the stock vials for addition to the 200 ml 100x RM+ supplements 
 
Epidermal growth factor (EGF)  
Final media concentration = 10 ng/ml 
Thus in 200 ml of 100x RM+ = 1 µg/ml 
In order to prepare 200 ml of 100x RM+ = 1 µg/ml, dissolve 1 mg in 10 ml ddH2O 
(double distilled water) = 100 µg/ml stock concentration and aliquot in 2 ml and store at 
-20
o
C. 
This EGF stock concentration is later diluted in 1:100, 2 ml EGF (100 µg/ml stock) in 
200 ml of 100x RM+ to give a final concentration of 1 µg/ml. 
 
Hydrocortisone 
Final media concentration = 0.4 µg/ml 
Thus in 200 ml of 100x RM+ = 40 µg/ml 
In order to prepare 200 ml of 100x RM+ = 40 µg/ml, dissolve 100 mg in 25 ml ddH2O 
(double distilled water) = 4 mg/ml stock concentration and aliquot in 2 ml and store at -
20
o
C. 
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This hydrocortisone stock concentration is later diluted in 1:100, 2 ml hydrocortisone (4 
mg/ml stock) in 200 ml of 100x RM+ to give a final concentration of 40 µg/ml. 
 
Insulin 
Final media concentration = 5 µg/ml 
Thus in 200 ml of 100x RM+ = 500 µg/ml 
In order to prepare 200 ml of 100x RM+ = 500 µg/ml, dissolve 500 mg in 10 ml 0.05 M 
HCl = 50 mg/ml stock concentration and aliquot in 2 ml and store at -20
o
C. 
This insulin stock concentration is later diluted in 1:100, 2 ml insulin (50 mg/ml stock) 
in 200 ml of 100x RM+ to give a final concentration of 500 µg/ml. 
 
To prepare 10 ml 0.05 M HCl, take 500 µl from 1 M HCl in 9.5 ml ddH2O (double 
distilled water). 
 
Cholera toxin  
Final media concentration = 0.1 nM or 10
-10
 M 
Thus in 200 ml of 100x RM+ = 10 nM or 10
-8
 M 
Molecular weight = 84,000 
In order to prepare 200 ml of 100x RM+ = 1 µM or 10
-6
 M, dissolve 1 mg (the actual 
amount is 0.84 mg but for ease of use 1 mg is dissolved instead) in 10 ml ddH2O 
(double distilled water) = 1 µM or 10
-6
 M stock concentration and aliquot in 2 ml and 
store at -20
o
C. 
This cholera toxin stock concentration is later diluted in 1:100, 2 ml cholera toxin (1 µM 
or 10
-6
 M mg/ml stock) in 200 ml of 100x RM+ to give a final concentration of 10 nM 
or 10
-8
 M or 1 µg/ml. 
 
Liothyronine 
Final media concentration = 20 pM or 2x10
-11
 M 
Thus in 200 ml of 100x RM+ = ~ 20 nM or 2x10
-9
 M 
Molecular weight = 651 
In order to prepare 200 ml of 100x RM+ = ~ 20 nM or 2x10
-9
 M, dissolve 6 mg in 200 
µl 1 N NaOH (for NaOH 1 N (Normality = 1 M), swirl and add 9.8 ml ddH2O (double 
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distilled water) = 0.92 mM or 9.2x10
-4
 M stock concentration (L1) and aliquot in 0.5 ml 
and store at -20
o
C. 
 
Then a dilution series is prepared as follows: 
 
L2 (1:26 dilution): Take 0.5 ml L1 and add 12.5 ml ddH2O (double distilled water) = 
35 µM or 3.5x10
-5
 M concentration (L2) and aliquot in 1 ml and store at -20
o
C. 
 
L3 (1:10 dilution): Take 1 ml L2 and add 9 ml ddH2O (double distilled water) = 3.5 
µM or 3.5x10
-6
 M concentration (L3) and aliquot in 1 ml and store at -20
o
C. 
 
Then take one of the 1 ml L3, 3.5 µM or 3.5x10
-6
 M concentration vials and aliquot it in 
100 µl/vial (L4) and store at -20
o
C. 
 
This L4 vial is later diluted in 1:2000, 100 µl liothyronine (3.5 µM or 3.5x10
-6
 M 
concentration) in 200 ml of 100x RM+ to give a final concentration of  2 nM or ~ 2x10
-9
 
M. 
 
Making up 200 ml 100x RM+ supplements 
 
Chemical Volume of stock in 200 
ml of 100x RM+ 
Final Concentration in 
200 ml 100x RM+ 
Hydrocortisone 2 ml 40 µg/ml 
Insulin 2 ml 500 µg/ml 
Epidermal Growth 
Factor 
2 ml 1 µg/ml 
Cholera Toxin 2 ml ~ 10
-8  
M (1 µg/ml) 
Transferrin 2 ml 500 µg/ml 
Liothyronine 100 µl 2 nM 
 
The indicated quantities of each stock chemicals described in the above table were 
added in a sterile measuring cylinder and were mixed with 100 ml of sterile ddH20 until 
they are completely dissolved, following the subsequent procedure: The first step was 
the re-suspension of insulin solution, which was performed as follows. The 2 ml of 
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insulin solution were pipetted along with 5 ml of ddH2O against a measuring cylinder 
very slowly. Then, 5 ml of ddH2O were used to wash the insulin vial in order to acquire 
any drops of insulin that may have been left in the vial. The same procedure was then 
followed for all other chemicals. Next, the cylinder was filled with ddH2O up to 100 ml. 
The 100 ml solution was then filter-sterilised through a 500 ml vaccum filter unit 
stericup with a pore size 0.22 µm filter (Fisher, Leicestershire, UK) into the sterile 500 
ml receiver (Fisher, Leicestershire, UK). Next, another 100 ml of DMEM/F12 were 
added to the cylinder and were also filtered as described above. The entire sterile 
filtered solution of 200 ml 100x RM+ was finally aliquoted in sterile bijoux tubes as 5 
ml/tube and was stored at -20
o
C.   
 
Each 5 ml aliquot of 100x RM+ was used for each 500 ml bottle of cell culture medium 
(1:100 dilution), giving the final media concentration for each supplement (1x RM+ 
supplements in 500 ml media). 
 
Doxycycline (Dox) 
Stock solution (1 mg/ml) (45 ml) 
Doxycycline (stored at 4
o
C in the dark) 45 mg 
dH2O sterile     45 ml 
 
Solution was filter-sterilised, aliquoted in 1 ml eppendorf tubes and stored at 4
o
C for 
short-term and at -20
o
C for long-term, wrapped in foil due to light sensitivity.  
 
Stock solution (10 µg/ml) (6 ml); (1:100 dilution of 1 mg/ml stock solution) 
Doxycycline (1 mg/ml)         60 µl 
dH2O sterile     6 ml (5940 µl) 
 
Solution was filter-sterilised, aliquoted in 1 ml eppendorf tubes and stored at 4
o
C for 
short-term and at -20
o
C for long-term, wrapped in foil due to light sensitivity.  
 
• For cell culture Dox (1 mg/ml) was diluted 1:100 in RM+ growth medium to achieve a 
final concentration of 10 µg/ml (100 µl Dox from 1 mg/ml stock solution in 10 ml RM+ 
growth medium). 
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• For cell culture Dox (10 µg/ml) was diluted 1:250 in RM+ growth medium to achieve a 
final concentration of 40 ng/ml (40 µl Dox from 10 µg/ml stock solution in 10 ml RM+ 
growth medium). 
 
Geneticin (G418)  
Stock solution (50 mg/ml) (2 ml) 
G418 (stored at 4
o
C)  100 mg 
PBS (1x) sterile  2 ml 
 
Solution was filter-sterilised, aliquoted in 1 ml eppendorf tubes and stored at -20
o
C.  
 
• For cell selection G418 was diluted 1:100 in RM+ growth medium to achieve a final 
concentration of 500 µg/ml (100 µl G418 from 50 mg/ml stock solution in 10 ml RM+ 
growth medium). 
 
• For cell maintenance G418 was diluted 1:200 in RM+ growth medium to achieve a final 
concentration of 250 µg/ml (50 µl G418 from 50 mg/ml stock solution in 10 ml RM+ 
growth medium). 
 
Hygromycin B (Hygro B) 
Stock solution (50 mg/ml) (20 ml) 
Already supplied as a solution from Clontech, Palo Alto, CA and stored at 4
o
C.  
 
• For cell selection Hygro B was diluted 1:500 in RM+ growth medium to achieve a final 
concentration of 100 µg/ml (20 µl Hygro B from 50 mg/ml stock solution in 10 ml RM+ 
growth medium). 
 
• For cell maintenance Hygro B was diluted 1:1000 in RM+ growth medium to achieve a 
final concentration of 50 µg/ml (10 µl G418 from 50 mg/ml stock solution in 10 ml 
RM+ growth medium). 
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Staining and Proliferation assays 
 
4% (v/v) Formaldehyde/Formalin (200 ml) 
         Final Concentration 
PBS 100x Tablets (Oxoid, Hampshire, UK)  2 tablets  1x  
37% (v/v) Formaldehyde/Formalin   21 ml   4% v/v 
dH2O       179 ml 
 
Stored at 4
o
C, wrapped in foil due to light sensitivity. 
 
 
MTT solution 
Stock solution (5 mg/ml) (10 ml) 
MTT   50 mg 
PBS (1x) sterile 10 ml 
 
Stored at 4
o
C, wrapped in foil due to light sensitivity. 
 
A final solution of MTT 500 µg/ml was prepared by diluting the working stock solution 
1:10 in growth medium (1 ml of stock solution (5 mg/ml) in 9 ml of growth medium) 
prior to adding to the target cells. 
 
 
Staining and Cell cycle analysis 
 
Hoechst-33342 
Stock solution (20 mg/ml) (2 ml) 
Hoechst-33342 100 mg 
dH2O sterile  2 ml 
 
Stored at 4
o
C, wrapped in foil due to light sensitivity. 
 
 
Working stock solution (10 mg/ml) (1 ml) 
Hoechst-33342 Stock solution (20 mg/ml) 500 µl 
dH2O sterile     500 µl 
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Stored at 4
o
C, wrapped in foil due to light sensitivity. 
 
To stain cells for flow cytometry analysis a final solution of Hoechst-33342 10 µg/ml 
was prepared by diluting the working stock solution 1:1000 in 1x sterile PBS (1 µl of 
working stock solution (10 mg/ml)  for each ml of 1x sterile PBS). 
 
70% Ethanol (200 ml) 
Ethanol (99.8% v/v)  60 ml 
dH2O    40 ml 
 
Kept at -20
o
C. 
 
 
NaCitrate (100 mM; 200 ml) 
            Final Concetration 
NaCitrate     25.8 g   100 mM 
 
Made up to 200 ml with dH2O (distilled water) and kept at RT. 
 
Propidium Iodide/RNaseA solution mix (1 ml) 
             Final Concentration 
Propidium Iodide (1 mg/ml)   50 µl   50 µg/ml 
RNase A (5 mg/ml)   25 µl   125 µg/ml 
NaCitrate (100 mM)   380 µl   38 mM 
PBS (1x) sterile   545 µl  
 
Kept on ice, wrapped in foil due to light sensitivity. 
 
 
RNase A solution (5 mg/ml; 2 ml) 
         Final Concentration 
RNase A (lyophilised powder) 10 mg   5 mg/ml 
dH2O     2 ml 
 
The RNAse A stock solution was aliquoted in 200 µl and was stored at -20
o
C. 
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DAPI solution  
Stock solution (20 mg/ml) (0.5 ml) 
DAPI     10 mg 
dH2O     0.5 ml 
 
Stored at -20
o
C, wrapped in foil due to light sensitivity. 
 
 
Working stock solution (20 µg/ml) (1 ml) 
DAPI Stock solution (20 mg/ml) 1 µl 
dH2O     999 µl 
 
Stored at -20
o
C, wrapped in foil due to light sensitivity. 
 
To stain cells a final solution of DAPI 200 ng/ml was prepared by diluting the working 
stock solution 1:100 in 1x Annexin V Binding Buffer or in 1x sterile PBS (1 µl of 
working stock solution (20 µg/ml) for each 100 µl of 1x Annexin V Binding Buffer or 
1x sterile PBS). 
 
      
Agarose gel electrophoresis 
DNA Loading Dye Buffer (2x; 10 ml) 
            Final Concentration 
Glycerol  7.5 ml     75%       v/v 
Bromophenol Blue 0.5 ml from 1.5% (w/v) stock  0.075%  v/v 
Xylene Cyanol 0.5 ml from 1.5% (w/v) stock  0.075%  v/v 
dH2O   1.5 ml   
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Whole, cytoplasmic and nuclear extraction buffers 
RIPA Buffer (1x; 250 ml) 
          Final Concentration 
Tris-base 1 M, pH 7.3   12.5 ml  50 mM 
NaCl     2.19 g   150 mM 
SDS 20% (w/v)   1.25 ml  0.1% v/v 
Nonidet P-40    2.5 ml   1% v/v 
Na3VO4 1 M      2.5 ml    10 mM 
(sodium orthovanadate) 
 
Made up to 250 ml with dH2O (distilled water) and kept on ice or stored at 4
o
C.  
 
SDS 20% (w/v) (100 ml) 
SDS  20 g    
 
Made up to 100 ml with dH2O (distilled water) and stored at room temperature (RT). 
 
Complete mini (CM) EDTA-free protease inhibitor cocktail tablets 
One tablet from 10x Complete mini EDTA-free protease inhibitor cocktail tablets is 
dissolved in 1 ml dH2O (10x stock of CM EDTA-free protease inhibitor cocktail) 
(vortex very well and wait 5-10 minutes until completely dissolved) and aliquoted in 
100 µl per eppendorf tube and stored at -20
o
C. 
 
To prepare either 1x RIPA Buffer containing 1x CM EDTA-free protease inhibitor 
cocktail, or 1x Reporter lysis buffer containing 1x CM EDTA-free protease inhibitor 
cocktail, the 10x stock of CM EDTA-free protease inhibitor cocktail was diluted 1:10 in 
1x RIPA or 1x Reporter lysis buffer,  vortexed very well and kept in ice. 
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1x PBS/PMSF (10 ml)  
10x PBS     1 ml    
(Imgenex, San Diego, CA) 
Deionized water     8.9 ml 
PMSF (100 mM)    100 µl 
(Imgenex, San Diego, CA) 
 
Kept on ice. 
 
1x Hypotonic Buffer (1 ml)  
10x Hypotonic buffer    100 µl    
(Imgenex, San Diego, CA) 
Deionized water     900 µl 
 
Kept on ice. 
 
 
Nuclear Lysis Buffer (100 µl) 
10 mM DTT     5 µl    
(Imgenex, San Diego, CA) 
Nuclear extraction buffer    94 µl 
(Imgenex, San Diego, CA) 
PIC (100x) (protease inhibitor cocktail) 1 µl 
(Imgenex, San Diego, CA) 
 
Kept on ice. 
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Western Blot Buffers 
10% (v/v) polyacrylamide gel (30 ml)  
30% (w/v) acrylamide    10 ml    
(Protogel, National Diagnostics, Atlanta,USA) 
1.5 M Tris-HCl, pH 8.8    7.5 ml 
10% (w/v) SDS     0.3 ml 
dH2O       11.88 ml 
TEMED (tetramethylethylenediamine)  20 µl 
10% (w/v) APS (ammonium persulfate)    300 µl 
 
8% (v/v) polyacrylamide gel (30 ml)  
30% (w/v) acrylamide    8 ml    
(Protogel, National Diagnostics, Atlanta,USA) 
1.5 M Tris-HCl, pH 8.8    7.5 ml 
10% (w/v) SDS     0.3 ml 
dH2O       11.88 ml 
TEMED (tetramethylethylenediamine)  20 µl 
10% (w/v) APS (ammonium persulfate)    300 µl 
 
5% (v/v) stacking gel (10 ml) 
30% (w/v) acrylamide    1.67 ml    
(Protogel, National Diagnostics, Atlanta,USA) 
1 M Tris-HCl, pH 6.8     1.25 ml 
10% (w/v) SDS     0.1 ml 
dH2O       6.87 ml 
TEMED (tetramethylethylenediamine)  10 µl 
10% (w/v) APS (ammonium persulfate)    100 µl 
 
SDS 10% (w/v) (100 ml) 
SDS  10 g    
 
Made up to 100 ml with dH2O (distilled water) and stored at room temperature (RT). 
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APS (ammonium persulfate) 10% (w/v) (3 ml) 
APS  0.3 g    
dH2O  2.7 ml 
 
Kept on ice and for longer-term storage at 4
o
C. 
 
Tris-HCl (pH 8.8; 1 L) 
    Final Concentration 
Tris-HCl 181.5 g  1.5 M 
dH2O  500 ml 
The pH of the solution was adjusted to 8.8 with 1 M HCl and 1 M NaOH and was 
finally brought to a final volume of 1 L with dH2O (distilled water) and stored at RT. 
 
Tris-HCl (pH 6.8; 1 L) 
    Final Concentration 
Tris-HCl 121 g   1 M 
 
The pH of the solution was adjusted to 6.8 with 1 M HCl and 1 M NaOH and was 
finally brought to a final volume of 1 L with dH2O (distilled water) and stored at RT. 
 
Running Buffer (10x; 1 L) 
      Final Concentration 
Tris-Base 30 g   0.25 M 
Glycine 144 g   192 mM 
SDS  10 g   10% w/v 
 
Made up to 1 L with dH2O (distilled water) and stored at room temperature (RT). 
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Transfer Buffer (10x; 1 L) 
       Final Concentration 
Tris-Base 60.4 g   0.5 M 
Glycine 288 g   384 mM 
 
Made up to 1 L with dH2O (distilled water) and stored at room temperature (RT). 
 
To make 1 L of 1x Protein transfer buffer, 100 ml of 10x Protein Transfer Buffer were 
mixed with 700 ml dH2O and 200 ml Methanol (20% (v/v) Methanol final 
concentration). 
 
Protein SDS Sample Buffer (5x; 10 ml) 
                      Final Concetration 
Tris-HCl  3.13 ml of 1 M Tris-HCl, pH 6.8           0.31 M 
Dithiothreitol (DTT) 1.25 ml of 2 M DTT                  0.25 M 
Bromophenol Blue 0.67 ml of 1.5% (w/v) stock     0.1% v/v 
Glycerol 5 ml     50% v/v 
SDS 1 g     10% w/v 
 
Aliquot 200 µl in eppendorf tubes and store at -20
o
C. 
 
Tris Buffered Saline (TBS) (pH 7.6) (10x; 1 L) 
       Final Concentration 
NaCl  86 g   150 mM 
Tris-Base 30 g   25 mM 
dH2O  500 ml 
The pH of the solution was adjusted to 7.6 with 1 M HCl and 1 M NaOH and was 
finally brought to a final volume of 1 L with dH2O (distilled water) and stored at RT. 
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Phosphate Buffered Saline (PBS) (pH 7.3 ± 0.2) (1x; 1 L) 
One tablet of 100x PBS (Oxoid, Hampshire, UK) is diluted in 100 ml dH2O (1x). To 
prepare 1 L of 1x PBS solution, 10 tablets of 100x PBS (Oxoid, Hampshire, UK) are 
diluted in 1 L dH2O (1x) which contains the following: 
          Final Concentration 
NaCl     8.0 g   137 mM 
KCl     0.2 g   2.7 mM 
Na2HPO4      1.15 g   10 mM 
(di-sodium hydrogen phosphate) 
KH2HPO4     0.2 g   1.76 mM 
(potassium di-hydrogen phosphate) 
 
Made up to 1 L with dH2O (distilled water) and stored at room temperature (RT). 
 
HCl (100 ml) 
       Final Concentration 
HCl (37%)  8.4 ml    1 M 
dH2O   91.6 ml 
 
 
NaOH (100 ml) 
        Final Concentration 
NaOH   4 g    1 M 
 
Made up to 100 ml with dH2O (distilled water) and stored at room temperature (RT). 
 
Tris-base (pH 7.3; 1 L) 
        Final Concentration 
Tris-base  121 g    1 M 
dH2O   500 ml 
The pH of the solution was adjusted to 7.3 with 1 M HCl and 1 M NaOH and was 
finally brought to a final volume of 1 L with dH2O (distilled water) and stored at RT. 
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5% (w/v) milk TBS/T or PBS/T (200 ml) 
Non-fat dry milk 10 g   
 
Made up to 200 ml with dH2O (distilled water) and kept at 4
o
C. 
 
3% (w/v) milk TBS/T or PBS/T (200 ml) 
Non-fat dry milk 6 g   
 
Made up to 200 ml with dH2O (distilled water) and kept at 4
o
C. 
 
 
M-FISH 
KCl (0.075 M; 200 ml) 
            Final Concetration 
KCl     1.1 g    0.075 M 
 
Made up to 200 ml with dH2O (distilled water) and kept at RT. 
 
Fix solution (100% methanol : 100% acetic acid = 3 : 1) (72ml) 
Methanol (99.9+%)  52 ml 
Acetic acid (99+%)  18 ml 
 
Kept at RT. 
 
20x Saline Sodium Citrate (SSC) (pH 7.0 - 7.5) (500 ml) 
20x SSC   132 g 
ddH2O    400 ml 
 
The pH of the solution was adjusted to 7.0 - 7.5 with 1 M HCl and 1 M NaOH and was 
finally brought to a final volume of 500 ml with ddH2O (double distilled water) and 
stored at RT. 
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2x Saline Sodium Citrate (SSC) (pH 7.0 - 7.4) (500 ml) 
20x SSC   50 ml 
ddH2O    400 ml 
 
The pH of the solution was adjusted to 7.0 - 7.4 with 1 M HCl and 1 M NaOH and was 
finally brought to a final volume of 500 ml with ddH2O (double distilled water) and 
stored at RT. 
 
0.4x Saline Sodium Citrate (SSC)/0.3% (v/v) NP-40 Wash solution (pH 7.0 - 7.5) 
(500 ml) 
20x SSC   10 ml 
ddH2O    470 ml 
NP-40    1.5 ml 
 
The pH of the solution was adjusted to 7.0 - 7.5 with 1 M HCl and 1 M NaOH and was 
finally brought to a final volume of 500 ml with ddH2O (double distilled water) and 
stored at RT. 
 
2x Saline Sodium Citrate (SSC)/0.1% (v/v) NP-40 Wash solution (pH 7.0 ± 0.2) 
(500 ml) 
20x SSC   50 ml 
ddH2O    420 ml 
NP-40    0.5 ml 
 
The pH of the solution was adjusted to 7.0 ± 0.2 with 1 M HCl and 1 M NaOH and was 
finally brought to a final volume of 500 ml with ddH2O (double distilled water) and 
stored at RT. 
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RNase A Stock (10 mg/ml; 1 ml) and Working (0.1 mg/ml; 1 ml) Solution 
Stock solution (10 mg/ml) (1 ml) 
RNase A (lyophilised powder) 10 mg    
2x Saline Sodium Citrate (SSC) 1 ml 
 
The RNAse A stock solution was aliquoted in 10 µl and was stored at -20
o
C. 
 
Working solution (0.1 mg/ml) (1 ml) 
RNase A stock solution (10 mg/ml) 10 µl    
2x Saline Sodium Citrate (SSC) 990 µl 
 
At time of use, the RNAse A stock solution (10 mg/ml; 10 µl) was defrosted and was 
diluted 1:100 in 2x SSC by adding 990 µl of 2x SSC in 10 µl RNAse A stock solution 
(vortexed to mix), giving a working solution with a concentration of 0.1 mg/ml (0.1 
mg/ml; 1 ml). 
 
Pepsin Stock (10% (w/v); 1 ml) and Working (0.005% (v/v); 70 ml) Solution 
Stock solution (10% (w/v)) (1 ml) 
Pepsin       0.1 g 
ddH2O (pre-warmed to 37
 o
C in a water bath) 1 ml 
 
The Pepsin stock solution was aliquoted in 40 µl and was stored at -20
o
C. 
 
Working solution (0.005% (v/v)) (70 ml) 
Pepsin stock solution (10% (w/v))   35 µl 
ddH2O (pre-warmed to 37
 o
C in a water bath) 69.3 ml 
1 M HCl (pre-warmed to 37
 o
C in a water bath) 0.7 ml 
 
At time of use, the Pepsin stock solution (10% (w/v); 40 µl) was defrosted and was 
diluted 1:2000, in pre-warmed 69.3 ml ddH2O and 0.7 ml 1 M HCl giving a 0.005% 
(v/v) working solution. A beaker containing 69.3 ml of ddH2O and 0.7 ml 1 M HCl, and 
a glass Coplin jar were all  pre-warmed to 37
 o
C using a water bath. Then 35 µl from the 
40 µl defrosted Pepsin stock solution (10% (w/v); 40 µl) were mixed into the solution of 
the beaker and then were all transferred to the pre-warmed glass Coplin jar. 
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Formaldehyde Fixation Solution (70 ml) 
            Final Concetration 
ddH2O    57.7 ml   
1 M MgCl2   3.5 ml    0.05 M 
10x PBS   7 ml    1x 
37% formaldehyde  1.89 ml   1% 
 
Prepared in a fume hood and kept at RT. 
 
Phosphate Buffered Saline (PBS) (10x; 100 ml) 
One tablet of 100x PBS (Oxoid, Hampshire, UK) is diluted in 10 ml dH2O (10x). To 
prepare 100 ml of 10x PBS solution, 10 tablets of 100x PBS (Oxoid, Hampshire, UK) 
are diluted in 100 ml dH2O (10x) and stored at room temperature (RT). 
 
 
MgCl2 (1 M) (50 ml)  
 Final Concetration 
MgCl2 · 6 H2O   10.16 g   1 M 
 
Made up to 50 ml with dH2O (distilled water) and kept at RT. 
 
 
Denaturation Solution (70% Formamide/2x SSC) (pH 7.0 - 8.0) (60 ml) 
            Final Concetration 
Formamide (100%)   42 ml   70% 
20x Saline Sodium Citrate (SSC) 6 ml   2x 
ddH2O     10 ml 
The pH of the solution was measured using pH indicator strips to verify pH is 7.0 - 8.0. 
and was finally brought to a final volume of 60 ml with ddH2O (double distilled water). 
The solution was prepared in a fume hood and kept at 4
o
C. 
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Appendix  II. Involucrin 
RNA was harvested from N/TERT, SINCE, and SINEG2 cells to examine the levels of 
involucrin mRNA expression using specific primers. Quantitative RT-PCR analysis of 
involucrin showed a decrease in SINEG2 cells compared to N/TERT and SINCE 
control cells. Each bar represents mean fold suppression relative to N/TERT (arbitary 
value of 1) ± s.e.m of triplicate samples. *** P≤0.001.  
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Appendix  III. 10K SNP Microarray Mapping Assay of human N/TERT 
keratinocytes 
The ploidy status of N/TERT keratinocytes was examined by means of 10K SNP 
Microarray Mapping Assay. Genomic DNA from N/TERT (top panel) and SINCE 
(bottom panel) keratinocytes was analysed against reference genomic DNA of primary 
keratinocytes derived form three separate healthy donors. The average ploidy status of 
all the SNPs located on each chromosome after Affymetrix GTYPE analysis was 
plotted. Both N/TERT and SINCE keratinocytes show a normal genotype apart from the 
fact that chromosome 20 (trisomy) was consistently gained in all samples tested. Note 
that that the large error bar for chromosome X is due to the sexual variability of primary 
keratinocyte reference samples. Bars represent the average ploidy status of all SNPs per 
chromosome ± s.e.m of three individual reference primary keratinocyte samples. 
Experiment and analysis was performed by Dr Muy-Teck Teh, Clinical and Diagnostic 
Oral Sciences, Institute of Dentistry, Barts and the London School of Medicine and 
Dentistry, London, UK. 
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